archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO BLEB ASSEMBLY,3.9926e-07,1.6202,1.3957,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,8.1192e-05,1.5121,1.2888,1,1
1,GO MEMBRANE RAFT ASSEMBLY,7.0571e-06,1.4257,1.5231,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,2.5122e-07,1.3066,1.1603,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,2.8891e-07,1.2317,1.0926,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00014418,1.1881,0.98381,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.9904e-06,1.1139,0.97689,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,1.2366e-07,1.1054,0.98596,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,3.3202e-07,1.0843,1.0301,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.0006154,1.0756,0.94856,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,1.6452e-07,1.0692,1.0508,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.5816e-05,1.0649,0.96077,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.2985e-07,1.054,0.91261,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,1.4963e-07,1.0301,0.86747,1,1
1,GO NEUTROPHIL HOMEOSTASIS,1.104e-05,1.0288,0.9251,1,1
1,GO HYALURONAN CATABOLIC PROCESS,1.4674e-06,1.0272,0.98847,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,9.389e-05,1.0145,0.87651,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,8.628e-07,1.0115,0.97766,1,1
1,GO RESPONSE TO INTERFERON ALPHA,2.8077e-06,1.0105,1.0672,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,8.3127e-06,0.98795,0.79839,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,7.889e-07,0.9695,0.92395,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00032948,0.96203,0.73375,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.0689e-05,0.9304,0.86227,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.6452e-07,0.92007,0.89428,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00024286,0.90973,0.72951,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,6.2367e-06,0.90936,0.86293,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.0779e-06,0.892,0.7645,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.2454e-05,0.89181,0.75609,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,0.0001547,0.8802,0.69752,1,1
1,GO MEMBRANE RAFT ORGANIZATION,9.7801e-06,0.87229,0.93217,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,2.6902e-06,0.86993,0.78746,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,2.9301e-06,0.86597,0.86339,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,4.5813e-07,0.86061,0.75652,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,3.0264e-07,0.85499,0.84946,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,3.1904e-06,0.8452,0.71879,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.2862e-06,0.83091,0.78294,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,1.5331e-06,0.82817,0.92754,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.4268e-07,0.82762,0.79249,1,1
1,GO CD40 SIGNALING PATHWAY,1.2971e-07,0.82693,0.77599,1,1
1,GO RESPONSE TO INTERFERON BETA,4.8612e-06,0.81918,0.92985,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,2.9301e-06,0.81777,0.75362,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,2.6307e-05,0.81615,0.76824,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.5201e-05,0.81582,0.93524,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.2962e-05,0.80747,0.81432,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,5.0194e-07,0.80446,0.67474,1,1
1,GO HEMIDESMOSOME ASSEMBLY,1.8521e-05,0.80373,0.91387,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,8.628e-07,0.80137,0.69417,1,1
1,GO ZYMOGEN INHIBITION,1.1237e-07,0.79652,0.84926,1,1
1,GO BONE TRABECULA FORMATION,0.0019282,0.78694,0.66313,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00057693,0.78408,0.67395,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,7.5427e-07,0.78406,0.6651,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,9.8628e-07,0.78229,0.68947,1,1
1,GO PLASMINOGEN ACTIVATION,0.00019753,0.77909,0.59725,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.1663e-05,0.77097,0.63158,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.3441e-06,0.77051,0.67479,1,1
1,GO DNA DEAMINATION,8.3127e-06,0.7672,0.6408,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,4.1617e-05,0.76685,0.62662,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,3.7145e-05,0.76678,0.68003,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00013433,0.76551,0.6038,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,2.6902e-06,0.76101,0.71497,1,1
1,GO ENDODERM FORMATION,7.6603e-06,0.76072,0.73679,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,1.0184e-05,0.75393,0.60341,1,1
1,GO HIPPO SIGNALING,5.0683e-06,0.75227,0.62253,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.9904e-06,0.75166,0.72184,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,1.1776e-06,0.74902,0.82201,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,5.753e-07,0.74649,0.72725,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,2.6307e-05,0.74383,0.65473,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,3.3287e-06,0.73881,0.64306,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,4.6623e-06,0.73765,0.78822,1,1
1,GO LATERAL MESODERM DEVELOPMENT,1.4044e-06,0.73685,0.64083,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.4039e-05,0.7297,0.64031,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.0829e-07,0.72952,0.64771,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,3.5759e-05,0.72759,0.6672,1,1
1,GO CELLULAR RESPONSE TO X RAY,0.00018427,0.72155,0.5304,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,4.3763e-07,0.72044,0.71725,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,1.7118e-05,0.71488,0.59951,1,1
1,GO EPIBOLY,4.6623e-06,0.71392,0.71857,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.7578e-07,0.71003,0.6839,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,3.6228e-06,0.7086,0.59955,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00072223,0.70781,0.53161,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.0604e-05,0.70407,0.77364,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,2.3654e-06,0.70342,0.66809,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,4.1802e-07,0.69716,0.66467,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.6902e-06,0.69595,0.67264,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,9.7801e-06,0.6933,0.62966,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,7.5427e-07,0.69195,0.64889,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,2.0829e-07,0.69042,0.61433,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.00013917,0.67972,0.67995,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,7.0571e-06,0.67857,0.80367,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,3.0576e-06,0.67808,0.59429,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00074557,0.67234,0.57467,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00016595,0.67201,0.6678,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,9.7346e-05,0.66933,0.62464,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,9.4334e-07,0.66879,0.67233,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,9.3916e-06,0.66835,0.61904,1,1
1,GO MUCUS SECRETION,0.00084609,0.66378,0.57868,1,1
1,GO RESPONSE TO INTERLEUKIN 18,0.0037331,0.66078,0.57346,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,4.6623e-06,0.66014,0.50538,1,1
1,GO T CELL EXTRAVASATION,0.00036427,0.65824,0.56867,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.389e-05,0.65756,0.56895,1,1
1,GO REGULATION OF PINOCYTOSIS,5.2837e-06,0.65699,0.6613,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,7.0571e-06,0.65376,0.62603,1,1
1,GO FIBRINOLYSIS,5.8301e-05,0.65363,0.73087,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,5.9841e-06,0.65247,0.67222,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,1.5201e-05,0.64834,0.68777,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,2.5122e-07,0.6482,0.73208,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,5.4121e-05,0.6478,0.55941,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00010092,0.64701,0.51738,1,1
1,GO GAP JUNCTION ASSEMBLY,1.7118e-05,0.64462,0.58393,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00013917,0.6445,0.51222,1,1
1,GO PIGMENT GRANULE MATURATION,6.2367e-06,0.64112,0.52246,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,3.3132e-05,0.63898,0.53633,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,1.8084e-07,0.62907,0.60635,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,2.4692e-06,0.62853,0.60796,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,9.7801e-06,0.62743,0.50568,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.8521e-05,0.62346,0.52649,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.1702e-06,0.62295,0.58252,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.725e-07,0.62179,0.65187,1,1
1,GO ENDODERM DEVELOPMENT,6.2367e-06,0.61775,0.59546,1,1
1,GO ZYMOGEN ACTIVATION,6.7596e-05,0.6166,0.51418,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0045306,0.61651,0.66628,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0001165,0.61622,0.5013,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,4.2876e-06,0.61406,0.59821,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,4.6623e-06,0.61323,0.51995,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.010245,0.61236,0.39839,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.7578e-07,0.61085,0.57039,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,2.6307e-05,0.60928,0.56943,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.0026572,0.60891,0.63123,1,1
1,GO LEUKOCYTE AGGREGATION,0.00081984,0.6074,0.5151,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,5.2139e-05,0.60729,0.43299,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,1.7806e-05,0.60628,0.65626,1,1
1,GO BIOLOGICAL PHASE,0.00028792,0.60413,0.59094,1,1
1,GO VASCULOGENESIS,3.4772e-07,0.60346,0.59267,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,2.5774e-06,0.60224,0.64401,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,3.9418e-06,0.60153,0.55727,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,8.6584e-06,0.59994,0.66284,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,3.3132e-05,0.59955,0.60472,1,1
1,GO APOPTOTIC CELL CLEARANCE,3.9418e-06,0.59943,0.64989,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,4.3218e-05,0.59921,0.49325,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,1.1776e-06,0.59784,0.73496,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0030654,0.59725,0.39995,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,4.8612e-06,0.59637,0.59926,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,8.7323e-05,0.59606,0.44058,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,6.2367e-06,0.5958,0.4279,1,1
1,GO CYTOLYSIS,1.8521e-05,0.59555,0.47077,1,1
1,GO LIVER REGENERATION,3.0576e-06,0.59534,0.5415,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,1.2454e-05,0.59458,0.5184,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.5201e-05,0.58733,0.54034,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,0.00024286,0.58625,0.48282,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,4.1112e-06,0.58625,0.51379,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00063551,0.58608,0.45339,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,5.2837e-06,0.58529,0.6175,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00044439,0.58453,0.52447,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,2.0784e-06,0.58278,0.55753,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,6.0198e-07,0.58243,0.56266,1,1
1,GO INTERLEUKIN 1 PRODUCTION,3.0689e-05,0.58224,0.46676,1,1
1,GO NOTOCHORD DEVELOPMENT,5.2837e-06,0.58159,0.63858,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,2.6902e-06,0.5807,0.51067,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,5.8301e-05,0.57926,0.56169,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,6.8936e-07,0.57919,0.5867,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,5.9841e-06,0.57865,0.60491,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,9.7346e-05,0.57818,0.64059,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,6.7596e-05,0.57809,0.55326,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,6.0504e-05,0.57539,0.61964,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.4044e-06,0.57534,0.47189,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,0.00016023,0.57413,0.54662,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,1.104e-05,0.57348,0.62689,1,1
1,GO ENTRY INTO HOST,1.0311e-06,0.57198,0.56994,1,1
1,GO HEME METABOLIC PROCESS,1.4044e-06,0.57183,0.52812,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.4346e-05,0.57123,0.58818,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00023468,0.57033,0.49294,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00081984,0.56741,0.58885,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,8.4205e-05,0.56622,0.51697,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,3.4421e-05,0.56455,0.57084,1,1
1,GO AMYLOID BETA CLEARANCE,3.1888e-05,0.56355,0.44185,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.0184e-05,0.5619,0.6594,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,5.2837e-06,0.5601,0.54034,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,3.9418e-06,0.55959,0.50427,1,1
1,GO TOLERANCE INDUCTION,0.00049035,0.55878,0.45802,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00026903,0.55702,0.48826,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,1.104e-05,0.55695,0.52321,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,0.00018427,0.55531,0.43429,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,2.6307e-05,0.55454,0.49991,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.5201e-05,0.55442,0.52659,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00022676,0.55338,0.52242,1,1
1,GO CELLULAR RESPONSE TO DSRNA,5.9841e-06,0.55324,0.53323,1,1
1,GO TYPE 2 IMMUNE RESPONSE,7.0571e-06,0.5506,0.556,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.547e-05,0.55056,0.42506,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,6.2786e-05,0.55054,0.45064,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00072223,0.55036,0.50734,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,7.6603e-06,0.54924,0.50633,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,9.4334e-07,0.54697,0.49811,1,1
1,GO RESPONSE TO X RAY,1.725e-07,0.54625,0.58124,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,2.2658e-06,0.54577,0.46327,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.1888e-05,0.54548,0.40941,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.547e-05,0.54509,0.52131,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,2.1831e-07,0.54479,0.63326,1,1
1,GO SALIVARY GLAND DEVELOPMENT,0.00023468,0.54391,0.50192,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00018427,0.54357,0.55042,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.9841e-06,0.54087,0.50546,1,1
1,GO INTERLEUKIN 13 PRODUCTION,0.00065623,0.54042,0.47741,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,2.6902e-06,0.5403,0.48195,1,1
1,GO VIRAL GENOME REPLICATION,3.9418e-06,0.53958,0.45233,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.0184e-05,0.53905,0.42778,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00014418,0.53707,0.45003,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,6.5149e-05,0.53538,0.49976,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,7.2111e-07,0.53503,0.58393,1,1
1,GO CELLULAR RESPONSE TO IRON ION,0.00012074,0.53361,0.49443,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.5813e-07,0.53268,0.52649,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.7145e-05,0.53245,0.3957,1,1
1,GO COLLAGEN CATABOLIC PROCESS,2.3418e-05,0.53243,0.5421,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,7.8282e-05,0.5317,0.41552,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00041602,0.53142,0.50595,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,3.4421e-05,0.53071,0.5597,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,7.9801e-06,0.52978,0.42911,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,1.9904e-06,0.52924,0.48881,1,1
1,GO RESPONSE TO TYPE I INTERFERON,9.7346e-05,0.52911,0.6007,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,5.4121e-05,0.5289,0.59621,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,2.0829e-07,0.52793,0.52745,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.0184e-05,0.52768,0.52038,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00034072,0.52752,0.40181,1,1
1,GO VAGINA DEVELOPMENT,2.7343e-05,0.5274,0.56462,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00063551,0.52599,0.35635,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.3287e-06,0.5233,0.5873,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,2.0829e-07,0.52267,0.49372,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.9301e-06,0.52137,0.47675,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0049174,0.52061,0.36033,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.3287e-06,0.51992,0.44348,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,3.4421e-05,0.51977,0.44153,1,1
1,GO STORE OPERATED CALCIUM ENTRY,6.7596e-05,0.51969,0.38597,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,2.7343e-05,0.51904,0.51738,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00027832,0.51714,0.40966,1,1
1,GO RESPONSE TO ANGIOTENSIN,3.17e-07,0.51612,0.49888,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00017186,0.51528,0.4657,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00010845,0.51455,0.4619,1,1
1,GO RECEPTOR CATABOLIC PROCESS,7.2111e-07,0.51135,0.46481,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,1.4674e-06,0.50967,0.42182,1,1
1,GO RESPONSE TO INTERFERON GAMMA,2.5308e-05,0.50958,0.48502,1,1
1,GO RESPONSE TO SALT STRESS,1.0184e-05,0.50893,0.38828,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.6729e-06,0.50763,0.468,1,1
1,GO T CELL MEDIATED IMMUNITY,8.6584e-06,0.50749,0.46159,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00074557,0.50574,0.45416,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00023468,0.50552,0.48921,1,1
1,GO ELASTIC FIBER ASSEMBLY,0.0073363,0.50279,0.59679,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,7.547e-05,0.50077,0.49398,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010092,0.50071,0.43046,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,9.0221e-07,0.5007,0.62714,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0021689,0.4997,0.38822,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,8.7323e-05,0.4983,0.45527,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,2.4692e-06,0.49818,0.42629,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.0779e-06,0.49805,0.45909,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.3418e-05,0.49586,0.40976,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.031748,0.49399,0.30596,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.013e-05,0.49354,0.36526,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,4.4878e-05,0.49344,0.42107,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00079435,0.49327,0.42378,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,4.3218e-05,0.49314,0.39942,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,7.0571e-06,0.49289,0.38754,1,1
1,GO MATURATION OF SSU RRNA,7.013e-05,0.4915,0.37101,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,2.1663e-05,0.48967,0.42667,1,1
1,GO RETINAL METABOLIC PROCESS,0.0053338,0.48923,0.35336,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.00014935,0.4887,0.42715,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,6.2985e-07,0.48604,0.54801,1,1
1,GO AORTIC VALVE DEVELOPMENT,0.00026003,0.48593,0.41418,1,1
1,GO PINOCYTOSIS,3.9926e-07,0.48579,0.61613,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00047456,0.48419,0.45417,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,1.0184e-05,0.48416,0.48318,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,5.0226e-05,0.48377,0.38988,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,9.389e-05,0.48321,0.66885,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.6597e-05,0.48284,0.35173,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00059588,0.48233,0.34521,1,1
1,GO REGULATION OF MYOBLAST FUSION,1.7118e-05,0.48168,0.55024,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,3.3132e-05,0.48084,0.42081,1,1
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.018836,0.48066,0.35725,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,1.8521e-05,0.48051,0.43902,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.007729,0.48008,0.2296,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,4.1802e-07,0.47881,0.41591,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0036303,0.47825,0.30549,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00081984,0.47813,0.4044,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0018173,0.47791,0.42846,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.00027832,0.47718,0.41691,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00014935,0.47666,0.37023,1,1
1,GO NIK NF KAPPAB SIGNALING,1.6452e-07,0.47654,0.43898,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0016129,0.47626,0.3752,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,5.508e-06,0.47622,0.4329,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,4.4712e-06,0.47553,0.41563,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,8.7323e-05,0.47511,0.43263,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,2.1663e-05,0.47505,0.37104,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,4.4712e-06,0.47487,0.47393,1,1
1,GO HAIR FOLLICLE MATURATION,0.0010206,0.4746,0.3475,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00047456,0.47433,0.39605,1,1
1,GO CYTOKINE METABOLIC PROCESS,4.1112e-06,0.47403,0.40011,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.5201e-05,0.47395,0.35869,1,1
1,GO VIRAL RNA GENOME REPLICATION,7.5427e-07,0.47388,0.44772,1,1
1,GO REGULATION OF TRANSPOSITION,0.0001165,0.47325,0.47218,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.8077e-06,0.47275,0.49483,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00098941,0.4724,0.34228,1,1
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.00047456,0.4719,0.60275,1,1
1,GO BLOOD VESSEL REMODELING,0.00024286,0.47136,0.39561,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0011199,0.4707,0.44371,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.0221e-07,0.46997,0.43709,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.00032948,0.46959,0.53804,1,1
1,GO RESPONSE TO INTERLEUKIN 12,5.4977e-07,0.46955,0.43261,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00090094,0.46929,0.38858,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00030804,0.46889,0.34737,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,2.6307e-05,0.46886,0.42364,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00047456,0.46849,0.37585,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,3.4772e-07,0.46825,0.44514,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,7.889e-07,0.46814,0.49432,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,2.4692e-06,0.46744,0.48672,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,7.8282e-05,0.46682,0.40917,1,1
1,GO DEFENSE RESPONSE TO VIRUS,1.2962e-05,0.46678,0.42182,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,4.6597e-05,0.46674,0.42398,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.0779e-06,0.46666,0.49681,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.00035231,0.46661,0.37846,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,3.0689e-05,0.46654,0.40542,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.104e-05,0.4665,0.39772,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0030654,0.46592,0.36541,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,5.7413e-06,0.46552,0.49463,1,1
1,GO HYALURONAN METABOLIC PROCESS,0.00019079,0.4653,0.43524,1,1
1,GO MATURATION OF LSU RRNA,3.1888e-05,0.46526,0.44119,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.0026572,0.46469,0.41319,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,3.8583e-05,0.46466,0.45707,1,1
1,GO RESPONSE TO HYPEROXIA,0.00044439,0.4646,0.42674,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,6.0504e-05,0.46419,0.41183,1,1
1,GO INTERLEUKIN 8 PRODUCTION,6.7728e-06,0.46405,0.40663,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0099891,0.46395,0.31686,1,1
1,GO RIG I SIGNALING PATHWAY,1.0779e-06,0.46367,0.43536,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0010528,0.46351,0.40739,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,5.0226e-05,0.46346,0.48464,1,1
1,GO MUSCLE CELL FATE COMMITMENT,0.0001547,0.46339,0.47152,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0018173,0.46336,0.38553,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,4.1112e-06,0.46315,0.3958,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,7.9801e-06,0.46301,0.65574,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,5.2837e-06,0.46233,0.39844,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,0.0001165,0.46159,0.64582,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,7.6603e-06,0.46056,0.42266,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00026003,0.46034,0.45689,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,7.6379e-08,0.45798,0.57132,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,8.6584e-06,0.45741,0.43501,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.0017641,0.45708,0.36804,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,5.0194e-07,0.45701,0.43243,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,5.6174e-05,0.45558,0.4119,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.00084609,0.4554,0.33115,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,2.9301e-06,0.45535,0.38867,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.00037661,0.45525,0.36044,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,4.1617e-05,0.45501,0.41578,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.1788e-07,0.45439,0.40471,1,1
1,GO PROTEASOME ASSEMBLY,6.7728e-06,0.45437,0.37866,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,2.0784e-06,0.45382,0.43796,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00012074,0.45343,0.34423,1,1
1,GO LYMPHANGIOGENESIS,2.3418e-05,0.45312,0.43636,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,4.8379e-05,0.4525,0.38028,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.02268,0.45146,0.26751,1,1
1,GO INTERLEUKIN 2 PRODUCTION,4.1802e-07,0.45124,0.46555,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00014935,0.45117,0.42249,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,0.00041602,0.45081,0.40696,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.9418e-06,0.45052,0.38864,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.017137,0.45033,0.37198,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,4.2876e-06,0.45007,0.38054,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00025131,0.44966,0.35601,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.4346e-05,0.44959,0.42544,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,5.508e-06,0.44945,0.41512,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00010845,0.44888,0.58664,1,1
1,GO PRIMARY MIRNA PROCESSING,2.9532e-05,0.44766,0.41171,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.6455e-05,0.44759,0.41263,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,1.3441e-06,0.44643,0.44348,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00021167,0.44599,0.38546,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,5.0683e-06,0.44554,0.47882,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.8521e-05,0.44479,0.57695,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.0011549,0.44472,0.43802,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,2.3654e-06,0.44463,0.498,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,2.8077e-06,0.44452,0.38166,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.2308e-06,0.44449,0.40553,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00038934,0.44432,0.54916,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0012662,0.44414,0.34153,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,6.5149e-05,0.44268,0.40266,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,2.8418e-05,0.44164,0.42649,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,7.0571e-06,0.44108,0.5269,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.5201e-05,0.43934,0.40627,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.1237e-07,0.43909,0.41866,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00042998,0.43773,0.4073,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,5.2139e-05,0.43747,0.45107,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0022992,0.4374,0.57632,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00032948,0.4373,0.60872,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,5.8301e-05,0.43489,0.37605,1,1
1,GO TYPE I INTERFERON PRODUCTION,1.0604e-05,0.43431,0.34281,1,1
1,GO PROTEIN ACTIVATION CASCADE,7.013e-05,0.43358,0.33543,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.012508,0.43292,0.34523,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.7118e-05,0.43292,0.47604,1,1
1,GO MACROPHAGE PROLIFERATION,0.0057817,0.43278,0.36432,1,1
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.0057817,0.43269,0.46344,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,5.6174e-05,0.43259,0.41551,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,5.2837e-06,0.43174,0.44988,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,6.7596e-05,0.43172,0.40725,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,2.0784e-06,0.43063,0.41302,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.5308e-05,0.43051,0.47144,1,1
1,GO PLATELET AGGREGATION,1.4674e-06,0.42999,0.38679,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.030383,0.42824,0.33538,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,9.8628e-07,0.42778,0.49838,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.5816e-05,0.42744,0.35387,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00067758,0.42727,0.58237,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,3.6228e-06,0.42704,0.51238,1,1
1,GO RIBOSOME ASSEMBLY,0.00028792,0.42689,0.34493,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,0.00072223,0.42641,0.38834,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0057817,0.42612,0.34386,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00014418,0.42516,0.40423,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,0.00018427,0.42445,0.37107,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00023468,0.42438,0.42738,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00069957,0.4241,0.343,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00047456,0.42338,0.38276,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,7.9801e-06,0.42291,0.39698,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,3.8583e-05,0.42226,0.31022,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0053338,0.42218,0.30648,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,3.4421e-05,0.42213,0.36917,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,5.9841e-06,0.42121,0.43398,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00040247,0.42118,0.48371,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.001228,0.42085,0.33334,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0024367,0.42075,0.34423,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,1.0604e-05,0.42048,0.40325,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.3441e-06,0.41965,0.37182,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,2.0033e-05,0.41936,0.33316,1,1
1,GO VIRAL LIFE CYCLE,4.3763e-07,0.41928,0.42213,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,1.104e-05,0.41924,0.42554,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,1.906e-06,0.41872,0.40747,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,7.013e-05,0.41838,0.43811,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,1.1493e-05,0.41807,0.47632,1,1
1,GO ENAMEL MINERALIZATION,0.0022992,0.4175,0.39985,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,5.0683e-06,0.41743,0.36083,1,1
1,GO MULTI ORGANISM LOCALIZATION,5.986e-08,0.41721,0.42011,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00017186,0.41699,0.33483,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,6.0504e-05,0.41699,0.35872,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,0.00016595,0.41664,0.55918,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,5.7413e-06,0.4163,0.5081,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.3916e-06,0.41589,0.3775,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0020453,0.41571,0.40457,1,1
1,GO ANIMAL ORGAN REGENERATION,1.7118e-05,0.41553,0.44192,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.00069957,0.41551,0.3804,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.8418e-05,0.41549,0.35012,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,0.0014299,0.41536,0.36168,1,1
1,GO DETECTION OF BIOTIC STIMULUS,7.013e-05,0.41491,0.419,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,2.2524e-05,0.41479,0.39294,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,3.1888e-05,0.41397,0.44134,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,2.3654e-06,0.41376,0.36529,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,4.4878e-05,0.41374,0.34508,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0010859,0.41356,0.41647,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,4.1802e-07,0.4132,0.40584,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,1.1788e-07,0.41314,0.40165,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,3.4421e-05,0.41302,0.39102,1,1
1,GO IMMATURE T CELL PROLIFERATION,5.4121e-05,0.41288,0.4502,1,1
1,GO VIRAL TRANSLATION,5.0683e-06,0.41209,0.41362,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,2.7343e-05,0.41157,0.32367,1,1
1,GO INTERFERON BETA PRODUCTION,0.00012074,0.41142,0.31503,1,1
1,GO VASCULAR TRANSPORT,0.029068,0.41092,0.44521,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00017796,0.41075,0.33976,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0028141,0.41022,0.30102,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,2.8418e-05,0.41019,0.36723,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.4039e-05,0.40945,0.43896,1,1
1,GO PEPTIDE CROSS LINKING,0.00010462,0.40915,0.46253,1,1
1,GO REGULATION OF MRNA BINDING,1.5201e-05,0.40814,0.36707,1,1
1,GO ERBB2 SIGNALING PATHWAY,1.349e-05,0.40799,0.35051,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00025131,0.40715,0.41089,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00023468,0.40708,0.41105,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,5.2139e-05,0.40611,0.37476,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,3.4728e-06,0.4053,0.49367,1,1
1,GO CYCLOOXYGENASE PATHWAY,0.02068,0.40521,0.34214,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.00017796,0.40504,0.54318,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,3.0576e-06,0.40446,0.39067,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,5.508e-06,0.4044,0.48429,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,9.7346e-05,0.40435,0.3833,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0001547,0.40416,0.37624,1,1
1,GO I KAPPAB PHOSPHORYLATION,8.4205e-05,0.40407,0.29778,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,2.9532e-05,0.40402,0.44761,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,1.6729e-06,0.40384,0.34478,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,2.0784e-06,0.40325,0.50713,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00016595,0.40267,0.42018,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,5.2837e-06,0.40259,0.36521,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00010092,0.4013,0.3297,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0051916,0.40126,0.37925,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,1.9904e-06,0.40039,0.39782,1,1
1,GO FIBROBLAST MIGRATION,0.00063551,0.40016,0.3504,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,6.2985e-07,0.40003,0.35742,1,1
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.012508,0.39904,0.30553,1,1
1,GO REGULATION OF STEROL TRANSPORT,3.0689e-05,0.39811,0.3285,1,1
1,GO BONE GROWTH,0.00037661,0.39804,0.38928,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,8.4205e-05,0.39785,0.36744,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00028792,0.39779,0.47398,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00020448,0.39778,0.38012,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0021062,0.39708,0.38766,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00012074,0.39707,0.45262,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.00036427,0.397,0.41675,1,1
1,GO EMBRYO IMPLANTATION,7.3528e-06,0.3963,0.47112,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,5.6174e-05,0.39564,0.30342,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,1.6729e-06,0.39555,0.42084,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.2971e-07,0.39552,0.41704,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0017641,0.39525,0.37051,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.6584e-06,0.39421,0.39242,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0099891,0.39287,0.28247,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.00016023,0.39208,0.28524,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,8.7323e-05,0.39174,0.39591,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.00067758,0.3914,0.32066,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00055855,0.39137,0.32459,1,1
1,GO T CELL APOPTOTIC PROCESS,2.1702e-06,0.39048,0.3671,1,1
1,GO CERAMIDE CATABOLIC PROCESS,0.00052342,0.38996,0.34096,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.1663e-05,0.38994,0.36368,1,1
1,GO INTERACTION WITH HOST,7.5427e-07,0.38851,0.43045,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.3654e-06,0.38821,0.39068,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00084609,0.38813,0.31587,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.4039e-05,0.38812,0.37197,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.00018427,0.38781,0.54037,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,1.7474e-06,0.38731,0.38453,1,1
1,GO RESPONSE TO ESTROGEN,8.628e-07,0.38605,0.38594,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.00029782,0.38585,0.3385,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,1.7474e-06,0.38534,0.3687,1,1
1,GO MATURATION OF 5 8S RRNA,9.7346e-05,0.38425,0.33464,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00023468,0.38396,0.31966,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.2308e-06,0.38382,0.38493,1,1
1,GO REGULATION OF GASTRULATION,5.9841e-06,0.38339,0.37265,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0031536,0.38332,0.32484,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.4039e-05,0.38263,0.34371,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.0311e-06,0.38246,0.36179,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00072223,0.38224,0.34491,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0013872,0.38206,0.35524,1,1
1,GO SPROUTING ANGIOGENESIS,1.7806e-05,0.38202,0.34709,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00055855,0.38197,0.30132,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,5.508e-06,0.38187,0.3241,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.1493e-05,0.38186,0.35393,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0011199,0.3818,0.34614,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.00011241,0.38,0.47016,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00023468,0.37959,0.31316,1,1
1,GO BEHAVIORAL RESPONSE TO PAIN,0.001191,0.37959,0.31552,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,6.0504e-05,0.3792,0.39861,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,1.8958e-07,0.3785,0.50019,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,1.6455e-05,0.37758,0.42092,1,1
1,GO MEMBRANE INVAGINATION,1.7118e-05,0.3772,0.33591,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0001547,0.37719,0.33031,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,9.7346e-05,0.37681,0.38165,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.0014299,0.37643,0.2966,1,1
1,GO MUSCLE FILAMENT SLIDING,4.8379e-05,0.37605,0.33182,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0026572,0.37515,0.39304,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,1.1964e-05,0.37484,0.31804,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,2.8891e-07,0.37476,0.3705,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,2.3418e-05,0.37454,0.30615,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,2.2524e-05,0.37434,0.29584,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,2.8418e-05,0.37424,0.32633,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,8.7323e-05,0.37407,0.37158,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,6.0504e-05,0.37282,0.36811,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.0054795,0.37219,0.23161,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,1.104e-05,0.37168,0.33127,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0021062,0.3716,0.31152,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,6.4994e-06,0.3715,0.32597,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00041602,0.37108,0.31465,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0027346,0.37075,0.30499,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00016023,0.37024,0.32614,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.4039e-05,0.36936,0.32904,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00074557,0.3692,0.31994,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,8.7323e-05,0.36906,0.35067,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,2.2658e-06,0.369,0.31609,1,1
1,GO MRNA TRANSCRIPTION,1.4039e-05,0.36896,0.36621,1,1
1,GO SNRNA PROCESSING,0.00084609,0.36826,0.5597,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,3.3287e-06,0.3678,0.34092,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00019079,0.36758,0.29975,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0001165,0.36751,0.30796,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,4.1112e-06,0.36739,0.29188,1,1
1,GO INTERACTION WITH SYMBIONT,1.7806e-05,0.36728,0.31965,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.0050528,0.367,0.39712,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00067758,0.36672,0.35964,1,1
1,GO INTERLEUKIN 17 PRODUCTION,9.7801e-06,0.36648,0.45344,1,1
1,GO GLIAL CELL ACTIVATION,0.001228,0.36566,0.31018,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,5.7413e-06,0.36556,0.32173,1,1
1,GO NCRNA PROCESSING,2.9532e-05,0.36512,0.28483,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,4.6597e-05,0.36482,0.33601,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00025131,0.36469,0.31166,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.9263e-05,0.36452,0.32314,1,1
1,GO REGULATION OF PHAGOCYTOSIS,1.2962e-05,0.36301,0.36829,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.1964e-05,0.36298,0.3799,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.00054072,0.36294,0.28092,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,5.7413e-06,0.36285,0.37553,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0017641,0.36245,0.31144,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0018173,0.36203,0.27611,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0027346,0.36187,0.36582,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00022676,0.36154,0.51146,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.01282,0.36133,0.36756,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00087311,0.36122,0.45187,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0012662,0.36108,0.30771,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,1.0604e-05,0.36099,0.33041,1,1
1,GO NECROTIC CELL DEATH,5.0683e-06,0.36079,0.44011,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00016595,0.35978,0.27059,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,8.3127e-06,0.35955,0.3486,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.0051916,0.35916,0.34041,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,2.2658e-06,0.35891,0.35473,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,7.3528e-06,0.35848,0.31998,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,7.013e-05,0.35847,0.27599,1,1
1,GO TRANSLATIONAL TERMINATION,0.00024286,0.35841,0.26613,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,8.1192e-05,0.35821,0.27399,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,5.2139e-05,0.35803,0.3933,1,1
1,GO INNATE IMMUNE RESPONSE,2.5308e-05,0.35779,0.27797,1,1
1,GO RESPONSE TO VIRUS,1.0604e-05,0.35752,0.35775,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0022992,0.35747,0.30616,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.5201e-05,0.35666,0.35833,1,1
1,GO RIBOSOME BIOGENESIS,0.00010462,0.35553,0.29718,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,2.6307e-05,0.35514,0.44642,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.014138,0.35505,0.37117,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,6.5149e-05,0.3549,0.26486,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00014935,0.35415,0.30298,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00018427,0.35402,0.28895,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.001872,0.35364,0.31632,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.025994,0.35294,0.43775,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00017186,0.35273,0.3849,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.013465,0.35247,0.43162,1,1
1,GO CYTOKINETIC PROCESS,3.1904e-06,0.35233,0.32908,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00010845,0.35188,0.36767,1,1
1,GO FOCAL ADHESION ASSEMBLY,0.00063551,0.35161,0.35611,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.031748,0.35151,0.26121,1,1
1,GO PIGMENT ACCUMULATION,0.00013917,0.35138,0.32497,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,1.6729e-06,0.35119,0.35296,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.001872,0.35089,0.27353,1,1
1,GO HYPOTONIC RESPONSE,0.0012662,0.35069,0.29844,1,1
1,GO B CELL MEDIATED IMMUNITY,2.4346e-05,0.35039,0.3078,1,1
1,GO FOREGUT MORPHOGENESIS,0.00012512,0.35005,0.40004,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,9.0551e-05,0.34959,0.36623,1,1
1,GO ARGININE METABOLIC PROCESS,0.0015189,0.3494,0.32554,1,1
1,GO MONONUCLEAR CELL MIGRATION,0.00019079,0.34928,0.31581,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,4.4712e-06,0.34904,0.32098,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00030804,0.34868,0.34281,1,1
1,GO ERAD PATHWAY,3.8583e-05,0.348,0.25827,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00098941,0.34775,0.33818,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.8418e-05,0.34748,0.33912,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,3.5759e-05,0.34673,0.36637,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0045306,0.34661,0.37792,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00055855,0.34661,0.29049,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00016595,0.34579,0.33916,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00032948,0.34556,0.37092,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00036427,0.34517,0.30326,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00092958,0.34513,0.34231,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.0689e-05,0.34484,0.27188,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00087311,0.34483,0.29017,1,1
1,GO FIBROBLAST PROLIFERATION,0.00025131,0.34444,0.29509,1,1
1,GO COPPER ION HOMEOSTASIS,7.9801e-06,0.34414,0.47265,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,5.4121e-05,0.34374,0.30771,1,1
1,GO NCRNA 3 END PROCESSING,0.0030654,0.34296,0.37691,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00055855,0.34235,0.41425,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00012074,0.34182,0.30785,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.0015653,0.34173,0.37575,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.349e-05,0.3417,0.36377,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0021062,0.34158,0.35089,1,1
1,GO RRNA METABOLIC PROCESS,0.00013433,0.34139,0.27879,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.02843,0.34117,0.28191,1,1
1,GO REGULATION OF PROTEIN FOLDING,2.2524e-05,0.34102,0.28965,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00040247,0.34086,0.3235,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.9263e-05,0.34062,0.37353,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00037661,0.34004,0.31432,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0028957,0.33988,0.31431,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00092958,0.33977,0.26611,1,1
1,GO VIRAL GENE EXPRESSION,4.3218e-05,0.33947,0.33929,1,1
1,GO GASTRULATION,2.1663e-05,0.33885,0.32929,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,0.0019282,0.33884,0.44336,1,1
1,GO RESPONSE TO PROGESTERONE,0.0069616,0.33875,0.28058,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0025817,0.3385,0.32583,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00020448,0.3383,0.35626,1,1
1,GO REGULATION OF LIPASE ACTIVITY,3.5759e-05,0.3378,0.26345,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0017123,0.33766,0.33009,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,2.4692e-06,0.33746,0.30383,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,2.2879e-07,0.33732,0.35442,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,0.0022992,0.33715,0.37587,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,9.0551e-05,0.33702,0.45177,1,1
1,GO RESPONSE TO INTERLEUKIN 1,2.5774e-06,0.33695,0.35649,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,7.3528e-06,0.33693,0.32782,1,1
1,GO NATURAL KILLER CELL ACTIVATION,2.4346e-05,0.33686,0.31571,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,9.389e-05,0.33586,0.44759,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0014299,0.3356,0.31629,1,1
1,GO ALPHA BETA T CELL ACTIVATION,0.00013917,0.33552,0.25301,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.00034072,0.33543,0.32746,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,6.0504e-05,0.33531,0.39129,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.0576e-06,0.33525,0.32394,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,1.1964e-05,0.3351,0.30587,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,9.3916e-06,0.33454,0.3933,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00017186,0.33454,0.27578,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,1.9904e-06,0.3344,0.338,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.7413e-06,0.33405,0.31729,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0023671,0.33323,0.32407,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.016339,0.33282,0.34926,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.8958e-07,0.33248,0.35338,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.0833e-05,0.33242,0.27667,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00032948,0.33193,0.24873,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0016129,0.33184,0.22537,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,6.2786e-05,0.33159,0.35615,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00012074,0.33137,0.38916,1,1
1,GO PROTEIN OXIDATION,0.052669,0.33122,0.29643,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,6.2786e-05,0.33093,0.27386,1,1
1,GO CELL SUBSTRATE ADHESION,4.8379e-05,0.3306,0.35911,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.011612,0.33058,0.25663,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,3.8583e-05,0.33054,0.37677,1,1
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.017137,0.33037,0.23916,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.0015189,0.33031,0.24798,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,6.0504e-05,0.33019,0.24692,1,1
1,GO PROTEIN TARGETING TO VACUOLE,0.00021909,0.33016,0.25491,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,5.2139e-05,0.32992,0.29985,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00074557,0.32965,0.29383,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.1663e-05,0.32958,0.32372,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.1888e-05,0.32926,0.28349,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00023468,0.32914,0.35243,1,1
1,GO RESPONSE TO MANGANESE ION,6.0504e-05,0.32904,0.31022,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.009256,0.32862,0.29419,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0026572,0.32858,0.33947,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,2.9532e-05,0.32852,0.51419,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00065623,0.32793,0.30866,1,1
1,GO IMMUNE EFFECTOR PROCESS,1.6455e-05,0.3277,0.28404,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0014299,0.32757,0.2605,1,1
1,GO PORE COMPLEX ASSEMBLY,0.00019753,0.32744,0.26788,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00042998,0.327,0.31046,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00055855,0.32695,0.33105,1,1
1,GO PLATELET MORPHOGENESIS,1.8521e-05,0.32641,0.29071,1,1
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.011047,0.32617,0.3625,1,1
1,GO CHONDROCYTE PROLIFERATION,0.0064317,0.32597,0.39307,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00016023,0.32513,0.34986,1,1
1,GO OSTEOCLAST DEVELOPMENT,7.2754e-05,0.32501,0.37602,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00012074,0.32438,0.22687,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00092958,0.32436,0.28102,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,3.1888e-05,0.32429,0.29559,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00069957,0.32418,0.29509,1,1
1,GO SNRNA METABOLIC PROCESS,0.00031859,0.32355,0.44802,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.7145e-05,0.32349,0.27818,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,0.00016023,0.32328,0.25653,1,1
1,GO MESODERM MORPHOGENESIS,1.7118e-05,0.32325,0.3174,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00026903,0.32317,0.25587,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.00098941,0.32292,0.31671,1,1
1,GO RNA 5 END PROCESSING,0.00024286,0.3228,0.28786,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00042998,0.32241,0.28994,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,7.013e-05,0.32222,0.32272,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,5.2139e-05,0.32215,0.44586,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0001547,0.32183,0.34225,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.033894,0.32172,0.24435,1,1
1,GO TRANSLATIONAL INITIATION,0.00052342,0.32166,0.28664,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.4421e-05,0.32138,0.29595,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0015189,0.32077,0.23886,1,1
1,GO PEPTIDE CATABOLIC PROCESS,0.00050664,0.32074,0.23697,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0030654,0.32056,0.21989,1,1
1,GO COPPER ION TRANSPORT,4.1617e-05,0.31969,0.32192,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,3.4421e-05,0.31946,0.26436,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,9.389e-05,0.3194,0.36691,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.00026003,0.31918,0.42276,1,1
1,GO MONOCYTE CHEMOTAXIS,0.00026003,0.31884,0.34891,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,9.0551e-05,0.31863,0.30954,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.0030654,0.31854,0.33091,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.017549,0.31817,0.26501,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,3.3287e-06,0.31788,0.33556,1,1
1,GO VIRAL RELEASE FROM HOST CELL,3.8583e-05,0.31754,0.29322,1,1
1,GO REGENERATION,4.1617e-05,0.3173,0.26388,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.00025131,0.31714,0.38033,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00054072,0.3157,0.28188,1,1
1,GO HISTONE PHOSPHORYLATION,4.6597e-05,0.31565,0.27407,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00024286,0.31539,0.29945,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.0029794,0.31524,0.24854,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,2.9532e-05,0.31482,0.32162,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,5.8301e-05,0.31478,0.26329,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,2.4346e-05,0.31461,0.30158,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00013433,0.31443,0.30511,1,1
1,GO NCRNA METABOLIC PROCESS,5.8301e-05,0.31443,0.25174,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.0033e-05,0.31366,0.31044,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0016129,0.31366,0.22848,1,1
1,GO VESICLE CARGO LOADING,2.1663e-05,0.31358,0.29633,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00040247,0.31352,0.33689,1,1
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0017641,0.31351,0.27097,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0025817,0.31324,0.28177,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0833e-05,0.31274,0.33104,1,1
1,GO SYMBIOTIC PROCESS,2.8891e-07,0.31248,0.28731,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00047456,0.31232,0.2932,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0012662,0.31214,0.27169,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0075304,0.31205,0.27038,1,1
1,GO SYNCYTIUM FORMATION,9.389e-05,0.31191,0.31342,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,2.9532e-05,0.31153,0.38896,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.001228,0.31114,0.25697,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,1.7118e-05,0.31034,0.29134,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0019282,0.30999,0.26357,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,2.2524e-05,0.30991,0.34417,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.015574,0.30976,0.30155,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.024846,0.30968,0.29175,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00059588,0.30968,0.27896,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.0025817,0.30964,0.24008,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,6.7728e-06,0.30961,0.34701,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.019739,0.30939,0.25599,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,2.7343e-05,0.30811,0.33454,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.00353,0.30801,0.28563,1,1
1,GO CHONDROCYTE DIFFERENTIATION,0.00034072,0.30746,0.27932,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.6729e-06,0.30727,0.28153,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0017641,0.30708,0.29187,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.0028957,0.30683,0.30134,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.0027346,0.30655,0.35307,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00067758,0.30639,0.28696,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.011904,0.30605,0.26357,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.4039e-05,0.30576,0.27989,1,1
1,GO TISSUE REGENERATION,0.00037661,0.30523,0.27292,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,2.5308e-05,0.30478,0.38181,1,1
1,GO ASTROCYTE ACTIVATION,0.0066042,0.30474,0.2739,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,6.2985e-07,0.3045,0.27665,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.015203,0.30418,0.39584,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.00098941,0.304,0.20245,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00035231,0.30395,0.25098,1,1
1,GO ACTIN FILAMENT SEVERING,0.0022332,0.30394,0.34924,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.0073e-05,0.30377,0.30623,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00011241,0.30376,0.33347,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.009256,0.30363,0.27188,1,1
1,GO VASCULATURE DEVELOPMENT,3.8583e-05,0.30356,0.28461,1,1
1,GO TRNA 5 LEADER REMOVAL,0.00019753,0.3035,0.33214,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.9904e-06,0.30344,0.23357,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.00069957,0.30326,0.34594,1,1
1,GO CYTOKINE PRODUCTION,4.6597e-05,0.30307,0.25563,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0026572,0.30294,0.35738,1,1
1,GO REPLICATIVE SENESCENCE,0.0073363,0.30279,0.36457,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.7791e-06,0.30251,0.43386,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,3.4421e-05,0.30227,0.25794,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,1.0311e-06,0.30217,0.31619,1,1
1,GO PIGMENT METABOLIC PROCESS,2.8418e-05,0.30198,0.25685,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00069957,0.30179,0.2162,1,1
1,GO CARNITINE METABOLIC PROCESS,0.013465,0.30166,0.2488,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.0053338,0.3013,0.22965,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00030804,0.30113,0.25674,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00035231,0.30084,0.24939,1,1
1,GO MACROPHAGE MIGRATION,4.8612e-06,0.30081,0.35775,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0040578,0.30076,0.26845,1,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.004408,0.30062,0.23728,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00024286,0.30006,0.20834,1,1
1,GO T CELL CYTOKINE PRODUCTION,2.9532e-05,0.29996,0.39267,1,1
1,GO MUSCLE CELL PROLIFERATION,1.2962e-05,0.29994,0.29921,1,1
1,GO URETER DEVELOPMENT,0.0036303,0.29983,0.29817,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00018427,0.29968,0.25199,1,1
1,GO RESPONSE TO CYTOKINE,1.9263e-05,0.29966,0.29208,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00065623,0.29954,0.24342,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,0.00019079,0.29938,0.23359,1,1
1,GO RRNA MODIFICATION,0.0020453,0.2993,0.21211,1,1
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00098941,0.29927,0.23932,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00012512,0.29918,0.29352,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.0029794,0.2991,0.3586,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0010528,0.29907,0.33454,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.00095906,0.29838,0.25679,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0027346,0.29833,0.26917,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,3.8583e-05,0.29831,0.30479,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,2.8077e-06,0.29831,0.30926,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00065623,0.29829,0.25478,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00024286,0.29828,0.22959,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0099891,0.29824,0.4015,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,0.00012074,0.29815,0.28293,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.0604e-05,0.29803,0.30704,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00042998,0.29797,0.2276,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.5759e-05,0.29781,0.23693,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,7.013e-05,0.29777,0.28742,1,1
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0026572,0.29765,0.33247,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0011549,0.29696,0.32403,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.00079435,0.2969,0.23221,1,1
1,GO PODOSOME ASSEMBLY,7.013e-05,0.2969,0.38997,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,4.1617e-05,0.29644,0.34107,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0010528,0.29622,0.24838,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00026903,0.29619,0.37838,1,1
1,GO ENDOTHELIAL CELL MIGRATION,7.2754e-05,0.29597,0.30658,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.02843,0.29537,0.3781,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00052342,0.2953,0.27673,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.7596e-05,0.29489,0.23356,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0047853,0.29484,0.27576,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.5774e-06,0.2948,0.28352,1,1
1,GO SELECTIVE AUTOPHAGY,1.1776e-06,0.29472,0.29955,1,1
1,GO CELLULAR RESPONSE TO VIRUS,8.6584e-06,0.29412,0.31565,1,1
1,GO REGULATION OF CELL AGING,2.4692e-06,0.29407,0.30357,1,1
1,GO SPERM EGG RECOGNITION,6.7596e-05,0.29394,0.24076,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0016129,0.29345,0.31072,1,1
1,GO GLAND MORPHOGENESIS,0.00036427,0.29338,0.3438,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0059384,0.29308,0.1831,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,3.5759e-05,0.29304,0.2898,1,1
1,GO T CELL CHEMOTAXIS,5.4121e-05,0.29304,0.26329,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.0073363,0.29263,0.21017,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00030804,0.29181,0.31435,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.00055855,0.29178,0.30459,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0001165,0.29172,0.24372,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00074557,0.29105,0.29146,1,1
1,GO MITOCHONDRIAL TRANSLATION,0.00095906,0.29091,0.22177,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.00012512,0.29066,0.25398,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.037747,0.29056,0.22054,1,1
1,GO LYMPH VESSEL DEVELOPMENT,0.0018173,0.29048,0.3143,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00049035,0.29039,0.29211,1,1
1,GO MYOBLAST DIFFERENTIATION,7.6603e-06,0.29037,0.32118,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.2962e-05,0.29034,0.31038,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00026003,0.28993,0.28218,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.00030804,0.28953,0.32322,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00052342,0.2893,0.21285,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.5201e-05,0.28929,0.30646,1,1
1,GO MYOBLAST MIGRATION,0.0022992,0.28919,0.44014,1,1
1,GO TRACHEA MORPHOGENESIS,0.0010528,0.28909,0.27126,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,0.00038934,0.28899,0.38686,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00013433,0.28896,0.22138,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00045924,0.28892,0.23298,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,6.2786e-05,0.28882,0.26314,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,8.628e-07,0.28881,0.28488,1,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0017641,0.28853,0.25921,1,1
1,GO RESPONSE TO DSRNA,6.5149e-05,0.28845,0.3282,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.0030654,0.28785,0.28414,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00028792,0.28779,0.29925,1,1
1,GO MYOBLAST FUSION,0.00017186,0.28771,0.33429,1,1
1,GO SERTOLI CELL DIFFERENTIATION,0.0028957,0.28759,0.25987,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0015653,0.28755,0.20048,1,1
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.001662,0.28736,0.26418,1,1
1,GO REGULATION OF RNA BINDING,9.7801e-06,0.28722,0.28969,1,1
1,GO WOUND HEALING,8.7323e-05,0.28717,0.30468,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,1.9904e-06,0.28707,0.27274,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.00013433,0.28691,0.29564,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.1802e-07,0.28667,0.30169,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00029782,0.28584,0.42322,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,1.8521e-05,0.28568,0.2464,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00042998,0.28566,0.28653,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,0.00054072,0.28523,0.29039,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00044439,0.28517,0.24482,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,0.00014935,0.28445,0.41232,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00030804,0.28441,0.29813,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00013917,0.28439,0.30166,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,2.9532e-05,0.28434,0.22491,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,3.4728e-06,0.28424,0.3367,1,1
1,GO RNA CATABOLIC PROCESS,7.2111e-07,0.28421,0.26553,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,0.0026572,0.2842,0.2881,1,1
1,GO CELL CELL RECOGNITION,3.9418e-06,0.28408,0.27963,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.016339,0.28406,0.20261,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0032441,0.28369,0.23735,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0013054,0.28302,0.2956,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.00069957,0.28287,0.35184,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00012964,0.28275,0.32583,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00019753,0.28262,0.25386,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,0.00032948,0.28245,0.32339,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0014299,0.28217,0.26883,1,1
1,GO DECIDUALIZATION,0.017549,0.28206,0.27599,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,1.9263e-05,0.28176,0.34596,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0017641,0.2817,0.24119,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.8583e-05,0.28105,0.24942,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00049035,0.28092,0.28541,1,1
1,GO SEQUESTERING OF METAL ION,0.00026903,0.28084,0.2613,1,1
1,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.014841,0.28058,0.23468,1,1
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.033166,0.28057,0.18419,1,1
1,GO PHAGOCYTOSIS,5.508e-06,0.2804,0.32036,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0060989,0.2804,0.33175,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,0.00020448,0.27967,0.23936,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,4.3218e-05,0.27951,0.21718,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.001228,0.27944,0.25624,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,2.6307e-05,0.27927,0.377,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.0064317,0.27899,0.31833,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00063551,0.27887,0.31931,1,1
1,GO NUCLEOSIDE SALVAGE,0.00081984,0.27852,0.42899,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,8.4205e-05,0.27782,0.26966,1,1
1,GO CHEMOKINE PRODUCTION,0.0020453,0.27751,0.24934,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.5816e-05,0.27713,0.27484,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00059588,0.27711,0.27779,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.013139,0.27702,0.22178,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,7.6603e-06,0.27674,0.26988,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00069957,0.27652,0.26404,1,1
1,GO T CELL ACTIVATION,0.0001547,0.27628,0.21391,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,3.8583e-05,0.27595,0.23898,1,1
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0067808,0.27563,0.21094,1,1
1,GO CARTILAGE DEVELOPMENT,0.0017123,0.27548,0.225,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,2.9532e-05,0.27544,0.3342,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.0067808,0.27542,0.17791,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00052342,0.27517,0.24391,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00024286,0.27467,0.24683,1,1
1,GO CELL REDOX HOMEOSTASIS,3.1888e-05,0.27441,0.27871,1,1
1,GO ASTROCYTE DEVELOPMENT,0.00042998,0.27406,0.29919,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,4.8379e-05,0.27378,0.21661,1,1
1,GO ACUTE PHASE RESPONSE,0.0060989,0.27373,0.25734,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,8.7323e-05,0.2735,0.23198,1,1
1,GO RESPONSE TO IONIZING RADIATION,3.3287e-06,0.2735,0.27005,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00016595,0.273,0.26527,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0010528,0.27299,0.23474,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0025817,0.27293,0.2131,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,0.0030654,0.27181,0.28109,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00072223,0.27165,0.24099,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.0011199,0.27164,0.34143,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,0.00090094,0.27146,0.32009,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,3.5759e-05,0.2712,0.2397,1,1
1,GO T CELL MIGRATION,0.00072223,0.27115,0.25813,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,1.2862e-06,0.27113,0.27174,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.016734,0.27104,0.22227,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,3.1888e-05,0.27086,0.28127,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00072223,0.2708,0.31769,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0013054,0.27078,0.30401,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00069957,0.27069,0.36586,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.4421e-05,0.27044,0.21743,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001986,0.2703,0.3197,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0049174,0.27001,0.2902,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00024286,0.26994,0.27278,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0083534,0.26958,0.20729,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.00032948,0.26924,0.20175,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.0007696,0.26924,0.21979,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.0053338,0.26889,0.21193,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,5.0226e-05,0.26849,0.28137,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0013872,0.2681,0.20463,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0019282,0.268,0.22054,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0018173,0.26754,0.21411,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00098941,0.26751,0.25773,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00011241,0.2674,0.39395,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.0042883,0.26706,0.29047,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.1493e-05,0.26688,0.35378,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0038387,0.26675,0.20169,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,0.0013457,0.26654,0.26252,1,1
1,GO MEMBRANE DISASSEMBLY,0.0050528,0.26613,0.24921,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.00079435,0.26552,0.20392,1,1
1,GO KERATINOCYTE MIGRATION,0.001872,0.26548,0.25797,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00014935,0.26537,0.24704,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.0057817,0.26522,0.30449,1,1
1,GO HISTONE H4 DEACETYLATION,0.0049174,0.26479,0.23153,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00038934,0.26476,0.25895,1,1
1,GO TRANSLATIONAL ELONGATION,0.00092958,0.2646,0.21184,1,1
1,GO IRON ION HOMEOSTASIS,1.1493e-05,0.26454,0.26054,1,1
1,GO PLASMA MEMBRANE TUBULATION,0.00014418,0.26446,0.29141,1,1
1,GO VIRION ASSEMBLY,1.1964e-05,0.26433,0.22917,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0045306,0.26425,0.2403,1,1
1,GO TRANSPOSITION,0.025994,0.26409,0.2092,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00084609,0.26387,0.23958,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0038387,0.26372,0.29784,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0013457,0.26363,0.42808,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,1.7806e-05,0.26346,0.39003,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,2.2524e-05,0.26333,0.24661,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.00025131,0.2633,0.29067,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.5201e-05,0.26314,0.32581,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.024846,0.26298,0.16793,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.1888e-05,0.26294,0.2682,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,4.0073e-05,0.26289,0.19758,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0016129,0.26284,0.25948,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0019282,0.26264,0.20873,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00052342,0.26233,0.25426,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,2.6307e-05,0.26219,0.24067,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00034072,0.26192,0.20871,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0012662,0.26154,0.21115,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0010859,0.26151,0.22382,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.0041716,0.26132,0.24233,1,1
1,GO NADP METABOLIC PROCESS,0.0099891,0.26127,0.20782,1,1
1,GO MITOCHONDRIAL GENE EXPRESSION,0.0015653,0.2612,0.20556,1,1
1,GO OSTEOBLAST DIFFERENTIATION,0.00059588,0.26112,0.24001,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0031536,0.26106,0.20988,1,1
1,GO AUTOPHAGOSOME MATURATION,6.5149e-05,0.26096,0.26182,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.8379e-05,0.2609,0.2612,1,1
1,GO STEROL TRANSPORT,0.0011549,0.26086,0.19787,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,2.3418e-05,0.26079,0.26977,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,3.1904e-06,0.26056,0.33024,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,6.0504e-05,0.26053,0.29347,1,1
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.025994,0.2605,0.14916,1,1
1,GO RESPONSE TO WOUNDING,0.00010845,0.26042,0.25377,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0010528,0.25988,0.22792,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00037661,0.25986,0.23348,1,1
1,GO REGULATION OF GENE SILENCING,2.0784e-06,0.25947,0.25481,1,1
1,GO DNA DEALKYLATION,0.00092958,0.25913,0.24444,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,2.0784e-06,0.25877,0.25293,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00074557,0.25865,0.21432,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0069616,0.25832,0.23541,1,1
1,GO RNA DESTABILIZATION,2.5308e-05,0.25812,0.25818,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00092958,0.2581,0.16276,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,8.7323e-05,0.25801,0.24964,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,2.4692e-06,0.25786,0.23826,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00044439,0.25753,0.29185,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.026586,0.25752,0.24451,1,1
1,GO GRANULOCYTE MIGRATION,0.00047456,0.2574,0.26925,1,1
1,GO CELL ACTIVATION,6.0504e-05,0.25723,0.22754,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,9.0551e-05,0.25674,0.33477,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0031536,0.25649,0.20109,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.0010528,0.25644,0.26581,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0010206,0.25642,0.22591,1,1
1,GO TRNA 5 END PROCESSING,0.00028792,0.25637,0.28881,1,1
1,GO CRISTAE FORMATION,0.015203,0.25634,0.20168,1,1
1,GO CHOLESTEROL EFFLUX,0.00030804,0.25607,0.24302,1,1
1,GO PROTEIN FOLDING,0.00036427,0.25591,0.2084,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,7.2754e-05,0.25568,0.24326,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0017123,0.25553,0.24099,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.0011549,0.25552,0.26642,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.044685,0.25513,0.24301,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00037661,0.2551,0.27881,1,1
1,GO CELL MATRIX ADHESION,0.00032948,0.25483,0.30045,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.023205,0.25482,0.32281,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0013872,0.2546,0.20229,1,1
1,GO RRNA TRANSCRIPTION,0.0010859,0.25457,0.23091,1,1
1,GO PROSTATE GLAND DEVELOPMENT,0.00087311,0.25454,0.33258,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,4.6597e-05,0.25431,0.22745,1,1
1,GO REGULATION OF IMMUNE RESPONSE,4.8379e-05,0.25381,0.21346,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.001872,0.25378,0.31171,1,1
1,GO COAGULATION,7.8282e-05,0.25352,0.27348,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,6.2786e-05,0.25346,0.25657,1,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.02843,0.25341,0.19188,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,7.0571e-06,0.25329,0.27148,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0027346,0.25316,0.237,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,4.2876e-06,0.253,0.24813,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00041602,0.25296,0.26689,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00012074,0.25286,0.20969,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.6015e-06,0.25279,0.22905,1,1
1,GO POSITIVE REGULATION OF CELL SIZE,0.041967,0.25229,0.22199,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00047456,0.25186,0.21525,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,2.9532e-05,0.25167,0.24354,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.00072223,0.2516,0.24453,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0012662,0.25097,0.2745,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00030804,0.25092,0.28924,1,1
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.046579,0.25089,0.15925,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0017123,0.25079,0.24592,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0020453,0.25077,0.20496,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.001986,0.2507,0.24499,1,1
1,GO REGULATION OF HEART GROWTH,0.00052342,0.25055,0.21439,1,1
1,GO ERK1 AND ERK2 CASCADE,4.0073e-05,0.25018,0.23143,1,1
1,GO REGULATION OF CELL ACTIVATION,0.00025131,0.25003,0.19607,1,1
1,GO PLATELET ACTIVATION,0.00028792,0.24983,0.23061,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,2.0833e-05,0.24972,0.2529,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0013457,0.24951,0.27919,1,1
1,GO LYMPHOCYTE MIGRATION,0.00098941,0.24937,0.20427,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.020205,0.24926,0.23606,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,1.349e-05,0.24925,0.24856,1,1
1,GO TRNA METHYLATION,0.00021909,0.24895,0.23175,1,1
1,GO REGULATION OF ORGAN GROWTH,5.9841e-06,0.24884,0.28224,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0037331,0.24872,0.23319,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.014138,0.2485,0.25172,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00044439,0.24842,0.21623,1,1
1,GO TOXIN TRANSPORT,0.0094949,0.2481,0.15797,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,5.6174e-05,0.24788,0.20396,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.3287e-06,0.24788,0.30815,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,3.5759e-05,0.24783,0.28613,1,1
1,GO MITOPHAGY,0.00035231,0.24745,0.2355,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00014935,0.24725,0.20774,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,2.8418e-05,0.24713,0.23511,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00055855,0.24698,0.21654,1,1
1,GO TRNA PROCESSING,0.00042998,0.2469,0.18179,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0013457,0.2468,0.25112,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.8521e-05,0.24665,0.34812,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.547e-05,0.24627,0.20785,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0001547,0.24621,0.44,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00021167,0.24615,0.22616,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,0.00021909,0.24613,0.24992,1,1
1,GO MIDBODY ABSCISSION,0.00095906,0.24608,0.26348,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.027188,0.24603,0.35099,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.00069957,0.24586,0.26087,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,5.4121e-05,0.24585,0.22762,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0011549,0.24579,0.17667,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.00047456,0.24559,0.17801,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,1.7118e-05,0.24559,0.21741,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0099891,0.24555,0.21671,1,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0071468,0.24553,0.21313,1,1
1,GO RESPONSE TO BACTERIUM,0.00010845,0.24518,0.24381,1,1
1,GO REGULATION OF HEMOPOIESIS,1.5201e-05,0.24503,0.21268,1,1
1,GO LIPID IMPORT INTO CELL,0.036164,0.24502,0.19441,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,3.8583e-05,0.24501,0.19682,1,1
1,GO METANEPHROS DEVELOPMENT,9.7346e-05,0.245,0.24616,1,1
1,GO REGULATION OF DEFENSE RESPONSE,0.00017186,0.24491,0.19959,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00021909,0.24468,0.19316,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00025131,0.24459,0.25013,1,1
1,GO LYMPHOCYTE ACTIVATION,0.00014418,0.24458,0.19315,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.011047,0.24439,0.20184,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.010506,0.24435,0.24159,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,7.8282e-05,0.24394,0.20963,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,0.0001165,0.24384,0.24281,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00353,0.24367,0.18904,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0019282,0.24281,0.24966,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0066042,0.24271,0.25654,1,1
1,GO RESPONSE TO GAMMA RADIATION,3.7145e-05,0.24248,0.24556,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.018836,0.24242,0.1651,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00052342,0.24174,0.19997,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,0.00038934,0.2417,0.27589,1,1
1,GO RESPONSE TO TESTOSTERONE,8.4205e-05,0.24163,0.26615,1,1
1,GO L GLUTAMATE IMPORT,0.037747,0.24156,0.17912,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00044439,0.24124,0.23592,1,1
1,GO TONGUE MORPHOGENESIS,0.029068,0.24098,0.27712,1,1
1,GO CELL KILLING,0.010773,0.24092,0.14573,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0013457,0.2409,0.18284,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0097392,0.24068,0.17891,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00020448,0.24023,0.20478,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0010206,0.24011,0.3314,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.001872,0.23979,0.25432,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,1.7806e-05,0.23978,0.22171,1,1
1,GO RESPONSE TO CORTICOSTEROID,0.0010528,0.23978,0.21771,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00019079,0.23965,0.22347,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0039469,0.23946,0.22762,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,2.7343e-05,0.23942,0.20357,1,1
1,GO HISTONE H2B UBIQUITINATION,0.00063551,0.23918,0.21001,1,1
1,GO MITRAL VALVE DEVELOPMENT,0.047551,0.23888,0.28063,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00027832,0.23884,0.22603,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.001986,0.23846,0.17115,1,1
1,GO POSITIVE REGULATION OF COAGULATION,0.007729,0.23845,0.25508,1,1
1,GO NEPHRON TUBULE FORMATION,0.026586,0.23827,0.24413,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.104e-05,0.2382,0.23967,1,1
1,GO RNA 3 END PROCESSING,3.3132e-05,0.23766,0.2125,1,1
1,GO NUCLEAR EXPORT,4.4712e-06,0.23723,0.21894,1,1
1,GO NEURAL TUBE PATTERNING,0.010773,0.23708,0.19163,1,1
1,GO REGULATION OF T CELL ACTIVATION,0.00074557,0.23676,0.18703,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0007696,0.23619,0.32206,1,1
1,GO PROTEIN PROCESSING,0.0010206,0.23607,0.19102,1,1
1,GO TISSUE MIGRATION,9.0551e-05,0.23604,0.28409,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0057817,0.23515,0.2074,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0016129,0.23508,0.31439,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,5.8301e-05,0.23496,0.22249,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0083534,0.23477,0.15871,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.0020453,0.23433,0.21793,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0060989,0.23395,0.28223,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0045306,0.23387,0.23548,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.012203,0.23377,0.32412,1,1
1,GO MESODERM DEVELOPMENT,6.0504e-05,0.23369,0.20219,1,1
1,GO LIPID STORAGE,0.00036427,0.23358,0.24103,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.031059,0.23255,0.18275,1,1
1,GO T CELL PROLIFERATION,0.0015189,0.23232,0.20009,1,1
1,GO RRNA METHYLATION,0.009256,0.23227,0.15734,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0013872,0.23208,0.25568,1,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.0041716,0.23201,0.25414,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,2.6902e-06,0.232,0.20803,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00057693,0.23168,0.29585,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.00012964,0.23146,0.34363,1,1
1,GO AXIS ELONGATION,0.009256,0.23132,0.25337,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,5.0226e-05,0.2312,0.23804,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,8.4205e-05,0.23097,0.20017,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,2.8418e-05,0.23091,0.23452,1,1
1,GO RNA MODIFICATION,8.4205e-05,0.23061,0.19649,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.013798,0.23029,0.19251,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0010528,0.23028,0.36092,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00021909,0.23025,0.22024,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0050528,0.23023,0.15979,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,1.4039e-05,0.23022,0.23193,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.046579,0.23012,0.2835,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,6.7596e-05,0.2298,0.28467,1,1
1,GO HYPEROSMOTIC RESPONSE,0.004408,0.22955,0.23424,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.029068,0.22915,0.1394,1,1
1,GO DE NOVO PROTEIN FOLDING,0.0039469,0.22912,0.17492,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,2.4346e-05,0.22888,0.21948,1,1
1,GO BODY FLUID SECRETION,0.00022676,0.22887,0.21845,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.00031859,0.22824,0.25793,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,5.0226e-05,0.22821,0.20483,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.1964e-05,0.22814,0.2121,1,1
1,GO OSTEOCLAST DIFFERENTIATION,7.013e-05,0.2281,0.20187,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00034072,0.22807,0.19955,1,1
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.00044439,0.22799,0.27463,1,1
1,GO PEPTIDE METABOLIC PROCESS,1.2454e-05,0.22794,0.19902,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,1.1493e-05,0.22789,0.23691,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0050528,0.22766,0.23052,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0075304,0.22756,0.23025,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0020453,0.22748,0.21291,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0040578,0.22743,0.19344,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,7.2754e-05,0.22728,0.26424,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.0604e-05,0.227,0.24473,1,1
1,GO RNA POLYADENYLATION,0.00022676,0.22693,0.18156,1,1
1,GO TRNA MODIFICATION,0.00072223,0.22664,0.1792,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00019079,0.22657,0.21338,1,1
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.013465,0.22654,0.1852,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0020453,0.22647,0.21528,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.041093,0.22626,0.20424,1,1
1,GO RUFFLE ORGANIZATION,0.00028792,0.22615,0.18025,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00021167,0.22599,0.2365,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00065623,0.22575,0.20545,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,2.9532e-05,0.2257,0.27981,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.0021689,0.22541,0.20526,1,1
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.036948,0.2252,0.18425,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00044439,0.22509,0.18472,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.00019753,0.22464,0.27276,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00072223,0.22453,0.30708,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.014841,0.22432,0.23505,1,1
1,GO CERAMIDE TRANSPORT,0.038561,0.2242,0.21445,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.0046564,0.22419,0.16833,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.00067758,0.22413,0.1829,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.001986,0.22398,0.21376,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00010462,0.22367,0.24166,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,0.0079323,0.22328,0.19698,1,1
1,GO LEUKOCYTE PROLIFERATION,0.0032441,0.22312,0.169,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00022676,0.22286,0.23472,1,1
1,GO BONE MORPHOGENESIS,0.0036303,0.22204,0.21887,1,1
1,GO CHYLOMICRON ASSEMBLY,0.0073363,0.22201,0.20547,1,1
1,GO PROTEIN KINASE B SIGNALING,0.00050664,0.22199,0.18497,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0066042,0.2217,0.18764,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0025083,0.22159,0.16038,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0057817,0.22126,0.16742,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.010245,0.22105,0.26983,1,1
1,GO MACROPHAGE CHEMOTAXIS,6.2786e-05,0.22063,0.33288,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.00013917,0.22058,0.22416,1,1
1,GO MYELOID CELL HOMEOSTASIS,5.4121e-05,0.22051,0.20809,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00042998,0.21998,0.18048,1,1
1,GO OVULATION,0.036164,0.21987,0.22594,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0013457,0.21975,0.24573,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0099891,0.21963,0.19169,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0050528,0.21909,0.19526,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.0031536,0.21901,0.22766,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,5.4121e-05,0.21894,0.21876,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0013872,0.21889,0.16791,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.02068,0.21887,0.13165,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00036427,0.2188,0.23295,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0097392,0.21856,0.21621,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,1.3441e-06,0.21853,0.20715,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.00049035,0.21841,0.21952,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,7.013e-05,0.21821,0.21463,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00017796,0.21813,0.18378,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.025414,0.2176,0.16326,1,1
1,GO TRNA METABOLIC PROCESS,0.00074557,0.21758,0.17607,1,1
1,GO ERBB SIGNALING PATHWAY,0.00026003,0.21744,0.23781,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.015574,0.21699,0.24982,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0094949,0.2168,0.19654,1,1
1,GO INTERFERON GAMMA PRODUCTION,0.00019753,0.21654,0.24949,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00044439,0.21649,0.17027,1,1
1,GO REGULATION OF URINE VOLUME,0.00098941,0.21647,0.22207,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.001662,0.2164,0.19404,1,1
1,GO PLASMA MEMBRANE FUSION,0.036164,0.21637,0.18681,1,1
1,GO RESPONSE TO RETINOIC ACID,0.0007696,0.21608,0.21074,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0011199,0.21592,0.21247,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,9.7346e-05,0.2159,0.26585,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0018173,0.21588,0.2003,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00057693,0.21583,0.19268,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0069616,0.21544,0.17107,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00050664,0.21527,0.20883,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,4.0073e-05,0.21526,0.17854,1,1
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.015574,0.21516,0.15113,1,1
1,GO VESICLE TARGETING,7.2754e-05,0.21491,0.22302,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0006154,0.21472,0.20847,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00030804,0.21456,0.19004,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0033369,0.21425,0.24762,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00032948,0.21412,0.1947,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,1.7118e-05,0.21408,0.19582,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00072223,0.21373,0.22192,1,1
1,GO RNA PROCESSING,8.7323e-05,0.21369,0.16966,1,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.050569,0.21355,0.23998,1,1
1,GO MRNA TRANSPORT,7.8282e-05,0.21354,0.1901,1,1
1,GO ORGANELLE INHERITANCE,0.00084609,0.21327,0.18272,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0022332,0.21308,0.17067,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00026003,0.21296,0.22886,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.00020448,0.21268,0.16655,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00353,0.21267,0.22414,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0042883,0.21238,0.17149,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.011904,0.21229,0.21386,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.024846,0.2118,0.17286,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.042857,0.2118,0.11976,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0026572,0.21173,0.29046,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0062634,0.21153,0.27922,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0022992,0.2115,0.21223,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,5.508e-06,0.21117,0.19448,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0011199,0.21109,0.16033,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0013457,0.21098,0.14793,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0013457,0.21078,0.20982,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0032441,0.21033,0.20221,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,2.9301e-06,0.2098,0.22786,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00020448,0.20918,0.22549,1,1
1,GO RNA METHYLATION,0.00027832,0.20916,0.19183,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0030654,0.2091,0.17716,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0017641,0.20902,0.20132,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.052669,0.20883,0.19179,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0020453,0.20854,0.176,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.013465,0.20852,0.16174,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00081984,0.20827,0.19659,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.030383,0.20823,0.24294,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,5.508e-06,0.20805,0.2105,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0022332,0.20801,0.19775,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00054072,0.20748,0.18107,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00012074,0.20696,0.19564,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00029782,0.20683,0.1866,1,1
1,GO ENDOSOME ORGANIZATION,0.00038934,0.20655,0.17273,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00044439,0.20654,0.17895,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0025083,0.20639,0.20065,1,1
1,GO MYELOID CELL DIFFERENTIATION,4.3218e-05,0.20609,0.17783,1,1
1,GO TOOTH MINERALIZATION,0.03245,0.2058,0.21843,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0036303,0.2057,0.18639,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0019282,0.20557,0.21352,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.047551,0.20552,0.17715,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.012203,0.20495,0.22614,1,1
1,GO RNA LOCALIZATION,8.4205e-05,0.20488,0.20366,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00021909,0.2047,0.18128,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00034072,0.20427,0.17861,1,1
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0010206,0.20418,0.21379,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,3.5759e-05,0.20392,0.19086,1,1
1,GO TRNA TRANSPORT,0.0041716,0.20381,0.18781,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.0001165,0.20346,0.22031,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0007696,0.20337,0.18647,1,1
1,GO PROTEIN MATURATION,0.00054072,0.20272,0.14604,1,1
1,GO STRESS FIBER ASSEMBLY,0.0019282,0.20259,0.2182,1,1
1,GO CELLULAR RESPONSE TO ATP,0.0010859,0.20257,0.19442,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0094949,0.20255,0.14998,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,6.0504e-05,0.20228,0.20034,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00090094,0.20208,0.19098,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0037331,0.20191,0.21281,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0025083,0.20189,0.15971,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0016129,0.20144,0.22573,1,1
1,GO REGULATION OF LIPID STORAGE,0.00098941,0.20122,0.23762,1,1
1,GO MITOTIC RECOMBINATION,0.0029794,0.20102,0.20263,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.001986,0.2006,0.21529,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00010462,0.2004,0.17371,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0026572,0.20026,0.23064,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.013139,0.20023,0.1707,1,1
1,GO TONGUE DEVELOPMENT,0.009256,0.2,0.24937,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0010206,0.19982,0.14742,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,3.3132e-05,0.19935,0.22181,1,1
1,GO MITOTIC CYTOKINESIS,0.0011549,0.19935,0.20166,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.0060989,0.19932,0.17847,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0007696,0.19931,0.23034,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0011199,0.19888,0.14247,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,1.0311e-06,0.19884,0.16361,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00032948,0.19807,0.16933,1,1
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0011549,0.19791,0.17478,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0099891,0.19748,0.16287,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00353,0.19721,0.15238,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0071468,0.19713,0.26421,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,4.8379e-05,0.19683,0.19881,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,1.8251e-06,0.19672,0.19143,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0010206,0.19671,0.17792,1,1
1,GO LACTATION,0.0037331,0.1965,0.18953,1,1
1,GO CELL AGING,5.9841e-06,0.19624,0.21193,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.0023671,0.19603,0.17005,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.0042883,0.19596,0.14517,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0066042,0.19587,0.17961,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0017641,0.19564,0.192,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.031748,0.19555,0.15768,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00025131,0.19549,0.19861,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,9.389e-05,0.19521,0.16845,1,1
1,GO TUBE MORPHOGENESIS,0.00044439,0.19429,0.20007,1,1
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.018398,0.19429,0.14614,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.02268,0.19387,0.14544,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,1.9263e-05,0.19381,0.17199,1,1
1,GO REGULATION OF RUFFLE ASSEMBLY,0.017969,0.1933,0.12135,1,1
1,GO RNA INTERFERENCE,0.034637,0.19302,0.15537,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.04854,0.19202,0.27113,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0060989,0.19191,0.16988,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.1888e-05,0.19162,0.19082,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,0.00011241,0.19137,0.15548,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,6.0504e-05,0.19026,0.18671,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.9904e-06,0.18985,0.18348,1,1
1,GO PROTEIN DENEDDYLATION,0.015203,0.18983,0.15017,1,1
1,GO NUCLEAR TRANSPORT,2.2524e-05,0.18981,0.162,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00028792,0.18977,0.19585,1,1
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.027188,0.18975,0.18581,1,1
1,GO KERATINOCYTE PROLIFERATION,0.0062634,0.18975,0.33395,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0099891,0.18956,0.14537,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,0.00030804,0.18952,0.16505,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00041602,0.1892,0.24035,1,1
1,GO VACUOLAR ACIDIFICATION,0.0050528,0.18904,0.16947,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.03245,0.18866,0.18126,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.011326,0.18863,0.17496,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,6.7596e-05,0.1883,0.20653,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.0038387,0.18797,0.1835,1,1
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.029719,0.18741,0.17628,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00019753,0.1872,0.19555,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,1.1776e-06,0.18718,0.17151,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00027832,0.18711,0.19847,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0083534,0.18702,0.15516,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00025131,0.18699,0.19125,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.0090226,0.18693,0.20305,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION,0.0036303,0.18681,0.16308,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.00079435,0.18661,0.17683,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.011326,0.1863,0.15933,1,1
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0071468,0.18616,0.17515,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,6.7728e-06,0.18588,0.22228,1,1
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.03939,0.18583,0.15983,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00021167,0.18551,0.1963,1,1
1,GO CENTRIOLE ASSEMBLY,0.0031536,0.1853,0.13807,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00353,0.18519,0.2361,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,1.5201e-05,0.18498,0.14743,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,0.00027832,0.18497,0.16631,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,5.0226e-05,0.18486,0.16166,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00063551,0.18428,0.17359,1,1
1,GO ESCRT COMPLEX DISASSEMBLY,0.044685,0.18403,0.15263,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.0046564,0.18378,0.14717,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00065623,0.18319,0.15843,1,1
1,GO MESENCHYME DEVELOPMENT,0.0022332,0.183,0.18645,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.3528e-06,0.18256,0.169,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.025414,0.1824,0.21707,1,1
1,GO PROTEIN NEDDYLATION,0.0013457,0.18232,0.18801,1,1
1,GO GOLGI VESICLE BUDDING,0.00049035,0.18208,0.18191,1,1
1,GO LEUKOCYTE DIFFERENTIATION,0.00040247,0.18194,0.16505,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00098941,0.18194,0.16927,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,1.4609e-05,0.18187,0.22785,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0038387,0.18145,0.17872,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00044439,0.18081,0.14485,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0057817,0.18074,0.21567,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,0.00010845,0.18067,0.15969,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.013465,0.18052,0.17049,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.0016129,0.18031,0.15188,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.0069616,0.18028,0.1636,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0026572,0.18006,0.16975,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,3.7145e-05,0.18001,0.20687,1,1
1,GO RNA CAPPING,4.0073e-05,0.17984,0.17955,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0030654,0.17981,0.15006,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00024286,0.17966,0.15591,1,1
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,8.7323e-05,0.1795,0.21587,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0014738,0.17879,0.1828,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.038561,0.1785,0.21619,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0013457,0.17841,0.15427,1,1
1,GO FACE DEVELOPMENT,0.0013054,0.17832,0.23535,1,1
1,GO CELLULAR RESPONSE TO LIPID,0.00069957,0.17739,0.17653,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00054072,0.17688,0.13697,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.022165,0.17619,0.14915,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,0.00029782,0.17532,0.19285,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00018427,0.17497,0.14421,1,1
1,GO HISTONE DEACETYLATION,0.00084609,0.17461,0.12594,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,2.9532e-05,0.17459,0.21057,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.00042998,0.17438,0.1474,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0010206,0.17413,0.16944,1,1
1,GO GOLGI VESICLE TRANSPORT,6.0504e-05,0.17379,0.15938,1,1
1,GO PROTEIN TARGETING,0.00072223,0.17315,0.15369,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00035231,0.17309,0.17913,1,1
1,GO CELLULAR EXTRAVASATION,0.0036303,0.17306,0.18129,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.012203,0.17266,0.17367,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.0012662,0.17242,0.17485,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.050569,0.17239,0.12843,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,6.2786e-05,0.17205,0.16352,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00020448,0.17203,0.17085,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0013457,0.172,0.1457,1,1
1,GO PROTEIN IMPORT,4.6597e-05,0.1717,0.1673,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0050528,0.17154,0.13589,1,1
1,GO STEROL IMPORT,0.0017123,0.17151,0.39713,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.013139,0.17146,0.16419,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.001662,0.17106,0.20749,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,2.6307e-05,0.17089,0.14946,1,1
1,GO RESPONSE TO KETONE,0.023205,0.17048,0.1118,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0056288,0.16934,0.1658,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.034637,0.16923,0.1531,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0031536,0.16916,0.14135,1,1
1,GO RRNA 3 END PROCESSING,0.0025817,0.16903,0.17091,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0011549,0.16866,0.23149,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.050569,0.16865,0.18787,1,1
1,GO MRNA METABOLIC PROCESS,3.0689e-05,0.16862,0.16171,1,1
1,GO INTERMEMBRANE LIPID TRANSFER,0.0028957,0.16847,0.15618,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.029068,0.16826,0.2146,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.001872,0.16809,0.11888,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.052669,0.16805,0.13802,1,1
1,GO IMPORT INTO NUCLEUS,0.00021909,0.16798,0.14618,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00025131,0.1677,0.22018,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00025131,0.16742,0.17059,1,1
1,GO SPINDLE LOCALIZATION,0.00057693,0.16731,0.15215,1,1
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0046564,0.16718,0.15797,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.021165,0.16695,0.1581,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00029782,0.16683,0.19198,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0051916,0.16668,0.17152,1,1
1,GO RESPONSE TO UV C,0.0059384,0.16649,0.24093,1,1
1,GO NEUTROPHIL MIGRATION,0.019739,0.16634,0.20815,1,1
1,GO REGULATION OF RESPONSE TO STRESS,0.00021167,0.16626,0.15059,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0034322,0.1658,0.13977,1,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.004408,0.1658,0.13995,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0051916,0.16574,0.13916,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0021062,0.16567,0.18735,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.017969,0.16565,0.16147,1,1
1,GO COPII COATED VESICLE BUDDING,0.0011199,0.16531,0.18042,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00047456,0.16525,0.19027,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,0.012508,0.16523,0.14233,1,1
1,GO PROTEIN KINASE A SIGNALING,0.00098941,0.16514,0.18856,1,1
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.023205,0.16504,0.14342,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,3.5759e-05,0.16465,0.16368,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0029794,0.16464,0.13611,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.0045306,0.16417,0.15017,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,1.6455e-05,0.16397,0.14746,1,1
1,GO LYMPHOCYTE COSTIMULATION,0.0034322,0.16395,0.15024,1,1
1,GO TRANSLESION SYNTHESIS,0.0007696,0.16296,0.16062,1,1
1,GO OSSIFICATION,0.010245,0.16293,0.15834,1,1
1,GO RESPONSE TO HEAT,0.00020448,0.1628,0.18267,1,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.030383,0.16267,0.11329,1,1
1,GO POSITIVE REGULATION OF BINDING,0.0012662,0.16234,0.14102,1,1
1,GO TELOMERE ORGANIZATION,0.00047456,0.16219,0.14022,1,1
1,GO VACUOLE ORGANIZATION,0.0011199,0.16206,0.12945,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,4.1617e-05,0.16175,0.17398,1,1
1,GO RECEPTOR RECYCLING,0.020205,0.16122,0.12322,1,1
1,GO PROTEIN POLYUBIQUITINATION,1.0184e-05,0.161,0.16219,1,1
1,GO SULFUR COMPOUND TRANSPORT,0.0022992,0.16089,0.13313,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00079435,0.1608,0.14446,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.017137,0.16069,0.14923,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.018398,0.16049,0.12005,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.018836,0.15931,0.15302,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,4.8379e-05,0.15897,0.15164,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.0013872,0.15896,0.15697,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0029794,0.15896,0.1415,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00042998,0.15834,0.17673,1,1
1,GO GLIAL CELL APOPTOTIC PROCESS,0.05161,0.15801,0.23768,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,4.6623e-06,0.15801,0.16315,1,1
1,GO REGULATION OF MITOPHAGY,0.024288,0.15751,0.17925,1,1
1,GO REGULATION OF LIPID TRANSPORT,0.0019282,0.15735,0.1424,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0045306,0.15703,0.11476,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,7.013e-05,0.15693,0.21631,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.0075304,0.1565,0.11965,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.024846,0.1565,0.1148,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.012203,0.15616,0.1432,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,2.8418e-05,0.15603,0.13904,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0046564,0.15523,0.17671,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.0028957,0.15513,0.20814,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.031059,0.15504,0.12782,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00019079,0.15488,0.1393,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.011612,0.15445,0.15974,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,4.0073e-05,0.154,0.14843,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00012512,0.15364,0.1497,1,1
1,GO MAINTENANCE OF LOCATION,9.0551e-05,0.1534,0.16322,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,5.0226e-05,0.15305,0.17078,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,0.00017796,0.15291,0.17667,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.013139,0.15267,0.12754,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0039469,0.15242,0.13091,1,1
1,GO BONE DEVELOPMENT,0.0029794,0.15235,0.17777,1,1
1,GO PROTEIN CATABOLIC PROCESS,4.3218e-05,0.15231,0.13385,1,1
1,GO REPLACEMENT OSSIFICATION,0.025994,0.15222,0.21449,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,1.5816e-05,0.15213,0.15624,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0085714,0.15194,0.20737,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0073363,0.15168,0.11887,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0010206,0.15136,0.1577,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00098941,0.15101,0.13665,1,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.031748,0.15088,0.15772,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.0017123,0.15088,0.11461,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.02068,0.15085,0.17911,1,1
1,GO DNA BIOSYNTHETIC PROCESS,2.0784e-06,0.15081,0.16466,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.0051916,0.15039,0.16887,1,1
1,GO TUBE DEVELOPMENT,0.0038387,0.15007,0.15137,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.027188,0.14962,0.15942,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.001662,0.14949,0.274,1,1
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.023741,0.14916,0.13149,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0040578,0.14901,0.13855,1,1
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.030383,0.14878,0.1342,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.0051916,0.14871,0.13627,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0025083,0.14833,0.15994,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.00021167,0.14777,0.15679,1,1
1,GO REGULATION OF BIOMINERALIZATION,0.049546,0.14774,0.16738,1,1
1,GO REGULATION OF BINDING,0.0050528,0.14765,0.11736,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00034072,0.14734,0.13433,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00042998,0.14727,0.15282,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.026586,0.14705,0.19356,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00012074,0.14654,0.14448,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00065623,0.14653,0.13666,1,1
1,GO REGULATION OF PROTEIN BINDING,0.0014299,0.14649,0.14025,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0085714,0.14636,0.12619,1,1
1,GO REGULATION OF CATABOLIC PROCESS,8.3127e-06,0.14626,0.14718,1,1
1,GO REGULATION OF CELL DEATH,0.0007696,0.14611,0.12253,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.001228,0.14597,0.12798,1,1
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.04854,0.14566,0.14632,1,1
1,GO CHROMOSOME LOCALIZATION,0.027803,0.14565,0.11549,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0069616,0.14544,0.11061,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.01282,0.1452,0.12295,1,1
1,GO NEURAL TUBE FORMATION,0.013798,0.14497,0.16372,1,1
1,GO NCRNA CATABOLIC PROCESS,0.044685,0.14454,0.1379,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00087311,0.14452,0.12345,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00025131,0.1445,0.17725,1,1
1,GO TRANSCYTOSIS,0.033894,0.14396,0.14216,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.0047853,0.14396,0.19645,1,1
1,GO BLASTOCYST GROWTH,0.0083534,0.14348,0.22245,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.024288,0.14317,0.15704,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00057693,0.14298,0.11548,1,1
1,GO RESPONSE TO UV,0.0017641,0.14281,0.13692,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00021909,0.14279,0.13806,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.00044439,0.14278,0.17324,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0075304,0.14268,0.14133,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.024288,0.14254,0.13236,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.052669,0.14225,0.097928,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00042998,0.1422,0.18317,1,1
1,GO HEART VALVE DEVELOPMENT,0.022165,0.14185,0.19389,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0012662,0.14083,0.17403,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.010773,0.14075,0.13709,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,0.0022332,0.14047,0.11008,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.014138,0.14036,0.13203,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,5.2139e-05,0.14031,0.13611,1,1
1,GO GENE SILENCING,6.5149e-05,0.14012,0.13875,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0045306,0.13997,0.15474,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.0025817,0.13995,0.12351,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.05161,0.13963,0.12189,1,1
1,GO POSTREPLICATION REPAIR,0.00063551,0.13961,0.14206,1,1
1,GO CELLULAR RESPONSE TO UV,0.0067808,0.13961,0.12866,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,4.0073e-05,0.13859,0.17591,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.00074557,0.13806,0.17902,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.035393,0.13771,0.095157,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.0016129,0.13765,0.12558,1,1
1,GO RESPONSE TO CHEMOKINE,0.023205,0.13739,0.17569,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.010245,0.13688,0.19336,1,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.034637,0.13605,0.069149,1,1
1,GO NUCLEUS ORGANIZATION,0.019739,0.13547,0.10785,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.007729,0.13541,0.19393,1,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.017137,0.13522,0.10809,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0053338,0.13485,0.089591,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0020453,0.1348,0.18059,1,1
1,GO BODY MORPHOGENESIS,0.038561,0.13442,0.13415,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,3.7145e-05,0.13404,0.14585,1,1
1,GO STEM CELL DIFFERENTIATION,0.00014418,0.13358,0.16694,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0090226,0.13328,0.16162,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.021165,0.13301,0.15418,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00052342,0.13283,0.13973,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0023671,0.13261,0.14533,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.001228,0.13258,0.14901,1,1
1,GO VIRAL BUDDING,0.0013872,0.13218,0.16172,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.015953,0.13196,0.097798,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.00026003,0.13195,0.13512,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.01282,0.13191,0.12295,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0025083,0.13123,0.098971,1,1
1,GO REGULATION OF CHEMOTAXIS,0.017969,0.13062,0.11933,1,1
1,GO GENITALIA DEVELOPMENT,0.025414,0.13028,0.098901,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.0037331,0.13023,0.14715,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00074557,0.13002,0.1283,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.013798,0.1297,0.092286,1,1
1,GO MRNA 3 END PROCESSING,0.0030654,0.12957,0.13614,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.00087311,0.12952,0.1097,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00031859,0.12923,0.15068,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.00087311,0.12876,0.12337,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.025994,0.12869,0.12267,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0046564,0.12865,0.13428,1,1
1,GO REGULATION OF SENSORY PERCEPTION,0.041093,0.12846,0.11738,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.012203,0.12816,0.097961,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0038387,0.12743,0.12521,1,1
1,GO METAPHASE PLATE CONGRESSION,0.015203,0.1273,0.11905,1,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.013798,0.12646,0.11062,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.029719,0.1261,0.18239,1,1
1,GO ORGAN GROWTH,0.0031536,0.12521,0.16762,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.019739,0.12488,0.12086,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.0045306,0.12407,0.091485,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.00052342,0.124,0.21988,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.001228,0.12391,0.11067,1,1
1,GO CYTOKINESIS,0.0090226,0.12373,0.10505,1,1
1,GO APOPTOTIC PROCESS,0.00079435,0.1235,0.11336,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0030654,0.12241,0.13441,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00025131,0.12222,0.11303,1,1
1,GO REGULATION OF ERAD PATHWAY,0.0083534,0.12215,0.1213,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.018836,0.1221,0.13221,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00022676,0.12208,0.11276,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0019282,0.12207,0.16077,1,1
1,GO ACTIN FILAMENT ORGANIZATION,0.041093,0.12171,0.096139,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.0049174,0.12098,0.11163,1,1
1,GO REGULATION OF HISTONE UBIQUITINATION,0.0081404,0.11871,0.14013,1,1
1,GO CELL DIVISION,0.012508,0.11853,0.091467,1,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.042857,0.11822,0.12083,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00030804,0.11775,0.12763,1,1
1,GO CELLULAR SENESCENCE,0.0029794,0.11703,0.12509,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0073363,0.11682,0.11664,1,1
1,GO TISSUE MORPHOGENESIS,0.001662,0.11597,0.15024,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.0049174,0.11547,0.16403,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.00084609,0.11502,0.1375,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0087944,0.1146,0.10431,1,1
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.041093,0.11358,0.14163,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0036303,0.11335,0.11658,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0047853,0.11332,0.10566,1,1
1,GO REGULATION OF DNA REPLICATION,0.012508,0.11296,0.094317,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0001165,0.11294,0.12809,1,1
1,GO REGULATION OF AUTOPHAGY,0.0010528,0.11277,0.11173,1,1
1,GO MEMBRANE ORGANIZATION,0.013139,0.11274,0.082158,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.017137,0.11223,0.097598,1,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.041093,0.11204,0.11507,1,1
1,GO ORGANELLE FISSION,0.02843,0.11178,0.076591,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00054072,0.11155,0.103,1,1
1,GO FEMALE GAMETE GENERATION,0.01282,0.11153,0.081845,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.0064317,0.11115,0.094958,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00055855,0.1109,0.15421,1,1
1,GO ESTROGEN METABOLIC PROCESS,0.02166,0.11086,0.14754,1,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.043763,0.11009,0.13576,1,1
1,GO HEART GROWTH,0.043763,0.10984,0.1187,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0020453,0.10974,0.10906,1,1
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.022165,0.10911,0.1106,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.00011241,0.10894,0.118,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.010506,0.10883,0.12597,1,1
1,GO MRNA EXPORT FROM NUCLEUS,0.010506,0.10851,0.11208,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00353,0.10794,0.091252,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00063551,0.1076,0.12054,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00012074,0.10751,0.10516,1,1
1,GO MACROAUTOPHAGY,7.547e-05,0.10746,0.13176,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.0018173,0.10742,0.096355,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,7.013e-05,0.10712,0.10474,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.013465,0.10624,0.14125,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.0021689,0.10542,0.11328,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.017549,0.1053,0.083644,1,1
1,GO SPINDLE ORGANIZATION,0.046579,0.10392,0.088331,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.016734,0.10354,0.13362,1,1
1,GO REGULATION OF DNA REPAIR,0.011612,0.10232,0.091418,1,1
1,GO NEGATIVE REGULATION OF BINDING,0.038561,0.10135,0.078448,1,1
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.014486,0.10134,0.12466,1,1
1,GO RNA SURVEILLANCE,0.00353,0.10112,0.16302,1,1
1,GO MITOTIC CELL CYCLE,0.00353,0.10003,0.098733,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0018173,0.099729,0.072648,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.027803,0.09936,0.087252,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.034637,0.098714,0.094361,1,1
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.035393,0.098571,0.090304,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00045924,0.098195,0.091999,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.035393,0.09817,0.082267,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00026903,0.098126,0.094432,1,1
1,GO RUFFLE ASSEMBLY,0.015203,0.096832,0.11848,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.0062634,0.096651,0.096257,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.029068,0.095725,0.084299,1,1
1,GO CHROMOSOME SEPARATION,0.017137,0.095352,0.12818,1,1
1,GO OUTFLOW TRACT MORPHOGENESIS,0.049546,0.093943,0.1875,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00035231,0.093265,0.10591,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.009256,0.093032,0.07966,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0014299,0.092091,0.13185,1,1
1,GO CELL CYCLE PROCESS,0.011612,0.092088,0.07622,1,1
1,GO ORGANELLE DISASSEMBLY,0.0014738,0.091245,0.11025,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.031059,0.0906,0.085434,1,1
1,GO DNA METABOLIC PROCESS,0.00063551,0.090204,0.095756,1,1
1,GO REGULATION OF CENTROSOME CYCLE,0.0042883,0.089521,0.12041,1,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.042857,0.088474,0.11477,1,1
1,GO TUBE FORMATION,0.029719,0.08837,0.11836,1,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.041967,0.088203,0.11796,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0064317,0.08754,0.071453,1,1
1,GO RESPONSE TO PEPTIDE,0.026586,0.087436,0.072104,1,1
1,GO REGULATION OF CELL CYCLE,0.015574,0.086329,0.066633,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.00047456,0.085755,0.085941,1,1
1,GO SNRNA TRANSCRIPTION,0.0042883,0.085252,0.099109,1,1
1,GO DNA INTEGRITY CHECKPOINT,0.050569,0.084952,0.079297,1,1
1,GO CELL CELL SIGNALING BY WNT,0.047551,0.084622,0.094761,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.017549,0.083705,0.053928,1,1
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.015953,0.083256,0.067405,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00035231,0.082616,0.10252,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.011904,0.081474,0.12437,1,1
1,GO HEART DEVELOPMENT,0.021165,0.080762,0.11303,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.010245,0.078081,0.096371,1,1
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.050569,0.077702,0.080763,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.035393,0.077628,0.081701,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.031748,0.077543,0.066286,1,1
1,GO CELL CYCLE,0.018398,0.077,0.063208,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.025994,0.075168,0.11064,1,1
1,GO CELL CYCLE CHECKPOINT,0.016339,0.075122,0.079891,1,1
1,GO CHROMOSOME SEGREGATION,0.038561,0.074881,0.082981,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.0069616,0.074853,0.10312,1,1
1,GO DNA MODIFICATION,0.017549,0.074223,0.088602,1,1
1,GO CHROMOSOME CONDENSATION,0.009256,0.074131,0.12035,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.046579,0.073238,0.061459,1,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.02843,0.070309,0.083239,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.016734,0.070249,0.083786,1,1
1,GO INTRACELLULAR TRANSPORT,0.0054795,0.069634,0.064029,1,1
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.045624,0.069617,0.083828,1,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.047551,0.067762,0.074774,1,1
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.026586,0.065553,0.10756,1,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.036948,0.063781,0.065656,1,1
1,GO DNA RECOMBINATION,0.02268,0.059759,0.095868,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.027803,0.059605,0.059179,1,1
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.035393,0.059512,0.10784,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.033894,0.059151,0.076623,1,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.036164,0.058854,0.098284,1,1
1,GO DNA REPAIR,0.0060989,0.058216,0.084605,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00059588,0.81242,0.6316,1,0
1,GO CYTIDINE TO URIDINE EDITING,0.00019753,0.74461,0.67881,1,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00028792,0.60764,0.52557,1,0
1,GO REGULATION OF FIBRINOLYSIS,0.00038934,0.54138,0.54167,1,0
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0021062,0.49603,0.40009,1,0
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00023468,0.47865,0.46716,1,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,3.7145e-05,0.46232,0.44502,1,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00065623,0.44536,0.39654,1,0
1,GO GERMINAL CENTER FORMATION,0.00072223,0.44344,0.39309,1,0
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00087311,0.42166,0.4213,1,0
1,GO CELL ADHESION MEDIATED BY INTEGRIN,7.013e-05,0.39385,0.4388,1,0
1,GO PROSTANOID METABOLIC PROCESS,2.2524e-05,0.39358,0.42935,1,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0011199,0.39069,0.36276,1,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0046564,0.38707,0.2725,1,0
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00055855,0.36366,0.3943,1,0
1,GO REGULATION OF COAGULATION,0.00025131,0.36015,0.38288,1,0
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0017123,0.35953,0.3139,1,0
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00054072,0.34043,0.39602,1,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.02843,0.34037,0.238,1,0
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00052342,0.33911,0.3699,1,0
1,GO PLATELET DEGRANULATION,0.00034072,0.33497,0.37413,1,0
1,GO PSEUDOURIDINE SYNTHESIS,0.0029794,0.32629,0.27505,1,0
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0053338,0.32102,0.27704,1,0
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.0226e-05,0.31847,0.29176,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.035393,0.3181,0.31142,1,0
1,GO REGULATION OF WOUND HEALING,0.00074557,0.31777,0.28617,1,0
1,GO PROTEIN DEGLYCOSYLATION,0.00081984,0.31014,0.28114,1,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.027188,0.30919,0.17863,1,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0054795,0.30866,0.33489,1,0
1,GO REGULATION OF ANOIKIS,0.014486,0.30642,0.25908,1,0
1,GO LEUKOCYTE MEDIATED IMMUNITY,2.4346e-05,0.30325,0.28835,1,0
1,GO EOSINOPHIL MIGRATION,0.018398,0.30125,0.30609,1,0
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.8583e-05,0.29279,0.31531,1,0
1,GO BARBED END ACTIN FILAMENT CAPPING,0.03939,0.29088,0.23143,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0012662,0.29054,0.24495,1,0
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.6307e-05,0.28976,0.3087,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00024286,0.28927,0.28551,1,0
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0012662,0.28884,0.21559,1,0
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.8282e-05,0.28802,0.35232,1,0
1,GO RESPONSE TO PROTOZOAN,0.00042998,0.28426,0.29939,1,0
1,GO GALACTOSE METABOLIC PROCESS,0.012203,0.28298,0.23709,1,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.001986,0.28221,0.31515,1,0
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0079323,0.28079,0.21595,1,0
1,GO ACUTE INFLAMMATORY RESPONSE,0.00036427,0.27906,0.30669,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,9.0551e-05,0.27809,0.26738,1,0
1,GO LUNG MORPHOGENESIS,0.0025817,0.27777,0.27184,1,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.016339,0.27725,0.20954,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.010245,0.27338,0.28182,1,0
1,GO RESPONSE TO THYROID HORMONE,0.0015653,0.27259,0.27612,1,0
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.0034322,0.27223,0.17982,1,0
1,GO REGULATION OF RESPONSE TO WOUNDING,0.0010859,0.2718,0.23741,1,0
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00052342,0.27134,0.26153,1,0
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0011549,0.27133,0.24598,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00065623,0.26938,0.25274,1,0
1,GO MUSCLE CELL MIGRATION,0.010506,0.26857,0.23628,1,0
1,GO MYELOID LEUKOCYTE ACTIVATION,9.7346e-05,0.26735,0.28143,1,0
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0050528,0.2673,0.20584,1,0
1,GO GTP METABOLIC PROCESS,0.00016023,0.26495,0.30332,1,0
1,GO DETECTION OF OTHER ORGANISM,0.011904,0.2637,0.26818,1,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.037747,0.26217,0.25219,1,0
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00041602,0.26208,0.27368,1,0
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00072223,0.26101,0.22551,1,0
1,GO BILE ACID AND BILE SALT TRANSPORT,0.049546,0.25951,0.11902,1,0
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00019753,0.25564,0.23393,1,0
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.011047,0.25536,0.28861,1,0
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.022165,0.25521,0.20542,1,0
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00016595,0.25502,0.25054,1,0
1,GO REGULATION OF CELL KILLING,0.0094949,0.25435,0.18829,1,0
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0081404,0.25197,0.26374,1,0
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0083534,0.25195,0.24709,1,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.036164,0.25134,0.18344,1,0
1,GO FATTY ACID BETA OXIDATION,0.0016129,0.24817,0.22211,1,0
1,GO LIPID OXIDATION,0.0083534,0.24758,0.16615,1,0
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0097392,0.24667,0.24378,1,0
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0060989,0.24659,0.33057,1,0
1,GO REGULATION OF LIGASE ACTIVITY,0.014841,0.24598,0.20738,1,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0012662,0.24462,0.23566,1,0
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.038561,0.24318,0.18464,1,0
1,GO TISSUE REMODELING,0.0022992,0.24263,0.22996,1,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0011199,0.2426,0.25509,1,0
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.010245,0.24214,0.18581,1,0
1,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00012512,0.24162,0.23695,1,0
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0057817,0.23955,0.20924,1,0
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,4.8379e-05,0.2394,0.37154,1,0
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0071468,0.23926,0.18156,1,0
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0057817,0.23862,0.20385,1,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0087944,0.23816,0.18695,1,0
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0025083,0.23797,0.20677,1,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0066042,0.23778,0.2153,1,0
1,GO EPOXYGENASE P450 PATHWAY,0.017137,0.2366,0.19092,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0049174,0.23562,0.30945,1,0
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,2.2524e-05,0.23516,0.23655,1,0
1,GO DEFENSE RESPONSE,0.00019079,0.23443,0.21186,1,0
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00034072,0.23353,0.351,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0006154,0.23332,0.24446,1,0
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0051916,0.23224,0.23801,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0045306,0.23165,0.20724,1,0
1,GO CELLULAR DEFENSE RESPONSE,0.010245,0.23087,0.25878,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0019282,0.22996,0.27294,1,0
1,GO REGULATION OF PROTEOLYSIS,0.00018427,0.22716,0.18204,1,0
1,GO FOAM CELL DIFFERENTIATION,0.0028957,0.22665,0.23289,1,0
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0015653,0.22612,0.24416,1,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.0083534,0.22533,0.2029,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.031748,0.22395,0.22476,1,0
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00042998,0.2233,0.32781,1,0
1,GO REGULATION OF VASCULOGENESIS,0.017137,0.22229,0.28856,1,0
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.014138,0.22089,0.22033,1,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.015203,0.21936,0.16967,1,0
1,GO SMOOTH MUSCLE CELL MIGRATION,0.047551,0.21744,0.19551,1,0
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.011047,0.21726,0.17123,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.0029794,0.21587,0.17787,1,0
1,GO LEUKOCYTE MIGRATION,0.0075304,0.21566,0.17549,1,0
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.001228,0.21359,0.1608,1,0
1,GO SUPEROXIDE ANION GENERATION,0.015203,0.21014,0.22618,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.014841,0.20909,0.23845,1,0
1,GO RESPONSE TO INTERLEUKIN 15,0.00063551,0.20794,0.33153,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0059384,0.20773,0.22121,1,0
1,GO FATTY ACID CATABOLIC PROCESS,0.013139,0.20736,0.14167,1,0
1,GO GRANULOCYTE CHEMOTAXIS,0.0081404,0.2054,0.23856,1,0
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0025817,0.20513,0.14783,1,0
1,GO REGULATION OF CELL CELL ADHESION,0.0031536,0.20235,0.15379,1,0
1,GO PROTEIN AUTOPROCESSING,0.027803,0.20206,0.13198,1,0
1,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00032948,0.20137,0.28109,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0014738,0.20136,0.17577,1,0
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.03939,0.20116,0.12839,1,0
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00025131,0.20037,0.22038,1,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0057817,0.19905,0.31457,1,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.0039469,0.19825,0.24576,1,0
1,GO AMINO SUGAR CATABOLIC PROCESS,0.0069616,0.19748,0.13256,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.009256,0.19739,0.19422,1,0
1,GO REGULATION OF PLATELET ACTIVATION,0.035393,0.19693,0.16496,1,0
1,GO REGULATION OF CELL ADHESION,0.0047853,0.19633,0.17584,1,0
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.001228,0.19627,0.18522,1,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.018398,0.19402,0.1216,1,0
1,GO REGULATION OF BODY FLUID LEVELS,0.0010859,0.19356,0.17729,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0028141,0.19318,0.1604,1,0
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0060989,0.19309,0.21152,1,0
1,GO B CELL ACTIVATION,0.0011549,0.1892,0.14484,1,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00098941,0.18892,0.20994,1,0
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0022332,0.18853,0.28317,1,0
1,GO IMMUNOGLOBULIN SECRETION,0.02843,0.18785,0.21728,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.004408,0.18779,0.16621,1,0
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.03245,0.18774,0.24951,1,0
1,GO REGULATION OF B CELL ACTIVATION,0.0087944,0.18691,0.12974,1,0
1,GO SUPEROXIDE METABOLIC PROCESS,0.025414,0.18653,0.13034,1,0
1,GO INFLAMMATORY RESPONSE,0.00057693,0.18622,0.22072,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.012203,0.18558,0.19428,1,0
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00059588,0.18356,0.33932,1,0
1,GO CELL CHEMOTAXIS,0.0064317,0.18333,0.18454,1,0
1,GO REGULATION OF BONE DEVELOPMENT,0.0021689,0.18233,0.23027,1,0
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.036164,0.1823,0.1644,1,0
1,GO PROTEIN N LINKED GLYCOSYLATION,0.0017123,0.18141,0.14984,1,0
1,GO TRNA WOBBLE BASE MODIFICATION,0.0054795,0.18043,0.17374,1,0
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.02843,0.18029,0.18242,1,0
1,GO AGING,0.00036427,0.1789,0.16438,1,0
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.025994,0.17885,0.14248,1,0
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0059384,0.17855,0.28304,1,0
1,GO LEUKOCYTE HOMEOSTASIS,0.00047456,0.1785,0.18476,1,0
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,2.7343e-05,0.17738,0.20721,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,7.547e-05,0.17718,0.24985,1,0
1,GO RETINOL METABOLIC PROCESS,0.0067808,0.17599,0.18048,1,0
1,GO DETOXIFICATION,0.009256,0.17533,0.14541,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.013798,0.17465,0.12585,1,0
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.050569,0.17464,0.11286,1,0
1,GO T CELL DIFFERENTIATION,0.0017641,0.17422,0.15391,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.016339,0.17354,0.16855,1,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.045624,0.17311,0.22504,1,0
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0010528,0.1712,0.14963,1,0
1,GO DEFENSE RESPONSE TO BACTERIUM,0.0083534,0.17045,0.15005,1,0
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.042857,0.16829,0.12508,1,0
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.011612,0.16827,0.31844,1,0
1,GO DRUG METABOLIC PROCESS,0.045624,0.16779,0.091395,1,0
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.020205,0.16775,0.13378,1,0
1,GO UBIQUINONE METABOLIC PROCESS,0.043763,0.1675,0.11161,1,0
1,GO POSITIVE CHEMOTAXIS,0.029719,0.16606,0.18804,1,0
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.03939,0.16382,0.12366,1,0
1,GO RESPONSE TO TUMOR CELL,0.05161,0.16372,0.17066,1,0
1,GO GLOMERULUS DEVELOPMENT,0.00041602,0.16344,0.34836,1,0
1,GO MATURE B CELL DIFFERENTIATION,0.011612,0.16176,0.21161,1,0
1,GO MYELOID LEUKOCYTE MIGRATION,0.02843,0.16166,0.1762,1,0
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.011904,0.16146,0.17001,1,0
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00029782,0.16123,0.16036,1,0
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00081984,0.16045,0.16534,1,0
1,GO RESPONSE TO MINERALOCORTICOID,0.0050528,0.16028,0.24521,1,0
1,GO ETHER METABOLIC PROCESS,0.04854,0.1593,0.16624,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.037747,0.15746,0.18903,1,0
1,GO PROTEOLYSIS,0.00017186,0.15686,0.13027,1,0
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0029794,0.15414,0.13716,1,0
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00087311,0.15278,0.17229,1,0
1,GO BONE REMODELING,0.013798,0.15253,0.15794,1,0
1,GO LYMPHOCYTE DIFFERENTIATION,0.00059588,0.15239,0.15364,1,0
1,GO FATTY ACID METABOLIC PROCESS,0.007729,0.15153,0.11121,1,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0064317,0.14993,0.15936,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.011326,0.1499,0.17985,1,0
1,GO T HELPER CELL LINEAGE COMMITMENT,0.017549,0.1498,0.17049,1,0
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.018398,0.1488,0.17522,1,0
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.043763,0.14784,0.10534,1,0
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.011612,0.14682,0.15816,1,0
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00079435,0.14495,0.13429,1,0
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.036948,0.14451,0.14128,1,0
1,GO PEROXISOMAL TRANSPORT,0.0030654,0.14358,0.17847,1,0
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0023671,0.14251,0.10571,1,0
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.034637,0.14249,0.096619,1,0
1,GO RESPONSE TO ANTIBIOTIC,0.0040578,0.142,0.16471,1,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0075304,0.14188,0.2674,1,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.025414,0.13951,0.11745,1,0
1,GO AMINE METABOLIC PROCESS,0.013139,0.1394,0.11107,1,0
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.03245,0.13888,0.17807,1,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.014841,0.13839,0.099012,1,0
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0016129,0.13689,0.13978,1,0
1,GO RESPONSE TO LIPID,0.0041716,0.13589,0.14131,1,0
1,GO ENDOCRINE PROCESS,0.0059384,0.13485,0.14979,1,0
1,GO EPITHELIAL CELL DEVELOPMENT,0.049546,0.13409,0.11281,1,0
1,GO REGULATION OF MAPK CASCADE,0.0030654,0.13398,0.1297,1,0
1,GO EXOCYTOSIS,0.0057817,0.13386,0.11791,1,0
1,GO REGULATION OF MAP KINASE ACTIVITY,0.0087944,0.13381,0.10975,1,0
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.021165,0.1338,0.10271,1,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0013457,0.13369,0.16509,1,0
1,GO POSITIVE REGULATION OF CELL DEATH,0.0047853,0.13368,0.1155,1,0
1,GO PEROXISOME ORGANIZATION,0.0032441,0.13308,0.16896,1,0
1,GO TRANSITION METAL ION TRANSPORT,0.0013872,0.13276,0.091691,1,0
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.019283,0.13249,0.098535,1,0
1,GO EPITHELIAL CELL PROLIFERATION,0.0087944,0.13195,0.15454,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0011199,0.13146,0.14455,1,0
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.012203,0.13121,0.17033,1,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.024288,0.13034,0.16899,1,0
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0036303,0.12977,0.10798,1,0
1,GO AEROBIC RESPIRATION,0.03939,0.12857,0.09567,1,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.009256,0.12847,0.16078,1,0
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.029068,0.12799,0.10466,1,0
1,GO MUSCLE ATROPHY,0.036948,0.12787,0.24012,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0036303,0.12635,0.12276,1,0
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00353,0.12631,0.13138,1,0
1,GO CELLULAR RESPIRATION,0.015574,0.12605,0.10996,1,0
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.011612,0.12584,0.11961,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.02068,0.12549,0.11746,1,0
1,GO GOLGI TO ENDOSOME TRANSPORT,0.019739,0.12362,0.14775,1,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.024846,0.12304,0.15005,1,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,0.0049174,0.12205,0.098396,1,0
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.016339,0.12191,0.12156,1,0
1,GO LIPID MODIFICATION,0.026586,0.12189,0.090843,1,0
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0041716,0.12088,0.094183,1,0
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0025817,0.12022,0.12142,1,0
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0030654,0.11959,0.16641,1,0
1,GO CENTRIOLE CENTRIOLE COHESION,0.013465,0.11876,0.1654,1,0
1,GO BASE EXCISION REPAIR,0.015574,0.11874,0.12906,1,0
1,GO OXIDATION REDUCTION PROCESS,0.011047,0.11854,0.09143,1,0
1,GO REGULATION OF OSSIFICATION,0.022165,0.11837,0.15118,1,0
1,GO REGULATION OF HYDROLASE ACTIVITY,0.015574,0.11826,0.089286,1,0
1,GO LIPID CATABOLIC PROCESS,0.026586,0.11815,0.073749,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0057817,0.11813,0.14944,1,0
1,GO GOLGI ORGANIZATION,0.0051916,0.11731,0.11124,1,0
1,GO HUMORAL IMMUNE RESPONSE,0.04854,0.11726,0.091386,1,0
1,GO REGULATION OF PROTEIN STABILITY,0.0022992,0.11689,0.10339,1,0
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0014299,0.11625,0.12088,1,0
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0071468,0.11568,0.12432,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.025994,0.11516,0.099523,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.041967,0.11315,0.12266,1,0
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.011904,0.11241,0.11997,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.027188,0.11231,0.12392,1,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0062634,0.11225,0.076285,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.045624,0.11207,0.098939,1,0
1,GO LIPID LOCALIZATION,0.049546,0.11159,0.064809,1,0
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.036164,0.11018,0.08308,1,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.034637,0.10888,0.18558,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0019282,0.10861,0.11321,1,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.040234,0.10721,0.20214,1,0
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0011199,0.10561,0.10639,1,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.025414,0.10536,0.24058,1,0
1,GO BONE RESORPTION,0.050569,0.10516,0.10384,1,0
1,GO B CELL DIFFERENTIATION,0.027188,0.10446,0.10894,1,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.029068,0.10385,0.1607,1,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.049546,0.10346,0.122,1,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.036948,0.10305,0.10625,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.046579,0.10284,0.20771,1,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.036164,0.10237,0.080462,1,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.038561,0.10224,0.06092,1,0
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.019283,0.10203,0.081995,1,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.04854,0.10099,0.14717,1,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.027803,0.10043,0.075846,1,0
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.035393,0.098241,0.086669,1,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.05161,0.09767,0.10372,1,0
1,GO NEPHRON DEVELOPMENT,0.023741,0.097375,0.16202,1,0
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.049546,0.097245,0.074178,1,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.038561,0.096924,0.18568,1,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0029794,0.096475,0.099852,1,0
1,GO REGULATION OF PHOSPHORYLATION,0.0073363,0.096333,0.094354,1,0
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.013798,0.096307,0.08611,1,0
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0034322,0.096167,0.10662,1,0
1,GO MYOTUBE DIFFERENTIATION,0.029068,0.094963,0.12466,1,0
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.00353,0.094944,0.089031,1,0
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0053338,0.093448,0.089749,1,0
1,GO HORMONE METABOLIC PROCESS,0.029719,0.091664,0.089009,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.038561,0.090494,0.065861,1,0
1,GO IRON ION TRANSPORT,0.017137,0.08938,0.085667,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.017549,0.088975,0.14635,1,0
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0046564,0.088307,0.11812,1,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.018836,0.088046,0.06461,1,0
1,GO VESICLE ORGANIZATION,0.042857,0.087253,0.068114,1,0
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.009256,0.086876,0.082554,1,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.015574,0.085725,0.064077,1,0
1,GO CELLULAR LIPID METABOLIC PROCESS,0.052669,0.084939,0.059204,1,0
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.014486,0.083716,0.077738,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.018398,0.082912,0.069807,1,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.044685,0.082175,0.07741,1,0
1,GO LIPID METABOLIC PROCESS,0.03245,0.081536,0.060341,1,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.041093,0.080863,0.078759,1,0
1,GO RESPONSE TO HORMONE,0.019283,0.080122,0.084885,1,0
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.011047,0.077444,0.091997,1,0
1,GO CARBOHYDRATE METABOLIC PROCESS,0.02166,0.077008,0.058521,1,0
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.031748,0.076283,0.066856,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.018836,0.075809,0.094948,1,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.041967,0.074622,0.055568,1,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.02166,0.074288,0.13794,1,0
1,GO PROTEIN TETRAMERIZATION,0.046579,0.072655,0.069273,1,0
1,GO NCRNA TRANSCRIPTION,0.033894,0.072448,0.090498,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE,0.031059,0.072369,0.064581,1,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.052669,0.071319,0.055739,1,0
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.013798,0.066613,0.075086,1,0
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.045624,0.065757,0.054909,1,0
1,GO ARTERY DEVELOPMENT,0.016734,0.062426,0.23014,1,0
1,GO DNA CATABOLIC PROCESS,0.052669,0.060456,0.054951,1,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.015953,0.060064,0.15327,1,0
1,GO MITOCHONDRIAL TRANSPORT,0.05161,0.051881,0.055516,1,0
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.017969,0.043411,0.050848,1,0
1,GO ORGANIC ANION TRANSPORT,0.025994,-0.040582,-0.082876,1,0
1,GO ANION TRANSPORT,0.016734,-0.043842,-0.082026,1,0
1,GO INORGANIC ANION TRANSPORT,0.036164,-0.054397,-0.079942,1,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.04854,-0.059381,-0.086845,1,0
1,GO PROTEIN ACETYLATION,0.014841,-0.061301,-0.073042,1,0
1,GO RESPONSE TO MONOSACCHARIDE,0.010506,-0.066938,-0.090996,1,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.016734,-0.066963,-0.11004,1,0
1,GO OOCYTE DIFFERENTIATION,0.04854,-0.069951,-0.097286,1,0
1,GO REGULATION OF GLUCOSE IMPORT,0.018836,-0.070924,-0.13502,1,0
1,GO RESPONSE TO CARBOHYDRATE,0.045624,-0.071733,-0.067973,1,0
1,GO ORGANIC ACID TRANSPORT,0.0011199,-0.073631,-0.11551,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.036164,-0.074074,-0.079667,1,0
1,GO REGULATION OF TRANSPORT,0.0045306,-0.078517,-0.081576,1,0
1,GO VESICLE LOCALIZATION,0.029068,-0.081321,-0.069145,1,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.043763,-0.083027,-0.15368,1,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.023205,-0.083327,-0.14205,1,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.043763,-0.086716,-0.084331,1,0
1,GO TRANSMEMBRANE TRANSPORT,0.0014738,-0.087343,-0.094297,1,0
1,GO ANION TRANSMEMBRANE TRANSPORT,0.024288,-0.092056,-0.082235,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00054072,-0.09381,-0.14145,1,0
1,GO HISTONE H3 K9 MODIFICATION,0.046579,-0.095328,-0.10001,1,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.01282,-0.096373,-0.13209,1,0
1,GO ADULT FEEDING BEHAVIOR,0.041093,-0.096581,-0.16847,1,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.027188,-0.098386,-0.091473,1,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.040234,-0.099015,-0.10854,1,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.0057817,-0.099647,-0.13035,1,0
1,GO GERM CELL DEVELOPMENT,0.040234,-0.099856,-0.081635,1,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.0069616,-0.10149,-0.10445,1,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.019739,-0.10368,-0.14903,1,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0059384,-0.10466,-0.15612,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.0036303,-0.10473,-0.14094,1,0
1,GO CELLULAR RESPONSE TO ALKALOID,0.041093,-0.1054,-0.12122,1,0
1,GO POSITIVE REGULATION OF SECRETION,0.00092958,-0.10706,-0.13128,1,0
1,GO ADIPOSE TISSUE DEVELOPMENT,0.04854,-0.10785,-0.15715,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.020205,-0.1126,-0.18837,1,0
1,GO CIRCULATORY SYSTEM PROCESS,0.023741,-0.11459,-0.085753,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00014935,-0.11603,-0.17448,1,0
1,GO DETECTION OF STIMULUS,3.0689e-05,-0.11718,-0.12749,1,0
1,GO OLIGODENDROCYTE DEVELOPMENT,0.0051916,-0.11769,-0.2155,1,0
1,GO REGULATION OF HORMONE LEVELS,0.00063551,-0.11789,-0.15298,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.024846,-0.11968,-0.18011,1,0
1,GO REGULATION OF ANION TRANSPORT,0.0028957,-0.12005,-0.15125,1,0
1,GO REGULATION OF NEURON MIGRATION,0.029068,-0.12009,-0.18165,1,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.046579,-0.1203,-0.12996,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.015574,-0.12039,-0.091332,1,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,0.0094949,-0.12062,-0.12317,1,0
1,GO ANATOMICAL STRUCTURE MATURATION,0.0042883,-0.12093,-0.11865,1,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.031748,-0.12097,-0.13319,1,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.038561,-0.12246,-0.11248,1,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0032441,-0.12251,-0.11569,1,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.023741,-0.1231,-0.12014,1,0
1,GO PEPTIDE SECRETION,0.00021167,-0.12425,-0.1417,1,0
1,GO REGULATION OF FERTILIZATION,0.024846,-0.12461,-0.16347,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0026572,-0.12579,-0.118,1,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.013798,-0.12825,-0.15903,1,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0081404,-0.12875,-0.099262,1,0
1,GO ION TRANSPORT,5.6174e-05,-0.12881,-0.13302,1,0
1,GO MATING BEHAVIOR,0.041967,-0.1301,-0.14632,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.016734,-0.13127,-0.14205,1,0
1,GO PHOTOTRANSDUCTION,0.0024367,-0.13223,-0.14488,1,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.018398,-0.13236,-0.2106,1,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.03939,-0.13259,-0.22796,1,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0060989,-0.1326,-0.14302,1,0
1,GO EATING BEHAVIOR,0.0060989,-0.13308,-0.13996,1,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.033894,-0.13403,-0.24897,1,0
1,GO REGULATION OF CILIUM ASSEMBLY,0.02166,-0.13477,-0.11342,1,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.014138,-0.13672,-0.12485,1,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.027188,-0.13771,-0.14688,1,0
1,GO WATER HOMEOSTASIS,0.036164,-0.13851,-0.12101,1,0
1,GO REGULATION OF PEPTIDE SECRETION,0.00052342,-0.13863,-0.13208,1,0
1,GO GLUTAMATE METABOLIC PROCESS,0.013139,-0.13948,-0.13065,1,0
1,GO SOMITOGENESIS,0.019739,-0.14167,-0.089996,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,0.00021167,-0.14479,-0.14813,1,0
1,GO CARBOHYDRATE HOMEOSTASIS,0.0010859,-0.14502,-0.13935,1,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.001986,-0.14553,-0.12828,1,0
1,GO SENSORY PERCEPTION OF TASTE,0.014841,-0.14698,-0.11489,1,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0075304,-0.14739,-0.20076,1,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00353,-0.14811,-0.16796,1,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0062634,-0.14855,-0.17415,1,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.044685,-0.14871,-0.14249,1,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.024846,-0.14911,-0.24254,1,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,0.001872,-0.14971,-0.17617,1,0
1,GO REGULATION OF CARDIAC CONDUCTION,0.0011549,-0.15008,-0.1803,1,0
1,GO REGULATION OF APPETITE,0.0038387,-0.15028,-0.1489,1,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0097392,-0.15065,-0.16725,1,0
1,GO PHAGOSOME ACIDIFICATION,0.040234,-0.15263,-0.14016,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00095906,-0.15287,-0.15148,1,0
1,GO REGULATION OF HISTONE METHYLATION,0.031059,-0.15287,-0.10845,1,0
1,GO CELL MATURATION,0.00031859,-0.15376,-0.1504,1,0
1,GO POST ANAL TAIL MORPHOGENESIS,0.025994,-0.15461,-0.1783,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00026903,-0.15542,-0.17214,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.011612,-0.15824,-0.12487,1,0
1,GO REGULATION OF RESPIRATORY BURST,0.049546,-0.15911,-0.20048,1,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.011326,-0.16026,-0.11372,1,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00069957,-0.16081,-0.13754,1,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.043763,-0.16156,-0.1096,1,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.019739,-0.16187,-0.14189,1,0
1,GO MULTICELLULAR ORGANISM AGING,0.0066042,-0.16362,-0.15169,1,0
1,GO HISTONE H4 K16 ACETYLATION,0.0026572,-0.16435,-0.21847,1,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.049546,-0.16517,-0.15965,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.011326,-0.16525,-0.14864,1,0
1,GO HISTONE H3 K9 METHYLATION,0.0057817,-0.16616,-0.14171,1,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.017969,-0.16653,-0.24484,1,0
1,GO FEAR RESPONSE,0.0010528,-0.16714,-0.18994,1,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.052669,-0.16838,-0.19391,1,0
1,GO LIPID DROPLET ORGANIZATION,0.019739,-0.16876,-0.13406,1,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.014486,-0.16893,-0.168,1,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0033369,-0.17065,-0.18721,1,0
1,GO DIGESTIVE SYSTEM PROCESS,0.046579,-0.17127,-0.1128,1,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.016339,-0.17156,-0.27229,1,0
1,GO ACID SECRETION,0.00063551,-0.17314,-0.19049,1,0
1,GO REGULATION OF SYSTEM PROCESS,1.0604e-05,-0.17437,-0.18056,1,0
1,GO CALCIUM ION IMPORT,0.0029794,-0.17476,-0.17423,1,0
1,GO REGULATION OF SECRETION,2.3654e-06,-0.17623,-0.18163,1,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.031059,-0.1763,-0.15008,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.041967,-0.17662,-0.16543,1,0
1,GO MECHANORECEPTOR DIFFERENTIATION,0.0027346,-0.17686,-0.20973,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,2.4346e-05,-0.17715,-0.19181,1,0
1,GO RESPONSE TO INTERLEUKIN 2,0.022165,-0.17733,-0.16994,1,0
1,GO MEMBRANE FISSION,0.0056288,-0.17975,-0.22549,1,0
1,GO CHLORIDE TRANSPORT,9.389e-05,-0.18174,-0.17291,1,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.010773,-0.18237,-0.21565,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00014935,-0.18366,-0.19688,1,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,0.011612,-0.184,-0.13733,1,0
1,GO POLYOL TRANSPORT,0.044685,-0.18584,-0.15047,1,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.0032441,-0.18591,-0.24417,1,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0014738,-0.18714,-0.21823,1,0
1,GO REGULATION OF CIRCADIAN RHYTHM,1.8251e-06,-0.18897,-0.20285,1,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00052342,-0.18972,-0.22957,1,0
1,GO NEURON PROJECTION ORGANIZATION,0.00059588,-0.19277,-0.21993,1,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.031748,-0.19294,-0.19371,1,0
1,GO IMPORT INTO CELL,0.00016023,-0.19358,-0.18168,1,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.001228,-0.1936,-0.22131,1,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.035393,-0.1946,-0.16257,1,0
1,GO DIGESTION,0.014486,-0.19629,-0.14627,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,3.0689e-05,-0.1966,-0.18694,1,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.0040578,-0.19728,-0.15019,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00017796,-0.19857,-0.18892,1,0
1,GO DORSAL AORTA DEVELOPMENT,0.042857,-0.19866,-0.187,1,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00087311,-0.20001,-0.18329,1,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0021062,-0.20084,-0.23964,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0051916,-0.20348,-0.20104,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.035393,-0.20565,-0.16514,1,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0087944,-0.2058,-0.21134,1,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00052342,-0.20796,-0.19544,1,0
1,GO RESPONSE TO ALKALOID,6.4994e-06,-0.20821,-0.22535,1,0
1,GO HAIR CELL DIFFERENTIATION,0.0079323,-0.20932,-0.23895,1,0
1,GO COPULATION,0.023205,-0.21131,-0.16463,1,0
1,GO LIPID TRANSLOCATION,0.0054795,-0.2115,-0.18918,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00026903,-0.21153,-0.20884,1,0
1,GO HISTONE H3 K9 DEMETHYLATION,0.0031536,-0.21191,-0.22514,1,0
1,GO TELENCEPHALON DEVELOPMENT,2.4346e-05,-0.21229,-0.21841,1,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,1.7118e-05,-0.21705,-0.21765,1,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.01282,-0.2194,-0.17779,1,0
1,GO REGULATION OF CELL MATURATION,0.0090226,-0.22172,-0.18019,1,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0021689,-0.22293,-0.31534,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.038561,-0.22383,-0.20343,1,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00032948,-0.22415,-0.23725,1,0
1,GO REGULATION OF HORMONE SECRETION,4.1802e-07,-0.22532,-0.26146,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,2.5308e-05,-0.22545,-0.22653,1,0
1,GO GENETIC IMPRINTING,0.014486,-0.22579,-0.14843,1,0
1,GO POSTSYNAPSE ORGANIZATION,1.7118e-05,-0.22796,-0.27656,1,0
1,GO REPRODUCTIVE BEHAVIOR,5.8301e-05,-0.22816,-0.28073,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0017641,-0.22847,-0.21757,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,6.7596e-05,-0.23119,-0.24781,1,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0033369,-0.23264,-0.28228,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00040247,-0.2351,-0.24371,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00052342,-0.23555,-0.24891,1,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00016595,-0.23746,-0.2457,1,0
1,GO BILE ACID METABOLIC PROCESS,0.023205,-0.2389,-0.15365,1,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.031059,-0.24352,-0.22572,1,0
1,GO RESPONSE TO AMPHETAMINE,0.00018427,-0.24536,-0.28522,1,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00010092,-0.24561,-0.22705,1,0
1,GO REGULATION OF ACROSOME REACTION,0.0067808,-0.2458,-0.29116,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,4.2876e-06,-0.24618,-0.24331,1,0
1,GO HIPPOCAMPUS DEVELOPMENT,0.00019079,-0.24679,-0.27656,1,0
1,GO PALLIUM DEVELOPMENT,5.4121e-05,-0.24965,-0.2349,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,0.00010845,-0.2501,-0.23205,1,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0039469,-0.2527,-0.24366,1,0
1,GO HORMONE TRANSPORT,1.4268e-07,-0.25276,-0.28245,1,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.00090094,-0.25334,-0.23575,1,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.0006154,-0.25383,-0.205,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0022992,-0.25393,-0.20474,1,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.0039469,-0.25489,-0.28531,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.001986,-0.25632,-0.28192,1,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0001165,-0.25794,-0.32731,1,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.016339,-0.25972,-0.20687,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,4.8612e-06,-0.25981,-0.2751,1,0
1,GO REGULATION OF ACTION POTENTIAL,0.0012662,-0.26057,-0.22087,1,0
1,GO PANCREAS DEVELOPMENT,0.00079435,-0.26139,-0.22534,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,1.1493e-05,-0.2622,-0.23767,1,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,2.0833e-05,-0.26228,-0.22844,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,4.7955e-07,-0.26497,-0.244,1,0
1,GO CAMP BIOSYNTHETIC PROCESS,0.0027346,-0.26581,-0.30416,1,0
1,GO STRIATUM DEVELOPMENT,0.00030804,-0.26605,-0.31609,1,0
1,GO ACROSOME REACTION,0.00081984,-0.26611,-0.23139,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,1.7806e-05,-0.26626,-0.27217,1,0
1,GO FEEDING BEHAVIOR,2.5122e-07,-0.26638,-0.28119,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.0053338,-0.26678,-0.20992,1,0
1,GO NEUROMUSCULAR PROCESS,1.349e-05,-0.26782,-0.26518,1,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0033369,-0.27124,-0.2374,1,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0025817,-0.27259,-0.28018,1,0
1,GO COCHLEA DEVELOPMENT,0.0013872,-0.27336,-0.27755,1,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.021165,-0.27514,-0.25237,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,5.2139e-05,-0.27549,-0.37976,1,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.013139,-0.27647,-0.23519,1,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0075304,-0.278,-0.23492,1,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,6.4994e-06,-0.28062,-0.24247,1,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.00022676,-0.28125,-0.35601,1,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0047853,-0.28526,-0.2116,1,0
1,GO SODIUM ION HOMEOSTASIS,7.6603e-06,-0.28586,-0.31106,1,0
1,GO RESPONSE TO FORSKOLIN,0.010245,-0.28703,-0.29944,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.029719,-0.2881,-0.20957,1,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.7343e-05,-0.28826,-0.42023,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,2.0033e-05,-0.2885,-0.3704,1,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,0.00044439,-0.28919,-0.26232,1,0
1,GO RESPONSE TO MAGNESIUM ION,0.034637,-0.29008,-0.21917,1,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.010506,-0.29069,-0.336,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.0057817,-0.29073,-0.32055,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015189,-0.2928,-0.32046,1,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0013054,-0.29299,-0.31501,1,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.00014935,-0.29634,-0.29023,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,2.2658e-06,-0.29656,-0.33004,1,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.00041602,-0.29721,-0.35709,1,0
1,GO AMINO ACID TRANSPORT,6.8936e-07,-0.29737,-0.28275,1,0
1,GO SIGNAL RELEASE,2.0038e-08,-0.29747,-0.31041,1,0
1,GO FOREBRAIN CELL MIGRATION,0.00036427,-0.29808,-0.26094,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.016339,-0.30163,-0.25802,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.024288,-0.30274,-0.24993,1,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.0311e-06,-0.30689,-0.27086,1,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0066042,-0.30929,-0.29046,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,1.2962e-05,-0.30994,-0.28925,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.0010206,-0.31081,-0.27148,1,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,5.753e-07,-0.31348,-0.32019,1,0
1,GO REGULATION OF INSULIN SECRETION,2.8891e-07,-0.31633,-0.31576,1,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,4.3218e-05,-0.31822,-0.30639,1,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,1.7474e-06,-0.32133,-0.31385,1,0
1,GO MITOCHONDRION DISTRIBUTION,0.0011199,-0.32165,-0.28559,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00018427,-0.32276,-0.30497,1,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0083534,-0.32343,-0.27818,1,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.0073e-05,-0.32504,-0.30835,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00017186,-0.32543,-0.26138,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,9.0179e-06,-0.32676,-0.29773,1,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.00020448,-0.32726,-0.25686,1,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00092958,-0.32759,-0.28353,1,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.00018427,-0.32921,-0.30985,1,0
1,GO AROMATIC AMINO ACID TRANSPORT,5.6174e-05,-0.32957,-0.37771,1,0
1,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.04854,-0.32982,-0.34462,1,0
1,GO CARDIAC CONDUCTION,2.4692e-06,-0.32988,-0.31423,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.3528e-06,-0.33155,-0.34934,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,2.0829e-07,-0.3316,-0.34936,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,1.9873e-07,-0.3317,-0.35088,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.0018173,-0.332,-0.32423,1,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,0.00024286,-0.333,-0.37073,1,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0029794,-0.33301,-0.29765,1,0
1,GO INSULIN SECRETION,9.7275e-08,-0.33443,-0.33808,1,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.00041602,-0.33498,-0.30858,1,0
1,GO PEPTIDE HORMONE SECRETION,3.6563e-08,-0.33809,-0.34609,1,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.017549,-0.33891,-0.24592,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,4.6826e-08,-0.33966,-0.32875,1,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.011047,-0.33996,-0.31789,1,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.00022676,-0.3403,-0.30562,1,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0013872,-0.34193,-0.41668,1,0
1,GO LIPID DROPLET FORMATION,0.044685,-0.34251,-0.25589,1,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0019282,-0.34283,-0.25177,1,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00016595,-0.34458,-0.31742,1,0
1,GO ADRENAL GLAND DEVELOPMENT,7.547e-05,-0.34487,-0.38527,1,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.00037661,-0.34611,-0.36795,1,0
1,GO MITOCHONDRION LOCALIZATION,0.00059588,-0.35054,-0.26735,1,0
1,GO MEGAKARYOCYTE DEVELOPMENT,0.0050528,-0.35164,-0.32272,1,0
1,GO ASSOCIATIVE LEARNING,5.2533e-07,-0.35167,-0.33136,1,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00055855,-0.35206,-0.30488,1,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,3.3132e-05,-0.35207,-0.38283,1,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.00021167,-0.35241,-0.32352,1,0
1,GO TOXIN METABOLIC PROCESS,0.017137,-0.35272,-0.23766,1,0
1,GO GLYCINE TRANSPORT,0.0020453,-0.35375,-0.35312,1,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.029068,-0.35669,-0.20969,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00013917,-0.36004,-0.30831,1,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0028141,-0.36127,-0.25298,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00087311,-0.36521,-0.31392,1,0
1,GO SYNAPSE ORGANIZATION,7.5427e-07,-0.36645,-0.33678,1,0
1,GO LEARNING,1.2971e-07,-0.36695,-0.37451,1,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,3.4728e-06,-0.37261,-0.37143,1,0
1,GO REGULATION OF EXOCYTOSIS,3.479e-08,-0.37292,-0.38057,1,0
1,GO NEUROTRANSMITTER REUPTAKE,4.8612e-06,-0.38218,-0.39971,1,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0010528,-0.38318,-0.32258,1,0
1,GO POTASSIUM ION TRANSPORT,2.0038e-08,-0.38401,-0.38145,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00049035,-0.38459,-0.41904,1,0
1,GO RESPONSE TO DIETARY EXCESS,3.3132e-05,-0.38683,-0.44828,1,0
1,GO NEURON CELLULAR HOMEOSTASIS,7.3528e-06,-0.38713,-0.45449,1,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0079323,-0.39365,-0.32677,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,2.8077e-06,-0.39569,-0.62677,1,0
1,GO MRNA SPLICE SITE SELECTION,3.4421e-05,-0.39984,-0.35622,1,0
1,GO TUBULIN DEACETYLATION,0.00049035,-0.40213,-0.3567,1,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,3.5759e-05,-0.40257,-0.38368,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,4.4712e-06,-0.40284,-0.41962,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0049174,-0.40463,-0.29189,1,0
1,GO FOREBRAIN REGIONALIZATION,0.00016023,-0.40746,-0.38766,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,2.0033e-05,-0.41172,-0.38605,1,0
1,GO SYNAPTIC VESICLE RECYCLING,5.0194e-07,-0.41209,-0.42115,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,2.2879e-07,-0.41369,-0.40901,1,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.00010092,-0.41413,-0.37986,1,0
1,GO METENCEPHALON DEVELOPMENT,3.9926e-07,-0.41531,-0.40624,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,6.0504e-05,-0.41785,-0.4328,1,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00081984,-0.41833,-0.45084,1,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.001662,-0.42031,-0.36321,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,3.1904e-06,-0.42301,-0.38769,1,0
1,GO REGULATION OF TUBULIN DEACETYLATION,0.00012964,-0.42368,-0.53163,1,0
1,GO NOREPINEPHRINE TRANSPORT,3.5759e-05,-0.42833,-0.34283,1,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.00016595,-0.42905,-0.33748,1,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.0062634,-0.43096,-0.29085,1,0
1,GO PARENTAL BEHAVIOR,9.7346e-05,-0.43186,-0.40867,1,0
1,GO DENTATE GYRUS DEVELOPMENT,0.017137,-0.43236,-0.40414,1,0
1,GO DENDRITIC TRANSPORT,0.0014738,-0.44296,-0.33387,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,5.753e-07,-0.45826,-0.4355,1,0
1,GO SYNAPSE ASSEMBLY,1.8958e-07,-0.45912,-0.46599,1,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,0.00016595,-0.46187,-0.47373,1,0
1,GO SUCKLING BEHAVIOR,1.8521e-05,-0.46444,-0.47116,1,0
1,GO OPTIC NERVE DEVELOPMENT,7.2754e-05,-0.46456,-0.43417,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,7.013e-05,-0.46707,-0.4332,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,4.1112e-06,-0.47445,-0.52508,1,0
1,GO ENDOCARDIUM DEVELOPMENT,0.0050528,-0.47578,-0.30516,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,2.7104e-08,-0.47698,-0.58131,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,2.9532e-05,-0.47828,-0.39471,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,5.0226e-05,-0.47914,-0.53926,1,0
1,GO EXOCYTIC PROCESS,2.5778e-08,-0.48015,-0.49094,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,3.1491e-08,-0.48127,-0.4894,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,9.389e-05,-0.48238,-0.5585,1,0
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.00063551,-0.4958,-0.55742,1,0
1,GO POSTSYNAPSE ASSEMBLY,8.7323e-05,-0.50538,-0.54342,1,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0030654,-0.50549,-0.28861,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,1.7806e-05,-0.51924,-0.48839,1,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0066042,-0.5202,-0.30485,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,4.6826e-08,-0.54163,-0.55565,1,0
1,GO REGULATION OF VESICLE FUSION,1.3441e-06,-0.54631,-0.552,1,0
1,GO REGULATION OF NEURON MATURATION,0.0033369,-0.55274,-0.44995,1,0
1,GO RESPONSE TO L GLUTAMATE,0.00010092,-0.55551,-0.5243,1,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,2.6322e-07,-0.55674,-0.55522,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,4.4572e-08,-0.5575,-0.55741,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,9.389e-05,-0.56394,-0.48834,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,4.1802e-07,-0.56657,-0.52265,1,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,3.6414e-07,-0.5719,-0.54472,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0033369,-0.57476,-0.35626,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00087311,-0.57633,-0.48889,1,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,4.3763e-07,-0.59011,-0.54302,1,0
1,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,-0.59167,-0.69885,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,1.071e-07,-0.59386,-0.64776,1,0
1,GO CGMP METABOLIC PROCESS,5.2533e-07,-0.59435,-0.57822,1,0
1,GO SIALYLATION,7.889e-07,-0.59769,-0.56458,1,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00029782,-0.60146,-0.63441,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,5.7413e-06,-0.60295,-0.58534,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,2.2167e-08,-0.60414,-0.59143,1,0
1,GO PYRAMIDAL NEURON DIFFERENTIATION,0.00023468,-0.60674,-0.61515,1,0
1,GO LUNG CELL DIFFERENTIATION,0.0062634,-0.6138,-0.40734,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,9.0221e-07,-0.61897,-0.65804,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00095906,-0.62189,-0.55188,1,0
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00069957,-0.62549,-0.5061,1,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,6.2985e-07,-0.64138,-0.63718,1,0
1,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.0006154,-0.64208,-0.49874,1,0
1,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,1.4674e-06,-0.65848,-0.58693,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,1.2862e-06,-0.66067,-0.58108,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.3218e-05,-0.66962,-0.55353,1,0
1,GO REGULATION OF SYNAPSE MATURATION,6.5896e-07,-0.67521,-0.72894,1,0
1,GO SYNAPTIC MEMBRANE ADHESION,5.508e-06,-0.67883,-0.61022,1,0
1,GO RESPONSE TO HISTAMINE,3.0264e-07,-0.69406,-0.73878,1,0
1,GO RESPONSE TO LITHIUM ION,6.4994e-06,-0.70196,-0.58744,1,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,8.3127e-06,-0.72507,-0.64723,1,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,1.071e-07,-0.73148,-0.81,1,0
1,GO THALAMUS DEVELOPMENT,3.17e-07,-0.73371,-0.67937,1,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,5.986e-08,-0.73533,-0.7255,1,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,2.1663e-05,-0.73726,-0.69458,1,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,0.011612,-0.73735,-0.54706,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,5.4977e-07,-0.76512,-0.82679,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.6729e-06,-0.78917,-0.74926,1,0
1,GO INNERVATION,2.1831e-07,-0.80254,-0.78225,1,0
1,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.1788e-07,-0.80721,-0.83927,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,4.0375e-08,-0.81644,-0.80316,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,7.889e-07,-0.82162,-0.91258,1,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,2.0038e-08,-0.82572,-0.84319,1,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,3.3202e-07,-0.82744,-0.88116,1,0
1,GO EPITHELIAL CELL FATE COMMITMENT,0.0020453,-0.8366,-0.61812,1,0
1,GO SYNAPSE MATURATION,6.2859e-08,-0.83824,-0.90636,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,9.2696e-08,-0.84741,-0.76864,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,9.3916e-06,-0.85528,-0.77755,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,2.1831e-07,-0.86294,-0.84743,1,0
1,GO SEROTONIN METABOLIC PROCESS,7.5427e-07,-0.88537,-0.73057,1,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,1.071e-07,-0.89905,-0.84146,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,4.9191e-08,-0.92226,-0.88376,1,0
1,GO SYNAPTIC VESICLE PRIMING,2.0038e-08,-0.95648,-0.97903,1,0
1,GO DENSE CORE GRANULE TRANSPORT,6.8936e-07,-0.96209,-1.0685,1,0
1,GO PREPULSE INHIBITION,4.6826e-08,-0.96905,-0.9126,1,0
1,GO REGULATION OF DENDRITE EXTENSION,6.93e-08,-0.97479,-0.91195,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,2.7104e-08,-0.97855,-0.96062,1,0
1,GO VOCALIZATION BEHAVIOR,2.0829e-07,-0.99095,-0.93413,1,0
1,GO NOSE DEVELOPMENT,5.0683e-06,-1.0142,-0.84601,1,0
1,GO PROTEIN LOCALIZATION TO AXON,8.8325e-08,-1.0259,-1.1025,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,2.7104e-08,-1.0634,-1.0593,1,0
1,GO SYNAPTIC VESICLE MATURATION,4.1112e-06,-1.1052,-0.92609,1,0
1,GO GANGLION DEVELOPMENT,3.8423e-08,-1.1058,-1.0325,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.1491e-08,-1.2215,-1.143,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,4.2424e-08,-1.2811,-1.233,1,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,3.9418e-06,-1.3246,-1.1753,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,2.2167e-08,-1.7372,-1.8138,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.060602,0.41193,0.25895,0,1
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.072231,0.40223,0.23612,0,1
1,GO LAMELLIPODIUM MORPHOGENESIS,0.079444,0.34915,0.22332,0,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.099158,0.33887,0.28611,0,1
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.059411,0.3342,0.16525,0,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.063042,0.325,0.20443,0,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.11039,0.32195,0.2729,0,1
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.12049,0.31136,0.21904,0,1
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.092194,0.31055,0.1567,0,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.19695,0.29652,0.21442,0,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.22235,0.29289,0.16052,0,1
1,GO AMYLOID FIBRIL FORMATION,0.093897,0.2873,0.19045,0,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.060602,0.28694,0.21936,0,1
1,GO FOREBRAIN MORPHOGENESIS,0.060602,0.27352,0.16286,0,1
1,GO PHOSPHOLIPID EFFLUX,0.39371,0.26987,0.16372,0,1
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.15264,0.25322,0.22276,0,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.0695,0.25206,0.36274,0,1
1,GO RESPONSE TO CADMIUM ION,0.088862,0.24916,0.13805,0,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.095625,0.24419,0.12674,0,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.053746,0.24064,0.17354,0,1
1,GO DISTAL TUBULE DEVELOPMENT,0.10845,0.24006,0.24638,0,1
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.084046,0.23911,0.1073,0,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.076492,0.23573,0.18355,0,1
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.22568,0.23379,0.098739,0,1
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.097379,0.22947,0.17318,0,1
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.26847,0.22485,0.1034,0,1
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.15517,0.22174,0.20303,0,1
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.10845,0.2204,0.18716,0,1
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.13355,0.21965,0.12233,0,1
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.15015,0.21298,0.20731,0,1
1,GO PROSTATIC BUD FORMATION,0.076492,0.20995,0.22851,0,1
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.15015,0.20829,0.15969,0,1
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.10096,0.20656,0.11374,0,1
1,GO DNA DEMETHYLATION,0.077957,0.20109,0.14921,0,1
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.14769,0.1983,0.21909,0,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.054842,0.19781,0.1425,0,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.084046,0.19484,0.28091,0,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.12259,0.19401,0.19816,0,1
1,GO MEMBRANE BIOGENESIS,0.073629,0.19312,0.15348,0,1
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.085627,0.19152,0.18028,0,1
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.13583,0.1911,0.1312,0,1
1,GO DENDRITIC CELL MIGRATION,0.093897,0.18871,0.20045,0,1
1,GO RESPONSE TO REDOX STATE,0.059411,0.18743,0.18289,0,1
1,GO NEURAL CREST CELL MIGRATION,0.076492,0.18637,0.16051,0,1
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.31653,0.18435,0.063709,0,1
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.12908,0.18151,0.11705,0,1
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.060602,0.17607,0.13093,0,1
1,GO CYTOPLASM ORGANIZATION,0.21579,0.17008,0.13425,0,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.14285,0.16919,0.14493,0,1
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.088862,0.16799,0.17056,0,1
1,GO GONADOTROPIN SECRETION,0.10465,0.16728,0.17901,0,1
1,GO HINDLIMB MORPHOGENESIS,0.17374,0.16595,0.11482,0,1
1,GO PROTEIN REFOLDING,0.064293,0.1656,0.14354,0,1
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.14048,0.16437,0.074453,0,1
1,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.41842,0.16258,0.072994,0,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.077957,0.1621,0.09196,0,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.059411,0.16131,0.14728,0,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.064293,0.1575,0.068237,0,1
1,GO KINETOCHORE ASSEMBLY,0.068167,0.15728,0.15909,0,1
1,GO REGULATION OF T CELL MIGRATION,0.084046,0.15274,0.11409,0,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.15517,0.15187,0.16575,0,1
1,GO ANIMAL ORGAN FORMATION,0.053746,0.15173,0.14129,0,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.05824,0.1501,0.12425,0,1
1,GO MAINTENANCE OF CELL NUMBER,0.092194,0.14971,0.1126,0,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.10465,0.14861,0.087914,0,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.19393,0.14848,0.083358,0,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.30815,0.14752,0.10553,0,1
1,GO DIOL BIOSYNTHETIC PROCESS,0.090515,0.14374,0.083526,0,1
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.077957,0.14359,0.18215,0,1
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.095625,0.1435,0.12557,0,1
1,GO CORPUS CALLOSUM DEVELOPMENT,0.17099,0.14262,0.10542,0,1
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.25363,0.14206,0.097189,0,1
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.057089,0.142,0.12808,0,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.093897,0.14097,0.092651,0,1
1,GO REGULATION OF HAIR CYCLE,0.17653,0.14064,0.13672,0,1
1,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.22905,0.14029,0.091658,0,1
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.10845,0.13982,0.1113,0,1
1,GO REGULATION OF MYELINATION,0.079444,0.1394,0.096224,0,1
1,GO RESPONSE TO DRUG,0.061812,0.13912,0.086229,0,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.063042,0.13135,0.10463,0,1
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.055956,0.13099,0.13986,0,1
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.084046,0.13083,0.084243,0,1
1,GO ENDOTHELIUM DEVELOPMENT,0.53742,0.13006,0.02136,0,1
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.085627,0.12937,0.089189,0,1
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.11039,0.12344,0.13265,0,1
1,GO POSITIVE REGULATION OF DNA BINDING,0.26471,0.12149,0.070471,0,1
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.061812,0.121,0.10523,0,1
1,GO REGULATION OF HISTONE DEACETYLATION,0.063042,0.12055,0.11265,0,1
1,GO REGULATION OF DNA BINDING,0.20309,0.12024,0.048234,0,1
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.29184,0.11797,0.079827,0,1
1,GO OOCYTE MATURATION,0.12473,0.11701,0.047668,0,1
1,GO MITOTIC DNA REPLICATION CHECKPOINT,0.092194,0.11476,0.1003,0,1
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.05824,0.11443,0.098,0,1
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.12049,0.1137,0.067782,0,1
1,GO OXIDATIVE PHOSPHORYLATION,0.070855,0.11113,0.10024,0,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.16559,0.11007,0.13138,0,1
1,GO POSITIVE REGULATION OF URINE VOLUME,0.16294,0.10891,0.1537,0,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.16294,0.10765,0.082437,0,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.27227,0.10596,0.04775,0,1
1,GO MESENCHYME MORPHOGENESIS,0.076492,0.10471,0.22771,0,1
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.12908,0.10262,0.11172,0,1
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.30402,0.1025,0.11949,0,1
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.33812,0.099716,0.049527,0,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.16294,0.098951,0.092195,0,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.060602,0.098451,0.10374,0,1
1,GO VIRAL LATENCY,0.40843,0.098098,0.04893,0,1
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.17374,0.097647,0.1469,0,1
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.090515,0.097376,0.048538,0,1
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.41842,0.096707,0.069239,0,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.05824,0.096575,0.070964,0,1
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.11039,0.096224,0.11535,0,1
1,GO TUMOR NECROSIS FACTOR SECRETION,0.11636,0.095473,0.13829,0,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.43367,0.093966,0.049128,0,1
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.16294,0.093787,0.13103,0,1
1,GO NEGATIVE REGULATION OF DNA BINDING,0.4598,0.092844,0.018005,0,1
1,GO G2 DNA DAMAGE CHECKPOINT,0.064293,0.092293,0.094872,0,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.12049,0.090769,0.13267,0,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.05824,0.09053,0.096407,0,1
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.059411,0.089788,0.078112,0,1
1,GO EPITHELIAL TUBE FORMATION,0.073629,0.089452,0.10796,0,1
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.064293,0.088713,0.16383,0,1
1,GO RETROGRADE AXONAL TRANSPORT,0.7495,0.08859,-0.019931,0,1
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.080955,0.088072,0.1242,0,1
1,GO ACTIVATION OF GTPASE ACTIVITY,0.090515,0.087618,0.086001,0,1
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.40843,0.087564,0.038645,0,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.085627,0.087243,0.12075,0,1
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.26847,0.086746,0.039843,0,1
1,GO REGULATION OF CYTOKINESIS,0.15773,0.086203,0.052527,0,1
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0695,0.086015,0.062935,0,1
1,GO ERYTHROCYTE DEVELOPMENT,0.060602,0.084779,0.11083,0,1
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.16559,0.083051,0.089985,0,1
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.22905,0.082826,0.060013,0,1
1,GO P BODY ASSEMBLY,0.36526,0.081734,0.040387,0,1
1,GO LACTATE METABOLIC PROCESS,0.11636,0.081435,0.11012,0,1
1,GO HISTONE EXCHANGE,0.18219,0.079686,0.072961,0,1
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.53167,0.077045,0.040012,0,1
1,GO AORTA DEVELOPMENT,0.080955,0.07674,0.20083,0,1
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.13583,0.075769,0.098304,0,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.075049,0.074679,0.068497,0,1
1,GO ACTIN FILAMENT BASED PROCESS,0.088862,0.073892,0.075325,0,1
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.38888,0.072355,0.0085551,0,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.082489,0.072316,0.070803,0,1
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.11434,0.069717,0.082448,0,1
1,GO MACROMOLECULE DEACYLATION,0.082489,0.069533,0.056305,0,1
1,GO SPINDLE ASSEMBLY,0.085627,0.067873,0.065653,0,1
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.11636,0.06631,0.061538,0,1
1,GO MRNA PROCESSING,0.11434,0.065998,0.055544,0,1
1,GO RNA SPLICING,0.097379,0.065347,0.054364,0,1
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.20309,0.064721,0.074155,0,1
1,GO RESPONSE TO LEAD ION,0.19393,0.064649,0.079278,0,1
1,GO REGULATION OF CELL DIVISION,0.097379,0.064538,0.067459,0,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.054842,0.062556,0.11441,0,1
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.095625,0.061591,0.039602,0,1
1,GO DNA CONFORMATION CHANGE,0.11434,0.06145,0.06017,0,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.063042,0.059341,0.075675,0,1
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.13355,0.058099,0.063091,0,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.12908,0.056697,0.088366,0,1
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.24643,0.054493,0.02887,0,1
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.076492,0.05399,0.085456,0,1
1,GO POSITIVE REGULATION OF CELL DIVISION,0.48678,0.051367,0.066423,0,1
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.14285,0.051363,0.041577,0,1
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.35607,0.051039,0.031341,0,1
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.11039,0.050787,0.036229,0,1
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.25001,0.042814,0.026217,0,1
1,GO RECOMBINATIONAL REPAIR,0.42855,0.040644,0.057618,0,1
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.28785,0.039512,0.049669,0,1
1,GO ORGANELLE ASSEMBLY,0.11636,0.038501,0.041617,0,1
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.079444,0.036016,0.063086,0,1
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.26847,0.022111,0.036289,0,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,3.4728e-06,0.68038,0.55859,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,7.3528e-06,0.65032,0.67375,0,0
1,GO IMMUNE RESPONSE TO TUMOR CELL,9.0551e-05,0.50369,0.45026,0,0
1,GO SKIN MORPHOGENESIS,0.00045924,0.49996,0.63011,0,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00027832,0.47262,0.52067,0,0
1,GO ETHANOL OXIDATION,0.010773,0.46201,0.42618,0,0
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0001165,0.44055,0.42483,0,0
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00010845,0.42,0.44515,0,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0017641,0.38153,0.48995,0,0
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.036948,0.3731,0.26486,0,0
1,GO ETHER BIOSYNTHETIC PROCESS,0.001228,0.37053,0.39182,0,0
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0049174,0.36404,0.32833,0,0
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.016339,0.36373,0.27931,0,0
1,GO NEGATIVE REGULATION OF WOUND HEALING,0.00014935,0.3613,0.38617,0,0
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.019739,0.34296,0.22206,0,0
1,GO PROTEIN HYDROXYLATION,0.0056288,0.34105,0.36545,0,0
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.016339,0.34035,0.37608,0,0
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.16294,0.332,0.1965,0,0
1,GO NADPH REGENERATION,0.00023468,0.32921,0.32807,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.012508,0.32783,0.18983,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00098941,0.32141,0.27787,0,0
1,GO PENTOSE METABOLIC PROCESS,0.0018173,0.31918,0.26189,0,0
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.0047853,0.3163,0.26792,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.10465,0.3143,0.1514,0,0
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.060602,0.31133,0.25049,0,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.065563,0.30232,0.27884,0,0
1,GO GLYCINE METABOLIC PROCESS,0.01282,0.30223,0.22872,0,0
1,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.0019282,0.29653,0.35974,0,0
1,GO PHAGOCYTOSIS RECOGNITION,0.0017641,0.28992,0.45696,0,0
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.022165,0.28801,0.27567,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0031536,0.28535,0.26584,0,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.010773,0.28398,0.40778,0,0
1,GO INTERLEUKIN 5 PRODUCTION,0.027803,0.28362,0.25541,0,0
1,GO MACROPHAGE DIFFERENTIATION,2.0033e-05,0.2823,0.35983,0,0
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.001872,0.28063,0.30361,0,0
1,GO FIBROBLAST ACTIVATION,0.00045924,0.27951,0.3285,0,0
1,GO TRABECULA FORMATION,0.0057817,0.27947,0.35518,0,0
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0073363,0.27946,0.27424,0,0
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,7.6603e-06,0.27825,0.25659,0,0
1,GO ASYMMETRIC CELL DIVISION,0.0017641,0.27633,0.24158,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.11434,0.27628,0.17399,0,0
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.017549,0.27516,0.21625,0,0
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.017137,0.27466,0.33889,0,0
1,GO HEPARIN METABOLIC PROCESS,0.027803,0.2716,0.29507,0,0
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.011612,0.27014,0.32429,0,0
1,GO RENAL VESICLE DEVELOPMENT,0.17374,0.2689,0.12103,0,0
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.001191,0.26799,0.23381,0,0
1,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.085627,0.26736,0.18773,0,0
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.21905,0.26671,0.15157,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.011326,0.26555,0.29292,0,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.033166,0.26543,0.20304,0,0
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.093897,0.26481,0.18409,0,0
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.0015189,0.26095,0.27211,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0050528,0.25869,0.24961,0,0
1,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.15015,0.25783,0.13008,0,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.044685,0.2549,0.36553,0,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.29184,0.25468,0.17915,0,0
1,GO EOSINOPHIL CHEMOTAXIS,0.11235,0.25318,0.264,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.093897,0.25216,0.25893,0,0
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.03939,0.25147,0.40019,0,0
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.0090226,0.24815,0.42178,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.055956,0.24698,0.20707,0,0
1,GO CARDIOLIPIN METABOLIC PROCESS,0.021165,0.24609,0.16619,0,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.4978,0.24453,0.18126,0,0
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.00022676,0.24332,0.24714,0,0
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0066042,0.24263,0.22718,0,0
1,GO REGULATION OF CALCIUM ION IMPORT,0.015953,0.24161,0.15445,0,0
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.40843,0.24125,0.10961,0,0
1,GO OXYGEN TRANSPORT,0.54903,0.24068,0.061542,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.12259,0.23959,0.11511,0,0
1,GO NUCLEOTIDE SALVAGE,0.16032,0.23881,0.22153,0,0
1,GO COMPLEMENT ACTIVATION,0.00092958,0.23792,0.2281,0,0
1,GO DNA LIGATION,0.00052342,0.23713,0.27782,0,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.001662,0.23605,0.27352,0,0
1,GO MITOCHONDRIAL DNA REPLICATION,0.00021167,0.23492,0.212,0,0
1,GO AMINOGLYCAN METABOLIC PROCESS,0.0019282,0.23332,0.22847,0,0
1,GO AMINE CATABOLIC PROCESS,0.0042883,0.23235,0.3154,0,0
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00035231,0.23093,0.26745,0,0
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0081404,0.23089,0.20731,0,0
1,GO GLUTATHIONE METABOLIC PROCESS,0.001872,0.23027,0.21936,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.036164,0.22958,0.1896,0,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0695,0.22893,0.2468,0,0
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.065563,0.22858,0.15446,0,0
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.036948,0.22851,0.35282,0,0
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.023741,0.22813,0.16212,0,0
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.063042,0.22758,0.31901,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.12049,0.22558,0.15651,0,0
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.10654,0.22268,0.23378,0,0
1,GO TRACHEA DEVELOPMENT,0.0060989,0.22186,0.25064,0,0
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.092194,0.22149,0.3215,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.027803,0.22001,0.28225,0,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.010506,0.21959,0.15011,0,0
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.17099,0.2192,0.12151,0,0
1,GO PLACENTA DEVELOPMENT,0.0013457,0.21915,0.19367,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.11235,0.21883,0.13114,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00087311,0.21687,0.35208,0,0
1,GO ETHANOL METABOLIC PROCESS,0.0083534,0.21647,0.30706,0,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0075304,0.21479,0.31537,0,0
1,GO LYSINE METABOLIC PROCESS,0.23589,0.21475,0.14096,0,0
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.024288,0.21399,0.17266,0,0
1,GO P38MAPK CASCADE,0.00020448,0.21368,0.30899,0,0
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0049174,0.21338,0.20503,0,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.0099891,0.21289,0.17529,0,0
1,GO REGULATION OF BMP SIGNALING PATHWAY,0.0099891,0.21284,0.2039,0,0
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.0053338,0.21259,0.15341,0,0
1,GO AMP METABOLIC PROCESS,0.084046,0.21059,0.21869,0,0
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.020205,0.21025,0.20218,0,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0036303,0.20984,0.18965,0,0
1,GO CELL JUNCTION DISASSEMBLY,0.11636,0.20878,0.11902,0,0
1,GO CELLULAR OXIDANT DETOXIFICATION,0.0041716,0.20594,0.16376,0,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.24288,0.20562,0.17641,0,0
1,GO NEGATIVE T CELL SELECTION,0.054842,0.20383,0.16179,0,0
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.014841,0.2033,0.11387,0,0
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.15517,0.20307,0.14964,0,0
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.001872,0.20253,0.17793,0,0
1,GO AMINO ACID ACTIVATION,0.010773,0.20154,0.18666,0,0
1,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.099158,0.2003,0.23693,0,0
1,GO GENITALIA MORPHOGENESIS,0.02268,0.20029,0.25234,0,0
1,GO RESPONSE TO INTERLEUKIN 4,0.00079435,0.19955,0.18518,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.11039,0.19944,0.18953,0,0
1,GO SCHWANN CELL DIFFERENTIATION,0.00095906,0.19785,0.18836,0,0
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.00054072,0.1955,0.19151,0,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.0094949,0.19532,0.15943,0,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.045624,0.19475,0.17151,0,0
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.12473,0.19458,0.17589,0,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0695,0.19424,0.11775,0,0
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0695,0.19389,0.1875,0,0
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00079435,0.19376,0.21149,0,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.060602,0.19308,0.1725,0,0
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.017137,0.19226,0.1634,0,0
1,GO REGULATION OF MESODERM DEVELOPMENT,0.35607,0.19209,0.1375,0,0
1,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.092194,0.19145,0.24011,0,0
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.14526,0.1908,0.12496,0,0
1,GO FIBROBLAST APOPTOTIC PROCESS,0.036948,0.19003,0.19438,0,0
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.057089,0.18999,0.1689,0,0
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.014138,0.18903,0.25948,0,0
1,GO PEPTIDYL ARGININE MODIFICATION,0.0013457,0.18864,0.14099,0,0
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.065563,0.18822,0.10552,0,0
1,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.061812,0.18793,0.16068,0,0
1,GO POSITIVE REGULATION OF CELL KILLING,0.080955,0.18737,0.11551,0,0
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.055956,0.18614,0.23124,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.061812,0.18596,0.16862,0,0
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0010206,0.18421,0.19971,0,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.12689,0.18382,0.079451,0,0
1,GO ALDITOL METABOLIC PROCESS,0.0016129,0.18344,0.22669,0,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.012508,0.18231,0.24807,0,0
1,GO ANOIKIS,0.10096,0.18169,0.13985,0,0
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.34702,0.18147,0.075088,0,0
1,GO NUCLEUS LOCALIZATION,0.092194,0.17989,0.11181,0,0
1,GO GAS TRANSPORT,0.23589,0.17923,0.1148,0,0
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.077957,0.17813,0.19538,0,0
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.44924,0.17709,0.074124,0,0
1,GO RESPONSE TO ISCHEMIA,0.00038934,0.17656,0.19071,0,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.32506,0.17646,0.12862,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.070855,0.1764,0.22748,0,0
1,GO NEUROINFLAMMATORY RESPONSE,0.11434,0.17636,0.17567,0,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.15264,0.17607,0.10952,0,0
1,GO BLASTOCYST FORMATION,0.0011199,0.17525,0.1667,0,0
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0069616,0.17506,0.12361,0,0
1,GO VACUOLAR TRANSPORT,0.0010528,0.17499,0.14663,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.073629,0.17493,0.24093,0,0
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0059384,0.17431,0.26319,0,0
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.188,0.17386,0.13065,0,0
1,GO T CELL DIFFERENTIATION IN THYMUS,0.00010092,0.17348,0.18511,0,0
1,GO TRANSEPITHELIAL TRANSPORT,0.0025083,0.17223,0.1703,0,0
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.49227,0.17193,0.1325,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0023671,0.17184,0.14995,0,0
1,GO LYSOSOMAL TRANSPORT,0.0013457,0.17139,0.16093,0,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.40349,0.17131,0.11772,0,0
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.093897,0.17121,0.1818,0,0
1,GO PROTEIN DEMANNOSYLATION,0.064293,0.17118,0.13708,0,0
1,GO LEFT RIGHT PATTERN FORMATION,0.021165,0.17109,0.2111,0,0
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.076492,0.17101,0.11027,0,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.00353,0.17057,0.16036,0,0
1,GO POSITIVE REGULATION OF WOUND HEALING,0.05824,0.17027,0.19935,0,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.16294,0.16989,0.17029,0,0
1,GO ANION HOMEOSTASIS,0.068167,0.16967,0.10071,0,0
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.011612,0.16907,0.17183,0,0
1,GO AMELOGENESIS,0.055956,0.16861,0.19304,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.036948,0.16759,0.14268,0,0
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0056288,0.16745,0.1475,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.25001,0.16732,0.24378,0,0
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00057693,0.1671,0.1448,0,0
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.10096,0.16699,0.092313,0,0
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.0069616,0.16669,0.20373,0,0
1,GO LAMELLIPODIUM ORGANIZATION,0.00059588,0.16612,0.21196,0,0
1,GO SEQUESTERING OF TRIGLYCERIDE,0.016734,0.16573,0.2713,0,0
1,GO IMP METABOLIC PROCESS,0.20937,0.16486,0.11547,0,0
1,GO PEPTIDYL ARGININE N METHYLATION,0.090515,0.16317,0.12134,0,0
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.21256,0.16317,0.08039,0,0
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0038387,0.16114,0.13758,0,0
1,GO RNA DECAPPING,0.0022992,0.16082,0.17221,0,0
1,GO MYOBLAST PROLIFERATION,0.20309,0.16006,0.090993,0,0
1,GO TRICARBOXYLIC ACID CYCLE,0.28785,0.16002,0.047788,0,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.001662,0.15995,0.19005,0,0
1,GO PLASMA MEMBRANE ORGANIZATION,0.02268,0.15957,0.11033,0,0
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.16559,0.15927,0.092554,0,0
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.060602,0.15887,0.20944,0,0
1,GO COPII COATED VESICLE CARGO LOADING,0.0016129,0.15842,0.17982,0,0
1,GO RNA STABILIZATION,0.015203,0.15833,0.13609,0,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.064293,0.15699,0.094083,0,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.20309,0.15627,0.067445,0,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.041967,0.15579,0.16047,0,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.013798,0.15539,0.15424,0,0
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.020205,0.15472,0.2356,0,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.016734,0.15433,0.13174,0,0
1,GO HEART TRABECULA FORMATION,0.34702,0.15432,0.12699,0,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.079444,0.15422,0.1738,0,0
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.17099,0.15365,0.23814,0,0
1,GO INTEGRIN ACTIVATION,0.017137,0.15167,0.16545,0,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.087232,0.15166,0.10555,0,0
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.049546,0.15161,0.13139,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.023205,0.15153,0.29717,0,0
1,GO FUCOSE METABOLIC PROCESS,0.188,0.15131,0.078698,0,0
1,GO ACTIVATION OF JNKK ACTIVITY,0.023205,0.1507,0.15431,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.31653,0.15012,0.066179,0,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.041093,0.15001,0.16727,0,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.0023671,0.14963,0.1421,0,0
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.037747,0.14949,0.21522,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.22235,0.14927,0.036279,0,0
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.021165,0.14916,0.19596,0,0
1,GO LAMELLIPODIUM ASSEMBLY,0.0025083,0.14892,0.16976,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.13355,0.14852,0.13192,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.98953,0.14849,0.023352,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.33812,0.14833,0.055103,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.013798,0.148,0.18279,0,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.093897,0.1479,0.08821,0,0
1,GO MALE GENITALIA DEVELOPMENT,0.21905,0.14772,0.076335,0,0
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.055956,0.14725,0.15416,0,0
1,GO REGULATION OF GONAD DEVELOPMENT,0.8303,0.14709,-0.037448,0,0
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.036164,0.1464,0.20162,0,0
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.14048,0.14633,0.077204,0,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.1313,0.14564,0.098494,0,0
1,GO GOLGI LOCALIZATION,0.30815,0.14502,0.10003,0,0
1,GO TRNA CATABOLIC PROCESS,0.12908,0.14498,0.20929,0,0
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0054795,0.14453,0.13341,0,0
1,GO PEPTIDYL ARGININE METHYLATION,0.066855,0.14385,0.11717,0,0
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.12049,0.14331,0.10849,0,0
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.00084609,0.14297,0.159,0,0
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.19695,0.14292,0.080998,0,0
1,GO NAD BIOSYNTHETIC PROCESS,0.12689,0.14261,0.14757,0,0
1,GO AMYLOID BETA FORMATION,0.15015,0.1423,0.095318,0,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.188,0.14222,0.070896,0,0
1,GO RENAL FILTRATION,0.11039,0.14166,0.16041,0,0
1,GO LIVER MORPHOGENESIS,0.092194,0.1414,0.15212,0,0
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.11434,0.14132,0.16214,0,0
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.077957,0.14105,0.21142,0,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.054842,0.1408,0.083507,0,0
1,GO EXTRACELLULAR TRANSPORT,0.15015,0.14052,0.091719,0,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.31232,0.14003,0.20093,0,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.015953,0.13972,0.11435,0,0
1,GO ERYTHROCYTE MATURATION,0.011326,0.13963,0.2281,0,0
1,GO MIDGUT DEVELOPMENT,0.35607,0.13942,0.10059,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.22235,0.13941,0.073962,0,0
1,GO TRABECULA MORPHOGENESIS,0.02843,0.13919,0.18404,0,0
1,GO ELECTRON TRANSPORT CHAIN,0.0087944,0.139,0.11245,0,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.011326,0.13865,0.11991,0,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.070855,0.13864,0.13109,0,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.018836,0.13839,0.13773,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0062634,0.13836,0.15839,0,0
1,GO ACTIVATED T CELL PROLIFERATION,0.17653,0.13829,0.084253,0,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.78962,0.13815,0.12549,0,0
1,GO SECRETION BY TISSUE,0.05824,0.13811,0.16183,0,0
1,GO ISOPRENOID METABOLIC PROCESS,0.11841,0.13773,0.094797,0,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.079444,0.13712,0.13276,0,0
1,GO REGULATION OF ENDOCYTOSIS,0.013139,0.13709,0.10573,0,0
1,GO REGULATION OF TISSUE REMODELING,0.090515,0.13683,0.079815,0,0
1,GO MONOSACCHARIDE CATABOLIC PROCESS,0.12908,0.13647,0.067541,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.25729,0.1363,0.035093,0,0
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.029719,0.13597,0.21114,0,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.3746,0.13591,0.0081117,0,0
1,GO STEROL HOMEOSTASIS,0.064293,0.1357,0.085561,0,0
1,GO XENOBIOTIC TRANSPORT,0.059411,0.13563,0.15667,0,0
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.14769,0.13549,0.10545,0,0
1,GO REGULATION OF PROTON TRANSPORT,0.017137,0.13498,0.16853,0,0
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.040234,0.13471,0.17964,0,0
1,GO STEROID ESTERIFICATION,0.20309,0.13444,0.11831,0,0
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.073629,0.1343,0.14386,0,0
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0045306,0.13415,0.20023,0,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.03939,0.13373,0.15506,0,0
1,GO MUSCLE ADAPTATION,0.087232,0.13341,0.08315,0,0
1,GO REGULATION OF CELLULAR RESPIRATION,0.23937,0.13316,0.076311,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.29184,0.13289,0.071417,0,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.064293,0.13287,0.10055,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.029068,0.13238,0.20867,0,0
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.23245,0.13213,0.16109,0,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,0.088862,0.13152,0.094712,0,0
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.12049,0.13118,0.079119,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.065563,0.13109,0.2054,0,0
1,GO RESPONSE TO VITAMIN A,0.16294,0.13041,0.093519,0,0
1,GO L PHENYLALANINE METABOLIC PROCESS,0.14769,0.13027,0.082352,0,0
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00084609,0.13015,0.11845,0,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.23245,0.1297,0.064439,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.31232,0.12957,0.1483,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.035393,0.1293,0.15624,0,0
1,GO RESPONSE TO LEPTIN,0.05161,0.12928,0.15102,0,0
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.059411,0.12928,0.19746,0,0
1,GO MIRNA METABOLIC PROCESS,0.0051916,0.12895,0.14777,0,0
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.39858,0.12882,0.044973,0,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0062634,0.12811,0.16599,0,0
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.53742,0.12746,0.030575,0,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.22905,0.12745,0.057169,0,0
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.24643,0.12696,0.17029,0,0
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.17934,0.1269,0.10192,0,0
1,GO LIPID DIGESTION,0.39858,0.12679,0.031475,0,0
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.44924,0.12665,0.12184,0,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.64605,0.12662,0.023771,0,0
1,GO RESPONSE TO INTERLEUKIN 6,0.11636,0.12644,0.094975,0,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.40349,0.12625,0.10492,0,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.02166,0.12605,0.17584,0,0
1,GO REVERSE CHOLESTEROL TRANSPORT,0.42347,0.12519,0.051,0,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.021165,0.12504,0.084751,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.22905,0.12493,0.12709,0,0
1,GO INTRACELLULAR STEROL TRANSPORT,0.4598,0.12487,0.037956,0,0
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.001662,0.12466,0.11995,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.31232,0.12441,0.1492,0,0
1,GO REGULATION OF TELOMERASE ACTIVITY,0.025414,0.1244,0.1242,0,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.12259,0.12407,0.049201,0,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.073629,0.1229,0.10511,0,0
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.00353,0.12281,0.19913,0,0
1,GO AMYLOID BETA METABOLIC PROCESS,0.12908,0.12281,0.087512,0,0
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0060989,0.12251,0.11351,0,0
1,GO PIRNA METABOLIC PROCESS,0.38408,0.12242,0.13568,0,0
1,GO SPHINGOID METABOLIC PROCESS,0.082489,0.12236,0.075626,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.89907,0.12192,-0.047936,0,0
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.8303,0.12161,-0.0078757,0,0
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.029719,0.12141,0.12932,0,0
1,GO PROTEIN KINASE C SIGNALING,0.68418,0.12136,-0.024001,0,0
1,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.24643,0.12135,0.068799,0,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.13355,0.12126,0.099338,0,0
1,GO INACTIVATION OF MAPK ACTIVITY,0.40843,0.12098,0.10332,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.23589,0.12093,0.10753,0,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.13583,0.12067,0.092851,0,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.11841,0.12067,0.15325,0,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.19095,0.12055,0.038641,0,0
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0027346,0.11978,0.10976,0,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.043763,0.11942,0.11195,0,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.11235,0.11942,0.17932,0,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.29586,0.11936,0.17549,0,0
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.36526,0.11901,0.12839,0,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.052669,0.11895,0.096961,0,0
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.15517,0.11858,0.089827,0,0
1,GO REGULATION OF AMYLOID BETA FORMATION,0.20937,0.11856,0.089796,0,0
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.035393,0.11851,0.075327,0,0
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.046579,0.11822,0.14724,0,0
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00052342,0.11811,0.13536,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.38408,0.11811,0.091267,0,0
1,GO B CELL PROLIFERATION,0.46512,0.11791,0.020309,0,0
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.099158,0.11742,0.13302,0,0
1,GO COLLECTING DUCT DEVELOPMENT,0.26471,0.1169,0.092997,0,0
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0097392,0.11685,0.17775,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.12049,0.11669,0.18358,0,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.068167,0.11661,0.096902,0,0
1,GO MITOTIC CELL CYCLE ARREST,0.26471,0.11614,0.082862,0,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.53742,0.11587,0.10076,0,0
1,GO MRNA CLEAVAGE,0.00047456,0.11584,0.13511,0,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.026586,0.11536,0.11716,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.53742,0.11524,0.16097,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.61497,0.1145,0.010297,0,0
1,GO NAD METABOLIC PROCESS,0.20621,0.11402,0.093738,0,0
1,GO HEXOSE CATABOLIC PROCESS,0.26471,0.11391,0.039846,0,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.62113,0.11386,0.0082855,0,0
1,GO RESPONSE TO ATP,0.05161,0.11372,0.091854,0,0
1,GO PROTEIN STABILIZATION,0.0011549,0.11335,0.12883,0,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.087232,0.11304,0.12292,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.56075,0.11288,0.020452,0,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,0.0031536,0.1128,0.14721,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.1028,0.11218,0.18515,0,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.23589,0.11182,0.072493,0,0
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.019283,0.1118,0.078868,0,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.13814,0.11176,0.10607,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0054795,0.11127,0.08802,0,0
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0695,0.11125,0.085282,0,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.32506,0.11109,0.064158,0,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.32077,0.11106,0.0385,0,0
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.41341,0.11101,0.045982,0,0
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.25363,0.11088,0.11656,0,0
1,GO FOLIC ACID METABOLIC PROCESS,0.21579,0.11081,0.05906,0,0
1,GO LEUKOCYTE CHEMOTAXIS,0.097379,0.1106,0.13635,0,0
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.097379,0.11036,0.1178,0,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.084046,0.10984,0.13103,0,0
1,GO CELLULAR PIGMENTATION,0.070855,0.10983,0.095223,0,0
1,GO RESPONSE TO HYDROPEROXIDE,0.43883,0.10974,0.10942,0,0
1,GO COENZYME A METABOLIC PROCESS,0.16828,0.10957,0.090251,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.91987,0.10919,-0.0026485,0,0
1,GO LIPID HOMEOSTASIS,0.072231,0.10914,0.053855,0,0
1,GO INTERLEUKIN 6 PRODUCTION,0.19393,0.10912,0.099911,0,0
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.30402,0.10896,0.094167,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.4545,0.10889,0.065975,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.14769,0.10865,0.069804,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.43883,0.10827,0.043485,0,0
1,GO LATERAL VENTRICLE DEVELOPMENT,0.12908,0.10817,0.1568,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.55487,0.10794,0.016468,0,0
1,GO ENGULFMENT OF APOPTOTIC CELL,0.50896,0.10788,0.021627,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.26471,0.10762,0.11719,0,0
1,GO REGULATION OF MAST CELL ACTIVATION,0.075049,0.10746,0.14638,0,0
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.12689,0.10728,0.11014,0,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.49227,0.1071,0.02541,0,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.26847,0.10708,0.085526,0,0
1,GO GLIAL CELL MIGRATION,0.11039,0.10696,0.11795,0,0
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0021062,0.10688,0.12405,0,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.045624,0.10673,0.12143,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.068167,0.10664,0.084585,0,0
1,GO PROSTATE GLAND MORPHOGENESIS,0.44924,0.10644,0.14728,0,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.026586,0.10623,0.083252,0,0
1,GO ER NUCLEUS SIGNALING PATHWAY,0.41341,0.10603,0.040547,0,0
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.001228,0.10557,0.18316,0,0
1,GO PERICARDIUM DEVELOPMENT,0.018836,0.1051,0.18255,0,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.11235,0.10509,0.073363,0,0
1,GO VITAMIN D METABOLIC PROCESS,0.19393,0.10499,0.14436,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.27999,0.10419,0.086629,0,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.59664,0.104,0.038811,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.40843,0.10379,0.093473,0,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.27227,0.10369,0.11517,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.040234,0.10344,0.09283,0,0
1,GO HISTONE ARGININE METHYLATION,0.23937,0.10344,0.063469,0,0
1,GO CARNITINE SHUTTLE,0.080955,0.10325,0.13615,0,0
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.076492,0.10318,0.18722,0,0
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0023671,0.10292,0.1301,0,0
1,GO FAT CELL DIFFERENTIATION,0.061812,0.10288,0.074778,0,0
1,GO OVULATION CYCLE PROCESS,0.33812,0.10287,0.061378,0,0
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.085627,0.10222,0.089957,0,0
1,GO MINERALOCORTICOID METABOLIC PROCESS,0.33812,0.10201,0.11771,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.055956,0.10177,0.1531,0,0
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.060602,0.1012,0.11275,0,0
1,GO REGULATION OF ATP METABOLIC PROCESS,0.097379,0.1012,0.060006,0,0
1,GO LYTIC VACUOLE ORGANIZATION,0.33812,0.10115,0.023447,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.077957,0.10106,0.16581,0,0
1,GO PYRUVATE METABOLIC PROCESS,0.60883,0.10073,0.021272,0,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.20621,0.10073,0.10856,0,0
1,GO REGULATION OF BONE MINERALIZATION,0.10465,0.10064,0.15114,0,0
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.4545,0.1004,0.084037,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.010506,0.10039,0.11162,0,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.001986,0.10026,0.10751,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.30815,0.10012,0.053152,0,0
1,GO ALCOHOL METABOLIC PROCESS,0.054842,0.10003,0.066375,0,0
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.18508,0.099761,0.12163,0,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.15015,0.0997,0.091903,0,0
1,GO OXALATE TRANSPORT,0.38888,0.099479,0.038065,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.21579,0.099475,0.11772,0,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.0695,0.099273,0.094612,0,0
1,GO THIOESTER METABOLIC PROCESS,0.14048,0.098845,0.084558,0,0
1,GO REGULATION OF FATTY ACID OXIDATION,0.41842,0.098392,0.05411,0,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.32506,0.098194,0.082305,0,0
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.13814,0.098172,0.13599,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.15517,0.098147,0.061917,0,0
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.11636,0.097964,0.16073,0,0
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.079444,0.097892,0.060474,0,0
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.072231,0.097866,0.080839,0,0
1,GO RESPONSE TO PH,0.11841,0.097757,0.12936,0,0
1,GO HEAD MORPHOGENESIS,0.027803,0.09765,0.19853,0,0
1,GO PROTEIN SUMOYLATION,0.070855,0.097258,0.077201,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.30402,0.097206,0.066392,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.38888,0.096612,0.08061,0,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.11841,0.096533,0.11077,0,0
1,GO HEART TRABECULA MORPHOGENESIS,0.19393,0.096442,0.092383,0,0
1,GO RESPONSE TO STEROL,0.16828,0.096247,0.090676,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.15773,0.095992,0.097088,0,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.24643,0.095923,0.035807,0,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.020205,0.095801,0.098729,0,0
1,GO GOLGI RIBBON FORMATION,0.14769,0.094949,0.13018,0,0
1,GO MANGANESE ION TRANSPORT,0.20621,0.094835,0.10797,0,0
1,GO RESPONSE TO GONADOTROPIN,0.073629,0.094305,0.17135,0,0
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.88523,0.094148,-0.020881,0,0
1,GO B CELL APOPTOTIC PROCESS,0.61497,0.093761,0.010643,0,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0075304,0.09351,0.16721,0,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.34702,0.093484,0.055968,0,0
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.066855,0.093447,0.088101,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.28785,0.093319,0.096336,0,0
1,GO COCHLEA MORPHOGENESIS,0.81668,0.093287,-0.030358,0,0
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.011047,0.092602,0.084116,0,0
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.22235,0.09226,0.051114,0,0
1,GO INTESTINAL LIPID ABSORPTION,0.29184,0.092128,0.058082,0,0
1,GO RESPONSE TO GROWTH FACTOR,0.009256,0.092111,0.12628,0,0
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.085627,0.091779,0.13204,0,0
1,GO DNA REPLICATION INITIATION,0.20309,0.091601,0.050706,0,0
1,GO RESPONSE TO NUTRIENT,0.25729,0.091502,0.069098,0,0
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0094949,0.091334,0.081324,0,0
1,GO REGULATION OF B CELL DIFFERENTIATION,0.63354,0.091295,0.070403,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.59059,0.091265,0.051567,0,0
1,GO PHOSPHOLIPID HOMEOSTASIS,0.16559,0.091144,0.13921,0,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.56666,0.091008,0.022032,0,0
1,GO REGULATION OF B CELL PROLIFERATION,0.66501,0.090847,-0.0054981,0,0
1,GO PIGMENT CELL DIFFERENTIATION,0.43883,0.090835,0.065249,0,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.20937,0.090624,0.099583,0,0
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.22905,0.090181,0.036125,0,0
1,GO POSITIVE REGULATION OF OSSIFICATION,0.21579,0.08995,0.1073,0,0
1,GO FLUID TRANSPORT,0.040234,0.08976,0.095969,0,0
1,GO NEGATIVE REGULATION OF SIGNALING,0.007729,0.089732,0.087781,0,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.11039,0.089624,0.27644,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0014738,0.089227,0.11481,0,0
1,GO FATTY ACID HOMEOSTASIS,0.35607,0.088891,0.054387,0,0
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.48678,0.088799,0.040277,0,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.12049,0.088764,0.069994,0,0
1,GO T CELL LINEAGE COMMITMENT,0.027188,0.088542,0.13023,0,0
1,GO MYELIN MAINTENANCE,0.56075,0.088396,0.046495,0,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.27227,0.088084,0.12692,0,0
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.057089,0.087934,0.37584,0,0
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.050569,0.087566,0.12632,0,0
1,GO RESPONSE TO VITAMIN,0.46512,0.087443,0.07684,0,0
1,GO GLIAL CELL DEVELOPMENT,0.43367,0.087071,0.026003,0,0
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.019283,0.087037,0.1365,0,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.2,0.086947,0.057816,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.12689,0.086394,0.13536,0,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00067758,0.086291,0.097239,0,0
1,GO ENDOCYTOSIS,0.009256,0.086194,0.10299,0,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.59664,0.085861,0.0043753,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.10465,0.085813,0.10052,0,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.28785,0.085743,0.048292,0,0
1,GO RESPONSE TO IRON ION,0.10654,0.085685,0.10755,0,0
1,GO MICROVILLUS ASSEMBLY,0.31653,0.085634,0.076319,0,0
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.15773,0.084999,0.087373,0,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.093897,0.08495,0.13134,0,0
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.015574,0.084843,0.10019,0,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.14526,0.084601,0.080711,0,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.26847,0.084528,0.094102,0,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.98953,0.084386,-0.030681,0,0
1,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.17934,0.084318,0.11322,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.052669,0.083992,0.1303,0,0
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.17653,0.083979,0.11681,0,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.23245,0.083955,0.090182,0,0
1,GO POLYOL BIOSYNTHETIC PROCESS,0.11434,0.083423,0.048864,0,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.63978,0.083294,0.037765,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0047853,0.083163,0.066217,0,0
1,GO CENTROSOME DUPLICATION,0.064293,0.083025,0.090664,0,0
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.24643,0.083008,0.038332,0,0
1,GO KERATINOCYTE DIFFERENTIATION,0.20621,0.082897,0.12547,0,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.65234,0.082681,0.018177,0,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.12049,0.082442,0.06987,0,0
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.025994,0.082129,0.090953,0,0
1,GO DNA GEOMETRIC CHANGE,0.029719,0.08162,0.11552,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.24288,0.081471,0.20313,0,0
1,GO KINETOCHORE ORGANIZATION,0.26847,0.081344,0.085805,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.30402,0.081307,0.05072,0,0
1,GO NUCLEOTIDE PHOSPHORYLATION,0.4978,0.081222,0.023931,0,0
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.16559,0.081171,0.050428,0,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.25001,0.081128,0.073704,0,0
1,GO RESPONSE TO WATER,0.85082,0.080941,0.0079415,0,0
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.13583,0.08093,0.064689,0,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.12689,0.080749,0.10928,0,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.057089,0.080502,0.054332,0,0
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.034637,0.080452,0.059552,0,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.39858,0.080078,0.057757,0,0
1,GO MACROPHAGE ACTIVATION,0.12908,0.080018,0.12144,0,0
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.26847,0.080004,0.075762,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.11434,0.079923,0.12155,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.39371,0.079801,0.030766,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.1028,0.079793,0.082856,0,0
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.095625,0.079326,0.087593,0,0
1,GO MULTI ORGANISM PROCESS,0.05824,0.079298,0.03715,0,0
1,GO FATTY ACID TRANSPORT,0.10845,0.079145,0.063857,0,0
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.54903,0.079083,0.046533,0,0
1,GO EPITHELIAL CELL CELL ADHESION,0.46512,0.079034,0.16276,0,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.15773,0.07869,0.088126,0,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.18219,0.078475,0.062443,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.81668,0.078468,0.15022,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.19095,0.078423,0.051249,0,0
1,GO TERPENOID METABOLIC PROCESS,0.28785,0.078365,0.073637,0,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.87144,0.078319,-0.01224,0,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.15773,0.077889,0.051711,0,0
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.27227,0.0778,0.073781,0,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.2,0.077582,0.14928,0,0
1,GO STEROID METABOLIC PROCESS,0.21256,0.077547,0.027803,0,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.62113,0.077484,0.048262,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.98255,0.077465,-0.027117,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.44924,0.077396,0.052701,0,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.13814,0.077115,0.094518,0,0
1,GO ACTIN FILAMENT NETWORK FORMATION,0.69061,0.077061,0.049127,0,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.090515,0.077036,0.051311,0,0
1,GO SULFATE TRANSPORT,0.03939,0.077033,0.082838,0,0
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.22568,0.077031,0.034561,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.39858,0.076941,0.056074,0,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,0.27999,0.07679,0.02201,0,0
1,GO CELLULAR RESPONSE TO KETONE,0.36991,0.076654,0.033053,0,0
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.014841,0.076609,0.090709,0,0
1,GO MALE SEX DIFFERENTIATION,0.11434,0.076574,0.094716,0,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.98255,0.076434,0.060181,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.28785,0.076403,0.069207,0,0
1,GO CELL PROLIFERATION IN HINDBRAIN,0.23589,0.076345,0.098344,0,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.092194,0.076329,0.062715,0,0
1,GO SULFATION,0.29992,0.076201,0.11401,0,0
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.42855,0.076133,0.070358,0,0
1,GO NEURAL CREST FORMATION,0.90599,0.075967,0.014521,0,0
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.065563,0.075955,0.068328,0,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.055956,0.075937,0.098607,0,0
1,GO INTERLEUKIN 12 PRODUCTION,0.20309,0.075755,0.080696,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.057089,0.075747,0.075863,0,0
1,GO NODAL SIGNALING PATHWAY,0.47049,0.075604,0.049171,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.12259,0.075176,0.11191,0,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.14285,0.075172,0.10386,0,0
1,GO CHROMATIN DISASSEMBLY,0.56075,0.075013,0.010796,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.12049,0.074471,0.076817,0,0
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.25363,0.073851,0.064935,0,0
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.41341,0.073687,0.049005,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.51459,0.073664,0.11888,0,0
1,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.54903,0.073556,0.037575,0,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.74288,0.073541,0.024468,0,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.32077,0.073471,0.029558,0,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.16294,0.073462,0.043133,0,0
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.22905,0.073294,0.053203,0,0
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.35153,0.073171,0.03946,0,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.2,0.073048,0.14806,0,0
1,GO BIOLOGICAL ADHESION,0.065563,0.073046,0.094376,0,0
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.17934,0.072883,0.10567,0,0
1,GO RESPIRATORY BURST,0.53167,0.072495,0.03201,0,0
1,GO KETONE CATABOLIC PROCESS,0.60883,0.072333,0.07034,0,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.35153,0.072214,0.10648,0,0
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.14769,0.07217,0.10607,0,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.033166,0.072057,0.31159,0,0
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.33373,0.071557,0.062424,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.27227,0.071422,0.037374,0,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.090515,0.071315,0.059135,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.037747,0.071161,0.14139,0,0
1,GO CELL MOTILITY,0.060602,0.071126,0.079206,0,0
1,GO HISTONE DEUBIQUITINATION,0.26471,0.071015,0.054538,0,0
1,GO RESPONSE TO UV B,0.47588,0.07095,0.10715,0,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.092194,0.070765,0.16982,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.20937,0.070703,0.10125,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.85768,0.070652,0.029405,0,0
1,GO REGULATION OF MUSCLE ADAPTATION,0.35607,0.070652,0.039218,0,0
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.14769,0.070592,0.18783,0,0
1,GO SEQUESTERING OF CALCIUM ION,0.16559,0.070576,0.064988,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.62732,0.070555,0.084057,0,0
1,GO STEROL METABOLIC PROCESS,0.46512,0.07038,0.018312,0,0
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.43367,0.070123,0.047388,0,0
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0090226,0.06994,0.10259,0,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.4978,0.069895,0.0031591,0,0
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.052669,0.069692,0.12357,0,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.40349,0.06956,0.1209,0,0
1,GO RESPONSE TO NITRIC OXIDE,0.4598,0.069371,0.053359,0,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.39858,0.06936,0.068158,0,0
1,GO RESPONSE TO TOXIC SUBSTANCE,0.52594,0.069053,0.017294,0,0
1,GO OVULATION CYCLE,0.19695,0.068509,0.10108,0,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.14769,0.068394,0.042942,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.72969,0.067837,0.059112,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.21905,0.067755,0.18454,0,0
1,GO MITOCHONDRION ORGANIZATION,0.0029794,0.067695,0.076056,0,0
1,GO NEUTROPHIL CHEMOTAXIS,0.25001,0.067281,0.15818,0,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.064293,0.067277,0.078383,0,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.37932,0.066826,0.047873,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.041967,0.066812,0.069104,0,0
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.12473,0.066541,0.067219,0,0
1,GO DIOL METABOLIC PROCESS,0.44402,0.066356,0.031762,0,0
1,GO PROTEIN DESTABILIZATION,0.26471,0.065932,0.038651,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.34256,0.065368,0.058246,0,0
1,GO CELL CELL ADHESION,0.32506,0.065342,0.045124,0,0
1,GO CHOLESTEROL STORAGE,0.51459,0.065054,0.076313,0,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.17099,0.064972,0.091794,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.03939,0.064966,0.089485,0,0
1,GO MYELOID CELL DEVELOPMENT,0.188,0.064467,0.07237,0,0
1,GO RESPONSE TO COPPER ION,0.44402,0.064379,0.084501,0,0
1,GO HISTONE H2A ACETYLATION,0.34256,0.064297,0.04135,0,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.50337,0.064293,0.037683,0,0
1,GO ATP METABOLIC PROCESS,0.066855,0.064126,0.06263,0,0
1,GO PROTEIN AUTOPHOSPHORYLATION,0.095625,0.063779,0.069646,0,0
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.19095,0.063454,0.056505,0,0
1,GO MAMMARY GLAND DEVELOPMENT,0.14048,0.063394,0.092857,0,0
1,GO GLYCEROLIPID METABOLIC PROCESS,0.053746,0.063351,0.050091,0,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.59664,0.063253,0.02999,0,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.17374,0.063244,0.082656,0,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.26471,0.063021,0.041119,0,0
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.05824,0.06294,0.12745,0,0
1,GO ACTIVATION OF MAPK ACTIVITY,0.1028,0.062924,0.058227,0,0
1,GO TISSUE HOMEOSTASIS,0.15264,0.062816,0.050694,0,0
1,GO ACETYL COA METABOLIC PROCESS,0.49227,0.062704,0.035264,0,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.1028,0.06264,0.074272,0,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.13583,0.062584,0.094363,0,0
1,GO APICAL JUNCTION ASSEMBLY,0.13583,0.062473,0.12661,0,0
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.69061,0.062392,0.027247,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.36064,0.062267,0.094205,0,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.69707,0.062245,0.0070007,0,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.26471,0.062168,0.092234,0,0
1,GO URONIC ACID METABOLIC PROCESS,0.36526,0.062151,0.041218,0,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,0.73628,0.062038,0.03915,0,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.8303,0.061814,0.1167,0,0
1,GO NADH METABOLIC PROCESS,0.38408,0.061784,0.059245,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.48678,0.06173,0.019736,0,0
1,GO CELL CYCLE ARREST,0.12259,0.06167,0.046515,0,0
1,GO DENDRITIC SPINE MAINTENANCE,0.19393,0.061495,0.1111,0,0
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.021165,0.061405,0.11174,0,0
1,GO HISTONE H3 K9 ACETYLATION,0.41842,0.061328,0.050949,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.29586,0.061298,0.10917,0,0
1,GO BONE CELL DEVELOPMENT,0.53167,0.061201,0.0472,0,0
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.13355,0.061166,0.053634,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.36064,0.061156,0.044652,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.41842,0.061041,0.030221,0,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.064293,0.061034,0.10331,0,0
1,GO EPITHELIUM DEVELOPMENT,0.10096,0.060936,0.075215,0,0
1,GO HISTONE H3 K27 METHYLATION,0.4545,0.060859,0.039314,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.31653,0.060584,0.13635,0,0
1,GO CALCINEURIN MEDIATED SIGNALING,0.39371,0.060444,0.049805,0,0
1,GO PROTEIN AUTOUBIQUITINATION,0.12049,0.060198,0.049147,0,0
1,GO REGULATION OF TELOMERE CAPPING,0.48678,0.059732,0.022028,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.099158,0.059721,0.080286,0,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.053746,0.059695,0.12353,0,0
1,GO GMP METABOLIC PROCESS,0.86455,0.059605,-0.0067701,0,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.29586,0.059543,0.060467,0,0
1,GO RESPONSE TO SALT,0.72969,0.059492,-0.018369,0,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.26098,0.059461,0.042588,0,0
1,GO REGULATION OF TUBE SIZE,0.21579,0.059309,0.068478,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.35153,0.05929,0.097697,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.83713,0.05927,-0.0032433,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.40349,0.058616,0.038568,0,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.19393,0.058594,0.15551,0,0
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.25001,0.058516,0.059578,0,0
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.053746,0.058396,0.079631,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.47049,0.058283,0.030519,0,0
1,GO DISACCHARIDE METABOLIC PROCESS,0.30402,0.057847,0.082309,0,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.2839,0.057784,0.050281,0,0
1,GO CARDIOCYTE DIFFERENTIATION,0.088862,0.057503,0.114,0,0
1,GO METHIONINE METABOLIC PROCESS,0.78289,0.057346,-0.032085,0,0
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.32938,0.056636,0.10472,0,0
1,GO NEURON PROJECTION REGENERATION,0.77618,0.056622,-0.0016787,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.71006,0.05661,0.0058673,0,0
1,GO PROSTAGLANDIN SECRETION,0.093897,0.056519,0.11858,0,0
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.059411,0.056398,0.064256,0,0
1,GO RESPONSE TO PROSTAGLANDIN E,0.67137,0.056255,0.024508,0,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.30402,0.056023,0.16652,0,0
1,GO ODONTOGENESIS,0.11841,0.055814,0.12202,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.33812,0.055813,0.075237,0,0
1,GO ENDOSOMAL TRANSPORT,0.023205,0.055684,0.077908,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.4978,0.055384,0.070555,0,0
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.099158,0.055361,0.068771,0,0
1,GO AMMONIUM TRANSPORT,0.12049,0.055347,0.13319,0,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0053338,0.054857,0.074243,0,0
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.12259,0.054847,0.046298,0,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.87833,0.054579,-0.03751,0,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.56666,0.054531,0.016069,0,0
1,GO CHLORIDE ION HOMEOSTASIS,0.64605,0.054489,0.022581,0,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.2839,0.054477,0.099757,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,0.96163,0.054236,0.0088377,0,0
1,GO RESPONSE TO ACIDIC PH,0.42855,0.0539,0.046906,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.98255,0.053589,0.019203,0,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.24288,0.05348,0.033593,0,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.20309,0.053458,0.077304,0,0
1,GO RESPONSE TO RADIATION,0.088862,0.053309,0.038365,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.61497,0.053146,0.023957,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.15517,0.052936,0.036127,0,0
1,GO DNA METHYLATION,0.5726,0.052655,0.010499,0,0
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.14285,0.052607,0.09456,0,0
1,GO PROSTAGLANDIN TRANSPORT,0.53167,0.052512,0.017057,0,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.39858,0.052035,0.069638,0,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.39858,0.051963,0.10403,0,0
1,GO REGULATION OF CELL SHAPE,0.050569,0.051665,0.135,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.35153,0.051594,0.093892,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.27999,0.051395,0.1004,0,0
1,GO POLYOL METABOLIC PROCESS,0.072231,0.051378,0.058704,0,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.14048,0.051338,0.037686,0,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.029719,0.051299,0.10637,0,0
1,GO HOMEOSTATIC PROCESS,0.49227,0.051231,0.0089713,0,0
1,GO CYTOKINE SECRETION,0.59059,0.050984,0.051688,0,0
1,GO REGULATION OF PROTEIN DEACETYLATION,0.7495,0.05094,-0.03016,0,0
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.23589,0.050807,0.14468,0,0
1,GO NOTCH RECEPTOR PROCESSING,0.54321,0.050769,0.06133,0,0
1,GO HEART VALVE FORMATION,0.94073,0.050734,0.0097191,0,0
1,GO NEGATIVE REGULATION OF GROWTH,0.36526,0.050453,0.033829,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.98953,0.050324,-0.015492,0,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.49227,0.050143,0.079475,0,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.65866,0.05,0.036019,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,0.17934,0.049563,0.063236,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.40349,0.04939,0.045776,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.12473,0.049102,0.058112,0,0
1,GO JNK CASCADE,0.17099,0.049037,0.045658,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.73628,0.049035,0.014326,0,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.34256,0.048877,0.026175,0,0
1,GO REGULATION OF MACROAUTOPHAGY,0.017969,0.048796,0.098069,0,0
1,GO RESPONSE TO STEROL DEPLETION,0.91987,0.048757,-0.015523,0,0
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.15015,0.048735,0.049449,0,0
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.19095,0.048647,0.11698,0,0
1,GO ENSHEATHMENT OF NEURONS,0.8303,0.048526,-0.0069173,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.42347,0.048417,0.05863,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.23589,0.048339,0.085945,0,0
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.36526,0.048177,0.055707,0,0
1,GO VITAMIN METABOLIC PROCESS,0.099158,0.048156,0.060516,0,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.0695,0.047968,0.049861,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.81668,0.047893,-0.048462,0,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.26847,0.047863,0.10268,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.18219,0.047779,0.049203,0,0
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.12689,0.04769,0.12028,0,0
1,GO PEPTIDYL SERINE MODIFICATION,0.23245,0.047639,0.038873,0,0
1,GO NUCLEAR MIGRATION,0.4978,0.047507,0.04609,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,0.30815,0.047495,0.063392,0,0
1,GO HISTONE H3 DEACETYLATION,0.37932,0.047461,0.052151,0,0
1,GO DNA REPLICATION CHECKPOINT,0.43367,0.047366,0.03918,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.92682,0.047259,-0.0001723,0,0
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.090515,0.047171,0.13613,0,0
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.67776,0.047169,0.028511,0,0
1,GO RESPONSE TO PROSTAGLANDIN,0.4545,0.047166,0.073366,0,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.43883,0.0471,0.021103,0,0
1,GO SKIN DEVELOPMENT,0.19393,0.047054,0.11464,0,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.63978,0.047019,0.04051,0,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.31653,0.046535,0.036426,0,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.4545,0.046432,0.1638,0,0
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.78289,0.046421,0.057684,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.25729,0.046397,0.096728,0,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.62732,0.046291,0.018928,0,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.53742,0.04623,0.036147,0,0
1,GO PRO B CELL DIFFERENTIATION,0.61497,0.045908,0.093526,0,0
1,GO SECRETION,0.15015,0.045892,0.040774,0,0
1,GO ARTERY MORPHOGENESIS,0.34256,0.045882,0.17602,0,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.35607,0.045873,0.047015,0,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.60272,0.045696,0.022539,0,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.20309,0.045684,0.033799,0,0
1,GO POSITIVE REGULATION OF NEURON DEATH,0.77618,0.045492,0.0089633,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.18219,0.045387,0.055793,0,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.74288,0.045369,-0.047348,0,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.36991,0.045363,0.10624,0,0
1,GO NEGATIVE REGULATION OF TRANSPORT,0.2,0.045285,0.044508,0,0
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.1028,0.045278,0.05488,0,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.96163,0.045176,-0.014863,0,0
1,GO TRANSFERRIN TRANSPORT,0.33373,0.045175,0.032601,0,0
1,GO CARDIAC CHAMBER DEVELOPMENT,0.1028,0.04488,0.10753,0,0
1,GO RESPONSE TO INSULIN,0.44402,0.04469,0.012701,0,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.33373,0.044629,0.05075,0,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.25001,0.044628,0.090108,0,0
1,GO HISTONE H3 ACETYLATION,0.52025,0.044558,0.019188,0,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.15773,0.044312,0.059116,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.99651,0.044161,-0.034906,0,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.36991,0.043989,0.038335,0,0
1,GO REGULATION OF MRNA POLYADENYLATION,0.22235,0.043379,0.059196,0,0
1,GO INOSITOL METABOLIC PROCESS,0.7495,0.043347,0.015797,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.66501,0.04327,-0.0047461,0,0
1,GO MICROVILLUS ORGANIZATION,0.32938,0.042972,-0.11218,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.62113,0.042959,0.04004,0,0
1,GO PROTEIN POLYMERIZATION,0.24643,0.042929,0.031943,0,0
1,GO RESPONSE TO ACID CHEMICAL,0.32077,0.042789,0.047336,0,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.50896,0.042747,0.13334,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.72969,0.04231,0.018304,0,0
1,GO OSTEOBLAST PROLIFERATION,0.39858,0.042074,0.11625,0,0
1,GO PROTEIN O LINKED GLYCOSYLATION,0.5726,0.041933,-0.0051349,0,0
1,GO HISTONE H3 K14 ACETYLATION,0.74288,0.041848,0.00078313,0,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.69061,0.041788,0.061742,0,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.27227,0.041623,0.042583,0,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.32077,0.041559,0.038691,0,0
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.23245,0.041264,0.10123,0,0
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.18219,0.041224,0.048127,0,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.32506,0.041077,0.074986,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.72969,0.041054,0.01035,0,0
1,GO ANIMAL ORGAN MORPHOGENESIS,0.20309,0.040901,0.059334,0,0
1,GO NEUROBLAST DIVISION,0.49227,0.040898,0.067255,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.53167,0.040792,0.032773,0,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.85082,0.040695,0.035047,0,0
1,GO RESPONSE TO ALCOHOL,0.59664,0.04056,0.021719,0,0
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.48678,0.040437,0.024675,0,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.38408,0.040223,0.050141,0,0
1,GO SPECIFICATION OF SYMMETRY,0.2,0.040005,0.053161,0,0
1,GO MUSCLE ORGAN DEVELOPMENT,0.03939,0.039935,0.087105,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.67776,0.039896,0.052313,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.26471,0.039891,0.052471,0,0
1,GO RESPONSE TO ZINC ION,0.63354,0.03988,0.028093,0,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.3746,0.039879,0.018128,0,0
1,GO POSITIVE REGULATION OF SIGNALING,0.12049,0.039844,0.045792,0,0
1,GO MRNA METHYLATION,0.4598,0.039841,0.059146,0,0
1,GO PHOTOPERIODISM,0.69707,0.039814,-0.0040856,0,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.39371,0.03979,0.015923,0,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.62113,0.039577,0.0073409,0,0
1,GO REPRODUCTION,0.25001,0.039184,0.024131,0,0
1,GO EXECUTION PHASE OF APOPTOSIS,0.15517,0.039071,0.045043,0,0
1,GO EMBRYONIC HEMOPOIESIS,0.60272,0.038977,-0.038811,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.42347,0.038862,0.041423,0,0
1,GO PRE MIRNA PROCESSING,0.59664,0.038828,0.030396,0,0
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.4978,0.038649,0.078726,0,0
1,GO ICOSANOID METABOLIC PROCESS,0.22235,0.03862,0.078402,0,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.4598,0.038584,0.034987,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.20309,0.037741,0.090311,0,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.36064,0.037533,0.014345,0,0
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.099158,0.037379,0.055354,0,0
1,GO CERAMIDE METABOLIC PROCESS,0.21579,0.037319,0.019461,0,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.39371,0.036775,0.01723,0,0
1,GO EMBRYO DEVELOPMENT,0.20621,0.036722,0.052727,0,0
1,GO POSITIVE REGULATION OF MYELINATION,0.74288,0.036617,0.046634,0,0
1,GO REGULATION OF PROTEIN SUMOYLATION,0.29992,0.036592,0.089946,0,0
1,GO ACTIN NUCLEATION,0.40843,0.036577,0.0034616,0,0
1,GO STEM CELL DIVISION,0.3746,0.036463,0.11222,0,0
1,GO RECEPTOR INTERNALIZATION,0.35607,0.03642,0.045801,0,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.47588,0.035723,0.040417,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.76948,0.035458,-0.01621,0,0
1,GO CELL VOLUME HOMEOSTASIS,0.39858,0.035431,0.03374,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.63978,0.03541,0.0019937,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.72313,0.035388,0.014749,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.85082,0.035096,-0.025969,0,0
1,GO REGULATION OF CELL SIZE,0.88523,0.034958,-0.02723,0,0
1,GO REGULATION OF GTPASE ACTIVITY,0.32077,0.034876,0.038614,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.18219,0.034862,0.06128,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.94073,0.034492,-0.023162,0,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.66501,0.034053,0.022242,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.69061,0.033958,-0.12534,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.92682,0.033795,-0.013774,0,0
1,GO REGULATION OF JUN KINASE ACTIVITY,0.32077,0.033773,0.04995,0,0
1,GO FEMALE GENITALIA DEVELOPMENT,0.53742,0.033742,0.058345,0,0
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.60272,0.033414,0.050778,0,0
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.44924,0.03341,0.029882,0,0
1,GO POSITIVE REGULATION OF JNK CASCADE,0.23245,0.033175,0.044757,0,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.20309,0.033088,0.095842,0,0
1,GO DNA REPLICATION,0.15015,0.032934,0.05159,0,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.61497,0.032916,0.0046625,0,0
1,GO ADAPTIVE THERMOGENESIS,0.76281,0.032685,0.0037292,0,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.32506,0.032605,0.042451,0,0
1,GO ENDOCRINE HORMONE SECRETION,0.8303,0.032526,0.018798,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION,0.64605,0.032487,0.010775,0,0
1,GO REGULATION OF PLATELET AGGREGATION,0.69061,0.032442,-0.059617,0,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.21579,0.032325,0.038894,0,0
1,GO ADHERENS JUNCTION ASSEMBLY,0.55487,0.032125,0.013449,0,0
1,GO MEMBRANE FUSION,0.71658,0.031889,-0.00021207,0,0
1,GO SISTER CHROMATID SEGREGATION,0.17099,0.031846,0.058137,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.69707,0.031637,0.029906,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.5726,0.031357,0.037536,0,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.095625,0.031231,0.089758,0,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.72969,0.031228,-0.059392,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,0.34256,0.030985,0.049518,0,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.56075,0.030814,0.01413,0,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.81668,0.030713,-0.00021495,0,0
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.80312,0.030669,-0.026205,0,0
1,GO PROTEIN TRIMERIZATION,0.98255,0.030527,0.0050115,0,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.50896,0.030508,0.016677,0,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.11039,0.030496,0.049734,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.86455,0.030331,-0.0093823,0,0
1,GO MUSCLE HYPERTROPHY,0.68418,0.030311,0.020426,0,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.27999,0.030118,0.13772,0,0
1,GO HISTONE UBIQUITINATION,0.44402,0.030082,0.042558,0,0
1,GO MISMATCH REPAIR,0.59059,0.030035,0.025693,0,0
1,GO REGULATION OF HELICASE ACTIVITY,0.53742,0.029976,0.065037,0,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.94073,0.029695,0.022323,0,0
1,GO FERTILIZATION,0.69061,0.029391,0.0073409,0,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.76281,0.029247,-0.058689,0,0
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.54903,0.029029,0.056336,0,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.77618,0.028968,0.018124,0,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.83713,0.028795,-0.01569,0,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,0.4545,0.028782,0.032489,0,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.31653,0.028606,0.035834,0,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.4978,0.028579,0.046577,0,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.59664,0.028544,0.015527,0,0
1,GO NEGATIVE REGULATION OF SECRETION,0.27611,0.028455,0.040338,0,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,0.73628,0.0284,-0.004563,0,0
1,GO THYROID GLAND DEVELOPMENT,0.65866,0.028396,0.05552,0,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.2839,0.028226,0.037515,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,0.56075,0.028199,0.030727,0,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.27999,0.02784,0.028685,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.62732,0.027818,0.021656,0,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.59059,0.027811,0.052454,0,0
1,GO CELLULAR RESPONSE TO PH,0.8303,0.027798,0.026979,0,0
1,GO MRNA MODIFICATION,0.46512,0.027591,0.056272,0,0
1,GO HEART MORPHOGENESIS,0.092194,0.027577,0.10498,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.71658,0.027338,-0.068617,0,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.67776,0.027211,0.017328,0,0
1,GO MIDBRAIN DEVELOPMENT,0.3746,0.02721,0.070525,0,0
1,GO HOMOLOGOUS RECOMBINATION,0.5726,0.027192,0.048018,0,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.80989,0.02713,0.00093684,0,0
1,GO VITAMIN TRANSPORT,0.56666,0.027053,0.02038,0,0
1,GO RRNA CATABOLIC PROCESS,0.58456,0.027047,0.031638,0,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.27611,0.026993,0.050302,0,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.36526,0.026987,0.035127,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.48678,0.026854,-0.09327,0,0
1,GO DEVELOPMENTAL PIGMENTATION,0.70355,0.026853,-0.022127,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.58456,0.026733,0.032599,0,0
1,GO CELLULAR RESPONSE TO ALCOHOL,0.56666,0.026671,0.037918,0,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.38888,0.026207,0.05185,0,0
1,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.80312,0.026094,0.023314,0,0
1,GO POSITIVE REGULATION OF DNA REPAIR,0.53167,0.02608,0.023955,0,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.5726,0.026005,0.028814,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.92682,0.02594,0.013129,0,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.19393,0.02593,0.092307,0,0
1,GO PEPTIDYL HISTIDINE MODIFICATION,0.64605,0.025876,0.032081,0,0
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.29586,0.025838,0.037172,0,0
1,GO ETHANOL CATABOLIC PROCESS,0.46512,0.025688,0.14729,0,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.52594,0.025616,0.018828,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.13355,0.025572,0.072787,0,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.4978,0.025559,0.027506,0,0
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.22568,0.025524,0.051753,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.63354,0.025521,0.024087,0,0
1,GO RENAL ABSORPTION,0.59059,0.025513,0.050517,0,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.33373,0.025494,0.10165,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.53742,0.02545,0.058042,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.65866,0.025353,0.017786,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.82348,0.025082,-0.045609,0,0
1,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.73628,0.02478,0.0015331,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.9686,0.02454,0.022746,0,0
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.50337,0.024374,0.030188,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.57857,0.024289,0.047943,0,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.94769,0.02427,-0.0039735,0,0
1,GO RESPONSE TO ACTIVITY,0.56666,0.024097,0.011338,0,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.63978,0.023952,-0.06786,0,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.18219,0.023686,0.11199,0,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.86455,0.023596,0.049929,0,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.37932,0.02357,0.020338,0,0
1,GO CYTOSKELETON ORGANIZATION,0.34256,0.023468,0.034272,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.74288,0.023449,-0.034557,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.5726,0.023387,0.030496,0,0
1,GO PHOSPHOLIPID TRANSPORT,0.85082,0.023372,-0.0052723,0,0
1,GO MUSCLE FIBER DEVELOPMENT,0.88523,0.02335,-0.0063153,0,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.39858,0.023311,0.029007,0,0
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.2839,0.023224,0.032429,0,0
1,GO TELOMERE CAPPING,0.81668,0.022819,0.0060849,0,0
1,GO RESPONSE TO ESTRADIOL,0.17374,0.022799,0.067347,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.40349,0.022731,0.034596,0,0
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.16828,0.022572,0.039343,0,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.39371,0.022398,0.047471,0,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.52025,0.021749,0.057731,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.73628,0.021694,-0.04223,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE,0.52025,0.021265,0.024685,0,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.24288,0.021237,0.042622,0,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.44402,0.021115,0.1239,0,0
1,GO AUTOPHAGIC CELL DEATH,0.84397,0.021031,0.01102,0,0
1,GO MITOCHONDRIAL FISSION,0.92682,0.021023,0.0060417,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.30815,0.020967,0.083827,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.54903,0.02088,0.0081283,0,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.54321,0.020563,-0.055545,0,0
1,GO METAL ION HOMEOSTASIS,0.80312,0.020519,0.0063634,0,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.89907,0.020338,0.021912,0,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.64605,0.020232,0.0001457,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.41842,0.019982,0.058534,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.72969,0.019827,-0.030713,0,0
1,GO CAMP METABOLIC PROCESS,0.51459,0.019544,0.099216,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.36991,0.01945,0.035285,0,0
1,GO HISTONE H3 K4 TRIMETHYLATION,0.8303,0.019439,0.026003,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.25729,0.019375,0.036839,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.35607,0.019199,0.031295,0,0
1,GO TEMPERATURE HOMEOSTASIS,0.8303,0.019152,-0.00223,0,0
1,GO HISTONE MONOUBIQUITINATION,0.55487,0.018931,0.029504,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.80312,0.018778,-0.027268,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.46512,0.018654,0.041783,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.58456,0.018625,0.012598,0,0
1,GO LIPOPROTEIN METABOLIC PROCESS,0.91293,0.01833,-0.034295,0,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,0.56075,0.018029,-0.041681,0,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.55487,0.018,0.036525,0,0
1,GO CELL PROJECTION ASSEMBLY,0.60272,0.017796,0.026481,0,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.80989,0.017764,-0.0067835,0,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.47049,0.017668,0.07682,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.4598,0.017633,0.044261,0,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.98255,0.017615,-0.010614,0,0
1,GO CYTOSOLIC TRANSPORT,0.41341,0.017442,0.034231,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.96163,0.017366,0.015795,0,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.62732,0.017253,0.076934,0,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.15517,0.017127,0.077467,0,0
1,GO RESPONSE TO MUSCLE INACTIVITY,0.50896,0.016616,0.078244,0,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.68418,0.016481,0.0048723,0,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.29586,0.016351,0.10027,0,0
1,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.73628,0.016278,-0.056408,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.25729,0.016268,0.033589,0,0
1,GO LIPID BIOSYNTHETIC PROCESS,0.47588,0.016236,0.0075302,0,0
1,GO REGULATION OF HISTONE MODIFICATION,0.76281,0.016185,0.015256,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.50337,0.016166,0.099024,0,0
1,GO CELLULAR RESPONSE TO DRUG,0.12908,0.016115,0.081621,0,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.89907,0.015719,0.014012,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.82348,0.015654,-0.032603,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.77618,0.01549,0.0069854,0,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.59664,0.015403,0.028434,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.52594,0.014942,0.039244,0,0
1,GO LIPID PHOSPHORYLATION,0.60883,0.014905,0.019163,0,0
1,GO RESPONSE TO CORTICOSTERONE,0.32506,0.01459,0.15025,0,0
1,GO PROTEIN LOCALIZATION TO CILIUM,0.91987,0.014543,-0.0045786,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.84397,0.014275,-0.027901,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.94769,0.014254,-0.0025757,0,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.67137,0.01409,0.0038901,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.4598,0.014047,0.052742,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.52594,0.014033,0.074987,0,0
1,GO ION HOMEOSTASIS,0.98953,0.013989,-0.0026094,0,0
1,GO RESPONSE TO CAMP,0.84397,0.013967,0.025859,0,0
1,GO CENTROSOME SEPARATION,0.34256,0.013641,0.068924,0,0
1,GO GLYCOSYLATION,0.93377,0.013578,-0.031055,0,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.8303,0.013572,-0.020084,0,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.52594,0.013363,0.12105,0,0
1,GO ONE CARBON METABOLIC PROCESS,0.67776,0.013162,-0.039866,0,0
1,GO EPIDERMIS DEVELOPMENT,0.54321,0.013151,0.071515,0,0
1,GO GROWTH,0.32938,0.013043,0.02779,0,0
1,GO ENDOCYTIC RECYCLING,0.16559,0.012798,0.061629,0,0
1,GO CELLULAR ION HOMEOSTASIS,0.56666,0.012534,0.013916,0,0
1,GO REGULATION OF BLOOD PRESSURE,0.96163,0.012151,0.01089,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.55487,0.012116,0.057098,0,0
1,GO CHROMOSOME ORGANIZATION,0.47588,0.012067,0.030172,0,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.71006,0.011855,0.048049,0,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.82348,0.011485,0.0092754,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.50337,0.011369,0.02518,0,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.60883,0.011265,0.037808,0,0
1,GO DNA DEPENDENT DNA REPLICATION,0.41842,0.011242,0.034962,0,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.85082,0.011217,-0.0299,0,0
1,GO BLASTODERM SEGMENTATION,0.63978,0.011208,0.06585,0,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.52594,0.010836,0.040188,0,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.40843,0.010659,0.025265,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.4545,0.010583,0.061587,0,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.85082,0.010504,-0.015368,0,0
1,GO GLUCOSE IMPORT,0.36064,0.010433,-0.062394,0,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.80989,0.010168,0.032565,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.84397,0.010089,0.014561,0,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.9686,0.010005,-0.03507,0,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.96163,0.0097933,-0.0035404,0,0
1,GO AORTA MORPHOGENESIS,0.84397,0.0096129,0.12662,0,0
1,GO RESPONSE TO NITROGEN COMPOUND,0.3746,0.0095524,0.024184,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.53167,0.0094272,-0.02078,0,0
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.80989,0.0090649,0.033848,0,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.69061,0.0089561,0.02858,0,0
1,GO DNA METHYLATION OR DEMETHYLATION,0.34256,0.0088834,0.053318,0,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,0.96163,0.0087368,0.0024594,0,0
1,GO STEROID BIOSYNTHETIC PROCESS,0.72969,0.0087181,-0.0484,0,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.79636,0.0087019,0.0062137,0,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.8303,0.0086359,-0.02384,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.5726,0.0084504,0.046314,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.80989,0.0083471,0.007477,0,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.80312,0.0083381,0.030997,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.33812,0.0083347,-0.06942,0,0
1,GO ZINC ION HOMEOSTASIS,0.84397,0.0082495,0.041887,0,0
1,GO SKIN EPIDERMIS DEVELOPMENT,0.94769,0.0081392,0.044278,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,0.91987,0.0080072,0.00086796,0,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,0.89907,0.0079758,0.0044391,0,0
1,GO PANCREATIC JUICE SECRETION,0.79636,0.0077407,0.036838,0,0
1,GO MICROTUBULE NUCLEATION,0.79636,0.0076721,-0.01065,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,0.73628,0.0076571,0.053419,0,0
1,GO ORGAN INDUCTION,0.32938,0.0072145,0.078405,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.35607,0.0068661,0.082957,0,0
1,GO L SERINE METABOLIC PROCESS,0.60883,0.0067769,0.030511,0,0
1,GO POSITIVE REGULATION OF GROWTH,0.89907,0.0067018,0.004681,0,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.85082,0.0066901,0.0012188,0,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.99651,0.0066548,-0.022089,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.90599,0.0066194,0.031082,0,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,0.98255,0.0064278,0.016281,0,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.4545,0.0063467,0.056624,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.76281,0.0062774,-0.008204,0,0
1,GO PEPTIDYL LYSINE MODIFICATION,0.63978,0.0061204,-0.020469,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.96163,0.006109,-0.0089163,0,0
1,GO CELLULAR RESPONSE TO FATTY ACID,0.85082,0.0059997,-0.0012011,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.72969,0.0059004,-0.013907,0,0
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.94769,0.0058778,0.0059692,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.22905,0.0058593,0.052814,0,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.66501,0.0057878,0.023971,0,0
1,GO HETEROTYPIC CELL CELL ADHESION,0.57857,0.00576,0.041739,0,0
1,GO SARCOMERE ORGANIZATION,0.75615,0.0057011,0.052285,0,0
1,GO STRESS GRANULE ASSEMBLY,0.56075,0.0056795,-0.035309,0,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.71006,0.0056082,-0.032398,0,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.92682,0.0055483,-0.038498,0,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.58456,0.0052667,0.0067976,0,0
1,GO B CELL HOMEOSTASIS,0.59059,0.0051746,0.025432,0,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.9686,0.0051197,0.007677,0,0
1,GO TELOMERIC LOOP DISASSEMBLY,0.7495,0.0050277,0.01665,0,0
1,GO REGULATION OF GROWTH,0.48131,0.0047398,0.018365,0,0
1,GO RESPONSE TO GROWTH HORMONE,0.72969,0.004669,0.036892,0,0
1,GO SNORNA METABOLIC PROCESS,0.76948,0.0046267,-0.0065935,0,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.60272,0.0043921,0.096716,0,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.59059,0.0042596,0.044414,0,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.76281,0.0041331,0.0040622,0,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.98953,0.0040743,-0.010897,0,0
1,GO MUSCLE CELL DIFFERENTIATION,0.40349,0.0035238,0.059692,0,0
1,GO ADHESION OF SYMBIONT TO HOST,0.18508,0.0034959,0.19211,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.82348,0.0033953,0.0086286,0,0
1,GO REGULATION OF CELLULAR PH,0.87833,0.0032145,-0.0041584,0,0
1,GO APPENDAGE DEVELOPMENT,0.99651,0.0030334,0.018715,0,0
1,GO PROTEIN HOMOOLIGOMERIZATION,0.77618,0.0029631,-0.010865,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.78289,0.002955,-0.013643,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.91987,0.0028732,0.029264,0,0
1,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.5726,0.0027906,-0.11448,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.76948,0.0025742,0.025937,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.99651,0.0024112,0.0035709,0,0
1,GO FUCOSYLATION,0.61497,0.0022545,-0.039425,0,0
1,GO RESPONSE TO MECHANICAL STIMULUS,0.94073,0.0018591,0.0071259,0,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,0.74288,0.001847,-0.028036,0,0
1,GO REGULATION OF GLUCONEOGENESIS,0.85768,0.0018253,-0.010074,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.44924,0.0016388,0.073991,0,0
1,GO REGULATION OF PROTEIN TARGETING,0.63978,0.0015472,0.019716,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.87833,0.0012256,0.026613,0,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.78962,0.0011268,-0.026614,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.85768,0.00076696,-0.048713,0,0
1,GO POSITIVE REGULATION OF TRANSPORT,0.85768,0.00071729,0.00064048,0,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.58456,0.00068242,0.044617,0,0
1,GO NEGATIVE CHEMOTAXIS,0.68418,0.00059101,0.018138,0,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.74288,0.00057775,-0.030806,0,0
1,GO TAXIS,0.60272,0.00055706,0.0070367,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.89907,0.00043354,0.011249,0,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.4545,0.00023964,0.09011,0,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.74288,0.00011649,-0.020067,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.78289,-0.00032872,0.027779,0,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.94769,-0.00074357,-0.0073125,0,0
1,GO GLAND DEVELOPMENT,0.40843,-0.00078003,0.041082,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.9686,-0.00081968,0.041751,0,0
1,GO UV PROTECTION,0.65234,-0.00089702,0.062269,0,0
1,GO REGULATION OF PH,0.98953,-0.00093359,-0.015561,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.96163,-0.00093799,-0.001738,0,0
1,GO DNA PACKAGING,0.81668,-0.0010755,0.00077447,0,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.63978,-0.0012403,0.071593,0,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.93377,-0.0013098,-0.0029942,0,0
1,GO MEIOTIC CELL CYCLE,0.91987,-0.0014108,0.01921,0,0
1,GO CARBOHYDRATE TRANSPORT,0.72969,-0.0015082,-0.033413,0,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.34256,-0.0016425,0.10425,0,0
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.30815,-0.0017501,0.072112,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.40349,-0.0020833,0.14242,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.91293,-0.0021318,0.043442,0,0
1,GO REPLICATION FORK PROCESSING,0.67137,-0.0022801,0.063156,0,0
1,GO MOLTING CYCLE,0.96163,-0.0023157,0.048621,0,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.83713,-0.0023557,-0.0098257,0,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.79636,-0.002362,-0.024284,0,0
1,GO INTERSTRAND CROSS LINK REPAIR,0.63354,-0.0026689,0.01272,0,0
1,GO ATP TRANSPORT,0.95466,-0.0028,-0.0096792,0,0
1,GO RESPONSE TO BMP,0.46512,-0.0029235,0.054523,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.91987,-0.0029491,-0.002217,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.71658,-0.0030207,0.051497,0,0
1,GO METHYLATION,0.94073,-0.0031648,0.0040062,0,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.75615,-0.0032135,0.050454,0,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.7495,-0.003231,-0.016904,0,0
1,GO HISTONE H2A UBIQUITINATION,0.96163,-0.0033038,0.0085122,0,0
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.83713,-0.0034376,0.016348,0,0
1,GO TOR SIGNALING,0.54321,-0.0036529,-0.017432,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.64605,-0.0039513,0.041895,0,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.77618,-0.0039871,-0.017608,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.84397,-0.0040201,0.017502,0,0
1,GO RETINA HOMEOSTASIS,0.72969,-0.0040532,-0.030267,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.59664,-0.0040554,0.039991,0,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.66501,-0.0040767,-0.070489,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.91987,-0.0040953,-0.0015516,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.87144,-0.0041661,0.012175,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.36991,-0.0042729,0.062516,0,0
1,GO NUCLEOSOME ORGANIZATION,0.86455,-0.0048712,-0.013902,0,0
1,GO RESPONSE TO AMYLOID BETA,0.89215,-0.0050477,0.013941,0,0
1,GO PROTEIN O LINKED MANNOSYLATION,0.74288,-0.005098,-0.031561,0,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.56666,-0.0051576,-0.075083,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.93377,-0.0053929,-0.0073345,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,0.49227,-0.0054378,-0.045079,0,0
1,GO DEFINITIVE HEMOPOIESIS,0.9686,-0.0054953,0.0083138,0,0
1,GO SINGLE STRAND BREAK REPAIR,0.88523,-0.0055247,0.0035831,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.53167,-0.0056576,-0.031963,0,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.62113,-0.0057069,0.12535,0,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.62113,-0.0058327,0.03429,0,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.89907,-0.0059612,0.006032,0,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.74288,-0.005991,0.034788,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.68418,-0.0060184,0.017997,0,0
1,GO RESPONSE TO COLD,0.40843,-0.0061696,-0.08443,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.87144,-0.0062998,0.019003,0,0
1,GO MUSCLE CELL DEVELOPMENT,0.8303,-0.0063392,0.04095,0,0
1,GO SINGLE FERTILIZATION,0.46512,-0.0063968,-0.035726,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.95466,-0.0065943,-0.044158,0,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.44924,-0.0066986,-0.061737,0,0
1,GO SNORNA 3 END PROCESSING,0.81668,-0.0068445,-0.013432,0,0
1,GO CELLULAR HOMEOSTASIS,0.59059,-0.0071592,0.011974,0,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.79636,-0.0074709,0.00012411,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.72313,-0.0075936,-0.052614,0,0
1,GO REGULATION OF RNA SPLICING,0.88523,-0.0076035,-0.019755,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.84397,-0.0079973,-0.013254,0,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.92682,-0.008039,-0.00021337,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.67776,-0.0082448,-0.071876,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,0.84397,-0.0082558,0.038591,0,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.1313,-0.0084851,-0.070327,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.41842,-0.0084982,-0.10843,0,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.46512,-0.0085606,0.22596,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.85768,-0.0086654,-0.030752,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.44402,-0.0087254,-0.076764,0,0
1,GO REGULATION OF MRNA PROCESSING,0.97557,-0.0087996,-0.010473,0,0
1,GO NUCLEOTIDE TRANSPORT,0.4978,-0.0089596,-0.052874,0,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.47588,-0.0090263,-0.05762,0,0
1,GO ONE CARBON COMPOUND TRANSPORT,0.82348,-0.0092098,-0.022756,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.25363,-0.0092463,-0.086429,0,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.73628,-0.0093563,0.030788,0,0
1,GO O GLYCAN PROCESSING,0.98953,-0.0093573,-0.024858,0,0
1,GO REGULATION OF CELL FATE SPECIFICATION,0.48678,-0.0097058,0.12571,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.54321,-0.0097587,-0.042735,0,0
1,GO CHEMICAL HOMEOSTASIS,0.29586,-0.010283,-0.041121,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.66501,-0.010521,-0.048294,0,0
1,GO PROSTATE GLAND GROWTH,0.70355,-0.010952,0.16183,0,0
1,GO MUSCLE ORGAN MORPHOGENESIS,0.59664,-0.01108,0.065416,0,0
1,GO ARACHIDONIC ACID SECRETION,0.41341,-0.011108,-0.092539,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.37932,-0.011143,-0.088567,0,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.42855,-0.011285,-0.046148,0,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.88523,-0.011315,0.026005,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,0.92682,-0.011327,-0.038959,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.55487,-0.01138,0.053145,0,0
1,GO COVALENT CHROMATIN MODIFICATION,0.4978,-0.011477,-0.017108,0,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.74288,-0.011482,-0.018979,0,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.81668,-0.011534,-0.025965,0,0
1,GO ENERGY RESERVE METABOLIC PROCESS,0.90599,-0.011553,0.0018445,0,0
1,GO NUCLEOSOME ASSEMBLY,0.62732,-0.01162,-0.038456,0,0
1,GO DNA STRAND ELONGATION,0.40349,-0.011679,-0.065884,0,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.50337,-0.011775,-0.032484,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.89907,-0.011964,-0.009063,0,0
1,GO MICROTUBULE ANCHORING,0.91293,-0.012188,0.0039443,0,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.89215,-0.012236,1.9233e-05,0,0
1,GO HISTAMINE TRANSPORT,0.9686,-0.012581,-0.019464,0,0
1,GO RENAL TUBULE DEVELOPMENT,0.41341,-0.012776,0.093754,0,0
1,GO FRUCTOSE METABOLIC PROCESS,0.59059,-0.012915,-0.098626,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.94769,-0.013086,0.0061894,0,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.7495,-0.013147,-0.018265,0,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.42347,-0.013247,-0.049274,0,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.55487,-0.013291,-0.048858,0,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.89907,-0.013929,-0.023796,0,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.90599,-0.014131,0.0092627,0,0
1,GO BIOMINERALIZATION,0.54321,-0.014146,0.070986,0,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.99651,-0.014376,-0.014639,0,0
1,GO NEPHRON MORPHOGENESIS,0.59664,-0.014495,0.039367,0,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.54903,-0.014569,0.044957,0,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.2839,-0.014722,-0.047539,0,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.94073,-0.014805,0.010551,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.98255,-0.01509,0.016438,0,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.40349,-0.015167,-0.05661,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.12259,-0.015337,-0.10372,0,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.71658,-0.015874,-0.01393,0,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.75615,-0.015929,-0.040449,0,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.71658,-0.015995,-0.0098331,0,0
1,GO THYMIC T CELL SELECTION,0.88523,-0.016054,-0.0044366,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.98953,-0.016404,-0.0051629,0,0
1,GO REGULATION OF CELL DIFFERENTIATION,0.78289,-0.016473,-0.0069666,0,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.80312,-0.016514,0.0054221,0,0
1,GO REGULATION OF CELLULAR LOCALIZATION,0.61497,-0.016531,-0.017448,0,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.87833,-0.01692,0.0038722,0,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.99651,-0.016949,0.024016,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.99651,-0.016959,0.0045993,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.63354,-0.01728,0.023194,0,0
1,GO LYSOSOME LOCALIZATION,0.59059,-0.017471,-0.028317,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.7495,-0.017739,0.029653,0,0
1,GO QUINONE METABOLIC PROCESS,0.56666,-0.017886,-0.0019581,0,0
1,GO REGULATION OF LYASE ACTIVITY,0.48131,-0.018204,-0.058685,0,0
1,GO SEXUAL REPRODUCTION,0.72969,-0.018466,-0.018879,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.40349,-0.018488,-0.12184,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.52025,-0.018857,-0.036806,0,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.36526,-0.018979,0.091834,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.75615,-0.018999,-0.023588,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.49227,-0.019194,0.076702,0,0
1,GO SEX DIFFERENTIATION,0.9686,-0.019303,0.0064538,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.56666,-0.019533,0.043829,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.83713,-0.019613,-0.0092295,0,0
1,GO MITOCHONDRIAL FUSION,0.79636,-0.019718,0.0057753,0,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.61497,-0.019855,-0.044875,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.59059,-0.01992,-0.038195,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.67137,-0.020313,-0.049147,0,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.17374,-0.020545,-0.068486,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.64605,-0.020551,-0.061718,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.87144,-0.020581,0.039521,0,0
1,GO RESPONSE TO LIGHT STIMULUS,0.24288,-0.020708,-0.038911,0,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.90599,-0.020838,0.024097,0,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.4598,-0.021056,-0.037228,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.96163,-0.021257,0.045952,0,0
1,GO SMOOTH MUSCLE CONTRACTION,0.78962,-0.021477,-0.0027645,0,0
1,GO PURINE NUCLEOTIDE TRANSPORT,0.53742,-0.02217,-0.042442,0,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.4978,-0.022224,-0.021692,0,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.72969,-0.022322,-0.0014214,0,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.50337,-0.022408,-0.025501,0,0
1,GO LYMPH NODE DEVELOPMENT,0.87144,-0.022506,0.062063,0,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.48131,-0.022777,-0.07196,0,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.93377,-0.023021,-0.035202,0,0
1,GO LIPID EXPORT FROM CELL,0.94073,-0.023226,-0.0064461,0,0
1,GO GLIAL CELL PROLIFERATION,0.70355,-0.023571,0.029826,0,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.92682,-0.023648,-0.015202,0,0
1,GO MANNOSYLATION,0.97557,-0.023953,-0.015156,0,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.71006,-0.024082,-0.0035622,0,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.26471,-0.024096,-0.073745,0,0
1,GO EXIT FROM MITOSIS,0.72969,-0.024208,-0.015241,0,0
1,GO GAMETE GENERATION,0.77618,-0.024593,-0.015862,0,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.98953,-0.024659,-0.00080513,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.85082,-0.024731,0.0066259,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.56666,-0.02477,-0.039299,0,0
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.53167,-0.025054,0.054771,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.8303,-0.025107,-0.037948,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.59664,-0.025166,-0.034732,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.31232,-0.025293,-0.057484,0,0
1,GO DRUG CATABOLIC PROCESS,0.93377,-0.025323,0.0055193,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.32077,-0.025348,-0.01873,0,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.79636,-0.025485,-0.013867,0,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.52025,-0.025614,-0.015252,0,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.54321,-0.025755,0.1136,0,0
1,GO REGULATION OF BONE REMODELING,0.92682,-0.025975,-0.011323,0,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.60272,-0.025982,-0.046086,0,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.73628,-0.02615,-0.025797,0,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.54903,-0.026187,0.00081858,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.98953,-0.026223,0.017938,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.3746,-0.026346,-0.033959,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.95466,-0.026367,0.026501,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.91293,-0.026431,0.011437,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.48131,-0.027128,0.079361,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.98953,-0.027145,0.027773,0,0
1,GO MUSCLE SYSTEM PROCESS,0.86455,-0.02745,-0.0044828,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.72313,-0.027555,-0.010789,0,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.74288,-0.027588,-0.022541,0,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.70355,-0.027607,-0.077766,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.73628,-0.027612,0.059451,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,0.85768,-0.02777,0.0013544,0,0
1,GO DEVELOPMENTAL GROWTH,0.54903,-0.02788,-0.020537,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.56666,-0.028138,0.064585,0,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,0.76948,-0.028225,-0.0075701,0,0
1,GO SPLEEN DEVELOPMENT,0.87833,-0.028422,0.029875,0,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.87833,-0.028692,0.0095876,0,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.27227,-0.028757,-0.13619,0,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.52594,-0.028846,-0.013891,0,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.57857,-0.028854,-0.036574,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.8303,-0.029044,-0.015382,0,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.78289,-0.029495,0.016312,0,0
1,GO MALE GAMETE GENERATION,0.35153,-0.02985,-0.031417,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.41842,-0.029866,-0.04726,0,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.88523,-0.030069,-0.0063389,0,0
1,GO HISTAMINE SECRETION,0.56666,-0.030177,0.053297,0,0
1,GO MUSCLE TISSUE DEVELOPMENT,0.9686,-0.030475,0.026135,0,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.92682,-0.03048,0.040317,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.61497,-0.030481,-0.038894,0,0
1,GO SKELETAL MUSCLE CONTRACTION,0.26847,-0.03063,-0.094783,0,0
1,GO SECONDARY METABOLIC PROCESS,0.83713,-0.030768,-0.035075,0,0
1,GO APPENDAGE MORPHOGENESIS,0.65234,-0.03115,-0.014079,0,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.25363,-0.031185,-0.043048,0,0
1,GO CELLULAR RESPONSE TO STEROL,0.46512,-0.031215,-0.043119,0,0
1,GO GLUCOSE METABOLIC PROCESS,0.54321,-0.031325,-0.030534,0,0
1,GO ZINC ION TRANSPORT,0.69061,-0.031351,0.03084,0,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.15015,-0.031516,-0.072049,0,0
1,GO REGULATION OF DEPHOSPHORYLATION,0.44924,-0.031685,-0.030241,0,0
1,GO EPIDERMAL CELL DIFFERENTIATION,0.93377,-0.031724,0.050432,0,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.41842,-0.031744,-0.094534,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.62732,-0.031754,-0.0024299,0,0
1,GO HISTONE H3 K9 TRIMETHYLATION,0.60883,-0.031783,-0.029398,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.4978,-0.031894,-0.048239,0,0
1,GO GLIOGENESIS,0.5726,-0.031936,-0.025989,0,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.54903,-0.031958,-0.08133,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.91987,-0.032033,-0.004154,0,0
1,GO ORGANELLE LOCALIZATION,0.17099,-0.032192,-0.039524,0,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.5726,-0.032254,-0.014685,0,0
1,GO STEM CELL PROLIFERATION,0.56666,-0.032641,-0.038117,0,0
1,GO KERATINOCYTE DEVELOPMENT,0.85768,-0.032948,-0.023294,0,0
1,GO PLASMA MEMBRANE REPAIR,0.76281,-0.03299,-0.12649,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.64605,-0.033019,-0.0095901,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.20309,-0.03311,-0.17325,0,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.61497,-0.033155,-0.068632,0,0
1,GO MULTICELLULAR ORGANISM GROWTH,0.18508,-0.033241,-0.048526,0,0
1,GO T CELL SELECTION,0.71006,-0.033423,0.032591,0,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.47588,-0.033614,-0.027646,0,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.91293,-0.033708,0.029289,0,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.7495,-0.033775,-0.030289,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.59059,-0.034107,-0.029444,0,0
1,GO BLASTOCYST DEVELOPMENT,0.62113,-0.034196,-0.014215,0,0
1,GO INTERLEUKIN 10 PRODUCTION,0.97557,-0.034244,0.038527,0,0
1,GO PIGMENTATION,0.58456,-0.034285,-0.0056531,0,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.76948,-0.034306,0.015578,0,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.39371,-0.034423,-0.036292,0,0
1,GO REGULATION OF MUSCLE CONTRACTION,0.41341,-0.034426,-0.030094,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.28785,-0.034585,-0.050773,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.59664,-0.034782,-0.059386,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.4545,-0.034795,-0.080988,0,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.98953,-0.034813,0.017396,0,0
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.62113,-0.035199,-0.051942,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.16032,-0.035355,-0.095753,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.82348,-0.035647,0.027651,0,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.65234,-0.035711,-0.013337,0,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.98953,-0.035803,0.0018631,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.74288,-0.035901,-0.016595,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.89215,-0.035976,0.013676,0,0
1,GO HETEROCHROMATIN ORGANIZATION,0.67137,-0.036289,-0.011447,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.26471,-0.036502,-0.047439,0,0
1,GO CELL GROWTH,0.52594,-0.036691,-0.024388,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.42347,-0.036705,0.052057,0,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.48131,-0.036863,-0.040151,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.88523,-0.037109,0.013249,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.4598,-0.037109,-0.045889,0,0
1,GO RESPONSE TO FATTY ACID,0.54321,-0.037439,-0.013843,0,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.90599,-0.037509,0.029365,0,0
1,GO CELL CYCLE DNA REPLICATION,0.4598,-0.037617,-0.049981,0,0
1,GO ORGANELLE MEMBRANE FUSION,0.27999,-0.037661,-0.073225,0,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.47049,-0.037777,-0.042485,0,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.11235,-0.037955,-0.070158,0,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,0.23589,-0.038264,-0.043448,0,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.40843,-0.038433,-0.082668,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.49227,-0.038515,-0.013039,0,0
1,GO OOGENESIS,0.17099,-0.03852,-0.066732,0,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.37932,-0.038547,-0.10376,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.47049,-0.038618,-0.081402,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.67776,-0.038846,-0.02304,0,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.88523,-0.038971,0.019296,0,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.12908,-0.03907,-0.076188,0,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.15773,-0.039076,-0.071493,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.34256,-0.039195,-0.070329,0,0
1,GO ACTIN FILAMENT BASED MOVEMENT,0.59059,-0.039337,-0.017442,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.17099,-0.039348,-0.061393,0,0
1,GO RESPONSE TO AXON INJURY,0.36526,-0.039354,-0.074348,0,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.23937,-0.039626,-0.16145,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.95466,-0.039647,0.009399,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.80989,-0.03999,0.0020358,0,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.44924,-0.040603,-0.070739,0,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.91293,-0.040686,0.00011589,0,0
1,GO SPERM MOTILITY,0.17099,-0.041421,-0.077212,0,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.43367,-0.041442,-0.10287,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,0.42855,-0.041512,-0.049879,0,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.079444,-0.041629,-0.080353,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.98953,-0.041707,-0.013062,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.77618,-0.041782,-0.020952,0,0
1,GO CHROMATIN ORGANIZATION,0.31232,-0.041857,-0.025016,0,0
1,GO PEPTIDYL LYSINE ACETYLATION,0.066855,-0.041878,-0.058965,0,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,0.2,-0.042151,-0.057572,0,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.47049,-0.042322,-0.020479,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.80989,-0.042724,0.014492,0,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.1028,-0.042849,-0.068014,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.51459,-0.042896,-0.014019,0,0
1,GO PROTEIN DEPHOSPHORYLATION,0.2,-0.043288,-0.042859,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.72969,-0.043381,-0.0014679,0,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.71658,-0.043935,-0.022035,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.44924,-0.04416,-0.049671,0,0
1,GO SPHINGOLIPID METABOLIC PROCESS,0.23245,-0.044561,-0.054037,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.32938,-0.044603,-0.058648,0,0
1,GO DRINKING BEHAVIOR,0.37932,-0.044622,-0.098152,0,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.32077,-0.044781,-0.036809,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.50337,-0.044831,-0.038478,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.38888,-0.045175,-0.065896,0,0
1,GO MESONEPHROS DEVELOPMENT,0.98255,-0.04523,0.018467,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.16294,-0.04551,-0.077694,0,0
1,GO RESPONSE TO ETHANOL,0.19393,-0.045589,-0.058137,0,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.79636,-0.045606,0.081314,0,0
1,GO REGULATION OF METAL ION TRANSPORT,0.11235,-0.045764,-0.04934,0,0
1,GO DEPHOSPHORYLATION,0.10096,-0.046054,-0.050617,0,0
1,GO MALE MEIOSIS I,0.76948,-0.046327,-0.01238,0,0
1,GO MEMBRANE HYPERPOLARIZATION,0.16294,-0.046467,-0.13087,0,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.56666,-0.046545,-0.0077278,0,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.13583,-0.046685,-0.088918,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.22235,-0.046698,-0.067526,0,0
1,GO SPERM CAPACITATION,0.39371,-0.046736,-0.065417,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.25363,-0.046973,-0.12365,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.2,-0.047028,-0.065862,0,0
1,GO ALCOHOL CATABOLIC PROCESS,0.53167,-0.047119,-0.003221,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.48678,-0.047223,-0.080146,0,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.52594,-0.047361,-0.050239,0,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.15264,-0.047447,-0.044518,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.91987,-0.047624,0.060211,0,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,0.94073,-0.047763,0.00031721,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.4598,-0.047826,-0.014164,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.50337,-0.047852,-0.050388,0,0
1,GO MICROTUBULE BASED PROCESS,0.18219,-0.048614,-0.054847,0,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.84397,-0.049044,0.0017566,0,0
1,GO BICARBONATE TRANSPORT,0.65866,-0.049155,-0.040564,0,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.090515,-0.049848,-0.087127,0,0
1,GO PHOSPHATE ION TRANSPORT,0.21905,-0.050037,-0.05793,0,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.94073,-0.050187,0.016526,0,0
1,GO REGULATION OF CELL MORPHOGENESIS,0.061812,-0.050393,-0.09171,0,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.35607,-0.050503,-0.082226,0,0
1,GO MUSCLE CONTRACTION,0.53742,-0.050507,-0.022286,0,0
1,GO POSITIVE T CELL SELECTION,0.83713,-0.050708,0.055587,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.27999,-0.050786,-0.057693,0,0
1,GO CONVERGENT EXTENSION,0.79636,-0.050948,-0.03083,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.86455,-0.051146,-0.0021926,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.42347,-0.051167,-0.069811,0,0
1,GO STEROID HORMONE SECRETION,0.53167,-0.051888,-0.069744,0,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.90599,-0.051899,0.023905,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.78289,-0.052154,-0.0050495,0,0
1,GO ECTODERM DEVELOPMENT,0.32077,-0.052218,-0.019717,0,0
1,GO ORGANELLE FUSION,0.17934,-0.05232,-0.067556,0,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.75615,-0.052617,-0.012731,0,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.94769,-0.052843,0.083349,0,0
1,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.44402,-0.052968,-0.09814,0,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.35153,-0.053055,-0.03963,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,0.41341,-0.053061,-0.0072442,0,0
1,GO DEMETHYLATION,0.46512,-0.05315,-0.011394,0,0
1,GO NEURON DEATH,0.068167,-0.053484,-0.060936,0,0
1,GO STEROID CATABOLIC PROCESS,0.98255,-0.053569,-0.0089745,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.13583,-0.053809,-0.096477,0,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.26847,-0.054139,-0.08356,0,0
1,GO RESPONSE TO STARVATION,0.16559,-0.054272,-0.066652,0,0
1,GO DOSAGE COMPENSATION,0.70355,-0.054625,-0.0066102,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.63354,-0.054872,-0.051138,0,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,0.22568,-0.055176,-0.099633,0,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.3746,-0.055292,-0.045759,0,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.74288,-0.055385,0.010224,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.20937,-0.055394,-0.083713,0,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.064293,-0.05565,-0.10682,0,0
1,GO AXON EXTENSION,0.18219,-0.056545,-0.093474,0,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.62113,-0.05665,-0.0081538,0,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.13355,-0.057149,-0.1034,0,0
1,GO REGULATION OF PROTEIN ACETYLATION,0.15015,-0.057288,-0.065041,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.37932,-0.057778,-0.057939,0,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.85768,-0.057879,0.0072563,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.97557,-0.058272,0.015571,0,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.31653,-0.058317,-0.047379,0,0
1,GO MEMBRANE DOCKING,0.15517,-0.058383,-0.060681,0,0
1,GO RESPIRATORY SYSTEM PROCESS,0.48131,-0.058404,-0.04375,0,0
1,GO T CELL HOMEOSTASIS,0.065563,-0.05849,-0.08136,0,0
1,GO GLIAL CELL DIFFERENTIATION,0.27999,-0.058692,-0.054532,0,0
1,GO REGULATION OF RESPONSE TO FOOD,0.036948,-0.059317,-0.13772,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.56666,-0.059438,-0.072945,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.48131,-0.06037,-0.030487,0,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.75615,-0.060384,-0.0187,0,0
1,GO MAST CELL ACTIVATION,0.16294,-0.060463,-0.1087,0,0
1,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.49227,-0.060483,-0.065627,0,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.32077,-0.060579,-0.032685,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.47049,-0.060646,-0.032503,0,0
1,GO ACTIN MEDIATED CELL CONTRACTION,0.71658,-0.06067,-0.0053145,0,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,0.21905,-0.060823,-0.059947,0,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.30402,-0.060884,-0.084416,0,0
1,GO MYELIN ASSEMBLY,0.65866,-0.060949,-0.029525,0,0
1,GO MYOFIBRIL ASSEMBLY,0.85768,-0.061116,0.036795,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,0.23589,-0.061331,-0.091644,0,0
1,GO FEMALE SEX DIFFERENTIATION,0.33812,-0.061684,-0.047993,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.40349,-0.061807,-0.074192,0,0
1,GO ACYLGLYCEROL HOMEOSTASIS,0.35153,-0.061913,-0.073422,0,0
1,GO METANEPHROS MORPHOGENESIS,0.53742,-0.061992,-0.063289,0,0
1,GO ER OVERLOAD RESPONSE,0.76281,-0.062297,0.034489,0,0
1,GO CHROMATIN REMODELING,0.31653,-0.062473,-0.055633,0,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.33812,-0.062555,-0.018183,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.46512,-0.062748,-0.039691,0,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.076492,-0.063208,-0.10858,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.23589,-0.063247,-0.062097,0,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.035393,-0.063666,-0.081876,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.53167,-0.063911,-0.020471,0,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.72969,-0.063983,0.014331,0,0
1,GO REGULATION OF CELL CYCLE ARREST,0.092194,-0.063993,-0.057051,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.22905,-0.064089,-0.045932,0,0
1,GO REGULATION OF ODONTOGENESIS,0.54903,-0.064309,-0.034601,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.12908,-0.064401,-0.07282,0,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.87833,-0.06457,0.0060753,0,0
1,GO POST EMBRYONIC DEVELOPMENT,0.47049,-0.064867,-0.027016,0,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.8303,-0.065663,-0.0069093,0,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.15015,-0.06573,-0.15371,0,0
1,GO LOCOMOTOR RHYTHM,0.73628,-0.06598,-0.015496,0,0
1,GO GLUTAMINE METABOLIC PROCESS,0.37932,-0.066035,-0.084339,0,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.44924,-0.066338,-0.026842,0,0
1,GO PHAGOSOME MATURATION,0.72313,-0.066357,-0.031644,0,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.52025,-0.066954,-0.075414,0,0
1,GO RESPONSE TO METAL ION,0.21579,-0.067214,-0.049395,0,0
1,GO PRENYLATION,0.49227,-0.068035,-0.078257,0,0
1,GO REGULATION OF DNA METHYLATION,0.95466,-0.068081,0.0027282,0,0
1,GO RESPONSE TO GLUCAGON,0.11841,-0.068504,-0.081729,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.21905,-0.068727,-0.08503,0,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,0.10465,-0.06878,-0.076003,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.19095,-0.069402,-0.13581,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.21256,-0.069427,-0.1154,0,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.16294,-0.069436,-0.066098,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.064293,-0.069843,-0.069126,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.080955,-0.06994,-0.10046,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.22235,-0.069959,-0.10023,0,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.0695,-0.070242,-0.072422,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.52594,-0.070304,-0.0363,0,0
1,GO BONE MINERALIZATION,0.53742,-0.070731,0.020606,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.036948,-0.070934,-0.081666,0,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,-0.071158,-0.11991,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.64605,-0.071398,0.11975,0,0
1,GO REGULATION OF GTP BINDING,0.47588,-0.071547,0.088576,0,0
1,GO CARDIAC CHAMBER FORMATION,0.35607,-0.072027,-0.16617,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.86455,-0.072491,-0.028144,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.26471,-0.072584,-0.033639,0,0
1,GO SISTER CHROMATID COHESION,0.52594,-0.072679,-0.039919,0,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.10654,-0.073177,-0.094611,0,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.25363,-0.073261,-0.096021,0,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.29184,-0.073523,-0.059046,0,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.02268,-0.073927,-0.11829,0,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.23589,-0.07419,-0.10373,0,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.061812,-0.074292,-0.18241,0,0
1,GO DIET INDUCED THERMOGENESIS,0.12473,-0.074351,-0.12649,0,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.10845,-0.074515,-0.055951,0,0
1,GO CELLULAR RESPONSE TO STARVATION,0.10096,-0.074545,-0.077849,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,0.35607,-0.074548,-0.070217,0,0
1,GO REGULATION OF ACTIN NUCLEATION,0.095625,-0.074608,-0.11284,0,0
1,GO SEGMENTATION,0.21256,-0.074612,-0.047638,0,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.53167,-0.074911,-0.12858,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.59664,-0.074991,-0.023142,0,0
1,GO LOCALIZATION WITHIN MEMBRANE,0.10465,-0.07504,-0.086765,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.40843,-0.075704,-0.10026,0,0
1,GO ALANINE TRANSPORT,0.11235,-0.075709,-0.14604,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.41842,-0.075979,-0.049682,0,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.99651,-0.076214,0.0072531,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.13814,-0.076343,-0.1323,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.53742,-0.076737,-0.071996,0,0
1,GO CALCIUM MEDIATED SIGNALING,0.047551,-0.077167,-0.069136,0,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.084046,-0.077175,-0.05176,0,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.21256,-0.077231,-0.10772,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.068167,-0.077237,-0.10284,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.67776,-0.077332,-0.054626,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.31653,-0.07768,-0.10849,0,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.23245,-0.077801,-0.068572,0,0
1,GO CELL RECOGNITION,0.093897,-0.077916,-0.077128,0,0
1,GO STRIATED MUSCLE ADAPTATION,0.25001,-0.077937,-0.078504,0,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.29992,-0.078382,-0.068015,0,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.13814,-0.07856,-0.059139,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.093897,-0.07863,-0.088526,0,0
1,GO REGULATION OF TOR SIGNALING,0.097379,-0.079197,-0.054324,0,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.61497,-0.079261,0.0019505,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.15517,-0.079561,-0.11536,0,0
1,GO MITOCHONDRIAL TRNA PROCESSING,0.73628,-0.079617,0.033569,0,0
1,GO DEVELOPMENTAL INDUCTION,0.090515,-0.079644,-0.11086,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.33812,-0.079805,-0.057132,0,0
1,GO PENILE ERECTION,0.1313,-0.079868,-0.12449,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.055956,-0.080374,-0.14036,0,0
1,GO WATER TRANSPORT,0.057089,-0.080515,-0.10473,0,0
1,GO POLYOL CATABOLIC PROCESS,0.15015,-0.080871,-0.089017,0,0
1,GO CELL MORPHOGENESIS,0.017969,-0.081443,-0.10547,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.37932,-0.081444,-0.065272,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,0.51459,-0.081658,-0.034768,0,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.087232,-0.081699,-0.13784,0,0
1,GO HISTONE H3 K36 METHYLATION,0.29586,-0.082195,-0.077973,0,0
1,GO BONE MATURATION,0.36991,-0.082357,-0.089128,0,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.19695,-0.082909,-0.090634,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.66501,-0.082988,0.012334,0,0
1,GO SENSORY SYSTEM DEVELOPMENT,0.40843,-0.0831,-0.035209,0,0
1,GO PIGMENT GRANULE LOCALIZATION,0.20937,-0.083147,-0.06465,0,0
1,GO REGULATION OF AXON GUIDANCE,0.26098,-0.083353,-0.10053,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.54903,-0.083484,-0.025477,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.96163,-0.083488,-0.032115,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.68418,-0.083493,-0.028358,0,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.18508,-0.083547,-0.073276,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.77618,-0.083567,-0.0073547,0,0
1,GO LINOLEIC ACID METABOLIC PROCESS,0.39371,-0.083642,-0.072735,0,0
1,GO CELL JUNCTION ASSEMBLY,0.21256,-0.083981,-0.047902,0,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.068167,-0.084012,-0.10216,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.39371,-0.084177,-0.035996,0,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.059411,-0.084312,-0.098395,0,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.0066042,-0.084481,-0.094914,0,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.48678,-0.084859,-0.11356,0,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.54903,-0.085146,-0.0027039,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.21256,-0.085205,-0.059731,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.31232,-0.086054,-0.060517,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.85082,-0.08608,-0.01307,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.072231,-0.086441,-0.080493,0,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.02268,-0.086489,-0.090609,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.41341,-0.08665,-0.080206,0,0
1,GO REGULATION OF CILIUM BEAT FREQUENCY,0.39858,-0.086837,-0.06751,0,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.31653,-0.086901,-0.066746,0,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.095625,-0.086931,-0.10318,0,0
1,GO MAST CELL MEDIATED IMMUNITY,0.25001,-0.087325,-0.077856,0,0
1,GO CAMERA TYPE EYE DEVELOPMENT,0.42347,-0.087372,-0.017405,0,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.25729,-0.087538,-0.072417,0,0
1,GO AMINO ACID IMPORT,0.3746,-0.087543,-0.061589,0,0
1,GO CELLULAR COMPONENT MAINTENANCE,0.061812,-0.087596,-0.11436,0,0
1,GO SENSORY ORGAN MORPHOGENESIS,0.21579,-0.087695,-0.057323,0,0
1,GO RHYTHMIC PROCESS,0.0049174,-0.087755,-0.082677,0,0
1,GO MAGNESIUM ION TRANSPORT,0.15773,-0.087865,-0.088412,0,0
1,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.095625,-0.087875,-0.12047,0,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.34702,-0.088169,-0.068941,0,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.010773,-0.088587,-0.096168,0,0
1,GO EAR MORPHOGENESIS,0.090515,-0.089167,-0.098636,0,0
1,GO MITOTIC DNA REPLICATION,0.28785,-0.089262,-0.071005,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.32506,-0.089319,-0.08731,0,0
1,GO REGULATION OF CYCLASE ACTIVITY,0.092194,-0.089369,-0.11227,0,0
1,GO PH REDUCTION,0.12259,-0.089952,-0.072959,0,0
1,GO RENAL SYSTEM PROCESS,0.26098,-0.090364,-0.061049,0,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.60883,-0.090493,-0.026769,0,0
1,GO ADAPTATION OF SIGNALING PATHWAY,0.21579,-0.090784,-0.10098,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.188,-0.091016,-0.12173,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.075049,-0.091359,-0.10002,0,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.077957,-0.092114,-0.17431,0,0
1,GO GASTRIC ACID SECRETION,0.68418,-0.092486,-0.017981,0,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.20937,-0.092687,-0.082581,0,0
1,GO HORMONE CATABOLIC PROCESS,0.60272,-0.0929,-0.070039,0,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.11636,-0.093022,-0.11642,0,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.4978,-0.0932,-0.070298,0,0
1,GO PROTEIN NITROSYLATION,0.30402,-0.09324,-0.10278,0,0
1,GO CILIUM MOVEMENT,0.11841,-0.093383,-0.080416,0,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.19095,-0.093476,-0.087976,0,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.26847,-0.093553,-0.031328,0,0
1,GO KIDNEY MORPHOGENESIS,0.50896,-0.093772,-0.029185,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.53167,-0.094012,-0.0047233,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.32938,-0.094227,-0.074287,0,0
1,GO ESTROGEN BIOSYNTHETIC PROCESS,0.56075,-0.094286,-0.039923,0,0
1,GO EXPLORATION BEHAVIOR,0.064293,-0.094317,-0.24491,0,0
1,GO ANATOMICAL STRUCTURE REGRESSION,0.079444,-0.094371,-0.24239,0,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0040578,-0.094619,-0.15417,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.11039,-0.094739,-0.097606,0,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.73628,-0.094864,-0.022034,0,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.48131,-0.094892,-0.019256,0,0
1,GO PROTEIN ACYLATION,0.00084609,-0.095026,-0.099282,0,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.17653,-0.095186,-0.066087,0,0
1,GO SENSORY PERCEPTION OF SMELL,0.004408,-0.095358,-0.099112,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.53742,-0.095706,-0.023756,0,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.2839,-0.095894,-0.042026,0,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.015953,-0.09704,-0.11686,0,0
1,GO ESTROUS CYCLE,0.65866,-0.098024,-0.038346,0,0
1,GO CHEMOSENSORY BEHAVIOR,0.084046,-0.098329,-0.15803,0,0
1,GO CILIUM ORGANIZATION,0.22905,-0.098534,-0.043919,0,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.39371,-0.09861,-0.0723,0,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.14048,-0.099156,-0.069704,0,0
1,GO MICROTUBULE BASED TRANSPORT,0.14048,-0.09929,-0.067136,0,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,0.013798,-0.099382,-0.10639,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.15264,-0.099635,-0.073387,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,0.53742,-0.099803,-0.084602,0,0
1,GO EMBRYONIC BODY MORPHOGENESIS,0.53742,-0.10048,-0.045216,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.64605,-0.10114,-0.024495,0,0
1,GO PROTEIN MANNOSYLATION,0.25001,-0.10136,-0.066175,0,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.84397,-0.10147,0.00029428,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.12689,-0.10181,-0.11448,0,0
1,GO MATING,0.0029794,-0.10194,-0.14789,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.17374,-0.102,-0.056275,0,0
1,GO WHITE FAT CELL DIFFERENTIATION,0.19695,-0.10328,-0.074944,0,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.56075,-0.10348,-0.056298,0,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.02843,-0.10385,-0.10401,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.15773,-0.10398,-0.077468,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.075049,-0.10402,-0.19022,0,0
1,GO CORNIFICATION,0.56075,-0.10419,-0.02174,0,0
1,GO CELLULAR ANION HOMEOSTASIS,0.19695,-0.10425,-0.088382,0,0
1,GO REGULATION OF ICOSANOID SECRETION,0.15264,-0.10429,-0.096844,0,0
1,GO RESPONSE TO MUSCLE STRETCH,0.68418,-0.1043,0.00011863,0,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.030383,-0.10445,-0.091287,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.48678,-0.10459,-0.018793,0,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.15773,-0.10485,-0.018492,0,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.065563,-0.1052,-0.14514,0,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.055956,-0.10528,-0.13802,0,0
1,GO PROTEIN DEMETHYLATION,0.092194,-0.10535,-0.12639,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.98255,-0.10572,0.048353,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.80312,-0.10622,0.026082,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.4598,-0.10669,-0.028792,0,0
1,GO L AMINO ACID TRANSPORT,0.085627,-0.10713,-0.10165,0,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.80312,-0.10747,0.01136,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.50337,-0.10774,-0.058374,0,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0064317,-0.10791,-0.13407,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.30815,-0.10842,-0.10957,0,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.54321,-0.10865,-0.030058,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.67776,-0.10866,-0.016032,0,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.39371,-0.10913,-0.068309,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.41341,-0.10914,-0.052031,0,0
1,GO G0 TO G1 TRANSITION,0.1313,-0.10986,-0.061248,0,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.079444,-0.10988,-0.0964,0,0
1,GO CARDIAC CELL DEVELOPMENT,0.27999,-0.11032,-0.024073,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.2839,-0.1104,-0.12566,0,0
1,GO SENSORY ORGAN DEVELOPMENT,0.073629,-0.11053,-0.080666,0,0
1,GO POSITIVE REGULATION OF HEART RATE,0.5726,-0.11057,-0.023202,0,0
1,GO TORC1 SIGNALING,0.045624,-0.11076,-0.076978,0,0
1,GO PATTERN SPECIFICATION PROCESS,0.064293,-0.1109,-0.10729,0,0
1,GO BASIC AMINO ACID TRANSPORT,0.082489,-0.11105,-0.17752,0,0
1,GO SECRETORY GRANULE ORGANIZATION,0.014841,-0.11112,-0.15879,0,0
1,GO MICROTUBULE BASED MOVEMENT,0.05824,-0.11119,-0.085803,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.49227,-0.11124,-0.029177,0,0
1,GO EXCRETION,0.082489,-0.11128,-0.076503,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.50337,-0.11182,-0.053942,0,0
1,GO CIRCADIAN RHYTHM,2.8418e-05,-0.11194,-0.13785,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.75615,-0.11202,-0.0033343,0,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.024846,-0.11207,-0.14183,0,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.11841,-0.11217,-0.036275,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0094949,-0.11239,-0.10252,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.11841,-0.11239,-0.097132,0,0
1,GO NEURON APOPTOTIC PROCESS,0.0007696,-0.11297,-0.11891,0,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.073629,-0.11344,-0.11588,0,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.14526,-0.11388,-0.18479,0,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.67137,-0.1139,-0.004211,0,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.065563,-0.11411,-0.13867,0,0
1,GO GDP METABOLIC PROCESS,0.093897,-0.1142,-0.198,0,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0075304,-0.11433,-0.13429,0,0
1,GO TRANSPORT ALONG MICROTUBULE,0.097379,-0.11435,-0.095342,0,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.082489,-0.11437,-0.11024,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.53742,-0.11458,-0.0755,0,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.092194,-0.11504,-0.17201,0,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.2839,-0.11517,-0.060311,0,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.36991,-0.11543,-0.075666,0,0
1,GO RESPONSE TO CALCIUM ION,0.070855,-0.11583,-0.096779,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,0.27611,-0.11615,-0.064884,0,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.2839,-0.11638,-0.06433,0,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.13355,-0.11652,-0.068114,0,0
1,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.19095,-0.11683,-0.11786,0,0
1,GO REGULATION OF SISTER CHROMATID COHESION,0.17653,-0.11687,-0.066185,0,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.099158,-0.1171,-0.19645,0,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.13814,-0.11725,-0.0085036,0,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.20309,-0.11753,-0.069836,0,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.017137,-0.11773,-0.15122,0,0
1,GO BROWN FAT CELL DIFFERENTIATION,0.43883,-0.11844,-0.053535,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.36991,-0.11869,-0.059949,0,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.29586,-0.1187,-0.060918,0,0
1,GO BRAIN MORPHOGENESIS,0.031748,-0.1193,-0.1413,0,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.2,-0.11979,-0.12021,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.28785,-0.11999,-0.11469,0,0
1,GO SPERM AXONEME ASSEMBLY,0.21579,-0.12027,-0.12351,0,0
1,GO EYE MORPHOGENESIS,0.22235,-0.1203,-0.046845,0,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.063042,-0.12037,-0.10799,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.093897,-0.12162,-0.18129,0,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.1313,-0.12193,-0.11255,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.27999,-0.1221,-0.064232,0,0
1,GO LONG TERM MEMORY,0.025994,-0.12257,-0.16928,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.1028,-0.12268,-0.066554,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.4978,-0.12319,-0.067007,0,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.00353,-0.1233,-0.17511,0,0
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.47049,-0.1238,-0.13615,0,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.068167,-0.12382,-0.088952,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.55487,-0.12418,-0.089347,0,0
1,GO FACIAL NERVE MORPHOGENESIS,0.24643,-0.12434,-0.1636,0,0
1,GO POSITIVE REGULATION OF RNA SPLICING,0.00049035,-0.12446,-0.14158,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.12473,-0.12467,-0.1808,0,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.054842,-0.12493,-0.15335,0,0
1,GO SOMITE DEVELOPMENT,0.010506,-0.12501,-0.11285,0,0
1,GO OXIDATIVE DEMETHYLATION,0.065563,-0.12586,-0.1031,0,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00026003,-0.12588,-0.15038,0,0
1,GO REGULATION OF CELL DEVELOPMENT,0.0014299,-0.12597,-0.14513,0,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.044685,-0.12608,-0.16643,0,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.055956,-0.12609,-0.1569,0,0
1,GO KERATINIZATION,0.35153,-0.12627,-0.050749,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.72969,-0.12683,0.14187,0,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.075049,-0.12712,-0.12043,0,0
1,GO HISTONE METHYLATION,0.025994,-0.12712,-0.10724,0,0
1,GO INCLUSION BODY ASSEMBLY,0.30815,-0.12715,-0.12994,0,0
1,GO RESPONSE TO INACTIVITY,0.24643,-0.12786,-0.090575,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.099158,-0.12812,-0.09276,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.26098,-0.12813,-0.076144,0,0
1,GO REGULATION OF OOGENESIS,0.075049,-0.12817,-0.070795,0,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.30402,-0.12851,-0.060403,0,0
1,GO RECEPTOR CLUSTERING,0.0036303,-0.12859,-0.20643,0,0
1,GO MOTOR NEURON AXON GUIDANCE,0.0051916,-0.12863,-0.18401,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.82348,-0.1287,-0.023353,0,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.12473,-0.12915,-0.21309,0,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.072231,-0.12977,-0.126,0,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0069616,-0.13001,-0.17738,0,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.75615,-0.13048,-0.0075086,0,0
1,GO ANIMAL ORGAN MATURATION,0.30402,-0.13068,-0.065247,0,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.013465,-0.13103,-0.14041,0,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.03939,-0.13106,-0.11129,0,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.077957,-0.13115,-0.11004,0,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0030654,-0.13169,-0.17085,0,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.21256,-0.13201,-0.1419,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.1313,-0.13224,-0.096375,0,0
1,GO CHROMATIN SILENCING,0.17374,-0.13225,-0.038896,0,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,0.001662,-0.1323,-0.11673,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.26098,-0.13254,-0.10233,0,0
1,GO SPERMATID DIFFERENTIATION,0.072231,-0.13256,-0.081116,0,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.25363,-0.13273,-0.080109,0,0
1,GO RESPONSE TO ETHER,0.14526,-0.13289,-0.11782,0,0
1,GO PEPTIDYL LYSINE METHYLATION,0.066855,-0.13319,-0.10259,0,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0023671,-0.13326,-0.12913,0,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.088862,-0.13326,-0.11162,0,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.0010528,-0.13336,-0.12376,0,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.013465,-0.13336,-0.15107,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0023671,-0.13383,-0.14795,0,0
1,GO HEART INDUCTION,0.51459,-0.13451,-0.083438,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.065563,-0.13466,-0.087351,0,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.12259,-0.13482,-0.086194,0,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.21905,-0.13494,-0.10383,0,0
1,GO METAL ION TRANSPORT,9.0551e-05,-0.13536,-0.13652,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.19393,-0.13555,-0.27709,0,0
1,GO REGULATION OF STEM CELL DIVISION,0.46512,-0.13606,-0.077046,0,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00025131,-0.13633,-0.18039,0,0
1,GO RESPONSE TO FUNGUS,0.059411,-0.13641,-0.1213,0,0
1,GO FEVER GENERATION,0.43883,-0.13648,0.035229,0,0
1,GO RESPONSE TO PAIN,0.053746,-0.13655,-0.15577,0,0
1,GO CGMP MEDIATED SIGNALING,0.10096,-0.13657,-0.12589,0,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.11235,-0.13658,-0.093037,0,0
1,GO BRONCHUS DEVELOPMENT,0.94073,-0.13662,0.021868,0,0
1,GO THYMUS DEVELOPMENT,0.39858,-0.13733,-0.051332,0,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.057089,-0.1375,-0.18026,0,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.23937,-0.13761,-0.051424,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.080955,-0.13771,-0.12934,0,0
1,GO REGULATION OF GLIOGENESIS,0.022165,-0.13792,-0.10871,0,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.084046,-0.13824,-0.13163,0,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0047853,-0.13832,-0.18411,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.15773,-0.13852,-0.14911,0,0
1,GO NOTCH SIGNALING PATHWAY,0.12473,-0.13861,-0.074433,0,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.0017641,-0.13883,-0.17801,0,0
1,GO CELL PROJECTION ORGANIZATION,0.0011549,-0.13918,-0.12983,0,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.15773,-0.13954,-0.053487,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.044685,-0.13988,-0.12488,0,0
1,GO V D J RECOMBINATION,0.38408,-0.14019,-0.048939,0,0
1,GO HINDBRAIN MORPHOGENESIS,0.007729,-0.14021,-0.16393,0,0
1,GO REGULATION OF CHLORIDE TRANSPORT,0.26847,-0.14032,-0.092245,0,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.17374,-0.14054,-0.1512,0,0
1,GO CELL JUNCTION ORGANIZATION,0.0031536,-0.1408,-0.12681,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.21579,-0.14118,-0.11658,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.78962,-0.1414,0.047166,0,0
1,GO PARTURITION,0.14048,-0.14227,-0.13813,0,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.10465,-0.14237,-0.10805,0,0
1,GO POSITIVE REGULATION OF CELL MATURATION,0.5726,-0.1427,-0.052044,0,0
1,GO REGULATION OF EXCRETION,0.15015,-0.14276,-0.1067,0,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.33373,-0.1429,-0.09819,0,0
1,GO REGULATION OF TORC1 SIGNALING,0.0015653,-0.14351,-0.15349,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.061812,-0.1438,-0.12547,0,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.064293,-0.14397,-0.16949,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.2139e-05,-0.14399,-0.12668,0,0
1,GO CELL CELL SIGNALING,2.3418e-05,-0.14429,-0.15226,0,0
1,GO CELLULAR RESPONSE TO CAMP,0.013798,-0.14476,-0.12795,0,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.004408,-0.14571,-0.17419,0,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.084046,-0.14651,-0.093699,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.017969,-0.14684,-0.12261,0,0
1,GO CELL FATE COMMITMENT,0.0062634,-0.14737,-0.14879,0,0
1,GO MEMBRANE REPOLARIZATION,0.0094949,-0.1479,-0.17745,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.41341,-0.14804,-0.065537,0,0
1,GO VASCULAR WOUND HEALING,0.18508,-0.14816,-0.16783,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.17099,-0.14835,-0.1175,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,0.10654,-0.14852,-0.092903,0,0
1,GO REGULATION OF CILIUM MOVEMENT,0.0029794,-0.14895,-0.15281,0,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.11841,-0.14905,-0.18992,0,0
1,GO INNER EAR MORPHOGENESIS,0.025414,-0.14937,-0.15247,0,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.087232,-0.15052,-0.1835,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.56075,-0.15057,-0.035199,0,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.059411,-0.15155,-0.11739,0,0
1,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.188,-0.1516,-0.15714,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.010773,-0.15186,-0.37975,0,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0036303,-0.15196,-0.17204,0,0
1,GO DIVALENT METAL ION EXPORT,0.36526,-0.15207,-0.079896,0,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.21256,-0.15215,-0.06267,0,0
1,GO DETERMINATION OF ADULT LIFESPAN,0.065563,-0.1522,-0.11872,0,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.010773,-0.15308,-0.21313,0,0
1,GO REGIONALIZATION,0.061812,-0.15342,-0.11902,0,0
1,GO MITOTIC SISTER CHROMATID COHESION,0.14285,-0.15359,-0.098617,0,0
1,GO MYOTUBE CELL DEVELOPMENT,0.085627,-0.15378,-0.14714,0,0
1,GO MICROTUBULE POLYMERIZATION,0.0018173,-0.15398,-0.18448,0,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0053338,-0.15442,-0.12907,0,0
1,GO RENAL WATER HOMEOSTASIS,0.0050528,-0.15511,-0.13888,0,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.090515,-0.15522,-0.10912,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.19695,-0.15547,-0.01645,0,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.19095,-0.156,-0.10775,0,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0099891,-0.15702,-0.12522,0,0
1,GO RESPONSE TO VITAMIN D,0.32077,-0.15744,-0.10366,0,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0075304,-0.15747,-0.13636,0,0
1,GO RESPONSE TO EPINEPHRINE,0.13814,-0.15785,-0.16997,0,0
1,GO HISTONE H2A MONOUBIQUITINATION,0.060602,-0.15787,-0.11166,0,0
1,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.43367,-0.15797,-0.068074,0,0
1,GO CRANIAL NERVE MORPHOGENESIS,0.12908,-0.15816,-0.14616,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.2,-0.15819,-0.12808,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.10845,-0.15821,-0.09403,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.71006,-0.15821,-0.020029,0,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.03939,-0.1583,-0.18877,0,0
1,GO ION TRANSMEMBRANE TRANSPORT,2.6307e-05,-0.15833,-0.15332,0,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.077957,-0.1585,-0.15364,0,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.052669,-0.15868,-0.13045,0,0
1,GO VASODILATION,0.14769,-0.15875,-0.14674,0,0
1,GO CATION TRANSPORT,7.0571e-06,-0.1589,-0.16515,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.16559,-0.15979,-0.076143,0,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.17934,-0.15991,-0.081259,0,0
1,GO DETECTION OF LIGHT STIMULUS,4.1617e-05,-0.16141,-0.19276,0,0
1,GO PROTEIN METHYLATION,0.023741,-0.16157,-0.11282,0,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.00050664,-0.16216,-0.19538,0,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.035393,-0.1622,-0.10854,0,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.00031859,-0.1624,-0.28301,0,0
1,GO REGULATION OF CHROMATIN BINDING,0.076492,-0.16342,-0.10715,0,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.00012074,-0.16361,-0.16847,0,0
1,GO MELANOCYTE DIFFERENTIATION,0.10654,-0.16397,-0.12525,0,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.18219,-0.16482,-0.080744,0,0
1,GO HISTONE H4 ACETYLATION,0.0042883,-0.16577,-0.13572,0,0
1,GO AXO DENDRITIC TRANSPORT,0.017137,-0.16596,-0.17393,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.52025,-0.16601,-0.042367,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.25001,-0.16628,-0.011584,0,0
1,GO SENSORY PERCEPTION,9.3916e-06,-0.16762,-0.15726,0,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.064293,-0.1679,-0.22961,0,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.13583,-0.16812,-0.081739,0,0
1,GO RHYTHMIC BEHAVIOR,0.0069616,-0.16835,-0.18175,0,0
1,GO INTESTINAL ABSORPTION,0.1313,-0.16847,-0.11793,0,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.037747,-0.16881,-0.22372,0,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.010506,-0.16998,-0.22078,0,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.22905,-0.17004,-0.14276,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.11841,-0.17259,-0.086386,0,0
1,GO DENDRITE SELF AVOIDANCE,0.057089,-0.17348,-0.16539,0,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.17099,-0.17361,-0.10308,0,0
1,GO HISTONE H3 K4 METHYLATION,0.047551,-0.1741,-0.16752,0,0
1,GO RENAL SODIUM EXCRETION,0.11434,-0.17472,-0.094394,0,0
1,GO AXIS SPECIFICATION,0.042857,-0.17495,-0.13276,0,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.015953,-0.17512,-0.18625,0,0
1,GO RESPONSE TO AMINO ACID STARVATION,0.0013457,-0.17568,-0.17519,0,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.19393,-0.17629,-0.15263,0,0
1,GO COLLATERAL SPROUTING,0.01282,-0.17792,-0.20274,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,0.02843,-0.17953,-0.14316,0,0
1,GO CATION TRANSMEMBRANE TRANSPORT,1.1964e-05,-0.17953,-0.16936,0,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,1.1964e-05,-0.17966,-0.1719,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.13814,-0.17968,-0.078298,0,0
1,GO DORSAL VENTRAL PATTERN FORMATION,0.016734,-0.17974,-0.20436,0,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.12049,-0.17978,-0.12024,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.18508,-0.17993,-0.095218,0,0
1,GO DEVELOPMENTAL CELL GROWTH,0.00023468,-0.17997,-0.19571,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.10465,-0.18024,-0.15029,0,0
1,GO MICROTUBULE SEVERING,0.084046,-0.18038,-0.12788,0,0
1,GO REGULATION OF BEHAVIOR,0.001191,-0.18043,-0.18117,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00014935,-0.18057,-0.17957,0,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.068167,-0.18065,-0.15201,0,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0017641,-0.18086,-0.16746,0,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,8.1192e-05,-0.18111,-0.18317,0,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.02268,-0.18123,-0.16299,0,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.14048,-0.18186,-0.10106,0,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.014841,-0.1821,-0.13888,0,0
1,GO CARTILAGE MORPHOGENESIS,0.29586,-0.18255,-0.1338,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.54903,-0.18273,-0.029276,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.19695,-0.18286,0.019511,0,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.015574,-0.18357,-0.18283,0,0
1,GO SODIUM ION TRANSPORT,1.1964e-05,-0.18378,-0.20478,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00013433,-0.1843,-0.24936,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.13583,-0.18601,-0.1362,0,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,2.0033e-05,-0.1864,-0.17316,0,0
1,GO HEAD DEVELOPMENT,0.00028792,-0.18641,-0.17958,0,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.0057817,-0.18673,-0.17138,0,0
1,GO NEUROBLAST PROLIFERATION,0.029068,-0.1877,-0.19065,0,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0051916,-0.18788,-0.18212,0,0
1,GO RESPONSE TO AMINE,0.0056288,-0.18821,-0.18485,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.001872,-0.18822,-0.22987,0,0
1,GO SLEEP,0.0001547,-0.18908,-0.21111,0,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.011904,-0.18925,-0.21584,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.17099,-0.18929,-0.1582,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.099158,-0.18933,-0.096151,0,0
1,GO CARDIAC VENTRICLE FORMATION,0.064293,-0.18991,-0.35578,0,0
1,GO RESPONSE TO CAFFEINE,0.11841,-0.19011,-0.11913,0,0
1,GO SNARE COMPLEX ASSEMBLY,0.085627,-0.19036,-0.118,0,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0019282,-0.19052,-0.21572,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.36991,-0.19086,-0.12215,0,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.082489,-0.19111,-0.15408,0,0
1,GO NEUROGENESIS,3.4421e-05,-0.19118,-0.19588,0,0
1,GO REGULATION OF ION TRANSPORT,2.4692e-06,-0.19236,-0.19951,0,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0067808,-0.19317,-0.27486,0,0
1,GO RESPONSE TO FOOD,4.3218e-05,-0.19346,-0.19647,0,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.0059384,-0.19415,-0.21585,0,0
1,GO EAR DEVELOPMENT,0.0016129,-0.19449,-0.18767,0,0
1,GO APICAL PROTEIN LOCALIZATION,0.073629,-0.19502,-0.21188,0,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,5.2139e-05,-0.19582,-0.18164,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.0062634,-0.19798,-0.2366,0,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,5.2139e-05,-0.19829,-0.25852,0,0
1,GO DETECTION OF VISIBLE LIGHT,3.3132e-05,-0.1987,-0.19571,0,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.16828,-0.199,-0.11487,0,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.0066042,-0.19941,-0.24769,0,0
1,GO KETONE BODY METABOLIC PROCESS,0.025414,-0.19948,-0.25548,0,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00016595,-0.19954,-0.21686,0,0
1,GO MAINTENANCE OF CELL POLARITY,0.0028957,-0.19986,-0.2292,0,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00095906,-0.20024,-0.18418,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.36526,-0.20162,-0.12502,0,0
1,GO DENDRITIC SPINE DEVELOPMENT,0.0019282,-0.20189,-0.18819,0,0
1,GO REGULATION OF BLOOD CIRCULATION,1.8521e-05,-0.20307,-0.20697,0,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,4.6597e-05,-0.20447,-0.21929,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0031536,-0.20479,-0.19802,0,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00072223,-0.20493,-0.19031,0,0
1,GO REGULATION OF NEURON DIFFERENTIATION,1.8521e-05,-0.20545,-0.24644,0,0
1,GO ORGANIC CATION TRANSPORT,2.3418e-05,-0.20569,-0.26045,0,0
1,GO PSEUDOPODIUM ORGANIZATION,0.76948,-0.20603,-0.0080412,0,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.027188,-0.20647,-0.11087,0,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.00067758,-0.20834,-0.19728,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.079444,-0.20904,-0.11278,0,0
1,GO CARDIAC MUSCLE CONTRACTION,0.00074557,-0.20912,-0.17389,0,0
1,GO EMBRYONIC PATTERN SPECIFICATION,0.0073363,-0.20962,-0.19974,0,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.033166,-0.20981,-0.14577,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.041093,-0.20993,-0.25726,0,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.085627,-0.21025,-0.24312,0,0
1,GO NEURON REMODELING,0.22235,-0.21029,-0.10983,0,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.054842,-0.21137,-0.20896,0,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.18508,-0.21192,-0.12972,0,0
1,GO FORELIMB MORPHOGENESIS,0.046579,-0.21206,-0.156,0,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0033369,-0.21321,-0.23439,0,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.28785,-0.21325,-0.13907,0,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0022992,-0.21337,-0.33702,0,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,2.9532e-05,-0.21356,-0.22313,0,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.087232,-0.21629,-0.11296,0,0
1,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.036948,-0.21712,-0.22387,0,0
1,GO CELLULAR RESPONSE TO VITAMIN D,0.076492,-0.21742,-0.1716,0,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,1.2962e-05,-0.21794,-0.24498,0,0
1,GO REGULATION OF AXONOGENESIS,2.6307e-05,-0.21854,-0.26248,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.14769,-0.21941,-0.12122,0,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.26471,-0.21958,-0.23447,0,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00069957,-0.22018,-0.23839,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.0049174,-0.22075,-0.22213,0,0
1,GO VESICLE DOCKING,0.00012074,-0.22076,-0.23113,0,0
1,GO NEURON PROJECTION EXTENSION,0.00027832,-0.22084,-0.22531,0,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,4.1617e-05,-0.22097,-0.19389,0,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,1.104e-05,-0.22101,-0.23294,0,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0032441,-0.22106,-0.26747,0,0
1,GO AXONAL TRANSPORT,0.0042883,-0.22117,-0.21992,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.14526,-0.22181,-0.20442,0,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.60883,-0.22214,-0.033297,0,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00087311,-0.22227,-0.2921,0,0
1,GO NEURON PROJECTION GUIDANCE,0.0006154,-0.22262,-0.22936,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,7.547e-05,-0.22396,-0.24204,0,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,6.4994e-06,-0.22426,-0.20477,0,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.041967,-0.22449,-0.16558,0,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.095625,-0.22458,-0.18942,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0023671,-0.22629,-0.19388,0,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0050528,-0.22632,-0.15647,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.0050528,-0.22637,-0.17925,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.0028957,-0.22656,-0.14964,0,0
1,GO SHORT TERM MEMORY,0.015953,-0.22714,-0.28965,0,0
1,GO ADULT HEART DEVELOPMENT,0.14769,-0.22772,-0.13548,0,0
1,GO NEURON DIFFERENTIATION,3.6228e-06,-0.22853,-0.24197,0,0
1,GO HEART PROCESS,1.7118e-05,-0.22855,-0.21186,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.085627,-0.22934,-0.16283,0,0
1,GO STRIATED MUSCLE CONTRACTION,8.7323e-05,-0.22935,-0.19584,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00021909,-0.22961,-0.3003,0,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0032441,-0.2298,-0.16257,0,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.00014935,-0.23014,-0.22217,0,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0046564,-0.23053,-0.30873,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.03245,-0.23055,-0.17408,0,0
1,GO REGULATION OF MICROTUBULE BINDING,0.00011241,-0.2308,-0.28672,0,0
1,GO IMMATURE B CELL DIFFERENTIATION,0.054842,-0.23203,-0.1464,0,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.0049174,-0.23206,-0.1425,0,0
1,GO AXON DEVELOPMENT,0.00010845,-0.23214,-0.2467,0,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.19095,-0.23265,-0.13683,0,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.52025,-0.23486,-0.0090589,0,0
1,GO FILOPODIUM ASSEMBLY,0.001986,-0.23507,-0.21868,0,0
1,GO ADHERENS JUNCTION ORGANIZATION,0.00087311,-0.23523,-0.24716,0,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.057089,-0.2356,-0.23972,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.011904,-0.23616,-0.24941,0,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00050664,-0.23665,-0.27529,0,0
1,GO DEVELOPMENTAL MATURATION,4.1112e-06,-0.23684,-0.23612,0,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.0013054,-0.23711,-0.19265,0,0
1,GO MEMORY,1.0779e-06,-0.23802,-0.27514,0,0
1,GO RESPONSE TO HYDROXYUREA,0.016339,-0.23848,-0.18229,0,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.010245,-0.2393,-0.17244,0,0
1,GO CELL FATE DETERMINATION,0.0075304,-0.23949,-0.23798,0,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.36526,-0.23976,-0.039153,0,0
1,GO SECONDARY PALATE DEVELOPMENT,0.0042883,-0.24023,-0.23416,0,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.00010845,-0.24039,-0.23144,0,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.19095,-0.24043,-0.15836,0,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.029719,-0.2407,-0.30153,0,0
1,GO NERVOUS SYSTEM PROCESS,9.2696e-08,-0.2424,-0.23003,0,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00031859,-0.24266,-0.22588,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,1.9263e-05,-0.24351,-0.26203,0,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0025083,-0.24364,-0.20433,0,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.00025131,-0.24428,-0.24119,0,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,1.104e-05,-0.24448,-0.31841,0,0
1,GO SPINAL CORD DEVELOPMENT,0.00012964,-0.24452,-0.27684,0,0
1,GO REGULATION OF FLAGELLATED SPERM MOTILITY,5.2139e-05,-0.24472,-0.21155,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00081984,-0.24531,-0.25458,0,0
1,GO RESPONSE TO CATECHOLAMINE,5.508e-06,-0.2454,-0.27069,0,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0017123,-0.24542,-0.21998,0,0
1,GO ACTIN FILAMENT BASED TRANSPORT,0.085627,-0.24596,-0.14598,0,0
1,GO PROTEIN DEPOLYMERIZATION,6.0504e-05,-0.24704,-0.23089,0,0
1,GO CRANIAL NERVE DEVELOPMENT,7.547e-05,-0.24715,-0.2938,0,0
1,GO MICROTUBULE BUNDLE FORMATION,0.0075304,-0.24739,-0.1757,0,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.042857,-0.24745,-0.25242,0,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.015574,-0.24881,-0.23557,0,0
1,GO HEART FORMATION,0.031748,-0.24922,-0.19035,0,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.6455e-05,-0.24972,-0.2175,0,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,4.2876e-06,-0.2498,-0.27428,0,0
1,GO HEAT GENERATION,0.22235,-0.25016,-0.11366,0,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.013465,-0.25018,-0.21863,0,0
1,GO CELL AGGREGATION,0.031748,-0.25135,-0.17246,0,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.025994,-0.25202,-0.13639,0,0
1,GO INTRACILIARY TRANSPORT,0.093897,-0.25219,-0.13904,0,0
1,GO NEURON DEVELOPMENT,3.9418e-06,-0.25282,-0.24651,0,0
1,GO LIMBIC SYSTEM DEVELOPMENT,4.1617e-05,-0.25359,-0.27316,0,0
1,GO SEX DETERMINATION,0.0097392,-0.2537,-0.21935,0,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.0007696,-0.25376,-0.27967,0,0
1,GO COGNITION,3.3202e-07,-0.25542,-0.27577,0,0
1,GO FOREBRAIN DEVELOPMENT,2.1663e-05,-0.25594,-0.22859,0,0
1,GO CELL PART MORPHOGENESIS,1.1964e-05,-0.25606,-0.24945,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.17374,-0.25722,-0.14344,0,0
1,GO CEREBRAL CORTEX DEVELOPMENT,0.00010845,-0.258,-0.23276,0,0
1,GO BEHAVIOR,5.986e-08,-0.25855,-0.27507,0,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,6.6003e-08,-0.25879,-0.25393,0,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.001228,-0.25889,-0.27231,0,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0056288,-0.26012,-0.45695,0,0
1,GO LONG TERM SYNAPTIC POTENTIATION,0.00010462,-0.2605,-0.2613,0,0
1,GO VISUAL BEHAVIOR,2.2524e-05,-0.26087,-0.24067,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00049035,-0.26136,-0.26295,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0001165,-0.26156,-0.297,0,0
1,GO UTERUS DEVELOPMENT,0.011612,-0.26168,-0.24732,0,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.023741,-0.26272,-0.22875,0,0
1,GO CELL FATE SPECIFICATION,0.00031859,-0.26372,-0.32534,0,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,3.6228e-06,-0.26427,-0.28094,0,0
1,GO INSEMINATION,0.068167,-0.26515,-0.16047,0,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00016023,-0.26622,-0.30021,0,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00074557,-0.26676,-0.28662,0,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.16828,-0.26858,-0.15484,0,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,7.0571e-06,-0.26894,-0.32545,0,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0006154,-0.26938,-0.31994,0,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.014138,-0.27042,-0.20312,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.014486,-0.27315,-0.20623,0,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.05824,-0.27689,-0.27574,0,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.036164,-0.27787,-0.16217,0,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,1.5816e-05,-0.28011,-0.29739,0,0
1,GO CHROMATIN SILENCING AT TELOMERE,3.0689e-05,-0.2811,-0.25217,0,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00017796,-0.28188,-0.30811,0,0
1,GO LIPOXYGENASE PATHWAY,0.025994,-0.28313,-0.26469,0,0
1,GO HISTONE H4 K5 ACETYLATION,0.00065623,-0.2835,-0.24981,0,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.00010845,-0.28481,-0.22192,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00027832,-0.28488,-0.32821,0,0
1,GO DENDRITIC SPINE MORPHOGENESIS,0.00017186,-0.28518,-0.31343,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.016339,-0.28539,-0.29829,0,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.11841,-0.28553,-0.17816,0,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,0.0011199,-0.28577,-0.23452,0,0
1,GO AXONEME ASSEMBLY,0.027803,-0.28703,-0.18921,0,0
1,GO DETECTION OF ABIOTIC STIMULUS,6.2859e-08,-0.28797,-0.3031,0,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,3.8583e-05,-0.28871,-0.2942,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0085714,-0.28999,-0.33395,0,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00038934,-0.29029,-0.2649,0,0
1,GO CELL JUNCTION MAINTENANCE,0.001228,-0.29324,-0.2652,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00011241,-0.29378,-0.29143,0,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.030383,-0.29427,-0.18098,0,0
1,GO GAMMA DELTA T CELL ACTIVATION,0.3746,-0.2944,-0.083464,0,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,3.0576e-06,-0.29607,-0.31274,0,0
1,GO REGULATION OF HEART RATE,4.6597e-05,-0.29709,-0.26306,0,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.020205,-0.29725,-0.26098,0,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.35607,-0.29763,-0.085352,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00065623,-0.29797,-0.28073,0,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,1.349e-05,-0.29886,-0.29442,0,0
1,GO RESPONSE TO DOPAMINE,5.0194e-07,-0.29898,-0.29493,0,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00011241,-0.30059,-0.36037,0,0
1,GO ENERGY HOMEOSTASIS,0.0062634,-0.30075,-0.23771,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.02166,-0.30082,-0.22259,0,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.0030654,-0.30125,-0.2131,0,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,9.7346e-05,-0.30144,-0.30203,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.054842,-0.3025,-0.19271,0,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.001191,-0.30337,-0.26902,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00017796,-0.3034,-0.28613,0,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.15517,-0.30515,-0.16801,0,0
1,GO WALKING BEHAVIOR,6.2367e-06,-0.30634,-0.36594,0,0
1,GO PRESYNAPSE ORGANIZATION,0.00036427,-0.31259,-0.31012,0,0
1,GO MICROTUBULE DEPOLYMERIZATION,1.8251e-06,-0.31274,-0.41158,0,0
1,GO SENSORY PERCEPTION OF PAIN,2.5122e-07,-0.31375,-0.29677,0,0
1,GO NUCLEAR BODY ORGANIZATION,0.0011549,-0.31529,-0.3162,0,0
1,GO ACROSOME ASSEMBLY,0.00021167,-0.31559,-0.28014,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00012074,-0.31635,-0.27792,0,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.00098941,-0.31648,-0.3889,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,5.7413e-06,-0.31735,-0.35234,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0069616,-0.31818,-0.28976,0,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00084609,-0.31911,-0.29143,0,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.27227,-0.32028,-0.13339,0,0
1,GO CELL MIGRATION IN HINDBRAIN,6.7596e-05,-0.32032,-0.43093,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0022332,-0.32077,-0.29994,0,0
1,GO PROTEIN PALMITOYLATION,1.5331e-06,-0.32239,-0.3257,0,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.14048,-0.32385,-0.26065,0,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.011612,-0.32425,-0.24547,0,0
1,GO HINDBRAIN DEVELOPMENT,9.0221e-07,-0.32556,-0.3293,0,0
1,GO POSITIVE REGULATION OF CILIUM MOVEMENT,6.2367e-06,-0.32619,-0.30997,0,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00059588,-0.32789,-0.35111,0,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.0041716,-0.32864,-0.22239,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0028141,-0.33055,-0.27211,0,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00013433,-0.33085,-0.30865,0,0
1,GO RESPONSE TO LIGHT INTENSITY,5.6174e-05,-0.33177,-0.34819,0,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.00010092,-0.33257,-0.30126,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.013465,-0.33295,-0.26889,0,0
1,GO POTASSIUM ION HOMEOSTASIS,2.0833e-05,-0.33354,-0.30524,0,0
1,GO CLATHRIN COAT ASSEMBLY,0.0067808,-0.33586,-0.27933,0,0
1,GO ACIDIC AMINO ACID TRANSPORT,1.3605e-07,-0.33703,-0.38476,0,0
1,GO OTIC VESICLE MORPHOGENESIS,0.041093,-0.33821,-0.35345,0,0
1,GO NOREPINEPHRINE SECRETION,6.4994e-06,-0.33854,-0.3868,0,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.015953,-0.3396,-0.31924,0,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,4.3218e-05,-0.34049,-0.30999,0,0
1,GO NEURON PROJECTION ARBORIZATION,0.00032948,-0.3405,-0.31321,0,0
1,GO RELAXATION OF MUSCLE,0.00025131,-0.34134,-0.32365,0,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,9.389e-05,-0.3414,-0.3665,0,0
1,GO DICARBOXYLIC ACID TRANSPORT,1.5691e-07,-0.34235,-0.32056,0,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.016339,-0.34292,-0.29162,0,0
1,GO PROTEIN POLYGLUTAMYLATION,3.7145e-05,-0.3432,-0.3416,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.03245,-0.34391,-0.24365,0,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,9.0179e-06,-0.34395,-0.34864,0,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,3.7791e-06,-0.34415,-0.35671,0,0
1,GO EMBRYONIC AXIS SPECIFICATION,0.00014418,-0.34486,-0.30221,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.8084e-07,-0.34677,-0.38894,0,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00012074,-0.35085,-0.35463,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.05824,-0.35727,-0.19005,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.009256,-0.35817,-0.28033,0,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,7.547e-05,-0.35874,-0.30802,0,0
1,GO DENDRITE DEVELOPMENT,8.2505e-07,-0.35968,-0.32486,0,0
1,GO SYNAPTIC VESICLE TRANSPORT,4.8612e-06,-0.3597,-0.40917,0,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0041716,-0.36031,-0.30992,0,0
1,GO REGULATION OF MEMBRANE POTENTIAL,1.6359e-08,-0.36042,-0.39192,0,0
1,GO DENDRITE MORPHOGENESIS,2.2658e-06,-0.36532,-0.34205,0,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0069616,-0.36716,-0.25423,0,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,6.0504e-05,-0.36773,-0.36848,0,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,1.4674e-06,-0.36788,-0.3639,0,0
1,GO N GLYCAN PROCESSING,0.00014418,-0.36795,-0.36797,0,0
1,GO NERVE DEVELOPMENT,1.8251e-06,-0.36885,-0.36665,0,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,3.0576e-06,-0.36907,-0.35159,0,0
1,GO ACTIN CROSSLINK FORMATION,0.041967,-0.36966,-0.24074,0,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,1.8251e-06,-0.37112,-0.39334,0,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0011549,-0.37193,-0.33202,0,0
1,GO ACTION POTENTIAL,2.6322e-07,-0.37252,-0.37664,0,0
1,GO HEART FIELD SPECIFICATION,0.04854,-0.37362,-0.26865,0,0
1,GO DETECTION OF MECHANICAL STIMULUS,8.6584e-06,-0.37388,-0.33032,0,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,2.1663e-05,-0.37617,-0.47485,0,0
1,GO SYNAPTIC SIGNALING,2.3313e-08,-0.37842,-0.39521,0,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00074557,-0.37947,-0.38295,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,2.6902e-06,-0.38015,-0.42532,0,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,4.3218e-05,-0.38031,-0.35516,0,0
1,GO MALE SEX DETERMINATION,0.0069616,-0.3805,-0.3007,0,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,7.8282e-05,-0.38107,-0.37956,0,0
1,GO SEGMENT SPECIFICATION,0.0001547,-0.38153,-0.4563,0,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0085714,-0.38302,-0.27735,0,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,8.628e-07,-0.3854,-0.41324,0,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,8.1192e-05,-0.38838,-0.38036,0,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,8.4155e-08,-0.38843,-0.38635,0,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,5.4121e-05,-0.39084,-0.41266,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.39371,-0.39397,-0.13347,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,8.6584e-06,-0.39408,-0.41267,0,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,4.5813e-07,-0.39629,-0.37581,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,8.628e-07,-0.39681,-0.41327,0,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,1.5331e-06,-0.39727,-0.45927,0,0
1,GO SKELETAL MUSCLE ADAPTATION,0.00045924,-0.40052,-0.29071,0,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,6.2859e-08,-0.40279,-0.43421,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.0056288,-0.40304,-0.41464,0,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,8.1192e-05,-0.4045,-0.48612,0,0
1,GO MEMBRANE DEPOLARIZATION,3.6414e-07,-0.40477,-0.39438,0,0
1,GO FAT CELL PROLIFERATION,0.00021167,-0.40618,-0.37476,0,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,7.2756e-08,-0.40682,-0.39779,0,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,7.9801e-06,-0.4079,-0.40067,0,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,2.3654e-06,-0.40798,-0.44512,0,0
1,GO LONG TERM SYNAPTIC DEPRESSION,1.0184e-05,-0.40823,-0.38145,0,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,2.9532e-05,-0.40927,-0.40706,0,0
1,GO LOCOMOTORY BEHAVIOR,2.4515e-08,-0.40932,-0.44117,0,0
1,GO REGULATION OF CELL PROJECTION SIZE,0.00012964,-0.40956,-0.41459,0,0
1,GO NEURON MIGRATION,1.2862e-06,-0.41124,-0.4215,0,0
1,GO SOMATIC STEM CELL DIVISION,0.068167,-0.4124,-0.20035,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,4.1802e-07,-0.4153,-0.46897,0,0
1,GO REGULATION OF HEAT GENERATION,0.036164,-0.41679,-0.29352,0,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,3.1904e-06,-0.42006,-0.38689,0,0
1,GO OTIC VESICLE DEVELOPMENT,0.1028,-0.42015,-0.23206,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.2454e-05,-0.42045,-0.47108,0,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0021689,-0.42088,-0.43007,0,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,1.7118e-05,-0.42119,-0.39739,0,0
1,GO RESPONSE TO NICOTINE,9.0551e-05,-0.4214,-0.30138,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.0050528,-0.42225,-0.30716,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.12473,-0.42276,-0.21681,0,0
1,GO PITUITARY GLAND DEVELOPMENT,1.4609e-05,-0.42356,-0.44635,0,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,3.8131e-07,-0.42472,-0.43084,0,0
1,GO RESPONSE TO POTASSIUM ION,0.0015189,-0.42646,-0.35153,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,7.013e-05,-0.42705,-0.38413,0,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,3.479e-08,-0.42934,-0.42563,0,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,3.3202e-07,-0.43391,-0.43702,0,0
1,GO SEROTONIN TRANSPORT,1.8084e-07,-0.43436,-0.58646,0,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.4878e-05,-0.43467,-0.39529,0,0
1,GO RESPONSE TO COCAINE,1.8084e-07,-0.43526,-0.4526,0,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,1.0779e-06,-0.43697,-0.47606,0,0
1,GO RESPONSE TO INSECTICIDE,2.3418e-05,-0.43913,-0.44401,0,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.0011549,-0.44136,-0.39073,0,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,7.9801e-06,-0.44173,-0.45387,0,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,4.1112e-06,-0.44568,-0.46596,0,0
1,GO GROOMING BEHAVIOR,5.7413e-06,-0.44832,-0.44599,0,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,6.5896e-07,-0.45052,-0.45026,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,1.3441e-06,-0.45146,-0.44632,0,0
1,GO DIENCEPHALON DEVELOPMENT,1.1267e-06,-0.45163,-0.42553,0,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.5759e-05,-0.4518,-0.559,0,0
1,GO REGULATION OF AMINO ACID TRANSPORT,3.479e-08,-0.45381,-0.48088,0,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,6.2786e-05,-0.4568,-0.52978,0,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,3.8583e-05,-0.45788,-0.46786,0,0
1,GO LIMB BUD FORMATION,0.065563,-0.46115,-0.25822,0,0
1,GO RESPONSE TO LEUCINE,0.0010528,-0.46122,-0.43267,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0023671,-0.46264,-0.44933,0,0
1,GO ADULT BEHAVIOR,1.6359e-08,-0.46329,-0.53964,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,2.9301e-06,-0.4634,-0.47645,0,0
1,GO EPITHELIAL CELL MATURATION,8.1192e-05,-0.46371,-0.45929,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.014841,-0.46375,-0.43412,0,0
1,GO RESPONSE TO ACETYLCHOLINE,3.3287e-06,-0.46538,-0.45198,0,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.00084609,-0.46871,-0.39154,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,1.906e-06,-0.46983,-0.52905,0,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,6.2367e-06,-0.4705,-0.49226,0,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,1.8521e-05,-0.47285,-0.41321,0,0
1,GO PRESYNAPTIC ENDOCYTOSIS,3.0264e-07,-0.47523,-0.46463,0,0
1,GO NEUROTRANSMITTER UPTAKE,5.0194e-07,-0.47568,-0.42745,0,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,7.889e-07,-0.47722,-0.44381,0,0
1,GO ADULT LOCOMOTORY BEHAVIOR,2.1077e-08,-0.48264,-0.49378,0,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.9957e-08,-0.48538,-0.50633,0,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.00018427,-0.48574,-0.46279,0,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,1.906e-06,-0.48887,-0.46518,0,0
1,GO CARDIOBLAST PROLIFERATION,0.016734,-0.48986,-0.38316,0,0
1,GO CATECHOLAMINE UPTAKE,2.0833e-05,-0.4908,-0.42194,0,0
1,GO SUBPALLIUM DEVELOPMENT,1.5201e-05,-0.49099,-0.49773,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,4.0073e-05,-0.4922,-0.45638,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.0028957,-0.49258,-0.35106,0,0
1,GO SYNAPTIC VESICLE LOCALIZATION,6.2985e-07,-0.49637,-0.55609,0,0
1,GO NEURAL RETINA DEVELOPMENT,1.4674e-06,-0.49953,-0.46853,0,0
1,GO NEURON MATURATION,2.5122e-07,-0.50011,-0.49199,0,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,3.0576e-06,-0.50031,-0.46647,0,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.073629,-0.50173,-0.2526,0,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,1.5201e-05,-0.51031,-0.38088,0,0
1,GO NEURON RECOGNITION,5.4977e-07,-0.51074,-0.52935,0,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,7.013e-05,-0.51721,-0.4209,0,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,8.4155e-08,-0.51864,-0.49459,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.0375e-08,-0.52257,-0.52577,0,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,6.2367e-06,-0.52635,-0.63452,0,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,1.2308e-06,-0.52774,-0.54522,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.024288,-0.53523,-0.48005,0,0
1,GO RETROGRADE TRANS SYNAPTIC SIGNALING,1.0604e-05,-0.53557,-0.65071,0,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0085714,-0.53639,-0.32771,0,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,4.1617e-05,-0.54267,-0.46132,0,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.04854,-0.54359,-0.29407,0,0
1,GO TRANSMISSION OF NERVE IMPULSE,3.479e-08,-0.5451,-0.55215,0,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0013054,-0.54752,-0.46953,0,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,2.5122e-07,-0.54788,-0.55342,0,0
1,GO SPINAL CORD PATTERNING,7.6603e-06,-0.54838,-0.56668,0,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,4.5813e-07,-0.55245,-0.52567,0,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,2.8496e-08,-0.55377,-0.54368,0,0
1,GO GLIAL CELL FATE COMMITMENT,0.00021167,-0.56253,-0.60226,0,0
1,GO AXONAL FASCICULATION,9.7346e-05,-0.56264,-0.53428,0,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,4.6623e-06,-0.56407,-0.63633,0,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,2.5308e-05,-0.56456,-0.47515,0,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,9.3916e-06,-0.56847,-0.56791,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,6.5896e-07,-0.57163,-0.53572,0,0
1,GO DOPAMINE METABOLIC PROCESS,9.7275e-08,-0.57283,-0.60057,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,1.9873e-07,-0.57457,-0.60754,0,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,3.0689e-05,-0.57489,-0.4275,0,0
1,GO DETECTION OF CALCIUM ION,2.4346e-05,-0.57858,-0.50939,0,0
1,GO MAST CELL MIGRATION,0.00013917,-0.58071,-0.51752,0,0
1,GO REFLEX,4.6623e-06,-0.58359,-0.60446,0,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,4.1112e-06,-0.58637,-0.60817,0,0
1,GO CEREBELLAR CORTEX FORMATION,5.2533e-07,-0.58696,-0.52959,0,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00012512,-0.58977,-0.48359,0,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,4.5813e-07,-0.59485,-0.5945,0,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,2.0038e-08,-0.59829,-0.60208,0,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.5691e-07,-0.59978,-0.61697,0,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,2.3418e-05,-0.60134,-0.59424,0,0
1,GO NEURAL NUCLEUS DEVELOPMENT,7.2111e-07,-0.60658,-0.50162,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,3.8131e-07,-0.60951,-0.55285,0,0
1,GO ADENOHYPOPHYSIS DEVELOPMENT,3.4421e-05,-0.60985,-0.63421,0,0
1,GO GROWTH HORMONE SECRETION,3.4772e-07,-0.61447,-0.59732,0,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,1.8521e-05,-0.61519,-0.4948,0,0
1,GO GLUTAMATE SECRETION,2.9957e-08,-0.61791,-0.60505,0,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,2.1077e-08,-0.61931,-0.63504,0,0
1,GO CATECHOLAMINE METABOLIC PROCESS,1.2366e-07,-0.62089,-0.57744,0,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,2.3418e-05,-0.62277,-0.74685,0,0
1,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,3.1904e-06,-0.62931,-0.65034,0,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,1.7806e-05,-0.63023,-0.66855,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS,3.1491e-08,-0.64582,-0.70606,0,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,1.8108e-08,-0.6502,-0.68241,0,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,2.2167e-08,-0.65364,-0.66001,0,0
1,GO REGULATION OF GLUTAMATE SECRETION,4.9191e-08,-0.65507,-0.66975,0,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,2.1077e-08,-0.65769,-0.70195,0,0
1,GO NEUROTRANSMITTER TRANSPORT,2.2167e-08,-0.65886,-0.65589,0,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.12473,-0.66317,-0.35136,0,0
1,GO NEURON FATE COMMITMENT,5.4977e-07,-0.66533,-0.70444,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,2.0784e-06,-0.66928,-0.59231,0,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,2.7578e-07,-0.6727,-0.66852,0,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,1.1267e-06,-0.67606,-0.6922,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,2.4692e-06,-0.68215,-0.63151,0,0
1,GO STARTLE RESPONSE,1.9873e-07,-0.68666,-0.63936,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,5.1671e-08,-0.71544,-0.69859,0,0
1,GO NEURONAL ACTION POTENTIAL,3.8423e-08,-0.7157,-0.73607,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,3.3202e-07,-0.71682,-0.60133,0,0
1,GO NEUROTRANSMITTER SECRETION,2.2167e-08,-0.71782,-0.72218,0,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,2.7578e-07,-0.72341,-0.68816,0,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,3.1491e-08,-0.72657,-0.73845,0,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,4.2424e-08,-0.74186,-0.68997,0,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,4.2424e-08,-0.74481,-0.70642,0,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,7.0571e-06,-0.76293,-0.62062,0,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,1.905e-08,-0.76832,-0.77529,0,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,2.7578e-07,-0.77322,-0.70008,0,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.01282,-0.78379,-0.48709,0,0
1,GO AMINE TRANSPORT,2.1077e-08,-0.78766,-0.72775,0,0
1,GO SEROTONIN SECRETION,3.3202e-07,-0.79114,-0.68978,0,0
1,GO MONOAMINE TRANSPORT,2.4515e-08,-0.80517,-0.76822,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,4.2424e-08,-0.80591,-0.83599,0,0
1,GO RESPONSE TO AUDITORY STIMULUS,8.0176e-08,-0.81447,-0.77858,0,0
1,GO SYNAPTIC VESICLE DOCKING,6.93e-08,-0.81637,-0.91308,0,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,2.3313e-08,-0.82188,-0.76774,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,3.6563e-08,-0.82798,-0.8554,0,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,1.4268e-07,-0.8381,-0.81263,0,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.4674e-06,-0.85251,-0.76395,0,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,3.479e-08,-0.85662,-0.87823,0,0
1,GO NEURON FATE SPECIFICATION,4.3763e-07,-0.86658,-0.95448,0,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,1.7474e-06,-0.86705,-0.78991,0,0
1,GO NEURON CELL CELL ADHESION,1.5691e-07,-0.87743,-1.0293,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,5.0683e-06,-0.87786,-0.79356,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,1.725e-07,-0.88779,-0.85889,0,0
1,GO DENDRITE EXTENSION,6.6003e-08,-0.9014,-0.80799,0,0
1,GO RETINA LAYER FORMATION,1.9904e-06,-0.92323,-0.74569,0,0
1,GO NEURONAL ION CHANNEL CLUSTERING,1.3441e-06,-0.94545,-0.88864,0,0
1,GO DOPAMINE TRANSPORT,4.2424e-08,-0.97561,-0.8942,0,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,6.8936e-07,-1.0061,-0.85453,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,2.9957e-08,-1.0127,-1.1091,0,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,6.8936e-07,-1.0183,-0.98251,0,0
1,GO CATECHOLAMINE SECRETION,2.8496e-08,-1.0262,-0.94062,0,0
1,GO SYNAPTIC VESICLE CLUSTERING,1.2366e-07,-1.0683,-1.0728,0,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,6.6003e-08,-1.0728,-0.95793,0,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,2.9957e-08,-1.0969,-1.1579,0,0
1,GO MECHANOSENSORY BEHAVIOR,4.4572e-08,-1.1358,-1.1728,0,0
1,GO GABAERGIC NEURON DIFFERENTIATION,8.2505e-07,-1.1388,-1.0104,0,0
1,GO REGULATION OF DOPAMINE SECRETION,4.2424e-08,-1.1705,-1.1059,0,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,4.0375e-08,-1.4227,-1.4025,0,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,1.8958e-07,-1.6358,-1.4989,0,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.6228e-06,0.94756,0.94014,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.9301e-06,0.91031,0.81499,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.071e-07,0.80365,0.80566,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0311e-06,0.79422,0.73973,1,1
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.8936e-07,0.7916,0.92578,1,1
2,GO RESPONSE TO HISTAMINE,2.2658e-06,0.74477,0.72042,1,1
2,GO RESPONSE TO L GLUTAMATE,4.2876e-06,0.69465,0.60666,1,1
2,GO SYNAPSE MATURATION,1.4674e-06,0.68545,0.7436,1,1
2,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,0.65007,0.54422,1,1
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.8418e-05,0.62605,0.56859,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.2454e-05,0.61639,0.52145,1,1
2,GO PYRAMIDAL NEURON DIFFERENTIATION,3.3132e-05,0.60719,0.59391,1,1
2,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,4.0073e-05,0.59411,0.55227,1,1
2,GO REGULATION OF SYNAPSE MATURATION,7.2754e-05,0.57877,0.59374,1,1
2,GO DENSE CORE GRANULE TRANSPORT,0.00041602,0.57831,0.51559,1,1
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.1112e-06,0.57691,0.53241,1,1
2,GO BRANCHING MORPHOGENESIS OF A NERVE,4.6623e-06,0.5716,0.67473,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.6584e-06,0.5636,0.52821,1,1
2,GO SYNAPTIC VESICLE MATURATION,1.5816e-05,0.56314,0.55209,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.2524e-05,0.55993,0.47787,1,1
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.906e-06,0.54883,0.56841,1,1
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013465,0.5278,0.27946,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.1617e-05,0.52422,0.50849,1,1
2,GO TELENCEPHALON GLIAL CELL MIGRATION,3.1888e-05,0.52089,0.44522,1,1
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00026003,0.51822,0.43648,1,1
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.8583e-05,0.51426,0.60361,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00029782,0.51233,0.39413,1,1
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.1904e-06,0.50604,0.55189,1,1
2,GO CORPUS CALLOSUM DEVELOPMENT,1.2366e-07,0.50581,0.55815,1,1
2,GO POSTSYNAPSE ASSEMBLY,2.2524e-05,0.50478,0.5522,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.001662,0.49835,0.41138,1,1
2,GO NEURON CELLULAR HOMEOSTASIS,1.5331e-06,0.49745,0.49407,1,1
2,GO SUCKLING BEHAVIOR,2.6902e-06,0.49306,0.46816,1,1
2,GO PLASMA MEMBRANE REPAIR,6.0198e-07,0.49163,0.5509,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00019753,0.4888,0.39291,1,1
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,5.2837e-06,0.48509,0.42077,1,1
2,GO UV PROTECTION,3.0576e-06,0.48315,0.47018,1,1
2,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0026572,0.48243,0.39301,1,1
2,GO OXYGEN TRANSPORT,0.007729,0.48098,0.47859,1,1
2,GO ADULT HEART DEVELOPMENT,2.9532e-05,0.46765,0.43997,1,1
2,GO GLYCINE TRANSPORT,0.010245,0.46638,0.32803,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1964e-05,0.46059,0.47156,1,1
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.547e-05,0.45958,0.48595,1,1
2,GO PROTEIN LOCALIZATION TO AXON,0.0037331,0.45649,0.45228,1,1
2,GO TELENCEPHALON REGIONALIZATION,0.0066042,0.45498,0.35935,1,1
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0047853,0.45378,0.36699,1,1
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.3287e-06,0.45296,0.44,1,1
2,GO MATURATION OF LSU RRNA,0.00014935,0.4519,0.37323,1,1
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00072223,0.45108,0.37243,1,1
2,GO RIBOSOME ASSEMBLY,0.00032948,0.44701,0.35206,1,1
2,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,0.44645,0.43335,1,1
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.3418e-05,0.44561,0.41876,1,1
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.5816e-05,0.44531,0.41464,1,1
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00026003,0.44497,0.40363,1,1
2,GO SYNAPTIC MEMBRANE ADHESION,0.00038934,0.44341,0.47686,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00013433,0.44103,0.35656,1,1
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,0.44058,0.41204,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0019282,0.43622,0.29455,1,1
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.7145e-05,0.43405,0.49431,1,1
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,5.2139e-05,0.43229,0.44291,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.02068,0.42852,0.26809,1,1
2,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.42822,0.27321,1,1
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.4039e-05,0.42626,0.40752,1,1
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00036427,0.41768,0.35519,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00052342,0.41701,0.41583,1,1
2,GO IMP METABOLIC PROCESS,9.0551e-05,0.41481,0.41783,1,1
2,GO CGMP METABOLIC PROCESS,0.00045924,0.41082,0.36304,1,1
2,GO CARDIAC VENTRICLE FORMATION,0.00040247,0.41063,0.57213,1,1
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,0.40928,0.41246,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00034072,0.40609,0.35238,1,1
2,GO RESPONSE TO ELECTRICAL STIMULUS,9.0551e-05,0.40382,0.32816,1,1
2,GO VITAMIN CATABOLIC PROCESS,0.01282,0.40346,0.31243,1,1
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,8.3127e-06,0.4005,0.35991,1,1
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0062634,0.3971,0.36548,1,1
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013139,0.39707,0.27753,1,1
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.3418e-05,0.39682,0.38372,1,1
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.5149e-05,0.39636,0.43113,1,1
2,GO ELASTIC FIBER ASSEMBLY,0.00045924,0.39581,0.47755,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0059384,0.39443,0.26069,1,1
2,GO MYOBLAST PROLIFERATION,4.6623e-06,0.39425,0.4101,1,1
2,GO SIALYLATION,0.0013457,0.39342,0.40768,1,1
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,2.2524e-05,0.3916,0.34173,1,1
2,GO CARDIAC CHAMBER FORMATION,0.00041602,0.39111,0.51814,1,1
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0057817,0.38824,0.30976,1,1
2,GO INNERVATION,0.00052342,0.38703,0.39486,1,1
2,GO FACIAL NERVE MORPHOGENESIS,0.0066042,0.38467,0.35033,1,1
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031859,0.38363,0.34614,1,1
2,GO NEGATIVE CHEMOTAXIS,0.00012512,0.38309,0.34246,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057817,0.38233,0.2726,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0027346,0.38146,0.25967,1,1
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00019753,0.38097,0.35262,1,1
2,GO CYTOPLASMIC TRANSLATION,0.00049035,0.38017,0.35101,1,1
2,GO VESICLE FUSION TO PLASMA MEMBRANE,7.9801e-06,0.37741,0.47846,1,1
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0069616,0.37522,0.29253,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001228,0.37444,0.36944,1,1
2,GO HEART VALVE FORMATION,0.00037661,0.37386,0.39291,1,1
2,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00045924,0.36967,0.38396,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,0.36937,0.37404,1,1
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012964,0.36873,0.41623,1,1
2,GO CHEMOSENSORY BEHAVIOR,0.0020453,0.36777,0.26236,1,1
2,GO DENTATE GYRUS DEVELOPMENT,7.8282e-05,0.36694,0.51687,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.009256,0.36495,0.27525,1,1
2,GO REGULATION OF VESICLE FUSION,4.4878e-05,0.36279,0.4105,1,1
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036303,0.35922,0.25656,1,1
2,GO PROTEIN TRIMERIZATION,0.00022676,0.3573,0.36141,1,1
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.033166,0.35692,0.22823,1,1
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.013e-05,0.3558,0.41317,1,1
2,GO L GLUTAMATE IMPORT,0.00045924,0.35529,0.29567,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00014418,0.3552,0.31646,1,1
2,GO ADAPTATION OF SIGNALING PATHWAY,0.0014299,0.35044,0.24031,1,1
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001547,0.34932,0.33442,1,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00065623,0.34881,0.3587,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00090094,0.34876,0.44965,1,1
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.5774e-06,0.34625,0.39766,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00022676,0.34618,0.32216,1,1
2,GO ADULT FEEDING BEHAVIOR,0.00065623,0.34356,0.22249,1,1
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021165,0.34351,0.2709,1,1
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0022992,0.34218,0.3393,1,1
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.00067758,0.34121,0.27606,1,1
2,GO TRANSLATIONAL INITIATION,0.0010528,0.3411,0.3039,1,1
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.7806e-05,0.34055,0.31045,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083534,0.33889,0.32249,1,1
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.03939,0.33738,0.25131,1,1
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0010859,0.33694,0.25895,1,1
2,GO GAS TRANSPORT,0.0066042,0.33673,0.37192,1,1
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0017641,0.33651,0.28969,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,0.33579,0.29889,1,1
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00031859,0.32762,0.38047,1,1
2,GO TELOMERASE RNA LOCALIZATION,0.00013917,0.32701,0.32189,1,1
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0604e-05,0.32643,0.36839,1,1
2,GO REGULATION OF NEURON MIGRATION,0.00036427,0.32467,0.28077,1,1
2,GO SYNAPTIC TRANSMISSION GABAERGIC,2.6307e-05,0.32293,0.28974,1,1
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0067808,0.32231,0.3593,1,1
2,GO SYNAPTIC VESICLE PRIMING,3.0689e-05,0.32128,0.41314,1,1
2,GO CELL PROLIFERATION IN FOREBRAIN,0.027803,0.32032,0.19312,1,1
2,GO NEUROTRANSMITTER REUPTAKE,0.00029782,0.31881,0.30582,1,1
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090094,0.31727,0.30085,1,1
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.027803,0.317,0.2786,1,1
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.0023671,0.31699,0.27417,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1617e-05,0.31621,0.33865,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,0.31598,0.29368,1,1
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00079435,0.31522,0.36813,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00087311,0.31486,0.26049,1,1
2,GO AORTA DEVELOPMENT,0.0016129,0.31397,0.20113,1,1
2,GO MATURATION OF SSU RRNA,0.00045924,0.31375,0.29689,1,1
2,GO PREPULSE INHIBITION,0.011047,0.31329,0.33627,1,1
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4609e-05,0.3125,0.37367,1,1
2,GO NEURON PROJECTION ORGANIZATION,3.1904e-06,0.31218,0.30704,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00059588,0.31056,0.29615,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0047853,0.31015,0.32372,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00047456,0.3101,0.30501,1,1
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00081984,0.30788,0.31239,1,1
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.041967,0.30776,0.23304,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.011904,0.30728,0.28329,1,1
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00042998,0.30492,0.26796,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.30332,0.24321,1,1
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0037331,0.30275,0.20971,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00069957,0.30273,0.3116,1,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.037747,0.30237,0.18672,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00019753,0.2983,0.34389,1,1
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0047853,0.29787,0.27686,1,1
2,GO DIVALENT METAL ION EXPORT,0.00059588,0.29766,0.39797,1,1
2,GO REGULATION OF LYASE ACTIVITY,3.0689e-05,0.29634,0.26996,1,1
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,4.4878e-05,0.2951,0.38378,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0021062,0.29468,0.22458,1,1
2,GO MATURATION OF 5 8S RRNA,0.0017641,0.29439,0.24399,1,1
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.041967,0.29417,0.18102,1,1
2,GO MATING BEHAVIOR,0.0025817,0.29386,0.21672,1,1
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0010206,0.29365,0.4059,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0079323,0.29304,0.18715,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.0038387,0.29273,0.25142,1,1
2,GO PEPTIDYL ARGININE N METHYLATION,0.00010462,0.29234,0.31636,1,1
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0075304,0.29187,0.24686,1,1
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0026572,0.29084,0.22203,1,1
2,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0036303,0.29063,0.33102,1,1
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0010528,0.29002,0.23738,1,1
2,GO NAD METABOLIC PROCESS,0.0028957,0.28961,0.2362,1,1
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0025083,0.28931,0.23327,1,1
2,GO L SERINE METABOLIC PROCESS,0.011904,0.28863,0.29792,1,1
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071468,0.28737,0.21499,1,1
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,4.2876e-06,0.28722,0.38318,1,1
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.7346e-05,0.28657,0.21378,1,1
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00072223,0.28487,0.2813,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.0010206,0.28381,0.22364,1,1
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.015203,0.2822,0.25272,1,1
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.9263e-05,0.2812,0.29651,1,1
2,GO RIBOSOME BIOGENESIS,0.00057693,0.27931,0.25228,1,1
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,9.389e-05,0.27784,0.31439,1,1
2,GO VOCALIZATION BEHAVIOR,0.030383,0.27735,0.35457,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.029068,0.27701,0.172,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00025131,0.27665,0.31857,1,1
2,GO REGULATION OF MRNA BINDING,0.00026003,0.27398,0.297,1,1
2,GO PEPTIDYL HISTIDINE MODIFICATION,0.00063551,0.27295,0.21766,1,1
2,GO MESODERMAL CELL FATE SPECIFICATION,0.041093,0.27198,0.18829,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.004408,0.27146,0.1994,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0015653,0.27089,0.28208,1,1
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.27016,0.23454,1,1
2,GO STRESS GRANULE ASSEMBLY,1.1493e-05,0.2701,0.24164,1,1
2,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,0.26871,0.22891,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00353,0.26731,0.20427,1,1
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0011199,0.26595,0.24764,1,1
2,GO BONE GROWTH,0.009256,0.2629,0.2313,1,1
2,GO GTP METABOLIC PROCESS,0.0021689,0.26286,0.23585,1,1
2,GO NEURON REMODELING,0.0010528,0.2624,0.29998,1,1
2,GO HYPOTONIC RESPONSE,0.025994,0.26188,0.17492,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.013139,0.26177,0.20083,1,1
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,4.0073e-05,0.26171,0.23927,1,1
2,GO LEARNING,3.5759e-05,0.26107,0.2771,1,1
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.016734,0.26084,0.2363,1,1
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0042883,0.26079,0.20316,1,1
2,GO MITOCHONDRION DISTRIBUTION,0.00014935,0.26009,0.25265,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00014935,0.25989,0.19652,1,1
2,GO TRANSLATIONAL ELONGATION,0.00038934,0.25826,0.22275,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0039469,0.25823,0.2013,1,1
2,GO RRNA MODIFICATION,0.007729,0.2571,0.21839,1,1
2,GO RRNA METABOLIC PROCESS,0.00084609,0.25574,0.22872,1,1
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00087311,0.25477,0.26261,1,1
2,GO REPRODUCTIVE BEHAVIOR,0.0018173,0.25446,0.24261,1,1
2,GO CELL JUNCTION DISASSEMBLY,0.0013054,0.25444,0.25289,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.0551e-05,0.25444,0.25267,1,1
2,GO VIRAL TRANSLATION,0.0013054,0.25369,0.28863,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00019753,0.25151,0.27618,1,1
2,GO CELL PROLIFERATION IN HINDBRAIN,0.013798,0.25024,0.23231,1,1
2,GO MITOCHONDRION LOCALIZATION,3.4421e-05,0.24872,0.21481,1,1
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.029068,0.24711,0.20917,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.015574,0.2463,0.21943,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0022332,0.24555,0.21421,1,1
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066042,0.24493,0.19261,1,1
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0022332,0.24364,0.23682,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0047853,0.24321,0.20474,1,1
2,GO NOREPINEPHRINE TRANSPORT,0.0021689,0.24248,0.20411,1,1
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0059384,0.24118,0.17636,1,1
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00079435,0.23776,0.19158,1,1
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.001228,0.23725,0.42057,1,1
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.037747,0.23697,0.22179,1,1
2,GO ASSOCIATIVE LEARNING,5.2139e-05,0.23591,0.24356,1,1
2,GO ONE CARBON COMPOUND TRANSPORT,0.020205,0.23556,0.15196,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0060989,0.23513,0.18145,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00026903,0.23406,0.20807,1,1
2,GO FOREBRAIN REGIONALIZATION,0.016339,0.23337,0.24722,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.025994,0.23302,0.20211,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00026903,0.23286,0.2258,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.23278,0.22524,1,1
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0094949,0.23246,0.20721,1,1
2,GO POLYOL TRANSPORT,0.0079323,0.23114,0.18719,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.0039469,0.2296,0.2025,1,1
2,GO SNORNA 3 END PROCESSING,0.00098941,0.22817,0.34461,1,1
2,GO TRNA MODIFICATION,0.00019079,0.22811,0.22381,1,1
2,GO RRNA TRANSCRIPTION,0.00054072,0.22764,0.21113,1,1
2,GO EXPLORATION BEHAVIOR,0.0081404,0.22547,0.28578,1,1
2,GO REGULATION OF CYCLASE ACTIVITY,6.2786e-05,0.22515,0.25885,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00019753,0.22483,0.2524,1,1
2,GO VIRAL GENE EXPRESSION,0.011904,0.22434,0.20572,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.0083534,0.22406,0.22513,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028141,0.22387,0.20694,1,1
2,GO TRNA METHYLATION,0.0022992,0.22314,0.17565,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0057817,0.22244,0.24928,1,1
2,GO SYNAPSE ORGANIZATION,9.0551e-05,0.22201,0.22157,1,1
2,GO POSTSYNAPSE ORGANIZATION,7.8282e-05,0.22101,0.24513,1,1
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0031536,0.22073,0.17238,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.22015,0.19904,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0026572,0.21849,0.17044,1,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.7323e-05,0.21784,0.23145,1,1
2,GO AROMATIC AMINO ACID TRANSPORT,0.004408,0.21751,0.34059,1,1
2,GO CELLULAR RESPONSE TO PH,0.00013433,0.21743,0.2188,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028141,0.21551,0.28893,1,1
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00087311,0.21531,0.21643,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00024286,0.21398,0.23165,1,1
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0083534,0.21394,0.15885,1,1
2,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.011612,0.21373,0.23113,1,1
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.023205,0.21365,0.20936,1,1
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0097392,0.21356,0.18451,1,1
2,GO REGULATION OF RNA BINDING,0.00035231,0.21323,0.24793,1,1
2,GO TUBULIN DEACETYLATION,0.014841,0.2129,0.1902,1,1
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017969,0.21275,0.19516,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00045924,0.21256,0.19071,1,1
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.21208,0.1453,1,1
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.033894,0.21116,0.18694,1,1
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0045306,0.21,0.19261,1,1
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0015189,0.20967,0.16934,1,1
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0075304,0.20888,0.1496,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,0.20799,0.17967,1,1
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.045624,0.20758,0.15517,1,1
2,GO OXIDATIVE PHOSPHORYLATION,0.0031536,0.20716,0.16271,1,1
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.010506,0.20713,0.17369,1,1
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.00087311,0.20663,0.2178,1,1
2,GO POSITIVE REGULATION OF HEART GROWTH,0.0071468,0.20653,0.178,1,1
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00035231,0.20626,0.23644,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00059588,0.20539,0.29311,1,1
2,GO URONIC ACID METABOLIC PROCESS,0.00055855,0.20522,0.1716,1,1
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00044439,0.20471,0.21521,1,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0046564,0.20437,0.16281,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.016734,0.20408,0.20365,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017641,0.20349,0.19653,1,1
2,GO TELOMERIC LOOP DISASSEMBLY,0.001191,0.20346,0.2066,1,1
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,6.0504e-05,0.2032,0.21928,1,1
2,GO REGULATION OF TUBULIN DEACETYLATION,0.027188,0.20276,0.20538,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012074,0.20188,0.20711,1,1
2,GO CRANIAL NERVE MORPHOGENESIS,0.033894,0.20162,0.20302,1,1
2,GO TRANSLATIONAL TERMINATION,0.0039469,0.20079,0.19092,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0034322,0.20069,0.15221,1,1
2,GO FEAR RESPONSE,0.0097392,0.19857,0.16602,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00050664,0.19822,0.19569,1,1
2,GO NCRNA PROCESSING,0.0012662,0.19782,0.18397,1,1
2,GO SNORNA METABOLIC PROCESS,0.0031536,0.1972,0.30796,1,1
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0049174,0.19691,0.19162,1,1
2,GO HISTONE ARGININE METHYLATION,0.00067758,0.1969,0.2115,1,1
2,GO IRON COORDINATION ENTITY TRANSPORT,0.0062634,0.19677,0.19911,1,1
2,GO AMINO ACID IMPORT,0.0041716,0.19661,0.18047,1,1
2,GO POSITIVE REGULATION OF MRNA PROCESSING,2.6902e-06,0.19536,0.20291,1,1
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00028792,0.19524,0.23795,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.014841,0.19511,0.13259,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0060989,0.19511,0.20831,1,1
2,GO RESPONSE TO PROSTAGLANDIN E,0.052669,0.1941,0.096069,1,1
2,GO AEROBIC RESPIRATION,0.0016129,0.1938,0.17211,1,1
2,GO RNA POLYADENYLATION,0.00042998,0.19367,0.14716,1,1
2,GO CELLULAR ANION HOMEOSTASIS,0.044685,0.19324,0.18555,1,1
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017969,0.1928,0.15027,1,1
2,GO MRNA MODIFICATION,0.0007696,0.19273,0.23559,1,1
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0018173,0.19214,0.17905,1,1
2,GO DENDRITE SELF AVOIDANCE,0.041967,0.19194,0.1856,1,1
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001191,0.19124,0.22808,1,1
2,GO PLASMA MEMBRANE TUBULATION,0.011326,0.19059,0.15792,1,1
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.00012074,0.19017,0.20882,1,1
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0006154,0.18942,0.15551,1,1
2,GO PROTEIN NITROSYLATION,0.020205,0.18795,0.19961,1,1
2,GO MEMBRANE DISASSEMBLY,0.026586,0.1872,0.12351,1,1
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0028141,0.18641,0.16102,1,1
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0039469,0.18635,0.20534,1,1
2,GO CRISTAE FORMATION,0.010773,0.18633,0.19498,1,1
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.001228,0.18625,0.18231,1,1
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.011047,0.18468,0.17127,1,1
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0069616,0.18464,0.14181,1,1
2,GO FOREBRAIN CELL MIGRATION,0.00049035,0.18415,0.23235,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0016129,0.18413,0.17665,1,1
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.0056288,0.18358,0.23025,1,1
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.024846,0.18345,0.22184,1,1
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.045624,0.18289,0.16825,1,1
2,GO PEPTIDYL ARGININE METHYLATION,0.00032948,0.18283,0.21665,1,1
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00026003,0.18249,0.2041,1,1
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.001191,0.18234,0.20343,1,1
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0049174,0.18212,0.1579,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.007729,0.18164,0.17887,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0007696,0.17987,0.13438,1,1
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0022992,0.17916,0.17914,1,1
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.014841,0.17909,0.14522,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.01282,0.17876,0.14442,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.17796,0.2271,1,1
2,GO PYRUVATE METABOLIC PROCESS,0.0045306,0.17695,0.12067,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0075304,0.17618,0.15109,1,1
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0034322,0.17482,0.21853,1,1
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0028957,0.17417,0.18703,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0023671,0.17411,0.13803,1,1
2,GO CELLULAR RESPIRATION,0.0041716,0.17387,0.14646,1,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0073363,0.17338,0.14406,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.17319,0.13409,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,0.00027832,0.17269,0.15609,1,1
2,GO EXCRETION,0.0056288,0.17257,0.13673,1,1
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0010859,0.17212,0.20056,1,1
2,GO CELLULAR RESPONSE TO HEAT,0.0013457,0.17064,0.12044,1,1
2,GO L AMINO ACID TRANSPORT,0.00063551,0.17017,0.19111,1,1
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0067808,0.17,0.1241,1,1
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00353,0.16997,0.15308,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023468,0.16976,0.15496,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013457,0.16916,0.2218,1,1
2,GO HISTONE H3 K9 DEMETHYLATION,0.0083534,0.16904,0.19259,1,1
2,GO TRNA PROCESSING,0.00090094,0.16875,0.17937,1,1
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.036948,0.16846,0.17184,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.010506,0.16785,0.18837,1,1
2,GO HIPPOCAMPUS DEVELOPMENT,0.0054795,0.16721,0.20077,1,1
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0064317,0.16709,0.21801,1,1
2,GO REGULATION OF SPINDLE CHECKPOINT,0.00092958,0.1669,0.14928,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0041716,0.16648,0.13209,1,1
2,GO RRNA METHYLATION,0.0081404,0.16645,0.18496,1,1
2,GO FOLIC ACID METABOLIC PROCESS,0.041967,0.16632,0.17031,1,1
2,GO CARBOHYDRATE PHOSPHORYLATION,0.012203,0.16623,0.14042,1,1
2,GO STRIATUM DEVELOPMENT,0.016339,0.16617,0.18751,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0079323,0.16511,0.13868,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.01282,0.16366,0.17074,1,1
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.041093,0.16341,0.1333,1,1
2,GO CARDIAC CONDUCTION,0.010773,0.16145,0.15299,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16121,0.17084,1,1
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0059384,0.16057,0.19391,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.011047,0.1597,0.20058,1,1
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0029794,0.15835,0.14723,1,1
2,GO MITOTIC DNA REPLICATION CHECKPOINT,0.010506,0.15666,0.14296,1,1
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.046579,0.15659,0.12563,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.033894,0.15562,0.12154,1,1
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.029068,0.15409,0.1588,1,1
2,GO THYROID GLAND DEVELOPMENT,0.022165,0.15356,0.18117,1,1
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.012203,0.15294,0.16955,1,1
2,GO IMPORT INTO CELL,0.00031859,0.15268,0.16949,1,1
2,GO MRNA METHYLATION,0.01282,0.15177,0.19339,1,1
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.011326,0.15121,0.21752,1,1
2,GO REGULATION OF CARDIAC CONDUCTION,0.024846,0.15042,0.12439,1,1
2,GO RNA SURVEILLANCE,0.033894,0.1503,0.12882,1,1
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.02268,0.14991,0.1987,1,1
2,GO SYNAPSE ASSEMBLY,0.012203,0.1488,0.16867,1,1
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.044685,0.1478,0.14767,1,1
2,GO NCRNA METABOLIC PROCESS,0.0029794,0.14765,0.15371,1,1
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.017137,0.14759,0.15602,1,1
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041093,0.1475,0.12282,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.00069957,0.1464,0.12066,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015574,0.14537,0.10928,1,1
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035393,0.14524,0.11023,1,1
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.007729,0.14423,0.10342,1,1
2,GO PROTEIN TARGETING,0.007729,0.14409,0.10904,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.0064317,0.14323,0.14307,1,1
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00026003,0.14301,0.15939,1,1
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.013e-05,0.14268,0.18832,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0054795,0.14261,0.13749,1,1
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0053338,0.13936,0.16664,1,1
2,GO PROTEIN HETEROOLIGOMERIZATION,0.0020453,0.13918,0.15842,1,1
2,GO RNA CATABOLIC PROCESS,0.012203,0.13892,0.11055,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.03939,0.13858,0.17548,1,1
2,GO SYNAPTIC VESICLE RECYCLING,0.029719,0.13856,0.14167,1,1
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.041093,0.13814,0.09988,1,1
2,GO REPLICATION FORK PROCESSING,0.0040578,0.13801,0.13472,1,1
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.03245,0.13664,0.1133,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042883,0.13658,0.11355,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0011549,0.13652,0.13207,1,1
2,GO REGULATION OF MRNA POLYADENYLATION,0.0014738,0.13645,0.12815,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0026572,0.13362,0.13974,1,1
2,GO ARTERY DEVELOPMENT,0.049546,0.13343,0.062324,1,1
2,GO REGULATION OF CELL CYCLE ARREST,0.011047,0.13304,0.088991,1,1
2,GO RNA METHYLATION,0.0039469,0.1329,0.13947,1,1
2,GO DNA REPLICATION CHECKPOINT,0.0041716,0.13282,0.1289,1,1
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.13277,0.23479,1,1
2,GO NEUROMUSCULAR PROCESS,0.0060989,0.13239,0.14602,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0016129,0.1315,0.11326,1,1
2,GO AMINO ACID TRANSPORT,0.00016595,0.13054,0.1682,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,0.0090226,0.13023,0.11092,1,1
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0010206,0.12938,0.11393,1,1
2,GO COCHLEA DEVELOPMENT,0.0085714,0.12808,0.14509,1,1
2,GO RESPONSE TO AMPHETAMINE,0.045624,0.1275,0.13089,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.01282,0.12653,0.14995,1,1
2,GO METENCEPHALON DEVELOPMENT,0.0054795,0.12488,0.16011,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0056288,0.12485,0.12084,1,1
2,GO TRNA TRANSPORT,0.007729,0.12413,0.1308,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.12014,1,1
2,GO ATP METABOLIC PROCESS,0.0024367,0.12365,0.10989,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02268,0.12358,0.10602,1,1
2,GO REGULATION OF MRNA PROCESSING,0.001228,0.12321,0.10397,1,1
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.041093,0.12291,0.091021,1,1
2,GO BASE EXCISION REPAIR,0.017549,0.12253,0.087776,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.0031536,0.12242,0.15681,1,1
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12167,0.10248,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0039469,0.12166,0.10347,1,1
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.029719,0.12095,0.11361,1,1
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.12071,0.11613,1,1
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.011904,0.11981,0.10207,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.11938,0.12948,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042857,0.11906,0.073813,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.03939,0.11847,0.11502,1,1
2,GO AMIDE BIOSYNTHETIC PROCESS,0.0087944,0.11847,0.11837,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0050528,0.11797,0.10938,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,0.033166,0.11753,0.11239,1,1
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.036164,0.11708,0.11111,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.024846,0.11601,0.12444,1,1
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.041967,0.11561,0.11825,1,1
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.007729,0.11555,0.076652,1,1
2,GO PROTEIN TETRAMERIZATION,0.00059588,0.11506,0.13276,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0099891,0.11483,0.10236,1,1
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0013054,0.1146,0.172,1,1
2,GO NCRNA 3 END PROCESSING,0.01282,0.11383,0.095253,1,1
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.015574,0.11325,0.13457,1,1
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0047853,0.11257,0.11194,1,1
2,GO MUSCLE ORGAN MORPHOGENESIS,0.031059,0.11238,0.095715,1,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.029068,0.11227,0.098242,1,1
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.033166,0.1119,0.10784,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.022165,0.11169,0.12288,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.0085714,0.11156,0.12578,1,1
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.016734,0.11143,0.084827,1,1
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033166,0.1105,0.076747,1,1
2,GO TELENCEPHALON DEVELOPMENT,0.0028141,0.11012,0.13391,1,1
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.036948,0.10884,0.10272,1,1
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0094949,0.10875,0.096243,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.009256,0.1067,0.12313,1,1
2,GO RNA 3 END PROCESSING,0.0064317,0.10664,0.082163,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0050528,0.10659,0.091621,1,1
2,GO MRNA 3 END PROCESSING,0.0075304,0.10424,0.078822,1,1
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.018398,0.10337,0.13184,1,1
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.016734,0.1032,0.091181,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02843,0.10275,0.079815,1,1
2,GO POTASSIUM ION TRANSPORT,0.035393,0.10273,0.1169,1,1
2,GO REGULATION OF SYSTEM PROCESS,0.016734,0.10271,0.089714,1,1
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0037331,0.10232,0.09644,1,1
2,GO LEUKOCYTE TETHERING OR ROLLING,0.009256,0.1022,0.12556,1,1
2,GO TELOMERE ORGANIZATION,0.0059384,0.1018,0.092471,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.047551,0.10107,0.0937,1,1
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.024846,0.10018,0.11791,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.024288,0.099497,0.10904,1,1
2,GO MRNA METABOLIC PROCESS,0.0014299,0.099475,0.10604,1,1
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.024846,0.097809,0.086502,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.004408,0.096457,0.12148,1,1
2,GO RNA PROCESSING,0.00044439,0.096204,0.11772,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001986,0.096203,0.10604,1,1
2,GO INTERSTRAND CROSS LINK REPAIR,0.0028141,0.095757,0.09109,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.044685,0.095589,0.080866,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.02268,0.093868,0.12209,1,1
2,GO NCRNA TRANSCRIPTION,0.0025083,0.093842,0.09324,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.024846,0.091317,0.082704,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0094949,0.090542,0.090551,1,1
2,GO PHOSPHATE ION TRANSPORT,0.02166,0.089491,0.090965,1,1
2,GO DNA DEPENDENT DNA REPLICATION,0.020205,0.089143,0.079149,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.029068,0.08883,0.090382,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.037747,0.087362,0.086978,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0012662,0.08686,0.10335,1,1
2,GO PALLIUM DEVELOPMENT,0.011612,0.086703,0.12236,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.025994,0.082868,0.082697,1,1
2,GO PROTEIN HETEROTETRAMERIZATION,0.0050528,0.082708,0.13026,1,1
2,GO MRNA PROCESSING,0.0010859,0.07968,0.091229,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016339,0.07527,0.067584,1,1
2,GO RNA SPLICING,0.0023671,0.072933,0.085108,1,1
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.036164,0.061913,0.066182,1,1
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.037747,0.053063,0.05135,1,1
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.036164,0.048604,0.11244,1,1
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00081984,0.49751,0.48283,1,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.0081404,0.35604,0.31425,1,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.013798,0.32666,0.44768,1,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.01282,0.30544,0.21362,1,0
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013465,0.29312,0.23126,1,0
2,GO BONE TRABECULA FORMATION,0.016339,0.29217,0.28867,1,0
2,GO ARGININE METABOLIC PROCESS,0.0079323,0.27497,0.29089,1,0
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.03245,0.26305,0.1703,1,0
2,GO COLLAGEN METABOLIC PROCESS,0.020205,0.24009,0.14035,1,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.03939,0.22828,0.26749,1,0
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0016129,0.22746,0.18799,1,0
2,GO RESPONSE TO INTERLEUKIN 7,0.00019753,0.22077,0.19118,1,0
2,GO HISTONE SERINE PHOSPHORYLATION,0.0037331,0.21351,0.17163,1,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.031059,0.20867,0.18668,1,0
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.019283,0.20829,0.13889,1,0
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.036948,0.19936,0.20169,1,0
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.047551,0.19713,0.17411,1,0
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.014486,0.19694,0.17506,1,0
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.05161,0.1833,0.11631,1,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0045306,0.18258,0.17858,1,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.013798,0.18198,0.12879,1,0
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.011904,0.18024,0.16927,1,0
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.045624,0.17967,0.12845,1,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0030654,0.17692,0.23384,1,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.02166,0.1762,0.13534,1,0
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.027803,0.17038,0.1883,1,0
2,GO POSITIVE REGULATION OF HEART RATE,0.040234,0.16813,0.18861,1,0
2,GO DENDRITIC TRANSPORT,0.010506,0.16695,0.24093,1,0
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.010506,0.16562,0.19049,1,0
2,GO MITOCHONDRIAL TRANSLATION,0.0042883,0.16381,0.19525,1,0
2,GO MITOCHONDRIAL GENE EXPRESSION,0.0046564,0.16254,0.19159,1,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.041967,0.16069,0.13783,1,0
2,GO NUCLEAR PORE ORGANIZATION,0.041093,0.15717,0.11028,1,0
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.042857,0.15679,0.097057,1,0
2,GO COPPER ION HOMEOSTASIS,0.024846,0.15663,0.14424,1,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.02068,0.15485,0.11071,1,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0069616,0.14894,0.15764,1,0
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0087944,0.14827,0.14805,1,0
2,GO PROTEIN DENEDDYLATION,0.033166,0.14066,0.13452,1,0
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.036164,0.13815,0.12703,1,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0094949,0.13631,0.16419,1,0
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.043763,0.13544,0.12947,1,0
2,GO LIVER REGENERATION,0.040234,0.13541,0.077176,1,0
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.0087944,0.13195,0.11512,1,0
2,GO MRNA SPLICE SITE SELECTION,0.042857,0.123,0.13568,1,0
2,GO PEPTIDE METABOLIC PROCESS,0.024846,0.11942,0.091635,1,0
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014138,0.11894,0.08456,1,0
2,GO REGULATION OF TELOMERE MAINTENANCE,0.0046564,0.1189,0.11692,1,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.015574,0.11796,0.081204,1,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.014486,0.11788,0.11892,1,0
2,GO RNA 5 END PROCESSING,0.035393,0.11506,0.12281,1,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.001986,0.11376,0.13349,1,0
2,GO NUCLEOBASE METABOLIC PROCESS,0.0037331,0.11212,0.17851,1,0
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.036948,0.11156,0.096039,1,0
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.045624,0.11137,0.11873,1,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0069616,0.11107,0.10628,1,0
2,GO TRNA METABOLIC PROCESS,0.0034322,0.10892,0.14407,1,0
2,GO CELLULAR IRON ION HOMEOSTASIS,0.015953,0.10552,0.11118,1,0
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.031059,0.10453,0.11387,1,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.034637,0.10317,0.086476,1,0
2,GO MITOTIC RECOMBINATION,0.03939,0.10239,0.12336,1,0
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.024846,0.099707,0.083464,1,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.031059,0.098422,0.099572,1,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.017969,0.098288,0.11512,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.015953,0.09826,0.081023,1,0
2,GO RNA MODIFICATION,0.0075304,0.09438,0.12402,1,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.04854,0.089731,0.099952,1,0
2,GO RESPONSE TO CALCIUM ION,0.050569,0.088902,0.089481,1,0
2,GO RESPONSE TO HEAT,0.017969,0.088863,0.079789,1,0
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.010245,0.088589,0.06583,1,0
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.033166,0.088546,0.11543,1,0
2,GO RNA LOCALIZATION,0.0079323,0.084538,0.089299,1,0
2,GO LACTATION,0.036948,0.081867,0.11724,1,0
2,GO NUCLEAR EXPORT,0.024846,0.070434,0.06326,1,0
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.047551,0.068477,0.092842,1,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.024846,0.067091,0.096255,1,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.016734,0.063443,0.10185,1,0
2,GO RNA EXPORT FROM NUCLEUS,0.041967,0.063385,0.083155,1,0
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.02068,0.061768,0.062723,1,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.044685,0.060003,0.063979,1,0
2,GO NUCLEOTIDE EXCISION REPAIR,0.05161,0.059969,0.059967,1,0
2,GO NUCLEAR TRANSPORT,0.023741,0.052646,0.053247,1,0
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.035393,0.052448,0.055266,1,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.049546,-0.031431,-0.054434,1,0
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.047551,-0.037358,-0.049977,1,0
2,GO CYTOKINESIS,0.046579,-0.038365,-0.070188,1,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.049546,-0.03837,-0.055105,1,0
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.049546,-0.04202,-0.041943,1,0
2,GO TISSUE MORPHOGENESIS,0.047551,-0.042047,-0.080539,1,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.004408,-0.042958,-0.071349,1,0
2,GO HETEROCHROMATIN ORGANIZATION,0.04854,-0.044763,-0.052471,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.027803,-0.046405,-0.057805,1,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.025414,-0.046584,-0.13269,1,0
2,GO METAPHASE PLATE CONGRESSION,0.014138,-0.047354,-0.09609,1,0
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.025994,-0.047781,-0.15593,1,0
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.042857,-0.048096,-0.056265,1,0
2,GO NON RECOMBINATIONAL REPAIR,0.029719,-0.049058,-0.070112,1,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.047551,-0.052509,-0.059863,1,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.037747,-0.053669,-0.068959,1,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.014138,-0.053852,-0.15297,1,0
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.037747,-0.055403,-0.066143,1,0
2,GO POSITIVE REGULATION OF SIGNALING,0.033166,-0.055813,-0.065149,1,0
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.009256,-0.056332,-0.085675,1,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.03245,-0.056358,-0.056157,1,0
2,GO MACROAUTOPHAGY,0.0054795,-0.057538,-0.080368,1,0
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.019283,-0.057979,-0.084699,1,0
2,GO ACTIN FILAMENT ORGANIZATION,0.017549,-0.058128,-0.094691,1,0
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.038561,-0.058545,-0.10222,1,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.019739,-0.058587,-0.081149,1,0
2,GO SEXUAL REPRODUCTION,0.0025817,-0.059443,-0.071044,1,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.024288,-0.059497,-0.077715,1,0
2,GO ORGANELLE FISSION,0.019283,-0.060777,-0.053453,1,0
2,GO HISTONE UBIQUITINATION,0.041093,-0.061309,-0.066636,1,0
2,GO PROTEIN AUTOUBIQUITINATION,0.027188,-0.061491,-0.065572,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.03939,-0.061936,-0.17826,1,0
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.045624,-0.0624,-0.12938,1,0
2,GO REGULATION OF HYDROLASE ACTIVITY,0.012203,-0.062843,-0.080199,1,0
2,GO HUMORAL IMMUNE RESPONSE,0.0013872,-0.063414,-0.13611,1,0
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.042857,-0.06359,-0.11612,1,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.023741,-0.063699,-0.12651,1,0
2,GO VACUOLE ORGANIZATION,0.049546,-0.063873,-0.080909,1,0
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0067808,-0.064341,-0.1042,1,0
2,GO CELL MOTILITY,0.036948,-0.064481,-0.079393,1,0
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.024288,-0.065264,-0.08581,1,0
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.042857,-0.065369,-0.13007,1,0
2,GO TUBE MORPHOGENESIS,0.041093,-0.06564,-0.099175,1,0
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.033894,-0.065921,-0.067849,1,0
2,GO LEUKOCYTE DIFFERENTIATION,0.011047,-0.066015,-0.10214,1,0
2,GO MULTICELLULAR ORGANISM AGING,0.017549,-0.066565,-0.12547,1,0
2,GO SECRETION,0.012508,-0.067035,-0.08332,1,0
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.03245,-0.067433,-0.079096,1,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.026586,-0.06747,-0.092176,1,0
2,GO GLYCEROLIPID METABOLIC PROCESS,0.024846,-0.067811,-0.070702,1,0
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.030383,-0.067849,-0.11162,1,0
2,GO TUBE DEVELOPMENT,0.033894,-0.069626,-0.094207,1,0
2,GO MUSCLE ADAPTATION,0.05161,-0.070042,-0.090495,1,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0079323,-0.070156,-0.080998,1,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.04854,-0.07016,-0.070453,1,0
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.001872,-0.070793,-0.12646,1,0
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.02166,-0.071389,-0.099685,1,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.025994,-0.071424,-0.085065,1,0
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.014138,-0.071536,-0.11367,1,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0038387,-0.072065,-0.074907,1,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.03245,-0.072305,-0.11245,1,0
2,GO LYMPHOCYTE ACTIVATION,0.0075304,-0.072443,-0.11104,1,0
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0085714,-0.072665,-0.087308,1,0
2,GO MULTI ORGANISM PROCESS,0.009256,-0.074202,-0.06881,1,0
2,GO PEPTIDE SECRETION,0.025414,-0.074792,-0.08505,1,0
2,GO REGULATION OF RESPONSE TO STRESS,0.0064317,-0.075297,-0.092052,1,0
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.038561,-0.076032,-0.079738,1,0
2,GO DNA METHYLATION OR DEMETHYLATION,0.023205,-0.076905,-0.071375,1,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.0097392,-0.07785,-0.076389,1,0
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.011326,-0.077982,-0.078376,1,0
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.041967,-0.078097,-0.11692,1,0
2,GO POSITIVE REGULATION OF SECRETION,0.031748,-0.078364,-0.079138,1,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.03245,-0.078499,-0.10286,1,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0039469,-0.078562,-0.08408,1,0
2,GO EXOCYTOSIS,0.011047,-0.078638,-0.10281,1,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.018836,-0.078865,-0.058864,1,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.017549,-0.079405,-0.10827,1,0
2,GO IMMUNE SYSTEM DEVELOPMENT,0.0015653,-0.079454,-0.10403,1,0
2,GO CHROMOSOME LOCALIZATION,0.0025817,-0.079572,-0.11324,1,0
2,GO DETECTION OF STIMULUS,0.0010859,-0.079666,-0.097326,1,0
2,GO PROTEIN MONOUBIQUITINATION,0.0049174,-0.079687,-0.077954,1,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.049546,-0.08022,-0.12088,1,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.027188,-0.080418,-0.06057,1,0
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.015574,-0.080753,-0.10773,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.037747,-0.080788,-0.11695,1,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.019739,-0.080956,-0.12703,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.042857,-0.081063,-0.10309,1,0
2,GO GAMETE GENERATION,0.0010206,-0.081244,-0.088169,1,0
2,GO TUBE FORMATION,0.023205,-0.081475,-0.096162,1,0
2,GO REGULATION OF HEMOPOIESIS,0.010773,-0.081738,-0.105,1,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.044685,-0.081822,-0.10828,1,0
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0064317,-0.08192,-0.10728,1,0
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.016339,-0.081932,-0.096147,1,0
2,GO REGULATION OF IMMUNE RESPONSE,0.010773,-0.082422,-0.11106,1,0
2,GO FATTY ACID METABOLIC PROCESS,0.031059,-0.082955,-0.10209,1,0
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.038561,-0.083001,-0.11834,1,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.012508,-0.083325,-0.12337,1,0
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.014486,-0.084075,-0.1136,1,0
2,GO MAST CELL MEDIATED IMMUNITY,0.019739,-0.084268,-0.18989,1,0
2,GO GLUCOSE METABOLIC PROCESS,0.044685,-0.084349,-0.067101,1,0
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0075304,-0.084664,-0.10493,1,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.035393,-0.084752,-0.069618,1,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.010773,-0.085104,-0.11029,1,0
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.013139,-0.085154,-0.12442,1,0
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0056288,-0.08531,-0.10888,1,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.011904,-0.08548,-0.080851,1,0
2,GO RESPONSE TO ANTIBIOTIC,0.037747,-0.085625,-0.11302,1,0
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.04854,-0.085844,-0.10889,1,0
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.011047,-0.085863,-0.17353,1,0
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.050569,-0.086101,-0.12924,1,0
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0094949,-0.086271,-0.12897,1,0
2,GO REGULATION OF PROTEOLYSIS,0.0057817,-0.086679,-0.112,1,0
2,GO GOLGI TO VACUOLE TRANSPORT,0.014486,-0.086788,-0.13458,1,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.041967,-0.08685,-0.069253,1,0
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.009256,-0.087266,-0.095113,1,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.013798,-0.087488,-0.13861,1,0
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.036948,-0.08754,-0.090013,1,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00081984,-0.087676,-0.10881,1,0
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.033166,-0.087948,-0.13159,1,0
2,GO EMBRYONIC MORPHOGENESIS,0.012203,-0.088139,-0.10272,1,0
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.047551,-0.088301,-0.081081,1,0
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.014841,-0.088522,-0.1165,1,0
2,GO LYMPHOCYTE DIFFERENTIATION,0.0021062,-0.088558,-0.11587,1,0
2,GO CELLULAR SENESCENCE,0.017549,-0.088653,-0.11054,1,0
2,GO PROTEOLYSIS,0.00044439,-0.089362,-0.10478,1,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.04854,-0.089702,-0.075698,1,0
2,GO NATURAL KILLER CELL ACTIVATION,0.011904,-0.089745,-0.13561,1,0
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.02268,-0.089912,-0.090142,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION,0.018398,-0.090064,-0.10809,1,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.030383,-0.090119,-0.20065,1,0
2,GO ACTIVATION OF GTPASE ACTIVITY,0.0064317,-0.090415,-0.098557,1,0
2,GO REGULATION OF CELLULAR PH,0.0049174,-0.090578,-0.097889,1,0
2,GO CELL CELL ADHESION,0.004408,-0.09071,-0.12249,1,0
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0069616,-0.09084,-0.1134,1,0
2,GO CELLULAR PIGMENTATION,0.0036303,-0.09092,-0.13554,1,0
2,GO REGULATION OF NUCLEAR DIVISION,0.0050528,-0.091131,-0.08089,1,0
2,GO CELL MATRIX ADHESION,0.038561,-0.091166,-0.1199,1,0
2,GO GERM CELL DEVELOPMENT,0.0056288,-0.091316,-0.088962,1,0
2,GO REGULATION OF PH,0.0062634,-0.091444,-0.094954,1,0
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.02268,-0.091575,-0.10198,1,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.010245,-0.091642,-0.12579,1,0
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.030383,-0.091662,-0.14272,1,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.016339,-0.092052,-0.097263,1,0
2,GO MALE SEX DIFFERENTIATION,0.0069616,-0.092178,-0.10836,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.012508,-0.092218,-0.10432,1,0
2,GO RESPONSE TO GAMMA RADIATION,0.036948,-0.092257,-0.093986,1,0
2,GO GLAND DEVELOPMENT,0.013139,-0.092267,-0.099714,1,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0099891,-0.092299,-0.10271,1,0
2,GO ERBB SIGNALING PATHWAY,0.02843,-0.092544,-0.11082,1,0
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.042857,-0.092571,-0.14696,1,0
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.012203,-0.092747,-0.12479,1,0
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0028957,-0.092966,-0.091004,1,0
2,GO PROTEIN MATURATION,0.015574,-0.092989,-0.10116,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.017137,-0.093242,-0.1859,1,0
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.019739,-0.093259,-0.14598,1,0
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.018836,-0.093434,-0.18171,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0024367,-0.093456,-0.1471,1,0
2,GO LIPID LOCALIZATION,0.0079323,-0.09371,-0.11778,1,0
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0042883,-0.09409,-0.12622,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.013798,-0.094359,-0.11699,1,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.04854,-0.094558,-0.099281,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0025083,-0.094888,-0.15669,1,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.02268,-0.095105,-0.13525,1,0
2,GO RESPONSE TO ALCOHOL,0.044685,-0.095276,-0.077525,1,0
2,GO GOLGI VESICLE BUDDING,0.0081404,-0.095367,-0.11661,1,0
2,GO ACTIVATION OF IMMUNE RESPONSE,0.0097392,-0.095573,-0.10692,1,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0013872,-0.095585,-0.121,1,0
2,GO POSTREPLICATION REPAIR,0.011904,-0.096376,-0.08894,1,0
2,GO COPII COATED VESICLE BUDDING,0.0053338,-0.096385,-0.11379,1,0
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.052669,-0.096441,-0.12145,1,0
2,GO REGULATION OF BODY FLUID LEVELS,0.0010859,-0.096588,-0.1364,1,0
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.038561,-0.09677,-0.13006,1,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.03939,-0.096774,-0.14335,1,0
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.041967,-0.097474,-0.17357,1,0
2,GO GENITALIA DEVELOPMENT,0.031748,-0.097801,-0.11878,1,0
2,GO GOLGI ORGANIZATION,0.0025083,-0.097875,-0.11643,1,0
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.015574,-0.098282,-0.13644,1,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.027803,-0.098302,-0.10269,1,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.050569,-0.098544,-0.10396,1,0
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.017549,-0.098956,-0.093767,1,0
2,GO ORGANELLE DISASSEMBLY,0.0087944,-0.099028,-0.092583,1,0
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.023205,-0.099219,-0.1092,1,0
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0069616,-0.099376,-0.12092,1,0
2,GO COAGULATION,0.0051916,-0.099857,-0.13878,1,0
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.009256,-0.099859,-0.13181,1,0
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00044439,-0.099918,-0.12903,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.022165,-0.099988,-0.15007,1,0
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.010773,-0.099989,-0.13459,1,0
2,GO APOPTOTIC SIGNALING PATHWAY,0.0041716,-0.10043,-0.1099,1,0
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.022165,-0.1009,-0.15697,1,0
2,GO ERAD PATHWAY,0.010506,-0.10131,-0.11486,1,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.011904,-0.10153,-0.12119,1,0
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00054072,-0.10187,-0.1406,1,0
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0060989,-0.10191,-0.14091,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0013054,-0.10192,-0.14426,1,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.014486,-0.10213,-0.14414,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.045624,-0.10218,-0.10611,1,0
2,GO REGULATION OF CELL ADHESION,0.0026572,-0.10247,-0.1538,1,0
2,GO REGULATION OF CELL ACTIVATION,0.0022992,-0.10248,-0.13089,1,0
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0023671,-0.10265,-0.10487,1,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.015574,-0.10293,-0.1546,1,0
2,GO ENDOCYTIC RECYCLING,0.0020453,-0.10297,-0.1284,1,0
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0053338,-0.10314,-0.1281,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0085714,-0.10358,-0.137,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00092958,-0.10358,-0.14937,1,0
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0025083,-0.10375,-0.13773,1,0
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00092958,-0.10393,-0.11064,1,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.026586,-0.10435,-0.085846,1,0
2,GO PH REDUCTION,0.0021689,-0.10437,-0.14997,1,0
2,GO CELL ACTIVATION,0.0027346,-0.10443,-0.13744,1,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.023741,-0.10443,-0.11891,1,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.041093,-0.10467,-0.12192,1,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.015574,-0.10467,-0.13052,1,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.03245,-0.10489,-0.13769,1,0
2,GO ADAPTIVE THERMOGENESIS,0.02268,-0.10497,-0.09286,1,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.043763,-0.10516,-0.10536,1,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.0060989,-0.10518,-0.13486,1,0
2,GO HISTONE MONOUBIQUITINATION,0.00026903,-0.10577,-0.13101,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.02166,-0.10578,-0.18634,1,0
2,GO DIGESTIVE SYSTEM PROCESS,0.033894,-0.10582,-0.12398,1,0
2,GO T CELL DIFFERENTIATION,0.0046564,-0.10597,-0.12217,1,0
2,GO PROTEIN POLYUBIQUITINATION,7.547e-05,-0.10635,-0.12601,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0022992,-0.10682,-0.21834,1,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.038561,-0.10693,-0.11031,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.011326,-0.10731,-0.18883,1,0
2,GO RESPONSE TO OSMOTIC STRESS,0.023205,-0.10739,-0.11405,1,0
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0069616,-0.10748,-0.13913,1,0
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.040234,-0.10761,-0.18224,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.033894,-0.10795,-0.1079,1,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.00049035,-0.10805,-0.13497,1,0
2,GO PROTEIN KINASE B SIGNALING,0.0042883,-0.10819,-0.13353,1,0
2,GO LIPID DIGESTION,0.012508,-0.10865,-0.28191,1,0
2,GO INTERLEUKIN 17 PRODUCTION,0.030383,-0.10907,-0.14524,1,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.026586,-0.10914,-0.17042,1,0
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.025414,-0.1093,-0.17811,1,0
2,GO PEPTIDYL TYROSINE MODIFICATION,0.0037331,-0.10936,-0.13087,1,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.042857,-0.10946,-0.09126,1,0
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,8.7323e-05,-0.10953,-0.14344,1,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.016734,-0.1097,-0.10881,1,0
2,GO REPRODUCTION,0.0007696,-0.10999,-0.092536,1,0
2,GO REGULATION OF PEPTIDE SECRETION,0.0083534,-0.11015,-0.099042,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.031748,-0.11072,-0.18395,1,0
2,GO VESICLE BUDDING FROM MEMBRANE,0.00087311,-0.11132,-0.14441,1,0
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.041093,-0.1115,-0.082264,1,0
2,GO REPLACEMENT OSSIFICATION,0.035393,-0.11165,-0.16091,1,0
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.00095906,-0.11176,-0.15167,1,0
2,GO RESPONSE TO BIOTIC STIMULUS,0.0023671,-0.11176,-0.13851,1,0
2,GO LYMPHOCYTE CHEMOTAXIS,0.020205,-0.11203,-0.13579,1,0
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00042998,-0.11209,-0.15393,1,0
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.041093,-0.1121,-0.089285,1,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0071468,-0.11215,-0.088894,1,0
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00087311,-0.11217,-0.14572,1,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00090094,-0.11244,-0.15274,1,0
2,GO HEMOGLOBIN METABOLIC PROCESS,0.010506,-0.11274,-0.16972,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.014486,-0.11296,-0.11908,1,0
2,GO INNATE IMMUNE RESPONSE,0.00092958,-0.11297,-0.16868,1,0
2,GO LEUKOCYTE CELL CELL ADHESION,0.001662,-0.11298,-0.15534,1,0
2,GO CARBOHYDRATE TRANSPORT,0.0067808,-0.11335,-0.10615,1,0
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00052342,-0.11337,-0.19464,1,0
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.014138,-0.11384,-0.10532,1,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.031748,-0.11388,-0.22195,1,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.044685,-0.11432,-0.19369,1,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0037331,-0.11433,-0.10729,1,0
2,GO MYELOID CELL DIFFERENTIATION,0.00025131,-0.11435,-0.12563,1,0
2,GO MITOTIC CYTOKINESIS,0.0030654,-0.11455,-0.12727,1,0
2,GO PLATELET MORPHOGENESIS,0.0051916,-0.11539,-0.20988,1,0
2,GO RESPONSE TO UV C,0.030383,-0.11551,-0.1629,1,0
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.049546,-0.11558,-0.19466,1,0
2,GO REGULATION OF T CELL ACTIVATION,0.00087311,-0.11577,-0.14916,1,0
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0019282,-0.11619,-0.11366,1,0
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.017969,-0.11697,-0.13148,1,0
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0064317,-0.11699,-0.1915,1,0
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.02268,-0.11734,-0.11495,1,0
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0036303,-0.11734,-0.21546,1,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.02166,-0.11741,-0.21897,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0021689,-0.11744,-0.21493,1,0
2,GO MYOBLAST DIFFERENTIATION,0.00353,-0.1177,-0.18566,1,0
2,GO DENDRITIC CELL MIGRATION,0.03939,-0.11815,-0.17082,1,0
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0042883,-0.11821,-0.15809,1,0
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.020205,-0.11829,-0.15136,1,0
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0030654,-0.1183,-0.175,1,0
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0071468,-0.11846,-0.13149,1,0
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00079435,-0.11849,-0.1507,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0046564,-0.11865,-0.10903,1,0
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.00037661,-0.11881,-0.14684,1,0
2,GO LYMPHOCYTE COSTIMULATION,0.016734,-0.1192,-0.12062,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00012074,-0.11925,-0.16242,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.014138,-0.11938,-0.17878,1,0
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.00057693,-0.1198,-0.17694,1,0
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0062634,-0.12015,-0.103,1,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00065623,-0.12034,-0.1434,1,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.049546,-0.12065,-0.13147,1,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.036948,-0.12079,-0.19372,1,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.036948,-0.12122,-0.16682,1,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.038561,-0.12132,-0.16502,1,0
2,GO DIGESTION,0.0037331,-0.12135,-0.15953,1,0
2,GO NOTCH SIGNALING PATHWAY,0.0041716,-0.12161,-0.12592,1,0
2,GO T CELL ACTIVATION,0.00084609,-0.1218,-0.15324,1,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.010245,-0.12181,-0.091078,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.027188,-0.12199,-0.11447,1,0
2,GO RESPONSE TO WOUNDING,0.0097392,-0.12206,-0.13851,1,0
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.043763,-0.12209,-0.13789,1,0
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.052669,-0.12216,-0.15298,1,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.036164,-0.12218,-0.12394,1,0
2,GO SPINDLE LOCALIZATION,0.001228,-0.12219,-0.14155,1,0
2,GO RESPONSE TO BACTERIUM,0.011612,-0.12235,-0.12854,1,0
2,GO PROTEIN DESTABILIZATION,0.0045306,-0.1224,-0.12012,1,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.036164,-0.12245,-0.17099,1,0
2,GO TISSUE MIGRATION,0.052669,-0.12264,-0.10693,1,0
2,GO CYTOKINE PRODUCTION,0.00021167,-0.12282,-0.17499,1,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.0045306,-0.1229,-0.11055,1,0
2,GO TISSUE HOMEOSTASIS,5.508e-06,-0.12321,-0.18363,1,0
2,GO EPITHELIUM DEVELOPMENT,4.6597e-05,-0.12322,-0.15616,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00014418,-0.12327,-0.15893,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0045306,-0.12336,-0.10713,1,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.00041602,-0.12341,-0.1536,1,0
2,GO BONE CELL DEVELOPMENT,0.021165,-0.12346,-0.13918,1,0
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00010845,-0.12354,-0.12675,1,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.015203,-0.12356,-0.19931,1,0
2,GO REGULATION OF DEFENSE RESPONSE,0.00049035,-0.12387,-0.14928,1,0
2,GO VIRAL LATENCY,0.024288,-0.12407,-0.12119,1,0
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.038561,-0.12409,-0.20943,1,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00013433,-0.12422,-0.14223,1,0
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0026572,-0.12426,-0.16489,1,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.0028141,-0.12432,-0.19311,1,0
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0085714,-0.1248,-0.21404,1,0
2,GO TRANSLESION SYNTHESIS,0.004408,-0.12481,-0.11409,1,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.031748,-0.12484,-0.12044,1,0
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.04854,-0.12484,-0.15094,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0037331,-0.1252,-0.19543,1,0
2,GO ACUTE INFLAMMATORY RESPONSE,0.0064317,-0.12528,-0.19474,1,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.04854,-0.12536,-0.11375,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.042857,-0.12547,-0.24358,1,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0014738,-0.12559,-0.16921,1,0
2,GO VESICLE TARGETING,0.0010859,-0.12596,-0.15258,1,0
2,GO DEFENSE RESPONSE,0.00067758,-0.12607,-0.14936,1,0
2,GO POLYAMINE METABOLIC PROCESS,0.05161,-0.12688,-0.10507,1,0
2,GO RESPIRATORY BURST,0.0030654,-0.12709,-0.24633,1,0
2,GO DNA DEALKYLATION,0.021165,-0.12709,-0.13663,1,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.0073363,-0.12709,-0.13064,1,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0050528,-0.12729,-0.17163,1,0
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.00024286,-0.12733,-0.1873,1,0
2,GO REGULATION OF PINOCYTOSIS,0.0049174,-0.12742,-0.21435,1,0
2,GO VIRAL LIFE CYCLE,0.0006154,-0.12754,-0.18525,1,0
2,GO INFLAMMATORY RESPONSE,0.0010528,-0.12767,-0.14813,1,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.029719,-0.1277,-0.13862,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0014738,-0.12842,-0.14968,1,0
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.013465,-0.12854,-0.12884,1,0
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.01282,-0.1286,-0.17838,1,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00023468,-0.12895,-0.16558,1,0
2,GO WOUND HEALING,0.0054795,-0.1293,-0.15726,1,0
2,GO FIBROBLAST MIGRATION,0.007729,-0.12942,-0.17907,1,0
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.014138,-0.12982,-0.14473,1,0
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00084609,-0.12995,-0.18643,1,0
2,GO RESPONSE TO INTERLEUKIN 6,0.0012662,-0.13027,-0.18833,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00042998,-0.13033,-0.17338,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.024288,-0.13054,-0.14495,1,0
2,GO PHAGOSOME ACIDIFICATION,0.011047,-0.13061,-0.16997,1,0
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.004408,-0.13062,-0.18148,1,0
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.019739,-0.13104,-0.13652,1,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.042857,-0.13113,-0.13624,1,0
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.05161,-0.13174,-0.18714,1,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00050664,-0.132,-0.16849,1,0
2,GO REGULATION OF CHEMOTAXIS,0.0025817,-0.13201,-0.13346,1,0
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0083534,-0.13223,-0.22541,1,0
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.042857,-0.13227,-0.10183,1,0
2,GO NEURAL TUBE DEVELOPMENT,0.00079435,-0.13232,-0.14758,1,0
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.013465,-0.13233,-0.11869,1,0
2,GO SENSORY PERCEPTION OF BITTER TASTE,0.00067758,-0.13237,-0.17463,1,0
2,GO HISTONE H2A UBIQUITINATION,0.0036303,-0.13238,-0.12349,1,0
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.052669,-0.13279,-0.10656,1,0
2,GO PEPTIDE CROSS LINKING,0.031059,-0.1329,-0.19153,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0031536,-0.1334,-0.14323,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0083534,-0.13365,-0.18128,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.004408,-0.13383,-0.18717,1,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.00067758,-0.13394,-0.14216,1,0
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00079435,-0.13405,-0.18566,1,0
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00037661,-0.1343,-0.18074,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0071468,-0.13466,-0.25989,1,0
2,GO PEPTIDYL THREONINE MODIFICATION,0.0010206,-0.13467,-0.13057,1,0
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.00045924,-0.13472,-0.18616,1,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.03245,-0.13487,-0.15042,1,0
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.0034322,-0.1352,-0.20747,1,0
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0010206,-0.13529,-0.18728,1,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.00012512,-0.13531,-0.11985,1,0
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0028957,-0.13533,-0.18301,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.017549,-0.1354,-0.11915,1,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.035393,-0.13556,-0.122,1,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.018398,-0.13599,-0.16919,1,0
2,GO B CELL ACTIVATION,1.349e-05,-0.13627,-0.16989,1,0
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00034072,-0.13627,-0.17261,1,0
2,GO REGULATION OF MAST CELL ACTIVATION,0.025994,-0.13635,-0.1584,1,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0057817,-0.13663,-0.16375,1,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.044685,-0.13707,-0.10245,1,0
2,GO RESPONSE TO CYTOKINE,0.0015653,-0.13722,-0.15304,1,0
2,GO LEUKOCYTE PROLIFERATION,5.2139e-05,-0.13752,-0.18262,1,0
2,GO CYTOKINE SECRETION,0.00036427,-0.13774,-0.16718,1,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.00059588,-0.13782,-0.13632,1,0
2,GO REGULATION OF T CELL CHEMOTAXIS,0.017969,-0.13784,-0.13105,1,0
2,GO ATP BIOSYNTHETIC PROCESS,0.017137,-0.13838,-0.12921,1,0
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0015653,-0.13838,-0.16625,1,0
2,GO CELLULAR RESPONSE TO ALCOHOL,0.0036303,-0.13851,-0.13108,1,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0022992,-0.13857,-0.19007,1,0
2,GO B CELL PROLIFERATION,0.0047853,-0.13915,-0.14366,1,0
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.025414,-0.13941,-0.14385,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION,0.0013457,-0.13943,-0.17667,1,0
2,GO RESPONSE TO PEPTIDOGLYCAN,0.0011199,-0.13949,-0.21885,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029782,-0.13965,-0.1945,1,0
2,GO REGULATION OF SPINDLE ORGANIZATION,0.00026003,-0.13967,-0.1549,1,0
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.019283,-0.14022,-0.1494,1,0
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.0085714,-0.14029,-0.15571,1,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0081404,-0.14034,-0.14479,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0011549,-0.14036,-0.19254,1,0
2,GO AMINO SUGAR CATABOLIC PROCESS,0.019739,-0.14046,-0.16668,1,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.0028957,-0.14073,-0.1457,1,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0001547,-0.14116,-0.15776,1,0
2,GO T CELL PROLIFERATION,0.00047456,-0.14122,-0.17393,1,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0028141,-0.14125,-0.16001,1,0
2,GO GRANULOCYTE MIGRATION,0.0039469,-0.14139,-0.1513,1,0
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.030383,-0.14149,-0.14655,1,0
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.016734,-0.14167,-0.18334,1,0
2,GO RESPONSE TO ETHER,0.024288,-0.14185,-0.11441,1,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0057817,-0.14203,-0.15264,1,0
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00035231,-0.14214,-0.22517,1,0
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00012512,-0.14214,-0.20648,1,0
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00029782,-0.14289,-0.16849,1,0
2,GO VIRAL RNA GENOME REPLICATION,0.0025083,-0.14291,-0.18684,1,0
2,GO PHOTOTRANSDUCTION,0.0073363,-0.14296,-0.14348,1,0
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0047853,-0.14328,-0.23072,1,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0024367,-0.14331,-0.18293,1,0
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.035393,-0.14355,-0.18871,1,0
2,GO BLOOD VESSEL REMODELING,0.0053338,-0.14366,-0.2213,1,0
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0011549,-0.14393,-0.18759,1,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.00013917,-0.14424,-0.15291,1,0
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.02068,-0.14432,-0.21244,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.009256,-0.14442,-0.18871,1,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.014486,-0.14453,-0.12149,1,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.042857,-0.14456,-0.15514,1,0
2,GO INTERLEUKIN 4 PRODUCTION,0.0014299,-0.14457,-0.20697,1,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0037331,-0.14465,-0.17389,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.013465,-0.14492,-0.17924,1,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.014841,-0.14516,-0.13223,1,0
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.035393,-0.14517,-0.18809,1,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.017137,-0.14525,-0.11333,1,0
2,GO CHEMOKINE PRODUCTION,0.00035231,-0.14531,-0.21654,1,0
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0018173,-0.14548,-0.14576,1,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0014738,-0.14601,-0.16132,1,0
2,GO MAST CELL ACTIVATION,0.0090226,-0.14638,-0.18771,1,0
2,GO ER NUCLEUS SIGNALING PATHWAY,0.017549,-0.14655,-0.14279,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0010528,-0.14678,-0.18093,1,0
2,GO MYELOID CELL DEVELOPMENT,0.00041602,-0.14679,-0.14912,1,0
2,GO SENSORY PERCEPTION OF TASTE,0.00087311,-0.14694,-0.17863,1,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00055855,-0.14704,-0.21074,1,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00019079,-0.14753,-0.18056,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00027832,-0.14789,-0.19066,1,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.001872,-0.14792,-0.17967,1,0
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.033166,-0.14877,-0.19191,1,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.05161,-0.1488,-0.1726,1,0
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.9904e-06,-0.14883,-0.18084,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0015653,-0.14894,-0.18765,1,0
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.011904,-0.14926,-0.19602,1,0
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.009256,-0.14942,-0.17523,1,0
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00353,-0.14945,-0.15172,1,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.00057693,-0.14947,-0.2105,1,0
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.013465,-0.14956,-0.1439,1,0
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.6174e-05,-0.14956,-0.17964,1,0
2,GO RENAL TUBULE DEVELOPMENT,0.001191,-0.14991,-0.17985,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0025817,-0.14994,-0.20246,1,0
2,GO POSITIVE REGULATION OF NEURON DEATH,0.0075304,-0.14999,-0.11888,1,0
2,GO NUCLEOTIDE TRANSPORT,0.033166,-0.15011,-0.098094,1,0
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00032948,-0.15014,-0.18851,1,0
2,GO SECRETION BY TISSUE,0.013465,-0.15017,-0.16291,1,0
2,GO SECONDARY METABOLIC PROCESS,0.0029794,-0.15038,-0.21197,1,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.02166,-0.15049,-0.19718,1,0
2,GO REGULATION OF B CELL ACTIVATION,0.00028792,-0.15059,-0.17344,1,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0038387,-0.15116,-0.14668,1,0
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00027832,-0.15117,-0.17891,1,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.0075304,-0.1512,-0.1891,1,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.0015653,-0.15155,-0.14694,1,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0032441,-0.15164,-0.14705,1,0
2,GO LEUKOCYTE MIGRATION,0.00052342,-0.15167,-0.16869,1,0
2,GO CYTOKINE METABOLIC PROCESS,0.0007696,-0.15171,-0.20216,1,0
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00013433,-0.15188,-0.18461,1,0
2,GO PINOCYTOSIS,0.017549,-0.15217,-0.18144,1,0
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00037661,-0.15284,-0.21262,1,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00019079,-0.15285,-0.22724,1,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.007729,-0.15288,-0.25354,1,0
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.031748,-0.15312,-0.2892,1,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.045624,-0.15342,-0.1403,1,0
2,GO DETERMINATION OF ADULT LIFESPAN,0.03939,-0.15348,-0.13741,1,0
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0039469,-0.15351,-0.21867,1,0
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00012074,-0.15356,-0.20431,1,0
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0049174,-0.15376,-0.16147,1,0
2,GO REGULATION OF CELL CELL ADHESION,0.00019753,-0.15387,-0.18583,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00036427,-0.15402,-0.19018,1,0
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,-0.15411,-0.20674,1,0
2,GO INTESTINAL LIPID ABSORPTION,0.0057817,-0.15426,-0.30133,1,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0066042,-0.15435,-0.18217,1,0
2,GO GRANULOCYTE CHEMOTAXIS,0.004408,-0.15444,-0.14176,1,0
2,GO DEFENSE RESPONSE TO BACTERIUM,5.0226e-05,-0.15451,-0.18967,1,0
2,GO IMMUNE EFFECTOR PROCESS,0.00027832,-0.15462,-0.18866,1,0
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0010528,-0.15478,-0.19313,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0032441,-0.15482,-0.23943,1,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.01282,-0.15482,-0.17457,1,0
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00027832,-0.15485,-0.20869,1,0
2,GO ACTIN NUCLEATION,9.3916e-06,-0.15517,-0.17974,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0054795,-0.15535,-0.19323,1,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.00084609,-0.15538,-0.14248,1,0
2,GO GENETIC IMPRINTING,0.001662,-0.1559,-0.18531,1,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.012508,-0.15608,-0.25662,1,0
2,GO T HELPER 1 CELL DIFFERENTIATION,0.020205,-0.15641,-0.32179,1,0
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.001191,-0.15661,-0.24229,1,0
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0056288,-0.15663,-0.43877,1,0
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00021909,-0.15674,-0.17691,1,0
2,GO RESPONSE TO REDOX STATE,0.042857,-0.15686,-0.15179,1,0
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00074557,-0.15704,-0.18448,1,0
2,GO INTERACTION WITH HOST,0.00019079,-0.15709,-0.20914,1,0
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.00079435,-0.15766,-0.18699,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0014299,-0.15773,-0.2157,1,0
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00057693,-0.15783,-0.1292,1,0
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00016023,-0.15786,-0.21085,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00067758,-0.15788,-0.18079,1,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.035393,-0.15803,-0.10595,1,0
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0026572,-0.15807,-0.2037,1,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0087944,-0.15853,-0.16251,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0038387,-0.15858,-0.15479,1,0
2,GO LINOLEIC ACID METABOLIC PROCESS,0.041967,-0.15888,-0.19555,1,0
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.00034072,-0.1591,-0.19399,1,0
2,GO FOAM CELL DIFFERENTIATION,0.019283,-0.15919,-0.17345,1,0
2,GO RESPONSE TO DSRNA,0.0051916,-0.1593,-0.15298,1,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00016023,-0.15932,-0.20877,1,0
2,GO HISTAMINE TRANSPORT,0.02843,-0.15977,-0.22185,1,0
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0060989,-0.15995,-0.27992,1,0
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00010092,-0.16008,-0.19963,1,0
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00017796,-0.16016,-0.18245,1,0
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.8379e-05,-0.16017,-0.21337,1,0
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.020205,-0.16021,-0.17337,1,0
2,GO CELL KILLING,0.00074557,-0.16039,-0.18127,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00023468,-0.16045,-0.19554,1,0
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.5816e-05,-0.16078,-0.24415,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.017549,-0.16089,-0.24785,1,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0025083,-0.16094,-0.13679,1,0
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00026903,-0.16179,-0.2271,1,0
2,GO ENDOTHELIAL CELL MIGRATION,0.017137,-0.16179,-0.13681,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0036303,-0.16222,-0.20852,1,0
2,GO RESPONSE TO VIRUS,7.2754e-05,-0.16236,-0.22056,1,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,8.7323e-05,-0.16304,-0.15477,1,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.023205,-0.16307,-0.22829,1,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0037331,-0.16314,-0.18802,1,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00024286,-0.16323,-0.17159,1,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0039469,-0.16341,-0.16958,1,0
2,GO LEUKOTRIENE METABOLIC PROCESS,0.017549,-0.16375,-0.15881,1,0
2,GO BONE RESORPTION,0.001662,-0.16393,-0.2021,1,0
2,GO EPITHELIAL CELL DEVELOPMENT,4.0073e-05,-0.16412,-0.20926,1,0
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.4121e-05,-0.16446,-0.21357,1,0
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0033369,-0.16459,-0.23974,1,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.014138,-0.16466,-0.14851,1,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,8.6584e-06,-0.16481,-0.16849,1,0
2,GO PROTEIN PROCESSING,0.00031859,-0.16503,-0.17643,1,0
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.016339,-0.16508,-0.20976,1,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.030383,-0.16509,-0.17813,1,0
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0099891,-0.16521,-0.21723,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00035231,-0.16611,-0.20067,1,0
2,GO PROTEIN DEMANNOSYLATION,0.016734,-0.16667,-0.1826,1,0
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00012512,-0.16682,-0.20585,1,0
2,GO REGULATION OF ICOSANOID SECRETION,0.043763,-0.16685,-0.13495,1,0
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,5.4121e-05,-0.16691,-0.21403,1,0
2,GO MEGAKARYOCYTE DIFFERENTIATION,4.4712e-06,-0.1672,-0.18873,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0090226,-0.16723,-0.18053,1,0
2,GO ALPHA BETA T CELL ACTIVATION,1.5816e-05,-0.16759,-0.22358,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00072223,-0.16822,-0.19688,1,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0087944,-0.16857,-0.18176,1,0
2,GO T CELL CYTOKINE PRODUCTION,0.0037331,-0.16864,-0.19095,1,0
2,GO RESPONSE TO PROGESTERONE,0.0049174,-0.1687,-0.22083,1,0
2,GO MESONEPHROS DEVELOPMENT,0.012508,-0.16888,-0.15112,1,0
2,GO MYELOID LEUKOCYTE MIGRATION,0.0014299,-0.16935,-0.16125,1,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.6455e-05,-0.16944,-0.1757,1,0
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.038561,-0.17029,-0.16591,1,0
2,GO ZYMOGEN ACTIVATION,0.0051916,-0.17036,-0.27421,1,0
2,GO RIG I SIGNALING PATHWAY,0.0025083,-0.17043,-0.18276,1,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0010859,-0.17043,-0.23775,1,0
2,GO EXECUTION PHASE OF APOPTOSIS,1.0184e-05,-0.17048,-0.1646,1,0
2,GO ENTRY INTO HOST,0.00050664,-0.17066,-0.26205,1,0
2,GO ACUTE PHASE RESPONSE,0.0031536,-0.17081,-0.1885,1,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.013465,-0.17095,-0.14719,1,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0022332,-0.17123,-0.19664,1,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0028141,-0.17125,-0.20777,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.1617e-05,-0.17141,-0.24649,1,0
2,GO RESPONSE TO ANGIOTENSIN,0.0024367,-0.17178,-0.21932,1,0
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00037661,-0.17193,-0.21364,1,0
2,GO DIOL METABOLIC PROCESS,0.019739,-0.17195,-0.17019,1,0
2,GO CENTROSOME DUPLICATION,9.389e-05,-0.17204,-0.17864,1,0
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.00055855,-0.17215,-0.159,1,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0025817,-0.17218,-0.21653,1,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00063551,-0.17254,-0.21976,1,0
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.033894,-0.17272,-0.17615,1,0
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0029794,-0.17299,-0.21201,1,0
2,GO REGULATION OF B CELL PROLIFERATION,0.0017123,-0.17333,-0.18159,1,0
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.036164,-0.17361,-0.19823,1,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0028957,-0.17377,-0.17369,1,0
2,GO ICOSANOID BIOSYNTHETIC PROCESS,0.012508,-0.17408,-0.20794,1,0
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0051916,-0.1742,-0.17726,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0014738,-0.17422,-0.17904,1,0
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0075304,-0.17471,-0.2284,1,0
2,GO CYTOLYSIS,0.0054795,-0.17473,-0.22888,1,0
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0013872,-0.17476,-0.1755,1,0
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0045306,-0.17502,-0.19628,1,0
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,6.7596e-05,-0.17559,-0.19025,1,0
2,GO O GLYCAN PROCESSING,0.0031536,-0.17579,-0.2369,1,0
2,GO REGULATION OF RUFFLE ASSEMBLY,0.00079435,-0.17596,-0.1982,1,0
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0025083,-0.17613,-0.17621,1,0
2,GO RETINA HOMEOSTASIS,0.00032948,-0.17619,-0.14676,1,0
2,GO DNA DEMETHYLATION,0.00029782,-0.17626,-0.19988,1,0
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.001228,-0.17636,-0.17727,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,5.2139e-05,-0.17658,-0.2252,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.015574,-0.17694,-0.22061,1,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0047853,-0.17737,-0.19456,1,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0001165,-0.17743,-0.194,1,0
2,GO EPOXYGENASE P450 PATHWAY,0.03939,-0.17744,-0.19399,1,0
2,GO PLATELET ACTIVATION,4.1617e-05,-0.17749,-0.21602,1,0
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.018836,-0.17791,-0.15795,1,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.013465,-0.17804,-0.23875,1,0
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.17827,-0.19891,1,0
2,GO B CELL DIFFERENTIATION,4.1112e-06,-0.17886,-0.20911,1,0
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.1663e-05,-0.1789,-0.24823,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0016129,-0.17895,-0.21136,1,0
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00036427,-0.17899,-0.16736,1,0
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.7806e-05,-0.17912,-0.19717,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00017186,-0.17933,-0.24299,1,0
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0036303,-0.17976,-0.23816,1,0
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0034322,-0.17994,-0.15644,1,0
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0011549,-0.18011,-0.26679,1,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0018173,-0.18039,-0.20622,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0031536,-0.18041,-0.17537,1,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0067808,-0.18146,-0.20684,1,0
2,GO PHOSPHOLIPID TRANSPORT,9.7346e-05,-0.18173,-0.18523,1,0
2,GO NEPHRON DEVELOPMENT,0.00034072,-0.18181,-0.18869,1,0
2,GO CELLULAR RESPONSE TO VIRUS,3.5759e-05,-0.18208,-0.22268,1,0
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0081404,-0.18208,-0.18681,1,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.00081984,-0.18246,-0.19194,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,-0.18284,-0.21292,1,0
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00019753,-0.18286,-0.20857,1,0
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00017796,-0.18323,-0.26212,1,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0053338,-0.1835,-0.18746,1,0
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00049035,-0.18353,-0.2607,1,0
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0046564,-0.18402,-0.23911,1,0
2,GO MYELOID CELL HOMEOSTASIS,1.7806e-05,-0.18416,-0.19416,1,0
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00090094,-0.18552,-0.17905,1,0
2,GO DEFENSE RESPONSE TO VIRUS,3.6228e-06,-0.18591,-0.29096,1,0
2,GO ENDOSOME ORGANIZATION,5.7413e-06,-0.18602,-0.1872,1,0
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0027346,-0.18632,-0.20252,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.7118e-05,-0.18636,-0.21519,1,0
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0046564,-0.18693,-0.22136,1,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0028957,-0.18694,-0.3128,1,0
2,GO REGULATION OF TISSUE REMODELING,0.00353,-0.18727,-0.18813,1,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,6.2786e-05,-0.18748,-0.24241,1,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.00017796,-0.18756,-0.15865,1,0
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00010845,-0.18759,-0.23729,1,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.010245,-0.18772,-0.19643,1,0
2,GO PRO B CELL DIFFERENTIATION,0.03939,-0.18773,-0.17599,1,0
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0039469,-0.18868,-0.22033,1,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.029068,-0.18875,-0.28838,1,0
2,GO ALPHA BETA T CELL DIFFERENTIATION,3.6228e-06,-0.18876,-0.24018,1,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0087944,-0.18891,-0.22537,1,0
2,GO IMMUNOGLOBULIN SECRETION,5.8301e-05,-0.18902,-0.32871,1,0
2,GO KERATINOCYTE PROLIFERATION,0.023741,-0.18905,-0.1901,1,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.020205,-0.18916,-0.18951,1,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0053338,-0.18936,-0.20841,1,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00026003,-0.18937,-0.20372,1,0
2,GO MULTIVESICULAR BODY SORTING PATHWAY,4.6597e-05,-0.18985,-0.20809,1,0
2,GO REGULATION OF SYMBIOTIC PROCESS,2.3418e-05,-0.19054,-0.23827,1,0
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.042857,-0.19116,-0.1446,1,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,4.1617e-05,-0.19125,-0.20666,1,0
2,GO MATURE B CELL DIFFERENTIATION,0.0079323,-0.19127,-0.24139,1,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00042998,-0.19132,-0.18364,1,0
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00045924,-0.19145,-0.25472,1,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.033166,-0.19155,-0.18675,1,0
2,GO MYELOID CELL APOPTOTIC PROCESS,0.0039469,-0.19155,-0.20908,1,0
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.009256,-0.1917,-0.21063,1,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0014738,-0.19173,-0.19582,1,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0007696,-0.19186,-0.24411,1,0
2,GO HISTONE H4 DEACETYLATION,0.0083534,-0.19221,-0.18168,1,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.019283,-0.19244,-0.19172,1,0
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.025994,-0.19261,-0.19316,1,0
2,GO MACROPHAGE MIGRATION,0.016734,-0.19285,-0.15018,1,0
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.014138,-0.19285,-0.19495,1,0
2,GO REGULATION OF GASTRULATION,0.0036303,-0.19303,-0.19391,1,0
2,GO TYPE I INTERFERON PRODUCTION,0.00012512,-0.19307,-0.22172,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.0073e-05,-0.19317,-0.20567,1,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0094949,-0.19414,-0.17633,1,0
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,-0.19418,-0.24207,1,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0053338,-0.1944,-0.18269,1,0
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.030383,-0.19452,-0.19046,1,0
2,GO RESPONSE TO INTERLEUKIN 2,0.0024367,-0.19464,-0.21173,1,0
2,GO LEUKOCYTE CHEMOTAXIS,0.00034072,-0.19467,-0.17473,1,0
2,GO RESPONSE TO INTERFERON GAMMA,0.0022992,-0.19468,-0.25638,1,0
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00020448,-0.19474,-0.22513,1,0
2,GO LIPID DROPLET ORGANIZATION,0.00057693,-0.19506,-0.24384,1,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.00072223,-0.19512,-0.22377,1,0
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00052342,-0.19534,-0.26544,1,0
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0041716,-0.19545,-0.23709,1,0
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.013798,-0.19553,-0.16904,1,0
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0028141,-0.19558,-0.17657,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0011549,-0.19644,-0.24342,1,0
2,GO B CELL MEDIATED IMMUNITY,4.1617e-05,-0.19658,-0.25168,1,0
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.013465,-0.19668,-0.20185,1,0
2,GO ENDODERMAL CELL FATE COMMITMENT,0.0027346,-0.19669,-0.18498,1,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0053338,-0.19672,-0.37465,1,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0001165,-0.19674,-0.23763,1,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0090226,-0.19698,-0.16844,1,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0025817,-0.19709,-0.1548,1,0
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0034322,-0.1971,-0.17857,1,0
2,GO RESPONSE TO OXYGEN RADICAL,0.00031859,-0.19742,-0.19113,1,0
2,GO ADAPTIVE IMMUNE RESPONSE,1.5201e-05,-0.19811,-0.24424,1,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0024367,-0.19818,-0.25076,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.001228,-0.19822,-0.26604,1,0
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.021165,-0.19857,-0.19446,1,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0031536,-0.19869,-0.15963,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0034322,-0.19925,-0.25923,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.050569,-0.19937,-0.14583,1,0
2,GO VIRAL GENOME REPLICATION,0.00019079,-0.19966,-0.25058,1,0
2,GO CELL CHEMOTAXIS,0.00014935,-0.19992,-0.19702,1,0
2,GO MICROVILLUS ORGANIZATION,0.0040578,-0.20036,-0.24987,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0038387,-0.20094,-0.21145,1,0
2,GO VASCULAR WOUND HEALING,0.047551,-0.20094,-0.1695,1,0
2,GO MOVEMENT IN HOST ENVIRONMENT,4.0073e-05,-0.20127,-0.26159,1,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00010092,-0.20136,-0.21635,1,0
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.0689e-05,-0.20164,-0.24896,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0027346,-0.20192,-0.23749,1,0
2,GO ERYTHROCYTE HOMEOSTASIS,3.1888e-05,-0.20196,-0.18645,1,0
2,GO ENDOCRINE PROCESS,0.0021689,-0.20277,-0.19742,1,0
2,GO MONONUCLEAR CELL MIGRATION,0.0015189,-0.2029,-0.20107,1,0
2,GO VIRION ASSEMBLY,4.8612e-06,-0.20303,-0.20821,1,0
2,GO T CELL MEDIATED CYTOTOXICITY,0.019739,-0.20305,-0.31241,1,0
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.018836,-0.2032,-0.29272,1,0
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0032441,-0.20377,-0.19792,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.1702e-06,-0.20405,-0.22395,1,0
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00090094,-0.20412,-0.23801,1,0
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.035393,-0.20415,-0.19456,1,0
2,GO RESPONSE TO COPPER ION,0.0094949,-0.20454,-0.28372,1,0
2,GO MACROPHAGE CHEMOTAXIS,0.015574,-0.20459,-0.15958,1,0
2,GO POSITIVE REGULATION OF CELL KILLING,0.00027832,-0.20468,-0.24762,1,0
2,GO ACTIN CYTOSKELETON REORGANIZATION,8.3127e-06,-0.20517,-0.19981,1,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.00090094,-0.20534,-0.19398,1,0
2,GO BONE REMODELING,0.0067808,-0.20576,-0.18857,1,0
2,GO CELLULAR DEFENSE RESPONSE,3.0576e-06,-0.20588,-0.28847,1,0
2,GO REGULATION OF RESPIRATORY BURST,0.0011549,-0.20635,-0.22913,1,0
2,GO CYTOKINETIC PROCESS,1.1493e-05,-0.20698,-0.2535,1,0
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.001872,-0.20732,-0.23,1,0
2,GO RESPONSE TO MECHANICAL STIMULUS,4.3218e-05,-0.20756,-0.21244,1,0
2,GO LIPID STORAGE,0.0019282,-0.20795,-0.18547,1,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.0016129,-0.20814,-0.22175,1,0
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0006154,-0.20853,-0.23021,1,0
2,GO SUPEROXIDE METABOLIC PROCESS,0.00031859,-0.2086,-0.20416,1,0
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00030804,-0.2088,-0.23571,1,0
2,GO REPLICATIVE SENESCENCE,0.037747,-0.2091,-0.18202,1,0
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00072223,-0.20911,-0.22309,1,0
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0015653,-0.20922,-0.2255,1,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00010092,-0.20979,-0.26298,1,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00030804,-0.21007,-0.19438,1,0
2,GO REGULATORY T CELL DIFFERENTIATION,0.0024367,-0.21051,-0.25494,1,0
2,GO REGULATION OF ACTIN NUCLEATION,7.013e-05,-0.21059,-0.23706,1,0
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.026586,-0.21085,-0.2233,1,0
2,GO MONOCYTE CHEMOTAXIS,0.00098941,-0.21086,-0.24741,1,0
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.001662,-0.21109,-0.17954,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00022676,-0.21165,-0.21018,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.017969,-0.21172,-0.29752,1,0
2,GO B CELL APOPTOTIC PROCESS,0.00049035,-0.21179,-0.25333,1,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00081984,-0.21195,-0.26482,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.9841e-06,-0.21209,-0.27498,1,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0013054,-0.2125,-0.18284,1,0
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.024846,-0.21262,-0.19456,1,0
2,GO HORMONE CATABOLIC PROCESS,0.0040578,-0.21298,-0.268,1,0
2,GO REGULATION OF CENTROSOME CYCLE,7.6603e-06,-0.21304,-0.1946,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00016595,-0.21323,-0.23457,1,0
2,GO ACTIVATED T CELL PROLIFERATION,0.00090094,-0.21349,-0.20102,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0039469,-0.2135,-0.28308,1,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00030804,-0.21379,-0.2708,1,0
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,5.8301e-05,-0.21386,-0.22757,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0033e-05,-0.21438,-0.24567,1,0
2,GO CELLULAR RESPONSE TO DSRNA,0.0015189,-0.21458,-0.24055,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0027346,-0.21505,-0.19654,1,0
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0022332,-0.21511,-0.20742,1,0
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0073363,-0.21563,-0.22312,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00023468,-0.21583,-0.2611,1,0
2,GO NEURAL TUBE FORMATION,5.508e-06,-0.21605,-0.21581,1,0
2,GO ERBB2 SIGNALING PATHWAY,2.0833e-05,-0.21644,-0.26576,1,0
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,7.547e-05,-0.21684,-0.28659,1,0
2,GO APICAL PROTEIN LOCALIZATION,0.0049174,-0.21697,-0.17376,1,0
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.5149e-05,-0.21721,-0.20417,1,0
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.036948,-0.21748,-0.15889,1,0
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.21769,-0.26093,1,0
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.018836,-0.21834,-0.1872,1,0
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0067808,-0.2186,-0.188,1,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.023741,-0.21892,-0.25559,1,0
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.044685,-0.21924,-0.23152,1,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00024286,-0.21992,-0.23488,1,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.018836,-0.22005,-0.2922,1,0
2,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0085714,-0.22029,-0.24136,1,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.013139,-0.22034,-0.24011,1,0
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0020453,-0.22041,-0.21338,1,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00014935,-0.22042,-0.22091,1,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00074557,-0.22052,-0.23118,1,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,6.7596e-05,-0.22062,-0.24206,1,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.0014738,-0.22117,-0.26106,1,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0042883,-0.22129,-0.15994,1,0
2,GO REGULATION OF MACROPHAGE MIGRATION,0.0050528,-0.22173,-0.1835,1,0
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.7343e-05,-0.22194,-0.24205,1,0
2,GO INTERLEUKIN 12 PRODUCTION,3.4728e-06,-0.22211,-0.29373,1,0
2,GO REGULATION OF CELL KILLING,4.8379e-05,-0.22214,-0.25679,1,0
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00063551,-0.22233,-0.19661,1,0
2,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0083534,-0.22244,-0.24134,1,0
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,5.8301e-05,-0.22287,-0.2445,1,0
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.011326,-0.22309,-0.29545,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.046579,-0.2238,-0.16822,1,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.017137,-0.22444,-0.21637,1,0
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.508e-06,-0.22459,-0.26358,1,0
2,GO MAMMARY GLAND MORPHOGENESIS,0.016734,-0.22463,-0.21877,1,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.012203,-0.2247,-0.24322,1,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0038387,-0.2247,-0.22273,1,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00021167,-0.22558,-0.22814,1,0
2,GO REGULATION OF CENTROSOME DUPLICATION,9.0179e-06,-0.22561,-0.22652,1,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00084609,-0.22566,-0.24754,1,0
2,GO MEMBRANE RAFT ORGANIZATION,0.015203,-0.22589,-0.30842,1,0
2,GO AUTOPHAGOSOME MATURATION,8.3127e-06,-0.22632,-0.24604,1,0
2,GO AMYLOID BETA CLEARANCE,0.00098941,-0.22633,-0.22719,1,0
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.8583e-05,-0.22652,-0.25966,1,0
2,GO PANCREAS DEVELOPMENT,0.00079435,-0.22667,-0.21684,1,0
2,GO ICOSANOID METABOLIC PROCESS,4.8612e-06,-0.22668,-0.29497,1,0
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.011326,-0.2269,-0.28724,1,0
2,GO HAIR CELL DIFFERENTIATION,0.00067758,-0.22705,-0.30225,1,0
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00018427,-0.22775,-0.31642,1,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.034637,-0.22817,-0.22697,1,0
2,GO EOSINOPHIL CHEMOTAXIS,0.015574,-0.22819,-0.32833,1,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.011047,-0.22869,-0.19893,1,0
2,GO EPITHELIAL CELL DIFFERENTIATION,1.349e-05,-0.22914,-0.21975,1,0
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0025083,-0.22917,-0.21106,1,0
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00019079,-0.22951,-0.28921,1,0
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00013433,-0.22958,-0.24524,1,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00018427,-0.22973,-0.26764,1,0
2,GO INTERFERON BETA PRODUCTION,7.8282e-05,-0.22975,-0.2223,1,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.0011199,-0.23004,-0.21837,1,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0014299,-0.23007,-0.22609,1,0
2,GO TISSUE REMODELING,0.00045924,-0.23097,-0.22321,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.8282e-05,-0.23157,-0.25202,1,0
2,GO T CELL MEDIATED IMMUNITY,0.00022676,-0.23181,-0.28114,1,0
2,GO LIVER MORPHOGENESIS,0.0060989,-0.23202,-0.26133,1,0
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.001872,-0.23253,-0.22796,1,0
2,GO SMOOTH MUSCLE CELL MIGRATION,6.5149e-05,-0.23294,-0.30385,1,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.011612,-0.23334,-0.22078,1,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.05161,-0.23341,-0.20904,1,0
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.4346e-05,-0.23393,-0.25058,1,0
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.02268,-0.23406,-0.20338,1,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0013457,-0.23426,-0.22204,1,0
2,GO REGULATION OF COAGULATION,0.00042998,-0.23454,-0.28661,1,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0018173,-0.23487,-0.22772,1,0
2,GO GLOMERULUS DEVELOPMENT,0.00040247,-0.23508,-0.27223,1,0
2,GO PIGMENT ACCUMULATION,0.00069957,-0.23533,-0.24213,1,0
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00011241,-0.23554,-0.26285,1,0
2,GO REGULATION OF RESPONSE TO WOUNDING,0.00016595,-0.2363,-0.24885,1,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.0032441,-0.23642,-0.22832,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.011326,-0.23688,-0.29969,1,0
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00084609,-0.23692,-0.31663,1,0
2,GO BILE ACID METABOLIC PROCESS,0.0001547,-0.23739,-0.24479,1,0
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0040578,-0.23753,-0.29836,1,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0099891,-0.23757,-0.19277,1,0
2,GO MULTIVESICULAR BODY ORGANIZATION,1.0311e-06,-0.23775,-0.24534,1,0
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.6455e-05,-0.23804,-0.24279,1,0
2,GO REGULATION OF BONE REMODELING,0.0059384,-0.23806,-0.20804,1,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.013798,-0.23846,-0.24683,1,0
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0011549,-0.2385,-0.23034,1,0
2,GO REGULATION OF B CELL DIFFERENTIATION,0.0016129,-0.23864,-0.21939,1,0
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.6584e-06,-0.23954,-0.27036,1,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0014738,-0.24015,-0.29273,1,0
2,GO REGULATION OF VIRAL LIFE CYCLE,9.3916e-06,-0.24069,-0.31282,1,0
2,GO RUFFLE ORGANIZATION,5.753e-07,-0.2416,-0.25942,1,0
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00023468,-0.24255,-0.22243,1,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.007729,-0.24275,-0.27836,1,0
2,GO REGULATION OF VIRAL GENOME REPLICATION,5.2139e-05,-0.24295,-0.32085,1,0
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.4421e-05,-0.24328,-0.26399,1,0
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00044439,-0.24388,-0.23842,1,0
2,GO REGULATION OF RECEPTOR BINDING,0.0051916,-0.24406,-0.24122,1,0
2,GO CELL CELL JUNCTION ORGANIZATION,3.4728e-06,-0.24465,-0.27055,1,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00049035,-0.24546,-0.21638,1,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.017549,-0.24561,-0.25071,1,0
2,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0053338,-0.24622,-0.29305,1,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0031536,-0.24657,-0.19922,1,0
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00069957,-0.2476,-0.32612,1,0
2,GO RUFFLE ASSEMBLY,7.889e-07,-0.24772,-0.25036,1,0
2,GO MAGNESIUM ION TRANSPORT,5.7413e-06,-0.24806,-0.30052,1,0
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00032948,-0.24865,-0.22503,1,0
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0013457,-0.24887,-0.22264,1,0
2,GO GLYCEROL ETHER METABOLIC PROCESS,0.00092958,-0.24896,-0.26571,1,0
2,GO NEGATIVE REGULATION OF CELL KILLING,0.016734,-0.24956,-0.38989,1,0
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00018427,-0.24982,-0.23766,1,0
2,GO INTERLEUKIN 6 PRODUCTION,1.0311e-06,-0.24986,-0.25164,1,0
2,GO SKIN DEVELOPMENT,3.1888e-05,-0.25008,-0.24267,1,0
2,GO INTERLEUKIN 8 PRODUCTION,3.4421e-05,-0.25161,-0.26375,1,0
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0067808,-0.25167,-0.24715,1,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00050664,-0.25182,-0.21858,1,0
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.040234,-0.25236,-0.22468,1,0
2,GO REGULATION OF EXOSOMAL SECRETION,5.7413e-06,-0.25266,-0.30234,1,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00016023,-0.25312,-0.30547,1,0
2,GO EOSINOPHIL MIGRATION,0.0039469,-0.25314,-0.33673,1,0
2,GO GLYCOSIDE METABOLIC PROCESS,0.040234,-0.25318,-0.31809,1,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.031748,-0.2535,-0.21394,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,8.2505e-07,-0.25363,-0.32642,1,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.03245,-0.25371,-0.31817,1,0
2,GO EPIDERMIS DEVELOPMENT,2.2524e-05,-0.2541,-0.2431,1,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00041602,-0.25555,-0.29162,1,0
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0038387,-0.25562,-0.29218,1,0
2,GO BIOLOGICAL PHASE,0.033166,-0.2559,-0.32727,1,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0001165,-0.25592,-0.26039,1,0
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0045306,-0.25629,-0.38517,1,0
2,GO GERMINAL CENTER FORMATION,0.017969,-0.25681,-0.28634,1,0
2,GO TRANSCYTOSIS,6.7596e-05,-0.25794,-0.24346,1,0
2,GO VIRAL RELEASE FROM HOST CELL,4.5813e-07,-0.25822,-0.27857,1,0
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0016129,-0.25925,-0.26186,1,0
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.5331e-06,-0.25932,-0.29812,1,0
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.016734,-0.26101,-0.26029,1,0
2,GO NECROTIC CELL DEATH,0.00069957,-0.26175,-0.24807,1,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0007696,-0.2618,-0.30188,1,0
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00013917,-0.26277,-0.25581,1,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,7.013e-05,-0.26277,-0.25226,1,0
2,GO EXTRACELLULAR VESICLE BIOGENESIS,4.4712e-06,-0.26339,-0.28481,1,0
2,GO ER OVERLOAD RESPONSE,0.033166,-0.26405,-0.20384,1,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00042998,-0.26408,-0.32444,1,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00012074,-0.26412,-0.24638,1,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.012203,-0.26518,-0.2249,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029782,-0.26547,-0.32186,1,0
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0010528,-0.26567,-0.28976,1,0
2,GO WATER HOMEOSTASIS,0.0010859,-0.2666,-0.24307,1,0
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0030654,-0.26752,-0.26249,1,0
2,GO ACTIN FILAMENT BASED TRANSPORT,0.00087311,-0.26765,-0.27725,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0099891,-0.26796,-0.43197,1,0
2,GO REGULATION OF WOUND HEALING,6.5149e-05,-0.26837,-0.28992,1,0
2,GO INTERLEUKIN 10 PRODUCTION,1.1964e-05,-0.26843,-0.2883,1,0
2,GO ENDOCARDIUM DEVELOPMENT,0.018398,-0.2693,-0.2307,1,0
2,GO LEFT RIGHT AXIS SPECIFICATION,0.0006154,-0.26939,-0.31114,1,0
2,GO INTERLEUKIN 13 PRODUCTION,0.0059384,-0.26991,-0.26897,1,0
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.3218e-05,-0.27,-0.25704,1,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0046564,-0.27219,-0.35907,1,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0018173,-0.27289,-0.32491,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.0576e-06,-0.27331,-0.32003,1,0
2,GO PROGRAMMED NECROTIC CELL DEATH,0.00036427,-0.27386,-0.27448,1,0
2,GO SIGNAL PEPTIDE PROCESSING,6.2786e-05,-0.27455,-0.35918,1,0
2,GO CELL CELL JUNCTION ASSEMBLY,1.8251e-06,-0.2747,-0.28631,1,0
2,GO GDP METABOLIC PROCESS,0.0099891,-0.27545,-0.23466,1,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,5.2533e-07,-0.27599,-0.30411,1,0
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0060989,-0.27599,-0.27453,1,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,4.1112e-06,-0.27697,-0.2946,1,0
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.019739,-0.27818,-0.22433,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.9532e-05,-0.27823,-0.2547,1,0
2,GO INTERLEUKIN 1 BETA PRODUCTION,6.2367e-06,-0.27843,-0.31747,1,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.02068,-0.2801,-0.36336,1,0
2,GO REGULATION OF PLATELET ACTIVATION,6.0504e-05,-0.28027,-0.3648,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00072223,-0.28173,-0.30843,1,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.7145e-05,-0.2822,-0.29097,1,0
2,GO ACTIN FILAMENT SEVERING,0.0047853,-0.2824,-0.31525,1,0
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,1.4674e-06,-0.28415,-0.31777,1,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,6.7596e-05,-0.28487,-0.29067,1,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.00014418,-0.2852,-0.26135,1,0
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00019079,-0.28537,-0.35242,1,0
2,GO DENDRITIC CELL DIFFERENTIATION,2.7343e-05,-0.28633,-0.34976,1,0
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0075304,-0.28692,-0.30594,1,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0081404,-0.28721,-0.20979,1,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00026903,-0.28802,-0.26272,1,0
2,GO INTERLEUKIN 1 PRODUCTION,2.2658e-06,-0.2884,-0.34316,1,0
2,GO PLATELET AGGREGATION,2.6307e-05,-0.28918,-0.28722,1,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,2.1702e-06,-0.28972,-0.2868,1,0
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00019079,-0.28997,-0.36913,1,0
2,GO POSITIVE REGULATION OF CELL SIZE,0.00012512,-0.29019,-0.33138,1,0
2,GO MUSCLE CELL MIGRATION,5.0226e-05,-0.29145,-0.2889,1,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00013433,-0.29179,-0.3439,1,0
2,GO INTESTINAL ABSORPTION,0.00014935,-0.29193,-0.32136,1,0
2,GO OLIGOPEPTIDE TRANSPORT,0.0013872,-0.29235,-0.36432,1,0
2,GO HETEROTYPIC CELL CELL ADHESION,3.0576e-06,-0.29252,-0.34378,1,0
2,GO REGULATION OF INTEGRIN ACTIVATION,0.00010462,-0.29321,-0.32558,1,0
2,GO HOMOTYPIC CELL CELL ADHESION,4.1617e-05,-0.29375,-0.31832,1,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.027803,-0.29423,-0.30208,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,7.0571e-06,-0.29463,-0.30316,1,0
2,GO SPLEEN DEVELOPMENT,1.4044e-06,-0.29584,-0.28265,1,0
2,GO OSTEOBLAST PROLIFERATION,0.00010462,-0.29629,-0.3177,1,0
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,9.0179e-06,-0.29686,-0.29205,1,0
2,GO DECIDUALIZATION,0.0038387,-0.29723,-0.29606,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.9904e-06,-0.29804,-0.33319,1,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00038934,-0.2983,-0.32016,1,0
2,GO ANOIKIS,1.104e-05,-0.29847,-0.32652,1,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.020205,-0.29852,-0.27063,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00054072,-0.29897,-0.33388,1,0
2,GO CELLULAR RESPONSE TO COPPER ION,0.019283,-0.29926,-0.345,1,0
2,GO T HELPER CELL LINEAGE COMMITMENT,4.8379e-05,-0.30004,-0.27867,1,0
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0075304,-0.30162,-0.26013,1,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0028957,-0.3024,-0.25799,1,0
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0054795,-0.30381,-0.29111,1,0
2,GO ALPHA BETA T CELL PROLIFERATION,1.7806e-05,-0.30409,-0.34839,1,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0059384,-0.30429,-0.41633,1,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00042998,-0.30511,-0.32144,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,3.9926e-07,-0.3054,-0.31235,1,0
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.017137,-0.30542,-0.47191,1,0
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00037661,-0.30585,-0.29082,1,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0079323,-0.30608,-0.25945,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.7145e-05,-0.30622,-0.36877,1,0
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,3.3132e-05,-0.30958,-0.33903,1,0
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.0087944,-0.31152,-0.43355,1,0
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,6.2367e-06,-0.31241,-0.29558,1,0
2,GO RESPONSE TO NITROSATIVE STRESS,0.00010092,-0.31387,-0.41922,1,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.011612,-0.3153,-0.23936,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,9.7801e-06,-0.316,-0.30444,1,0
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0010528,-0.31782,-0.3985,1,0
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.014138,-0.31831,-0.24614,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.2754e-05,-0.3189,-0.30745,1,0
2,GO NATURAL KILLER CELL PROLIFERATION,0.00022676,-0.31933,-0.35296,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00012512,-0.31948,-0.27264,1,0
2,GO EMBRYONIC PLACENTA DEVELOPMENT,2.5774e-06,-0.32067,-0.35368,1,0
2,GO BARBED END ACTIN FILAMENT CAPPING,0.00013433,-0.32067,-0.4067,1,0
2,GO ETHER METABOLIC PROCESS,0.00024286,-0.32158,-0.3238,1,0
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0081404,-0.32171,-0.29305,1,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.00013433,-0.32177,-0.30842,1,0
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00010092,-0.32231,-0.41032,1,0
2,GO REGULATION OF NECROTIC CELL DEATH,0.00022676,-0.32293,-0.31857,1,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00029782,-0.32306,-0.3267,1,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0053338,-0.32368,-0.23044,1,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00087311,-0.32478,-0.33323,1,0
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,2.4346e-05,-0.32514,-0.37414,1,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.17e-07,-0.32574,-0.36739,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.906e-06,-0.32644,-0.35873,1,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,9.0551e-05,-0.32649,-0.49659,1,0
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0062634,-0.32858,-0.25416,1,0
2,GO KERATINOCYTE DEVELOPMENT,0.025414,-0.33042,-0.28399,1,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.031059,-0.33255,-0.23364,1,0
2,GO BILE ACID AND BILE SALT TRANSPORT,3.5759e-05,-0.33346,-0.36409,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,9.3916e-06,-0.33422,-0.36738,1,0
2,GO PROGESTERONE METABOLIC PROCESS,0.00044439,-0.3345,-0.46742,1,0
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00063551,-0.33785,-0.39231,1,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.8301e-05,-0.33818,-0.3144,1,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,1.4044e-06,-0.33845,-0.33214,1,0
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0010206,-0.33953,-0.36921,1,0
2,GO SUPEROXIDE ANION GENERATION,0.00017186,-0.34021,-0.32774,1,0
2,GO TRANSPOSITION,1.7118e-05,-0.34022,-0.41665,1,0
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0019282,-0.34024,-0.27362,1,0
2,GO ZYMOGEN INHIBITION,0.00018427,-0.34126,-0.40275,1,0
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.00054072,-0.3422,-0.34746,1,0
2,GO RESPONSE TO INTERFERON ALPHA,0.0024367,-0.34261,-0.46016,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,4.3218e-05,-0.34314,-0.35544,1,0
2,GO PROSTANOID METABOLIC PROCESS,2.3418e-05,-0.34391,-0.43093,1,0
2,GO DETECTION OF OTHER ORGANISM,4.3218e-05,-0.34508,-0.39188,1,0
2,GO IMMUNOLOGICAL MEMORY PROCESS,8.1192e-05,-0.34512,-0.34359,1,0
2,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.0069616,-0.34711,-0.41594,1,0
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,6.7596e-05,-0.34729,-0.42145,1,0
2,GO LIPID TRANSLOCATION,1.8251e-06,-0.34769,-0.32187,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,8.1192e-05,-0.34789,-0.33195,1,0
2,GO EPIDERMAL CELL DIFFERENTIATION,9.7801e-06,-0.34994,-0.32441,1,0
2,GO HISTAMINE SECRETION,0.004408,-0.35224,-0.34449,1,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,5.2533e-07,-0.35314,-0.34367,1,0
2,GO MITOTIC CYTOKINETIC PROCESS,5.1671e-08,-0.35462,-0.38135,1,0
2,GO KERATINOCYTE DIFFERENTIATION,1.104e-05,-0.35542,-0.33714,1,0
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0021062,-0.35735,-0.34442,1,0
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.8891e-07,-0.35749,-0.37725,1,0
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0016129,-0.35752,-0.4848,1,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,7.2754e-05,-0.35926,-0.38583,1,0
2,GO PROTEIN ADP RIBOSYLATION,1.1493e-05,-0.35936,-0.31088,1,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,7.0571e-06,-0.35948,-0.3418,1,0
2,GO POSITIVE REGULATION OF COAGULATION,2.8077e-06,-0.35968,-0.36426,1,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.0039469,-0.35989,-0.27633,1,0
2,GO VIRAL BUDDING,4.1802e-07,-0.36018,-0.30959,1,0
2,GO REGULATION OF ANOIKIS,3.5759e-05,-0.36079,-0.41494,1,0
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0014299,-0.36235,-0.41913,1,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00016595,-0.36442,-0.39438,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0079323,-0.36585,-0.46838,1,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,5.4977e-07,-0.36655,-0.37184,1,0
2,GO HEPATOCYTE DIFFERENTIATION,0.00072223,-0.36744,-0.33667,1,0
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,4.0073e-05,-0.36865,-0.39858,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0021062,-0.36881,-0.41526,1,0
2,GO RESPONSE TO INTERFERON BETA,0.0015189,-0.36925,-0.47942,1,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,5.2837e-06,-0.36938,-0.38245,1,0
2,GO ADRENAL GLAND DEVELOPMENT,0.00045924,-0.36996,-0.30908,1,0
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00016595,-0.3702,-0.37092,1,0
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,7.3528e-06,-0.37291,-0.4365,1,0
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00027832,-0.37409,-0.36678,1,0
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.6455e-05,-0.37503,-0.39173,1,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.0010528,-0.37541,-0.29342,1,0
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,2.9532e-05,-0.37623,-0.38386,1,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.035393,-0.37892,-0.28382,1,0
2,GO GAP JUNCTION ASSEMBLY,3.8583e-05,-0.37954,-0.47572,1,0
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.4039e-05,-0.37995,-0.37162,1,0
2,GO RESPONSE TO MUSCLE INACTIVITY,2.9532e-05,-0.38095,-0.37791,1,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.00028792,-0.38116,-0.38153,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.9263e-05,-0.3813,-0.36927,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,3.3132e-05,-0.38141,-0.47901,1,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0014738,-0.38151,-0.48088,1,0
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.5201e-05,-0.3827,-0.38461,1,0
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00017186,-0.38724,-0.38847,1,0
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.2879e-07,-0.38762,-0.46097,1,0
2,GO POSITIVE REGULATION OF CELL MATURATION,7.8282e-05,-0.38891,-0.42751,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,6.0504e-05,-0.38909,-0.49545,1,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00092958,-0.39007,-0.34123,1,0
2,GO INTERFERON ALPHA PRODUCTION,9.4334e-07,-0.39028,-0.38184,1,0
2,GO TOXIN METABOLIC PROCESS,0.010506,-0.39189,-0.28136,1,0
2,GO DNA DEAMINATION,0.001191,-0.39408,-0.37956,1,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.5816e-05,-0.3966,-0.39359,1,0
2,GO RESPONSE TO TYPE I INTERFERON,1.5816e-05,-0.3972,-0.51811,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.0194e-07,-0.40082,-0.44143,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,3.0689e-05,-0.40384,-0.38688,1,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,2.5774e-06,-0.40399,-0.41128,1,0
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,3.3287e-06,-0.40454,-0.44126,1,0
2,GO INFLAMMATORY RESPONSE TO WOUNDING,0.038561,-0.40676,-0.32394,1,0
2,GO PARAXIAL MESODERM DEVELOPMENT,0.00040247,-0.4106,-0.35141,1,0
2,GO VASCULAR TRANSPORT,0.00032948,-0.41351,-0.43145,1,0
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,4.6623e-06,-0.41442,-0.5307,1,0
2,GO REGULATION OF PLATELET AGGREGATION,7.8282e-05,-0.41461,-0.4927,1,0
2,GO REGULATION OF TRANSPOSITION,7.9801e-06,-0.4174,-0.47822,1,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,3.1888e-05,-0.41765,-0.35528,1,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,2.2879e-07,-0.41917,-0.37594,1,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0025817,-0.41948,-0.3296,1,0
2,GO TOLERANCE INDUCTION,0.00035231,-0.41976,-0.4532,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,6.4994e-06,-0.42159,-0.52534,1,0
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,6.2786e-05,-0.42252,-0.46546,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,1.6015e-06,-0.4252,-0.49017,1,0
2,GO KERATINIZATION,2.7343e-05,-0.42753,-0.36981,1,0
2,GO POSITIVE REGULATION OF WOUND HEALING,5.2533e-07,-0.42842,-0.47284,1,0
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,3.7145e-05,-0.4294,-0.39364,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,8.1192e-05,-0.4321,-0.41443,1,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,1.2366e-07,-0.43419,-0.49423,1,0
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00013917,-0.43491,-0.44366,1,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.00017796,-0.43898,-0.42635,1,0
2,GO LEYDIG CELL DIFFERENTIATION,0.001986,-0.44113,-0.40441,1,0
2,GO REGULATION OF TOLERANCE INDUCTION,2.6902e-06,-0.44317,-0.50979,1,0
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.4268e-07,-0.44578,-0.45789,1,0
2,GO RESPONSE TO INTERLEUKIN 18,0.00017796,-0.44644,-0.5171,1,0
2,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0012662,-0.45043,-0.52504,1,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.7801e-06,-0.45496,-0.55607,1,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00042998,-0.45839,-0.45926,1,0
2,GO CORNIFICATION,3.5759e-05,-0.45883,-0.41776,1,0
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,5.0226e-05,-0.45926,-0.63387,1,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,7.2754e-05,-0.46042,-0.40321,1,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,5.7413e-06,-0.46129,-0.46877,1,0
2,GO LABYRINTHINE LAYER DEVELOPMENT,1.2962e-05,-0.46211,-0.39934,1,0
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00017186,-0.46555,-0.43602,1,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00065623,-0.46852,-0.37734,1,0
2,GO RESPONSE TO WATER,6.7596e-05,-0.46905,-0.42596,1,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0013872,-0.4696,-0.39297,1,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0833e-05,-0.47305,-0.4793,1,0
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,5.508e-06,-0.47602,-0.47528,1,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.00036427,-0.48016,-0.39339,1,0
2,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,1.1964e-05,-0.48384,-0.45744,1,0
2,GO MIDBODY ABSCISSION,1.5691e-07,-0.48641,-0.48507,1,0
2,GO RESPONSE TO LITHIUM ION,3.7145e-05,-0.49709,-0.47986,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00095906,-0.50367,-0.36502,1,0
2,GO RESPONSE TO FORSKOLIN,4.2876e-06,-0.50527,-0.46257,1,0
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,9.3916e-06,-0.50832,-0.45937,1,0
2,GO SEROTONIN METABOLIC PROCESS,0.011326,-0.50881,-0.31563,1,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00050664,-0.52989,-0.49198,1,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.6597e-05,-0.5309,-0.47422,1,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,5.6174e-05,-0.53712,-0.45348,1,0
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0045306,-0.53873,-0.35833,1,0
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,5.2837e-06,-0.55036,-0.52776,1,0
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,2.2524e-05,-0.55124,-0.4387,1,0
2,GO EPITHELIAL CELL MORPHOGENESIS,4.1112e-06,-0.5572,-0.53601,1,0
2,GO APICAL JUNCTION ASSEMBLY,4.9191e-08,-0.56098,-0.52845,1,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.00021909,-0.56212,-0.45463,1,0
2,GO REGULATION OF WATER LOSS VIA SKIN,0.00032948,-0.57307,-0.47633,1,0
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.4712e-06,-0.57605,-0.58621,1,0
2,GO NEGATIVE REGULATION OF ANOIKIS,2.8077e-06,-0.57759,-0.60574,1,0
2,GO ENTRY OF BACTERIUM INTO HOST CELL,2.3418e-05,-0.57882,-0.57934,1,0
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.389e-05,-0.58673,-0.52029,1,0
2,GO PSEUDOPODIUM ORGANIZATION,0.00020448,-0.5905,-0.44339,1,0
2,GO GAMMA DELTA T CELL ACTIVATION,1.4044e-06,-0.59862,-0.56138,1,0
2,GO MUCUS SECRETION,0.00084609,-0.60014,-0.52376,1,0
2,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,2.1702e-06,-0.61866,-0.60316,1,0
2,GO CYTIDINE TO URIDINE EDITING,0.0001165,-0.61921,-0.65655,1,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,6.4994e-06,-0.63775,-0.59594,1,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,4.3218e-05,-0.64222,-0.63275,1,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,7.2754e-05,-0.64706,-0.7541,1,0
2,GO LUNG CELL DIFFERENTIATION,0.00012074,-0.65646,-0.51701,1,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,8.3127e-06,-0.66246,-0.65678,1,0
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,9.4334e-07,-0.67958,-0.63089,1,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.6322e-07,-0.74931,-0.65572,1,0
2,GO LIPID DROPLET FORMATION,7.3528e-06,-0.767,-0.68572,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,6.0504e-05,-0.8094,-0.88752,1,0
2,GO NOSE DEVELOPMENT,0.0001547,-0.96706,-0.65925,1,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,5.0194e-07,-0.96787,-0.81736,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,7.8282e-05,-0.99536,-1.0952,1,0
2,GO HEPATOCYTE APOPTOTIC PROCESS,1.8084e-07,-0.99605,-1.0676,1,0
2,GO LABYRINTHINE LAYER MORPHOGENESIS,3.0264e-07,-1.0047,-0.89157,1,0
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,1.2308e-06,-1.1075,-0.9977,1,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.14048,0.3332,0.13527,0,1
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.060602,0.30348,0.18271,0,1
2,GO GLYCINE METABOLIC PROCESS,0.054842,0.29931,0.20115,0,1
2,GO TOOTH MINERALIZATION,0.075049,0.29597,0.14282,0,1
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.054842,0.29297,0.1712,0,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.10465,0.27498,0.12566,0,1
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.11235,0.2487,0.20634,0,1
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.054842,0.24402,0.13174,0,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.079444,0.23858,0.17847,0,1
2,GO THALAMUS DEVELOPMENT,0.42347,0.211,0.095315,0,1
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.29586,0.20077,0.089066,0,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.14285,0.19643,0.11303,0,1
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.10654,0.19335,0.18023,0,1
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.30402,0.18828,0.071766,0,1
2,GO RESPONSE TO VITAMIN A,0.15015,0.18388,0.10886,0,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.12908,0.18381,0.11776,0,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.065563,0.17947,0.11335,0,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.092194,0.1745,0.11047,0,1
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.20937,0.16977,0.091043,0,1
2,GO ODONTOGENESIS,0.13814,0.16051,0.075846,0,1
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.061812,0.15431,0.10314,0,1
2,GO NUCLEUS LOCALIZATION,0.082489,0.15271,0.095375,0,1
2,GO NERVE DEVELOPMENT,0.11841,0.15175,0.09633,0,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.26098,0.14593,0.088138,0,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.11235,0.13913,0.10017,0,1
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.10096,0.13825,0.077172,0,1
2,GO MESODERMAL CELL FATE COMMITMENT,0.28785,0.13813,0.055579,0,1
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.060602,0.13743,0.11847,0,1
2,GO T CELL HOMEOSTASIS,0.12689,0.13464,0.053061,0,1
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.075049,0.12975,0.11657,0,1
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.20937,0.12905,0.064557,0,1
2,GO AORTIC VALVE DEVELOPMENT,0.18508,0.12903,0.083409,0,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.52594,0.12846,0.04104,0,1
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.13583,0.12709,0.104,0,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.057089,0.12452,0.17914,0,1
2,GO SMOOTH MUSCLE CONTRACTION,0.11636,0.12434,0.063471,0,1
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.11039,0.12311,0.08545,0,1
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.093897,0.12094,0.068757,0,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.19695,0.12009,0.063184,0,1
2,GO RESPONSE TO LIGHT INTENSITY,0.14769,0.12009,0.1245,0,1
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.099158,0.11908,0.091544,0,1
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.16294,0.11889,0.09017,0,1
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.10096,0.11796,0.079862,0,1
2,GO MITOCHONDRIAL RNA PROCESSING,0.070855,0.11661,0.15768,0,1
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.053746,0.11627,0.18126,0,1
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.30402,0.11099,0.064195,0,1
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.25001,0.11002,0.084059,0,1
2,GO SLEEP,0.29184,0.10954,0.05629,0,1
2,GO HEART VALVE DEVELOPMENT,0.27227,0.10804,0.063939,0,1
2,GO ALDEHYDE CATABOLIC PROCESS,0.064293,0.10773,0.10406,0,1
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.26847,0.10608,0.07133,0,1
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.076492,0.1043,0.078154,0,1
2,GO REGULATION OF METAL ION TRANSPORT,0.082489,0.10141,0.067514,0,1
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.17099,0.10112,0.059583,0,1
2,GO RESPONSE TO LEAD ION,0.2,0.099167,0.066486,0,1
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.10654,0.096015,0.079689,0,1
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.070855,0.095187,0.082986,0,1
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.070855,0.093583,0.11512,0,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.095625,0.091975,0.14316,0,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.12908,0.091841,0.068493,0,1
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.14769,0.090338,0.086928,0,1
2,GO RRNA 3 END PROCESSING,0.1313,0.090271,0.099363,0,1
2,GO CELLULAR RESPONSE TO UV,0.090515,0.086893,0.060283,0,1
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.30815,0.085366,0.044127,0,1
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.093897,0.083683,0.095142,0,1
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.11434,0.082719,0.083548,0,1
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.25363,0.081677,0.04365,0,1
2,GO REGULATION OF PROTEIN TARGETING,0.059411,0.080954,0.067854,0,1
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.3746,0.078174,0.024524,0,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.082489,0.076793,0.056017,0,1
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.55487,0.076436,0.026264,0,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.17653,0.075733,0.040967,0,1
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.77618,0.074206,-0.012709,0,1
2,GO HISTONE H3 K36 METHYLATION,0.51459,0.07244,0.031562,0,1
2,GO ESTROGEN BIOSYNTHETIC PROCESS,0.60272,0.070872,0.029586,0,1
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.37932,0.069578,0.054866,0,1
2,GO RECOMBINATIONAL REPAIR,0.084046,0.066379,0.049275,0,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.063042,0.064006,0.038941,0,1
2,GO MISMATCH REPAIR,0.26098,0.061634,0.040266,0,1
2,GO PRENYLATION,0.43883,0.060469,0.026651,0,1
2,GO HISTONE DEUBIQUITINATION,0.22905,0.058474,0.029267,0,1
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.17934,0.057919,0.052955,0,1
2,GO CHROMOSOME CONDENSATION,0.10465,0.056019,0.064779,0,1
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.25363,0.050937,0.02684,0,1
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.11434,0.050566,0.041946,0,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.16828,0.043899,0.12862,0,1
2,GO DNA REPAIR,0.077957,0.037393,0.035463,0,1
2,GO TORC1 SIGNALING,0.088862,0.033763,0.062223,0,1
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.17099,0.0333,0.029814,0,1
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,2.3418e-05,0.58202,0.62154,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00059588,0.56333,0.5821,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.020205,0.4197,0.32519,0,0
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.010773,0.38101,0.2694,0,0
2,GO ANATOMICAL STRUCTURE REGRESSION,0.0049174,0.37793,0.30971,0,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,9.0551e-05,0.37466,0.4369,0,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00028792,0.37316,0.34224,0,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.00090094,0.36122,0.49279,0,0
2,GO SHORT TERM MEMORY,0.0022332,0.35017,0.32134,0,0
2,GO LIMB BUD FORMATION,0.015203,0.33666,0.37697,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,2.1663e-05,0.32993,0.32988,0,0
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.079444,0.32819,0.20651,0,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.053746,0.31706,0.17246,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.027188,0.31677,0.24137,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0047853,0.3128,0.27844,0,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00042998,0.30979,0.37234,0,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00017186,0.30909,0.303,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0073363,0.30895,0.2251,0,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0010528,0.30801,0.47087,0,0
2,GO REGULATION OF HIPPO SIGNALING,0.087232,0.30609,0.1616,0,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.21256,0.29727,0.11575,0,0
2,GO PHAGOCYTOSIS RECOGNITION,0.052669,0.29655,0.16095,0,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.031748,0.29573,0.37958,0,0
2,GO PENTOSE METABOLIC PROCESS,0.0037331,0.2933,0.23187,0,0
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00044439,0.29292,0.22038,0,0
2,GO EMBRYONIC BRAIN DEVELOPMENT,8.1192e-05,0.29082,0.31637,0,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0075304,0.28483,0.24571,0,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0057817,0.28372,0.27887,0,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0010859,0.28339,0.25764,0,0
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.015953,0.28339,0.195,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0027346,0.28208,0.29485,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0064317,0.27528,0.21508,0,0
2,GO GLUTAMATE SECRETION,0.00029782,0.27482,0.30144,0,0
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00016023,0.27422,0.2883,0,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0010859,0.27257,0.30115,0,0
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.077957,0.2721,0.20978,0,0
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.018398,0.27165,0.20893,0,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.012203,0.2705,0.32617,0,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,9.0551e-05,0.2694,0.31875,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.013465,0.26825,0.30375,0,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0031536,0.26779,0.27331,0,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.019739,0.2609,0.27203,0,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.2,0.25982,0.18244,0,0
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.0038387,0.25753,0.34078,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0053338,0.25352,0.22196,0,0
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.00035231,0.24686,0.23419,0,0
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0051916,0.24683,0.26074,0,0
2,GO REGULATION OF DOPAMINE SECRETION,0.025414,0.24193,0.30834,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0015653,0.2416,0.24139,0,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,2.0033e-05,0.2415,0.25324,0,0
2,GO NEUROTRANSMITTER UPTAKE,0.0012662,0.23757,0.23734,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0056288,0.23754,0.21434,0,0
2,GO RESPONSE TO HYPEROXIA,0.21905,0.23675,0.093777,0,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.033166,0.2364,0.23571,0,0
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0026572,0.23251,0.2819,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.034637,0.2307,0.16896,0,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,6.7596e-05,0.22515,0.29582,0,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.097379,0.22447,0.14673,0,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,3.1888e-05,0.22368,0.30447,0,0
2,GO SYNAPTIC VESICLE DOCKING,0.023741,0.22255,0.26474,0,0
2,GO LONG TERM SYNAPTIC DEPRESSION,0.0087944,0.2208,0.20689,0,0
2,GO ENAMEL MINERALIZATION,0.19393,0.22049,0.12673,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.05824,0.21712,0.14067,0,0
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0027346,0.2165,0.26938,0,0
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0073363,0.21512,0.19907,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.095625,0.21504,0.16926,0,0
2,GO NEURON RECOGNITION,0.014841,0.21085,0.20202,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.097379,0.21014,0.1369,0,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00021909,0.20953,0.26645,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.05824,0.2088,0.19463,0,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.00016023,0.20566,0.23771,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.1028,0.20502,0.1412,0,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0056288,0.20426,0.24748,0,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.036948,0.20256,0.14063,0,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0062634,0.20156,0.21024,0,0
2,GO NEUROBLAST DIVISION,0.10465,0.20113,0.16202,0,0
2,GO NEPHRIC DUCT MORPHOGENESIS,0.0695,0.20112,0.27288,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0079323,0.20082,0.20231,0,0
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.3746,0.20026,0.1234,0,0
2,GO SEROTONIN TRANSPORT,0.092194,0.19987,0.13843,0,0
2,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.066855,0.19852,0.15497,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.12689,0.19843,0.1108,0,0
2,GO AMP METABOLIC PROCESS,0.14769,0.19832,0.097326,0,0
2,GO GLUCOSE CATABOLIC PROCESS,0.011612,0.19776,0.2154,0,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0022332,0.1974,0.26312,0,0
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.064293,0.197,0.15482,0,0
2,GO CGMP MEDIATED SIGNALING,0.022165,0.19695,0.13884,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.015203,0.19653,0.20902,0,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.014138,0.19562,0.16247,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.15773,0.19313,0.1908,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.26471,0.19306,0.087065,0,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00024286,0.19188,0.24956,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.01282,0.18917,0.28102,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.31232,0.18914,0.10494,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0060989,0.1887,0.20607,0,0
2,GO AXONAL FASCICULATION,0.066855,0.18785,0.20241,0,0
2,GO RESPONSE TO MANGANESE ION,0.095625,0.18754,0.10711,0,0
2,GO NEURAL CREST CELL MIGRATION,0.064293,0.18719,0.12956,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.2839,0.18712,0.13208,0,0
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.18219,0.18645,0.15957,0,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0013054,0.18509,0.20822,0,0
2,GO COCHLEA MORPHOGENESIS,0.070855,0.185,0.11256,0,0
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.25001,0.18443,0.067083,0,0
2,GO RESPONSE TO MUSCLE ACTIVITY,0.11434,0.18411,0.11316,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.013139,0.18303,0.13074,0,0
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0695,0.18298,0.16604,0,0
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.013798,0.18278,0.18877,0,0
2,GO NEURON PROJECTION GUIDANCE,0.0056288,0.18235,0.16389,0,0
2,GO PRESYNAPSE ORGANIZATION,0.007729,0.18186,0.20793,0,0
2,GO MICROTUBULE DEPOLYMERIZATION,0.030383,0.18146,0.16576,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS,0.15264,0.18144,0.16619,0,0
2,GO BEHAVIORAL RESPONSE TO PAIN,0.18508,0.18137,0.13887,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.049546,0.18136,0.15569,0,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.045624,0.18131,0.1476,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0099891,0.18129,0.18737,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.12473,0.18122,0.10465,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.19095,0.1812,0.11729,0,0
2,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.055956,0.17964,0.1357,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.012203,0.17899,0.17322,0,0
2,GO NEUROTRANSMITTER TRANSPORT,0.00084609,0.17881,0.23235,0,0
2,GO NEURON PROJECTION EXTENSION,0.00065623,0.1778,0.17702,0,0
2,GO ALDITOL METABOLIC PROCESS,0.0056288,0.17726,0.17885,0,0
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.1313,0.17674,0.16827,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00069957,0.17671,0.2571,0,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0081404,0.17668,0.20275,0,0
2,GO ACIDIC AMINO ACID TRANSPORT,0.00014935,0.17661,0.21319,0,0
2,GO LONG TERM MEMORY,0.0041716,0.17645,0.19976,0,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.1313,0.17567,0.12315,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.092194,0.17496,0.12255,0,0
2,GO MIDDLE EAR MORPHOGENESIS,0.41341,0.17478,0.035279,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.13583,0.17471,0.16587,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.21256,0.17362,0.047425,0,0
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.20309,0.17338,0.15988,0,0
2,GO RELAXATION OF MUSCLE,0.082489,0.17281,0.12867,0,0
2,GO PROSTATE GLAND GROWTH,0.17099,0.17216,0.068806,0,0
2,GO LEUKOCYTE AGGREGATION,0.077957,0.17168,0.13519,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.51459,0.17098,0.078423,0,0
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.077957,0.17053,0.092339,0,0
2,GO MINERALOCORTICOID METABOLIC PROCESS,0.22905,0.17035,0.096224,0,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.043763,0.17035,0.16556,0,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0011549,0.17007,0.27365,0,0
2,GO NEUROTRANSMITTER SECRETION,0.0013054,0.16961,0.24314,0,0
2,GO NADH METABOLIC PROCESS,0.0020453,0.16892,0.23118,0,0
2,GO HEME METABOLIC PROCESS,0.13814,0.16832,0.099533,0,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0073363,0.1681,0.19008,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.059411,0.16806,0.13846,0,0
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.092194,0.16715,0.09528,0,0
2,GO FATTY ACID HOMEOSTASIS,0.044685,0.16644,0.20355,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0075304,0.16634,0.16894,0,0
2,GO FIBROBLAST APOPTOTIC PROCESS,0.099158,0.1652,0.11653,0,0
2,GO RESPONSE TO ACETYLCHOLINE,0.04854,0.16384,0.18446,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.10654,0.163,0.088909,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.13583,0.16295,0.09286,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,0.16219,0.099699,0,0
2,GO DENDRITE MORPHOGENESIS,0.0014738,0.16149,0.18245,0,0
2,GO RESPONSE TO AMINE,0.0094949,0.16148,0.17707,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.082489,0.16141,0.11853,0,0
2,GO RECEPTOR CLUSTERING,0.065563,0.16141,0.10745,0,0
2,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.12908,0.16023,0.13459,0,0
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.18508,0.16014,0.11315,0,0
2,GO RESPONSE TO PROTOZOAN,0.55487,0.15933,0.020455,0,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.11235,0.1591,0.15054,0,0
2,GO HEPARIN METABOLIC PROCESS,0.045624,0.15858,0.22973,0,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00081984,0.15747,0.20098,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.015203,0.15686,0.17096,0,0
2,GO NEURONAL ION CHANNEL CLUSTERING,0.1313,0.15494,0.20744,0,0
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.060602,0.15474,0.11877,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.20937,0.15455,0.1298,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.30815,0.15376,0.0535,0,0
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.13814,0.15332,0.096099,0,0
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.015203,0.15295,0.097831,0,0
2,GO VASCULOGENESIS,0.32077,0.15279,0.034338,0,0
2,GO RESPONSE TO CAFFEINE,0.10096,0.15263,0.1189,0,0
2,GO PROTEIN DEMETHYLATION,0.037747,0.15217,0.11321,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.029068,0.15185,0.30318,0,0
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.042857,0.15178,0.12137,0,0
2,GO DENDRITE DEVELOPMENT,0.00087311,0.15132,0.17742,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.010506,0.14997,0.14022,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.15517,0.14983,0.13446,0,0
2,GO MEMBRANE REPOLARIZATION,0.014138,0.14965,0.13738,0,0
2,GO XENOBIOTIC TRANSPORT,0.23937,0.14962,0.036327,0,0
2,GO AXON EXTENSION,0.0028957,0.14933,0.15833,0,0
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.043763,0.14864,0.13656,0,0
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.072231,0.14838,0.1029,0,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.014486,0.14824,0.12566,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.12908,0.14773,0.09882,0,0
2,GO BONE MORPHOGENESIS,0.10654,0.1475,0.072442,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.054842,0.14706,0.17956,0,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,0.0046564,0.14683,0.19829,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.68418,0.14644,0.042439,0,0
2,GO COLLATERAL SPROUTING,0.02843,0.14592,0.15473,0,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.34702,0.14582,0.067119,0,0
2,GO BONE TRABECULA MORPHOGENESIS,0.12259,0.14555,0.1142,0,0
2,GO MUSCLE CELL FATE COMMITMENT,0.2839,0.14515,0.061047,0,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.047551,0.14515,0.10055,0,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.013798,0.14497,0.14402,0,0
2,GO FIBRINOLYSIS,0.27227,0.14489,-0.014555,0,0
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0026572,0.14459,0.15038,0,0
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.084046,0.14438,0.14979,0,0
2,GO DEVELOPMENTAL CELL GROWTH,0.00074557,0.14342,0.149,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.16294,0.14334,0.094518,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.20621,0.14262,0.15547,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.47588,0.14236,-0.15827,0,0
2,GO PROTEIN ACTIVATION CASCADE,0.68418,0.14226,-0.019158,0,0
2,GO REGULATION OF AXON GUIDANCE,0.059411,0.14205,0.091043,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.18219,0.14187,0.077712,0,0
2,GO LIPID IMPORT INTO CELL,0.27999,0.14127,0.061506,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.24643,0.14089,0.051468,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.04854,0.13973,0.12553,0,0
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.031059,0.1397,0.13311,0,0
2,GO REGULATION OF AXONOGENESIS,0.012203,0.13962,0.14762,0,0
2,GO CELL AGGREGATION,0.073629,0.13892,0.10884,0,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0011549,0.13884,0.15637,0,0
2,GO ALANINE TRANSPORT,0.14048,0.13877,0.13747,0,0
2,GO RESPONSE TO UV B,0.89215,0.13872,-0.044541,0,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.26471,0.13871,0.055067,0,0
2,GO DNA REPLICATION INITIATION,0.0018173,0.13857,0.14311,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.097379,0.13833,0.14589,0,0
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00047456,0.13806,0.24592,0,0
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.47049,0.13733,-0.044057,0,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.033894,0.13709,0.18228,0,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0033369,0.13635,0.21006,0,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.13583,0.13599,0.14502,0,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.009256,0.13573,0.11999,0,0
2,GO PARENTAL BEHAVIOR,0.27611,0.13494,0.093322,0,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0090226,0.13417,0.19615,0,0
2,GO STARTLE RESPONSE,0.22235,0.13404,0.12204,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0026572,0.13383,0.1528,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.092194,0.1338,0.0909,0,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.18219,0.13362,0.096613,0,0
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0038387,0.13277,0.1505,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.004408,0.13276,0.139,0,0
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.15773,0.13179,0.072583,0,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.04854,0.13163,0.11612,0,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.0030654,0.13151,0.15901,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.064293,0.1315,0.14118,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.11841,0.13124,0.05568,0,0
2,GO PROTEIN OXIDATION,0.12049,0.13088,0.072808,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.17374,0.13022,0.10472,0,0
2,GO PRESYNAPTIC ENDOCYTOSIS,0.034637,0.13006,0.14386,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.20621,0.12996,0.08712,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.085627,0.12959,0.12237,0,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.054842,0.12954,0.15753,0,0
2,GO REGULATION OF STEROL TRANSPORT,0.49227,0.12951,0.027337,0,0
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.27999,0.1293,0.10607,0,0
2,GO REGULATION OF MEMBRANE POTENTIAL,0.02166,0.12912,0.12848,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.54903,0.12856,0.062475,0,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0695,0.1279,0.11656,0,0
2,GO CATECHOLAMINE UPTAKE,0.16828,0.12781,0.13783,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.019739,0.12764,0.15135,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0010528,0.12762,0.16732,0,0
2,GO SYNAPTIC SIGNALING,0.001986,0.12747,0.172,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.27611,0.12734,0.10221,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.8303,0.1273,0.00708,0,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0025083,0.12726,0.12677,0,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.077957,0.12711,0.08124,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.064293,0.12701,0.11209,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.077957,0.127,0.090624,0,0
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.12908,0.1266,0.11207,0,0
2,GO CARDIOLIPIN METABOLIC PROCESS,0.23589,0.12658,0.067219,0,0
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.29184,0.12632,0.084081,0,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.20937,0.1263,0.14382,0,0
2,GO ENDODERM DEVELOPMENT,0.2839,0.12617,0.025249,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.099158,0.12532,0.16393,0,0
2,GO MEMORY,0.0067808,0.12525,0.13818,0,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.13355,0.12514,0.23131,0,0
2,GO REGULATION OF ODONTOGENESIS,0.40843,0.12506,0.031587,0,0
2,GO REGULATION OF CELLULAR RESPIRATION,0.097379,0.12458,0.11837,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.070855,0.12428,0.11219,0,0
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.53167,0.12415,0.026669,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.10096,0.12406,0.11849,0,0
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.59059,0.12406,0.0070754,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.10654,0.12351,0.24502,0,0
2,GO REGULATION OF HEART RATE,0.10465,0.12348,0.095051,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.39858,0.12348,0.09055,0,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.11235,0.12275,0.11146,0,0
2,GO NEURAL CREST FORMATION,0.36991,0.12272,0.07721,0,0
2,GO CAMP METABOLIC PROCESS,0.31232,0.12264,0.054026,0,0
2,GO NEUROBLAST PROLIFERATION,0.14048,0.12256,0.087126,0,0
2,GO MATING,0.033166,0.12237,0.091484,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.17099,0.12222,0.077015,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.34702,0.12148,0.1034,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.20937,0.12099,0.079371,0,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.070855,0.12077,0.10228,0,0
2,GO SYNAPTIC VESICLE LOCALIZATION,0.014841,0.11988,0.19226,0,0
2,GO RESPONSE TO NITRIC OXIDE,0.0060989,0.11975,0.1029,0,0
2,GO LYMPH VESSEL DEVELOPMENT,0.14769,0.11937,0.073455,0,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.12689,0.11897,0.11581,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.20937,0.11875,0.13745,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.188,0.11867,0.089562,0,0
2,GO MECHANOSENSORY BEHAVIOR,0.36526,0.1182,0.17894,0,0
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.026586,0.11785,0.1383,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.080955,0.1175,0.098141,0,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.23245,0.11711,0.078572,0,0
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.11235,0.11693,0.064552,0,0
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.014138,0.1168,0.11783,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.14285,0.11668,0.19877,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.066855,0.11658,0.080127,0,0
2,GO STORE OPERATED CALCIUM ENTRY,0.44402,0.11647,0.034577,0,0
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.91987,0.11642,0.029245,0,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.14526,0.11641,0.08259,0,0
2,GO AXON DEVELOPMENT,0.0050528,0.11594,0.15111,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.059411,0.11573,0.1537,0,0
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.052669,0.11532,0.078129,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.022165,0.11502,0.13665,0,0
2,GO CELL PART MORPHOGENESIS,0.0024367,0.11485,0.1479,0,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.010506,0.11484,0.11228,0,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.21256,0.11469,0.12975,0,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.066855,0.11431,0.13884,0,0
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.046579,0.1143,0.11196,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.1313,0.11422,0.1157,0,0
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.043763,0.1138,0.13072,0,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.017137,0.11306,0.15792,0,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.26098,0.11301,0.14473,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.03245,0.11289,0.1031,0,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.12908,0.11274,0.14697,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.35607,0.11239,0.068419,0,0
2,GO GLIAL CELL MIGRATION,0.052669,0.11218,0.13199,0,0
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.17653,0.11182,0.05138,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.018836,0.11181,0.17577,0,0
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.20621,0.11179,0.051553,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.25729,0.1117,0.072017,0,0
2,GO URETER DEVELOPMENT,0.41842,0.11161,0.072538,0,0
2,GO COGNITION,0.0031536,0.11159,0.15657,0,0
2,GO SEQUESTERING OF METAL ION,0.11841,0.11155,0.077539,0,0
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.34256,0.11099,0.048058,0,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.061812,0.11097,0.13005,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.16828,0.11045,0.16887,0,0
2,GO NEURON MIGRATION,0.042857,0.11025,0.14875,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.2,0.11014,0.02765,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.26471,0.10971,0.089985,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.088862,0.10951,0.10544,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.015203,0.10934,0.19385,0,0
2,GO MYELIN MAINTENANCE,0.46512,0.10871,0.05417,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.10845,0.10842,0.17539,0,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.013139,0.10831,0.12606,0,0
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.066855,0.10823,0.083208,0,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.047551,0.1078,0.085432,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.30402,0.10773,0.091316,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.004408,0.10765,0.16898,0,0
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.079444,0.10761,0.13606,0,0
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.21905,0.1076,0.065025,0,0
2,GO DORSAL AORTA DEVELOPMENT,0.24288,0.10736,0.086646,0,0
2,GO ANION HOMEOSTASIS,0.17934,0.10723,0.076362,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.19393,0.10666,0.1672,0,0
2,GO DOPAMINE TRANSPORT,0.33812,0.10662,0.15678,0,0
2,GO ASYMMETRIC CELL DIVISION,0.39371,0.10648,0.0629,0,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.14526,0.10629,0.11146,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.023741,0.10627,0.11456,0,0
2,GO PHOSPHOLIPID HOMEOSTASIS,0.39858,0.10609,0.041172,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.029068,0.10605,0.11104,0,0
2,GO SECRETORY GRANULE ORGANIZATION,0.22568,0.10553,0.055856,0,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.15264,0.10543,0.064202,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.20621,0.10501,0.038164,0,0
2,GO CELLULAR RESPONSE TO ETHANOL,0.11434,0.105,0.12598,0,0
2,GO TOXIN TRANSPORT,0.10096,0.10474,0.067394,0,0
2,GO GROWTH HORMONE SECRETION,0.16294,0.10466,0.10545,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.27227,0.10464,0.079484,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.12908,0.10451,0.12432,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.36064,0.10427,0.032545,0,0
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.59059,0.10414,0.032692,0,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.34702,0.10387,0.057386,0,0
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.075049,0.10372,0.095769,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.19695,0.10371,0.094687,0,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.016734,0.1037,0.11503,0,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.016734,0.10328,0.12458,0,0
2,GO RESPONSE TO AMYLOID BETA,0.0094949,0.10326,0.1324,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.19095,0.10319,0.058589,0,0
2,GO TRNA 5 END PROCESSING,0.12473,0.10284,0.079239,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.60272,0.1027,0.03177,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.084046,0.10254,0.11759,0,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.097379,0.10248,0.094569,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.05824,0.10243,0.090781,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0023671,0.10243,0.09872,0,0
2,GO WALKING BEHAVIOR,0.004408,0.10242,0.20944,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.26098,0.10238,0.15396,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.060602,0.10188,0.083724,0,0
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.38408,0.10184,0.054856,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.44924,0.1016,0.14169,0,0
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.32506,0.10158,0.057278,0,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.011047,0.10155,0.11642,0,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.049546,0.10137,0.11162,0,0
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.19393,0.10101,-0.010585,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.22235,0.10099,0.074943,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.14048,0.1007,0.081393,0,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.23589,0.10064,0.1404,0,0
2,GO AXO DENDRITIC TRANSPORT,0.043763,0.10041,0.10129,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.65866,0.10026,0.046327,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.57857,0.10015,-0.021418,0,0
2,GO PROSTAGLANDIN SECRETION,0.17099,0.10012,0.085141,0,0
2,GO NAD BIOSYNTHETIC PROCESS,0.5726,0.099913,0.02916,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.29992,0.099778,0.059685,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.63978,0.099585,0.039394,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.41341,0.099415,0.015277,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.17653,0.099388,0.090573,0,0
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.22235,0.099251,0.049878,0,0
2,GO ACROSOME ASSEMBLY,0.15773,0.098843,0.14126,0,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.14285,0.098716,0.046371,0,0
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.70355,0.098621,0.01751,0,0
2,GO METAL ION TRANSPORT,0.031059,0.098552,0.068972,0,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0060989,0.098297,0.099857,0,0
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.4545,0.097984,0.073768,0,0
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.25363,0.097836,0.044028,0,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.16032,0.097756,0.10818,0,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.31653,0.097516,0.041001,0,0
2,GO REGULATION OF ATP METABOLIC PROCESS,0.065563,0.097368,0.064835,0,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.23245,0.097273,0.072781,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.044685,0.097259,0.12093,0,0
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.029068,0.097005,0.08091,0,0
2,GO RENAL VESICLE DEVELOPMENT,0.18219,0.09686,0.12136,0,0
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17374,0.09671,0.085387,0,0
2,GO LATERAL MESODERM DEVELOPMENT,0.99651,0.096493,-0.042264,0,0
2,GO REVERSE CHOLESTEROL TRANSPORT,0.72969,0.096301,-0.0135,0,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.038561,0.096255,0.11449,0,0
2,GO RENAL SODIUM EXCRETION,0.095625,0.096118,0.077543,0,0
2,GO BICARBONATE TRANSPORT,0.16828,0.095931,0.057661,0,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.020205,0.095754,0.083423,0,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.36526,0.095619,0.024502,0,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.18508,0.095579,0.15747,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.068167,0.09548,0.080124,0,0
2,GO ENDODERM FORMATION,0.25363,0.095455,0.025382,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.05824,0.095351,0.080819,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0079323,0.09519,0.12173,0,0
2,GO TRANSEPITHELIAL TRANSPORT,0.060602,0.095126,0.071842,0,0
2,GO PIGMENT METABOLIC PROCESS,0.13355,0.094987,0.079327,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.18219,0.094937,0.063127,0,0
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.29586,0.094911,0.033694,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011326,0.094873,0.17996,0,0
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.4978,0.094615,0.011696,0,0
2,GO CELL RECOGNITION,0.057089,0.094592,0.072826,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.041967,0.09449,0.13653,0,0
2,GO DENDRITIC SPINE MAINTENANCE,0.14048,0.094365,0.078247,0,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.54903,0.09376,0.037638,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.2,0.093725,0.074412,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.32938,0.093651,0.17063,0,0
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.27227,0.0934,0.11352,0,0
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.44402,0.093148,0.037235,0,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.021165,0.093074,0.086229,0,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.010773,0.092962,0.11854,0,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0024367,0.092894,0.131,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,0.44402,0.092883,0.11071,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.054842,0.092556,0.08351,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.092194,0.09236,0.080909,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.072231,0.09215,0.069895,0,0
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.11636,0.092058,0.10672,0,0
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.0695,0.091905,0.040213,0,0
2,GO MEMBRANE DEPOLARIZATION,0.14769,0.091862,0.10733,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.27999,0.091737,0.027537,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.63354,0.09169,0.023899,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.85768,0.091628,-0.035297,0,0
2,GO AMELOGENESIS,0.72313,0.091497,0.017454,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.29992,0.091025,0.062368,0,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.079444,0.090943,0.089883,0,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.12908,0.090858,0.07639,0,0
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.19393,0.090771,0.067024,0,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.073629,0.090744,0.0655,0,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.42855,0.090715,0.051687,0,0
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.36526,0.090547,0.066859,0,0
2,GO NUCLEOTIDE SALVAGE,0.16032,0.090474,0.12384,0,0
2,GO SODIUM ION TRANSPORT,0.04854,0.090093,0.07834,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.017137,0.089889,0.14576,0,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.0022992,0.089404,0.10202,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.15264,0.089392,0.1084,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.02843,0.089345,0.091656,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.045624,0.089295,0.096514,0,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.036164,0.089277,0.11426,0,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.079444,0.089231,0.081202,0,0
2,GO AMINO ACID ACTIVATION,0.17099,0.089177,0.096164,0,0
2,GO REGULATION OF GLUTAMATE SECRETION,0.17653,0.089087,0.13757,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.2,0.088542,0.06317,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.064293,0.088449,0.097257,0,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.43367,0.088351,0.053667,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.15773,0.088278,0.063281,0,0
2,GO CATECHOLAMINE SECRETION,0.070855,0.088274,0.21533,0,0
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.94769,0.088241,-0.017123,0,0
2,GO RECEPTOR INTERNALIZATION,0.049546,0.088196,0.094469,0,0
2,GO RNA STABILIZATION,0.13583,0.088143,0.071223,0,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.060602,0.088074,0.064686,0,0
2,GO GROOMING BEHAVIOR,0.20621,0.088031,0.11623,0,0
2,GO COPPER ION TRANSPORT,0.19695,0.087859,0.074573,0,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.47588,0.087791,0.047237,0,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.39371,0.087635,0.037074,0,0
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.25363,0.087382,0.067867,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.72969,0.087255,0.00042408,0,0
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.32938,0.087207,0.028107,0,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.39858,0.086961,0.037733,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.047551,0.086679,0.097788,0,0
2,GO SKELETAL MUSCLE CONTRACTION,0.11039,0.086276,0.085481,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.033894,0.086043,0.089639,0,0
2,GO ORGANIC CATION TRANSPORT,0.02268,0.085963,0.1203,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.36526,0.085893,0.021861,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.13814,0.08582,0.079721,0,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.17099,0.085525,0.043005,0,0
2,GO REGULATION OF ION TRANSPORT,0.14285,0.085163,0.060629,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0099891,0.085126,0.18506,0,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.28785,0.085014,0.067548,0,0
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.74288,0.084953,-0.011379,0,0
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.5726,0.084937,0.0074552,0,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.25729,0.084792,0.1637,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.075049,0.084777,0.056319,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.14526,0.084508,0.05929,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.38408,0.084446,0.047501,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.10845,0.084391,0.088945,0,0
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.38408,0.084332,0.03121,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.34256,0.084212,0.065424,0,0
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.088862,0.084073,0.16487,0,0
2,GO BLASTOCYST FORMATION,0.10465,0.083901,0.07186,0,0
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.29184,0.083715,0.0484,0,0
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.67776,0.083643,-0.0021424,0,0
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.3746,0.083425,0.053785,0,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.016734,0.083355,0.11394,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.013139,0.083289,0.099556,0,0
2,GO MESODERMAL CELL DIFFERENTIATION,0.31232,0.082899,0.010792,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.044685,0.082305,0.1067,0,0
2,GO PLASMINOGEN ACTIVATION,0.46512,0.082181,-0.039713,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.75615,0.082149,-0.074696,0,0
2,GO POSITIVE REGULATION OF RNA SPLICING,0.044685,0.081949,0.065575,0,0
2,GO PODOSOME ASSEMBLY,0.67137,0.081675,-0.064838,0,0
2,GO ZINC ION TRANSPORT,0.23937,0.081671,0.059316,0,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.28785,0.081668,0.10687,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.25001,0.081626,0.029616,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.74288,0.08162,0.0065297,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.23937,0.081615,0.073582,0,0
2,GO TONGUE MORPHOGENESIS,0.4598,0.081393,0.12758,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.17934,0.081261,0.082883,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.064293,0.081174,0.14722,0,0
2,GO REGULATION OF AMYLOID BETA FORMATION,0.60272,0.080998,0.035328,0,0
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.42347,0.080935,0.03634,0,0
2,GO OTIC VESICLE MORPHOGENESIS,0.22235,0.080834,0.17572,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.32077,0.080806,0.049153,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.32077,0.080729,0.029259,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.041093,0.080665,0.085237,0,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.50896,0.080652,0.027984,0,0
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.31232,0.08065,0.072418,0,0
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.095625,0.080499,0.080015,0,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.55487,0.080271,0.037342,0,0
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.2,0.080203,0.10426,0,0
2,GO GLIAL CELL ACTIVATION,0.69707,0.080002,0.010975,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.14526,0.079913,0.088509,0,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.52594,0.079881,0.033788,0,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.23245,0.079584,0.11512,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.36991,0.079189,0.044649,0,0
2,GO REGULATION OF DNA METHYLATION,0.55487,0.078676,0.022381,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.18508,0.078595,0.066106,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.12049,0.078554,0.08366,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.31653,0.078538,0.044265,0,0
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.5726,0.07847,0.015,0,0
2,GO CELL GROWTH,0.075049,0.078358,0.049189,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0695,0.078322,0.089378,0,0
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.11039,0.078308,0.051503,0,0
2,GO SEQUESTERING OF CALCIUM ION,0.30402,0.078271,0.048713,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.10845,0.078262,0.069084,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.60272,0.078197,0.048157,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.084046,0.078058,0.085615,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.21905,0.07805,0.047038,0,0
2,GO NUCLEAR MIGRATION,0.093897,0.077994,0.098162,0,0
2,GO TRABECULA FORMATION,0.22568,0.077658,0.066652,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.043763,0.077645,0.10789,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.25729,0.077515,0.06121,0,0
2,GO AMINO SUGAR METABOLIC PROCESS,0.29184,0.077403,0.034278,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.87833,0.077391,-0.031794,0,0
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.4598,0.077289,0.012326,0,0
2,GO ADULT BEHAVIOR,0.055956,0.077249,0.14414,0,0
2,GO DRUG CATABOLIC PROCESS,0.085627,0.077231,0.084308,0,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.070855,0.077169,0.095196,0,0
2,GO AXONAL TRANSPORT,0.070855,0.077143,0.10062,0,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.26098,0.077094,0.10614,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.56075,0.077027,0.080368,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.4545,0.076803,0.039002,0,0
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.19095,0.076794,0.038257,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.47049,0.076733,0.087098,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.46512,0.076668,0.05701,0,0
2,GO MAINTENANCE OF CELL POLARITY,0.23937,0.076611,0.073465,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.61497,0.076578,0.019408,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.52594,0.076353,0.023953,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.67776,0.076184,0.045548,0,0
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.88523,0.076182,-0.051929,0,0
2,GO MONONUCLEAR CELL DIFFERENTIATION,0.31653,0.075882,0.091314,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.32938,0.075861,0.085015,0,0
2,GO REGULATION OF EXCRETION,0.12259,0.075844,0.11051,0,0
2,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.3746,0.075674,0.0491,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.35607,0.075559,0.08742,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.37932,0.075513,0.046886,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.082489,0.07523,0.11739,0,0
2,GO CATION TRANSPORT,0.05824,0.075116,0.060237,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.30815,0.07504,0.048406,0,0
2,GO IRON ION HOMEOSTASIS,0.20309,0.074902,0.055373,0,0
2,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.14769,0.074629,0.10781,0,0
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0056288,0.074586,0.08917,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.76281,0.074518,0.0086407,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.66501,0.074091,-0.012677,0,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.085627,0.074082,0.062271,0,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.11636,0.07407,0.079286,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.1313,0.073811,0.11994,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.068167,0.073734,0.06478,0,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.026586,0.073598,0.10531,0,0
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.21905,0.073492,0.093333,0,0
2,GO THIOESTER METABOLIC PROCESS,0.25729,0.073276,0.052488,0,0
2,GO CELL CYCLE DNA REPLICATION,0.044685,0.07298,0.079722,0,0
2,GO PROTEIN KINASE A SIGNALING,0.2839,0.07278,0.047207,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.94073,0.072656,-0.016114,0,0
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.33812,0.072441,0.057914,0,0
2,GO LOCOMOTORY BEHAVIOR,0.036164,0.072435,0.13478,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.23245,0.072351,0.14897,0,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.48131,0.072182,0.03863,0,0
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.085627,0.07167,0.091229,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.27999,0.071191,0.043413,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.12049,0.071179,0.052823,0,0
2,GO REGULATION OF BLOOD CIRCULATION,0.17099,0.07079,0.06219,0,0
2,GO RESPONSE TO COCAINE,0.47049,0.070694,0.053782,0,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.32506,0.070677,0.023749,0,0
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.054842,0.070652,0.070367,0,0
2,GO CELL JUNCTION ORGANIZATION,0.188,0.07046,0.04718,0,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.17934,0.070351,0.051365,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.34702,0.070264,0.030359,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.4545,0.070237,0.023566,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.14526,0.070001,0.11623,0,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.075049,0.069941,0.066948,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.090515,0.069754,0.13252,0,0
2,GO TRABECULA MORPHOGENESIS,0.68418,0.069601,0.00042882,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.32506,0.069519,0.047766,0,0
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.037747,0.069404,0.071298,0,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.065563,0.069382,0.070423,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.78962,0.069356,-0.046214,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.12908,0.069332,0.057547,0,0
2,GO RESPONSE TO ACIDIC PH,0.61497,0.069269,-0.0041426,0,0
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.33812,0.068977,0.040546,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.32506,0.068946,0.054595,0,0
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.05824,0.068821,0.071223,0,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.22905,0.068786,0.12685,0,0
2,GO REGULATION OF DNA BINDING,0.32506,0.068703,0.035944,0,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.092194,0.068576,0.10112,0,0
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.059411,0.068576,0.062462,0,0
2,GO RESPONSE TO INTERLEUKIN 12,0.40349,0.068368,0.034789,0,0
2,GO FATTY ACYL COA METABOLIC PROCESS,0.054842,0.06832,0.13079,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.40349,0.067964,0.057793,0,0
2,GO INTRACELLULAR LIPID TRANSPORT,0.32506,0.067907,0.051331,0,0
2,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.39371,0.067675,0.031582,0,0
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.16559,0.067378,0.083294,0,0
2,GO MITOCHONDRIAL FISSION,0.17934,0.066962,0.067096,0,0
2,GO ACTION POTENTIAL,0.31653,0.066927,0.062919,0,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.03245,0.066848,0.090725,0,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.092194,0.066661,0.065468,0,0
2,GO NEURON DEVELOPMENT,0.015574,0.066648,0.10551,0,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.11039,0.066519,0.060207,0,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.4545,0.066267,0.05857,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.22235,0.066172,0.060251,0,0
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.63354,0.066041,-0.0040107,0,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.060602,0.065935,0.06487,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.14048,0.065507,0.039674,0,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.85768,0.065444,-0.0028137,0,0
2,GO HIPPO SIGNALING,0.68418,0.065365,-0.024942,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.024288,0.065336,0.096793,0,0
2,GO HEXOSE CATABOLIC PROCESS,0.4598,0.065182,0.035594,0,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.17653,0.065071,0.077566,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.3746,0.064971,0.040328,0,0
2,GO CELLULAR RESPONSE TO X RAY,0.41842,0.064863,0.016317,0,0
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.073629,0.064843,0.15596,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.055956,0.064814,0.067937,0,0
2,GO HISTONE H3 K27 METHYLATION,0.40349,0.064767,0.041694,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.30402,0.064586,0.12124,0,0
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.12689,0.064443,0.07886,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.21905,0.064149,0.10092,0,0
2,GO SYNAPTIC VESICLE TRANSPORT,0.11434,0.063924,0.11139,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.42855,0.063734,0.056971,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.93377,0.063732,-0.0072338,0,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.72969,0.063652,0.0051246,0,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.082489,0.063571,0.083382,0,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.05824,0.063493,0.061114,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.39371,0.063293,0.046665,0,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.54903,0.063118,0.086518,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.32938,0.062669,0.024869,0,0
2,GO RESPONSE TO SALT,0.92682,0.062643,0.00048644,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.22235,0.06263,0.0745,0,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.28785,0.062444,0.041102,0,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.58456,0.062265,0.054427,0,0
2,GO NEURON MATURATION,0.073629,0.062192,0.1618,0,0
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.50337,0.062074,0.015222,0,0
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.90599,0.062055,-0.0055476,0,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.31232,0.062028,0.069046,0,0
2,GO COLLAGEN CATABOLIC PROCESS,0.52025,0.062015,0.00011165,0,0
2,GO BEHAVIOR,0.013139,0.062013,0.11244,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.3746,0.06199,0.028828,0,0
2,GO MULTI ORGANISM LOCALIZATION,0.15264,0.061525,0.032862,0,0
2,GO SNRNA PROCESSING,0.15773,0.061408,-0.0063667,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.63978,0.061342,0.018724,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.44924,0.061284,0.069574,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.58456,0.061271,0.021532,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.76281,0.061217,0.038906,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.13355,0.061175,0.11112,0,0
2,GO NEURON DIFFERENTIATION,0.033166,0.061143,0.09311,0,0
2,GO RNA CAPPING,0.087232,0.061067,0.064207,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.40349,0.061015,0.054946,0,0
2,GO HEART PROCESS,0.12259,0.06089,0.068836,0,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.2,0.060871,0.062917,0,0
2,GO CERAMIDE TRANSPORT,0.11434,0.060835,0.045107,0,0
2,GO OPTIC NERVE DEVELOPMENT,0.32938,0.060655,0.088409,0,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.10654,0.060355,0.045853,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76281,0.060279,-0.055547,0,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.049546,0.060199,0.081212,0,0
2,GO POSITIVE REGULATION OF URINE VOLUME,0.5726,0.060194,0.011848,0,0
2,GO REGULATION OF CELL SIZE,0.027803,0.06009,0.078054,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.041093,0.060038,0.10921,0,0
2,GO REGULATION OF MRNA 3 END PROCESSING,0.12049,0.060029,0.062462,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.36526,0.059805,0.094879,0,0
2,GO NUCLEOSIDE METABOLIC PROCESS,0.12908,0.059782,0.047589,0,0
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.26098,0.059782,0.039865,0,0
2,GO NEURON PROJECTION ARBORIZATION,0.49227,0.059684,0.069472,0,0
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.87144,0.059626,-0.016596,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.12689,0.059588,0.062803,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.38888,0.059495,0.059975,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.96163,0.059474,0.0074326,0,0
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.1028,0.059414,0.067347,0,0
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.71006,0.059403,-0.061317,0,0
2,GO REGULATION OF EXOCYTOSIS,0.12908,0.059169,0.083328,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.69061,0.059045,0.016918,0,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.23245,0.058912,0.051956,0,0
2,GO PROTEIN FOLDING,0.19695,0.058895,0.037073,0,0
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.21905,0.05883,0.18293,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.39858,0.058732,0.057713,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.36991,0.058589,0.04793,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.48678,0.058587,0.043292,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.42855,0.058445,0.01996,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.40349,0.058248,0.034762,0,0
2,GO MRNA EXPORT FROM NUCLEUS,0.059411,0.057863,0.069993,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.188,0.057766,0.070135,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.67137,0.057761,-0.0024584,0,0
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.088862,0.057756,0.05304,0,0
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.32938,0.057662,0.027942,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.41341,0.057564,0.03109,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.12908,0.057514,0.096921,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.83713,0.057268,-0.011995,0,0
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.045624,0.057252,0.082736,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.25001,0.057197,0.081448,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.12689,0.056973,0.054069,0,0
2,GO FEEDING BEHAVIOR,0.088862,0.056843,0.084705,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.92682,0.056737,-0.0044084,0,0
2,GO MITOCHONDRIAL DNA REPLICATION,0.44924,0.056697,0.032179,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.56666,0.056407,0.022729,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.031059,0.056379,0.062983,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.72969,0.05629,-0.0008014,0,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.11636,0.05621,0.064125,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.14526,0.056149,0.057714,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.85768,0.056012,-0.042994,0,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.47049,0.055942,0.047177,0,0
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.16032,0.055811,0.040261,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.48678,0.055774,-0.077812,0,0
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.88523,0.05573,0.0054114,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.23589,0.055727,0.111,0,0
2,GO NEPHRON TUBULE FORMATION,0.79636,0.055653,0.036197,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.079444,0.055331,0.075593,0,0
2,GO NOREPINEPHRINE SECRETION,0.37932,0.055307,0.052206,0,0
2,GO REGULATION OF HEART GROWTH,0.23589,0.055286,0.066202,0,0
2,GO DNA GEOMETRIC CHANGE,0.054842,0.055228,0.060255,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.25729,0.055025,0.049114,0,0
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.065563,0.055002,0.04809,0,0
2,GO ANIMAL ORGAN REGENERATION,0.4978,0.054878,-0.0026538,0,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.81668,0.054837,-0.034905,0,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.71006,0.054812,0.0049911,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.68418,0.0548,0.015893,0,0
2,GO G0 TO G1 TRANSITION,0.43367,0.05475,0.036869,0,0
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.24643,0.054744,0.073746,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.40349,0.054687,0.035538,0,0
2,GO TRACHEA DEVELOPMENT,0.4598,0.054649,0.060868,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.34702,0.054639,0.074693,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.29992,0.054492,0.03947,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.56666,0.054206,0.020814,0,0
2,GO PROSTAGLANDIN TRANSPORT,0.58456,0.05399,0.016902,0,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.26471,0.053979,0.072737,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.71658,0.053975,0.017606,0,0
2,GO OSTEOBLAST DEVELOPMENT,0.71658,0.053807,-0.021909,0,0
2,GO PROTEASOME ASSEMBLY,0.2,0.053773,0.053468,0,0
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.76948,0.053703,0.016269,0,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.11841,0.053664,0.080307,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.14526,0.053577,0.068468,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.42347,0.053419,0.04701,0,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.14526,0.053381,0.070599,0,0
2,GO PROTEIN NEDDYLATION,0.12049,0.053309,0.067427,0,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.26098,0.053132,0.13369,0,0
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.14048,0.05306,0.053304,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.33373,0.052918,0.067288,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.1313,0.052863,0.075474,0,0
2,GO MAINTENANCE OF LOCATION IN CELL,0.29184,0.052824,0.043541,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.41842,0.05282,0.050627,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.84397,0.052755,-0.028331,0,0
2,GO NEURON CELL CELL ADHESION,0.61497,0.052642,0.10326,0,0
2,GO PROTEIN POLYGLUTAMYLATION,0.36064,0.052559,0.035699,0,0
2,GO MYELIN ASSEMBLY,0.49227,0.052436,0.042426,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.83713,0.05231,-0.055094,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.63354,0.052278,0.024987,0,0
2,GO NUCLEOSOME ORGANIZATION,0.14526,0.052174,0.050352,0,0
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.72969,0.052144,0.013265,0,0
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.32506,0.052067,0.043894,0,0
2,GO RESPONSE TO CATECHOLAMINE,0.47588,0.051724,0.0425,0,0
2,GO MUSCLE CONTRACTION,0.13814,0.051623,0.053266,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.63978,0.05139,0.023118,0,0
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.14769,0.05134,0.11065,0,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.2839,0.051251,0.057719,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.59664,0.051103,-0.044502,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.71658,0.051083,0.0022241,0,0
2,GO MONOAMINE TRANSPORT,0.55487,0.051073,0.10533,0,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.16294,0.051029,0.064254,0,0
2,GO RESPONSE TO POTASSIUM ION,0.59059,0.050913,0.052922,0,0
2,GO GRANULOCYTE DIFFERENTIATION,0.96163,0.050771,-0.026791,0,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.24288,0.050528,0.091945,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.38408,0.050521,0.079565,0,0
2,GO ADHESION OF SYMBIONT TO HOST,0.5726,0.050321,0.033531,0,0
2,GO PEPTIDYL METHIONINE MODIFICATION,0.15015,0.050316,0.06293,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.33812,0.050176,0.083192,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.94769,0.050105,-0.0076313,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.53167,0.050087,0.016322,0,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.40349,0.049989,0.026336,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.25363,0.049893,0.036914,0,0
2,GO RHYTHMIC BEHAVIOR,0.47049,0.049745,0.042894,0,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.11434,0.049733,0.11575,0,0
2,GO DEFENSE RESPONSE TO FUNGUS,0.69061,0.049532,0.0085766,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.98953,0.049408,-0.006554,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.15015,0.049344,0.041168,0,0
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.70355,0.049297,-0.011863,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.11841,0.049215,0.040787,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.98255,0.049192,-0.017618,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.16294,0.049185,0.099555,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.83713,0.049162,-0.0024512,0,0
2,GO RESPONSE TO CORTICOSTERONE,0.91987,0.049093,-0.019411,0,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.42347,0.049075,0.01986,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.72313,0.048968,0.017815,0,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.86455,0.048931,0.016773,0,0
2,GO REGULATION OF HISTONE UBIQUITINATION,0.33373,0.048465,0.043883,0,0
2,GO CHROMATIN DISASSEMBLY,0.22235,0.048408,0.125,0,0
2,GO ACYLGLYCEROL HOMEOSTASIS,0.42347,0.048374,0.038189,0,0
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.33812,0.048365,0.058467,0,0
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.43883,0.048133,0.06176,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.087232,0.048035,0.062806,0,0
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.17099,0.048005,0.046503,0,0
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.81668,0.047761,0.0094245,0,0
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.38888,0.04765,0.031904,0,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.42855,0.047545,0.038869,0,0
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.58456,0.04754,0.013204,0,0
2,GO REGULATION OF ORGAN GROWTH,0.35607,0.04754,0.035379,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.25729,0.047341,0.061132,0,0
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.23937,0.047273,0.047214,0,0
2,GO MRNA TRANSPORT,0.095625,0.047191,0.05429,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.62732,0.047146,0.030781,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.62113,0.047105,0.047123,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.69061,0.04698,0.0037934,0,0
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.86455,0.046963,-0.036538,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.22905,0.046955,0.076249,0,0
2,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.62113,0.046823,0.028654,0,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.9686,0.046602,-0.055373,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.43883,0.046447,0.052152,0,0
2,GO ACROSOME REACTION,0.54321,0.046437,0.028279,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.65234,0.046422,-0.0089847,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.41842,0.046411,0.052284,0,0
2,GO NEUROGENESIS,0.075049,0.046395,0.071918,0,0
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.55487,0.046293,0.032767,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.15773,0.046282,0.068317,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.60883,0.046193,0.036286,0,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.35153,0.046032,0.060186,0,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.082489,0.045935,0.10175,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.60883,0.04592,0.03141,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.25729,0.045851,0.068885,0,0
2,GO MICROTUBULE POLYMERIZATION,0.044685,0.045838,0.11001,0,0
2,GO CEREBELLAR CORTEX FORMATION,0.63978,0.045735,0.048536,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.10465,0.045604,0.064125,0,0
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.71006,0.045453,-0.0036157,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.33812,0.045402,0.066379,0,0
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.21905,0.045383,0.045223,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.95466,0.045349,-0.026062,0,0
2,GO MYOBLAST FUSION,0.89215,0.045198,-0.025843,0,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.69707,0.045174,0.0098476,0,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.31232,0.044919,0.059493,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.093897,0.044885,0.10197,0,0
2,GO RESPONSE TO DOPAMINE,0.61497,0.044837,0.033992,0,0
2,GO CHROMATIN SILENCING,0.46512,0.044804,0.026672,0,0
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.71006,0.044783,0.016251,0,0
2,GO ORGAN GROWTH,0.54903,0.044716,0.018631,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.86455,0.044645,-0.072866,0,0
2,GO RRNA CATABOLIC PROCESS,0.62732,0.044437,0.04833,0,0
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.78962,0.044324,0.0072863,0,0
2,GO HEART TRABECULA FORMATION,0.95466,0.044239,-0.0041626,0,0
2,GO HISTONE METHYLATION,0.1028,0.044139,0.047003,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.81668,0.044039,-0.020328,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.061812,0.043714,0.131,0,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.32077,0.043609,0.049395,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.95466,0.043547,-0.012278,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.42347,0.04348,0.037169,0,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.38888,0.043411,0.05894,0,0
2,GO MICROTUBULE NUCLEATION,0.67137,0.043043,0.030211,0,0
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.10654,0.042921,0.09844,0,0
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.22905,0.042914,0.041127,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.48678,0.042716,0.033185,0,0
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.88523,0.042581,0.023569,0,0
2,GO REGULATION OF PODOSOME ASSEMBLY,0.50896,0.042552,-0.11406,0,0
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.20621,0.042531,0.072654,0,0
2,GO PROTEIN HYDROXYLATION,0.78289,0.042499,0.014227,0,0
2,GO PROTEIN PALMITOYLATION,0.30815,0.042405,0.061275,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.21256,0.04236,0.096539,0,0
2,GO BONE DEVELOPMENT,0.3746,0.042278,0.014209,0,0
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.89907,0.042198,-0.021191,0,0
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.14285,0.041947,0.040574,0,0
2,GO TRNA 5 LEADER REMOVAL,0.63354,0.041775,0.01211,0,0
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.092194,0.041691,0.050936,0,0
2,GO PROTEIN STABILIZATION,0.52025,0.041628,0.017604,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.69707,0.041617,0.042231,0,0
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,1,0.041609,-0.013308,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.60272,0.04137,-0.015169,0,0
2,GO LYMPHANGIOGENESIS,0.26098,0.041195,0.057051,0,0
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.41341,0.041186,0.027773,0,0
2,GO NADP METABOLIC PROCESS,0.70355,0.041152,-0.016033,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.05824,0.041143,0.037228,0,0
2,GO ELECTRON TRANSPORT CHAIN,0.37932,0.040798,0.031763,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.10654,0.040787,0.053955,0,0
2,GO CARTILAGE MORPHOGENESIS,0.35153,0.04077,0.14204,0,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.4598,0.040627,0.046269,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.75615,0.040613,-0.040405,0,0
2,GO SNRNA METABOLIC PROCESS,0.25001,0.040524,-0.0053469,0,0
2,GO PROTEIN IMPORT,0.58456,0.040337,0.0071906,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.64605,0.039969,-0.042298,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.91987,0.039865,-0.0085776,0,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.86455,0.039813,-0.0023915,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.78962,0.039672,-0.0087641,0,0
2,GO RESPONSE TO UV,0.12259,0.039584,0.042676,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.99651,0.039419,-0.019693,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.80989,0.03933,0.024745,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.84397,0.039168,-0.0045513,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.91293,0.039067,-0.013666,0,0
2,GO CELL MORPHOGENESIS,0.14526,0.038997,0.058199,0,0
2,GO REGULATION OF URINE VOLUME,0.65234,0.038963,0.011216,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.95466,0.038951,-0.010853,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.29184,0.038797,0.040875,0,0
2,GO POLYOL METABOLIC PROCESS,0.24288,0.038771,0.036067,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.96163,0.03877,-0.010743,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.42855,0.038761,0.046427,0,0
2,GO OXIDATIVE DEMETHYLATION,0.15517,0.038625,0.072435,0,0
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.038561,0.038589,0.066038,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.20621,0.038547,0.030599,0,0
2,GO ION TRANSPORT,0.23937,0.038322,0.031685,0,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.25729,0.038216,0.080229,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.76948,0.038215,0.0055821,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.78962,0.03819,-0.0078515,0,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.33373,0.038161,0.031432,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.76948,0.038053,0.035254,0,0
2,GO MITOCHONDRION ORGANIZATION,0.17653,0.038028,0.029368,0,0
2,GO IMMATURE T CELL PROLIFERATION,0.72969,0.038013,-0.01894,0,0
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.30402,0.037981,0.042514,0,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.9686,0.037969,-0.025374,0,0
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.41842,0.03795,0.046741,0,0
2,GO CELL CELL SIGNALING,0.13355,0.037895,0.047582,0,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.17099,0.037849,0.099701,0,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.50896,0.037847,0.02657,0,0
2,GO REGULATION OF GENE SILENCING,0.28785,0.037828,0.031926,0,0
2,GO PROTEIN KINASE C SIGNALING,0.98953,0.037794,-0.0076044,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.090515,0.037701,0.056622,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.073629,0.037433,0.12602,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.68418,0.037332,0.015243,0,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.67137,0.037196,0.016443,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.49227,0.037067,0.057624,0,0
2,GO DEVELOPMENTAL GROWTH,0.14285,0.037026,0.047565,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.38888,0.037015,0.016176,0,0
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.78289,0.036885,0.008726,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.71658,0.036778,-0.0092596,0,0
2,GO BLASTOCYST GROWTH,0.47049,0.036748,0.016377,0,0
2,GO COENZYME A METABOLIC PROCESS,0.80312,0.03672,0.013962,0,0
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.041093,0.036656,0.074008,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.56075,0.036493,0.040761,0,0
2,GO RESPONSE TO RETINOIC ACID,0.76948,0.036452,-0.016635,0,0
2,GO RESPONSE TO LEUCINE,0.4978,0.03628,0.078433,0,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.52025,0.036273,0.026461,0,0
2,GO GMP METABOLIC PROCESS,0.80989,0.03627,0.042603,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.15773,0.036244,0.048961,0,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.8303,0.036212,0.032197,0,0
2,GO REGULATION OF DNA REPAIR,0.7495,0.036026,0.0030106,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.67776,0.036019,0.00746,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.031748,0.035939,0.067457,0,0
2,GO REGULATION OF ACROSOME REACTION,0.39371,0.035938,0.070154,0,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.13814,0.035896,0.10478,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.4598,0.035834,0.062649,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.89907,0.035827,-0.026239,0,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.21905,0.035753,0.10856,0,0
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.69707,0.035704,-0.011069,0,0
2,GO CRANIAL NERVE DEVELOPMENT,0.67137,0.035667,-0.061516,0,0
2,GO CHLORIDE TRANSPORT,0.49227,0.035636,0.025545,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.29184,0.035526,0.036014,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.47588,0.03537,0.020826,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.34702,0.035361,0.020919,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.47049,0.035198,0.041503,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.98953,0.035074,-0.014027,0,0
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.63354,0.035062,0.0040174,0,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.17099,0.034998,0.078447,0,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.61497,0.034779,-0.010887,0,0
2,GO RESPONSE TO ESTROGEN,0.48678,0.034711,0.0087973,0,0
2,GO I KAPPAB PHOSPHORYLATION,0.98953,0.034662,-0.030051,0,0
2,GO AMYLOID BETA FORMATION,0.84397,0.034629,0.0047639,0,0
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.16828,0.034385,0.030482,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.11434,0.034342,0.062309,0,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.71006,0.034128,0.023519,0,0
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.36991,0.034056,0.024522,0,0
2,GO AORTA MORPHOGENESIS,0.89215,0.034007,-0.028269,0,0
2,GO GROWTH,0.51459,0.033947,0.014628,0,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.63978,0.033925,0.0085486,0,0
2,GO REGULATION OF FERTILIZATION,0.39371,0.033886,0.034041,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.50337,0.033874,-0.070401,0,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.89907,0.033782,0.011946,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.26847,0.033624,0.05577,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.48678,0.03326,0.034975,0,0
2,GO CHOLESTEROL EFFLUX,0.70355,0.033257,-0.045448,0,0
2,GO REGULATION OF CELL DEVELOPMENT,0.12473,0.033246,0.058581,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.43367,0.033047,0.036882,0,0
2,GO CELLULAR HOMEOSTASIS,0.23589,0.033012,0.031681,0,0
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.74288,0.032724,-0.042776,0,0
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.050569,0.032713,0.064769,0,0
2,GO CARTILAGE DEVELOPMENT,0.73628,0.032683,-0.0058453,0,0
2,GO PORE COMPLEX ASSEMBLY,0.80989,0.032664,-0.034393,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.85768,0.032642,-0.01039,0,0
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.56075,0.032546,0.027683,0,0
2,GO DNA CONFORMATION CHANGE,0.16032,0.032404,0.03942,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.70355,0.032357,-0.046804,0,0
2,GO RNA INTERFERENCE,0.20621,0.03234,0.069483,0,0
2,GO METHYLATION,0.033166,0.032322,0.058393,0,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.47588,0.032237,0.011778,0,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.4978,0.032095,0.0372,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.55487,0.03197,0.044068,0,0
2,GO PROTEIN ACETYLATION,0.26847,0.031965,0.017669,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.52594,0.031952,0.059015,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.3746,0.031909,0.033044,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.59664,0.031803,0.021365,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.71658,0.031783,0.0052435,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.24643,0.031667,0.018889,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.85082,0.031627,9.4196e-05,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.75615,0.031621,-0.0013877,0,0
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.097379,0.031562,0.062583,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.53167,0.031557,0.022321,0,0
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.2,0.031533,0.02891,0,0
2,GO NADPH REGENERATION,0.97557,0.03146,-0.014396,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.68418,0.031428,0.018659,0,0
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.86455,0.031386,0.010408,0,0
2,GO FOREBRAIN DEVELOPMENT,0.15773,0.031358,0.064155,0,0
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.25001,0.031311,0.038895,0,0
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.44402,0.031263,0.018939,0,0
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.67137,0.031137,0.014411,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.26847,0.030901,0.038266,0,0
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.42855,0.030871,0.025901,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.92682,0.030773,0.0029153,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.80989,0.030645,-0.0048553,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.78962,0.030489,0.0047626,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.51459,0.030433,0.023195,0,0
2,GO MUSCLE SYSTEM PROCESS,0.23937,0.030397,0.038068,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.78962,0.030362,0.0039012,0,0
2,GO ION HOMEOSTASIS,0.53742,0.030339,0.017595,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.20937,0.030078,0.067402,0,0
2,GO OVULATION CYCLE PROCESS,0.40349,0.030026,0.040106,0,0
2,GO DNA PACKAGING,0.33373,0.029913,0.028574,0,0
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.81668,0.029894,-0.012265,0,0
2,GO ENERGY HOMEOSTASIS,0.55487,0.029863,0.050136,0,0
2,GO QUINONE METABOLIC PROCESS,0.32938,0.029856,-0.15592,0,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.50896,0.029631,0.028245,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.58456,0.029594,0.057225,0,0
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.94769,0.029519,0.0078431,0,0
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.96163,0.029503,-0.013801,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.14769,0.02944,0.043423,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.9686,0.029394,-0.0081614,0,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.44924,0.029312,0.026918,0,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.91987,0.029294,-0.067343,0,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.71006,0.029261,-0.043304,0,0
2,GO SENSORY PERCEPTION OF PAIN,0.82348,0.029227,0.024267,0,0
2,GO RESPONSE TO GONADOTROPIN,0.92682,0.029167,-0.018143,0,0
2,GO MIRNA METABOLIC PROCESS,0.95466,0.029152,-0.00043178,0,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.66501,0.029119,0.0058449,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.94073,0.029071,-0.037658,0,0
2,GO DEVELOPMENTAL MATURATION,0.22905,0.028994,0.059102,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.96163,0.028993,0.013514,0,0
2,GO HISTONE EXCHANGE,0.31653,0.028887,0.039289,0,0
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.62113,0.028843,-0.063157,0,0
2,GO LYMPH NODE DEVELOPMENT,0.87144,0.028811,-0.013562,0,0
2,GO ACTIVATION OF MAPKK ACTIVITY,0.94769,0.028809,-0.0032546,0,0
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.67137,0.028734,0.051423,0,0
2,GO CONVERGENT EXTENSION,0.56666,0.028632,0.041216,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.4978,0.028512,0.02142,0,0
2,GO CHYLOMICRON ASSEMBLY,0.78962,0.028507,-0.019807,0,0
2,GO DNA REPLICATION,0.17653,0.028502,0.033985,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.29184,0.028124,0.017059,0,0
2,GO MIDBRAIN DEVELOPMENT,0.76281,0.028068,-0.035876,0,0
2,GO OXIDATION REDUCTION PROCESS,0.68418,0.028046,0.0095475,0,0
2,GO INORGANIC ANION TRANSPORT,0.42347,0.027832,0.015758,0,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.42855,0.027774,0.047455,0,0
2,GO METAL ION HOMEOSTASIS,0.84397,0.02774,0.0037628,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.23245,0.027726,0.10127,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.94073,0.027714,0.004058,0,0
2,GO CELL CYCLE ARREST,0.33373,0.027653,0.025913,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.42347,0.027639,0.031295,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.61497,0.027606,0.0067171,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.89907,0.027545,-0.023932,0,0
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.56075,0.027486,0.042877,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.52594,0.027418,0.038913,0,0
2,GO IRON ION TRANSPORT,0.77618,0.027225,-0.0098631,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.47049,0.027036,0.011729,0,0
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.46512,0.027007,0.03849,0,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.36526,0.026823,0.032309,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.5726,0.026772,0.026549,0,0
2,GO LAMELLIPODIUM MORPHOGENESIS,0.22568,0.026735,-0.14412,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.42347,0.026586,0.049709,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.25363,0.026583,0.047106,0,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.42347,0.026536,0.024151,0,0
2,GO PROTEIN ACYLATION,0.13583,0.026497,0.027667,0,0
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.80989,0.026417,0.0048714,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.88523,0.026403,-0.0021909,0,0
2,GO MRNA CLEAVAGE,0.22235,0.026381,0.051584,0,0
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.72969,0.026187,0.014482,0,0
2,GO CELLULAR RESPONSE TO RADIATION,0.72313,0.026019,-0.0023432,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.56075,0.026014,0.010009,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.12689,0.025895,0.046954,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.55487,0.025797,0.023933,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.55487,0.025671,0.027042,0,0
2,GO SEGMENTATION,0.48678,0.025492,0.021605,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.87833,0.025299,-0.040874,0,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.92682,0.025244,-0.012407,0,0
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.41842,0.025238,0.03403,0,0
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.87144,0.025062,-0.039824,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.58456,0.024944,-0.06273,0,0
2,GO NERVOUS SYSTEM PROCESS,0.34702,0.024861,0.038292,0,0
2,GO REGULATION OF GLIOGENESIS,0.78289,0.024815,0.012054,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.38408,0.024716,0.01842,0,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.54321,0.02446,0.042752,0,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.82348,0.024273,0.004358,0,0
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.9686,0.02426,-0.035691,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.70355,0.02423,-0.006168,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.81668,0.024143,-0.031975,0,0
2,GO REGULATION OF FIBRINOLYSIS,0.68418,0.024101,-0.09294,0,0
2,GO FILOPODIUM ASSEMBLY,0.46512,0.023969,0.037676,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.88523,0.023937,-0.016667,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.63978,0.02391,0.020487,0,0
2,GO CHROMOSOME SEPARATION,0.42855,0.02386,0.025272,0,0
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.98255,0.023852,-0.025406,0,0
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.39371,0.023753,0.024745,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.72969,0.023648,0.032474,0,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.34256,0.023635,0.060195,0,0
2,GO HISTONE H3 K4 METHYLATION,0.95466,0.023547,0.0012104,0,0
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.65234,0.023542,0.012827,0,0
2,GO REGULATION OF TELOMERASE ACTIVITY,0.83713,0.023357,-0.018905,0,0
2,GO REGULATION OF GROWTH,0.90599,0.023354,-0.00044268,0,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.96163,0.023258,-0.033939,0,0
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.13814,0.023166,0.084946,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.96163,0.02307,-0.010031,0,0
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.86455,0.023017,-0.017188,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.13583,0.022928,0.060352,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.70355,0.022912,0.010331,0,0
2,GO INTERACTION WITH SYMBIONT,0.4545,0.022889,0.0019219,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.72313,0.022857,-0.06373,0,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.62732,0.022769,0.022613,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.98953,0.022752,-0.017444,0,0
2,GO WATER TRANSPORT,0.91293,0.022676,-0.0035743,0,0
2,GO REGULATION OF RECEPTOR RECYCLING,0.61497,0.022614,-0.038741,0,0
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.16828,0.022592,0.024635,0,0
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.64605,0.022425,0.03981,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.61497,0.022396,0.049255,0,0
2,GO REGULATION OF RNA SPLICING,0.2,0.021959,0.036933,0,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.61497,0.021905,0.09446,0,0
2,GO INTERMEMBRANE LIPID TRANSFER,0.95466,0.021783,-0.0027989,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.37932,0.02162,0.035968,0,0
2,GO DNA METABOLIC PROCESS,0.39858,0.021597,0.015568,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.60272,0.021583,0.044211,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.72313,0.021456,0.004522,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.60272,0.021411,-0.075543,0,0
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.79636,0.021405,-0.0081328,0,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.71006,0.021397,-0.059285,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.73628,0.021363,-0.015008,0,0
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.26471,0.021339,0.07162,0,0
2,GO PROTEIN METHYLATION,0.59059,0.021317,0.020162,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.39371,0.021265,0.10921,0,0
2,GO REGULATION OF BEHAVIOR,0.67137,0.021183,0.017133,0,0
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.98953,0.021103,0.002342,0,0
2,GO PEPTIDYL ARGININE MODIFICATION,0.13814,0.020855,0.082401,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.53167,0.020774,0.023525,0,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.70355,0.020711,0.020402,0,0
2,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.36064,0.020512,0.024503,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.70355,0.020481,0.0053225,0,0
2,GO DNA RECOMBINATION,0.50896,0.020447,0.011395,0,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.17653,0.020436,0.12032,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.32938,0.02037,-0.10796,0,0
2,GO SNRNA TRANSCRIPTION,0.23937,0.020297,0.025213,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.85082,0.02027,0.0037798,0,0
2,GO FOREGUT MORPHOGENESIS,0.8303,0.02027,-0.019063,0,0
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.72313,0.020237,-0.00023766,0,0
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.39371,0.020216,0.097113,0,0
2,GO CHROMATIN REMODELING,0.23589,0.020082,0.036679,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.36991,0.020018,0.057893,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.57857,0.019838,0.017424,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.94769,0.019723,-0.004214,0,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.56666,0.01962,-0.096087,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.68418,0.019617,0.028103,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.66501,0.019419,0.0024772,0,0
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.27999,0.019343,0.048686,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.42347,0.019231,0.069953,0,0
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.31653,0.01916,0.034708,0,0
2,GO NEURAL TUBE PATTERNING,0.98953,0.019061,-0.0099716,0,0
2,GO REGULATION OF MYELINATION,0.51459,0.019049,0.051814,0,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.78962,0.018996,-0.01939,0,0
2,GO SECONDARY PALATE DEVELOPMENT,0.53167,0.018966,-0.057617,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.91293,0.018898,0.0007021,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.30402,0.018874,0.14205,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.95466,0.018871,-0.019809,0,0
2,GO BRAIN MORPHOGENESIS,0.67776,0.018857,0.044687,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.67776,0.018855,0.01276,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.48678,0.018828,0.059431,0,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.50896,0.018781,0.026803,0,0
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.92682,0.0187,0.014684,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.67776,0.018616,-0.066419,0,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.42855,0.018591,0.029812,0,0
2,GO DENDRITE EXTENSION,0.34702,0.018508,0.14333,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.43883,0.018494,0.025655,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.42347,0.018441,0.05027,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.4598,0.018052,0.021581,0,0
2,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.94073,0.018001,0.039363,0,0
2,GO HISTONE H3 K4 TRIMETHYLATION,0.87833,0.017889,-0.011816,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.24643,0.017792,0.042424,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.47588,0.017532,0.01762,0,0
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.86455,0.017507,-0.0079791,0,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.27611,0.017285,0.039654,0,0
2,GO PROSTATIC BUD FORMATION,0.83713,0.017271,-0.094231,0,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.63354,0.017071,-0.059135,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.80312,0.017066,-0.0033325,0,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.85768,0.017032,-0.022861,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.46512,0.016925,0.02599,0,0
2,GO TRANSITION METAL ION HOMEOSTASIS,0.56075,0.016895,0.015071,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.84397,0.016853,0.0044396,0,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.26847,0.016798,0.038712,0,0
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.27611,0.016703,0.053101,0,0
2,GO REGULATION OF OOGENESIS,0.44924,0.01662,-0.056119,0,0
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.90599,0.01645,0.007407,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.71006,0.016362,0.020384,0,0
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.53167,0.016183,0.025218,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.63354,0.016057,0.035845,0,0
2,GO DETECTION OF VISIBLE LIGHT,0.48131,0.0159,0.044241,0,0
2,GO ORGANELLE FUSION,0.80989,0.015796,-0.0066239,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.89215,0.015664,-0.032996,0,0
2,GO NODAL SIGNALING PATHWAY,0.9686,0.015654,-0.016513,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.42347,0.015603,0.049487,0,0
2,GO VESICLE DOCKING,0.48678,0.015435,0.035588,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.85082,0.015429,-0.010858,0,0
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.35607,0.015387,0.027589,0,0
2,GO ENSHEATHMENT OF NEURONS,0.75615,0.015249,0.0062892,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.38888,0.015212,0.045411,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.38888,0.015163,0.026909,0,0
2,GO SOMATIC STEM CELL DIVISION,0.87144,0.015116,0.024833,0,0
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.95466,0.015107,-0.01713,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.69707,0.015035,-0.00017288,0,0
2,GO RESPONSE TO CAMP,0.29184,0.014955,0.047401,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.64605,0.014931,0.018597,0,0
2,GO REGULATION OF PROTEIN MATURATION,0.78289,0.014886,-0.048514,0,0
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.99651,0.014794,-0.053607,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.82348,0.014788,0.015365,0,0
2,GO COMPLEMENT ACTIVATION,0.8303,0.014705,-0.056068,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.4598,0.014615,0.040127,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.94073,0.014529,-0.013746,0,0
2,GO LYSOSOME LOCALIZATION,0.43883,0.014507,-0.054235,0,0
2,GO RESPONSE TO PROSTAGLANDIN,0.54903,0.014507,0.016201,0,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.93377,0.014461,-0.018421,0,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.92682,0.014395,-0.020453,0,0
2,GO HISTONE DEACETYLATION,0.86455,0.014311,-0.0095593,0,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.81668,0.014272,-0.058788,0,0
2,GO SYNCYTIUM FORMATION,0.91293,0.014208,-0.00773,0,0
2,GO CELLULAR ION HOMEOSTASIS,0.78962,0.014174,0.0070492,0,0
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.98953,0.014172,-0.014974,0,0
2,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.63354,0.014161,0.030027,0,0
2,GO REGULATION OF MICROTUBULE BINDING,0.36064,0.014122,0.06788,0,0
2,GO CELL CYCLE PHASE TRANSITION,0.91987,0.01403,-0.0022613,0,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.73628,0.014016,-0.00043295,0,0
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.78962,0.013994,-0.0028564,0,0
2,GO MEMBRANE BIOGENESIS,0.91293,0.013919,-0.016019,0,0
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.56075,0.013905,0.031828,0,0
2,GO REGULATION OF ENDOCYTOSIS,0.97557,0.013786,-0.000796,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.98953,0.013741,9.2521e-05,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.99651,0.013716,0.0016867,0,0
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.23937,0.013563,0.0867,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.63354,0.013491,0.030871,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.48131,0.013438,0.010475,0,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.49227,0.013319,-0.052704,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.41341,0.013302,0.020149,0,0
2,GO RESPONSE TO MUSCLE STRETCH,0.65234,0.012963,0.019026,0,0
2,GO TERPENOID METABOLIC PROCESS,0.53167,0.012959,-0.048455,0,0
2,GO CELL CELL SIGNALING BY WNT,0.67776,0.012924,0.0040329,0,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,1,0.012924,-0.010853,0,0
2,GO SOMITOGENESIS,0.75615,0.012884,-0.013891,0,0
2,GO NCRNA CATABOLIC PROCESS,0.92682,0.012874,-0.00061769,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.50337,0.012845,-0.03428,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.8303,0.012791,-0.0018795,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.68418,0.012757,0.015022,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.93377,0.012426,-0.011165,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.5726,0.012155,-0.022016,0,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.22905,0.01208,0.023931,0,0
2,GO HINDBRAIN DEVELOPMENT,0.34702,0.012054,0.056454,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.97557,0.011896,-0.010103,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.85768,0.011887,0.0023157,0,0
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.82348,0.01186,0.010332,0,0
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.79636,0.011832,-0.0006604,0,0
2,GO VASODILATION,0.30402,0.011816,0.058037,0,0
2,GO MITOCHONDRIAL TRNA PROCESSING,0.29184,0.011812,0.1047,0,0
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.68418,0.011693,0.037641,0,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.72313,0.011683,0.0096705,0,0
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.62732,0.011669,-0.044504,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.52025,0.011663,-0.060471,0,0
2,GO MANNOSYLATION,0.72313,0.01166,-0.041711,0,0
2,GO MITOCHONDRIAL TRANSPORT,0.57857,0.011623,0.0083721,0,0
2,GO MESENCHYME DEVELOPMENT,0.92682,0.011533,-0.017653,0,0
2,GO HEAD DEVELOPMENT,0.38888,0.011522,0.035896,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.85768,0.011515,-0.0063422,0,0
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.97557,0.011501,-0.0084849,0,0
2,GO DOUBLE STRAND BREAK REPAIR,0.70355,0.011466,0.010564,0,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.76948,0.011348,0.00081077,0,0
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.40843,0.011263,-0.051516,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.95466,0.011262,-0.0044998,0,0
2,GO RESPONSE TO ATP,0.54321,0.011184,0.023555,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.90599,0.011106,-0.077073,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.57857,0.011054,-0.021601,0,0
2,GO VISUAL BEHAVIOR,0.48678,0.011038,0.036199,0,0
2,GO REGULATION OF LIPASE ACTIVITY,0.76948,0.011037,-0.010956,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.9686,0.010961,-0.042987,0,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.92682,0.010889,-0.0036678,0,0
2,GO DNA LIGATION,0.97557,0.010881,-0.0011536,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.71006,0.010711,0.0058404,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.9686,0.0107,-0.01829,0,0
2,GO SOMITE DEVELOPMENT,0.72969,0.010665,0.01032,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.57857,0.010611,0.05109,0,0
2,GO RECEPTOR METABOLIC PROCESS,0.69707,0.010605,0.01992,0,0
2,GO CELL FATE COMMITMENT,0.77618,0.01056,-0.019383,0,0
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.56666,0.010495,0.017299,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.98953,0.010484,-0.0071665,0,0
2,GO HINDBRAIN MORPHOGENESIS,0.5726,0.010333,0.045606,0,0
2,GO REGULATION OF FEEDING BEHAVIOR,0.19095,0.010159,0.10225,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.87833,0.010127,-0.010742,0,0
2,GO MITOTIC DNA REPLICATION,0.90599,0.010126,-0.013772,0,0
2,GO THYMUS DEVELOPMENT,0.93377,0.010049,-0.0022784,0,0
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.78289,0.010027,0.0062207,0,0
2,GO RHYTHMIC PROCESS,0.90599,0.0097994,0.002983,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76281,0.0097513,0.011355,0,0
2,GO STEM CELL DIFFERENTIATION,0.76281,0.0096906,-0.018138,0,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.76948,0.0096897,-0.0073922,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.65866,0.0095956,0.0069814,0,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.81668,0.0094596,0.0014535,0,0
2,GO GLIAL CELL PROLIFERATION,0.72969,0.0093701,-0.038691,0,0
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.59059,0.0093476,0.01958,0,0
2,GO RESPONSE TO DRUG,0.57857,0.0091927,0.020593,0,0
2,GO INTRACELLULAR TRANSPORT,0.9686,0.0091498,-0.0026833,0,0
2,GO LYMPHOCYTE HOMEOSTASIS,0.89907,0.0091333,-0.010242,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.91987,0.0091104,0.0022079,0,0
2,GO HEAD MORPHOGENESIS,0.73628,0.0090675,-0.054164,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.82348,0.0090306,0.012044,0,0
2,GO INSEMINATION,0.56666,0.0090097,-0.071983,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.83713,0.0088583,-0.029768,0,0
2,GO RESPONSE TO IONIZING RADIATION,0.60272,0.0086388,-0.036803,0,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.78289,0.0085554,-0.042887,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.86455,0.0083696,-0.047653,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.71006,0.0083209,-0.041158,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.63978,0.0083131,-0.031907,0,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.73628,0.0082851,0.011449,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.52594,0.0082561,0.044908,0,0
2,GO REGULATION OF ATPASE ACTIVITY,0.9686,0.0081832,-0.010798,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.87144,0.0081344,-0.0070383,0,0
2,GO FIBROBLAST ACTIVATION,0.80312,0.0081279,-0.041497,0,0
2,GO NUCLEOSOME ASSEMBLY,0.55487,0.0080678,0.024743,0,0
2,GO RESPONSE TO FATTY ACID,0.63354,0.007977,0.014849,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.32077,0.0079634,-0.06499,0,0
2,GO CALCIUM MEDIATED SIGNALING,0.5726,0.0078482,0.013017,0,0
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.39858,0.0078203,-0.050042,0,0
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.96163,0.0078085,-0.0010393,0,0
2,GO REGULATION OF DENDRITE EXTENSION,0.5726,0.0077551,0.11384,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.62732,0.0077524,0.039512,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.61497,0.0077184,-0.037848,0,0
2,GO POSITIVE REGULATION OF BINDING,0.89215,0.0076239,0.005204,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.76948,0.0075946,-0.023653,0,0
2,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.59059,0.007441,-0.043833,0,0
2,GO ENDOCYTOSIS,0.73628,0.0073062,0.0071156,0,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.41341,0.0072445,0.032636,0,0
2,GO TETRAPYRROLE METABOLIC PROCESS,0.78289,0.0070853,0.00025501,0,0
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.91987,0.0070363,-0.024636,0,0
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.43883,0.0069035,0.021505,0,0
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.96163,0.0068807,-0.025694,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.91987,0.0068506,-0.020342,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.72969,0.0068365,0.021299,0,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.90599,0.0067852,-0.0039021,0,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.73628,0.0067294,-0.0023183,0,0
2,GO DNA STRAND ELONGATION,0.79636,0.0066817,0.033476,0,0
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.40349,0.006628,0.032395,0,0
2,GO SPINAL CORD DEVELOPMENT,0.56666,0.0065917,0.036106,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.8303,0.0064893,-0.02342,0,0
2,GO ISOPRENOID METABOLIC PROCESS,0.41842,0.0064745,-0.050097,0,0
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.39858,0.0064415,-0.082113,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.71006,0.0064107,-0.062065,0,0
2,GO PEPTIDYL LYSINE MODIFICATION,0.81668,0.0064007,-0.0014967,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.3746,0.0063876,0.036079,0,0
2,GO TRANSITION METAL ION TRANSPORT,0.9686,0.0062893,-0.012317,0,0
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.69707,0.0062535,-0.03318,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.9686,0.0061402,0.0075368,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.85768,0.0060765,-0.0030939,0,0
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.71658,0.0059511,-0.039991,0,0
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.50337,0.0059337,-0.048614,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.96163,0.0058761,-0.011583,0,0
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.74288,0.005827,0.038529,0,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.74288,0.005808,-0.056682,0,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.98953,0.0056344,0.0085193,0,0
2,GO VESICLE CARGO LOADING,0.96163,0.0055976,-0.034602,0,0
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.47049,0.0055959,-0.076542,0,0
2,GO STEROL TRANSPORT,0.5726,0.0055668,-0.042278,0,0
2,GO COVALENT CHROMATIN MODIFICATION,0.84397,0.0055293,0.0032237,0,0
2,GO ASTROCYTE DIFFERENTIATION,0.98953,0.0053946,0.0052026,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.85768,0.0053581,-0.0010191,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.79636,0.005149,-0.026913,0,0
2,GO MIDGUT DEVELOPMENT,0.96163,0.0051445,-0.015151,0,0
2,GO CHONDROCYTE PROLIFERATION,0.91987,0.0051153,0.0016201,0,0
2,GO CELLULAR RESPONSE TO ATP,0.3746,0.0050817,0.047175,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.41842,0.0050806,0.031823,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.72969,0.0050624,-0.043073,0,0
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.94073,0.0050359,-0.0048989,0,0
2,GO HEART GROWTH,0.2839,0.0050315,0.056927,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.30815,0.0050261,0.037477,0,0
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.63354,0.0049954,0.013793,0,0
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.61497,0.0049698,0.037935,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.97557,0.0049425,-0.0017851,0,0
2,GO CHROMATIN ORGANIZATION,0.98255,0.004924,-0.0017387,0,0
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.85082,0.0049136,-0.061184,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.48131,0.0048492,0.023663,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.52025,0.0048344,0.01364,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.66501,0.0047222,-0.063692,0,0
2,GO MACROMOLECULE DEACYLATION,0.65866,0.0047171,0.015379,0,0
2,GO CELL CYCLE PROCESS,0.89215,0.0046228,-0.003076,0,0
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.74288,0.0046221,-0.027191,0,0
2,GO RECEPTOR RECYCLING,0.91293,0.004562,-0.012386,0,0
2,GO ADULT LOCOMOTORY BEHAVIOR,0.38408,0.0044266,0.080401,0,0
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.31653,0.0043766,0.044046,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.69061,0.0042673,-0.0027631,0,0
2,GO REGULATION OF BINDING,0.62732,0.0042594,-0.01871,0,0
2,GO HYPEROSMOTIC RESPONSE,0.78289,0.0042529,-0.031204,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.90599,0.004252,0.011128,0,0
2,GO PEPTIDYL SERINE MODIFICATION,0.33812,0.0041312,-0.028558,0,0
2,GO REGULATION OF PROTEIN STABILITY,0.62732,0.0041212,-0.016858,0,0
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.90599,0.0039969,-0.011779,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.52594,0.0038315,0.034647,0,0
2,GO ACTIN FILAMENT BASED MOVEMENT,0.85082,0.0037939,-0.0089701,0,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.7495,0.0037598,0.0014151,0,0
2,GO DRUG METABOLIC PROCESS,0.7495,0.0037539,-0.0068088,0,0
2,GO METHIONINE METABOLIC PROCESS,0.91293,0.0036902,-0.018883,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.73628,0.0036781,-0.043312,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.63978,0.0034803,-0.040616,0,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.63354,0.0034268,0.01767,0,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.72313,0.0033832,0.014453,0,0
2,GO REGULATION OF CELL CYCLE PROCESS,0.97557,0.0033497,-0.0034348,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.33812,0.0033183,0.048085,0,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.77618,0.0032772,-0.0396,0,0
2,GO POSITIVE REGULATION OF MYELINATION,0.53167,0.0032278,0.045445,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.91293,0.0032274,-0.017486,0,0
2,GO MAST CELL MIGRATION,0.79636,0.0030541,-0.057608,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.9686,0.0030387,-0.0057029,0,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.72969,0.0030025,0.01727,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.75615,0.0029931,0.03214,0,0
2,GO MITOTIC CELL CYCLE,0.87144,0.0029303,-0.009113,0,0
2,GO DOPAMINE METABOLIC PROCESS,0.96163,0.0028974,0.028137,0,0
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.93377,0.0028891,-0.0074689,0,0
2,GO ACTIVATION OF JNKK ACTIVITY,0.89215,0.0028527,-0.012984,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.59059,0.0027225,-0.033148,0,0
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.68418,0.0026018,0.0055043,0,0
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.75615,0.0024251,0.011794,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.56666,0.0021858,0.027748,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.66501,0.0021491,-0.012893,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.96163,0.0020983,-0.00019962,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.42855,0.0020975,0.092799,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.65234,0.0019754,0.060867,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.49227,0.0019008,-0.065546,0,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.76948,0.0018088,-0.0023158,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.91987,0.0017719,0.0062413,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.69061,0.001762,0.016804,0,0
2,GO CELL PROJECTION ORGANIZATION,0.66501,0.0017527,0.018766,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.71658,0.0017109,0.023363,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.75615,0.0015939,-0.042717,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.9686,0.0014908,-0.0014358,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.9686,0.0014733,-0.0091945,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.85082,0.0014074,-0.034616,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.52025,0.0012349,0.026247,0,0
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.89907,0.0012121,-0.012278,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.31232,0.0011984,-0.059052,0,0
2,GO RESPONSE TO INTERLEUKIN 4,0.59059,0.0011784,-0.036901,0,0
2,GO IMPORT INTO NUCLEUS,0.93377,0.0011547,-0.0035695,0,0
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.78289,0.0011132,-0.048874,0,0
2,GO LIPID PHOSPHORYLATION,0.50337,0.0010831,0.041144,0,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.53167,0.0010643,-0.039973,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.65866,0.0010595,0.033711,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.44402,0.00094454,0.029056,0,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.78962,0.00092425,-0.029875,0,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.72969,0.00085306,-0.076354,0,0
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.87144,0.00066066,0.0056869,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.97557,0.00061569,-0.001468,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.80312,0.00058415,0.013009,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.83713,0.00054748,-0.013983,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.85768,0.00049936,-0.030225,0,0
2,GO RESPONSE TO NICOTINE,0.69061,0.00045567,0.027831,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.54321,0.00034335,-0.014881,0,0
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.41341,0.00014907,0.021634,0,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.91293,0.00013118,0.00040004,0,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.75615,0.00011039,0.014211,0,0
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.83713,5.2757e-05,-0.039116,0,0
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.5726,-4.8057e-05,-0.016782,0,0
2,GO MAINTENANCE OF LOCATION,0.78289,-6.148e-05,0.0098354,0,0
2,GO PROTEIN AUTOPROCESSING,0.98953,-0.00016379,-0.022545,0,0
2,GO PIRNA METABOLIC PROCESS,0.48131,-0.0002303,-0.10914,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.52025,-0.00023226,-0.028183,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.77618,-0.00036335,0.0048093,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.63354,-0.000428,-0.044165,0,0
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.96163,-0.00048452,0.0017186,0,0
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.80312,-0.00049308,-0.05234,0,0
2,GO MUSCLE HYPERTROPHY,0.72969,-0.00058105,-0.028925,0,0
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.41842,-0.0007005,-0.034803,0,0
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,1,-0.00076563,-0.031239,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.76948,-0.00085104,-0.029858,0,0
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.62732,-0.00086836,0.019572,0,0
2,GO FEVER GENERATION,0.53742,-0.0010039,0.030955,0,0
2,GO REGULATION OF RESPONSE TO FOOD,0.69061,-0.001153,-0.019731,0,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.80989,-0.0011931,-0.0028538,0,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.50896,-0.0012676,-0.044833,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.79636,-0.0012742,0.0056948,0,0
2,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.96163,-0.0012755,-0.0061296,0,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.52594,-0.0013027,0.025534,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.78962,-0.001415,-0.014481,0,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.89215,-0.0014205,0.011426,0,0
2,GO BODY FLUID SECRETION,0.81668,-0.0014761,0.0029811,0,0
2,GO RESPONSE TO GLUCAGON,0.91987,-0.0015068,-0.014708,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.60883,-0.0015098,-0.030795,0,0
2,GO OVULATION CYCLE,0.4978,-0.0015213,0.032306,0,0
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.97557,-0.0016361,0.0037829,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.63354,-0.0016612,-0.02543,0,0
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.85768,-0.0016885,-0.0014084,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.94769,-0.0017264,-0.012812,0,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.67137,-0.0017465,-0.066126,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.59664,-0.0019113,-0.030114,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.39858,-0.0019951,0.039776,0,0
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.85768,-0.0020953,-0.059625,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.78962,-0.0021106,-0.043574,0,0
2,GO REGULATION OF CYTOKINESIS,0.43883,-0.002141,-0.032988,0,0
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.78289,-0.0021447,0.0050345,0,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.97557,-0.0021541,-0.011407,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.7495,-0.0021752,-0.039342,0,0
2,GO NUCLEOSIDE SALVAGE,0.36991,-0.0022156,0.039444,0,0
2,GO EXOCYTIC PROCESS,0.56666,-0.002245,0.062948,0,0
2,GO PIGMENT GRANULE MATURATION,0.85768,-0.0023048,-0.054706,0,0
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.97557,-0.0023323,-0.0083782,0,0
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.84397,-0.0023651,-0.025005,0,0
2,GO TAXIS,0.7495,-0.0024014,-0.010814,0,0
2,GO NEURON DEATH,0.92682,-0.0025196,-0.0017035,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.95466,-0.0026231,-0.013383,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.83713,-0.0030017,0.0066233,0,0
2,GO DOSAGE COMPENSATION,0.8303,-0.0030349,-0.013877,0,0
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.58456,-0.0030703,-0.15633,0,0
2,GO CHROMOSOME ORGANIZATION,0.87833,-0.0030851,0.0056816,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.37932,-0.0032129,-0.048803,0,0
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.40349,-0.003424,0.021385,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.93377,-0.0035655,-0.017228,0,0
2,GO RESPONSE TO LIGHT STIMULUS,0.60883,-0.0037699,0.020089,0,0
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.80989,-0.0038033,0.010839,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.68418,-0.0038524,-0.013559,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.53742,-0.0038826,0.035653,0,0
2,GO CHEMICAL HOMEOSTASIS,0.95466,-0.003967,-0.0080533,0,0
2,GO HEART MORPHOGENESIS,0.99651,-0.0041449,-0.018148,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.54903,-0.0041466,-0.019115,0,0
2,GO ORGANIC ACID TRANSPORT,0.55487,-0.0042215,0.017458,0,0
2,GO REGULATION OF CATABOLIC PROCESS,0.94073,-0.004325,-0.0048182,0,0
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.97557,-0.0043475,-0.013154,0,0
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.94769,-0.0043516,-0.016717,0,0
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.80312,-0.0043878,-0.024818,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.67776,-0.0045072,0.0046049,0,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.52025,-0.0047153,-0.030987,0,0
2,GO RESPONSE TO PH,0.76948,-0.004738,-0.027486,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.69707,-0.0047639,-0.021699,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.71658,-0.0048014,-0.013175,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.80312,-0.0048961,-0.015413,0,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.75615,-0.0049049,-0.025801,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.97557,-0.005009,0.0067403,0,0
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.72313,-0.005061,-0.052126,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.55487,-0.0050735,0.08997,0,0
2,GO MACROMOLECULE CATABOLIC PROCESS,0.90599,-0.0050959,-0.0070516,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.61497,-0.0051145,-0.021377,0,0
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.87144,-0.0051889,0.013658,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.72313,-0.0052208,-0.050558,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.82348,-0.0052434,-0.0048747,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.65866,-0.0052449,-0.048825,0,0
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.66501,-0.005382,-0.043445,0,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.20621,-0.0057439,-0.059669,0,0
2,GO CELLULAR OXIDANT DETOXIFICATION,0.87144,-0.0061845,-0.014707,0,0
2,GO LIPID CATABOLIC PROCESS,0.47588,-0.0062484,-0.037588,0,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.65234,-0.0063962,-0.022471,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.56666,-0.0064213,-0.021922,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.3746,-0.0064736,0.045386,0,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.91293,-0.0065886,-0.010019,0,0
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.95466,-0.0066102,-0.030804,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.85768,-0.0067242,0.0015205,0,0
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.48131,-0.0067761,0.044148,0,0
2,GO HEAT GENERATION,0.62113,-0.0067979,-0.041792,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.76281,-0.0068298,-0.040138,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.49227,-0.0068596,-0.061985,0,0
2,GO BLASTODERM SEGMENTATION,0.4978,-0.0069007,0.08959,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.44402,-0.0069391,-0.061373,0,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.31232,-0.006964,-0.10786,0,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.58456,-0.0069784,-0.030028,0,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.76948,-0.0071088,-0.0088894,0,0
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.86455,-0.0071364,0.018294,0,0
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.87833,-0.007325,-0.045401,0,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.7495,-0.0073674,-0.011251,0,0
2,GO HINDLIMB MORPHOGENESIS,0.66501,-0.0074091,0.010561,0,0
2,GO POLYOL BIOSYNTHETIC PROCESS,0.86455,-0.0074578,-0.016199,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.84397,-0.0076558,-0.01464,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.76281,-0.0076769,-0.0092746,0,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.92682,-0.0077309,-0.018139,0,0
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.80989,-0.008001,-0.01596,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.89907,-0.0080193,-0.0045908,0,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.70355,-0.0080197,-0.011913,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.65234,-0.0080541,-0.025212,0,0
2,GO SERTOLI CELL DEVELOPMENT,0.89215,-0.0080773,0.020725,0,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.83713,-0.0081249,-0.022048,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.71006,-0.0081736,-0.041355,0,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.61497,-0.008546,0.029044,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.80989,-0.0085715,-0.015401,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.54321,-0.0086583,-0.029287,0,0
2,GO APOPTOTIC CELL CLEARANCE,0.82348,-0.0088617,-0.082832,0,0
2,GO ERK1 AND ERK2 CASCADE,0.51459,-0.0089105,-0.046951,0,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.85768,-0.0089968,-0.012245,0,0
2,GO TRACHEA MORPHOGENESIS,0.89907,-0.0091072,-0.018687,0,0
2,GO DRINKING BEHAVIOR,0.7495,-0.0093318,-0.0030326,0,0
2,GO PIGMENT GRANULE ORGANIZATION,0.97557,-0.0093498,0.0090277,0,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.69707,-0.009508,-0.004935,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.87144,-0.00953,-0.011361,0,0
2,GO RESPONSE TO X RAY,0.60272,-0.0096007,-0.065705,0,0
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.50896,-0.0096237,-0.068419,0,0
2,GO FIBROBLAST PROLIFERATION,0.54903,-0.0097005,0.024163,0,0
2,GO MITRAL VALVE DEVELOPMENT,0.59664,-0.00975,-0.0624,0,0
2,GO PERICARDIUM DEVELOPMENT,0.94073,-0.0097832,-0.011658,0,0
2,GO RESPONSE TO ETHANOL,0.99651,-0.0098929,-0.00047781,0,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.60883,-0.010035,-0.049841,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.65866,-0.01009,-0.037508,0,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.62732,-0.010112,-0.030351,0,0
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.53167,-0.010163,-0.041355,0,0
2,GO PROSTATE GLAND DEVELOPMENT,0.69707,-0.010221,-0.027857,0,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.49227,-0.010278,0.037499,0,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.8303,-0.010279,-0.010079,0,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.73628,-0.010351,-0.018502,0,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.81668,-0.010369,0.0030049,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.65234,-0.010619,-0.0232,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.97557,-0.010684,-0.013915,0,0
2,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.60272,-0.010713,-0.10836,0,0
2,GO HEART DEVELOPMENT,0.48678,-0.010727,-0.037599,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.36064,-0.010749,-0.084745,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.99651,-0.010795,-0.023231,0,0
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.31653,-0.010802,-0.029142,0,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.80989,-0.010999,-0.0041155,0,0
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.95466,-0.011084,0.01409,0,0
2,GO GENE SILENCING,0.40843,-0.011122,-0.021814,0,0
2,GO SENSORY PERCEPTION OF SMELL,0.44924,-0.011182,-0.034949,0,0
2,GO CELLULAR RESPONSE TO ZINC ION,0.67776,-0.011203,-0.1668,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.68418,-0.011264,-0.036411,0,0
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.64605,-0.011307,0.058723,0,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.19095,-0.011431,-0.080238,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.4545,-0.011468,-0.032258,0,0
2,GO RESPONSE TO AXON INJURY,0.91293,-0.011778,-0.0012456,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.62113,-0.011837,-0.034786,0,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.44402,-0.011893,0.12852,0,0
2,GO VESICLE LOCALIZATION,0.26847,-0.012029,-0.033037,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.47049,-0.012085,-0.032097,0,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.69061,-0.012213,-0.018482,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.40843,-0.012282,-0.041562,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.44924,-0.012391,-0.031789,0,0
2,GO MESODERM DEVELOPMENT,0.44924,-0.012459,-0.050142,0,0
2,GO FEMALE SEX DIFFERENTIATION,0.56075,-0.012515,-0.022809,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.62732,-0.012588,0.025694,0,0
2,GO PROTEIN SUMOYLATION,0.77618,-0.012736,-0.0075734,0,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.50337,-0.012781,-0.022183,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.87833,-0.012867,-0.0079675,0,0
2,GO BIOMINERALIZATION,0.89215,-0.012871,-0.020201,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.34256,-0.012913,-0.031051,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.55487,-0.012973,0.085402,0,0
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.17934,-0.013086,-0.058279,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.21579,-0.013223,-0.045768,0,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.33812,-0.01325,-0.059833,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.93377,-0.013264,0.0035065,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.57857,-0.013331,-0.027579,0,0
2,GO DNA BIOSYNTHETIC PROCESS,0.65866,-0.013388,-0.013358,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.76948,-0.013403,0.024341,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.20309,-0.013471,-0.05008,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.56666,-0.013499,-0.066469,0,0
2,GO POLYOL CATABOLIC PROCESS,0.78962,-0.013535,-0.024826,0,0
2,GO GASTRULATION,0.65866,-0.013544,-0.044904,0,0
2,GO MICROTUBULE ANCHORING,0.63978,-0.013549,-0.024947,0,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.56666,-0.013641,-0.035936,0,0
2,GO PHOTOPERIODISM,0.88523,-0.013648,-0.015083,0,0
2,GO BLASTOCYST DEVELOPMENT,0.60272,-0.013652,-0.018421,0,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.98255,-0.013772,-0.0020253,0,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.36064,-0.013815,-0.055739,0,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.7495,-0.013861,-0.027981,0,0
2,GO SERTOLI CELL DIFFERENTIATION,0.96163,-0.013871,-5.346e-05,0,0
2,GO RETROGRADE AXONAL TRANSPORT,0.93377,-0.013925,0.012308,0,0
2,GO REGULATION OF FATTY ACID OXIDATION,0.65866,-0.013971,0.046057,0,0
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.8303,-0.013999,0.0024329,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.36526,-0.014096,-0.039662,0,0
2,GO NEUROINFLAMMATORY RESPONSE,0.72969,-0.014098,-0.032344,0,0
2,GO REGULATION OF BIOMINERALIZATION,0.59664,-0.014158,-0.038722,0,0
2,GO MITOPHAGY,0.33812,-0.014368,-0.059769,0,0
2,GO VITAMIN TRANSPORT,0.78289,-0.01444,0.035671,0,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.96163,-0.014539,-0.053293,0,0
2,GO HISTONE PHOSPHORYLATION,0.5726,-0.014694,-0.040065,0,0
2,GO HISTONE H3 K9 METHYLATION,0.59664,-0.01473,-0.027067,0,0
2,GO CELL DIVISION,0.48131,-0.014868,-0.022416,0,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.80312,-0.015031,-0.031949,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.60272,-0.015053,-0.043052,0,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.60272,-0.015136,-0.0088106,0,0
2,GO REGULATION OF HISTONE MODIFICATION,0.89215,-0.015318,-0.0092663,0,0
2,GO REGULATION OF T CELL MIGRATION,0.42347,-0.015403,-0.054232,0,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.40843,-0.015546,-0.019983,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.87144,-0.015547,-0.015575,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.81668,-0.015593,-0.0057824,0,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.15517,-0.015865,-0.045594,0,0
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.98255,-0.015901,-0.023011,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.39371,-0.015977,-0.05669,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.4545,-0.016055,-0.03357,0,0
2,GO SPINDLE ORGANIZATION,0.39858,-0.016137,-0.028088,0,0
2,GO GLIOGENESIS,0.74288,-0.016142,-0.017504,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.59664,-0.016208,-0.068997,0,0
2,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.61497,-0.016301,0.028317,0,0
2,GO RESPONSE TO STEROL,0.77618,-0.016342,-0.017548,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.56666,-0.016354,-0.024477,0,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.39371,-0.016433,-0.052615,0,0
2,GO ORGAN INDUCTION,0.4978,-0.016484,-0.074804,0,0
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.15264,-0.016519,-0.058883,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.24288,-0.016529,-0.032371,0,0
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.50337,-0.016546,-0.015016,0,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.50896,-0.016593,-0.053644,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.20937,-0.016604,-0.065645,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.44924,-0.016703,-0.027995,0,0
2,GO SISTER CHROMATID COHESION,0.92682,-0.016719,0.0106,0,0
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.68418,-0.016808,-0.052488,0,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.72313,-0.016871,-0.073009,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.46512,-0.016947,-0.030799,0,0
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.80312,-0.01708,-0.062657,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.4545,-0.017094,-0.030825,0,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.83713,-0.017231,-0.034079,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.33373,-0.017298,-0.048122,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.72969,-0.017307,-0.013092,0,0
2,GO AUTOPHAGIC CELL DEATH,0.52594,-0.017344,-0.05563,0,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.70355,-0.017345,-0.030833,0,0
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.76281,-0.017359,-0.012146,0,0
2,GO REGULATION OF TRANSPORT,0.61497,-0.017377,-0.014246,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.53742,-0.017379,-0.029342,0,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.5726,-0.01739,-0.0339,0,0
2,GO GLAND MORPHOGENESIS,0.46512,-0.017413,-0.092293,0,0
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.27611,-0.017446,-0.045449,0,0
2,GO CALCIUM ION IMPORT,0.65866,-0.017459,0.027533,0,0
2,GO TRANSPORT ALONG MICROTUBULE,0.89907,-0.01748,0.01167,0,0
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.53167,-0.017485,-0.019121,0,0
2,GO KERATAN SULFATE METABOLIC PROCESS,0.77618,-0.017605,-0.041129,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.86455,-0.017617,-0.029001,0,0
2,GO ACETYL COA METABOLIC PROCESS,0.74288,-0.017803,0.024424,0,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.58456,-0.017903,-0.012086,0,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.72313,-0.017932,-0.0043403,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.47049,-0.017987,-0.049102,0,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.36991,-0.01823,-0.09678,0,0
2,GO SISTER CHROMATID SEGREGATION,0.60272,-0.018329,-0.011517,0,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.91293,-0.01838,-0.080202,0,0
2,GO ANION TRANSPORT,0.7495,-0.018423,-0.010151,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.94769,-0.018629,0.018076,0,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.88523,-0.018726,-0.024389,0,0
2,GO RESPONSE TO ZINC ION,0.62113,-0.018737,-0.069647,0,0
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.58456,-0.018831,0.020753,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.53742,-0.018839,-0.060528,0,0
2,GO REGULATION OF DNA METABOLIC PROCESS,0.71006,-0.018859,-0.010004,0,0
2,GO PROTEIN N LINKED GLYCOSYLATION,0.34702,-0.018873,-0.071356,0,0
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.32506,-0.018886,-0.078006,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.53167,-0.01915,-0.046456,0,0
2,GO REGULATION OF CELL CYCLE,0.30815,-0.019229,-0.020215,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.41341,-0.019283,-0.022807,0,0
2,GO ORGANELLE INHERITANCE,0.49227,-0.019439,-0.037226,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.48131,-0.019447,-0.032394,0,0
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.49227,-0.019517,-0.042666,0,0
2,GO VASCULATURE DEVELOPMENT,0.25363,-0.019522,-0.066452,0,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.48678,-0.019665,-0.050587,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.58456,-0.019705,0.028858,0,0
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.23589,-0.019711,-0.054555,0,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.39858,-0.019807,-0.060449,0,0
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.56666,-0.019892,-0.028081,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.2,-0.019967,-0.071375,0,0
2,GO REGULATION OF AUTOPHAGY,0.4978,-0.019997,-0.022612,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.68418,-0.020077,-0.014108,0,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.50896,-0.020125,0.067618,0,0
2,GO POSITIVE REGULATION OF GROWTH,0.67776,-0.020305,-0.012599,0,0
2,GO REGULATION OF PHOSPHORYLATION,0.20937,-0.020325,-0.042632,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.15264,-0.020357,-0.080097,0,0
2,GO LAMELLIPODIUM ORGANIZATION,0.23245,-0.020431,-0.059592,0,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.77618,-0.02049,-0.033878,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.65234,-0.020664,-0.02965,0,0
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.24643,-0.020679,-0.10669,0,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.65866,-0.021099,-0.030584,0,0
2,GO MEMBRANE FUSION,0.27999,-0.021176,-0.048341,0,0
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.89907,-0.021317,0.071593,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.25363,-0.02133,-0.028237,0,0
2,GO MICROTUBULE BASED MOVEMENT,0.27227,-0.021344,-0.033256,0,0
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.89907,-0.021446,-0.0045247,0,0
2,GO MUSCLE FILAMENT SLIDING,0.91987,-0.021468,-0.016047,0,0
2,GO ORGANIC ACID METABOLIC PROCESS,0.81668,-0.021567,-0.016558,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.4598,-0.021573,-0.051162,0,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.67776,-0.021645,-0.032571,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.51459,-0.021663,-0.03962,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.4545,-0.021732,-0.015393,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.53167,-0.021734,-0.026713,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.67776,-0.021846,-0.0047164,0,0
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.70355,-0.021862,-0.021587,0,0
2,GO REGULATION OF VASCULOGENESIS,0.33373,-0.021997,-0.093101,0,0
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.50337,-0.022015,-0.027923,0,0
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.78289,-0.022044,-0.03604,0,0
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.67137,-0.022119,-0.031084,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.72313,-0.02213,-0.051099,0,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.59664,-0.022203,-0.017086,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.21905,-0.022287,-0.090021,0,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.47588,-0.022386,-0.021315,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.80312,-0.022407,-0.038593,0,0
2,GO RESPONSE TO OXYGEN LEVELS,0.93377,-0.022455,-0.013078,0,0
2,GO FERTILIZATION,0.26098,-0.022487,-0.028927,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.188,-0.022569,-0.04408,0,0
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.29586,-0.022607,-0.034894,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.18219,-0.02268,-0.13403,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.50337,-0.022701,-0.035619,0,0
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.89907,-0.022744,-0.020357,0,0
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.92682,-0.022747,-0.0033542,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.77618,-0.02277,-0.02659,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.61497,-0.02287,-0.023392,0,0
2,GO CELLULAR RESPONSE TO KETONE,0.32938,-0.022926,-0.066363,0,0
2,GO BODY MORPHOGENESIS,0.31653,-0.022946,-0.081159,0,0
2,GO INTERLEUKIN 2 PRODUCTION,0.72313,-0.023015,-0.049528,0,0
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.59664,-0.023039,-0.081571,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.21579,-0.023048,-0.1047,0,0
2,GO P BODY ASSEMBLY,0.61497,-0.023064,-0.018746,0,0
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.95466,-0.023077,0.00022288,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.36991,-0.023133,-0.057583,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.32506,-0.023137,-0.056151,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.78962,-0.023186,-0.082528,0,0
2,GO DNA INTEGRITY CHECKPOINT,0.29586,-0.023214,-0.038719,0,0
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.36064,-0.02324,-0.063778,0,0
2,GO ORGANIC ACID CATABOLIC PROCESS,0.40349,-0.023243,-0.049346,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.17374,-0.023355,-0.046619,0,0
2,GO FATTY ACID TRANSPORT,0.72969,-0.023384,-0.024542,0,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.49227,-0.023425,-0.050692,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.49227,-0.023635,-0.021057,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.38408,-0.023652,-0.068116,0,0
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.15773,-0.024099,-0.049024,0,0
2,GO AMINE CATABOLIC PROCESS,0.44924,-0.024209,-0.093456,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.30402,-0.024269,-0.1025,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.27611,-0.024315,-0.054826,0,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.32938,-0.024508,-0.030476,0,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.52025,-0.024594,-0.023625,0,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.35607,-0.024607,-0.033533,0,0
2,GO CARBOHYDRATE METABOLIC PROCESS,0.80989,-0.024674,-0.0090311,0,0
2,GO REGULATION OF DNA REPLICATION,0.92682,-0.02468,-0.0045385,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.65866,-0.024829,-0.01931,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.36064,-0.024879,-0.07039,0,0
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.41341,-0.024891,-0.055045,0,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.67137,-0.024914,-0.030866,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.019739,-0.024923,-0.086715,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.30815,-0.024951,-0.031347,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.98255,-0.024992,0.01505,0,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.35153,-0.025158,-0.071753,0,0
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.38888,-0.025203,-0.024403,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.41842,-0.025215,-0.021795,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.43367,-0.025222,-0.056351,0,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.78962,-0.025276,-0.01593,0,0
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.2839,-0.025285,-0.029132,0,0
2,GO PATTERN SPECIFICATION PROCESS,0.44924,-0.025338,-0.030402,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.60272,-0.025653,-0.045093,0,0
2,GO AMINE TRANSPORT,0.99651,-0.025839,0.064469,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.98953,-0.025852,0.045742,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.53742,-0.025889,-0.011043,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.99651,-0.025897,0.0025506,0,0
2,GO CELLULAR KETONE METABOLIC PROCESS,0.5726,-0.02593,-0.053479,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.11841,-0.025953,-0.040729,0,0
2,GO CELL CYCLE,0.25001,-0.025977,-0.022523,0,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.27227,-0.026075,-0.049069,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.24288,-0.026102,-0.018355,0,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.72313,-0.02615,0.0020184,0,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.87144,-0.026156,-0.015939,0,0
2,GO MEMBRANE DOCKING,0.20309,-0.026247,-0.029645,0,0
2,GO MAMMARY GLAND DEVELOPMENT,0.20621,-0.026289,-0.071253,0,0
2,GO RESPONSE TO RADIATION,0.65866,-0.02629,-0.0067871,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.24643,-0.026311,-0.028875,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.40349,-0.026345,-0.042672,0,0
2,GO MACROPHAGE ACTIVATION,0.84397,-0.026365,-0.024553,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.56075,-0.026375,-0.047339,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,1,-0.026387,-0.012159,0,0
2,GO T CELL MIGRATION,0.43367,-0.026446,-0.06959,0,0
2,GO TRANSMISSION OF NERVE IMPULSE,0.9686,-0.026471,0.027409,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.25363,-0.026567,-0.076366,0,0
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.36064,-0.026647,-0.055413,0,0
2,GO BLEB ASSEMBLY,0.33373,-0.026684,-0.25347,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.15773,-0.026729,-0.097364,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.43367,-0.026904,-0.028678,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.50337,-0.026967,-0.044751,0,0
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.36064,-0.027007,-0.033968,0,0
2,GO AXIS SPECIFICATION,0.69707,-0.027023,-0.00131,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.46512,-0.027051,-0.040504,0,0
2,GO COPII COATED VESICLE CARGO LOADING,0.62732,-0.027099,-0.023682,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.87144,-0.027157,-0.0027098,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.85082,-0.02721,-0.0089129,0,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.17934,-0.027252,-0.048935,0,0
2,GO HOMEOSTATIC PROCESS,0.26847,-0.02729,-0.030685,0,0
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.15264,-0.027331,-0.13456,0,0
2,GO MUSCLE ATROPHY,0.51459,-0.027353,-0.093716,0,0
2,GO FACE DEVELOPMENT,0.2,-0.027398,-0.098459,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.81668,-0.02754,-0.022786,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.34256,-0.027581,-0.03578,0,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.33373,-0.027635,-0.03034,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.67776,-0.027651,-0.017569,0,0
2,GO REGULATION OF ACTION POTENTIAL,0.78289,-0.027837,-0.022079,0,0
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.56075,-0.027854,-0.10173,0,0
2,GO RESPONSE TO INSULIN,0.23937,-0.027872,-0.040946,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.95466,-0.027884,0.0057815,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.7495,-0.027931,-0.0022154,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.96163,-0.028046,-0.020998,0,0
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.34256,-0.028056,-0.028641,0,0
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.61497,-0.028077,-0.044532,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.68418,-0.028218,-0.021905,0,0
2,GO RESPONSE TO STARVATION,0.69707,-0.028266,-0.019755,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.32077,-0.028559,-0.044567,0,0
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.32938,-0.028631,-0.061288,0,0
2,GO CHROMOSOME SEGREGATION,0.4598,-0.028657,-0.022158,0,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.12473,-0.028662,-0.054169,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.83713,-0.028844,-0.0091235,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.67776,-0.028846,0.028935,0,0
2,GO ORGANIC ANION TRANSPORT,0.52594,-0.028995,-0.022643,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.87144,-0.029194,-0.039638,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.69707,-0.0292,-0.0099276,0,0
2,GO CELL SUBSTRATE ADHESION,0.56666,-0.029225,-0.050192,0,0
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.88523,-0.029295,-0.023462,0,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.5726,-0.029314,-0.027981,0,0
2,GO OSSIFICATION,0.33373,-0.029494,-0.057957,0,0
2,GO REGULATION OF CELL DIVISION,0.25729,-0.029523,-0.04194,0,0
2,GO MUSCLE CELL PROLIFERATION,0.61497,-0.029577,-0.039756,0,0
2,GO FOCAL ADHESION ASSEMBLY,0.43883,-0.029639,-0.064164,0,0
2,GO LEUKOCYTE HOMEOSTASIS,0.28785,-0.02964,-0.067543,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.20937,-0.029771,-0.10267,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.27227,-0.029816,-0.030102,0,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.25729,-0.029835,-0.058054,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.25729,-0.029843,-0.056505,0,0
2,GO NIK NF KAPPAB SIGNALING,0.27227,-0.029898,-0.085049,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.059411,-0.02991,-0.065,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.070855,-0.030125,-0.036356,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.25001,-0.030207,-0.042938,0,0
2,GO MOLTING CYCLE,0.63354,-0.030221,-0.044955,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.31653,-0.03029,-0.057567,0,0
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.62113,-0.030407,-0.03705,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.21256,-0.030434,-0.071756,0,0
2,GO CELL JUNCTION ASSEMBLY,0.31232,-0.030441,-0.050339,0,0
2,GO STEM CELL DIVISION,0.94769,-0.03047,-0.0068845,0,0
2,GO ALCOHOL CATABOLIC PROCESS,0.4978,-0.030495,-0.053634,0,0
2,GO ACID SECRETION,0.90599,-0.030511,-0.0013233,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.77618,-0.030557,-0.010788,0,0
2,GO CELLULAR EXTRAVASATION,0.56075,-0.030612,-0.031455,0,0
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.50896,-0.030648,-0.056695,0,0
2,GO GLUTATHIONE METABOLIC PROCESS,0.91987,-0.030648,-0.02002,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.40349,-0.030654,-0.052955,0,0
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.30402,-0.030756,-0.068411,0,0
2,GO T CELL RECEPTOR SIGNALING PATHWAY,0.080955,-0.030783,-0.083591,0,0
2,GO REGULATION OF GLUCONEOGENESIS,0.76948,-0.030822,-0.021881,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.69707,-0.030851,-0.027205,0,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.14526,-0.03092,-0.079507,0,0
2,GO REGULATION OF CELL AGING,0.32506,-0.030984,-0.064828,0,0
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.14526,-0.031013,-0.041615,0,0
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.20621,-0.031033,-0.058887,0,0
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.22568,-0.031154,-0.053133,0,0
2,GO AGING,0.1028,-0.031162,-0.074528,0,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.54321,-0.031173,-0.040351,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.23589,-0.031365,-0.062076,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.69707,-0.031397,-0.026546,0,0
2,GO HAIR FOLLICLE MATURATION,0.27611,-0.031505,-0.10466,0,0
2,GO PROTEIN CATABOLIC PROCESS,0.095625,-0.031539,-0.052693,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.47588,-0.031565,-0.039208,0,0
2,GO SKIN MORPHOGENESIS,0.39371,-0.031647,-0.14764,0,0
2,GO SULFATE TRANSPORT,0.073629,-0.031684,-0.062673,0,0
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.69061,-0.03171,-0.032563,0,0
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.38888,-0.031726,-0.06098,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.068167,-0.031776,-0.037793,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.4545,-0.031787,-0.045034,0,0
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0695,-0.031794,-0.043171,0,0
2,GO LAMELLIPODIUM ASSEMBLY,0.44402,-0.031798,-0.036458,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.65234,-0.031911,-0.028526,0,0
2,GO DNA CATABOLIC PROCESS,0.15773,-0.032259,-0.067355,0,0
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.23245,-0.032418,-0.05419,0,0
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.78962,-0.032572,-0.052148,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.15264,-0.03268,-0.16772,0,0
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.51459,-0.032754,-0.026166,0,0
2,GO REGULATION OF PHAGOCYTOSIS,0.22235,-0.032766,-0.090831,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.24643,-0.032795,-0.071503,0,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.90599,-0.032901,-0.019411,0,0
2,GO SODIUM ION HOMEOSTASIS,0.27999,-0.032947,-0.046438,0,0
2,GO REGULATION OF PROTEIN BINDING,0.36064,-0.03295,-0.037602,0,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.89907,-0.033011,0.01014,0,0
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.22568,-0.033062,-0.068204,0,0
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.61497,-0.033134,-0.010585,0,0
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.23245,-0.033202,-0.07845,0,0
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.11039,-0.033212,-0.03158,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.60272,-0.033233,-0.022539,0,0
2,GO HISTONE H2B UBIQUITINATION,0.19095,-0.033276,-0.077911,0,0
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.36064,-0.033339,-0.15957,0,0
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.15517,-0.033368,-0.037576,0,0
2,GO DNA METHYLATION,0.59664,-0.033528,-0.014798,0,0
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.60883,-0.033558,-0.077682,0,0
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.85768,-0.03357,0.0008337,0,0
2,GO LYSOSOMAL TRANSPORT,0.32506,-0.033694,-0.053499,0,0
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.46512,-0.033767,-0.044268,0,0
2,GO HISTONE H3 K9 ACETYLATION,0.32938,-0.033798,-0.055461,0,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.5726,-0.033834,-0.029344,0,0
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.22905,-0.033836,-0.080209,0,0
2,GO RESPONSE TO METAL ION,0.29184,-0.033855,-0.042174,0,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.17099,-0.033886,-0.03698,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.89907,-0.033909,0.016014,0,0
2,GO ALCOHOL METABOLIC PROCESS,0.69707,-0.033941,-0.029167,0,0
2,GO DETOXIFICATION,0.53167,-0.033965,-0.044965,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.48678,-0.033968,-0.067663,0,0
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.35607,-0.034059,-0.10266,0,0
2,GO FLUID TRANSPORT,0.25363,-0.034061,-0.074638,0,0
2,GO SIGNAL RELEASE,0.65866,-0.034071,-0.0010474,0,0
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.20309,-0.034174,-0.10134,0,0
2,GO INTRACELLULAR STEROL TRANSPORT,0.57857,-0.034258,-0.055949,0,0
2,GO MICROTUBULE BASED PROCESS,0.38408,-0.034271,-0.014227,0,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.12259,-0.034518,-0.043649,0,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.81668,-0.034534,0.0091153,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.62113,-0.03477,-0.047274,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.38408,-0.034804,-0.028389,0,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.99651,-0.034977,-0.0036248,0,0
2,GO CYTOSOLIC TRANSPORT,0.36526,-0.03502,-0.030797,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.51459,-0.035137,-0.030078,0,0
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.2,-0.035363,-0.031391,0,0
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.79636,-0.03559,-0.02196,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.39371,-0.035609,-0.026577,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.67776,-0.035659,-0.014561,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.43367,-0.035699,-0.042587,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.21256,-0.035736,-0.040174,0,0
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.093897,-0.035767,-0.054094,0,0
2,GO RESPONSE TO PEPTIDE,0.25729,-0.035808,-0.036664,0,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.22235,-0.035875,-0.065438,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.89215,-0.035892,0.015056,0,0
2,GO CIRCADIAN RHYTHM,0.24643,-0.035946,-0.029111,0,0
2,GO RESPONSE TO HYDROXYUREA,0.27999,-0.035971,-0.074191,0,0
2,GO REGULATION OF HEAT GENERATION,0.54903,-0.036122,-0.056632,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.031059,-0.036167,-0.13545,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.58456,-0.036219,-0.018153,0,0
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.31653,-0.036249,-0.052113,0,0
2,GO CERAMIDE CATABOLIC PROCESS,0.55487,-0.03626,-0.098518,0,0
2,GO CELL REDOX HOMEOSTASIS,0.92682,-0.036266,-0.024957,0,0
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.54321,-0.03635,-0.019318,0,0
2,GO PIGMENT CELL DIFFERENTIATION,0.38408,-0.036384,-0.055867,0,0
2,GO RESPONSE TO HYDROPEROXIDE,0.95466,-0.03645,-0.0058813,0,0
2,GO NEURON APOPTOTIC PROCESS,0.63978,-0.036481,-0.0072482,0,0
2,GO RESPONSE TO THYROID HORMONE,0.82348,-0.036511,-0.029967,0,0
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.38408,-0.036559,-0.050379,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.72313,-0.036686,0.025592,0,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.13583,-0.036791,-0.10331,0,0
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.38408,-0.036805,-0.071526,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.26471,-0.036864,-0.060497,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.36991,-0.036872,-0.066441,0,0
2,GO RESPONSE TO ACID CHEMICAL,0.80989,-0.036963,-0.013388,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE,0.14769,-0.037064,-0.045112,0,0
2,GO DENDRITIC CELL CHEMOTAXIS,0.27999,-0.037255,-0.097812,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.93377,-0.03729,-0.0008696,0,0
2,GO VESICLE ORGANIZATION,0.053746,-0.037366,-0.070643,0,0
2,GO NEPHRON MORPHOGENESIS,0.20309,-0.037413,-0.073062,0,0
2,GO LIPID MODIFICATION,0.061812,-0.037429,-0.071872,0,0
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.28785,-0.037451,-0.044029,0,0
2,GO GLIAL CELL DEVELOPMENT,0.40349,-0.037506,-0.044883,0,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.73628,-0.037519,-0.033958,0,0
2,GO LOCOMOTOR RHYTHM,0.94073,-0.037552,0.010264,0,0
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.51459,-0.037629,-0.069764,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.12049,-0.037645,-0.032588,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.29992,-0.03767,-0.062206,0,0
2,GO RENAL SYSTEM PROCESS,0.084046,-0.037818,-0.092098,0,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.84397,-0.038001,-0.039616,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.2,-0.038061,-0.10665,0,0
2,GO DE NOVO PROTEIN FOLDING,0.31653,-0.038069,-0.038373,0,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.59664,-0.038191,-0.018397,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.53167,-0.038201,-0.051807,0,0
2,GO RESPONSE TO ACTIVITY,0.23937,-0.03821,-0.067827,0,0
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.54903,-0.038384,-0.041155,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.20309,-0.03839,-0.059884,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.51459,-0.038394,-0.014103,0,0
2,GO N GLYCAN PROCESSING,0.39858,-0.038396,-0.10408,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.11841,-0.038424,-0.059097,0,0
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.49227,-0.038452,-0.11563,0,0
2,GO APPENDAGE DEVELOPMENT,0.12689,-0.038465,-0.09591,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.3746,-0.038467,-0.10747,0,0
2,GO CARNITINE SHUTTLE,0.91293,-0.038579,0.013771,0,0
2,GO ORGANELLE LOCALIZATION,0.05824,-0.038687,-0.039002,0,0
2,GO TRANSFERRIN TRANSPORT,0.2839,-0.038787,-0.062721,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.084046,-0.038791,-0.06953,0,0
2,GO REGULATION OF MITOTIC CELL CYCLE,0.073629,-0.038847,-0.04078,0,0
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.48678,-0.038902,-0.067253,0,0
2,GO DIET INDUCED THERMOGENESIS,0.73628,-0.038937,0.06081,0,0
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.29586,-0.039185,-0.04237,0,0
2,GO DNA MODIFICATION,0.17653,-0.039344,-0.043046,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.057089,-0.039424,-0.10535,0,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.12473,-0.039426,-0.062679,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.099158,-0.03947,-0.056999,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.84397,-0.039504,0.013789,0,0
2,GO REGENERATION,0.44924,-0.039542,-0.050252,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.061812,-0.039547,-0.085658,0,0
2,GO PEROXISOMAL TRANSPORT,0.33812,-0.039597,-0.047467,0,0
2,GO REGULATION OF INSULIN SECRETION,0.91987,-0.039604,-0.00057665,0,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.22905,-0.039639,-0.047706,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.59664,-0.039711,-0.031453,0,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.86455,-0.03972,-0.00070276,0,0
2,GO NEURON PROJECTION REGENERATION,0.89215,-0.039762,0.010796,0,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.84397,-0.039803,-0.0012998,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.71658,-0.039815,-0.06205,0,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.11039,-0.0399,-0.060889,0,0
2,GO AXIS ELONGATION,0.43883,-0.039958,-0.092542,0,0
2,GO REGULATION OF BLOOD PRESSURE,0.27611,-0.039994,-0.057518,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.80312,-0.039999,-0.020449,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.26847,-0.04001,-0.029269,0,0
2,GO LIPID OXIDATION,0.39371,-0.040258,-0.057369,0,0
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.51459,-0.040537,-0.031294,0,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.20309,-0.040573,-0.078009,0,0
2,GO METANEPHROS DEVELOPMENT,0.18219,-0.040599,-0.08717,0,0
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.59664,-0.040689,-0.083843,0,0
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.9686,-0.040872,-0.0072722,0,0
2,GO VAGINA DEVELOPMENT,0.66501,-0.040942,-0.065526,0,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.30402,-0.040996,-0.030411,0,0
2,GO REGULATION OF GASTRIC ACID SECRETION,0.74288,-0.041092,-0.053444,0,0
2,GO ANIMAL ORGAN FORMATION,0.64605,-0.041307,-0.04753,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.62113,-0.041312,-0.014243,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.070855,-0.041433,-0.062038,0,0
2,GO CHOLESTEROL STORAGE,0.55487,-0.041642,-0.043475,0,0
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.43367,-0.041695,-0.070172,0,0
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.31232,-0.041744,-0.037809,0,0
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.11841,-0.041768,-0.1354,0,0
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.41341,-0.041783,-0.041813,0,0
2,GO STEROID BIOSYNTHETIC PROCESS,0.5726,-0.041792,-0.0294,0,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.13355,-0.041859,-0.046722,0,0
2,GO PROTEIN AUTOPHOSPHORYLATION,0.47588,-0.04197,-0.025186,0,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.65234,-0.041986,-0.10079,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.98953,-0.042116,0.020262,0,0
2,GO CERAMIDE METABOLIC PROCESS,0.12049,-0.042272,-0.079071,0,0
2,GO PEROXISOME ORGANIZATION,0.22905,-0.04234,-0.053457,0,0
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.75615,-0.042351,-0.032161,0,0
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.26847,-0.042466,-0.059192,0,0
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.71658,-0.042635,0.017626,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.19695,-0.042642,-0.054506,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.96163,-0.042652,-0.013778,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.21256,-0.042748,-0.068053,0,0
2,GO OOGENESIS,0.093897,-0.042759,-0.089788,0,0
2,GO VITAMIN D METABOLIC PROCESS,0.53167,-0.042766,-0.062195,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.53742,-0.042845,-0.027221,0,0
2,GO CD40 SIGNALING PATHWAY,0.34702,-0.042873,-0.12019,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.1313,-0.04288,-0.061497,0,0
2,GO REGULATION OF CILIUM MOVEMENT,0.061812,-0.042892,-0.10529,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.61497,-0.04295,-0.0063505,0,0
2,GO REGULATION OF APPETITE,0.31232,-0.042951,-0.063649,0,0
2,GO ZINC ION HOMEOSTASIS,0.52594,-0.042958,-0.094631,0,0
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.72969,-0.043058,-0.013679,0,0
2,GO ASTROCYTE ACTIVATION,0.30402,-0.043064,-0.078155,0,0
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.38408,-0.043199,-0.024521,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.29184,-0.043241,-0.051012,0,0
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.19095,-0.043286,-0.058209,0,0
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.064293,-0.04336,-0.054893,0,0
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.53167,-0.043416,-0.034598,0,0
2,GO MAINTENANCE OF CELL NUMBER,0.1028,-0.043477,-0.074725,0,0
2,GO MEMBRANE ORGANIZATION,0.33812,-0.043611,-0.030583,0,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.082489,-0.043676,-0.056599,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.79636,-0.043696,-0.0084209,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.78289,-0.043801,-0.027243,0,0
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.36991,-0.043886,-0.054294,0,0
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.16294,-0.044033,-0.045415,0,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.46512,-0.044044,-0.047773,0,0
2,GO REGULATION OF MITOPHAGY,0.25729,-0.044058,-0.068177,0,0
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.55487,-0.044097,-0.048412,0,0
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.56666,-0.04418,-0.033172,0,0
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.21256,-0.044222,-0.038824,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.14526,-0.044224,-0.094239,0,0
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.44924,-0.044239,-0.077296,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.05824,-0.044253,-0.04826,0,0
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.14769,-0.044285,-0.058075,0,0
2,GO PROTEIN POLYMERIZATION,0.42855,-0.044392,-0.022277,0,0
2,GO TOR SIGNALING,0.15517,-0.044434,-0.034649,0,0
2,GO RESPONSE TO HORMONE,0.29184,-0.044482,-0.03894,0,0
2,GO REGULATION OF SECRETION,0.17099,-0.044584,-0.046648,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.31232,-0.044735,-0.068603,0,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.52025,-0.044783,-0.023919,0,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.29586,-0.044801,-0.12579,0,0
2,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.78962,-0.044913,0.036864,0,0
2,GO SPINDLE ASSEMBLY,0.05824,-0.044964,-0.053659,0,0
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.41842,-0.04497,-0.073289,0,0
2,GO RESPONSE TO INTERLEUKIN 1,0.088862,-0.044973,-0.10864,0,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.85082,-0.045019,-0.013569,0,0
2,GO POSITIVE REGULATION OF CELL DEATH,0.21905,-0.045074,-0.044078,0,0
2,GO PHOSPHOLIPID CATABOLIC PROCESS,0.054842,-0.045134,-0.14388,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.8303,-0.045257,-0.051683,0,0
2,GO ORGANELLE ASSEMBLY,0.0066042,-0.045259,-0.058024,0,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.42347,-0.045265,-0.037511,0,0
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.72969,-0.04527,-0.037436,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.17099,-0.045311,-0.073217,0,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.1313,-0.045372,-0.06962,0,0
2,GO POSITIVE REGULATION OF TRANSPORT,0.14769,-0.045383,-0.037579,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.83713,-0.045384,-0.031136,0,0
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.94769,-0.045392,-0.018674,0,0
2,GO RECEPTOR CATABOLIC PROCESS,0.44402,-0.045482,-0.055209,0,0
2,GO RESPONSE TO KETONE,0.17099,-0.045567,-0.077068,0,0
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.69061,-0.045643,-0.045265,0,0
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.079444,-0.045653,-0.065112,0,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0695,-0.045681,-0.090317,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.20309,-0.045849,-0.066294,0,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.22568,-0.045864,-0.093317,0,0
2,GO NEGATIVE REGULATION OF CELL DEATH,0.055956,-0.046016,-0.073182,0,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.62113,-0.046024,0.076036,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.48678,-0.046026,-0.060973,0,0
2,GO ASTROCYTE DEVELOPMENT,0.43883,-0.046047,-0.057739,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.73628,-0.046056,-0.023494,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.17653,-0.04608,-0.052696,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.23937,-0.046175,-0.13623,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.18219,-0.046193,-0.029822,0,0
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.24643,-0.046277,-0.050009,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.12259,-0.0464,-0.055246,0,0
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.60272,-0.046604,-0.025664,0,0
2,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.27999,-0.046728,-0.2537,0,0
2,GO BONE MINERALIZATION,0.59664,-0.046734,-0.031952,0,0
2,GO RESPONSE TO NUTRIENT,0.32938,-0.046753,-0.060608,0,0
2,GO REGULATION OF GLUCOSE IMPORT,0.29586,-0.046767,-0.05418,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.44402,-0.046786,-0.032654,0,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.24643,-0.046825,-0.039587,0,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.22235,-0.046875,-0.044578,0,0
2,GO RESPONSE TO PAIN,0.65866,-0.047002,-0.062546,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.077957,-0.047005,-0.087691,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.13814,-0.047021,-0.037595,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.13583,-0.047041,-0.062751,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.25363,-0.047043,-0.053979,0,0
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.085627,-0.047119,-0.056345,0,0
2,GO STEROL BIOSYNTHETIC PROCESS,0.7495,-0.047182,0.022279,0,0
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.11039,-0.047234,-0.072339,0,0
2,GO LIPID HOMEOSTASIS,0.18508,-0.047324,-0.072075,0,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.54903,-0.047375,-0.017306,0,0
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.030383,-0.047395,-0.0479,0,0
2,GO JNK CASCADE,0.17653,-0.047471,-0.046982,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.9686,-0.047642,0.0054404,0,0
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.092194,-0.047734,-0.074036,0,0
2,GO NUCLEUS ORGANIZATION,0.066855,-0.047765,-0.048761,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.43367,-0.047786,-0.033608,0,0
2,GO OSTEOCLAST DIFFERENTIATION,0.59664,-0.047815,-0.013753,0,0
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.077957,-0.048062,-0.084675,0,0
2,GO REGULATION OF LIPID LOCALIZATION,0.25729,-0.048159,-0.055455,0,0
2,GO CELLULAR RESPONSE TO STEROL,0.98255,-0.048185,0.0053542,0,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.29992,-0.048244,-0.041564,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.8303,-0.048266,-0.017858,0,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.15015,-0.048332,-0.12801,0,0
2,GO GLUCOSE IMPORT,0.25363,-0.048497,-0.047554,0,0
2,GO PENILE ERECTION,0.74288,-0.048522,-0.028242,0,0
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.12049,-0.048531,-0.082053,0,0
2,GO VACUOLAR ACIDIFICATION,0.16294,-0.048637,-0.11439,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.18219,-0.048821,-0.045107,0,0
2,GO MANGANESE ION TRANSPORT,0.72313,-0.048862,-0.010146,0,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.21905,-0.048885,-0.066053,0,0
2,GO HISTONE H3 ACETYLATION,0.13583,-0.048885,-0.042872,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.092194,-0.049001,-0.069983,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.3746,-0.049032,-0.15971,0,0
2,GO RESPONSE TO TUMOR CELL,0.26098,-0.049036,-0.1034,0,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.64605,-0.049193,-0.053361,0,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.11039,-0.049196,-0.049893,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.82348,-0.049413,-0.061782,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.26847,-0.049473,-0.043069,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.060602,-0.049595,-0.054655,0,0
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.22905,-0.049611,-0.14107,0,0
2,GO INTEGRIN ACTIVATION,0.35153,-0.049632,-0.079514,0,0
2,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.83713,-0.049665,0.00089528,0,0
2,GO MEMBRANE INVAGINATION,0.20937,-0.049668,-0.072821,0,0
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.15517,-0.049676,-0.13311,0,0
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.10096,-0.049693,-0.16087,0,0
2,GO SCHWANN CELL DIFFERENTIATION,0.43883,-0.04979,-0.039119,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.22568,-0.049796,-0.044982,0,0
2,GO SINGLE FERTILIZATION,0.090515,-0.049836,-0.05013,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.1313,-0.04992,-0.059113,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.77618,-0.049942,-0.013333,0,0
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.075049,-0.049967,-0.085534,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.44402,-0.049996,-0.022489,0,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.7495,-0.050075,-0.022681,0,0
2,GO BIOLOGICAL ADHESION,0.13355,-0.050117,-0.073472,0,0
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.23589,-0.050222,-0.094412,0,0
2,GO LYMPHOCYTE MIGRATION,0.24288,-0.050246,-0.078135,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.21905,-0.050306,-0.091423,0,0
2,GO ARACHIDONIC ACID SECRETION,0.26847,-0.050416,-0.084436,0,0
2,GO REGIONALIZATION,0.29992,-0.050447,-0.039031,0,0
2,GO KINETOCHORE ORGANIZATION,0.41341,-0.050601,-0.055677,0,0
2,GO EPITHELIAL CELL PROLIFERATION,0.053746,-0.050618,-0.10607,0,0
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.20937,-0.050746,-0.1183,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.70355,-0.050754,-0.029724,0,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.93377,-0.050779,0.004387,0,0
2,GO RESPONSE TO ALKALOID,0.33373,-0.050782,-0.045193,0,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.17653,-0.050807,-0.069296,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.26471,-0.05083,-0.039678,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.12689,-0.050997,-0.040191,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.99651,-0.051017,-0.015055,0,0
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.11434,-0.051027,-0.046379,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.91987,-0.051057,-0.0029276,0,0
2,GO STRESS FIBER ASSEMBLY,0.40349,-0.051068,-0.051594,0,0
2,GO REGULATION OF LIPID TRANSPORT,0.32077,-0.051105,-0.056605,0,0
2,GO REGULATION OF TUBE SIZE,0.19393,-0.051248,-0.067098,0,0
2,GO CELL CYCLE CHECKPOINT,0.082489,-0.05134,-0.045361,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.19393,-0.051372,-0.079947,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.28785,-0.051375,-0.076763,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.50337,-0.051386,-0.034784,0,0
2,GO ACTIN FILAMENT BASED PROCESS,0.036948,-0.05139,-0.072544,0,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.14526,-0.051479,-0.072734,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.48678,-0.05157,-0.073262,0,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.25729,-0.051725,-0.090823,0,0
2,GO PIGMENTATION,0.12908,-0.051755,-0.068555,0,0
2,GO OVULATION,0.44402,-0.051842,-0.081234,0,0
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.20309,-0.05186,-0.10054,0,0
2,GO RESPONSE TO CHEMOKINE,0.54903,-0.051865,-0.045098,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.093897,-0.051995,-0.11452,0,0
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.24643,-0.052098,-0.041733,0,0
2,GO REGULATION OF CELL DEATH,0.079444,-0.052102,-0.059277,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.15517,-0.052159,-0.046643,0,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.33373,-0.052205,-0.060209,0,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.35153,-0.052596,-0.088513,0,0
2,GO RESPONSE TO VITAMIN,0.55487,-0.052661,-0.045344,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.54321,-0.052702,-0.047104,0,0
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.3746,-0.052811,-0.037548,0,0
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.71006,-0.052823,-0.083316,0,0
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.036948,-0.052873,-0.041961,0,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.17374,-0.052919,-0.042604,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.75615,-0.053214,-0.024949,0,0
2,GO RESPONSE TO TOXIC SUBSTANCE,0.13583,-0.053266,-0.066299,0,0
2,GO REGULATION OF GTPASE ACTIVITY,0.38888,-0.0533,-0.023923,0,0
2,GO PHAGOCYTOSIS,0.2839,-0.053521,-0.068683,0,0
2,GO NEGATIVE REGULATION OF SECRETION,0.12473,-0.053615,-0.055788,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.46512,-0.053724,-0.024273,0,0
2,GO ATP TRANSPORT,0.89907,-0.053776,0.0065594,0,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.52594,-0.053879,-0.040107,0,0
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.10096,-0.053887,-0.04293,0,0
2,GO EMBRYO DEVELOPMENT,0.1028,-0.053924,-0.053059,0,0
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.22235,-0.053968,-0.061382,0,0
2,GO ESTROGEN METABOLIC PROCESS,0.27227,-0.054029,-0.073494,0,0
2,GO THYMIC T CELL SELECTION,0.20309,-0.054055,-0.050215,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.27999,-0.054061,-0.15296,0,0
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.5726,-0.05411,-0.066397,0,0
2,GO SYMBIOTIC PROCESS,0.087232,-0.054117,-0.079782,0,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.20309,-0.054237,-0.035746,0,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.093897,-0.054293,-0.060521,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.63354,-0.054364,-0.021443,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.43367,-0.054601,-0.011595,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.11039,-0.054657,-0.054942,0,0
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.25729,-0.054699,-0.077944,0,0
2,GO MESENCHYME MORPHOGENESIS,0.092194,-0.054741,-0.13341,0,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.48131,-0.054777,-0.025516,0,0
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.43367,-0.054815,-0.060493,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.32938,-0.054824,-0.034578,0,0
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.2,-0.05483,-0.098465,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.69061,-0.055013,-0.013454,0,0
2,GO ACTIVATION OF MAPK ACTIVITY,0.2,-0.055256,-0.055429,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.076492,-0.055397,-0.065251,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.39858,-0.055449,-0.042461,0,0
2,GO PRE MIRNA PROCESSING,0.51459,-0.055494,-0.034901,0,0
2,GO SELECTIVE AUTOPHAGY,0.19695,-0.055543,-0.07192,0,0
2,GO CYTOSKELETON ORGANIZATION,0.04854,-0.055548,-0.051262,0,0
2,GO APOPTOTIC PROCESS,0.1028,-0.055601,-0.054798,0,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.41842,-0.055681,-0.052568,0,0
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.25001,-0.055796,-0.043774,0,0
2,GO DEVELOPMENTAL PIGMENTATION,0.14769,-0.055822,-0.076351,0,0
2,GO DEMETHYLATION,0.088862,-0.055835,-0.051845,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.47588,-0.05587,-0.023843,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.2839,-0.056102,-0.05852,0,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.10654,-0.056109,-0.057024,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.13355,-0.056217,-0.044563,0,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.53742,-0.056224,0.12115,0,0
2,GO MALE GAMETE GENERATION,0.0045306,-0.056225,-0.08556,0,0
2,GO CELL CELL RECOGNITION,0.11841,-0.056289,-0.073026,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.93377,-0.056476,-0.015392,0,0
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.34702,-0.05653,-0.031693,0,0
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.43367,-0.056572,-0.024253,0,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.14048,-0.056629,-0.12413,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.74288,-0.056701,-0.022079,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.38408,-0.056713,-0.047228,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.22235,-0.056787,-0.051562,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.60272,-0.057025,-0.0053905,0,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.16032,-0.05722,-0.075605,0,0
2,GO POSITIVE REGULATION OF JNK CASCADE,0.12259,-0.057266,-0.061562,0,0
2,GO REGULATION OF BONE MINERALIZATION,0.32506,-0.057299,-0.06991,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.065563,-0.05744,-0.13976,0,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.43367,-0.057444,-0.057828,0,0
2,GO RESPONSE TO TESTOSTERONE,0.4598,-0.057452,-0.053363,0,0
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.33812,-0.057477,-0.081057,0,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.11039,-0.057543,-0.13967,0,0
2,GO PROTEIN MANNOSYLATION,0.69707,-0.057564,-0.020375,0,0
2,GO MICROTUBULE BASED TRANSPORT,0.16828,-0.05759,-0.040918,0,0
2,GO HISTONE H4 ACETYLATION,0.087232,-0.057684,-0.047474,0,0
2,GO SENSORY PERCEPTION,0.11841,-0.057936,-0.04304,0,0
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.32077,-0.058163,-0.063558,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.12908,-0.058167,-0.06074,0,0
2,GO AMYLOID BETA METABOLIC PROCESS,0.30402,-0.058198,-0.055448,0,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.38408,-0.058241,-0.092118,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.042857,-0.058243,-0.13615,0,0
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.077957,-0.058284,-0.05069,0,0
2,GO RESPONSE TO DEXAMETHASONE,0.49227,-0.058314,-0.050802,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.18219,-0.058361,-0.082675,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.91987,-0.058464,0.0099453,0,0
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.15517,-0.058631,-0.077146,0,0
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.31653,-0.05865,-0.095502,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.059411,-0.058702,-0.086829,0,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.11434,-0.058703,-0.11516,0,0
2,GO GLYCOSYLATION,0.15517,-0.058708,-0.07068,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.32077,-0.058723,-0.035755,0,0
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.16828,-0.058764,-0.069985,0,0
2,GO FATTY ACID BETA OXIDATION,0.32077,-0.058862,-0.064597,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.085627,-0.059026,-0.091971,0,0
2,GO CAMP BIOSYNTHETIC PROCESS,0.36064,-0.059118,-0.096058,0,0
2,GO NEURONAL ACTION POTENTIAL,0.25001,-0.059138,-0.076407,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.76948,-0.059148,-0.0038809,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.19095,-0.05917,-0.1236,0,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.35607,-0.059229,-0.048949,0,0
2,GO TONGUE DEVELOPMENT,0.41341,-0.059263,-0.085089,0,0
2,GO GOLGI RIBBON FORMATION,0.38888,-0.059418,-0.062741,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.48678,-0.059444,-0.068701,0,0
2,GO GLYCOLIPID CATABOLIC PROCESS,0.24643,-0.059615,-0.15713,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.12049,-0.059713,-0.082747,0,0
2,GO RESPONSE TO FUNGUS,0.30815,-0.059877,-0.047315,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.18219,-0.05992,-0.097341,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.095625,-0.059945,-0.069165,0,0
2,GO T CELL CHEMOTAXIS,0.12049,-0.059949,-0.082357,0,0
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.98953,-0.059995,0.029895,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.23937,-0.060031,-0.081232,0,0
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.059411,-0.060173,-0.10032,0,0
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.26098,-0.06027,-0.040523,0,0
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.12473,-0.060364,-0.082909,0,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.13583,-0.06039,-0.067139,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.20309,-0.0604,-0.10067,0,0
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.12259,-0.060446,-0.085593,0,0
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.36991,-0.060454,-0.041694,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.92682,-0.060632,0.0018042,0,0
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.12908,-0.060711,-0.11151,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.14048,-0.060887,-0.052195,0,0
2,GO RESPONSE TO INTERLEUKIN 15,0.17653,-0.060934,-0.11468,0,0
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.44402,-0.061,-0.041059,0,0
2,GO APPENDAGE MORPHOGENESIS,0.15773,-0.061007,-0.10467,0,0
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.53742,-0.061014,-0.037754,0,0
2,GO SEX DIFFERENTIATION,0.11636,-0.061016,-0.050249,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.19095,-0.061072,-0.057507,0,0
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.36991,-0.061221,-0.056979,0,0
2,GO FC RECEPTOR SIGNALING PATHWAY,0.082489,-0.061364,-0.077825,0,0
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.2,-0.061378,-0.1525,0,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.25729,-0.061488,-0.067297,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.63978,-0.061547,-0.025898,0,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.15517,-0.061581,-0.11519,0,0
2,GO REGULATION OF TOR SIGNALING,0.15015,-0.061624,-0.047396,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.11841,-0.0617,-0.068346,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.013139,-0.061745,-0.099152,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.05161,-0.061757,-0.075136,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.25001,-0.061778,-0.080982,0,0
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.24288,-0.061829,-0.1638,0,0
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.059411,-0.061852,-0.081493,0,0
2,GO RENAL FILTRATION,0.55487,-0.061867,-0.041388,0,0
2,GO HISTONE H3 K14 ACETYLATION,0.33812,-0.06193,-0.0471,0,0
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.51459,-0.062005,-0.030543,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.16294,-0.062178,-0.10012,0,0
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.22235,-0.062194,-0.090051,0,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.16559,-0.062198,-0.044743,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.80312,-0.062241,-0.021675,0,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.44402,-0.062587,-0.02347,0,0
2,GO CELLULAR LIPID METABOLIC PROCESS,0.053746,-0.062759,-0.071512,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.33373,-0.062824,-0.10819,0,0
2,GO REGULATION OF VASOCONSTRICTION,0.19695,-0.062861,-0.070382,0,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.019739,-0.062998,-0.085776,0,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.32077,-0.063034,-0.033723,0,0
2,GO HYALURONAN METABOLIC PROCESS,0.35153,-0.063039,-0.069863,0,0
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.15015,-0.063307,-0.057595,0,0
2,GO POSITIVE REGULATION OF CELL AGING,0.1028,-0.063568,-0.11919,0,0
2,GO OOCYTE MATURATION,0.66501,-0.063675,-0.020409,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.065563,-0.063757,-0.063544,0,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.13583,-0.0638,-0.086583,0,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.25001,-0.063803,-0.094649,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.85768,-0.063809,0.0040887,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.36064,-0.063845,-0.049305,0,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.23589,-0.063872,-0.10514,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.70355,-0.064012,-0.031214,0,0
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.14048,-0.06404,-0.070882,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.13583,-0.064134,-0.12509,0,0
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.27611,-0.064153,-0.061548,0,0
2,GO REGULATION OF CELL MATURATION,0.087232,-0.064441,-0.072833,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.55487,-0.064485,0.094908,0,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.066855,-0.06483,-0.10504,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.18219,-0.064888,-0.10029,0,0
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.053746,-0.064966,-0.079914,0,0
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.43367,-0.065007,-0.031353,0,0
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.18219,-0.065068,-0.11325,0,0
2,GO LIPID BIOSYNTHETIC PROCESS,0.060602,-0.065325,-0.070494,0,0
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.16294,-0.065333,-0.050958,0,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.21579,-0.065418,-0.049418,0,0
2,GO PRIMARY MIRNA PROCESSING,0.48131,-0.065474,-0.048068,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.52594,-0.065615,-0.050706,0,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.49227,-0.065623,-0.042442,0,0
2,GO REGULATION OF EXIT FROM MITOSIS,0.14048,-0.065695,-0.089292,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.76948,-0.065715,0.0055686,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.18219,-0.065767,-0.079642,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.11434,-0.065784,-0.15275,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.068167,-0.065843,-0.055671,0,0
2,GO FATTY ACID CATABOLIC PROCESS,0.088862,-0.066178,-0.098585,0,0
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.059411,-0.066245,-0.086528,0,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.12259,-0.066303,-0.10011,0,0
2,GO REGULATION OF ANION TRANSPORT,0.092194,-0.066316,-0.072435,0,0
2,GO RESPONSE TO MINERALOCORTICOID,0.24643,-0.066361,-0.08214,0,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.22568,-0.06646,-0.10443,0,0
2,GO EPIBOLY,0.29184,-0.066593,-0.129,0,0
2,GO EATING BEHAVIOR,0.21905,-0.066676,-0.069817,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.69061,-0.06671,0.0053828,0,0
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.061812,-0.066742,-0.086157,0,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.05824,-0.066789,-0.083841,0,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.65866,-0.066992,-0.020116,0,0
2,GO TUMOR NECROSIS FACTOR SECRETION,0.05161,-0.067007,-0.10693,0,0
2,GO INTERFERON GAMMA PRODUCTION,0.12049,-0.06706,-0.076101,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.59664,-0.067076,-0.059338,0,0
2,GO VITAMIN METABOLIC PROCESS,0.98255,-0.067183,0.0024998,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.74288,-0.067271,-0.035863,0,0
2,GO NEURAL RETINA DEVELOPMENT,0.78289,-0.067299,-0.0081928,0,0
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.082489,-0.067305,-0.089652,0,0
2,GO CELLULAR RESPONSE TO SALT STRESS,0.4598,-0.067345,-0.088499,0,0
2,GO RESPONSE TO OXIDATIVE STRESS,0.095625,-0.067411,-0.069622,0,0
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.095625,-0.067649,-0.063693,0,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.10845,-0.067715,-0.05579,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.4545,-0.06773,-0.059121,0,0
2,GO REGULATION OF JUN KINASE ACTIVITY,0.064293,-0.067756,-0.080653,0,0
2,GO HISTONE H2A ACETYLATION,0.22235,-0.067757,-0.061376,0,0
2,GO REGULATION OF BONE DEVELOPMENT,0.16559,-0.067791,-0.08264,0,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.81668,-0.067959,0.006514,0,0
2,GO REGULATION OF MAPK CASCADE,0.21256,-0.068029,-0.055321,0,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.097379,-0.068033,-0.14833,0,0
2,GO MEMBRANE RAFT ASSEMBLY,0.4598,-0.068115,-0.19913,0,0
2,GO STEROID HORMONE SECRETION,0.25001,-0.068121,-0.099478,0,0
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.39858,-0.068122,-0.048999,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,0.25363,-0.068167,-0.091611,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.27611,-0.068202,-0.070329,0,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.94769,-0.06822,0.063735,0,0
2,GO STEROID CATABOLIC PROCESS,0.4545,-0.068223,-0.067968,0,0
2,GO LIPID METABOLIC PROCESS,0.082489,-0.06838,-0.061218,0,0
2,GO BONE MATURATION,0.39371,-0.068413,-0.070685,0,0
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.10465,-0.068465,-0.090477,0,0
2,GO CELLULAR RESPONSE TO LIPID,0.17653,-0.068646,-0.067613,0,0
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.38888,-0.068737,-0.15186,0,0
2,GO TROPHOBLAST CELL MIGRATION,0.24643,-0.068763,-0.17683,0,0
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.11636,-0.068841,-0.13751,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.11039,-0.068864,-0.084924,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.15773,-0.068878,-0.087709,0,0
2,GO DETECTION OF BIOTIC STIMULUS,0.49227,-0.069196,-0.09461,0,0
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.25729,-0.069239,-0.044835,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.44924,-0.069307,-0.059768,0,0
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.32938,-0.069376,-0.083875,0,0
2,GO REGULATION OF PROTEIN IMPORT,0.14048,-0.069387,-0.10439,0,0
2,GO RESPONSE TO CORTICOSTEROID,0.10845,-0.069552,-0.097558,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.063042,-0.069572,-0.07148,0,0
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.055956,-0.069583,-0.079324,0,0
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.14285,-0.06961,-0.12077,0,0
2,GO MAGNESIUM ION HOMEOSTASIS,0.52025,-0.069614,-0.072431,0,0
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.65866,-0.069665,-0.029161,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.42347,-0.069711,-0.12189,0,0
2,GO STEM CELL PROLIFERATION,0.085627,-0.069873,-0.088511,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.49227,-0.069902,-0.047194,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.14048,-0.069984,-0.069522,0,0
2,GO RESPONSE TO EPINEPHRINE,1,-0.070059,0.0084342,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.36526,-0.070127,-0.11902,0,0
2,GO L PHENYLALANINE METABOLIC PROCESS,0.34256,-0.070147,-0.16427,0,0
2,GO RESPONSE TO SALT STRESS,0.17099,-0.070179,-0.097227,0,0
2,GO CELLULAR RESPONSE TO FATTY ACID,0.55487,-0.07019,-0.051358,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.32077,-0.070281,-0.075533,0,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.21579,-0.070396,-0.15765,0,0
2,GO OOCYTE DIFFERENTIATION,0.088862,-0.070457,-0.11075,0,0
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.23589,-0.070469,-0.048612,0,0
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.077957,-0.070546,-0.10172,0,0
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.076492,-0.070944,-0.075557,0,0
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.52025,-0.071008,-0.14249,0,0
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.18508,-0.071112,-0.073072,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.12473,-0.071121,-0.13684,0,0
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.088862,-0.07116,-0.081142,0,0
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.26471,-0.071183,-0.050459,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.41842,-0.07124,-0.038872,0,0
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.34702,-0.071327,-0.081445,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.66501,-0.071361,-0.014335,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.19393,-0.071443,-0.10888,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.12908,-0.071506,-0.057411,0,0
2,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.16032,-0.071682,-0.19393,0,0
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.20309,-0.071726,-0.19148,0,0
2,GO RESPONSE TO STEROID HORMONE,0.090515,-0.071862,-0.082773,0,0
2,GO REGULATION OF ERAD PATHWAY,0.11039,-0.072218,-0.056497,0,0
2,GO NEUTROPHIL CHEMOTAXIS,0.088862,-0.072555,-0.076916,0,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.079444,-0.072652,-0.096508,0,0
2,GO CELL MATURATION,0.095625,-0.072739,-0.059033,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.26098,-0.072774,-0.040754,0,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.22905,-0.072841,-0.10171,0,0
2,GO FEMALE GAMETE GENERATION,0.05824,-0.072977,-0.071017,0,0
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.14526,-0.073112,-0.063294,0,0
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.11636,-0.073163,-0.12615,0,0
2,GO RESPONSE TO GROWTH HORMONE,0.38888,-0.073195,-0.069182,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.42855,-0.073636,-0.063622,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.31232,-0.073693,-0.086789,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.19695,-0.073724,-0.14012,0,0
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.084046,-0.073751,-0.072273,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.059411,-0.073851,-0.076544,0,0
2,GO REGULATION OF HORMONE SECRETION,0.17653,-0.074032,-0.05161,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.013139,-0.074079,-0.11156,0,0
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.13583,-0.074207,-0.10346,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.19695,-0.074241,-0.085051,0,0
2,GO SPERM EGG RECOGNITION,0.14526,-0.07425,-0.060326,0,0
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.015203,-0.074726,-0.069842,0,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.25729,-0.074747,-0.10372,0,0
2,GO FUCOSE METABOLIC PROCESS,0.33812,-0.074971,-0.086857,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.082489,-0.075002,-0.073294,0,0
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.27999,-0.075064,-0.074805,0,0
2,GO NEGATIVE T CELL SELECTION,0.0027346,-0.075183,-0.16075,0,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.29586,-0.075212,-0.11366,0,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.10654,-0.075306,-0.11015,0,0
2,GO SPERM MOTILITY,0.012203,-0.075329,-0.091459,0,0
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.16559,-0.075576,-0.098151,0,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.077957,-0.075608,-0.077803,0,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.42347,-0.075615,-0.030029,0,0
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.095625,-0.075639,-0.089565,0,0
2,GO CELLULAR RESPONSE TO IRON ION,0.076492,-0.075751,-0.2086,0,0
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.10096,-0.075787,-0.081429,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.34256,-0.075824,-0.063825,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.66501,-0.075893,-0.013919,0,0
2,GO HISTONE H3 DEACETYLATION,0.16294,-0.076023,-0.060796,0,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.017969,-0.07604,-0.099561,0,0
2,GO REGULATION OF VIRAL TRANSCRIPTION,0.068167,-0.07605,-0.079694,0,0
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.27227,-0.076241,-0.12255,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.188,-0.076252,-0.099063,0,0
2,GO EAR DEVELOPMENT,0.035393,-0.0763,-0.099769,0,0
2,GO OXALATE TRANSPORT,0.18508,-0.076339,-0.070137,0,0
2,GO STEROL METABOLIC PROCESS,0.36991,-0.076559,-0.044179,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.28785,-0.076608,-0.048475,0,0
2,GO GOLGI VESICLE TRANSPORT,0.064293,-0.076635,-0.067156,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.12259,-0.076699,-0.13211,0,0
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.14285,-0.076791,-0.075534,0,0
2,GO PEPTIDE HORMONE SECRETION,0.53167,-0.077103,-0.0186,0,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.25363,-0.077124,-0.059487,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.16032,-0.077268,-0.064251,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.12049,-0.077274,-0.06012,0,0
2,GO KIDNEY MORPHOGENESIS,0.054842,-0.077294,-0.10155,0,0
2,GO RESPONSE TO LIPID,0.13355,-0.077308,-0.066226,0,0
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.070855,-0.077435,-0.099518,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.031059,-0.07751,-0.091504,0,0
2,GO RESPONSE TO VITAMIN D,0.80989,-0.077594,0.039877,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.53167,-0.077645,-0.031668,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.40349,-0.077647,-0.11588,0,0
2,GO DEPHOSPHORYLATION,0.021165,-0.077657,-0.058171,0,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.19095,-0.077662,-0.098862,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.084046,-0.077666,-0.067344,0,0
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.16294,-0.077716,-0.099133,0,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.21905,-0.077791,-0.1154,0,0
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.63354,-0.07786,0.021852,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.16559,-0.077919,-0.073781,0,0
2,GO NEUTROPHIL MIGRATION,0.082489,-0.078095,-0.096768,0,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.041967,-0.078222,-0.095114,0,0
2,GO CELL AGING,0.061812,-0.078269,-0.080006,0,0
2,GO ARTERY MORPHOGENESIS,0.11039,-0.078324,-0.10161,0,0
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.1313,-0.078506,-0.057484,0,0
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.093897,-0.078605,-0.17566,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.21579,-0.078614,-0.08538,0,0
2,GO REGULATION OF HORMONE LEVELS,0.095625,-0.078628,-0.068587,0,0
2,GO DEVELOPMENTAL INDUCTION,0.17099,-0.078658,-0.1118,0,0
2,GO REGULATION OF OSSIFICATION,0.12049,-0.078785,-0.0924,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.10845,-0.07879,-0.13168,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.15517,-0.078833,-0.093369,0,0
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.077957,-0.078852,-0.08791,0,0
2,GO FOREBRAIN MORPHOGENESIS,0.82348,-0.078887,-0.0056324,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.17653,-0.078912,-0.081512,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.087232,-0.079113,-0.065285,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.13814,-0.079144,-0.091213,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.072231,-0.079169,-0.082162,0,0
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.39858,-0.079174,-0.063072,0,0
2,GO INCLUSION BODY ASSEMBLY,0.89907,-0.079179,0.033338,0,0
2,GO MACROPHAGE DIFFERENTIATION,0.045624,-0.079261,-0.13395,0,0
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.082489,-0.079539,-0.095341,0,0
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.62732,-0.079689,-0.12377,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.17653,-0.079723,-0.071325,0,0
2,GO STEROID ESTERIFICATION,0.11434,-0.079851,-0.19435,0,0
2,GO EMBRYO IMPLANTATION,0.24643,-0.079902,-0.10811,0,0
2,GO CENTRIOLE ASSEMBLY,0.13814,-0.079905,-0.068935,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.10096,-0.079933,-0.089764,0,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.15517,-0.079957,-0.097999,0,0
2,GO HEMIDESMOSOME ASSEMBLY,0.66501,-0.079977,-0.12878,0,0
2,GO PHOSPHOLIPID EFFLUX,0.21905,-0.080125,-0.1366,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.088862,-0.080256,-0.13641,0,0
2,GO HORMONE TRANSPORT,0.19695,-0.080339,-0.05185,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.32938,-0.080418,-0.079,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.21256,-0.08045,-0.092696,0,0
2,GO KERATINOCYTE MIGRATION,0.61497,-0.08049,-0.039674,0,0
2,GO AMINE METABOLIC PROCESS,0.12049,-0.080577,-0.079885,0,0
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.60883,-0.080587,-0.0053089,0,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.11434,-0.08078,-0.068347,0,0
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.14285,-0.08084,-0.24794,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.17934,-0.080883,-0.082861,0,0
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.38888,-0.081216,-0.039415,0,0
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.89907,-0.08135,0.012913,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.0021062,-0.081483,-0.10326,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.79636,-0.081497,-0.014733,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.36064,-0.081499,-0.088131,0,0
2,GO REGULATION OF GLIAL CELL MIGRATION,0.46512,-0.081511,-0.043248,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.21905,-0.081737,-0.10744,0,0
2,GO MALE MEIOSIS I,0.14526,-0.081746,-0.16335,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.0018173,-0.081769,-0.08676,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.27999,-0.081823,-0.079765,0,0
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.045624,-0.081921,-0.088216,0,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.36991,-0.081949,-0.11858,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.11039,-0.081967,-0.073009,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.17934,-0.082008,-0.068604,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.98953,-0.082031,0.0090464,0,0
2,GO ENDOSOMAL TRANSPORT,0.00028792,-0.082157,-0.10138,0,0
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.057089,-0.082351,-0.1822,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,0.12908,-0.082473,-0.10733,0,0
2,GO VACUOLAR TRANSPORT,0.0094949,-0.082562,-0.1011,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.049546,-0.082713,-0.09224,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.11636,-0.082782,-0.07921,0,0
2,GO REGULATION OF LIPID STORAGE,0.087232,-0.082949,-0.091851,0,0
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.14526,-0.082951,-0.092192,0,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.21579,-0.082956,-0.10327,0,0
2,GO ERYTHROCYTE MATURATION,0.12049,-0.08344,-0.088107,0,0
2,GO FAT CELL DIFFERENTIATION,0.0067808,-0.083727,-0.12377,0,0
2,GO PROTEIN DEGLYCOSYLATION,0.11039,-0.08417,-0.14361,0,0
2,GO REGULATION OF HAIR CYCLE,0.20937,-0.084269,-0.10289,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.027803,-0.08431,-0.14589,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.20937,-0.084536,-0.056248,0,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.39858,-0.084864,-0.049769,0,0
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.12473,-0.0849,-0.10945,0,0
2,GO EXIT FROM MITOSIS,0.022165,-0.084988,-0.10847,0,0
2,GO GASTRIC ACID SECRETION,0.60883,-0.08499,-0.037888,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.20309,-0.085085,-0.06729,0,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.55487,-0.085163,-0.041185,0,0
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.10654,-0.085236,-0.081822,0,0
2,GO B CELL HOMEOSTASIS,0.32506,-0.085482,-0.0654,0,0
2,GO P38MAPK CASCADE,0.095625,-0.085628,-0.11232,0,0
2,GO INNER EAR MORPHOGENESIS,0.055956,-0.085652,-0.10908,0,0
2,GO CILIUM MOVEMENT,0.0020453,-0.085741,-0.127,0,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.18508,-0.085753,-0.10198,0,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.076492,-0.086105,-0.076304,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.36064,-0.086299,-0.092187,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.29586,-0.086473,-0.083811,0,0
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.082489,-0.086596,-0.067863,0,0
2,GO TEMPERATURE HOMEOSTASIS,0.087232,-0.086657,-0.064314,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.25363,-0.086693,-0.11179,0,0
2,GO INOSITOL METABOLIC PROCESS,0.060602,-0.086994,-0.11438,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.13814,-0.087059,-0.083389,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.059411,-0.0872,-0.13205,0,0
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.67776,-0.087223,-0.074606,0,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.092194,-0.087339,-0.18318,0,0
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.13814,-0.087407,-0.19943,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.057089,-0.087547,-0.16547,0,0
2,GO OTIC VESICLE DEVELOPMENT,0.68418,-0.087736,-0.044953,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.080955,-0.087739,-0.094854,0,0
2,GO ACTIN CROSSLINK FORMATION,0.87144,-0.087869,0.077755,0,0
2,GO STEROL HOMEOSTASIS,0.20621,-0.088167,-0.089323,0,0
2,GO TISSUE REGENERATION,0.1028,-0.088299,-0.11001,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.13814,-0.088552,-0.066869,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.13583,-0.088655,-0.096032,0,0
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.10096,-0.088765,-0.076278,0,0
2,GO WHITE FAT CELL DIFFERENTIATION,0.095625,-0.088786,-0.10801,0,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.13355,-0.088807,-0.1344,0,0
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.072231,-0.089101,-0.11879,0,0
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.16559,-0.089316,-0.093759,0,0
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.053746,-0.089326,-0.087658,0,0
2,GO POSITIVE CHEMOTAXIS,0.068167,-0.089478,-0.12492,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.15015,-0.089579,-0.11969,0,0
2,GO DISTAL TUBULE DEVELOPMENT,0.28785,-0.089763,-0.11846,0,0
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.043763,-0.089812,-0.09272,0,0
2,GO RNA DESTABILIZATION,0.087232,-0.090047,-0.076442,0,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.91987,-0.090175,-0.0011283,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.87144,-0.090279,-0.050626,0,0
2,GO FUCOSYLATION,0.42347,-0.090311,-0.05878,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.12473,-0.090507,-0.078158,0,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.31653,-0.090544,-0.089967,0,0
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.26098,-0.09056,-0.093363,0,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.084046,-0.09068,-0.10219,0,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.21256,-0.090789,-0.040896,0,0
2,GO CYCLOOXYGENASE PATHWAY,0.89907,-0.090943,-0.0083277,0,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.087232,-0.091064,-0.091989,0,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.0087944,-0.091301,-0.11058,0,0
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.054842,-0.091353,-0.054921,0,0
2,GO INSULIN SECRETION,0.41842,-0.091501,-0.034162,0,0
2,GO MEIOTIC CELL CYCLE,0.00037661,-0.091734,-0.09741,0,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.015953,-0.091744,-0.12223,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.072231,-0.091962,-0.18076,0,0
2,GO MACROPHAGE PROLIFERATION,0.43883,-0.091977,-0.11518,0,0
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.073629,-0.092056,-0.086216,0,0
2,GO LUNG MORPHOGENESIS,0.072231,-0.092227,-0.14341,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.015203,-0.092248,-0.10601,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.21256,-0.092277,-0.063994,0,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.095625,-0.092371,-0.060268,0,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.12908,-0.092676,-0.074987,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.063042,-0.0929,-0.13949,0,0
2,GO RNA DECAPPING,0.063042,-0.093165,-0.084048,0,0
2,GO RESPONSE TO FOOD,0.064293,-0.093167,-0.092211,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.12689,-0.093304,-0.11504,0,0
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.38408,-0.093305,-0.080008,0,0
2,GO PHAGOSOME MATURATION,0.14526,-0.093437,-0.085654,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.14285,-0.093568,-0.094321,0,0
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.10096,-0.093605,-0.091261,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.017969,-0.093974,-0.093809,0,0
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.48678,-0.093985,-0.065317,0,0
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.12049,-0.094103,-0.18566,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.75615,-0.09437,-0.026685,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.080955,-0.094409,-0.083872,0,0
2,GO SUBPALLIUM DEVELOPMENT,0.21905,-0.094589,-0.086714,0,0
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.063042,-0.094642,-0.11428,0,0
2,GO KINETOCHORE ASSEMBLY,0.57857,-0.094721,-0.053244,0,0
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.010245,-0.094843,-0.12706,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.15264,-0.095036,-0.13654,0,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.090515,-0.095162,-0.13351,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.44402,-0.095188,-0.03795,0,0
2,GO STEROID METABOLIC PROCESS,0.079444,-0.095191,-0.083801,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.099158,-0.095222,-0.11135,0,0
2,GO PROTEIN REFOLDING,0.29586,-0.09544,-0.053965,0,0
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.99651,-0.095512,-0.06923,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.18508,-0.095779,-0.12623,0,0
2,GO MITOCHONDRIAL FUSION,0.031748,-0.0959,-0.098395,0,0
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.30402,-0.096014,-0.34622,0,0
2,GO RESPONSE TO BMP,0.042857,-0.096422,-0.11419,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.16294,-0.096559,-0.099548,0,0
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.44402,-0.09674,-0.097956,0,0
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.23937,-0.097144,-0.072208,0,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.20309,-0.097336,-0.073089,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.070855,-0.097522,-0.078017,0,0
2,GO CYTOPLASM ORGANIZATION,0.084046,-0.097634,-0.12684,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.0032441,-0.097681,-0.12134,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.64605,-0.097792,-0.053434,0,0
2,GO RENAL WATER HOMEOSTASIS,0.13355,-0.097948,-0.091902,0,0
2,GO ECTODERM DEVELOPMENT,0.015574,-0.09795,-0.11081,0,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.15264,-0.09813,-0.10051,0,0
2,GO CATECHOLAMINE METABOLIC PROCESS,0.81668,-0.098187,0.018086,0,0
2,GO SPROUTING ANGIOGENESIS,0.073629,-0.098418,-0.10615,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.054842,-0.098654,-0.13863,0,0
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.19695,-0.098759,-0.10064,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.001986,-0.098769,-0.11462,0,0
2,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.5726,-0.098813,-0.040628,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.12473,-0.098825,-0.1131,0,0
2,GO MESODERM MORPHOGENESIS,0.077957,-0.098903,-0.11643,0,0
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.060602,-0.099032,-0.18398,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.080955,-0.099088,-0.11472,0,0
2,GO ANDROGEN METABOLIC PROCESS,0.47588,-0.09924,-0.057015,0,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.23937,-0.099259,-0.062738,0,0
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.26098,-0.099356,-0.063304,0,0
2,GO RESPONSE TO STEROL DEPLETION,0.25363,-0.099511,-0.10718,0,0
2,GO T CELL APOPTOTIC PROCESS,0.084046,-0.099884,-0.11709,0,0
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.12259,-0.099893,-0.08762,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.62732,-0.10003,-0.082911,0,0
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.085627,-0.10012,-0.096106,0,0
2,GO HEART INDUCTION,0.36064,-0.10018,-0.082211,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0023671,-0.1002,-0.15959,0,0
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.4978,-0.10032,-0.068885,0,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.33812,-0.10033,-0.061251,0,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.072231,-0.10036,-0.1479,0,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.32938,-0.10056,-0.14047,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.097379,-0.10059,-0.072517,0,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.64605,-0.10088,-0.066347,0,0
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.20309,-0.10109,-0.14733,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.092194,-0.10111,-0.078679,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.60883,-0.10114,-0.049575,0,0
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.34256,-0.10131,-0.11721,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.46512,-0.10141,-0.083864,0,0
2,GO NOTOCHORD DEVELOPMENT,0.39371,-0.10143,-0.12899,0,0
2,GO MACROPHAGE APOPTOTIC PROCESS,0.11434,-0.10143,-0.12999,0,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00050664,-0.1016,-0.097924,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.11636,-0.1018,-0.11731,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.03939,-0.10185,-0.078305,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0054795,-0.10192,-0.097993,0,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.034637,-0.10216,-0.10785,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.047551,-0.10217,-0.13505,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.15773,-0.10298,-0.10393,0,0
2,GO GOLGI LOCALIZATION,0.095625,-0.10299,-0.088866,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.35607,-0.10336,-0.057254,0,0
2,GO RESPONSE TO COLD,0.090515,-0.10342,-0.13864,0,0
2,GO EAR MORPHOGENESIS,0.012203,-0.1035,-0.12465,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.20621,-0.10359,-0.083018,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.34256,-0.10408,-0.054531,0,0
2,GO SULFATION,0.11235,-0.10413,-0.13199,0,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.16828,-0.10432,-0.20675,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.23937,-0.10438,-0.14381,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.033166,-0.10445,-0.079391,0,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.10845,-0.10455,-0.077879,0,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.85768,-0.10474,-0.010847,0,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.7495,-0.10487,-0.049168,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.05824,-0.10505,-0.15867,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.47049,-0.10567,-0.069096,0,0
2,GO PANCREATIC JUICE SECRETION,0.24288,-0.10591,-0.073648,0,0
2,GO RESPONSE TO ESTRADIOL,0.093897,-0.10593,-0.083027,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.55487,-0.10596,-0.081441,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,0.40843,-0.10605,-0.070457,0,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.22235,-0.10614,-0.084726,0,0
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.12049,-0.1064,-0.078279,0,0
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.1313,-0.1066,-0.088014,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.7495,-0.10672,-0.023395,0,0
2,GO SPERMATID DIFFERENTIATION,0.0087944,-0.1071,-0.10775,0,0
2,GO SEX DETERMINATION,0.033894,-0.10741,-0.13898,0,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.012508,-0.10772,-0.16527,0,0
2,GO DIENCEPHALON DEVELOPMENT,0.092194,-0.10818,-0.10951,0,0
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.25363,-0.10856,-0.05197,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0049174,-0.10864,-0.10882,0,0
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.38408,-0.10867,-0.090366,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.27227,-0.10892,-0.076187,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.097379,-0.10894,-0.1109,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.24643,-0.1092,-0.076207,0,0
2,GO MRNA TRANSCRIPTION,0.25363,-0.10935,-0.072209,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.41341,-0.10941,-0.042975,0,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.053746,-0.10949,-0.15808,0,0
2,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.63978,-0.10983,-0.14513,0,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.016734,-0.11011,-0.10868,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.082489,-0.11013,-0.081344,0,0
2,GO FAT CELL PROLIFERATION,0.26098,-0.11081,-0.081584,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.16828,-0.11097,-0.14394,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.072231,-0.11222,-0.16981,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.0023671,-0.11228,-0.11441,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.75615,-0.11251,-0.048589,0,0
2,GO KETONE CATABOLIC PROCESS,0.070855,-0.11282,-0.1894,0,0
2,GO RESPONSE TO INSECTICIDE,0.80989,-0.11311,-0.013078,0,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.079444,-0.11333,-0.084827,0,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.12049,-0.1136,-0.28901,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.068167,-0.11386,-0.18963,0,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.47588,-0.11402,-0.045653,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.21579,-0.1141,-0.11565,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.099158,-0.11447,-0.17675,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.91293,-0.11454,0.022408,0,0
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.12259,-0.11456,-0.16197,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.0085714,-0.1146,-0.11829,0,0
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.060602,-0.11507,-0.16772,0,0
2,GO LIPOPROTEIN LOCALIZATION,0.14285,-0.11514,-0.10287,0,0
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.072231,-0.11557,-0.12803,0,0
2,GO MYOTUBE DIFFERENTIATION,0.10096,-0.11618,-0.088465,0,0
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.12049,-0.11621,-0.17828,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.23937,-0.11666,-0.12927,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.042857,-0.11675,-0.12906,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.088862,-0.11691,-0.12826,0,0
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.25001,-0.11722,-0.16384,0,0
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.2,-0.11725,-0.11246,0,0
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.092194,-0.11832,-0.1604,0,0
2,GO NEURON FATE COMMITMENT,0.41341,-0.11835,-0.040205,0,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.15015,-0.11851,-0.15717,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.095625,-0.11896,-0.12616,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.17934,-0.11901,-0.068565,0,0
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.090515,-0.11902,-0.13531,0,0
2,GO HORMONE METABOLIC PROCESS,0.11434,-0.1193,-0.098397,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.72313,-0.11935,-0.041044,0,0
2,GO STEROL IMPORT,0.34702,-0.11938,-0.055777,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.030383,-0.1196,-0.11207,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.085627,-0.11962,-0.18799,0,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.25729,-0.11971,-0.079686,0,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.054842,-0.11977,-0.10854,0,0
2,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.27611,-0.12024,-0.076403,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.016339,-0.12098,-0.13489,0,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.087232,-0.12111,-0.15455,0,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.11434,-0.12172,-0.08329,0,0
2,GO HEART FORMATION,0.25001,-0.12187,-0.08206,0,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.41842,-0.12194,-0.056898,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0073363,-0.1225,-0.12381,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.085627,-0.12254,-0.10509,0,0
2,GO T HELPER 2 CELL DIFFERENTIATION,0.33373,-0.12264,-0.19267,0,0
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.36064,-0.12265,-0.09638,0,0
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.16828,-0.12326,-0.14239,0,0
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.25001,-0.12327,-0.12467,0,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.012508,-0.12338,-0.14282,0,0
2,GO NEGATIVE REGULATION OF CELL SIZE,0.082489,-0.12343,-0.094469,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.15015,-0.12357,-0.10189,0,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.63354,-0.12361,-0.079345,0,0
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.22568,-0.12369,-0.10727,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.35153,-0.12382,-0.085274,0,0
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.084046,-0.12411,-0.18517,0,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.14285,-0.12419,-0.11158,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0036303,-0.12448,-0.13972,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.13583,-0.12451,-0.12157,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.21579,-0.12457,-0.073951,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.12908,-0.125,-0.10917,0,0
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.10096,-0.12573,-0.1186,0,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.00017186,-0.12589,-0.15114,0,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.18219,-0.126,-0.11398,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.036948,-0.12609,-0.18719,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.05161,-0.12619,-0.18499,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.054842,-0.12653,-0.11945,0,0
2,GO CYSTEINE METABOLIC PROCESS,0.56666,-0.12668,-0.065246,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.054842,-0.12674,-0.11463,0,0
2,GO RESPONSE TO DIETARY EXCESS,0.46512,-0.12681,-0.073083,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.15264,-0.12731,-0.085475,0,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.076492,-0.1274,-0.17121,0,0
2,GO RESPONSE TO CADMIUM ION,0.11039,-0.12778,-0.12653,0,0
2,GO RESPONSE TO IRON ION,0.017969,-0.12784,-0.15696,0,0
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.075049,-0.12815,-0.11737,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.060602,-0.12853,-0.15283,0,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.0046564,-0.12856,-0.12382,0,0
2,GO NEUTROPHIL HOMEOSTASIS,0.29992,-0.12898,-0.14992,0,0
2,GO CILIUM ORGANIZATION,0.00052342,-0.12901,-0.13345,0,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.042857,-0.12913,-0.2315,0,0
2,GO REGULATION OF GTP BINDING,0.40843,-0.12916,-0.069615,0,0
2,GO REGULATION OF CELL SHAPE,0.007729,-0.12957,-0.13399,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.090515,-0.12965,-0.19235,0,0
2,GO ETHER BIOSYNTHETIC PROCESS,0.12689,-0.12983,-0.19409,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.076492,-0.1303,-0.10402,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.095625,-0.13039,-0.10267,0,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.017549,-0.13045,-0.11113,0,0
2,GO AMMONIUM TRANSPORT,0.10845,-0.13054,-0.19741,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.072231,-0.1308,-0.1429,0,0
2,GO LIPID EXPORT FROM CELL,0.076492,-0.1312,-0.11281,0,0
2,GO SPECIFICATION OF SYMMETRY,0.001986,-0.13171,-0.11453,0,0
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.057089,-0.13195,-0.10423,0,0
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.077957,-0.13235,-0.13666,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0032441,-0.13243,-0.12134,0,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.12908,-0.13297,-0.23336,0,0
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.12689,-0.13369,-0.12255,0,0
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.13355,-0.13395,-0.18851,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.099158,-0.13406,-0.087686,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.32938,-0.13435,-0.081308,0,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.01282,-0.1348,-0.14885,0,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.010245,-0.13504,-0.138,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0073363,-0.13507,-0.13492,0,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.066855,-0.1352,-0.15909,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.072231,-0.13536,-0.10553,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.00044439,-0.13553,-0.14304,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.00040247,-0.13585,-0.15198,0,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.1313,-0.13603,-0.097823,0,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.29992,-0.13626,-0.13545,0,0
2,GO PIGMENT GRANULE LOCALIZATION,0.01282,-0.13658,-0.1564,0,0
2,GO REGULATION OF NEURON MATURATION,0.4598,-0.13662,-0.043819,0,0
2,GO RETINOL METABOLIC PROCESS,0.057089,-0.13684,-0.17424,0,0
2,GO PLASMA MEMBRANE FUSION,0.13814,-0.13697,-0.13578,0,0
2,GO FORELIMB MORPHOGENESIS,0.15264,-0.137,-0.11631,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.19695,-0.13708,-0.070767,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.2839,-0.13874,-0.069496,0,0
2,GO UTERUS DEVELOPMENT,0.27999,-0.14048,-0.068691,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.12473,-0.14058,-0.11492,0,0
2,GO MEMBRANE FISSION,0.055956,-0.14069,-0.11701,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.24288,-0.14184,-0.10259,0,0
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.37932,-0.1419,-0.095205,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.05824,-0.14226,-0.10691,0,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.013465,-0.14252,-0.17536,0,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.052669,-0.14262,-0.11501,0,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.097379,-0.14286,-0.1077,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0057817,-0.14298,-0.17715,0,0
2,GO V D J RECOMBINATION,0.011904,-0.14309,-0.19634,0,0
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.21905,-0.14358,-0.11073,0,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.16294,-0.14358,-0.17508,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0028957,-0.1439,-0.19045,0,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.082489,-0.14419,-0.11358,0,0
2,GO EPITHELIAL TUBE FORMATION,0.00022676,-0.14479,-0.15709,0,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.00022676,-0.14503,-0.1583,0,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.24288,-0.14552,-0.19843,0,0
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.15264,-0.14566,-0.16436,0,0
2,GO ANIMAL ORGAN MATURATION,0.13355,-0.14576,-0.10707,0,0
2,GO CARNITINE METABOLIC PROCESS,0.38888,-0.14588,-0.064017,0,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.26847,-0.14619,-0.090231,0,0
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.53742,-0.14649,-0.16679,0,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.10845,-0.14707,-0.17964,0,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.35607,-0.1471,-0.082958,0,0
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.066855,-0.14727,-0.1549,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.19393,-0.14817,-0.10305,0,0
2,GO PLATELET DEGRANULATION,0.20621,-0.1483,-0.1132,0,0
2,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.21256,-0.14852,-0.17387,0,0
2,GO ENDOTHELIUM DEVELOPMENT,0.0013872,-0.14899,-0.16446,0,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.015574,-0.1494,-0.12683,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.48131,-0.14951,-0.075744,0,0
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00059588,-0.14964,-0.12514,0,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.32506,-0.14965,-0.11279,0,0
2,GO MICROTUBULE BUNDLE FORMATION,0.00087311,-0.14969,-0.16357,0,0
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.093897,-0.14977,-0.11086,0,0
2,GO COPULATION,0.068167,-0.1504,-0.11843,0,0
2,GO REGULATION OF MYOBLAST FUSION,0.12049,-0.15075,-0.17769,0,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.20309,-0.15141,-0.14563,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.26098,-0.15142,-0.14635,0,0
2,GO CELL PROJECTION ASSEMBLY,5.4121e-05,-0.15189,-0.12875,0,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.21579,-0.15203,-0.12687,0,0
2,GO DETECTION OF CALCIUM ION,0.2,-0.15249,-0.13043,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.22568,-0.15254,-0.10321,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.023205,-0.15258,-0.1816,0,0
2,GO MICROTUBULE SEVERING,0.024846,-0.15297,-0.14641,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.20309,-0.15304,-0.15205,0,0
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.12689,-0.15324,-0.15939,0,0
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0028957,-0.15332,-0.18154,0,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.070855,-0.15402,-0.13608,0,0
2,GO MYOFIBRIL ASSEMBLY,0.0013054,-0.15403,-0.1654,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.15015,-0.15425,-0.13189,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.0049174,-0.1545,-0.18074,0,0
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.17099,-0.1547,-0.067165,0,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.29586,-0.15483,-0.054061,0,0
2,GO AMYLOID FIBRIL FORMATION,0.33373,-0.15512,-0.11336,0,0
2,GO SEROTONIN SECRETION,0.14526,-0.15553,-0.095884,0,0
2,GO EYE MORPHOGENESIS,0.0007696,-0.15573,-0.15378,0,0
2,GO GANGLION DEVELOPMENT,0.1313,-0.15648,-0.18093,0,0
2,GO HYALURONAN CATABOLIC PROCESS,0.20309,-0.15652,-0.16605,0,0
2,GO EPITHELIAL CELL MATURATION,0.070855,-0.1566,-0.13123,0,0
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.020205,-0.15667,-0.12284,0,0
2,GO T CELL EXTRAVASATION,0.13583,-0.15669,-0.23466,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.073629,-0.15673,-0.15122,0,0
2,GO TELOMERE CAPPING,0.0041716,-0.15682,-0.11467,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.23589,-0.15705,-0.067929,0,0
2,GO NEURAL NUCLEUS DEVELOPMENT,0.019739,-0.1571,-0.15153,0,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.007729,-0.1573,-0.18045,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0037331,-0.15743,-0.14227,0,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.18508,-0.15763,-0.13072,0,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.014486,-0.15774,-0.12947,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.0017641,-0.15846,-0.16745,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.12259,-0.15903,-0.20717,0,0
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.25363,-0.15953,-0.13287,0,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.054842,-0.1597,-0.22913,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.070855,-0.16018,-0.14161,0,0
2,GO MALE GENITALIA DEVELOPMENT,0.036164,-0.16024,-0.16504,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.033894,-0.16114,-0.19282,0,0
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.25001,-0.16144,-0.11423,0,0
2,GO TYPE 2 IMMUNE RESPONSE,0.065563,-0.16191,-0.19482,0,0
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.42347,-0.1623,-0.10631,0,0
2,GO CELL FATE DETERMINATION,0.0094949,-0.16255,-0.18638,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.21256,-0.16348,-0.1121,0,0
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0050528,-0.16395,-0.16202,0,0
2,GO LACTATE METABOLIC PROCESS,0.077957,-0.16484,-0.14518,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.019739,-0.16498,-0.16212,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.74288,-0.16555,-0.03071,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.011904,-0.16609,-0.13149,0,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0053338,-0.16686,-0.18038,0,0
2,GO LYSINE METABOLIC PROCESS,0.082489,-0.16717,-0.21034,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.20621,-0.16786,-0.12081,0,0
2,GO RESPONSE TO ISCHEMIA,0.001986,-0.16838,-0.16397,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.080955,-0.16839,-0.11155,0,0
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0042883,-0.1685,-0.20823,0,0
2,GO TRNA CATABOLIC PROCESS,0.24643,-0.16872,-0.13514,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.00095906,-0.16935,-0.21586,0,0
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0033369,-0.16957,-0.33203,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.10465,-0.16995,-0.22625,0,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.049546,-0.17037,-0.23522,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.024846,-0.17045,-0.16178,0,0
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.025414,-0.17053,-0.3756,0,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.00035231,-0.17079,-0.15974,0,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.18219,-0.17115,-0.077585,0,0
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0015653,-0.17192,-0.16732,0,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.004408,-0.17196,-0.17018,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.53167,-0.17269,-0.038424,0,0
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.23245,-0.17407,-0.10281,0,0
2,GO ERYTHROCYTE DEVELOPMENT,0.0032441,-0.17411,-0.13457,0,0
2,GO PROSTANOID BIOSYNTHETIC PROCESS,0.019283,-0.17445,-0.2578,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.044685,-0.17453,-0.14119,0,0
2,GO DORSAL VENTRAL PATTERN FORMATION,0.0037331,-0.17487,-0.14148,0,0
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.0022992,-0.17542,-0.16577,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.016339,-0.17563,-0.15797,0,0
2,GO ENDOCRINE HORMONE SECRETION,0.0056288,-0.17573,-0.15316,0,0
2,GO METANEPHROS MORPHOGENESIS,0.25001,-0.17581,-0.075415,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.00052342,-0.17744,-0.15958,0,0
2,GO SPERM AXONEME ASSEMBLY,0.018398,-0.17897,-0.14658,0,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.11039,-0.17905,-0.12555,0,0
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.14769,-0.17951,-0.12749,0,0
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.21256,-0.17955,-0.1377,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.036164,-0.17974,-0.1366,0,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00067758,-0.1798,-0.18452,0,0
2,GO BRONCHUS DEVELOPMENT,0.20309,-0.18006,-0.13595,0,0
2,GO REGULATION OF CILIUM BEAT FREQUENCY,0.013139,-0.18018,-0.17527,0,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0056288,-0.1806,-0.16351,0,0
2,GO ETHANOL CATABOLIC PROCESS,0.27999,-0.18063,-0.10727,0,0
2,GO CELL FATE SPECIFICATION,0.013798,-0.18077,-0.14292,0,0
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00052342,-0.18189,-0.2359,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.12689,-0.18205,-0.097632,0,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.10654,-0.18215,-0.1864,0,0
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.080955,-0.18238,-0.2116,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00036427,-0.18249,-0.21438,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0029794,-0.18274,-0.23216,0,0
2,GO RESPONSE TO INACTIVITY,0.02166,-0.18324,-0.15967,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.0025083,-0.18534,-0.14784,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0011549,-0.18602,-0.16315,0,0
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.12689,-0.18625,-0.15532,0,0
2,GO INTRACILIARY TRANSPORT,0.0025083,-0.18655,-0.20942,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00032948,-0.18658,-0.16686,0,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.16032,-0.1866,-0.18686,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0056288,-0.18666,-0.16861,0,0
2,GO GENITALIA MORPHOGENESIS,0.1028,-0.18737,-0.14642,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0069616,-0.18822,-0.15997,0,0
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.072231,-0.18966,-0.20207,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.22235,-0.18976,-0.20246,0,0
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.080955,-0.18988,-0.14246,0,0
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.32938,-0.18998,-0.11467,0,0
2,GO RESPONSE TO AUDITORY STIMULUS,0.11235,-0.19042,-0.13911,0,0
2,GO RENAL ABSORPTION,0.082489,-0.19141,-0.23081,0,0
2,GO ETHANOL OXIDATION,0.15773,-0.19142,-0.23688,0,0
2,GO CELL MIGRATION IN HINDBRAIN,0.041093,-0.19215,-0.19747,0,0
2,GO REGULATION OF CHLORIDE TRANSPORT,0.05824,-0.19226,-0.1733,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0011549,-0.19228,-0.17259,0,0
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0040578,-0.19241,-0.17525,0,0
2,GO GALACTOSE METABOLIC PROCESS,0.10465,-0.19284,-0.15601,0,0
2,GO SEGMENT SPECIFICATION,0.016734,-0.1934,-0.22752,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.17934,-0.19379,-0.14419,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.0062634,-0.19384,-0.15592,0,0
2,GO FEMALE GENITALIA DEVELOPMENT,0.0030654,-0.19429,-0.21205,0,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0083534,-0.19517,-0.14355,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.18508,-0.19669,-0.13112,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,2.8418e-05,-0.19715,-0.20872,0,0
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.17934,-0.19725,-0.1207,0,0
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.12473,-0.1974,-0.18682,0,0
2,GO MICROVILLUS ASSEMBLY,0.053746,-0.19753,-0.20991,0,0
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.073629,-0.19844,-0.1825,0,0
2,GO SARCOMERE ORGANIZATION,0.0040578,-0.19847,-0.18119,0,0
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00035231,-0.1996,-0.20529,0,0
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.017549,-0.19969,-0.24726,0,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0047853,-0.20082,-0.23713,0,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.075049,-0.20108,-0.12896,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.10654,-0.20179,-0.12994,0,0
2,GO ETHANOL METABOLIC PROCESS,0.018836,-0.20221,-0.22088,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.11636,-0.20224,-0.095155,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.1313,-0.20253,-0.1455,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014486,-0.20301,-0.21454,0,0
2,GO PARTURITION,0.082489,-0.2036,-0.1589,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0016129,-0.20414,-0.21579,0,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.070855,-0.20441,-0.18912,0,0
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.17374,-0.20468,-0.1526,0,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.017549,-0.20492,-0.26988,0,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.049546,-0.20493,-0.15013,0,0
2,GO REGULATION OF PROTEIN SUMOYLATION,0.043763,-0.20577,-0.115,0,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.036948,-0.2058,-0.3584,0,0
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,9.389e-05,-0.2064,-0.21255,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.11039,-0.20747,-0.10216,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.25729,-0.20766,-0.15062,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.033166,-0.20879,-0.1891,0,0
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.00014935,-0.2089,-0.20287,0,0
2,GO CENTROSOME SEPARATION,0.0067808,-0.20902,-0.19563,0,0
2,GO REGULATION OF STEM CELL DIVISION,0.12259,-0.20926,-0.10614,0,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,0.13583,-0.20935,-0.15585,0,0
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0034322,-0.20965,-0.15386,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00010462,-0.21082,-0.26754,0,0
2,GO POSITIVE T CELL SELECTION,0.0020453,-0.21266,-0.17666,0,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,0.40349,-0.21308,-0.034826,0,0
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.12473,-0.2133,-0.15283,0,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.16828,-0.21457,-0.11528,0,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.05161,-0.21646,-0.16836,0,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0028141,-0.21714,-0.20972,0,0
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.076492,-0.21747,-0.23213,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.00026903,-0.21769,-0.26574,0,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.059411,-0.21796,-0.28744,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.040234,-0.21923,-0.20719,0,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.21579,-0.22055,-0.073047,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0032441,-0.22215,-0.3142,0,0
2,GO MALE SEX DETERMINATION,0.0038387,-0.22247,-0.24751,0,0
2,GO POSITIVE REGULATION OF CHEMOTAXIS,3.5759e-05,-0.22635,-0.21966,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00011241,-0.22664,-0.19871,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.10845,-0.22751,-0.16087,0,0
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.060602,-0.22914,-0.31862,0,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.063042,-0.22994,-0.19183,0,0
2,GO SPERM CAPACITATION,0.00035231,-0.23005,-0.20641,0,0
2,GO ESTROUS CYCLE,0.0071468,-0.23163,-0.24358,0,0
2,GO CELL JUNCTION MAINTENANCE,0.0011549,-0.23176,-0.2268,0,0
2,GO THYMOCYTE APOPTOTIC PROCESS,0.079444,-0.23252,-0.16641,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.12689,-0.23289,-0.19345,0,0
2,GO PLACENTA DEVELOPMENT,5.2837e-06,-0.23308,-0.24538,0,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.21905,-0.23403,-0.11081,0,0
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.084046,-0.23463,-0.20178,0,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0020453,-0.23597,-0.2163,0,0
2,GO REGULATION OF GLOMERULAR FILTRATION,0.076492,-0.23651,-0.24512,0,0
2,GO SKELETAL MUSCLE ADAPTATION,0.04854,-0.23652,-0.1312,0,0
2,GO RESPONSE TO LEPTIN,0.014841,-0.23696,-0.21683,0,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.17934,-0.23766,-0.081558,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.029068,-0.23779,-0.17505,0,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0024367,-0.2387,-0.29907,0,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.23937,-0.23921,-0.13675,0,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.15264,-0.23973,-0.14753,0,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.03245,-0.23999,-0.22587,0,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.001191,-0.24059,-0.28135,0,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0066042,-0.24254,-0.23492,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,1.8521e-05,-0.24306,-0.24897,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011904,-0.2446,-0.21774,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0047853,-0.24528,-0.28865,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.027188,-0.24568,-0.13963,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00081984,-0.24588,-0.26629,0,0
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00011241,-0.24842,-0.29403,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00084609,-0.24956,-0.22203,0,0
2,GO RETINAL METABOLIC PROCESS,0.077957,-0.25064,-0.21635,0,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.014486,-0.25132,-0.20024,0,0
2,GO REGULATION OF SPINDLE ASSEMBLY,7.3528e-06,-0.25391,-0.26491,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,4.8379e-05,-0.25406,-0.28955,0,0
2,GO SPINAL CORD PATTERNING,0.0087944,-0.25563,-0.24283,0,0
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0015189,-0.25565,-0.26237,0,0
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.054842,-0.25594,-0.24168,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00036427,-0.25617,-0.26599,0,0
2,GO EMBRYONIC HEMOPOIESIS,0.001228,-0.2566,-0.21903,0,0
2,GO PITUITARY GLAND DEVELOPMENT,0.001986,-0.25694,-0.27516,0,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.19393,-0.25813,-0.1016,0,0
2,GO T CELL SELECTION,0.0025817,-0.25841,-0.17252,0,0
2,GO BROWN FAT CELL DIFFERENTIATION,5.0226e-05,-0.25842,-0.31036,0,0
2,GO MYOBLAST MIGRATION,0.082489,-0.2586,-0.2141,0,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.015574,-0.26558,-0.25503,0,0
2,GO HEART FIELD SPECIFICATION,0.060602,-0.26833,-0.17541,0,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.029719,-0.26862,-0.19443,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.061812,-0.26905,-0.21526,0,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0017123,-0.26948,-0.25984,0,0
2,GO FRUCTOSE METABOLIC PROCESS,0.079444,-0.2717,-0.24901,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.00050664,-0.2724,-0.26348,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.00055855,-0.27266,-0.22664,0,0
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.036164,-0.2733,-0.22995,0,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.068167,-0.27576,-0.22095,0,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.043763,-0.2761,-0.25581,0,0
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0010528,-0.28029,-0.33755,0,0
2,GO INTERLEUKIN 5 PRODUCTION,0.011047,-0.28092,-0.21074,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.041967,-0.28645,-0.22356,0,0
2,GO EXTRACELLULAR TRANSPORT,1.104e-05,-0.28703,-0.35817,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0024367,-0.28859,-0.21119,0,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.070855,-0.29173,-0.17678,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.018836,-0.29395,-0.20767,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00067758,-0.29434,-0.31884,0,0
2,GO CARDIOBLAST PROLIFERATION,0.43883,-0.2964,-0.11467,0,0
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.023205,-0.29949,-0.23421,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,1.0184e-05,-0.30264,-0.28678,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.02843,-0.30537,-0.18731,0,0
2,GO AXONEME ASSEMBLY,3.1888e-05,-0.30878,-0.31671,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,6.0504e-05,-0.31164,-0.4274,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.00052342,-0.31439,-0.28122,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.057089,-0.31534,-0.16377,0,0
2,GO IMMATURE B CELL DIFFERENTIATION,0.0019282,-0.31535,-0.23545,0,0
2,GO T CELL LINEAGE COMMITMENT,3.7145e-05,-0.31675,-0.28651,0,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00081984,-0.31857,-0.24577,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,9.7346e-05,-0.32053,-0.26301,0,0
2,GO GABAERGIC NEURON DIFFERENTIATION,0.095625,-0.32207,-0.1348,0,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.097379,-0.32331,-0.24581,0,0
2,GO LIPOXYGENASE PATHWAY,0.0015653,-0.32839,-0.35137,0,0
2,GO LEFT RIGHT PATTERN FORMATION,0.00012964,-0.32909,-0.30426,0,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,7.3528e-06,-0.33772,-0.40042,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.017969,-0.34458,-0.29141,0,0
2,GO REFLEX,0.00087311,-0.34684,-0.36676,0,0
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0031536,-0.3503,-0.31511,0,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00010462,-0.35389,-0.41795,0,0
2,GO GONADOTROPIN SECRETION,0.00055855,-0.35713,-0.35836,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0021062,-0.36436,-0.37608,0,0
2,GO MOTILE CILIUM ASSEMBLY,0.00059588,-0.36813,-0.30731,0,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0025083,-0.36907,-0.34298,0,0
2,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0099891,-0.37217,-0.32764,0,0
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0017641,-0.38506,-0.33924,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.12689,-0.38618,-0.17745,0,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0059384,-0.3883,-0.31908,0,0
2,GO GLIAL CELL FATE COMMITMENT,0.0079323,-0.41107,-0.33351,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0085714,-0.42279,-0.3354,0,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00012512,-0.43125,-0.3942,0,0
2,GO NEURON FATE SPECIFICATION,0.0081404,-0.43561,-0.28917,0,0
2,GO ADENOHYPOPHYSIS DEVELOPMENT,0.04854,-0.43791,-0.27687,0,0
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0019282,-0.43953,-0.34183,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00016595,-0.44235,-0.4661,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00074557,-0.44239,-0.4068,0,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,6.7728e-06,-0.44842,-0.39402,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,9.0551e-05,-0.45104,-0.41235,0,0
2,GO RETINA LAYER FORMATION,0.00010845,-0.48066,-0.42623,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0050528,-0.48127,-0.48072,0,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.038561,-0.49499,-0.24544,0,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,3.9418e-06,-0.49691,-0.52259,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,2.4692e-06,-0.51142,-0.47635,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.0027346,-0.52433,-0.42865,0,0
2,GO NOTCH RECEPTOR PROCESSING,8.6584e-06,-0.52724,-0.48523,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00020448,-0.53073,-0.48748,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,5.7413e-06,-0.53986,-0.59671,0,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.00024286,-0.54336,-0.47666,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00016595,-0.56502,-0.52614,0,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00049035,-0.5793,-0.43966,0,0
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0025817,-0.63422,-0.53362,0,0
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,7.6603e-06,-0.72682,-0.57253,0,0
2,GO EPITHELIAL CELL CELL ADHESION,1.5691e-07,-0.7504,-0.79986,0,0
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,3.1904e-06,-0.77652,-0.71411,0,0
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,2.8891e-07,-0.92382,-0.82664,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00024286,1.6395,1.2343,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00025131,1.3107,0.98562,1,1
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,7.5427e-07,1.2926,1.2254,1,1
3,GO CYTIDINE TO URIDINE EDITING,2.3418e-05,0.87532,0.75995,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00087311,0.87266,0.68576,1,1
3,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,3.5759e-05,0.8674,0.72023,1,1
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,9.0179e-06,0.84588,0.65533,1,1
3,GO TOLERANCE INDUCTION,1.0604e-05,0.79848,0.72928,1,1
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,3.1904e-06,0.77816,0.80166,1,1
3,GO MUCUS SECRETION,0.0001165,0.76818,0.64236,1,1
3,GO PROGESTERONE METABOLIC PROCESS,2.5308e-05,0.76646,0.89138,1,1
3,GO GLYCOSIDE METABOLIC PROCESS,0.00034072,0.76369,0.8256,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00087311,0.75446,0.53117,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.3287e-06,0.75103,0.66387,1,1
3,GO HISTAMINE SECRETION,2.6322e-07,0.72977,0.76558,1,1
3,GO LIPID DROPLET FORMATION,1.9904e-06,0.72109,0.717,1,1
3,GO EOSINOPHIL CHEMOTAXIS,3.7145e-05,0.70833,0.52409,1,1
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0028957,0.67893,0.44564,1,1
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.00045924,0.67161,0.55164,1,1
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00040247,0.65651,0.51015,1,1
3,GO RESPONSE TO TYPE I INTERFERON,1.5816e-05,0.6564,0.61199,1,1
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,9.389e-05,0.65203,0.49497,1,1
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,3.3287e-06,0.6518,0.60856,1,1
3,GO HISTAMINE TRANSPORT,6.0198e-07,0.64859,0.70122,1,1
3,GO ACTIN FILAMENT NETWORK FORMATION,0.00032948,0.64318,0.49791,1,1
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,5.4272e-08,0.64091,0.6443,1,1
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.00025131,0.63787,0.51859,1,1
3,GO RESPONSE TO IMMOBILIZATION STRESS,7.2111e-07,0.63728,0.54152,1,1
3,GO EOSINOPHIL MIGRATION,5.2139e-05,0.635,0.50112,1,1
3,GO LIPID DIGESTION,5.7413e-06,0.6329,0.65297,1,1
3,GO INTESTINAL LIPID ABSORPTION,1.0779e-06,0.63284,0.72986,1,1
3,GO DENDRITIC CELL DIFFERENTIATION,8.6584e-06,0.62672,0.53198,1,1
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,2.1663e-05,0.62499,0.60286,1,1
3,GO GERMINAL CENTER FORMATION,6.5149e-05,0.62464,0.50613,1,1
3,GO T CELL MEDIATED CYTOTOXICITY,0.00044439,0.6241,0.46851,1,1
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.6455e-05,0.61712,0.60264,1,1
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,5.4121e-05,0.61535,0.46017,1,1
3,GO MATURE B CELL DIFFERENTIATION,3.1888e-05,0.61012,0.44787,1,1
3,GO RENAL ABSORPTION,1.4039e-05,0.60893,0.6637,1,1
3,GO INTESTINAL ABSORPTION,3.6563e-08,0.60799,0.7016,1,1
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00090094,0.6077,0.49668,1,1
3,GO POSITIVE REGULATION OF CELL MATURATION,5.7413e-06,0.60589,0.56994,1,1
3,GO SEROTONIN METABOLIC PROCESS,2.7343e-05,0.60488,0.59991,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,2.9532e-05,0.60097,0.59853,1,1
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,2.5774e-06,0.60002,0.59075,1,1
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,2.9532e-05,0.59911,0.54725,1,1
3,GO SPHINGOMYELIN METABOLIC PROCESS,3.3202e-07,0.59359,0.55486,1,1
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,1.2962e-05,0.5878,0.47106,1,1
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,5.4121e-05,0.58767,0.57658,1,1
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00014935,0.58478,0.59576,1,1
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0013457,0.58407,0.55109,1,1
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,2.2524e-05,0.58031,0.56023,1,1
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,9.7801e-06,0.5764,0.54905,1,1
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.00069957,0.57526,0.61019,1,1
3,GO DETECTION OF OTHER ORGANISM,1.0604e-05,0.57053,0.58636,1,1
3,GO LEYDIG CELL DIFFERENTIATION,0.00010462,0.56517,0.54152,1,1
3,GO QUINONE METABOLIC PROCESS,6.0504e-05,0.56322,0.64371,1,1
3,GO RESPONSE TO NITROSATIVE STRESS,1.7118e-05,0.5629,0.53522,1,1
3,GO ADHESION OF SYMBIONT TO HOST,0.00022676,0.56022,0.46356,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00022676,0.55884,0.49921,1,1
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,3.0689e-05,0.55526,0.50585,1,1
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,2.0833e-05,0.55286,0.5271,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0001547,0.54408,0.52954,1,1
3,GO O GLYCAN PROCESSING,7.2111e-07,0.54305,0.52944,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00084609,0.54259,0.59125,1,1
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,1.104e-05,0.54053,0.62316,1,1
3,GO TOXIN METABOLIC PROCESS,2.0784e-06,0.53844,0.52619,1,1
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00013433,0.53687,0.50055,1,1
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00032948,0.53607,0.38023,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,8.7323e-05,0.53324,0.48941,1,1
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.9904e-06,0.53172,0.5471,1,1
3,GO KETONE CATABOLIC PROCESS,0.00011241,0.53151,0.47323,1,1
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00028792,0.53068,0.40979,1,1
3,GO NEGATIVE REGULATION OF ANOIKIS,4.6597e-05,0.52772,0.64403,1,1
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.011612,0.52689,0.30699,1,1
3,GO REGULATION OF PLATELET AGGREGATION,0.00012512,0.52634,0.44624,1,1
3,GO AMMONIUM ION METABOLIC PROCESS,1.2454e-05,0.52345,0.51454,1,1
3,GO CERAMIDE CATABOLIC PROCESS,0.0045306,0.51734,0.39034,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00021909,0.51501,0.39108,1,1
3,GO RESPONSE TO EPINEPHRINE,0.0025817,0.51035,0.35664,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,8.7323e-05,0.50897,0.40789,1,1
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0022332,0.50882,0.38007,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0001165,0.50847,0.43982,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.0571e-06,0.50785,0.51253,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,7.013e-05,0.50746,0.46987,1,1
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,1.2454e-05,0.50249,0.48074,1,1
3,GO RETINAL METABOLIC PROCESS,0.00026903,0.50162,0.57734,1,1
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00010462,0.49794,0.45921,1,1
3,GO RESPONSE TO COLD,5.9841e-06,0.49588,0.42409,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0022992,0.49544,0.36968,1,1
3,GO RESPONSE TO INTERLEUKIN 18,0.0022332,0.49506,0.45426,1,1
3,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00032948,0.4949,0.53046,1,1
3,GO REGULATION OF WATER LOSS VIA SKIN,3.3132e-05,0.49381,0.46694,1,1
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.6623e-06,0.48662,0.42753,1,1
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00014935,0.48639,0.50168,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00031859,0.48408,0.36877,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00014418,0.48394,0.43873,1,1
3,GO EPITHELIAL CELL MORPHOGENESIS,0.00025131,0.47659,0.40172,1,1
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,2.8418e-05,0.4758,0.44633,1,1
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00023468,0.4749,0.34177,1,1
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00069957,0.47287,0.45078,1,1
3,GO MEMBRANE LIPID CATABOLIC PROCESS,3.5759e-05,0.4714,0.45476,1,1
3,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00057693,0.47018,0.4776,1,1
3,GO SECONDARY METABOLIC PROCESS,6.7596e-05,0.46942,0.43603,1,1
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00055855,0.46618,0.42183,1,1
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0031536,0.46573,0.34936,1,1
3,GO NEGATIVE REGULATION OF BONE REMODELING,2.1663e-05,0.46518,0.49516,1,1
3,GO REGULATION OF PLATELET ACTIVATION,1.4039e-05,0.46359,0.41499,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0010528,0.46193,0.46487,1,1
3,GO AMINE BIOSYNTHETIC PROCESS,1.3605e-07,0.46157,0.47968,1,1
3,GO L PHENYLALANINE METABOLIC PROCESS,3.7145e-05,0.4614,0.6391,1,1
3,GO REGULATION OF INTEGRIN ACTIVATION,2.1702e-06,0.45984,0.48183,1,1
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00031859,0.45942,0.37456,1,1
3,GO REGULATION OF NEURON MATURATION,4.1112e-06,0.45856,0.43617,1,1
3,GO FRUCTOSE METABOLIC PROCESS,0.0024367,0.4567,0.49806,1,1
3,GO RESPONSE TO REDOX STATE,5.0683e-06,0.4565,0.42445,1,1
3,GO REGULATION OF BONE REMODELING,4.2876e-06,0.4563,0.44374,1,1
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.0833e-05,0.45616,0.40425,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,2.1663e-05,0.45455,0.50848,1,1
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0001547,0.45412,0.5093,1,1
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,1.6455e-05,0.45388,0.50209,1,1
3,GO REGULATION OF ANOIKIS,0.00010462,0.45357,0.49197,1,1
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,2.9532e-05,0.45325,0.36132,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00014418,0.45175,0.39616,1,1
3,GO RESPONSE TO STEROL DEPLETION,3.3287e-06,0.44979,0.50004,1,1
3,GO RESPONSE TO DIETARY EXCESS,0.00014418,0.44928,0.41616,1,1
3,GO ZYMOGEN ACTIVATION,0.00019079,0.44914,0.39656,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00059588,0.44804,0.36996,1,1
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0010206,0.44773,0.3429,1,1
3,GO MICROVILLUS ORGANIZATION,0.00019753,0.44611,0.38749,1,1
3,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00026903,0.44608,0.51779,1,1
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.0012662,0.4457,0.47213,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,3.7145e-05,0.4452,0.42901,1,1
3,GO PHAGOLYSOSOME ASSEMBLY,4.4712e-06,0.44519,0.45778,1,1
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.9904e-06,0.4441,0.46047,1,1
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.2786e-05,0.44309,0.44317,1,1
3,GO BONE RESORPTION,1.8251e-06,0.44246,0.44254,1,1
3,GO REGULATION OF ACROSOME REACTION,0.0010206,0.44121,0.40828,1,1
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,8.3127e-06,0.44076,0.47936,1,1
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.013798,0.43999,0.32229,1,1
3,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,7.547e-05,0.43938,0.45171,1,1
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0033369,0.43937,0.3515,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00087311,0.43885,0.36367,1,1
3,GO REGULATION OF TISSUE REMODELING,3.9418e-06,0.43875,0.39641,1,1
3,GO SIGNAL PEPTIDE PROCESSING,5.2139e-05,0.43827,0.41736,1,1
3,GO GALACTOSE METABOLIC PROCESS,0.001662,0.4369,0.45424,1,1
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,3.8583e-05,0.43678,0.40439,1,1
3,GO ALPHA BETA T CELL PROLIFERATION,2.6307e-05,0.43613,0.39232,1,1
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,1.4039e-05,0.43454,0.39546,1,1
3,GO CELLULAR RESPONSE TO COPPER ION,0.004408,0.43409,0.55022,1,1
3,GO PARTURITION,0.0037331,0.43332,0.30792,1,1
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00047456,0.43277,0.36445,1,1
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,2.1663e-05,0.43262,0.4469,1,1
3,GO REGULATORY T CELL DIFFERENTIATION,0.00019079,0.43202,0.36969,1,1
3,GO IMMUNOGLOBULIN SECRETION,5.6174e-05,0.4306,0.3827,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,6.5149e-05,0.4304,0.46867,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.9532e-05,0.43023,0.39753,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0011199,0.42959,0.31217,1,1
3,GO LIVER MORPHOGENESIS,7.8282e-05,0.42898,0.40022,1,1
3,GO CELL ADHESION MEDIATED BY INTEGRIN,6.0504e-05,0.4289,0.38955,1,1
3,GO ACTIN FILAMENT SEVERING,0.0015189,0.42814,0.37536,1,1
3,GO PLASMINOGEN ACTIVATION,0.0013054,0.42654,0.4091,1,1
3,GO POSITIVE REGULATION OF FERTILIZATION,0.0013457,0.42406,0.32864,1,1
3,GO NEUROTRANSMITTER METABOLIC PROCESS,2.0833e-05,0.42364,0.39734,1,1
3,GO INTRACELLULAR STEROL TRANSPORT,7.0571e-06,0.42364,0.39636,1,1
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.010245,0.42357,0.33641,1,1
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.00031859,0.42207,0.30007,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.4044e-06,0.41896,0.47841,1,1
3,GO B CELL APOPTOTIC PROCESS,2.6902e-06,0.41876,0.44159,1,1
3,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00063551,0.41822,0.45735,1,1
3,GO CELLULAR DEFENSE RESPONSE,1.9904e-06,0.41768,0.42557,1,1
3,GO MUSCLE ATROPHY,0.0010859,0.41647,0.32484,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,9.0551e-05,0.41596,0.43354,1,1
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0056288,0.41593,0.36462,1,1
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00030804,0.41464,0.31632,1,1
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,2.0833e-05,0.41406,0.43307,1,1
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.001228,0.41176,0.29283,1,1
3,GO T CELL MEDIATED IMMUNITY,0.00027832,0.41129,0.31105,1,1
3,GO PROTEIN DEMANNOSYLATION,6.0504e-05,0.41112,0.3994,1,1
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,6.2786e-05,0.41045,0.40771,1,1
3,GO VITAMIN D METABOLIC PROCESS,1.6455e-05,0.41001,0.3978,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0013054,0.40728,0.31466,1,1
3,GO BARBED END ACTIN FILAMENT CAPPING,0.00020448,0.40717,0.42964,1,1
3,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.00052342,0.40716,0.39898,1,1
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.00084609,0.40573,0.37751,1,1
3,GO FOAM CELL DIFFERENTIATION,0.00012512,0.40448,0.3095,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00353,0.40342,0.30877,1,1
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.0226e-05,0.40314,0.34233,1,1
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00019079,0.40249,0.36185,1,1
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00030804,0.40242,0.27953,1,1
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,5.7413e-06,0.40206,0.36594,1,1
3,GO STEROID ESTERIFICATION,0.00028792,0.40201,0.44248,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,2.8418e-05,0.40164,0.34707,1,1
3,GO LUNG CELL DIFFERENTIATION,0.00012964,0.40107,0.48516,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.001986,0.3998,0.415,1,1
3,GO MITOCHONDRIAL DEPOLARIZATION,8.6584e-06,0.39919,0.38599,1,1
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.6174e-05,0.39901,0.36721,1,1
3,GO IMMUNOLOGICAL MEMORY PROCESS,6.0504e-05,0.39885,0.38348,1,1
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00011241,0.39883,0.38594,1,1
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0027346,0.39844,0.39987,1,1
3,GO PROSTANOID METABOLIC PROCESS,0.00036427,0.39715,0.41218,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,4.4878e-05,0.39655,0.35278,1,1
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.011612,0.39619,0.34872,1,1
3,GO REGULATION OF VIRAL LIFE CYCLE,0.00021167,0.39616,0.29339,1,1
3,GO POSITIVE REGULATION OF WOUND HEALING,3.4421e-05,0.39602,0.37055,1,1
3,GO DIGESTION,7.889e-07,0.39593,0.3712,1,1
3,GO REGULATION OF PROTEIN GLYCOSYLATION,4.3218e-05,0.3955,0.49612,1,1
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00067758,0.39438,0.29028,1,1
3,GO INSEMINATION,0.00038934,0.39401,0.36693,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00092958,0.39378,0.47311,1,1
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00022676,0.39346,0.31452,1,1
3,GO RESPONSE TO THYROID HORMONE,0.0018173,0.39334,0.26873,1,1
3,GO RESPONSE TO INTERFERON GAMMA,0.00032948,0.39285,0.31992,1,1
3,GO RESPONSE TO LITHIUM ION,1.4674e-06,0.39243,0.51347,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.9841e-06,0.39231,0.41743,1,1
3,GO DIGESTIVE SYSTEM PROCESS,6.8936e-07,0.39141,0.34897,1,1
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,1.6455e-05,0.39121,0.37349,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00081984,0.39069,0.45478,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0013872,0.3894,0.32031,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00081984,0.38709,0.2602,1,1
3,GO BILE ACID AND BILE SALT TRANSPORT,0.00012512,0.38681,0.58946,1,1
3,GO RESPONSE TO COPPER ION,0.00017796,0.38601,0.52715,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0018173,0.3855,0.41416,1,1
3,GO ANOIKIS,2.0833e-05,0.38393,0.39349,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.1192e-05,0.38254,0.28698,1,1
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00018427,0.38238,0.32261,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0069616,0.38197,0.4271,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00016023,0.38134,0.36364,1,1
3,GO DEFENSE RESPONSE TO VIRUS,0.00017186,0.38114,0.27926,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,3.5759e-05,0.38112,0.42995,1,1
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,7.547e-05,0.38098,0.33108,1,1
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0022992,0.38048,0.3271,1,1
3,GO SUPEROXIDE ANION GENERATION,9.389e-05,0.37997,0.39988,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0039469,0.37898,0.32624,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00025131,0.37869,0.31157,1,1
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.2876e-06,0.37814,0.36341,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,6.2786e-05,0.37695,0.34194,1,1
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,3.7145e-05,0.37683,0.32027,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00017186,0.3757,0.34279,1,1
3,GO ACUTE PHASE RESPONSE,0.00021167,0.37529,0.32725,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0025083,0.37501,0.26456,1,1
3,GO RESPONSE TO MAGNESIUM ION,9.7346e-05,0.37406,0.44349,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,3.7791e-06,0.37397,0.34945,1,1
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.7343e-05,0.37373,0.42972,1,1
3,GO REGULATION OF VASCULOGENESIS,0.0011549,0.37368,0.36563,1,1
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0020453,0.37284,0.29401,1,1
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0030654,0.37254,0.4588,1,1
3,GO CORTICOSTEROID HORMONE SECRETION,0.0033369,0.37233,0.33497,1,1
3,GO CYCLOOXYGENASE PATHWAY,0.0020453,0.372,0.44842,1,1
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00035231,0.37067,0.2925,1,1
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00030804,0.37066,0.33769,1,1
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00026003,0.37055,0.29114,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,4.3218e-05,0.36972,0.41666,1,1
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,1.2962e-05,0.36967,0.34072,1,1
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00050664,0.36963,0.2913,1,1
3,GO PROTEIN O LINKED GLYCOSYLATION,4.4712e-06,0.36949,0.35196,1,1
3,GO VASODILATION,0.00087311,0.36921,0.37171,1,1
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,8.1192e-05,0.36893,0.39497,1,1
3,GO TISSUE REMODELING,9.0179e-06,0.36757,0.32564,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.4346e-05,0.36748,0.34456,1,1
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,4.0073e-05,0.36738,0.33572,1,1
3,GO MOVEMENT IN HOST ENVIRONMENT,0.00042998,0.36725,0.24301,1,1
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0030654,0.36696,0.30704,1,1
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,8.628e-07,0.36681,0.37198,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.00020448,0.36623,0.29299,1,1
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.001662,0.3658,0.28283,1,1
3,GO REGULATION OF LIGASE ACTIVITY,0.00067758,0.36499,0.2583,1,1
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00016595,0.3648,0.34301,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,5.0226e-05,0.36475,0.29758,1,1
3,GO LIPID TRANSLOCATION,1.349e-05,0.36472,0.31147,1,1
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0014738,0.36363,0.37241,1,1
3,GO REGULATION OF ICOSANOID SECRETION,1.0779e-06,0.36362,0.41412,1,1
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00081984,0.36353,0.28463,1,1
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,9.389e-05,0.36257,0.28969,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00081984,0.36177,0.36524,1,1
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0059384,0.36123,0.27541,1,1
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.0023671,0.36122,0.39804,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,4.0073e-05,0.3603,0.29965,1,1
3,GO RESPONSE TO INTERLEUKIN 2,2.5308e-05,0.35966,0.31278,1,1
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.00050664,0.35926,0.33338,1,1
3,GO EPOXYGENASE P450 PATHWAY,0.014138,0.3591,0.2668,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00032948,0.35869,0.31403,1,1
3,GO REGULATION OF COAGULATION,0.00055855,0.35867,0.30451,1,1
3,GO VIRAL GENOME REPLICATION,0.00030804,0.35831,0.25823,1,1
3,GO REGULATION OF EXOSOMAL SECRETION,2.9532e-05,0.35826,0.31466,1,1
3,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00069957,0.35821,0.31966,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00098941,0.35807,0.32382,1,1
3,GO LEUKOTRIENE METABOLIC PROCESS,0.00010092,0.3575,0.33037,1,1
3,GO B CELL MEDIATED IMMUNITY,0.00018427,0.35743,0.25721,1,1
3,GO STEROL HOMEOSTASIS,2.7343e-05,0.3557,0.35036,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0020453,0.35548,0.2561,1,1
3,GO LYMPHOCYTE MEDIATED IMMUNITY,6.7596e-05,0.35533,0.26445,1,1
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00028792,0.35468,0.2632,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,1.7118e-05,0.35395,0.30964,1,1
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00027832,0.35385,0.30706,1,1
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00036427,0.35331,0.36353,1,1
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0045306,0.35294,0.27115,1,1
3,GO BONE REMODELING,1.4039e-05,0.35275,0.35981,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,9.7801e-06,0.35265,0.32522,1,1
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,2.6307e-05,0.35249,0.31485,1,1
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00095906,0.35146,0.3264,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00084609,0.35144,0.23651,1,1
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0025817,0.35141,0.29223,1,1
3,GO ANTIBACTERIAL HUMORAL RESPONSE,2.1663e-05,0.35128,0.36331,1,1
3,GO ACUTE INFLAMMATORY RESPONSE,2.8418e-05,0.35102,0.35243,1,1
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.0090226,0.35012,0.33217,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.1617e-05,0.34987,0.2783,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00052342,0.34981,0.2866,1,1
3,GO PHOSPHOLIPID EFFLUX,0.00045924,0.34937,0.36905,1,1
3,GO RESPONSE TO WATER,0.0071468,0.34868,0.27654,1,1
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00012964,0.34805,0.24475,1,1
3,GO NATURAL KILLER CELL PROLIFERATION,0.0022332,0.34763,0.3229,1,1
3,GO MAGNESIUM ION TRANSPORT,0.00026003,0.34741,0.29631,1,1
3,GO FUCOSE METABOLIC PROCESS,0.0094949,0.34715,0.30354,1,1
3,GO PHAGOSOME ACIDIFICATION,2.2658e-06,0.34703,0.36183,1,1
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00014935,0.34699,0.28741,1,1
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.0021062,0.34688,0.2956,1,1
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,7.013e-05,0.3465,0.32734,1,1
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00024286,0.34617,0.27581,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.00026003,0.34614,0.40431,1,1
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.031059,0.34606,0.26855,1,1
3,GO AMINO SUGAR CATABOLIC PROCESS,5.4121e-05,0.34592,0.3575,1,1
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0007696,0.34576,0.28094,1,1
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.016339,0.3456,0.26467,1,1
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,1.349e-05,0.34546,0.40103,1,1
3,GO LYTIC VACUOLE ORGANIZATION,5.2533e-07,0.34517,0.35566,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0010859,0.34516,0.2987,1,1
3,GO LIPID DROPLET ORGANIZATION,2.0033e-05,0.34421,0.30384,1,1
3,GO ICOSANOID METABOLIC PROCESS,3.6228e-06,0.34403,0.38241,1,1
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00067758,0.34369,0.23134,1,1
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,1.8521e-05,0.34319,0.26498,1,1
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0026572,0.34252,0.30948,1,1
3,GO MYOBLAST FUSION,0.0010528,0.34153,0.2522,1,1
3,GO SMOOTH MUSCLE CELL MIGRATION,0.0015653,0.3414,0.2759,1,1
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,5.8301e-05,0.34121,0.28416,1,1
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,8.7323e-05,0.34116,0.35339,1,1
3,GO REGULATION OF FERTILIZATION,0.00012074,0.34114,0.34535,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00027832,0.34043,0.28524,1,1
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,2.7343e-05,0.33995,0.36072,1,1
3,GO REGULATION OF B CELL PROLIFERATION,1.5816e-05,0.3398,0.33406,1,1
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00023468,0.33934,0.34983,1,1
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00016023,0.3389,0.24658,1,1
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,1.5201e-05,0.33854,0.30825,1,1
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0085714,0.3385,0.25001,1,1
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,2.6307e-05,0.33837,0.30346,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.5308e-05,0.33835,0.26401,1,1
3,GO STEROL METABOLIC PROCESS,1.104e-05,0.33812,0.2955,1,1
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,2.5308e-05,0.33803,0.27927,1,1
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.0020453,0.33756,0.24011,1,1
3,GO RESPONSE TO MINERALOCORTICOID,3.7145e-05,0.33744,0.31368,1,1
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.019283,0.33698,0.19975,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,5.508e-06,0.33605,0.35005,1,1
3,GO KERATINIZATION,1.1493e-05,0.33601,0.30051,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0013457,0.33575,0.37461,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0012662,0.33567,0.38671,1,1
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0001547,0.33538,0.33403,1,1
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00023468,0.3352,0.30473,1,1
3,GO STEROID BIOSYNTHETIC PROCESS,1.0184e-05,0.33492,0.29541,1,1
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,7.8282e-05,0.33484,0.30915,1,1
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.001662,0.33463,0.36439,1,1
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.5816e-05,0.3343,0.31177,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.015574,0.33429,0.29543,1,1
3,GO DORSAL AORTA DEVELOPMENT,0.0039469,0.33426,0.25999,1,1
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0057817,0.33394,0.32211,1,1
3,GO REGULATION OF CELL KILLING,9.389e-05,0.33388,0.30888,1,1
3,GO ETHER METABOLIC PROCESS,0.0046564,0.33312,0.21333,1,1
3,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.0038387,0.33278,0.25164,1,1
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.5816e-05,0.33182,0.33864,1,1
3,GO CORNIFICATION,1.2454e-05,0.33161,0.34097,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00013917,0.33118,0.25072,1,1
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.5201e-05,0.33114,0.45224,1,1
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.7118e-05,0.33039,0.28802,1,1
3,GO CELL KILLING,9.7801e-06,0.33,0.27109,1,1
3,GO CELLULAR RESPONSE TO FATTY ACID,0.00022676,0.32995,0.31588,1,1
3,GO SNARE COMPLEX ASSEMBLY,0.0011199,0.32886,0.25052,1,1
3,GO RESPONSE TO PEPTIDOGLYCAN,0.0012662,0.32883,0.24195,1,1
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,1.1493e-05,0.32844,0.29839,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0025083,0.32792,0.23287,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00044439,0.32786,0.30036,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0049174,0.32759,0.22882,1,1
3,GO INNATE IMMUNE RESPONSE,4.8379e-05,0.32685,0.25081,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,7.2754e-05,0.32679,0.27124,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.0033e-05,0.32667,0.31082,1,1
3,GO KETONE BIOSYNTHETIC PROCESS,0.00065623,0.32632,0.28695,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,3.5759e-05,0.32616,0.25187,1,1
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00353,0.32588,0.34461,1,1
3,GO IMMUNE EFFECTOR PROCESS,5.2139e-05,0.32569,0.24549,1,1
3,GO METHIONINE METABOLIC PROCESS,1.2454e-05,0.32564,0.33214,1,1
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,9.389e-05,0.32557,0.31646,1,1
3,GO HYPOTHALAMUS DEVELOPMENT,0.00087311,0.32554,0.28684,1,1
3,GO RESPONSE TO INTERLEUKIN 15,0.0059384,0.32537,0.25476,1,1
3,GO APICAL JUNCTION ASSEMBLY,2.9301e-06,0.32437,0.39234,1,1
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00087311,0.32376,0.25727,1,1
3,GO RESPONSE TO CADMIUM ION,0.0016129,0.32369,0.27752,1,1
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00010092,0.32356,0.35153,1,1
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,6.7596e-05,0.32342,0.3875,1,1
3,GO TYPE I INTERFERON PRODUCTION,0.00012074,0.32338,0.25064,1,1
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00069957,0.32336,0.24007,1,1
3,GO POSITIVE REGULATION OF TISSUE REMODELING,6.0504e-05,0.32325,0.35928,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015189,0.32214,0.25001,1,1
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00016595,0.3217,0.25493,1,1
3,GO STEROID METABOLIC PROCESS,3.9418e-06,0.32163,0.31732,1,1
3,GO TRNA CATABOLIC PROCESS,0.0053338,0.32152,0.34666,1,1
3,GO REGULATION OF WOUND HEALING,0.00024286,0.32088,0.27559,1,1
3,GO RESPONSE TO CORTICOSTERONE,0.00047456,0.32029,0.31689,1,1
3,GO REGULATION OF NEUTROPHIL MIGRATION,7.013e-05,0.32024,0.32603,1,1
3,GO EPITHELIAL CELL FATE COMMITMENT,0.017137,0.32022,0.25621,1,1
3,GO PLATELET DEGRANULATION,0.001872,0.31951,0.22382,1,1
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0037331,0.31927,0.31453,1,1
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,3.1888e-05,0.31897,0.24238,1,1
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00041602,0.31829,0.33492,1,1
3,GO OLIGOPEPTIDE TRANSPORT,0.00057693,0.31817,0.37536,1,1
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,5.6174e-05,0.31794,0.40739,1,1
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00022676,0.31775,0.37691,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00013433,0.31756,0.23613,1,1
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00018427,0.31755,0.35825,1,1
3,GO RETINOL METABOLIC PROCESS,0.00017796,0.31713,0.40605,1,1
3,GO RESPONSE TO VIRUS,0.0001547,0.31712,0.24111,1,1
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00023468,0.31651,0.33232,1,1
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0036303,0.31636,0.2808,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00050664,0.31629,0.22896,1,1
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,4.8379e-05,0.31617,0.30426,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0094949,0.31579,0.17911,1,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.0062634,0.31546,0.29769,1,1
3,GO ADRENAL GLAND DEVELOPMENT,6.7596e-05,0.31537,0.42877,1,1
3,GO RESPONSE TO GROWTH HORMONE,5.0683e-06,0.31526,0.37199,1,1
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00027832,0.31477,0.30305,1,1
3,GO PROTEIN DEGLYCOSYLATION,0.00023468,0.31471,0.3541,1,1
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.014486,0.31431,0.27403,1,1
3,GO UBIQUINONE METABOLIC PROCESS,9.7801e-06,0.31423,0.32759,1,1
3,GO GDP METABOLIC PROCESS,0.0028141,0.31419,0.28492,1,1
3,GO KERATINOCYTE DEVELOPMENT,0.011326,0.31414,0.28955,1,1
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,3.0689e-05,0.3137,0.32067,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0006154,0.31323,0.33648,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00017186,0.31307,0.24263,1,1
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,3.5759e-05,0.31267,0.25644,1,1
3,GO LEUKOCYTE MEDIATED IMMUNITY,5.8301e-05,0.31236,0.25356,1,1
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,2.6307e-05,0.31186,0.35905,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.00059588,0.31161,0.28178,1,1
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0022332,0.31143,0.30952,1,1
3,GO REGULATION OF ACTIN NUCLEATION,4.4878e-05,0.31106,0.33076,1,1
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.1888e-05,0.31103,0.25607,1,1
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0056288,0.3107,0.24677,1,1
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00023468,0.31067,0.30302,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00028792,0.30991,0.279,1,1
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.5759e-05,0.30983,0.27617,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0007696,0.3092,0.2129,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00038934,0.30832,0.31387,1,1
3,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0016129,0.30828,0.28362,1,1
3,GO HETEROTYPIC CELL CELL ADHESION,0.0028957,0.30815,0.21288,1,1
3,GO GLYCOSYLATION,9.0179e-06,0.30808,0.30143,1,1
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.001986,0.30802,0.22887,1,1
3,GO B CELL PROLIFERATION,2.7343e-05,0.30786,0.26434,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.01282,0.3078,0.17792,1,1
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.012203,0.30768,0.20139,1,1
3,GO REGULATION OF FIBRINOLYSIS,0.0054795,0.30762,0.33473,1,1
3,GO REGULATION OF B CELL ACTIVATION,4.6597e-05,0.30747,0.24926,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0028141,0.30662,0.21738,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.013e-05,0.30526,0.24386,1,1
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,7.3528e-06,0.30469,0.29282,1,1
3,GO T CELL CYTOKINE PRODUCTION,0.0022992,0.3045,0.2246,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.104e-05,0.3044,0.34043,1,1
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,7.547e-05,0.30427,0.22777,1,1
3,GO LIPID LOCALIZATION,1.1964e-05,0.30354,0.26777,1,1
3,GO RESPONSE TO DEXAMETHASONE,0.00079435,0.30327,0.24423,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,1.9904e-06,0.30322,0.30491,1,1
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00026003,0.30315,0.39472,1,1
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0015189,0.30275,0.29325,1,1
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.4609e-05,0.30203,0.25682,1,1
3,GO B CELL HOMEOSTASIS,0.00012512,0.3019,0.27624,1,1
3,GO RESPONSE TO CAFFEINE,0.00098941,0.30171,0.25938,1,1
3,GO POSITIVE REGULATION OF CELL SIZE,5.0226e-05,0.30155,0.37243,1,1
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.024288,0.30123,0.16362,1,1
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.00069957,0.30108,0.37873,1,1
3,GO REGULATION OF SYMBIOTIC PROCESS,0.00034072,0.30104,0.21493,1,1
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,0.30069,0.24789,1,1
3,GO INTERLEUKIN 1 PRODUCTION,0.00067758,0.30043,0.22968,1,1
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.010773,0.30029,0.24804,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0001165,0.29997,0.27393,1,1
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00024286,0.29991,0.24405,1,1
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,7.8282e-05,0.29979,0.26372,1,1
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.7118e-05,0.29979,0.30237,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00029782,0.29977,0.3554,1,1
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00030804,0.29966,0.34201,1,1
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,5.4121e-05,0.29962,0.24915,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00023468,0.29937,0.24092,1,1
3,GO KERATAN SULFATE METABOLIC PROCESS,0.0014299,0.29919,0.23475,1,1
3,GO BILE ACID METABOLIC PROCESS,1.2962e-05,0.29912,0.36752,1,1
3,GO DIET INDUCED THERMOGENESIS,0.00084609,0.29902,0.25733,1,1
3,GO MEGAKARYOCYTE DEVELOPMENT,0.00065623,0.29885,0.3265,1,1
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,2.2524e-05,0.29869,0.35969,1,1
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00045924,0.29835,0.34341,1,1
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00038934,0.29833,0.2985,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00084609,0.2979,0.25473,1,1
3,GO FUCOSYLATION,0.0014299,0.29784,0.29319,1,1
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.007729,0.29746,0.30248,1,1
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.00019079,0.29689,0.31744,1,1
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00027832,0.29671,0.21697,1,1
3,GO OPTIC NERVE DEVELOPMENT,0.00059588,0.29647,0.34262,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00014935,0.29637,0.25699,1,1
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.019739,0.29633,0.30331,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00035231,0.29627,0.2995,1,1
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00020448,0.29613,0.2205,1,1
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00021167,0.29608,0.27955,1,1
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.0083534,0.29605,0.30211,1,1
3,GO REGULATION OF RECEPTOR BINDING,0.021165,0.29593,0.23574,1,1
3,GO INTERLEUKIN 8 PRODUCTION,0.00019753,0.29592,0.26778,1,1
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0001547,0.2959,0.25377,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0036303,0.29575,0.19621,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00036427,0.29574,0.23735,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00038934,0.29573,0.22196,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,1.7118e-05,0.29563,0.24397,1,1
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0030654,0.29533,0.29901,1,1
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,4.3218e-05,0.29522,0.32142,1,1
3,GO WATER HOMEOSTASIS,9.0551e-05,0.29514,0.28476,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,9.7346e-05,0.29511,0.27845,1,1
3,GO INTERLEUKIN 13 PRODUCTION,0.010245,0.29497,0.24328,1,1
3,GO RESPONSE TO FORSKOLIN,0.015574,0.29453,0.25998,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00081984,0.29432,0.29433,1,1
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0064317,0.29429,0.30418,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0025083,0.2941,0.18881,1,1
3,GO OSTEOBLAST PROLIFERATION,0.00067758,0.29337,0.2758,1,1
3,GO MYELOID LEUKOCYTE ACTIVATION,0.00010092,0.29333,0.24228,1,1
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00028792,0.29318,0.27891,1,1
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00042998,0.29231,0.27334,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.5201e-05,0.29225,0.33362,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00063551,0.29157,0.20246,1,1
3,GO INTERLEUKIN 6 PRODUCTION,6.2786e-05,0.29113,0.23322,1,1
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00081984,0.29082,0.21406,1,1
3,GO REGULATION OF RESPIRATORY BURST,5.6174e-05,0.29029,0.36841,1,1
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.050569,0.29028,0.29435,1,1
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.015203,0.29027,0.27576,1,1
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00010462,0.28982,0.2866,1,1
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00010092,0.28979,0.24148,1,1
3,GO DEFENSE RESPONSE TO BACTERIUM,5.2837e-06,0.28973,0.26559,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00034072,0.28939,0.31218,1,1
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.001662,0.28903,0.24262,1,1
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.4421e-05,0.28863,0.24407,1,1
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00092958,0.2885,0.21859,1,1
3,GO GOLGI TO ENDOSOME TRANSPORT,0.0010528,0.28833,0.27154,1,1
3,GO REGULATION OF NECROTIC CELL DEATH,0.00045924,0.28827,0.28187,1,1
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.00021167,0.28812,0.29061,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00081984,0.2874,0.32901,1,1
3,GO INTERLEUKIN 10 PRODUCTION,6.7596e-05,0.28714,0.25964,1,1
3,GO OLIGODENDROCYTE DEVELOPMENT,0.00045924,0.2869,0.24666,1,1
3,GO ADAPTIVE IMMUNE RESPONSE,0.00012964,0.28652,0.25281,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0031536,0.28612,0.24594,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0032441,0.28607,0.2371,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0016129,0.28594,0.26547,1,1
3,GO EXTRACELLULAR VESICLE BIOGENESIS,1.349e-05,0.28579,0.27147,1,1
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00031859,0.28538,0.27237,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.013465,0.28528,0.21539,1,1
3,GO LUNG EPITHELIUM DEVELOPMENT,0.0033369,0.28475,0.26958,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00055855,0.2847,0.3151,1,1
3,GO DEFENSE RESPONSE,3.5759e-05,0.28421,0.22849,1,1
3,GO TRANSPOSITION,0.0037331,0.28405,0.28174,1,1
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00042998,0.28386,0.30234,1,1
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00020448,0.28375,0.2318,1,1
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0041716,0.28358,0.19044,1,1
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.013465,0.28354,0.27389,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00020448,0.28335,0.29415,1,1
3,GO PROSTAGLANDIN TRANSPORT,0.00072223,0.28315,0.33169,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0017123,0.28297,0.26506,1,1
3,GO RESPIRATORY BURST,0.00030804,0.28287,0.26463,1,1
3,GO REGULATION OF INNATE IMMUNE RESPONSE,1.6455e-05,0.28257,0.25766,1,1
3,GO POLYOL TRANSPORT,0.0010206,0.28253,0.32142,1,1
3,GO PROTEIN N LINKED GLYCOSYLATION,0.00012512,0.28218,0.25491,1,1
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.00052342,0.28212,0.24575,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0054795,0.282,0.31182,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,9.7346e-05,0.28196,0.26689,1,1
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0017123,0.28153,0.24423,1,1
3,GO CELLULAR RESPONSE TO ALCOHOL,0.00072223,0.28123,0.19004,1,1
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.00034072,0.28096,0.25466,1,1
3,GO CELL CELL JUNCTION ORGANIZATION,6.7596e-05,0.28093,0.24778,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00016595,0.28084,0.20679,1,1
3,GO ZINC ION HOMEOSTASIS,0.0094949,0.28069,0.30538,1,1
3,GO RESPONSE TO TUMOR CELL,0.00021909,0.28051,0.33345,1,1
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.4712e-06,0.28051,0.31735,1,1
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00020448,0.28041,0.22262,1,1
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.00010845,0.27992,0.37228,1,1
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0017641,0.27973,0.24242,1,1
3,GO CELL CELL JUNCTION ASSEMBLY,1.4039e-05,0.27968,0.27359,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,4.3218e-05,0.27967,0.28943,1,1
3,GO STEROL BIOSYNTHETIC PROCESS,1.8521e-05,0.27962,0.28753,1,1
3,GO CELLULAR RESPONSE TO STARVATION,1.104e-05,0.27942,0.2516,1,1
3,GO MAST CELL MEDIATED IMMUNITY,0.00055855,0.2792,0.2472,1,1
3,GO REGULATION OF ORGANIC ACID TRANSPORT,7.547e-05,0.27909,0.29449,1,1
3,GO REVERSE CHOLESTEROL TRANSPORT,0.0017641,0.27903,0.40699,1,1
3,GO HAIR CELL DIFFERENTIATION,8.4205e-05,0.27896,0.25498,1,1
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,3.4421e-05,0.27888,0.26064,1,1
3,GO CHEMOKINE PRODUCTION,0.00081984,0.27842,0.20519,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0025083,0.27811,0.20271,1,1
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,1.5201e-05,0.27786,0.24801,1,1
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0027346,0.27785,0.32305,1,1
3,GO AMELOGENESIS,0.0066042,0.27758,0.23001,1,1
3,GO BONE CELL DEVELOPMENT,0.00023468,0.27722,0.23874,1,1
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.2524e-05,0.27721,0.26558,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00010845,0.27697,0.28521,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.010506,0.27685,0.16803,1,1
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,4.4712e-06,0.27672,0.25751,1,1
3,GO STEROL TRANSPORT,3.5759e-05,0.27647,0.27844,1,1
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0021062,0.2764,0.22344,1,1
3,GO ER NUCLEUS SIGNALING PATHWAY,0.00055855,0.27607,0.27206,1,1
3,GO CERAMIDE BIOSYNTHETIC PROCESS,4.1617e-05,0.27585,0.2423,1,1
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00034072,0.27532,0.20431,1,1
3,GO AMINE METABOLIC PROCESS,3.0576e-06,0.27516,0.2811,1,1
3,GO RESPONSE TO INTERLEUKIN 6,0.00090094,0.27506,0.26455,1,1
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00049035,0.2749,0.28774,1,1
3,GO LEUKOCYTE PROLIFERATION,0.00016595,0.27484,0.21589,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00087311,0.27478,0.19159,1,1
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.00019753,0.27476,0.23073,1,1
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.00017796,0.27453,0.25224,1,1
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0066042,0.27447,0.30604,1,1
3,GO PHOSPHOLIPID HOMEOSTASIS,0.0097392,0.2744,0.24124,1,1
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.013139,0.27439,0.16684,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00021167,0.27416,0.23041,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.015953,0.27353,0.26742,1,1
3,GO VACUOLAR ACIDIFICATION,7.6603e-06,0.27274,0.34698,1,1
3,GO RESPONSE TO BIOTIC STIMULUS,7.2754e-05,0.27261,0.20707,1,1
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0083534,0.27254,0.21956,1,1
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.00084609,0.27246,0.24325,1,1
3,GO RESPONSE TO FATTY ACID,0.0010206,0.27234,0.21429,1,1
3,GO RESPONSE TO ACIDIC PH,0.011047,0.27204,0.24437,1,1
3,GO PHOSPHOLIPID TRANSPORT,2.9532e-05,0.27184,0.23705,1,1
3,GO TISSUE HOMEOSTASIS,9.7801e-06,0.27171,0.23018,1,1
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.3441e-06,0.27153,0.26085,1,1
3,GO DETERMINATION OF ADULT LIFESPAN,0.00034072,0.27149,0.27997,1,1
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0051916,0.27144,0.22637,1,1
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,1.8521e-05,0.27076,0.30674,1,1
3,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.27059,0.31432,1,1
3,GO ENDOCRINE PROCESS,0.00059588,0.27055,0.24712,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00022676,0.27011,0.21971,1,1
3,GO DIOL METABOLIC PROCESS,0.00024286,0.26943,0.32323,1,1
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,1.7474e-06,0.26941,0.32184,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00087311,0.26872,0.20286,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0024367,0.26871,0.31729,1,1
3,GO LIPID STORAGE,0.00057693,0.26833,0.24455,1,1
3,GO HORMONE CATABOLIC PROCESS,0.0030654,0.26823,0.36512,1,1
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.00090094,0.26778,0.25027,1,1
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0094949,0.26776,0.23367,1,1
3,GO ANTIMICROBIAL HUMORAL RESPONSE,5.0226e-05,0.26765,0.24143,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0032441,0.2676,0.19055,1,1
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,7.9801e-06,0.26757,0.32993,1,1
3,GO REGULATION OF B CELL DIFFERENTIATION,0.0006154,0.26741,0.25506,1,1
3,GO RESPONSE TO NUTRIENT,0.0037331,0.26733,0.16281,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0011199,0.26726,0.20272,1,1
3,GO INTERLEUKIN 4 PRODUCTION,0.0050528,0.26702,0.2063,1,1
3,GO DRUG METABOLIC PROCESS,0.00021909,0.26696,0.33012,1,1
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.5816e-05,0.26685,0.26139,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,5.0226e-05,0.26674,0.32827,1,1
3,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.052669,0.26655,0.16884,1,1
3,GO CYTOPLASM ORGANIZATION,0.00025131,0.26633,0.30009,1,1
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00038934,0.26609,0.21429,1,1
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,6.2367e-06,0.26603,0.25807,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,7.013e-05,0.26602,0.24781,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,0.00013917,0.26573,0.25653,1,1
3,GO REGULATION OF MUSCLE ADAPTATION,0.00092958,0.26558,0.17741,1,1
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0039469,0.26547,0.30568,1,1
3,GO REGULATION OF FATTY ACID TRANSPORT,5.2837e-06,0.26531,0.3893,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,1.2962e-05,0.26522,0.26365,1,1
3,GO ENDOCARDIUM DEVELOPMENT,0.02268,0.26505,0.22569,1,1
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0051916,0.26484,0.2578,1,1
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.0051916,0.2647,0.22004,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00023468,0.2646,0.22596,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00067758,0.26449,0.22985,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0064317,0.26432,0.24836,1,1
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00017186,0.26415,0.24687,1,1
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0036303,0.26392,0.22308,1,1
3,GO KERATINOCYTE DIFFERENTIATION,3.1888e-05,0.26325,0.26222,1,1
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0001165,0.26322,0.22375,1,1
3,GO MEMBRANE LIPID METABOLIC PROCESS,2.9532e-05,0.2631,0.26391,1,1
3,GO INTERLEUKIN 12 PRODUCTION,9.7801e-06,0.26287,0.30003,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.00036427,0.26286,0.32271,1,1
3,GO TRANSFERRIN TRANSPORT,2.0784e-06,0.26283,0.33676,1,1
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00024286,0.26271,0.25071,1,1
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.00022676,0.26238,0.25109,1,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,5.0683e-06,0.26216,0.21535,1,1
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00019753,0.26211,0.30151,1,1
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.001872,0.26204,0.23717,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.001662,0.26197,0.20738,1,1
3,GO CELLULAR RESPONSE TO STEROL,0.00040247,0.26162,0.28997,1,1
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00040247,0.26133,0.26896,1,1
3,GO DENDRITIC CELL MIGRATION,0.010506,0.26118,0.17431,1,1
3,GO SECRETION BY TISSUE,0.0006154,0.26114,0.23717,1,1
3,GO PLASMA MEMBRANE FUSION,0.0026572,0.26113,0.2528,1,1
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0090226,0.26105,0.21988,1,1
3,GO MAST CELL ACTIVATION,0.00013433,0.26093,0.26069,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00016023,0.26085,0.26123,1,1
3,GO DISACCHARIDE METABOLIC PROCESS,0.00087311,0.26068,0.34604,1,1
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,6.5149e-05,0.26031,0.22381,1,1
3,GO MYELOID LEUKOCYTE MIGRATION,0.00021167,0.26021,0.20236,1,1
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.034637,0.25891,0.17194,1,1
3,GO LYMPHOCYTE MIGRATION,0.00049035,0.25889,0.19667,1,1
3,GO FATTY ACID CATABOLIC PROCESS,0.00018427,0.25881,0.24149,1,1
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.4609e-05,0.25855,0.26208,1,1
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.033166,0.25803,0.29254,1,1
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.004408,0.25773,0.19755,1,1
3,GO RESPONSE TO PROTOZOAN,0.0040578,0.25771,0.17515,1,1
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0021062,0.25733,0.1756,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00027832,0.2573,0.18911,1,1
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.049546,0.2573,0.18243,1,1
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.043763,0.25729,0.18022,1,1
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00050664,0.25711,0.25201,1,1
3,GO HORMONE METABOLIC PROCESS,0.00063551,0.25697,0.2624,1,1
3,GO REGULATION OF CELL CELL ADHESION,0.00017796,0.25681,0.21196,1,1
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.011612,0.25647,0.18211,1,1
3,GO RESPONSE TO GONADOTROPIN,0.0006154,0.25639,0.24027,1,1
3,GO SPHINGOLIPID METABOLIC PROCESS,1.5816e-05,0.25635,0.27323,1,1
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00036427,0.25597,0.19098,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00025131,0.25593,0.20411,1,1
3,GO VASCULAR WOUND HEALING,0.011047,0.25579,0.31486,1,1
3,GO ORGANELLE MEMBRANE FUSION,0.00052342,0.25565,0.20748,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.9263e-05,0.25558,0.25386,1,1
3,GO INFLAMMATORY RESPONSE,9.389e-05,0.25514,0.20799,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00021909,0.25487,0.3222,1,1
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.011326,0.25458,0.23365,1,1
3,GO PIRNA METABOLIC PROCESS,0.001662,0.25452,0.29653,1,1
3,GO MUSCLE HYPERTROPHY,0.00014935,0.25427,0.21602,1,1
3,GO CELLULAR RESPONSE TO ALKALOID,2.4346e-05,0.25383,0.25528,1,1
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,6.4994e-06,0.25374,0.23957,1,1
3,GO ANDROGEN METABOLIC PROCESS,0.00035231,0.25349,0.37269,1,1
3,GO POSITIVE REGULATION OF HORMONE SECRETION,5.8301e-05,0.25324,0.23988,1,1
3,GO ALANINE TRANSPORT,0.017137,0.2531,0.24917,1,1
3,GO MONOCYTE CHEMOTAXIS,0.0029794,0.25294,0.20052,1,1
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00013917,0.25267,0.23306,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,0.00027832,0.25262,0.22715,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.025414,0.25246,0.26996,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.25239,0.23547,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.017549,0.25215,0.21587,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.043763,0.25215,0.1736,1,1
3,GO RESPONSE TO CYTOKINE,0.00017186,0.25125,0.19623,1,1
3,GO CERAMIDE METABOLIC PROCESS,5.0226e-05,0.25095,0.25704,1,1
3,GO EXOCYTOSIS,0.00013433,0.25079,0.19475,1,1
3,GO SPHINGOID METABOLIC PROCESS,0.001191,0.25071,0.26846,1,1
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0028141,0.25001,0.26054,1,1
3,GO NOTCH SIGNALING PATHWAY,0.00038934,0.24999,0.19403,1,1
3,GO REGULATION OF RESPONSE TO WOUNDING,0.0018173,0.24996,0.20767,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,4.4712e-06,0.24994,0.24998,1,1
3,GO LEUKOCYTE MIGRATION,0.00017796,0.24985,0.21966,1,1
3,GO VESICLE BUDDING FROM MEMBRANE,0.00067758,0.24972,0.20289,1,1
3,GO CARBOHYDRATE TRANSPORT,4.2876e-06,0.24963,0.26196,1,1
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.010506,0.24943,0.22941,1,1
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.00019079,0.24941,0.26581,1,1
3,GO RESPONSE TO BACTERIUM,0.00021167,0.24938,0.19851,1,1
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00041602,0.24915,0.25366,1,1
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.029068,0.24904,0.17844,1,1
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0021062,0.24897,0.38317,1,1
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0014299,0.2486,0.2002,1,1
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,4.4712e-06,0.24856,0.25476,1,1
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00017186,0.24843,0.25067,1,1
3,GO MEMBRANE FISSION,0.009256,0.2483,0.22039,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0015189,0.24822,0.18008,1,1
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0026572,0.24808,0.23341,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0041716,0.24806,0.191,1,1
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00029782,0.24803,0.23481,1,1
3,GO MEMBRANE FUSION,0.00012964,0.248,0.20454,1,1
3,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.0056288,0.24771,0.33926,1,1
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00032948,0.24766,0.25716,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0087944,0.24738,0.25147,1,1
3,GO T CELL PROLIFERATION,0.00040247,0.2473,0.20922,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0010859,0.24708,0.24586,1,1
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.00021909,0.24701,0.22225,1,1
3,GO REGULATION OF T CELL MIGRATION,0.01282,0.247,0.19021,1,1
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00038934,0.24687,0.23046,1,1
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,7.013e-05,0.24686,0.23382,1,1
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0054795,0.24682,0.21491,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.1663e-05,0.2468,0.24287,1,1
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.0689e-05,0.24676,0.23131,1,1
3,GO REGULATION OF DEFENSE RESPONSE,4.4878e-05,0.24663,0.20879,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0036303,0.24639,0.2779,1,1
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0039469,0.2463,0.22437,1,1
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.02843,0.24622,0.1695,1,1
3,GO PRO B CELL DIFFERENTIATION,0.024846,0.24615,0.18492,1,1
3,GO T CELL MIGRATION,0.0083534,0.2457,0.17551,1,1
3,GO COAGULATION,0.0014738,0.2457,0.16487,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,1.2962e-05,0.24557,0.2568,1,1
3,GO NADP METABOLIC PROCESS,0.0012662,0.24528,0.2864,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0025083,0.24495,0.2964,1,1
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0013457,0.24492,0.28957,1,1
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.025994,0.24488,0.14972,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.3218e-05,0.2443,0.21926,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,7.013e-05,0.24428,0.32489,1,1
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.017137,0.24419,0.15243,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION,0.00065623,0.24407,0.19026,1,1
3,GO CELLULAR RESPONSE TO KETONE,0.00032948,0.24372,0.22529,1,1
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00038934,0.24364,0.19302,1,1
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,3.4421e-05,0.24362,0.23511,1,1
3,GO CAMP BIOSYNTHETIC PROCESS,0.036164,0.24342,0.18959,1,1
3,GO RESPONSE TO PROGESTERONE,0.0017641,0.24299,0.21966,1,1
3,GO REGULATION OF ACTION POTENTIAL,0.0026572,0.24255,0.21297,1,1
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00063551,0.2425,0.19193,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00029782,0.24249,0.21176,1,1
3,GO LIPOPROTEIN METABOLIC PROCESS,0.00010462,0.24245,0.21366,1,1
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,2.4346e-05,0.24191,0.21303,1,1
3,GO RENAL SYSTEM PROCESS,0.0007696,0.2419,0.19242,1,1
3,GO DIOL BIOSYNTHETIC PROCESS,0.00079435,0.24142,0.33474,1,1
3,GO SYNCYTIUM FORMATION,0.0022992,0.2413,0.18161,1,1
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.0031536,0.24079,0.18416,1,1
3,GO AUTOPHAGY OF NUCLEUS,0.0045306,0.24038,0.22071,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.0689e-05,0.24028,0.2175,1,1
3,GO CYTOKINE PRODUCTION,0.00010462,0.24024,0.21474,1,1
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.0010528,0.23977,0.22186,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0010859,0.23952,0.1888,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00052342,0.2395,0.24417,1,1
3,GO LEUKOCYTE CELL CELL ADHESION,0.00027832,0.23941,0.20194,1,1
3,GO PANCREATIC JUICE SECRETION,0.016734,0.23926,0.17971,1,1
3,GO REGULATION OF BODY FLUID LEVELS,0.00045924,0.23899,0.17687,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00098941,0.23886,0.18622,1,1
3,GO MUSCLE ADAPTATION,0.00028792,0.2386,0.1912,1,1
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00018427,0.23853,0.2191,1,1
3,GO GLIAL CELL PROLIFERATION,0.0067808,0.23849,0.19431,1,1
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.00072223,0.23833,0.22777,1,1
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0011199,0.23809,0.21069,1,1
3,GO PANCREAS DEVELOPMENT,0.0056288,0.23777,0.18027,1,1
3,GO POSITIVE CHEMOTAXIS,0.0056288,0.23755,0.15515,1,1
3,GO EATING BEHAVIOR,0.00018427,0.23753,0.22129,1,1
3,GO VESICLE TARGETING,0.00069957,0.23752,0.21247,1,1
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,8.1192e-05,0.23741,0.22396,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.0017123,0.23727,0.19625,1,1
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.042857,0.23701,0.16497,1,1
3,GO AMMONIUM TRANSPORT,0.010773,0.23701,0.18848,1,1
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00027832,0.23694,0.1832,1,1
3,GO ALCOHOL METABOLIC PROCESS,2.1663e-05,0.23674,0.24621,1,1
3,GO RESPONSE TO STARVATION,1.9263e-05,0.23661,0.2331,1,1
3,GO POLYSACCHARIDE METABOLIC PROCESS,7.547e-05,0.23647,0.21818,1,1
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.0028141,0.23645,0.2265,1,1
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00090094,0.23641,0.20141,1,1
3,GO PIGMENTATION,0.00047456,0.23614,0.16212,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00041602,0.23605,0.18383,1,1
3,GO PROTEIN PROCESSING,9.0551e-05,0.2355,0.2436,1,1
3,GO SPLEEN DEVELOPMENT,0.00032948,0.23534,0.21907,1,1
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00030804,0.23527,0.192,1,1
3,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.011904,0.23525,0.267,1,1
3,GO INTERFERON ALPHA PRODUCTION,0.00022676,0.23524,0.23132,1,1
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0031536,0.23523,0.2384,1,1
3,GO B CELL ACTIVATION,7.547e-05,0.23521,0.19978,1,1
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.00038934,0.23516,0.23765,1,1
3,GO ALPHA BETA T CELL ACTIVATION,0.00016595,0.23513,0.22083,1,1
3,GO LEUKOCYTE CHEMOTAXIS,0.00030804,0.2351,0.19386,1,1
3,GO REGULATION OF BLOOD PRESSURE,0.00019079,0.23477,0.18416,1,1
3,GO POSITIVE REGULATION OF HEART RATE,0.0041716,0.2347,0.25951,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00012512,0.23467,0.22218,1,1
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.007729,0.23433,0.17568,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00042998,0.2343,0.19299,1,1
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0081404,0.23425,0.15789,1,1
3,GO CELL CHEMOTAXIS,0.00017796,0.23395,0.20247,1,1
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0056288,0.23362,0.24531,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00047456,0.23332,0.27095,1,1
3,GO REGULATION OF IMMUNE RESPONSE,0.00044439,0.23331,0.17212,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00074557,0.2333,0.22749,1,1
3,GO SODIUM ION HOMEOSTASIS,0.00019079,0.23288,0.21026,1,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.015574,0.23271,0.19618,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.014486,0.23237,0.20797,1,1
3,GO EPIDERMIS DEVELOPMENT,0.0001165,0.23201,0.20431,1,1
3,GO RESPONSE TO METAL ION,7.6603e-06,0.232,0.22546,1,1
3,GO ER OVERLOAD RESPONSE,0.0073363,0.23187,0.23076,1,1
3,GO AMYLOID FIBRIL FORMATION,0.012508,0.23181,0.19601,1,1
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0059384,0.23181,0.21049,1,1
3,GO GRANULOCYTE MIGRATION,0.00054072,0.23178,0.18978,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00037661,0.23145,0.2229,1,1
3,GO CELL ACTIVATION,0.00022676,0.23137,0.18274,1,1
3,GO PURINE NUCLEOTIDE TRANSPORT,5.8301e-05,0.23133,0.23758,1,1
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,2.7343e-05,0.23115,0.24694,1,1
3,GO PH REDUCTION,5.0226e-05,0.23106,0.23731,1,1
3,GO VITAMIN METABOLIC PROCESS,0.0041716,0.2309,0.20639,1,1
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00042998,0.2309,0.25709,1,1
3,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0025083,0.23088,0.27798,1,1
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00024286,0.23071,0.18546,1,1
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00014935,0.23033,0.20027,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00059588,0.23006,0.19138,1,1
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00017796,0.23001,0.17558,1,1
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.00069957,0.22998,0.19077,1,1
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0023671,0.22974,0.13323,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00098941,0.22949,0.2565,1,1
3,GO GOLGI VESICLE BUDDING,0.00011241,0.22943,0.2189,1,1
3,GO REGULATION OF HORMONE SECRETION,0.00012964,0.22919,0.19435,1,1
3,GO REGULATION OF PEPTIDE SECRETION,1.349e-05,0.22915,0.20418,1,1
3,GO ACTIVATION OF IMMUNE RESPONSE,0.00017796,0.22914,0.18604,1,1
3,GO PEPTIDE SECRETION,3.8583e-05,0.22899,0.20095,1,1
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.042857,0.22897,0.15233,1,1
3,GO MANNOSYLATION,4.1617e-05,0.22889,0.2562,1,1
3,GO NEUTRAL AMINO ACID TRANSPORT,0.015574,0.22889,0.24139,1,1
3,GO NUCLEOTIDE TRANSPORT,2.5308e-05,0.22835,0.23531,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0013457,0.22814,0.18798,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.009256,0.22812,0.23404,1,1
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.00065623,0.22804,0.23691,1,1
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0054795,0.22803,0.20114,1,1
3,GO REGULATION OF PEPTIDASE ACTIVITY,7.8282e-05,0.22794,0.22706,1,1
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00019753,0.22788,0.18732,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.00021909,0.22781,0.19455,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0017641,0.22779,0.15972,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.017137,0.22743,0.15466,1,1
3,GO CYTOKINE SECRETION,9.7346e-05,0.22741,0.22284,1,1
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.035393,0.22729,0.15588,1,1
3,GO HORMONE TRANSPORT,6.5149e-05,0.22704,0.21142,1,1
3,GO LIPID HOMEOSTASIS,0.00019753,0.22697,0.23681,1,1
3,GO LINOLEIC ACID METABOLIC PROCESS,0.017549,0.22686,0.26584,1,1
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0062634,0.22644,0.23809,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.00038934,0.22641,0.20352,1,1
3,GO REGULATION OF CELLULAR PH,8.6584e-06,0.22619,0.22024,1,1
3,GO SKIN DEVELOPMENT,0.00021167,0.22608,0.19588,1,1
3,GO CHLORIDE ION HOMEOSTASIS,0.01282,0.22601,0.17702,1,1
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,5.2139e-05,0.22582,0.19887,1,1
3,GO REGULATION OF RUFFLE ASSEMBLY,0.0034322,0.2258,0.20442,1,1
3,GO RESPONSE TO CORTICOSTEROID,0.00074557,0.22543,0.18879,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,9.389e-05,0.22532,0.20037,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.0576e-06,0.22502,0.21994,1,1
3,GO RESPONSE TO PH,0.0087944,0.22501,0.16675,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.7413e-06,0.22495,0.20707,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00079435,0.22479,0.1907,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.00072223,0.22467,0.22708,1,1
3,GO ARACHIDONIC ACID SECRETION,0.00036427,0.22466,0.24421,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00081984,0.22458,0.17221,1,1
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00090094,0.22381,0.2266,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.044685,0.22362,0.09939,1,1
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.041093,0.22351,0.20873,1,1
3,GO INSULIN SECRETION,0.00012964,0.2234,0.19603,1,1
3,GO REGULATION OF LIPID TRANSPORT,0.00019079,0.22338,0.23814,1,1
3,GO DETOXIFICATION,0.043763,0.2232,0.16924,1,1
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,2.2524e-05,0.22315,0.23302,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.007729,0.22304,0.1784,1,1
3,GO RESPONSE TO CALCIUM ION,0.00049035,0.22276,0.19532,1,1
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0037331,0.22274,0.15853,1,1
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00012964,0.22272,0.19979,1,1
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0027346,0.22266,0.17147,1,1
3,GO MUSCLE CELL MIGRATION,0.010245,0.22236,0.17112,1,1
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,7.2754e-05,0.22231,0.19826,1,1
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00013433,0.2223,0.32641,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0022332,0.22227,0.14901,1,1
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0028141,0.22209,0.20343,1,1
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.018398,0.22207,0.18165,1,1
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.010773,0.22191,0.1423,1,1
3,GO RESPONSE TO KETONE,0.00045924,0.22161,0.17426,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0019282,0.22148,0.17994,1,1
3,GO RESPONSE TO ALCOHOL,0.00016595,0.22136,0.17171,1,1
3,GO LYMPHOCYTE HOMEOSTASIS,0.00044439,0.22113,0.20093,1,1
3,GO REGULATION OF GLUCONEOGENESIS,2.0833e-05,0.221,0.27056,1,1
3,GO PHAGOSOME MATURATION,0.00017186,0.22091,0.26968,1,1
3,GO REGULATION OF NUCLEASE ACTIVITY,0.0024367,0.22077,0.18203,1,1
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.019283,0.22074,0.19181,1,1
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00098941,0.22028,0.22452,1,1
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0016129,0.21963,0.16286,1,1
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0001547,0.2196,0.17876,1,1
3,GO APOPTOTIC SIGNALING PATHWAY,0.00019079,0.21958,0.17318,1,1
3,GO ACTIN NUCLEATION,2.5308e-05,0.21947,0.23036,1,1
3,GO WOUND HEALING,0.0040578,0.21933,0.14803,1,1
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.020205,0.21911,0.22166,1,1
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00016595,0.21881,0.17887,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00040247,0.21861,0.17431,1,1
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00037661,0.21835,0.2136,1,1
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,5.0226e-05,0.21821,0.23297,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,4.0073e-05,0.21799,0.25351,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,8.1192e-05,0.21787,0.18518,1,1
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.010773,0.21778,0.25537,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0051916,0.21771,0.18409,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION,0.0001547,0.21655,0.1924,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00055855,0.21613,0.23858,1,1
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.0017123,0.21597,0.24788,1,1
3,GO LAMELLIPODIUM MORPHOGENESIS,0.015203,0.21591,0.2183,1,1
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0064317,0.21585,0.16594,1,1
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0036303,0.21564,0.1681,1,1
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00069957,0.21524,0.18979,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0041716,0.21521,0.28741,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0013457,0.21506,0.15058,1,1
3,GO RESPONSE TO INORGANIC SUBSTANCE,1.1493e-05,0.21503,0.18155,1,1
3,GO LIPID EXPORT FROM CELL,0.0062634,0.21499,0.24272,1,1
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00036427,0.21469,0.19224,1,1
3,GO B CELL DIFFERENTIATION,2.9532e-05,0.21419,0.2117,1,1
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00095906,0.21382,0.17481,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00013433,0.21378,0.18346,1,1
3,GO T CELL ACTIVATION,0.00030804,0.21355,0.18402,1,1
3,GO GRANULOCYTE CHEMOTAXIS,0.001228,0.21318,0.15562,1,1
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.011904,0.21297,0.20464,1,1
3,GO ADIPOSE TISSUE DEVELOPMENT,0.00084609,0.21276,0.19245,1,1
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,8.7323e-05,0.21253,0.219,1,1
3,GO TRANSITION METAL ION HOMEOSTASIS,0.0049174,0.21253,0.15599,1,1
3,GO REGULATION OF CELL ACTIVATION,0.0015189,0.2125,0.15126,1,1
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.011612,0.21244,0.22221,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0075304,0.2122,0.12902,1,1
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.018398,0.21204,0.21824,1,1
3,GO REGULATION OF MAST CELL ACTIVATION,0.009256,0.2118,0.17633,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,5.6174e-05,0.21175,0.19691,1,1
3,GO WHITE FAT CELL DIFFERENTIATION,0.0007696,0.21165,0.22203,1,1
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00013433,0.21161,0.22758,1,1
3,GO REGULATION OF HORMONE LEVELS,4.4878e-05,0.21148,0.22221,1,1
3,GO RNA INTERFERENCE,0.037747,0.21131,0.1313,1,1
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.018836,0.21121,0.17889,1,1
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.036164,0.21104,0.18559,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00095906,0.21087,0.21504,1,1
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0025083,0.21072,0.14805,1,1
3,GO RESPONSE TO DSRNA,0.001662,0.2106,0.15611,1,1
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0030654,0.21044,0.20899,1,1
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0014299,0.21016,0.15678,1,1
3,GO REGULATION OF ENDOCRINE PROCESS,0.00081984,0.21006,0.2261,1,1
3,GO TERPENOID METABOLIC PROCESS,0.0027346,0.21002,0.20525,1,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.012508,0.20965,0.17706,1,1
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00057693,0.20933,0.17024,1,1
3,GO TRANSCYTOSIS,0.0028957,0.20923,0.23264,1,1
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0037331,0.20899,0.18277,1,1
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0006154,0.20897,0.30742,1,1
3,GO ADAPTIVE THERMOGENESIS,5.9841e-06,0.20858,0.2185,1,1
3,GO PROSTAGLANDIN SECRETION,0.0064317,0.2082,0.23396,1,1
3,GO RESPONSE TO STEROL,0.0034322,0.20799,0.20339,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.040234,0.20793,0.13291,1,1
3,GO VACUOLE ORGANIZATION,5.9841e-06,0.20791,0.23127,1,1
3,GO PROTEIN AUTOPROCESSING,0.0039469,0.20787,0.27894,1,1
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00045924,0.20773,0.18491,1,1
3,GO NEUTROPHIL MIGRATION,0.00026003,0.2077,0.18865,1,1
3,GO LIPID OXIDATION,0.0024367,0.20755,0.17658,1,1
3,GO CARBOHYDRATE HOMEOSTASIS,0.00021167,0.20742,0.1869,1,1
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.010245,0.20709,0.14822,1,1
3,GO REGULATION OF CELL ADHESION,0.0013872,0.20709,0.16452,1,1
3,GO RESPONSE TO OSMOTIC STRESS,0.0022332,0.20696,0.18836,1,1
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00020448,0.20684,0.17241,1,1
3,GO PLATELET MORPHOGENESIS,0.0033369,0.20679,0.18889,1,1
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.00090094,0.20662,0.23413,1,1
3,GO GLUTAMATE METABOLIC PROCESS,0.0047853,0.20649,0.17537,1,1
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0038387,0.20639,0.15148,1,1
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0017641,0.20618,0.15782,1,1
3,GO NECROTIC CELL DEATH,0.00044439,0.20613,0.26175,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00084609,0.20591,0.20795,1,1
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,9.0179e-06,0.20578,0.21691,1,1
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,3.0689e-05,0.20567,0.23659,1,1
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.017137,0.20564,0.18046,1,1
3,GO LEUKOCYTE DIFFERENTIATION,0.00017186,0.20544,0.16659,1,1
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00018427,0.20542,0.18288,1,1
3,GO ORGANELLE FUSION,0.00069957,0.2054,0.16914,1,1
3,GO CHOLESTEROL STORAGE,0.0021062,0.2054,0.23223,1,1
3,GO PEPTIDE HORMONE SECRETION,9.389e-05,0.20529,0.20057,1,1
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00028792,0.20504,0.16391,1,1
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.012203,0.20492,0.15427,1,1
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00019753,0.2049,0.19778,1,1
3,GO CELL CELL ADHESION,0.0028957,0.20398,0.14422,1,1
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0010206,0.20395,0.20368,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00092958,0.20353,0.16357,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.00063551,0.20341,0.17419,1,1
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0027346,0.20322,0.22181,1,1
3,GO RESPONSE TO MECHANICAL STIMULUS,0.00021909,0.20285,0.19068,1,1
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.00049035,0.20271,0.18996,1,1
3,GO LYMPHOCYTE ACTIVATION,0.00063551,0.2026,0.15218,1,1
3,GO XENOBIOTIC TRANSPORT,0.0062634,0.20258,0.26434,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00016595,0.20238,0.25977,1,1
3,GO FC RECEPTOR SIGNALING PATHWAY,0.00038934,0.20236,0.1533,1,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.017137,0.20232,0.11388,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0057817,0.20222,0.17869,1,1
3,GO REGULATION OF LIPID STORAGE,0.0047853,0.20219,0.17073,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00050664,0.20211,0.19293,1,1
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0079323,0.20182,0.14756,1,1
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.010773,0.20166,0.27262,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.001872,0.20163,0.13651,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00031859,0.20157,0.20156,1,1
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.023741,0.20154,0.1882,1,1
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.00098941,0.20121,0.18956,1,1
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0075304,0.20117,0.14872,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,4.3218e-05,0.20093,0.23447,1,1
3,GO REGULATION OF PH,3.3132e-05,0.20089,0.20737,1,1
3,GO PROTEIN MATURATION,0.00030804,0.20084,0.19,1,1
3,GO PLATELET ACTIVATION,0.00084609,0.20081,0.17774,1,1
3,GO SECRETION,0.00013917,0.20073,0.17061,1,1
3,GO COPII COATED VESICLE BUDDING,0.00022676,0.20059,0.20349,1,1
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0038387,0.20059,0.15918,1,1
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00054072,0.20017,0.17405,1,1
3,GO GPI ANCHOR METABOLIC PROCESS,0.0023671,0.20011,0.21017,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,2.1663e-05,0.2001,0.25242,1,1
3,GO MACROMOLECULE DEPALMITOYLATION,0.00081984,0.20005,0.2293,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0057817,0.19971,0.19128,1,1
3,GO POSITIVE REGULATION OF COAGULATION,0.0069616,0.19971,0.20608,1,1
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00098941,0.19868,0.18662,1,1
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0046564,0.19849,0.23199,1,1
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0017641,0.19801,0.22129,1,1
3,GO PROTEIN ADP RIBOSYLATION,0.017549,0.19776,0.1531,1,1
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.02068,0.19742,0.17762,1,1
3,GO NCRNA CATABOLIC PROCESS,0.0094949,0.19712,0.13853,1,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.00065623,0.197,0.19034,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0026572,0.19687,0.14729,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00092958,0.19686,0.17358,1,1
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.010506,0.19662,0.19227,1,1
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0017123,0.19656,0.19694,1,1
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.013798,0.19654,0.28607,1,1
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,4.1617e-05,0.19652,0.19168,1,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.025994,0.19651,0.13366,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00095906,0.19646,0.17355,1,1
3,GO ENDOCYTIC RECYCLING,0.0051916,0.19645,0.1348,1,1
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.004408,0.19639,0.14653,1,1
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.011612,0.19622,0.14634,1,1
3,GO RESPONSE TO INSULIN,9.0551e-05,0.19606,0.17459,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,2.6307e-05,0.19601,0.20422,1,1
3,GO EPITHELIUM DEVELOPMENT,0.00047456,0.19595,0.13952,1,1
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.017969,0.1959,0.19393,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0045306,0.19581,0.14939,1,1
3,GO REGULATION OF LIPID LOCALIZATION,0.0010206,0.19577,0.19941,1,1
3,GO T CELL DIFFERENTIATION,0.00027832,0.19552,0.15885,1,1
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.047551,0.19543,0.13084,1,1
3,GO FATTY ACID METABOLIC PROCESS,0.00018427,0.19533,0.22094,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.00087311,0.19502,0.15769,1,1
3,GO VESICLE ORGANIZATION,0.00050664,0.1947,0.16802,1,1
3,GO ENGULFMENT OF APOPTOTIC CELL,0.023741,0.19453,0.13275,1,1
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.019283,0.19445,0.12637,1,1
3,GO LIPID METABOLIC PROCESS,0.00013433,0.19435,0.1885,1,1
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.016734,0.19404,0.19042,1,1
3,GO REGULATION OF TUBE SIZE,0.0036303,0.19401,0.1569,1,1
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0019282,0.19398,0.17748,1,1
3,GO REPLICATIVE SENESCENCE,0.022165,0.1939,0.20209,1,1
3,GO REGULATION OF INSULIN SECRETION,0.00044439,0.19343,0.17268,1,1
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.0053338,0.19329,0.14835,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0027346,0.19297,0.19099,1,1
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0038387,0.1929,0.16677,1,1
3,GO DENDRITIC CELL CHEMOTAXIS,0.05161,0.19287,0.126,1,1
3,GO REGULATION OF APPETITE,0.013798,0.19264,0.12015,1,1
3,GO SEQUESTERING OF CALCIUM ION,0.0016129,0.19223,0.15949,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.001662,0.19218,0.13496,1,1
3,GO REGULATION OF HEMOPOIESIS,0.00023468,0.19211,0.15101,1,1
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.016734,0.19167,0.15024,1,1
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.033894,0.19155,0.14312,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0059384,0.19153,0.19484,1,1
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00022676,0.19139,0.16329,1,1
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00021167,0.19134,0.17351,1,1
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0022332,0.19117,0.15625,1,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.033894,0.19103,0.15228,1,1
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0022992,0.19102,0.14803,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0015189,0.19101,0.1626,1,1
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00054072,0.19098,0.18032,1,1
3,GO HUMORAL IMMUNE RESPONSE,3.1888e-05,0.1906,0.21609,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00042998,0.19057,0.19238,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.00079435,0.19049,0.1898,1,1
3,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.014841,0.18993,0.17592,1,1
3,GO PROTEIN KINASE B SIGNALING,0.0049174,0.18988,0.12776,1,1
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00057693,0.18967,0.1523,1,1
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.044685,0.18964,0.14659,1,1
3,GO REGULATION OF DENDRITE EXTENSION,0.0099891,0.18959,0.31561,1,1
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0067808,0.18945,0.18972,1,1
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00041602,0.18911,0.22046,1,1
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.015574,0.18897,0.17342,1,1
3,GO EXECUTION PHASE OF APOPTOSIS,7.5427e-07,0.18892,0.2151,1,1
3,GO SENSORY PERCEPTION OF TASTE,0.0018173,0.18888,0.15332,1,1
3,GO SUPEROXIDE METABOLIC PROCESS,0.00063551,0.18886,0.22225,1,1
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.0013872,0.18878,0.1728,1,1
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0033369,0.18861,0.24468,1,1
3,GO RESPONSE TO MUSCLE INACTIVITY,0.042857,0.1886,0.17997,1,1
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00040247,0.18847,0.16942,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,0.00012074,0.18835,0.1897,1,1
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.014486,0.18814,0.18732,1,1
3,GO DEVELOPMENTAL PIGMENTATION,0.0028957,0.18792,0.14372,1,1
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0031536,0.18785,0.23331,1,1
3,GO POSITIVE REGULATION OF SECRETION,3.3132e-05,0.18772,0.2019,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0026572,0.18771,0.18064,1,1
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0062634,0.18759,0.16671,1,1
3,GO EPITHELIAL CELL DEVELOPMENT,0.0060989,0.18754,0.13574,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.00040247,0.18701,0.16645,1,1
3,GO LEUKOCYTE HOMEOSTASIS,0.0056288,0.18695,0.1429,1,1
3,GO GAMMA DELTA T CELL ACTIVATION,0.017969,0.18667,0.23137,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.7145e-05,0.18666,0.17834,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0036303,0.18632,0.13407,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.014486,0.18623,0.1864,1,1
3,GO MYOTUBE DIFFERENTIATION,0.00092958,0.18617,0.17545,1,1
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0028141,0.18606,0.14252,1,1
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0013457,0.186,0.21178,1,1
3,GO IRON ION TRANSPORT,6.5149e-05,0.18597,0.23923,1,1
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0025817,0.18554,0.15663,1,1
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.7596e-05,0.18551,0.22746,1,1
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00045924,0.18551,0.22392,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.02843,0.18546,0.10521,1,1
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.001986,0.18476,0.26563,1,1
3,GO GLUCOSE METABOLIC PROCESS,3.5759e-05,0.18474,0.217,1,1
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00065623,0.18469,0.15857,1,1
3,GO GOLGI RIBBON FORMATION,0.0066042,0.18462,0.18817,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,6.0504e-05,0.18452,0.16889,1,1
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0059384,0.18435,0.17842,1,1
3,GO ACID SECRETION,0.0036303,0.18391,0.15574,1,1
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.0097392,0.18384,0.17747,1,1
3,GO CHLORIDE TRANSPORT,0.0007696,0.18369,0.14822,1,1
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0054795,0.18354,0.1566,1,1
3,GO PROTEIN O LINKED MANNOSYLATION,0.0099891,0.18338,0.18869,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00031859,0.18306,0.13828,1,1
3,GO FIBROBLAST PROLIFERATION,0.03245,0.18291,0.119,1,1
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00026003,0.1828,0.16989,1,1
3,GO RESPONSE TO WOUNDING,0.009256,0.18272,0.12674,1,1
3,GO CARBOHYDRATE METABOLIC PROCESS,0.00057693,0.18254,0.17491,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.033166,0.18251,0.16588,1,1
3,GO OXIDATION REDUCTION PROCESS,0.00042998,0.18239,0.18325,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0032441,0.18236,0.25299,1,1
3,GO ENDOTHELIAL CELL MIGRATION,0.0090226,0.18232,0.14555,1,1
3,GO RENAL TUBULE DEVELOPMENT,0.018398,0.1823,0.11516,1,1
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,1.104e-05,0.18209,0.21102,1,1
3,GO PROTON TRANSMEMBRANE TRANSPORT,2.0033e-05,0.18201,0.21251,1,1
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0020453,0.18165,0.24001,1,1
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00038934,0.1815,0.20025,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,0.00042998,0.18132,0.1416,1,1
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.025994,0.18127,0.13162,1,1
3,GO NEUTROPHIL CHEMOTAXIS,0.0006154,0.18074,0.14617,1,1
3,GO RESPONSE TO LIPID,0.0019282,0.18072,0.13629,1,1
3,GO TEMPERATURE HOMEOSTASIS,0.00012074,0.18064,0.17615,1,1
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.013139,0.18026,0.15585,1,1
3,GO RESPONSE TO CHEMOKINE,0.00057693,0.17992,0.15247,1,1
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0045306,0.17979,0.16241,1,1
3,GO CHEMICAL HOMEOSTASIS,6.5149e-05,0.17955,0.16593,1,1
3,GO MECHANORECEPTOR DIFFERENTIATION,0.00037661,0.17938,0.18278,1,1
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0017123,0.17932,0.17246,1,1
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0001547,0.17929,0.16133,1,1
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00012512,0.17925,0.17168,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0025083,0.17918,0.26506,1,1
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0075304,0.17903,0.1749,1,1
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0062634,0.17878,0.20415,1,1
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.00022676,0.1786,0.19323,1,1
3,GO PROTEIN DESTABILIZATION,0.00027832,0.17843,0.17514,1,1
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.043763,0.17812,0.15911,1,1
3,GO ORGANELLE INHERITANCE,0.0013457,0.17796,0.15578,1,1
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00059588,0.17784,0.1329,1,1
3,GO RESPONSE TO PROSTAGLANDIN,0.014138,0.17783,0.1966,1,1
3,GO POLYOL BIOSYNTHETIC PROCESS,0.0013457,0.17782,0.20834,1,1
3,GO MYELOID CELL DIFFERENTIATION,0.00024286,0.17776,0.14826,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0045306,0.17742,0.14315,1,1
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0081404,0.17736,0.19928,1,1
3,GO RESPONSE TO STEROID HORMONE,0.0014738,0.17733,0.15115,1,1
3,GO REGULATION OF SODIUM ION TRANSPORT,0.019283,0.17722,0.14101,1,1
3,GO GLOMERULUS DEVELOPMENT,0.0066042,0.17713,0.17927,1,1
3,GO INTERFERON GAMMA PRODUCTION,0.01282,0.17698,0.12533,1,1
3,GO LIPID CATABOLIC PROCESS,9.7346e-05,0.17659,0.20999,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.0040578,0.17574,0.15219,1,1
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00022676,0.1756,0.14778,1,1
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0083534,0.17553,0.19074,1,1
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00023468,0.17522,0.15209,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.00030804,0.17502,0.21932,1,1
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00067758,0.17501,0.14034,1,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00057693,0.17468,0.1582,1,1
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.018836,0.1746,0.13301,1,1
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00040247,0.17425,0.17689,1,1
3,GO ORGANIC ANION TRANSPORT,0.00017186,0.17416,0.18387,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0049174,0.17389,0.17142,1,1
3,GO METAL ION HOMEOSTASIS,0.00029782,0.17349,0.13988,1,1
3,GO REGULATION OF ANION TRANSPORT,0.00063551,0.17344,0.22227,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00050664,0.17302,0.17858,1,1
3,GO RESPONSE TO MONOSACCHARIDE,0.0018173,0.17273,0.14015,1,1
3,GO REGULATION OF BONE DEVELOPMENT,0.01282,0.17225,0.13938,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,0.00018427,0.17198,0.13508,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.010245,0.1718,0.16842,1,1
3,GO RESPONSE TO ETHER,0.0019282,0.17168,0.18319,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.0069616,0.17167,0.14803,1,1
3,GO OOCYTE DIFFERENTIATION,0.0010528,0.1715,0.15532,1,1
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.0051916,0.17141,0.13711,1,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.022165,0.17085,0.24674,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.02166,0.17083,0.1219,1,1
3,GO ANION TRANSMEMBRANE TRANSPORT,0.00069957,0.17079,0.15543,1,1
3,GO DETECTION OF STIMULUS,5.2139e-05,0.17072,0.1403,1,1
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0071468,0.17053,0.16458,1,1
3,GO REGULATION OF SECRETION,0.00019753,0.17039,0.15572,1,1
3,GO FATTY ACID TRANSPORT,0.0015653,0.16959,0.18967,1,1
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0060989,0.16955,0.1183,1,1
3,GO CELLULAR PIGMENTATION,0.0010528,0.16927,0.17475,1,1
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0007696,0.16913,0.18671,1,1
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0016129,0.16868,0.15642,1,1
3,GO RESPONSE TO CARBOHYDRATE,0.0018173,0.16858,0.1393,1,1
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.016339,0.16725,0.14853,1,1
3,GO MONONUCLEAR CELL MIGRATION,0.015574,0.16722,0.12318,1,1
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.03939,0.16719,0.16174,1,1
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,5.0226e-05,0.16716,0.18241,1,1
3,GO INORGANIC ANION TRANSPORT,0.00041602,0.16693,0.14316,1,1
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.009256,0.16693,0.13047,1,1
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0045306,0.16666,0.14929,1,1
3,GO RESPONSE TO OXIDATIVE STRESS,0.0010206,0.16658,0.14099,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00079435,0.16656,0.13474,1,1
3,GO REGULATION OF PROTEOLYSIS,0.00050664,0.16654,0.15323,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,0.00026903,0.16649,0.15519,1,1
3,GO BIOLOGICAL ADHESION,0.013798,0.16627,0.10982,1,1
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.00055855,0.16621,0.2052,1,1
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0025083,0.16616,0.17727,1,1
3,GO PROTEOLYSIS,0.00016595,0.16613,0.14075,1,1
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.01282,0.16613,0.13625,1,1
3,GO AGING,0.00084609,0.16607,0.12825,1,1
3,GO REGULATION OF RESPONSE TO STRESS,0.0010206,0.166,0.12574,1,1
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.024846,0.16557,0.10393,1,1
3,GO RESPONSE TO DRUG,0.0015653,0.16528,0.14794,1,1
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0057817,0.16519,0.16562,1,1
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.00034072,0.16513,0.13986,1,1
3,GO CIRCULATORY SYSTEM PROCESS,0.001228,0.16462,0.12796,1,1
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.001228,0.16462,0.22921,1,1
3,GO ANION TRANSPORT,0.00014935,0.1646,0.16899,1,1
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.00087311,0.16412,0.14964,1,1
3,GO ION HOMEOSTASIS,0.00037661,0.16357,0.14258,1,1
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00092958,0.16291,0.17417,1,1
3,GO FATTY ACID BETA OXIDATION,0.019283,0.16289,0.15803,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00049035,0.16257,0.13983,1,1
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.020205,0.16251,0.1512,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0040578,0.16244,0.12903,1,1
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0047853,0.1623,0.13072,1,1
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.014841,0.16219,0.13846,1,1
3,GO ACTIVATED T CELL PROLIFERATION,0.013465,0.16198,0.14938,1,1
3,GO RUFFLE ORGANIZATION,0.00092958,0.1617,0.1898,1,1
3,GO COPULATION,0.031748,0.16167,0.15776,1,1
3,GO ORGANELLE DISASSEMBLY,0.00025131,0.16154,0.16541,1,1
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.026586,0.16152,0.097956,1,1
3,GO CELLULAR RESPONSE TO LIPID,0.0069616,0.16152,0.1183,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0013054,0.16143,0.16704,1,1
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.050569,0.16138,0.11691,1,1
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0025817,0.16135,0.20168,1,1
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.01282,0.16089,0.16924,1,1
3,GO REGULATION OF GLUCOSE IMPORT,0.0049174,0.16078,0.15916,1,1
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.031059,0.1605,0.1251,1,1
3,GO MANGANESE ION TRANSPORT,0.0049174,0.16036,0.17666,1,1
3,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0041716,0.16032,0.37934,1,1
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.041093,0.16024,0.12703,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0010528,0.16009,0.13141,1,1
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0007696,0.15968,0.17696,1,1
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0013872,0.15967,0.18375,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.012508,0.15963,0.13304,1,1
3,GO EPITHELIAL CELL PROLIFERATION,0.0099891,0.15958,0.11497,1,1
3,GO MULTIVESICULAR BODY ORGANIZATION,0.0011199,0.15957,0.1496,1,1
3,GO REGULATION OF CELL MATURATION,0.0033369,0.15932,0.15568,1,1
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0029794,0.15931,0.12713,1,1
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.049546,0.15916,0.10638,1,1
3,GO LUNG MORPHOGENESIS,0.049546,0.15909,0.11403,1,1
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.031748,0.15902,0.14477,1,1
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0010859,0.15891,0.16536,1,1
3,GO TRANSLESION SYNTHESIS,0.0018173,0.15881,0.13166,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0069616,0.15864,0.15704,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00025131,0.15835,0.16104,1,1
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.013139,0.15822,0.16198,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.011612,0.15748,0.16774,1,1
3,GO MYELOID CELL DEVELOPMENT,0.001662,0.15727,0.13774,1,1
3,GO MULTICELLULAR ORGANISM AGING,0.0026572,0.15704,0.15143,1,1
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.016734,0.15647,0.15353,1,1
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0017123,0.15647,0.14063,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00052342,0.15591,0.13086,1,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0032441,0.15582,0.12714,1,1
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0018173,0.15581,0.14117,1,1
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,8.4205e-05,0.15567,0.21459,1,1
3,GO GLIAL CELL APOPTOTIC PROCESS,0.042857,0.15566,0.17859,1,1
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.001872,0.15555,0.19249,1,1
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0075304,0.15551,0.14124,1,1
3,GO REGULATION OF CELL MATRIX ADHESION,0.0083534,0.15536,0.16938,1,1
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.013139,0.15459,0.14253,1,1
3,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0014738,0.15452,0.15547,1,1
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00022676,0.1544,0.17001,1,1
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0025083,0.15419,0.11511,1,1
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.00065623,0.15403,0.15945,1,1
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.015203,0.15401,0.10712,1,1
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00090094,0.15361,0.16272,1,1
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.011612,0.1536,0.16063,1,1
3,GO REGULATION OF PEPTIDE TRANSPORT,4.8379e-05,0.15356,0.14764,1,1
3,GO RESPONSE TO ALKALOID,0.0036303,0.15332,0.14391,1,1
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00072223,0.15329,0.14077,1,1
3,GO PEROXISOME ORGANIZATION,0.0030654,0.15318,0.17428,1,1
3,GO LYSOSOME LOCALIZATION,0.0042883,0.15311,0.14139,1,1
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.00049035,0.15287,0.15087,1,1
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0099891,0.15252,0.14938,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.025414,0.15249,0.12804,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0051916,0.15193,0.16016,1,1
3,GO REGULATION OF MAP KINASE ACTIVITY,0.0022332,0.15156,0.13838,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.017549,0.15153,0.1496,1,1
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0049174,0.15151,0.21357,1,1
3,GO GLAND DEVELOPMENT,0.0013872,0.15138,0.12833,1,1
3,GO RESPONSE TO ANTIBIOTIC,0.0010528,0.15138,0.17859,1,1
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0037331,0.15123,0.14063,1,1
3,GO CALCIUM ION IMPORT,0.021165,0.15116,0.10811,1,1
3,GO HOMEOSTATIC PROCESS,8.4205e-05,0.15108,0.13588,1,1
3,GO SIGNAL RELEASE,0.001872,0.15085,0.13286,1,1
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.013465,0.1507,0.14948,1,1
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0040578,0.15068,0.13672,1,1
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.04854,0.15047,0.11433,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0014299,0.15039,0.16302,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00353,0.15033,0.13372,1,1
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00045924,0.15027,0.15063,1,1
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.049546,0.14991,0.08666,1,1
3,GO ENDOSOME ORGANIZATION,0.00035231,0.14987,0.17368,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.001986,0.14964,0.12585,1,1
3,GO ACTIN FILAMENT BASED TRANSPORT,0.014138,0.14962,0.20978,1,1
3,GO PSEUDOPODIUM ORGANIZATION,0.049546,0.1492,0.22122,1,1
3,GO ACROSOME REACTION,0.020205,0.14917,0.18068,1,1
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.001872,0.14872,0.12648,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00012964,0.14871,0.16072,1,1
3,GO POLYOL CATABOLIC PROCESS,0.0033369,0.14865,0.15323,1,1
3,GO CELL MOTILITY,0.019739,0.1486,0.090384,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00030804,0.14843,0.18117,1,1
3,GO RESPONSE TO ACID CHEMICAL,0.0056288,0.14832,0.11618,1,1
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0022332,0.14831,0.11477,1,1
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0013872,0.14815,0.1199,1,1
3,GO BIOMINERALIZATION,0.0087944,0.14814,0.13121,1,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0016129,0.1481,0.11907,1,1
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0051916,0.14802,0.11394,1,1
3,GO PEROXISOMAL TRANSPORT,0.0030654,0.14796,0.1839,1,1
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.024288,0.14777,0.10896,1,1
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0013457,0.14763,0.12307,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.015953,0.14749,0.22845,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0024367,0.14746,0.13337,1,1
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.033166,0.14696,0.11288,1,1
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.00054072,0.14673,0.19309,1,1
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0087944,0.14657,0.10954,1,1
3,GO RESPONSE TO HORMONE,0.00079435,0.14653,0.13967,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0019282,0.14623,0.17313,1,1
3,GO ORGANIC ACID CATABOLIC PROCESS,0.0073363,0.14612,0.16725,1,1
3,GO AUTOPHAGY OF MITOCHONDRION,0.00090094,0.14608,0.16716,1,1
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.014841,0.14566,0.075161,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0017123,0.14559,0.12047,1,1
3,GO CELL MATURATION,0.00017186,0.14547,0.14975,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.017969,0.1453,0.1127,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE,0.00095906,0.14489,0.12674,1,1
3,GO DNA CATABOLIC PROCESS,0.00041602,0.14484,0.13751,1,1
3,GO ORGANIC ACID TRANSPORT,0.00055855,0.14471,0.1826,1,1
3,GO MEMBRANE ORGANIZATION,0.0067808,0.14444,0.096234,1,1
3,GO REGULATION OF PROTEIN BINDING,0.0069616,0.1438,0.12157,1,1
3,GO ALCOHOL CATABOLIC PROCESS,0.0026572,0.14355,0.16184,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.009256,0.14343,0.14644,1,1
3,GO PHOTOTRANSDUCTION,0.0081404,0.14334,0.097881,1,1
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.027803,0.14289,0.099521,1,1
3,GO GLUCOSE IMPORT,0.0056288,0.14246,0.15952,1,1
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00072223,0.14183,0.15495,1,1
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.004408,0.1417,0.14392,1,1
3,GO RESPONSE TO PEPTIDE HORMONE,0.00038934,0.14169,0.13554,1,1
3,GO ACTIVATION OF MAPK ACTIVITY,0.0021689,0.14155,0.12045,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.015953,0.14148,0.10286,1,1
3,GO POSITIVE REGULATION OF CELL AGING,0.021165,0.14145,0.18253,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00042998,0.14143,0.14393,1,1
3,GO REGULATION OF MAPK CASCADE,0.0085714,0.14108,0.11069,1,1
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0017123,0.14075,0.1245,1,1
3,GO RETINA HOMEOSTASIS,0.0037331,0.14057,0.099368,1,1
3,GO RESPONSE TO TOXIC SUBSTANCE,0.0017641,0.14034,0.18138,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00049035,0.13993,0.13026,1,1
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.023205,0.13966,0.11367,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00045924,0.13962,0.12972,1,1
3,GO CELLULAR ION HOMEOSTASIS,0.0010206,0.13958,0.12439,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0017123,0.13952,0.11475,1,1
3,GO RESPONSE TO ETHANOL,0.0083534,0.13943,0.11912,1,1
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0034322,0.13934,0.11488,1,1
3,GO TISSUE MIGRATION,0.0094949,0.13913,0.13727,1,1
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.001872,0.13887,0.15284,1,1
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0013457,0.13879,0.12769,1,1
3,GO TRANSMEMBRANE TRANSPORT,0.00059588,0.13802,0.13532,1,1
3,GO ORGANIC ACID METABOLIC PROCESS,0.0027346,0.1377,0.15711,1,1
3,GO MAMMARY GLAND DEVELOPMENT,0.024846,0.13759,0.10532,1,1
3,GO FEEDING BEHAVIOR,0.02068,0.13754,0.11872,1,1
3,GO PROTEIN AUTOUBIQUITINATION,0.00019753,0.13753,0.12538,1,1
3,GO ERBB SIGNALING PATHWAY,0.024846,0.13749,0.11284,1,1
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0046564,0.13658,0.12941,1,1
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0057817,0.13632,0.1724,1,1
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.019283,0.13627,0.10043,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00045924,0.13624,0.13926,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.035393,0.13597,0.15191,1,1
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00045924,0.13592,0.15552,1,1
3,GO RESPONSE TO NITROGEN COMPOUND,0.00090094,0.13562,0.11191,1,1
3,GO ION TRANSPORT,0.00055855,0.13539,0.13944,1,1
3,GO EXOCYTIC PROCESS,0.012203,0.13513,0.15488,1,1
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.037747,0.13399,0.085239,1,1
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00069957,0.13392,0.17091,1,1
3,GO REGULATION OF HYDROLASE ACTIVITY,0.0029794,0.1336,0.10774,1,1
3,GO LIPID MODIFICATION,0.0007696,0.13355,0.15197,1,1
3,GO EXCRETION,0.016339,0.13355,0.11073,1,1
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0094949,0.13332,0.10628,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.004408,0.13285,0.16494,1,1
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.015953,0.13252,0.14004,1,1
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0071468,0.13197,0.1089,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0024367,0.13193,0.14674,1,1
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.017549,0.13183,0.10271,1,1
3,GO RESPONSE TO ESTRADIOL,0.04854,0.13157,0.075075,1,1
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.041967,0.1314,0.08592,1,1
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0032441,0.13121,0.10641,1,1
3,GO ERYTHROCYTE HOMEOSTASIS,0.0021062,0.13104,0.12857,1,1
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.0024367,0.13079,0.11272,1,1
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.004408,0.13062,0.11429,1,1
3,GO DRUG CATABOLIC PROCESS,0.0064317,0.13028,0.2252,1,1
3,GO RESPONSE TO OXYGEN LEVELS,0.0051916,0.13023,0.11824,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.02166,0.13017,0.12369,1,1
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.019739,0.12975,0.15222,1,1
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.0075304,0.12942,0.11221,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.026586,0.12917,0.095864,1,1
3,GO T CELL HOMEOSTASIS,0.02843,0.12911,0.12048,1,1
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.022165,0.12908,0.087029,1,1
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.025994,0.12878,0.14027,1,1
3,GO RESPONSE TO PEPTIDE,0.0015189,0.12876,0.11853,1,1
3,GO TRANSITION METAL ION TRANSPORT,0.00026003,0.12873,0.20556,1,1
3,GO REGULATION OF TRANSPORT,0.0023671,0.12863,0.09751,1,1
3,GO RESPONSE TO ACTIVITY,0.0099891,0.12851,0.14795,1,1
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0026572,0.12839,0.13127,1,1
3,GO NEPHRON DEVELOPMENT,0.045624,0.12782,0.086589,1,1
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.02843,0.12756,0.14526,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION,0.0015189,0.12745,0.10232,1,1
3,GO REGULATION OF CELL DEATH,0.0017641,0.12694,0.10856,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0079323,0.1269,0.12969,1,1
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.029068,0.12688,0.126,1,1
3,GO GOLGI ORGANIZATION,0.00026003,0.12648,0.15889,1,1
3,GO SINGLE FERTILIZATION,0.0085714,0.12646,0.094661,1,1
3,GO POSITIVE REGULATION OF SIGNALING,0.00079435,0.12628,0.11647,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.021165,0.12623,0.13786,1,1
3,GO POLYOL METABOLIC PROCESS,0.0054795,0.12612,0.12626,1,1
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0060989,0.126,0.13175,1,1
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.05161,0.12597,0.079052,1,1
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0027346,0.12596,0.10191,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0097392,0.1258,0.10034,1,1
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0087944,0.12523,0.11282,1,1
3,GO THYMIC T CELL SELECTION,0.050569,0.12519,0.076334,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.05161,0.12496,0.14341,1,1
3,GO MESONEPHROS DEVELOPMENT,0.020205,0.12443,0.11024,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.0020453,0.12397,0.11708,1,1
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0094949,0.12395,0.11021,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0030654,0.12391,0.10048,1,1
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00092958,0.12374,0.12392,1,1
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0027346,0.12361,0.13996,1,1
3,GO SOMITOGENESIS,0.0075304,0.12298,0.11065,1,1
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0051916,0.12226,0.12252,1,1
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.017549,0.122,0.1236,1,1
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0014299,0.12195,0.11275,1,1
3,GO REGULATION OF TOR SIGNALING,0.00014418,0.12162,0.12346,1,1
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0099891,0.12096,0.09958,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.001872,0.12069,0.10651,1,1
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.02843,0.12041,0.10955,1,1
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.011904,0.12031,0.1286,1,1
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.0029794,0.12013,0.16704,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.03939,0.11995,0.074557,1,1
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0038387,0.11988,0.11314,1,1
3,GO PEPTIDYL TYROSINE MODIFICATION,0.0099891,0.11954,0.10916,1,1
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.010506,0.11944,0.12645,1,1
3,GO POSITIVE REGULATION OF CELL DEATH,0.0075304,0.11934,0.09971,1,1
3,GO ACTIVATION OF GTPASE ACTIVITY,0.0069616,0.11927,0.097033,1,1
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.024288,0.11859,0.10853,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0039469,0.11856,0.12659,1,1
3,GO OOGENESIS,0.029068,0.11829,0.083935,1,1
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.047551,0.1177,0.12461,1,1
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0020453,0.11731,0.11067,1,1
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0054795,0.1171,0.095334,1,1
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0069616,0.11709,0.13457,1,1
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.0046564,0.11704,0.11737,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.011612,0.11689,0.087758,1,1
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.02166,0.11678,0.076581,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00019753,0.11666,0.13006,1,1
3,GO TOR SIGNALING,4.4878e-05,0.11657,0.11111,1,1
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0056288,0.11614,0.12165,1,1
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0022332,0.11581,0.13244,1,1
3,GO VIRAL BUDDING,0.0032441,0.11537,0.1501,1,1
3,GO LYMPH NODE DEVELOPMENT,0.02843,0.11534,0.1533,1,1
3,GO RESPONSE TO SALT,0.02166,0.1153,0.11703,1,1
3,GO FATTY ACYL COA METABOLIC PROCESS,0.015203,0.11528,0.16745,1,1
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.043763,0.11505,0.11297,1,1
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.012203,0.11428,0.11547,1,1
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00047456,0.11425,0.13088,1,1
3,GO ANATOMICAL STRUCTURE MATURATION,0.0053338,0.11408,0.10172,1,1
3,GO APOPTOTIC PROCESS,0.0013457,0.11407,0.11118,1,1
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.052669,0.11373,0.076961,1,1
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.0087944,0.11341,0.099344,1,1
3,GO RESPONSE TO ABIOTIC STIMULUS,0.001986,0.11296,0.099434,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0040578,0.11278,0.11439,1,1
3,GO NEGATIVE REGULATION OF CELL DEATH,0.0046564,0.11234,0.10379,1,1
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0049174,0.1121,0.095623,1,1
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.015203,0.11186,0.10071,1,1
3,GO RUFFLE ASSEMBLY,0.050569,0.11175,0.1094,1,1
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.012203,0.11165,0.17069,1,1
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.025994,0.11142,0.10261,1,1
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.018398,0.11117,0.085774,1,1
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.029719,0.1106,0.11873,1,1
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.019283,0.1103,0.12188,1,1
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0083534,0.10983,0.092377,1,1
3,GO POSITIVE REGULATION OF TRANSPORT,0.0021689,0.10978,0.10654,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.044685,0.10925,0.12129,1,1
3,GO REGULATION OF ATP METABOLIC PROCESS,0.025414,0.1091,0.097324,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.011904,0.1084,0.10469,1,1
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.018398,0.10754,0.081408,1,1
3,GO CELLULAR HOMEOSTASIS,0.0022992,0.10737,0.11169,1,1
3,GO BODY FLUID SECRETION,0.030383,0.10641,0.087398,1,1
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.017137,0.10609,0.092323,1,1
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00044439,0.10565,0.12904,1,1
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00045924,0.10491,0.14944,1,1
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0069616,0.10469,0.097781,1,1
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0053338,0.10449,0.091579,1,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.018836,0.10447,0.097305,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.016734,0.10425,0.083415,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0025817,0.10374,0.11005,1,1
3,GO MULTI ORGANISM PROCESS,0.02268,0.10252,0.068445,1,1
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0062634,0.10176,0.097566,1,1
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.044685,0.10115,0.081777,1,1
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.027803,0.099952,0.093385,1,1
3,GO POSITIVE REGULATION OF NEURON DEATH,0.0075304,0.099901,0.12582,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.015574,0.099547,0.1108,1,1
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.020205,0.099346,0.17499,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.015203,0.09916,0.093914,1,1
3,GO JNK CASCADE,0.013798,0.098803,0.10266,1,1
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.021165,0.098234,0.0806,1,1
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.02166,0.098003,0.11549,1,1
3,GO REGULATION OF PROTEIN STABILITY,0.0030654,0.097367,0.10446,1,1
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.018398,0.097021,0.07864,1,1
3,GO ACTIN FILAMENT ORGANIZATION,0.047551,0.096972,0.069518,1,1
3,GO FERTILIZATION,0.015953,0.096811,0.078782,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.01282,0.09659,0.084872,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.029719,0.096461,0.086809,1,1
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.013798,0.094521,0.12516,1,1
3,GO REGULATION OF PHOSPHORYLATION,0.0062634,0.093668,0.088926,1,1
3,GO PROTEIN AUTOPHOSPHORYLATION,0.019739,0.093621,0.079344,1,1
3,GO BLASTOCYST DEVELOPMENT,0.0010206,0.091934,0.10786,1,1
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.013139,0.091238,0.079177,1,1
3,GO REPRODUCTION,0.0094949,0.091163,0.079481,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0067808,0.089947,0.10395,1,1
3,GO REGULATION OF AUTOPHAGY,0.0017641,0.089513,0.11498,1,1
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.011904,0.089413,0.07827,1,1
3,GO COBALAMIN METABOLIC PROCESS,0.020205,0.088844,0.22056,1,1
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0038387,0.088291,0.09015,1,1
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.015203,0.088287,0.090424,1,1
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.010773,0.088254,0.078366,1,1
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.012203,0.087474,0.07671,1,1
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.007729,0.087366,0.083463,1,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.047551,0.087265,0.0745,1,1
3,GO POSITIVE REGULATION OF BINDING,0.04854,0.087128,0.068513,1,1
3,GO REGULATION OF EXOCYTOSIS,0.020205,0.086981,0.10693,1,1
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.012203,0.086719,0.099805,1,1
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0034322,0.086554,0.095057,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.024288,0.086479,0.13321,1,1
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.013139,0.085515,0.099149,1,1
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0036303,0.085158,0.1107,1,1
3,GO REGULATION OF OSSIFICATION,0.036164,0.084586,0.090831,1,1
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.036164,0.084275,0.065206,1,1
3,GO CYTOSOLIC TRANSPORT,0.01282,0.083011,0.087034,1,1
3,GO MALE SEX DIFFERENTIATION,0.05161,0.082424,0.087856,1,1
3,GO TUBE DEVELOPMENT,0.052669,0.082063,0.07018,1,1
3,GO NEGATIVE REGULATION OF TRANSPORT,0.04854,0.079597,0.066755,1,1
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.013798,0.079462,0.078101,1,1
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.04854,0.078901,0.11083,1,1
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0054795,0.078131,0.089991,1,1
3,GO VESICLE LOCALIZATION,0.02268,0.077178,0.09118,1,1
3,GO DNA MODIFICATION,0.042857,0.074619,0.05439,1,1
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.011326,0.073097,0.0845,1,1
3,GO NEURON DEATH,0.05161,0.072877,0.054786,1,1
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.0051916,0.072863,0.10532,1,1
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.015574,0.071852,0.064108,1,1
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.040234,0.071169,0.057666,1,1
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.014841,0.070833,0.082227,1,1
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.041093,0.070567,0.12879,1,1
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.011904,0.070548,0.063561,1,1
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.024288,0.070072,0.070492,1,1
3,GO DNA METHYLATION OR DEMETHYLATION,0.05161,0.069713,0.066724,1,1
3,GO GERM CELL DEVELOPMENT,0.05161,0.068916,0.057818,1,1
3,GO INTRACELLULAR TRANSPORT,0.016734,0.068648,0.061097,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.03939,0.0685,0.065484,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE,0.025994,0.067266,0.057089,1,1
3,GO MITOCHONDRIAL TRANSPORT,0.023205,0.065633,0.072125,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0054795,0.062657,0.064778,1,1
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.049546,0.062551,0.046632,1,1
3,GO SEXUAL REPRODUCTION,0.027803,0.061944,0.059534,1,1
3,GO REGULATION OF CIRCADIAN RHYTHM,0.041093,0.061863,0.086973,1,1
3,GO GAMETE GENERATION,0.044685,0.058099,0.05447,1,1
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.031748,0.056636,0.048077,1,1
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0059384,0.051948,0.083655,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.018836,0.05034,0.06502,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.012203,0.049143,0.055688,1,1
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0027346,0.81827,0.62689,1,0
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,7.013e-05,0.78029,0.76784,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0054795,0.66173,0.51391,1,0
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00087311,0.64438,0.40836,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00067758,0.6157,0.48235,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00014935,0.5861,0.47339,1,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.00087311,0.5729,0.38419,1,0
3,GO RESPONSE TO INTERFERON BETA,0.0025083,0.57173,0.39699,1,0
3,GO RESPONSE TO INTERFERON ALPHA,0.010773,0.57095,0.3028,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00017186,0.56985,0.48464,1,0
3,GO NEGATIVE REGULATION OF CELL KILLING,0.0075304,0.56406,0.43583,1,0
3,GO GLYCOLIPID CATABOLIC PROCESS,0.00087311,0.51878,0.47276,1,0
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0060989,0.50334,0.37357,1,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00054072,0.47261,0.30682,1,0
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.00025131,0.4681,0.44228,1,0
3,GO MEMBRANE RAFT ASSEMBLY,0.05161,0.44436,0.26923,1,0
3,GO GAP JUNCTION ASSEMBLY,0.0085714,0.43059,0.2971,1,0
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0057817,0.41337,0.32393,1,0
3,GO T CELL EXTRAVASATION,0.013465,0.40973,0.41873,1,0
3,GO ENTRY INTO HOST,0.0006154,0.40241,0.25925,1,0
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0022332,0.39989,0.37353,1,0
3,GO MEMBRANE RAFT ORGANIZATION,0.0038387,0.38837,0.30409,1,0
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00010845,0.38625,0.31175,1,0
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00063551,0.38504,0.32954,1,0
3,GO BLOOD VESSEL REMODELING,6.5149e-05,0.38058,0.30481,1,0
3,GO NEGATIVE REGULATION OF COAGULATION,0.0026572,0.37812,0.31575,1,0
3,GO RESPONSE TO HISTAMINE,0.015574,0.37057,0.37295,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.034637,0.36727,0.2158,1,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0013872,0.36554,0.29384,1,0
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.00049035,0.36267,0.25344,1,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00040247,0.3606,0.34925,1,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0011199,0.35977,0.30613,1,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0013872,0.35654,0.34797,1,0
3,GO REGULATION OF MYOBLAST FUSION,0.00026903,0.35276,0.34998,1,0
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0013457,0.35244,0.32697,1,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.00052342,0.34975,0.3216,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00042998,0.34659,0.37324,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00037661,0.34442,0.28366,1,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00098941,0.34154,0.25465,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0014738,0.34141,0.22205,1,0
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00038934,0.3388,0.23419,1,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.033894,0.33877,0.20164,1,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0026572,0.33444,0.29082,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.00037661,0.33081,0.26744,1,0
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0017123,0.32659,0.24087,1,0
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00054072,0.32425,0.21279,1,0
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00098941,0.32117,0.23881,1,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0025083,0.32005,0.22853,1,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0020453,0.31684,0.24647,1,0
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0010859,0.31597,0.22492,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00012074,0.31577,0.23641,1,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0021062,0.31234,0.22001,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.0040578,0.31195,0.27226,1,0
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.018836,0.31044,0.30687,1,0
3,GO ZYMOGEN INHIBITION,0.00057693,0.31038,0.2749,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0014738,0.31002,0.27153,1,0
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.001872,0.30595,0.2975,1,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0051916,0.30485,0.25946,1,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.017137,0.30461,0.31111,1,0
3,GO REGULATION OF TRANSPOSITION,0.0075304,0.3021,0.28134,1,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.052669,0.29748,0.12472,1,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0015653,0.29628,0.22453,1,0
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0066042,0.29401,0.20497,1,0
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00063551,0.2927,0.1909,1,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.00030804,0.29127,0.21613,1,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0056288,0.29013,0.20278,1,0
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0090226,0.28222,0.28152,1,0
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.027803,0.28091,0.30553,1,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.0075304,0.28075,0.15613,1,0
3,GO DNA DEAMINATION,0.0049174,0.27893,0.32308,1,0
3,GO DETECTION OF BIOTIC STIMULUS,0.0021689,0.27797,0.27356,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0014738,0.27767,0.28928,1,0
3,GO INTERACTION WITH HOST,0.0006154,0.27766,0.19618,1,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.021165,0.27567,0.31031,1,0
3,GO BEHAVIORAL RESPONSE TO PAIN,0.02166,0.27246,0.21742,1,0
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0056288,0.27129,0.2526,1,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.015953,0.26789,0.2565,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00095906,0.26567,0.21882,1,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.02068,0.26399,0.1859,1,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.029068,0.26346,0.17839,1,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.013139,0.26339,0.22548,1,0
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.025414,0.2629,0.24991,1,0
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.019283,0.26147,0.25084,1,0
3,GO HOMOTYPIC CELL CELL ADHESION,0.0001165,0.26086,0.27668,1,0
3,GO CYTOKINE METABOLIC PROCESS,0.001228,0.26064,0.16626,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.015953,0.25959,0.17448,1,0
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.02068,0.25779,0.15637,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0047853,0.25736,0.15661,1,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0028141,0.25586,0.18313,1,0
3,GO CELL CELL RECOGNITION,0.0011199,0.25062,0.19524,1,0
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00021167,0.24886,0.21667,1,0
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00084609,0.24836,0.28367,1,0
3,GO TYPE 2 IMMUNE RESPONSE,0.029068,0.24761,0.1598,1,0
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0064317,0.24637,0.16925,1,0
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0036303,0.246,0.22809,1,0
3,GO INTERFERON BETA PRODUCTION,0.0037331,0.24438,0.1779,1,0
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.001872,0.24289,0.2199,1,0
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.0069616,0.24028,0.15093,1,0
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0011549,0.24027,0.19042,1,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.0064317,0.24007,0.16352,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.010506,0.23735,0.1811,1,0
3,GO PROTEIN TARGETING TO LYSOSOME,0.0054795,0.23609,0.23768,1,0
3,GO CELLULAR RESPONSE TO DSRNA,0.0038387,0.23578,0.19225,1,0
3,GO PROGRAMMED NECROTIC CELL DEATH,0.00047456,0.2347,0.27436,1,0
3,GO HYALURONAN METABOLIC PROCESS,0.00353,0.23288,0.15163,1,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00098941,0.23255,0.18465,1,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0053338,0.23178,0.24515,1,0
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.029068,0.23111,0.17155,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.009256,0.23093,0.19307,1,0
3,GO VIRAL LIFE CYCLE,0.00074557,0.2306,0.17673,1,0
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.007729,0.22692,0.15978,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0020453,0.2257,0.19544,1,0
3,GO CYTOLYSIS,0.030383,0.22463,0.15498,1,0
3,GO CELLULAR RESPONSE TO VIRUS,0.00010092,0.22412,0.2219,1,0
3,GO RESPONSE TO INTERLEUKIN 1,0.00041602,0.22357,0.17811,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.02843,0.22205,0.1768,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.010506,0.22172,0.19576,1,0
3,GO KERATINOCYTE PROLIFERATION,0.0097392,0.21999,0.17142,1,0
3,GO ANIMAL ORGAN REGENERATION,0.0039469,0.21886,0.15582,1,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0045306,0.21747,0.14038,1,0
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.017969,0.21718,0.21516,1,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.023205,0.21619,0.15406,1,0
3,GO REGULATION OF ISOTYPE SWITCHING,0.014138,0.21546,0.10265,1,0
3,GO PLATELET AGGREGATION,0.0060989,0.21534,0.16834,1,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.017969,0.2147,0.21313,1,0
3,GO AMYLOID BETA CLEARANCE,0.0028957,0.21441,0.19369,1,0
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0050528,0.21371,0.15789,1,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.036164,0.21266,0.14359,1,0
3,GO AUTOPHAGOSOME MATURATION,0.0019282,0.21119,0.20546,1,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.016339,0.20851,0.14065,1,0
3,GO RECEPTOR CATABOLIC PROCESS,0.030383,0.20794,0.11193,1,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00044439,0.20761,0.19162,1,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0062634,0.20686,0.16186,1,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0040578,0.20617,0.1745,1,0
3,GO VIRAL RELEASE FROM HOST CELL,0.0012662,0.20427,0.1872,1,0
3,GO NIK NF KAPPAB SIGNALING,0.0014299,0.20424,0.15521,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.010506,0.204,0.15118,1,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.016734,0.20362,0.17459,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0094949,0.20188,0.1737,1,0
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0041716,0.20108,0.18323,1,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.036164,0.20056,0.25039,1,0
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.023741,0.19973,0.1727,1,0
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.017137,0.19904,0.16795,1,0
3,GO NATURAL KILLER CELL ACTIVATION,0.00072223,0.19821,0.17802,1,0
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.010506,0.19774,0.1649,1,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0037331,0.19761,0.17511,1,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.037747,0.19753,0.16516,1,0
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0064317,0.19748,0.1403,1,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.033166,0.19739,0.15489,1,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0069616,0.19644,0.1472,1,0
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.03939,0.19407,0.10824,1,0
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0042883,0.19187,0.16621,1,0
3,GO CD40 SIGNALING PATHWAY,0.012508,0.19148,0.14323,1,0
3,GO LYMPHOCYTE CHEMOTAXIS,0.020205,0.19021,0.099491,1,0
3,GO POLYAMINE METABOLIC PROCESS,0.025994,0.1901,0.1602,1,0
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00041602,0.19008,0.19906,1,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0032441,0.18923,0.2267,1,0
3,GO PHAGOCYTOSIS,0.0067808,0.18884,0.13402,1,0
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00050664,0.18858,0.31835,1,0
3,GO REGULATION OF STEROL TRANSPORT,0.0028141,0.18847,0.17929,1,0
3,GO RIG I SIGNALING PATHWAY,0.0032441,0.18775,0.15476,1,0
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0022332,0.18675,0.22108,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.021165,0.18654,0.16777,1,0
3,GO SELECTIVE AUTOPHAGY,0.0016129,0.18574,0.18558,1,0
3,GO REGULATION OF CARDIAC CONDUCTION,0.0064317,0.18356,0.13559,1,0
3,GO IMMUNOGLOBULIN PRODUCTION,0.00037661,0.18315,0.1596,1,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0060989,0.18116,0.15006,1,0
3,GO RESPONSE TO TESTOSTERONE,0.049546,0.18072,0.11518,1,0
3,GO VIRION ASSEMBLY,0.0016129,0.18062,0.13984,1,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0032441,0.18033,0.18795,1,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.040234,0.17965,0.12041,1,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.041093,0.17868,0.15269,1,0
3,GO RESPONSE TO ANGIOTENSIN,0.014138,0.17851,0.19498,1,0
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.0069616,0.1782,0.15433,1,0
3,GO MIDBODY ABSCISSION,0.00065623,0.17787,0.24272,1,0
3,GO HEPATOCYTE DIFFERENTIATION,0.0073363,0.17725,0.24106,1,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0099891,0.17531,0.18067,1,0
3,GO SPERM EGG RECOGNITION,0.0028957,0.17475,0.14679,1,0
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.0047853,0.17238,0.16351,1,0
3,GO CELL REDOX HOMEOSTASIS,0.0037331,0.17194,0.21341,1,0
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0066042,0.17179,0.20891,1,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.013139,0.17127,0.14557,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.02843,0.17006,0.12871,1,0
3,GO CYTOKINETIC PROCESS,0.0081404,0.16959,0.13199,1,0
3,GO VIRAL RNA GENOME REPLICATION,0.0056288,0.16953,0.14844,1,0
3,GO OSTEOCLAST DEVELOPMENT,0.02068,0.1694,0.16072,1,0
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0050528,0.16782,0.18978,1,0
3,GO PROTEIN TARGETING TO VACUOLE,0.0054795,0.16686,0.15988,1,0
3,GO SYMBIOTIC PROCESS,0.0026572,0.16483,0.11649,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0062634,0.16373,0.12624,1,0
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.05161,0.16249,0.12031,1,0
3,GO RESPONSE TO OXYGEN RADICAL,0.00063551,0.16173,0.19847,1,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0033369,0.1616,0.17391,1,0
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.042857,0.16146,0.17383,1,0
3,GO TETRAPYRROLE METABOLIC PROCESS,0.019739,0.16082,0.20094,1,0
3,GO MACROPHAGE MIGRATION,0.046579,0.1605,0.099306,1,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.013139,0.15864,0.10833,1,0
3,GO TRNA 5 LEADER REMOVAL,0.041093,0.15794,0.13179,1,0
3,GO ERK1 AND ERK2 CASCADE,0.031748,0.15714,0.11244,1,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.025414,0.1565,0.21413,1,0
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0010859,0.15587,0.20941,1,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0050528,0.15574,0.16195,1,0
3,GO MITOTIC CYTOKINETIC PROCESS,0.04854,0.15564,0.11006,1,0
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.029719,0.15563,0.18755,1,0
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.035393,0.155,0.14224,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.043763,0.15431,0.20112,1,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.012508,0.15381,0.16607,1,0
3,GO CELL MATRIX ADHESION,0.020205,0.15204,0.11436,1,0
3,GO CHOLESTEROL EFFLUX,0.0054795,0.15115,0.18084,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.035393,0.1507,0.20642,1,0
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0017641,0.15064,0.21988,1,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.011612,0.14976,0.13418,1,0
3,GO PEPTIDE CATABOLIC PROCESS,0.035393,0.14828,0.17599,1,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0056288,0.1472,0.15704,1,0
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.0029794,0.14714,0.14818,1,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.02268,0.14705,0.10412,1,0
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.012508,0.14464,0.13647,1,0
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.023205,0.14459,0.13212,1,0
3,GO SULFUR COMPOUND TRANSPORT,0.0022992,0.14394,0.17783,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.033894,0.14343,0.10962,1,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.037747,0.14313,0.12286,1,0
3,GO OSTEOCLAST DIFFERENTIATION,0.027188,0.14239,0.098642,1,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0040578,0.14143,0.1155,1,0
3,GO RESPONSE TO FLUID SHEAR STRESS,0.017549,0.1397,0.16309,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.029068,0.1382,0.1162,1,0
3,GO MAINTENANCE OF LOCATION,0.0053338,0.13737,0.1099,1,0
3,GO ERAD PATHWAY,0.015203,0.13733,0.11791,1,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.004408,0.13714,0.23548,1,0
3,GO REGULATION OF CHEMOTAXIS,0.017549,0.13706,0.097488,1,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.046579,0.13685,0.1379,1,0
3,GO MYELOID CELL HOMEOSTASIS,0.0053338,0.13679,0.11784,1,0
3,GO CHYLOMICRON ASSEMBLY,0.050569,0.13639,0.21407,1,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.052669,0.13566,0.098104,1,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.013465,0.13527,0.12852,1,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0097392,0.13176,0.22921,1,0
3,GO MITOPHAGY,0.0075304,0.13131,0.14214,1,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.014486,0.13103,0.14493,1,0
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.040234,0.13023,0.1375,1,0
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.033894,0.12983,0.11071,1,0
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.043763,0.12929,0.15462,1,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.025994,0.12911,0.11978,1,0
3,GO MUSCLE CELL PROLIFERATION,0.02068,0.12844,0.094663,1,0
3,GO AUTOPHAGOSOME ORGANIZATION,0.00065623,0.12838,0.18578,1,0
3,GO CELLULAR RESPONSE TO IRON ION,0.038561,0.12782,0.20384,1,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0094949,0.12763,0.11609,1,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.047551,0.12748,0.097348,1,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.014486,0.12622,0.1868,1,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.007729,0.12618,0.18775,1,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.015574,0.12558,0.1079,1,0
3,GO REGULATION OF MACROPHAGE MIGRATION,0.030383,0.12552,0.11322,1,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0042883,0.12458,0.15303,1,0
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.036164,0.12424,0.14843,1,0
3,GO REGULATION OF VASOCONSTRICTION,0.011612,0.12399,0.14417,1,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.034637,0.12371,0.11425,1,0
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0051916,0.12208,0.12194,1,0
3,GO MAINTENANCE OF LOCATION IN CELL,0.0053338,0.12203,0.10319,1,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.024846,0.12096,0.16197,1,0
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.001872,0.11944,0.11403,1,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0099891,0.11851,0.25571,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.015574,0.11678,0.084473,1,0
3,GO MACROPHAGE CHEMOTAXIS,0.046579,0.11598,0.08327,1,0
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.042857,0.11587,0.076516,1,0
3,GO PROTEIN CATABOLIC PROCESS,0.0013457,0.11562,0.10268,1,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0099891,0.11508,0.16599,1,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.02068,0.11496,0.12061,1,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.040234,0.11375,0.086531,1,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.050569,0.11268,0.1214,1,0
3,GO T CELL APOPTOTIC PROCESS,0.052669,0.11129,0.12573,1,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.019739,0.11122,0.082171,1,0
3,GO POSTREPLICATION REPAIR,0.0099891,0.10978,0.085608,1,0
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.025414,0.109,0.1293,1,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.036948,0.10878,0.13081,1,0
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.019283,0.10777,0.095039,1,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.033894,0.10723,0.078917,1,0
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.033894,0.10485,0.12904,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.029719,0.10322,0.10072,1,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.025994,0.10303,0.063966,1,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0032441,0.10299,0.10947,1,0
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.017549,0.10099,0.11962,1,0
3,GO TRICARBOXYLIC ACID CYCLE,0.045624,0.097923,0.16732,1,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.041093,0.097542,0.076871,1,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0060989,0.096918,0.1024,1,0
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.041967,0.09656,0.11572,1,0
3,GO REGULATION OF PROTEIN MATURATION,0.052669,0.096157,0.094852,1,0
3,GO PROTEIN POLYUBIQUITINATION,0.00030804,0.096046,0.11516,1,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.040234,0.093592,0.062186,1,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0099891,0.092277,0.081813,1,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.016734,0.091927,0.10209,1,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0011199,0.091776,0.10169,1,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.011904,0.090723,0.14517,1,0
3,GO CELLULAR RESPIRATION,0.041967,0.090219,0.12613,1,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0083534,0.087749,0.11824,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.017969,0.08523,0.069235,1,0
3,GO MACROMOLECULE CATABOLIC PROCESS,0.020205,0.085064,0.06656,1,0
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.022165,0.084412,0.10621,1,0
3,GO CELLULAR COMPONENT DISASSEMBLY,0.047551,0.081593,0.063796,1,0
3,GO RESPONSE TO INTERLEUKIN 7,0.03939,0.081432,0.10436,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.03939,0.077436,0.086172,1,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.022165,0.077405,0.060918,1,0
3,GO REGULATION OF VACUOLE ORGANIZATION,0.026586,0.076522,0.11656,1,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.044685,0.075857,0.054117,1,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.031748,0.075783,0.052316,1,0
3,GO GOLGI VESICLE TRANSPORT,0.011326,0.073987,0.098333,1,0
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.027188,0.073495,0.049524,1,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.02268,0.071664,0.076078,1,0
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.038561,0.070029,0.077162,1,0
3,GO MACROAUTOPHAGY,0.0013872,0.069691,0.12184,1,0
3,GO REGULATION OF CATABOLIC PROCESS,0.029719,0.069353,0.064541,1,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.03939,0.067915,0.14517,1,0
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.03245,0.063328,0.038429,1,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0042883,0.062252,0.079849,1,0
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.044685,0.058509,0.065666,1,0
3,GO AEROBIC RESPIRATION,0.030383,0.058174,0.14528,1,0
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.045624,0.052125,0.10313,1,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.025994,0.048639,0.070532,1,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.046579,0.046947,0.042502,1,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.045624,-0.036943,-0.076686,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.036948,-0.038893,-0.080489,1,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.031748,-0.042661,-0.074376,1,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.025994,-0.047631,-0.059064,1,0
3,GO DNA DEPENDENT DNA REPLICATION,0.045624,-0.056013,-0.076999,1,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.050569,-0.057269,-0.070586,1,0
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.036164,-0.05761,-0.083629,1,0
3,GO MRNA PROCESSING,0.024288,-0.059239,-0.063368,1,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.016734,-0.060875,-0.11361,1,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.030383,-0.064071,-0.091811,1,0
3,GO CELLULAR RESPONSE TO X RAY,0.010773,-0.069195,-0.20416,1,0
3,GO RNA SPLICING,0.0053338,-0.071689,-0.080262,1,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.04854,-0.075487,-0.128,1,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.043763,-0.077262,-0.10384,1,0
3,GO NUCLEOSOME ORGANIZATION,0.02068,-0.078249,-0.086291,1,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.017137,-0.079203,-0.10788,1,0
3,GO BASE EXCISION REPAIR,0.013798,-0.086332,-0.096925,1,0
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.02268,-0.086904,-0.087941,1,0
3,GO REGULATION OF MRNA PROCESSING,0.0090226,-0.088378,-0.090428,1,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.038561,-0.089141,-0.10341,1,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.044685,-0.089649,-0.11214,1,0
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0026572,-0.090139,-0.10195,1,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0022992,-0.091532,-0.1272,1,0
3,GO REPLICATION FORK PROCESSING,0.021165,-0.092257,-0.13613,1,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.033894,-0.092848,-0.16002,1,0
3,GO REGULATION OF TELOMERE MAINTENANCE,0.0051916,-0.094764,-0.11072,1,0
3,GO MUSCLE FILAMENT SLIDING,0.0083534,-0.095402,-0.21945,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0081404,-0.09609,-0.10093,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00353,-0.09675,-0.09649,1,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.052669,-0.097187,-0.12604,1,0
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.017137,-0.10064,-0.11543,1,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.0046564,-0.10139,-0.11552,1,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.00042998,-0.10432,-0.12223,1,0
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0030654,-0.10503,-0.14501,1,0
3,GO LYMPHANGIOGENESIS,0.03245,-0.10761,-0.19257,1,0
3,GO STRESS GRANULE ASSEMBLY,0.031748,-0.10832,-0.12055,1,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.037747,-0.10895,-0.085016,1,0
3,GO POST ANAL TAIL MORPHOGENESIS,0.033894,-0.1095,-0.13336,1,0
3,GO TRNA WOBBLE BASE MODIFICATION,0.01282,-0.11028,-0.1617,1,0
3,GO REGULATION OF DNA REPAIR,0.00032948,-0.11029,-0.11587,1,0
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.030383,-0.11098,-0.21522,1,0
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0021689,-0.11137,-0.10281,1,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.017969,-0.11139,-0.16105,1,0
3,GO NEURAL TUBE PATTERNING,0.0031536,-0.11339,-0.18795,1,0
3,GO MITOCHONDRION LOCALIZATION,0.0013872,-0.11474,-0.12932,1,0
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.045624,-0.11624,-0.083746,1,0
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00018427,-0.1199,-0.13528,1,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.05161,-0.12201,-0.1012,1,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00014935,-0.1239,-0.13597,1,0
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0038387,-0.12676,-0.13217,1,0
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0023671,-0.12689,-0.22903,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.023205,-0.1278,-0.16189,1,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.013139,-0.12909,-0.11364,1,0
3,GO SNORNA 3 END PROCESSING,0.041093,-0.13228,-0.15467,1,0
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.038561,-0.13457,-0.1583,1,0
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.019739,-0.13575,-0.14577,1,0
3,GO BONE MORPHOGENESIS,0.011612,-0.1374,-0.16363,1,0
3,GO REGULATION OF SENSORY PERCEPTION,0.046579,-0.1404,-0.11753,1,0
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.019739,-0.14212,-0.15219,1,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00059588,-0.14263,-0.13405,1,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0021689,-0.14389,-0.14541,1,0
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.015574,-0.14473,-0.26784,1,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.042857,-0.14559,-0.10965,1,0
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0026572,-0.14843,-0.19188,1,0
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0057817,-0.14961,-0.19303,1,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.0038387,-0.14974,-0.23066,1,0
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.017549,-0.15067,-0.23995,1,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.02068,-0.15145,-0.13215,1,0
3,GO HISTONE H3 K9 DEMETHYLATION,0.015574,-0.15149,-0.17249,1,0
3,GO TELENCEPHALON DEVELOPMENT,0.017969,-0.15167,-0.11326,1,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.031748,-0.15274,-0.13456,1,0
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.019739,-0.1549,-0.16617,1,0
3,GO REPLACEMENT OSSIFICATION,0.022165,-0.15509,-0.17628,1,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0014738,-0.15555,-0.13159,1,0
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,7.9801e-06,-0.15683,-0.1532,1,0
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0066042,-0.15685,-0.22801,1,0
3,GO CELLULAR RESPONSE TO SALT STRESS,0.033166,-0.15818,-0.2526,1,0
3,GO PALLIUM DEVELOPMENT,0.023741,-0.15975,-0.099836,1,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0075304,-0.16013,-0.15239,1,0
3,GO FOREBRAIN CELL MIGRATION,0.046579,-0.16048,-0.15854,1,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.045624,-0.16314,-0.16088,1,0
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0032441,-0.16344,-0.2148,1,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.015203,-0.16347,-0.114,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.011904,-0.16565,-0.14415,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.035393,-0.1662,-0.12818,1,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.035393,-0.1662,-0.2108,1,0
3,GO SYNAPSE ORGANIZATION,0.029719,-0.16707,-0.13393,1,0
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00090094,-0.16943,-0.16448,1,0
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0025817,-0.17009,-0.18682,1,0
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.023205,-0.17101,-0.12093,1,0
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.02843,-0.17288,-0.179,1,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0085714,-0.1747,-0.1375,1,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.031059,-0.17483,-0.10801,1,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0085714,-0.17541,-0.17445,1,0
3,GO MITRAL VALVE DEVELOPMENT,0.018836,-0.17598,-0.26081,1,0
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.021165,-0.17642,-0.26158,1,0
3,GO FOREBRAIN REGIONALIZATION,0.014841,-0.18302,-0.22056,1,0
3,GO BONE TRABECULA MORPHOGENESIS,0.031059,-0.18366,-0.26803,1,0
3,GO MITOCHONDRION DISTRIBUTION,0.0037331,-0.18529,-0.16812,1,0
3,GO HIPPO SIGNALING,0.0033369,-0.18537,-0.25801,1,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,1.4039e-05,-0.18625,-0.16641,1,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00020448,-0.18755,-0.22479,1,0
3,GO LATERAL MESODERM DEVELOPMENT,0.0079323,-0.1884,-0.30319,1,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.023741,-0.1887,-0.19751,1,0
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.036948,-0.18986,-0.19039,1,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.013465,-0.19048,-0.15715,1,0
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0067808,-0.19089,-0.17193,1,0
3,GO NEURON CELLULAR HOMEOSTASIS,0.043763,-0.19205,-0.21096,1,0
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.029719,-0.19328,-0.17977,1,0
3,GO REGULATION OF LYASE ACTIVITY,0.00353,-0.19365,-0.17422,1,0
3,GO REGULATION OF HIPPO SIGNALING,0.0090226,-0.19423,-0.24518,1,0
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.043763,-0.19564,-0.15296,1,0
3,GO REGULATION OF CYCLASE ACTIVITY,0.00041602,-0.19723,-0.22738,1,0
3,GO POSTSYNAPSE ORGANIZATION,0.0015653,-0.2001,-0.21098,1,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.0046564,-0.20033,-0.26377,1,0
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.00037661,-0.20153,-0.22805,1,0
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00018427,-0.2025,-0.19356,1,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0015653,-0.20257,-0.24361,1,0
3,GO MRNA SPLICE SITE SELECTION,0.0029794,-0.20804,-0.18374,1,0
3,GO TELOMERASE RNA LOCALIZATION,0.025414,-0.20904,-0.20545,1,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00067758,-0.20981,-0.23187,1,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.017549,-0.2102,-0.23847,1,0
3,GO NEGATIVE CHEMOTAXIS,0.033166,-0.21172,-0.19618,1,0
3,GO HIPPOCAMPUS DEVELOPMENT,0.0071468,-0.21322,-0.16193,1,0
3,GO CELL PROLIFERATION IN HINDBRAIN,0.020205,-0.21326,-0.21368,1,0
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.011326,-0.21401,-0.16721,1,0
3,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0017641,-0.21471,-0.27478,1,0
3,GO MUSCLE CELL FATE COMMITMENT,0.0034322,-0.21688,-0.27221,1,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,1.7118e-05,-0.21776,-0.30626,1,0
3,GO TELOMERIC LOOP DISASSEMBLY,0.00026003,-0.22009,-0.21591,1,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.014841,-0.22153,-0.22242,1,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.013465,-0.22199,-0.25417,1,0
3,GO NEPHRON TUBULE FORMATION,0.02843,-0.22247,-0.25174,1,0
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00018427,-0.22309,-0.2536,1,0
3,GO NEURON PROJECTION ORGANIZATION,0.0013872,-0.22715,-0.20927,1,0
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,1.349e-05,-0.22978,-0.28315,1,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0067808,-0.23165,-0.22794,1,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0030654,-0.23204,-0.20889,1,0
3,GO MESODERMAL CELL FATE SPECIFICATION,0.023205,-0.23249,-0.19072,1,0
3,GO LEUKOCYTE AGGREGATION,0.02166,-0.23309,-0.31648,1,0
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00020448,-0.2337,-0.27828,1,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.014841,-0.23466,-0.2408,1,0
3,GO REGULATION OF NEURON MIGRATION,0.00037661,-0.23512,-0.29278,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.036948,-0.23525,-0.15705,1,0
3,GO ADULT HEART DEVELOPMENT,0.0062634,-0.23656,-0.23028,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.025414,-0.23726,-0.21459,1,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.0069616,-0.23776,-0.25317,1,0
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.00098941,-0.24355,-0.221,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.023741,-0.24456,-0.30138,1,0
3,GO BONE GROWTH,0.00035231,-0.24498,-0.31039,1,0
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0032441,-0.24602,-0.32135,1,0
3,GO CARDIOBLAST DIFFERENTIATION,0.0030654,-0.24757,-0.279,1,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.00025131,-0.24951,-0.25503,1,0
3,GO TONGUE DEVELOPMENT,0.025994,-0.25468,-0.24068,1,0
3,GO CELL PROLIFERATION IN FOREBRAIN,0.00012074,-0.25523,-0.27045,1,0
3,GO SECRETORY GRANULE LOCALIZATION,0.044685,-0.25665,-0.20009,1,0
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.012203,-0.25676,-0.20468,1,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,6.0504e-05,-0.25693,-0.24324,1,0
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00079435,-0.25822,-0.3508,1,0
3,GO RESPONSE TO L GLUTAMATE,0.029068,-0.25946,-0.22614,1,0
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.0015189,-0.26067,-0.25534,1,0
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0050528,-0.26248,-0.20027,1,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0029794,-0.26301,-0.24325,1,0
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.00052342,-0.26428,-0.3243,1,0
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,2.1663e-05,-0.27033,-0.24112,1,0
3,GO UV PROTECTION,0.0099891,-0.27124,-0.24009,1,0
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00037661,-0.27381,-0.33662,1,0
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.016339,-0.27709,-0.27705,1,0
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0051916,-0.27976,-0.21964,1,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0022992,-0.28327,-0.28553,1,0
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.00019079,-0.28356,-0.36516,1,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.037747,-0.29218,-0.27448,1,0
3,GO BONE TRABECULA FORMATION,0.0046564,-0.29379,-0.42894,1,0
3,GO DENDRITIC TRANSPORT,0.0021062,-0.29505,-0.28075,1,0
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.034637,-0.29587,-0.3337,1,0
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00090094,-0.29634,-0.29776,1,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0069616,-0.30147,-0.33744,1,0
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.010245,-0.30185,-0.33207,1,0
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0017123,-0.3041,-0.29031,1,0
3,GO MYOBLAST MIGRATION,0.0087944,-0.30435,-0.35276,1,0
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.014841,-0.30493,-0.25302,1,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0010859,-0.30607,-0.24367,1,0
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0090226,-0.31056,-0.30287,1,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0007696,-0.31325,-0.26482,1,0
3,GO GTP METABOLIC PROCESS,0.001986,-0.31728,-0.25428,1,0
3,GO SYNAPTIC MEMBRANE ADHESION,0.030383,-0.31929,-0.29133,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,1.349e-05,-0.32392,-0.38389,1,0
3,GO TONGUE MORPHOGENESIS,0.046579,-0.32504,-0.2597,1,0
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,2.7343e-05,-0.32692,-0.38421,1,0
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.010506,-0.33216,-0.25153,1,0
3,GO LATERAL VENTRICLE DEVELOPMENT,0.0023671,-0.33396,-0.33685,1,0
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00035231,-0.34052,-0.33264,1,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0085714,-0.34183,-0.34347,1,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,7.2754e-05,-0.34194,-0.36784,1,0
3,GO EMBRYONIC EYE MORPHOGENESIS,8.1192e-05,-0.34238,-0.30234,1,0
3,GO CENTRIOLE CENTRIOLE COHESION,1.7806e-05,-0.37242,-0.34719,1,0
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,8.4205e-05,-0.37291,-0.38871,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.8583e-05,-0.3765,-0.31068,1,0
3,GO ELASTIC FIBER ASSEMBLY,0.0014299,-0.37744,-0.41098,1,0
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.017969,-0.37885,-0.28802,1,0
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,7.9801e-06,-0.38122,-0.51139,1,0
3,GO SYNAPTIC VESICLE MATURATION,0.0021062,-0.38332,-0.30499,1,0
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.00030804,-0.38554,-0.3965,1,0
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,1.5201e-05,-0.38838,-0.41445,1,0
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0042883,-0.39089,-0.29982,1,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00022676,-0.39287,-0.42878,1,0
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00038934,-0.39693,-0.32638,1,0
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00010845,-0.43212,-0.39668,1,0
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,4.1617e-05,-0.43476,-0.48949,1,0
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00016023,-0.44638,-0.3638,1,0
3,GO VOCALIZATION BEHAVIOR,0.02843,-0.44779,-0.34473,1,0
3,GO TELENCEPHALON REGIONALIZATION,0.014138,-0.48622,-0.35161,1,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0001547,-0.48677,-0.47085,1,0
3,GO CORPUS CALLOSUM DEVELOPMENT,4.1617e-05,-0.49485,-0.41825,1,0
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,-0.52234,-0.42141,1,0
3,GO EXCITATORY SYNAPSE ASSEMBLY,9.7801e-06,-0.52674,-0.58121,1,0
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.6307e-05,-0.52796,-0.61432,1,0
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,9.7346e-05,-0.53636,-0.49803,1,0
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.00028792,-0.54036,-0.51367,1,0
3,GO CARDIAC CHAMBER FORMATION,6.2786e-05,-0.56084,-0.57111,1,0
3,GO CARDIAC VENTRICLE FORMATION,0.00010845,-0.60446,-0.58707,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,5.6174e-05,-0.61655,-0.62096,1,0
3,GO POSTSYNAPSE ASSEMBLY,0.00016595,-0.67966,-0.5692,1,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,7.013e-05,-0.68641,-0.78751,1,0
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,9.7801e-06,-0.70204,-0.66661,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.0033e-05,-0.84371,-0.82238,1,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.064293,0.52689,0.58535,0,1
3,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.05824,0.40647,0.21543,0,1
3,GO CELLULAR RESPONSE TO ZINC ION,0.066855,0.37664,0.42579,0,1
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.15773,0.37331,0.17639,0,1
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.25729,0.32062,0.11987,0,1
3,GO MALE MEIOSIS I,0.10465,0.26066,0.17252,0,1
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.188,0.2427,0.14358,0,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.085627,0.22829,0.11413,0,1
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.092194,0.22644,0.23656,0,1
3,GO REGULATION OF CHLORIDE TRANSPORT,0.12908,0.22338,0.22201,0,1
3,GO PARAXIAL MESODERM DEVELOPMENT,0.1028,0.22279,0.1454,0,1
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.13583,0.21885,0.12451,0,1
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.35607,0.21822,0.12418,0,1
3,GO RESPONSE TO UV B,0.19695,0.21592,0.07814,0,1
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.14769,0.21361,0.12455,0,1
3,GO NADPH REGENERATION,0.16294,0.20875,0.13773,0,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.068167,0.20829,0.088214,0,1
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.14285,0.20415,0.1951,0,1
3,GO SYNAPTIC VESICLE BUDDING,0.11235,0.20076,0.16213,0,1
3,GO HEXOSE CATABOLIC PROCESS,0.17099,0.194,0.13132,0,1
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.24288,0.19099,0.089537,0,1
3,GO ALDEHYDE CATABOLIC PROCESS,0.092194,0.18729,0.094547,0,1
3,GO MAINTENANCE OF CELL POLARITY,0.17934,0.18693,0.11049,0,1
3,GO REGULATION OF RESPONSE TO FOOD,0.24643,0.18361,0.052032,0,1
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.10465,0.18345,0.16504,0,1
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.1313,0.18308,0.09465,0,1
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.10845,0.18182,0.10986,0,1
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.1028,0.18055,0.13164,0,1
3,GO CARNITINE METABOLIC PROCESS,0.11636,0.17999,0.15159,0,1
3,GO GANGLIOSIDE METABOLIC PROCESS,0.2,0.17461,0.08435,0,1
3,GO MITOCHONDRIAL TRNA PROCESSING,0.15517,0.17224,0.10627,0,1
3,GO PLACENTA DEVELOPMENT,0.059411,0.17203,0.10144,0,1
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.12259,0.17191,0.06818,0,1
3,GO RENAL WATER HOMEOSTASIS,0.13355,0.17079,0.065464,0,1
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.087232,0.16864,0.11163,0,1
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.15517,0.16824,0.12,0,1
3,GO MICROVILLUS ASSEMBLY,0.084046,0.16763,0.16949,0,1
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.32506,0.16638,0.1655,0,1
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0695,0.16563,0.11751,0,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.16032,0.16519,0.11581,0,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.1028,0.16488,0.1212,0,1
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.082489,0.16418,0.13544,0,1
3,GO RETINOIC ACID METABOLIC PROCESS,0.092194,0.16268,0.10612,0,1
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.12049,0.16212,0.10012,0,1
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.15015,0.16008,0.083739,0,1
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.16559,0.15999,0.11078,0,1
3,GO RESPONSE TO VITAMIN,0.23589,0.15855,0.057966,0,1
3,GO RESPONSE TO AMINE,0.29992,0.15816,0.065649,0,1
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.31232,0.15792,0.07134,0,1
3,GO DNA DEMETHYLATION,0.084046,0.15742,0.12516,0,1
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.10654,0.15599,0.13701,0,1
3,GO PEPTIDYL METHIONINE MODIFICATION,0.42347,0.15553,0.12448,0,1
3,GO AORTA MORPHOGENESIS,0.27999,0.15551,0.060144,0,1
3,GO GLIAL CELL DEVELOPMENT,0.064293,0.15178,0.091553,0,1
3,GO DRINKING BEHAVIOR,0.50337,0.15101,0.037232,0,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.077957,0.15007,0.11025,0,1
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.12908,0.14416,0.070796,0,1
3,GO DEFINITIVE HEMOPOIESIS,0.16828,0.14071,0.059473,0,1
3,GO CELLULAR EXTRAVASATION,0.084046,0.1396,0.08034,0,1
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.21905,0.13947,0.059291,0,1
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.076492,0.13733,0.14738,0,1
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.080955,0.13698,0.11177,0,1
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.4978,0.13593,0.049975,0,1
3,GO ENDOCYTOSIS,0.063042,0.13586,0.072075,0,1
3,GO CRANIAL NERVE DEVELOPMENT,0.1028,0.13504,0.10917,0,1
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.05824,0.13458,0.19197,0,1
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.099158,0.1345,0.119,0,1
3,GO ESTROGEN BIOSYNTHETIC PROCESS,0.10465,0.13404,0.18691,0,1
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.13583,0.13274,0.068316,0,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.2839,0.12979,0.10665,0,1
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.066855,0.12906,0.10006,0,1
3,GO SERTOLI CELL DIFFERENTIATION,0.088862,0.12891,0.099074,0,1
3,GO ESTROGEN METABOLIC PROCESS,0.070855,0.12837,0.15714,0,1
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.12908,0.12715,0.12148,0,1
3,GO RESPONSE TO NITRIC OXIDE,0.072231,0.12711,0.070807,0,1
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.075049,0.12703,0.12194,0,1
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.17099,0.12592,0.054428,0,1
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.34702,0.12535,0.079779,0,1
3,GO METANEPHROS MORPHOGENESIS,0.14285,0.12505,0.11238,0,1
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.12259,0.12495,0.097165,0,1
3,GO HYPEROSMOTIC RESPONSE,0.2,0.12325,0.089702,0,1
3,GO POSITIVE REGULATION OF MYELINATION,0.092194,0.12308,0.078602,0,1
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.076492,0.12186,0.091469,0,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.11841,0.1215,0.13229,0,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.077957,0.11916,0.085912,0,1
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.12473,0.11852,0.083112,0,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.20309,0.1165,0.069218,0,1
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.20621,0.11522,0.05725,0,1
3,GO REGULATION OF CHROMATIN BINDING,0.11039,0.11439,0.088646,0,1
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.31653,0.1143,0.067656,0,1
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.059411,0.11371,0.074179,0,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.073629,0.11159,0.13598,0,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.70355,0.11141,0.013026,0,1
3,GO CERAMIDE TRANSPORT,0.15015,0.11118,0.15589,0,1
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.053746,0.1111,0.06028,0,1
3,GO ACETYL COA METABOLIC PROCESS,0.10465,0.11014,0.11106,0,1
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.070855,0.10888,0.079933,0,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.063042,0.10777,0.098708,0,1
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.11636,0.10773,0.072927,0,1
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.15517,0.10742,0.088014,0,1
3,GO MUSCLE CELL DIFFERENTIATION,0.11039,0.10737,0.054946,0,1
3,GO TUMOR NECROSIS FACTOR SECRETION,0.090515,0.10736,0.077104,0,1
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.076492,0.10686,0.064168,0,1
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.47588,0.10638,0.040596,0,1
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.087232,0.1058,0.13195,0,1
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.19393,0.10562,0.072055,0,1
3,GO SULFATE TRANSPORT,0.25363,0.10554,0.061011,0,1
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.064293,0.10328,0.058839,0,1
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.20309,0.10204,0.066368,0,1
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.082489,0.10191,0.077097,0,1
3,GO DETECTION OF LIGHT STIMULUS,0.10465,0.10164,0.041428,0,1
3,GO PRESYNAPTIC ENDOCYTOSIS,0.25363,0.10139,0.069085,0,1
3,GO REGULATION OF METAL ION TRANSPORT,0.0695,0.10082,0.0604,0,1
3,GO MODIFIED AMINO ACID TRANSPORT,0.0695,0.10034,0.11338,0,1
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.12689,0.099212,0.060098,0,1
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.05824,0.098952,0.092643,0,1
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.060602,0.097222,0.070705,0,1
3,GO POSITIVE THYMIC T CELL SELECTION,0.17099,0.094785,0.063311,0,1
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.21905,0.09466,0.095036,0,1
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.23937,0.0943,0.064223,0,1
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.066855,0.093634,0.079104,0,1
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.055956,0.093238,0.088101,0,1
3,GO HEAD MORPHOGENESIS,0.74288,0.092914,-0.014066,0,1
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.29184,0.092756,0.026311,0,1
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.32077,0.091225,0.061947,0,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.23245,0.091212,0.05313,0,1
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.064293,0.091197,0.055038,0,1
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.064293,0.090714,0.075846,0,1
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.068167,0.089831,0.063503,0,1
3,GO SEGMENTATION,0.37932,0.08823,0.043144,0,1
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.063042,0.086767,0.052532,0,1
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.15517,0.086365,0.039388,0,1
3,GO ACTIN FILAMENT BASED PROCESS,0.14526,0.085084,0.046528,0,1
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.11434,0.084931,0.062892,0,1
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.33812,0.084319,0.051658,0,1
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.15015,0.083629,0.043374,0,1
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.37932,0.080605,0.036684,0,1
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.11841,0.080157,0.10058,0,1
3,GO ATP TRANSPORT,0.20937,0.079047,0.061595,0,1
3,GO REGULATION OF PROTEIN SUMOYLATION,0.25363,0.078755,0.059327,0,1
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.32077,0.078226,0.034861,0,1
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.059411,0.077839,0.062066,0,1
3,GO CENTROSOME SEPARATION,0.33812,0.077459,0.065524,0,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.070855,0.077168,0.048869,0,1
3,GO ENSHEATHMENT OF NEURONS,0.22568,0.075624,0.051706,0,1
3,GO REGULATION OF CELLULAR LOCALIZATION,0.063042,0.075227,0.044798,0,1
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.1313,0.075215,0.054896,0,1
3,GO RENAL SODIUM EXCRETION,0.053746,0.075117,0.14372,0,1
3,GO MALE GENITALIA DEVELOPMENT,0.15517,0.074746,0.10598,0,1
3,GO KIDNEY MORPHOGENESIS,0.25729,0.072152,0.054976,0,1
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.23937,0.071805,0.033605,0,1
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.16828,0.070769,0.031464,0,1
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.093897,0.070419,0.053947,0,1
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.088862,0.069758,0.049868,0,1
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.18508,0.068442,0.04624,0,1
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.15517,0.067821,0.052828,0,1
3,GO PIGMENT GRANULE ORGANIZATION,0.092194,0.065229,0.077321,0,1
3,GO REGULATION OF ODONTOGENESIS,0.94073,0.064855,-0.046163,0,1
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.11039,0.064592,0.052142,0,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.42347,0.064224,0.037636,0,1
3,GO REGULATION OF BINDING,0.054842,0.063386,0.068656,0,1
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.11235,0.062265,0.062239,0,1
3,GO RNA DECAPPING,0.4978,0.05945,0.047628,0,1
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.087232,0.057066,0.037342,0,1
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.46512,0.0536,0.022539,0,1
3,GO MALE GAMETE GENERATION,0.055956,0.052207,0.055822,0,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.053746,0.050642,0.051768,0,1
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.28785,0.049717,0.029012,0,1
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.20937,0.047561,0.05058,0,1
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.40843,0.045777,0.029638,0,1
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.31232,0.043794,0.022291,0,1
3,GO REGULATION OF CELL CYCLE,0.14526,0.043426,0.028047,0,1
3,GO REGULATION OF EXCRETION,0.56075,0.042441,0.032819,0,1
3,GO POSITIVE REGULATION OF CELL DIVISION,0.29992,0.041333,0.031091,0,1
3,GO CELL CYCLE ARREST,0.25363,0.037153,0.032878,0,1
3,GO METHYLATION,0.26471,0.036486,0.013076,0,1
3,GO ORGANELLE LOCALIZATION,0.12689,0.033485,0.03543,0,1
3,GO PROTEIN POLYMERIZATION,0.54321,0.03277,0.011626,0,1
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.00028792,0.53499,0.59652,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0010206,0.45237,0.35667,0,0
3,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.011904,0.44261,0.32029,0,0
3,GO RESPONSE TO PAIN,2.3418e-05,0.43688,0.41526,0,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0034322,0.43036,0.38485,0,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.087232,0.41655,0.23455,0,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0019282,0.41069,0.38626,0,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00049035,0.39914,0.46165,0,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0014738,0.38156,0.39419,0,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00034072,0.3807,0.44647,0,0
3,GO REFLEX,0.0021062,0.37472,0.35274,0,0
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00072223,0.36227,0.32145,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0019282,0.36162,0.49402,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.001662,0.35804,0.37514,0,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.012508,0.35727,0.29261,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.12259,0.35328,0.19536,0,0
3,GO LIPOXYGENASE PATHWAY,0.019739,0.34909,0.27315,0,0
3,GO N GLYCAN PROCESSING,0.0022992,0.34777,0.28755,0,0
3,GO RESPONSE TO MUSCLE STRETCH,0.0015653,0.34631,0.34591,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0013872,0.3373,0.31169,0,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.011904,0.33512,0.26293,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0017641,0.32945,0.3832,0,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.011904,0.32801,0.33603,0,0
3,GO NEURONAL ACTION POTENTIAL,0.00032948,0.32443,0.41424,0,0
3,GO STEROID HORMONE SECRETION,0.0047853,0.32371,0.25596,0,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0028957,0.31327,0.38742,0,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.0033369,0.31075,0.32764,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.05824,0.30519,0.13164,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.047551,0.30147,0.17839,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.0083534,0.30079,0.25632,0,0
3,GO LUNG ALVEOLUS DEVELOPMENT,1.7806e-05,0.29939,0.32205,0,0
3,GO DETECTION OF CALCIUM ION,0.0066042,0.29858,0.31002,0,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.10845,0.29772,0.19563,0,0
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00065623,0.29062,0.47001,0,0
3,GO ETHANOL OXIDATION,0.029068,0.29016,0.39197,0,0
3,GO GLIAL CELL FATE COMMITMENT,0.061812,0.28617,0.25366,0,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00013917,0.28515,0.35744,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.066855,0.28415,0.21287,0,0
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,4.8379e-05,0.28012,0.25825,0,0
3,GO PARENTAL BEHAVIOR,0.070855,0.27837,0.18896,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.019739,0.27755,0.25381,0,0
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0037331,0.27369,0.26969,0,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.011326,0.27212,0.24267,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.00074557,0.27139,0.24129,0,0
3,GO SEGMENT SPECIFICATION,0.22905,0.27064,0.13822,0,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.0031536,0.26719,0.24835,0,0
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0069616,0.26589,0.28069,0,0
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.007729,0.26542,0.33015,0,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,7.2754e-05,0.25917,0.32485,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.034637,0.25562,0.21451,0,0
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.061812,0.2539,0.20139,0,0
3,GO INTEGRIN ACTIVATION,4.4878e-05,0.25194,0.30161,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0040578,0.25081,0.25987,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0025817,0.25033,0.189,0,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.088862,0.24869,0.13822,0,0
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.05161,0.24678,0.15267,0,0
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,3.8583e-05,0.24634,0.25398,0,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.037747,0.2448,0.19115,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.04854,0.24465,0.24886,0,0
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.099158,0.24334,0.18258,0,0
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0020453,0.2397,0.33104,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0085714,0.2396,0.32829,0,0
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.00049035,0.23758,0.24306,0,0
3,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.14526,0.23725,0.098056,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.21579,0.2371,0.11223,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.58456,0.23663,0.097617,0,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.023205,0.23616,0.1552,0,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.01282,0.23405,0.27644,0,0
3,GO MALE SEX DETERMINATION,0.060602,0.23327,0.16837,0,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00044439,0.23238,0.20463,0,0
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.070855,0.23149,0.17555,0,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.072231,0.23035,0.11569,0,0
3,GO INTERLEUKIN 5 PRODUCTION,0.04854,0.22678,0.18566,0,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0081404,0.22649,0.19065,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.34256,0.22248,0.063961,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.10654,0.22243,0.17777,0,0
3,GO EPITHELIAL CELL CELL ADHESION,0.0038387,0.22241,0.3699,0,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0097392,0.21988,0.17812,0,0
3,GO CYSTEINE METABOLIC PROCESS,0.47049,0.21628,0.1109,0,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.072231,0.21595,0.18421,0,0
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.29184,0.21585,0.12741,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.090515,0.21574,0.1525,0,0
3,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.057089,0.21571,0.24354,0,0
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00074557,0.21569,0.17975,0,0
3,GO PROTEIN HYDROXYLATION,0.088862,0.21565,0.15075,0,0
3,GO ENAMEL MINERALIZATION,0.10096,0.21513,0.16065,0,0
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.063042,0.21425,0.12628,0,0
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00095906,0.2124,0.18145,0,0
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.063042,0.21174,0.16958,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.025414,0.21079,0.17317,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.063042,0.21063,0.16625,0,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0034322,0.21007,0.16577,0,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.14048,0.20984,0.083461,0,0
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.014486,0.20975,0.21243,0,0
3,GO DOPAMINE TRANSPORT,0.0071468,0.20969,0.29193,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.27999,0.2095,0.071214,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.024288,0.20935,0.20794,0,0
3,GO HYALURONAN CATABOLIC PROCESS,0.21256,0.20887,0.043794,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.0027346,0.20849,0.21986,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.041093,0.20833,0.16465,0,0
3,GO THYMOCYTE APOPTOTIC PROCESS,0.057089,0.20829,0.15563,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.57857,0.20809,0.019564,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0029794,0.20804,0.2022,0,0
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0053338,0.20779,0.43143,0,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00022676,0.20739,0.2052,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.12259,0.20706,0.063213,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.15773,0.20552,0.13604,0,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.095625,0.20294,0.13447,0,0
3,GO MEMBRANE DEPOLARIZATION,0.0017641,0.20259,0.21399,0,0
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00098941,0.20231,0.20113,0,0
3,GO REGULATION OF AMINO ACID TRANSPORT,0.02166,0.20166,0.1738,0,0
3,GO ETHER BIOSYNTHETIC PROCESS,0.093897,0.20114,0.10515,0,0
3,GO INCLUSION BODY ASSEMBLY,0.044685,0.20099,0.20263,0,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.14285,0.20005,0.051502,0,0
3,GO REGULATION OF DOPAMINE SECRETION,0.099158,0.19984,0.26474,0,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.029068,0.19984,0.20906,0,0
3,GO MYELIN MAINTENANCE,0.095625,0.19975,0.1833,0,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.053746,0.19965,0.1839,0,0
3,GO AMYLOID BETA FORMATION,0.011612,0.19963,0.16928,0,0
3,GO REGULATION OF AMYLOID BETA FORMATION,0.02268,0.19958,0.17274,0,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0047853,0.19874,0.19186,0,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0090226,0.19858,0.16598,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.057089,0.19784,0.16785,0,0
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.031059,0.19759,0.17101,0,0
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.080955,0.19748,0.28666,0,0
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.32938,0.19706,0.093593,0,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.16828,0.19705,0.092391,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.097379,0.19686,0.14947,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.0085714,0.19601,0.26672,0,0
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.010506,0.1954,0.17694,0,0
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0049174,0.1943,0.187,0,0
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.10845,0.19368,0.12513,0,0
3,GO REGULATION OF HEART RATE,0.0031536,0.19327,0.18193,0,0
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.085627,0.19306,0.17177,0,0
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.22568,0.19287,0.076447,0,0
3,GO RESPONSE TO LEPTIN,0.016339,0.19195,0.19121,0,0
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.087232,0.19163,0.14837,0,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.188,0.19151,0.067909,0,0
3,GO CATECHOLAMINE METABOLIC PROCESS,0.009256,0.19138,0.21636,0,0
3,GO T HELPER 2 CELL DIFFERENTIATION,0.26471,0.19138,0.0082781,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.027803,0.18972,0.16881,0,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.19695,0.18953,0.03386,0,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.24643,0.18934,0.089831,0,0
3,GO RESPONSE TO IRON ION,0.017137,0.18932,0.1624,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.050569,0.18926,0.154,0,0
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.030383,0.18844,0.12989,0,0
3,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.17934,0.18798,0.088444,0,0
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0087944,0.1873,0.23746,0,0
3,GO AMINOGLYCAN METABOLIC PROCESS,0.0081404,0.18728,0.15034,0,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.080955,0.18679,0.22076,0,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.097379,0.18664,0.11607,0,0
3,GO INOSITOL METABOLIC PROCESS,0.0047853,0.18616,0.21985,0,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.14285,0.1858,0.090985,0,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.027188,0.18452,0.20573,0,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0033369,0.18273,0.2676,0,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.14769,0.18225,0.19322,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.26098,0.18107,0.084069,0,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.66501,0.18017,0.047217,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00023468,0.17995,0.17194,0,0
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00030804,0.17986,0.20978,0,0
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.047551,0.17929,0.14162,0,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.16828,0.17894,0.18374,0,0
3,GO CAMP METABOLIC PROCESS,0.14285,0.17805,0.10649,0,0
3,GO OXALATE TRANSPORT,0.0097392,0.17778,0.15788,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.36064,0.17776,0.13389,0,0
3,GO BROWN FAT CELL DIFFERENTIATION,0.0029794,0.17769,0.21809,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.013798,0.17741,0.29348,0,0
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.02166,0.17731,0.22627,0,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0066042,0.17694,0.33738,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.012508,0.17692,0.24266,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.24288,0.1769,0.24854,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.063042,0.17571,0.31008,0,0
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.055956,0.17563,0.15595,0,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0033369,0.17561,0.21891,0,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0053338,0.17513,0.23896,0,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.13583,0.17486,0.096942,0,0
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.020205,0.17423,0.183,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.041967,0.17421,0.22665,0,0
3,GO BASIC AMINO ACID TRANSPORT,0.054842,0.17381,0.27042,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.087232,0.17381,0.16438,0,0
3,GO FLUID TRANSPORT,0.0066042,0.17359,0.15937,0,0
3,GO TRANSMISSION OF NERVE IMPULSE,0.0090226,0.17357,0.20817,0,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.49227,0.17347,0.073892,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.20621,0.17339,0.11167,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.014138,0.1733,0.13479,0,0
3,GO RESPONSE TO HYPEROXIA,0.23589,0.17301,0.056663,0,0
3,GO DOPAMINE METABOLIC PROCESS,0.0079323,0.17223,0.23673,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.021165,0.17154,0.1739,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.17099,0.17148,0.092167,0,0
3,GO REGULATION OF VASCULAR PERMEABILITY,0.0038387,0.17137,0.20926,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.15517,0.17024,0.15633,0,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.092194,0.17017,0.17814,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0069616,0.16952,0.14854,0,0
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0032441,0.16944,0.26971,0,0
3,GO GLAND MORPHOGENESIS,0.0695,0.16939,0.10834,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.099158,0.16875,0.21675,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.13583,0.16822,0.14595,0,0
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.11235,0.16813,0.094486,0,0
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0054795,0.16743,0.23728,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.48131,0.16705,0.0341,0,0
3,GO PODOSOME ASSEMBLY,0.50337,0.16683,0.02353,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.011904,0.16644,0.1417,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.30402,0.16609,0.11708,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.065563,0.16608,0.10372,0,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.077957,0.16573,0.12294,0,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.014138,0.1651,0.12237,0,0
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.79636,0.16508,-0.054569,0,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.12259,0.16435,0.16186,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.12689,0.16364,0.14101,0,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0038387,0.16358,0.15838,0,0
3,GO RESPONSE TO INSECTICIDE,0.012508,0.16296,0.26047,0,0
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0047853,0.1626,0.25516,0,0
3,GO ENDOCRINE HORMONE SECRETION,0.0045306,0.16243,0.14521,0,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.27227,0.16048,-0.01747,0,0
3,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.023741,0.16024,0.1558,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.073629,0.15999,0.11678,0,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.017549,0.15978,0.13277,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0056288,0.15935,0.18387,0,0
3,GO SENSORY PERCEPTION OF SMELL,0.00055855,0.1593,0.14181,0,0
3,GO MITOTIC DNA REPLICATION,0.046579,0.15843,0.12437,0,0
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.10465,0.15834,0.15385,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.087232,0.15791,0.14223,0,0
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.029068,0.15779,0.12041,0,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.037747,0.1576,0.17928,0,0
3,GO VASCULAR TRANSPORT,0.10465,0.15752,0.18471,0,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.077957,0.15739,0.12076,0,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.11235,0.15732,0.089767,0,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.26098,0.15662,0.14262,0,0
3,GO ETHANOL METABOLIC PROCESS,0.12473,0.15634,0.15287,0,0
3,GO HEART INDUCTION,0.23589,0.15632,0.15794,0,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.065563,0.15619,0.11435,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.13814,0.15602,0.076428,0,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.053746,0.15593,0.21904,0,0
3,GO SKIN MORPHOGENESIS,0.94769,0.1558,-0.071542,0,0
3,GO MACROPHAGE PROLIFERATION,0.10096,0.15565,0.17287,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.092194,0.15554,0.13355,0,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0097392,0.15535,0.13231,0,0
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0027346,0.15534,0.16203,0,0
3,GO REGULATION OF BLOOD CIRCULATION,0.014138,0.15503,0.10764,0,0
3,GO NERVE DEVELOPMENT,0.079444,0.15476,0.11776,0,0
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.099158,0.15453,0.074362,0,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.32077,0.15392,0.033461,0,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.082489,0.1538,0.15615,0,0
3,GO MACROPHAGE DIFFERENTIATION,0.03939,0.15378,0.12637,0,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.077957,0.15369,0.076179,0,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.064293,0.15315,0.19378,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.019739,0.15275,0.14452,0,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0085714,0.1526,0.17453,0,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.0051916,0.15258,0.14928,0,0
3,GO PINOCYTOSIS,0.12689,0.15255,0.058744,0,0
3,GO ENERGY HOMEOSTASIS,0.023741,0.15236,0.15931,0,0
3,GO NUCLEOTIDE SALVAGE,0.073629,0.15206,0.18239,0,0
3,GO RRNA CATABOLIC PROCESS,0.011326,0.15192,0.15991,0,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.12049,0.15187,0.10223,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.11636,0.15158,0.085038,0,0
3,GO LOCOMOTOR RHYTHM,0.055956,0.15156,0.13377,0,0
3,GO CARDIOLIPIN METABOLIC PROCESS,0.16032,0.15131,0.066505,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.9686,0.1513,-0.030051,0,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.13355,0.1512,0.060352,0,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.12908,0.15104,0.11651,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.099158,0.15085,0.12729,0,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.10845,0.15072,0.094676,0,0
3,GO HEART TRABECULA FORMATION,0.072231,0.1507,0.2193,0,0
3,GO CARDIAC CELL DEVELOPMENT,0.02068,0.15054,0.11193,0,0
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.35607,0.15048,0.074292,0,0
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.097379,0.15027,0.11021,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.10465,0.15018,0.11134,0,0
3,GO ZINC ION TRANSPORT,0.023205,0.15,0.15914,0,0
3,GO I KAPPAB PHOSPHORYLATION,0.12259,0.14957,0.1068,0,0
3,GO DEFENSE RESPONSE TO FUNGUS,0.009256,0.14912,0.13163,0,0
3,GO PROTEIN LOCALIZATION TO AXON,0.12473,0.1487,0.20994,0,0
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.41341,0.14816,0.036535,0,0
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.12473,0.14781,0.052287,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.10465,0.14781,0.16002,0,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.0079323,0.14763,0.1057,0,0
3,GO REPRODUCTIVE BEHAVIOR,0.12689,0.14752,0.091846,0,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.25001,0.14734,0.030015,0,0
3,GO HORMONE BIOSYNTHETIC PROCESS,0.10654,0.14676,0.12669,0,0
3,GO PROTEIN MANNOSYLATION,0.01282,0.1462,0.15952,0,0
3,GO REGULATION OF ION TRANSPORT,0.0081404,0.14615,0.1065,0,0
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0019282,0.14599,0.11993,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.78962,0.14547,0.030295,0,0
3,GO PROTEIN KINASE C SIGNALING,0.063042,0.14525,0.16768,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.097379,0.14518,0.080188,0,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.32506,0.14494,-0.0023098,0,0
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.022165,0.14491,0.14877,0,0
3,GO RESPONSE TO ISCHEMIA,0.0007696,0.14485,0.21638,0,0
3,GO AMINO ACID IMPORT,0.12473,0.14439,0.11529,0,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.3746,0.14408,0.044604,0,0
3,GO PLASMA MEMBRANE ORGANIZATION,0.0053338,0.14399,0.14945,0,0
3,GO AMINE TRANSPORT,0.02166,0.14384,0.1919,0,0
3,GO ENDOTHELIUM DEVELOPMENT,0.022165,0.14366,0.12639,0,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.1028,0.14364,0.11569,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.016339,0.14363,0.14488,0,0
3,GO ADENOHYPOPHYSIS DEVELOPMENT,0.38408,0.14356,0.11948,0,0
3,GO RESPONSE TO FUNGUS,0.00090094,0.14343,0.1588,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.060602,0.1434,0.10669,0,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.11636,0.14291,0.1028,0,0
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.054842,0.14249,0.079793,0,0
3,GO MYELOID CELL APOPTOTIC PROCESS,0.23245,0.14243,0.068493,0,0
3,GO NEUROINFLAMMATORY RESPONSE,0.080955,0.14206,0.077545,0,0
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.046579,0.1419,0.11019,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.010506,0.14179,0.18537,0,0
3,GO STRIATED MUSCLE ADAPTATION,0.019283,0.14151,0.15608,0,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.11434,0.14132,0.083464,0,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.043763,0.14093,0.22453,0,0
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.011326,0.14077,0.18103,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0019282,0.14039,0.22435,0,0
3,GO RESPONSE TO LIGHT INTENSITY,0.15517,0.14031,0.096972,0,0
3,GO ACTION POTENTIAL,0.013465,0.14005,0.14843,0,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.05824,0.13928,0.19085,0,0
3,GO PITUITARY GLAND DEVELOPMENT,0.14526,0.13918,0.13927,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.40843,0.13885,0.094036,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.12689,0.13865,0.20047,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.027803,0.13808,0.12909,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.15517,0.13799,0.079454,0,0
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.10654,0.13786,0.17159,0,0
3,GO PRE MIRNA PROCESSING,0.60272,0.1376,0.025072,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.029068,0.13731,0.19965,0,0
3,GO SODIUM ION TRANSPORT,0.0073363,0.13689,0.13138,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.063042,0.1366,0.13447,0,0
3,GO BLEB ASSEMBLY,0.57857,0.13635,-0.074207,0,0
3,GO FIBRINOLYSIS,0.23245,0.13607,0.13225,0,0
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.25729,0.13547,0.096394,0,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.023741,0.13531,0.19715,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.75615,0.13513,0.051479,0,0
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0025817,0.13493,0.2116,0,0
3,GO ARGININE METABOLIC PROCESS,0.12908,0.13491,0.24179,0,0
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.19695,0.1347,0.084972,0,0
3,GO MYELIN ASSEMBLY,0.12689,0.13386,0.10979,0,0
3,GO CELLULAR ANION HOMEOSTASIS,0.35153,0.1337,0.037945,0,0
3,GO ANION HOMEOSTASIS,0.097379,0.13344,0.1129,0,0
3,GO ALDITOL METABOLIC PROCESS,0.17934,0.13338,0.081455,0,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.26098,0.13294,0.069242,0,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.13355,0.13282,0.058975,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.28785,0.13268,0.11219,0,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.16559,0.13247,0.13512,0,0
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0094949,0.13246,0.1569,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.2839,0.13229,0.069724,0,0
3,GO GLYCINE TRANSPORT,0.53167,0.13197,0.065865,0,0
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.33373,0.13184,0.033966,0,0
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.20937,0.13159,0.10792,0,0
3,GO MEMBRANE HYPERPOLARIZATION,0.10465,0.13137,0.11066,0,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.022165,0.13135,0.11408,0,0
3,GO REGULATION OF VESICLE FUSION,0.23589,0.13086,0.12233,0,0
3,GO SPERM CAPACITATION,0.0049174,0.13052,0.20063,0,0
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.99651,0.12995,-0.037436,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.033894,0.1299,0.10162,0,0
3,GO PIGMENT GRANULE LOCALIZATION,0.0090226,0.12985,0.13883,0,0
3,GO PROTEIN REFOLDING,0.055956,0.12978,0.15519,0,0
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.064293,0.12943,0.12517,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.23589,0.12929,0.12824,0,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.15264,0.12922,0.078971,0,0
3,GO PIGMENT CELL DIFFERENTIATION,0.055956,0.12917,0.081154,0,0
3,GO HEART PROCESS,0.040234,0.12917,0.084124,0,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.019739,0.12883,0.089617,0,0
3,GO ION TRANSMEMBRANE TRANSPORT,0.0020453,0.1285,0.11627,0,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.47049,0.12844,0.032504,0,0
3,GO METAL ION TRANSPORT,0.0046564,0.12836,0.10959,0,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.14526,0.12829,0.070949,0,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.010245,0.12826,0.14363,0,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.23589,0.12822,0.02653,0,0
3,GO ENERGY RESERVE METABOLIC PROCESS,0.0069616,0.12816,0.1444,0,0
3,GO HEMOGLOBIN METABOLIC PROCESS,0.188,0.12791,0.058781,0,0
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.075049,0.12763,0.10328,0,0
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.012508,0.12759,0.19115,0,0
3,GO REGENERATION,0.11235,0.12759,0.059433,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.029719,0.12753,0.14343,0,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.029068,0.12753,0.14616,0,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.38888,0.12743,0.061024,0,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.13583,0.12717,0.14577,0,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.059411,0.12695,0.10036,0,0
3,GO PENILE ERECTION,0.47588,0.12666,0.045453,0,0
3,GO NEURON MATURATION,0.043763,0.12601,0.15152,0,0
3,GO POTASSIUM ION HOMEOSTASIS,0.063042,0.12598,0.10372,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.15773,0.12582,0.10574,0,0
3,GO FAT CELL PROLIFERATION,0.70355,0.1258,0.062102,0,0
3,GO NEGATIVE T CELL SELECTION,0.033166,0.12577,0.07258,0,0
3,GO SEX DETERMINATION,0.22568,0.12568,0.061349,0,0
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.085627,0.12548,0.18853,0,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.36064,0.12543,0.048918,0,0
3,GO RESPONSE TO ESTROGEN,0.47049,0.12516,0.038312,0,0
3,GO AMINE CATABOLIC PROCESS,0.047551,0.12515,0.21684,0,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.58456,0.12493,-0.01379,0,0
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.10845,0.12483,0.15465,0,0
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.24643,0.12473,0.14833,0,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.061812,0.12429,0.082831,0,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.055956,0.12391,0.19329,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.025414,0.12386,0.09478,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.65234,0.12352,0.029313,0,0
3,GO KERATINOCYTE MIGRATION,0.061812,0.12341,0.10311,0,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.025994,0.12337,0.111,0,0
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.052669,0.12336,0.11116,0,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.14048,0.12236,0.10758,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.29586,0.1223,0.055634,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.36991,0.12229,0.11392,0,0
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0057817,0.1218,0.16988,0,0
3,GO TISSUE REGENERATION,0.057089,0.12171,0.12356,0,0
3,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.11039,0.12147,0.083959,0,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.040234,0.12133,0.085788,0,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.087232,0.12104,0.127,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.41341,0.12083,0.072421,0,0
3,GO MONOAMINE TRANSPORT,0.075049,0.12046,0.1838,0,0
3,GO AXONEME ASSEMBLY,0.20621,0.1204,0.083575,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.63978,0.12035,-0.062613,0,0
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.19393,0.12023,0.060526,0,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.0695,0.12005,0.17447,0,0
3,GO CALCIUM MEDIATED SIGNALING,0.0037331,0.11979,0.087058,0,0
3,GO DNA DEALKYLATION,0.24643,0.11948,0.074536,0,0
3,GO FIBROBLAST ACTIVATION,0.24288,0.11914,0.05994,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.188,0.11871,0.05699,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.088862,0.1187,0.089983,0,0
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.93377,0.11854,0.01301,0,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.007729,0.11848,0.14532,0,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0013872,0.11831,0.17141,0,0
3,GO NUCLEOSIDE SALVAGE,0.30402,0.11816,0.037452,0,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.16294,0.11807,0.16711,0,0
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.076492,0.11771,0.12016,0,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0023671,0.11759,0.13569,0,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.38408,0.11748,-0.0020726,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.18219,0.11714,0.17549,0,0
3,GO FAT CELL DIFFERENTIATION,0.0062634,0.11682,0.13639,0,0
3,GO ORGANIC CATION TRANSPORT,0.017549,0.11665,0.15668,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.22905,0.11662,0.058276,0,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.13814,0.11603,0.105,0,0
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.16828,0.11593,0.079723,0,0
3,GO MACROPHAGE ACTIVATION,0.018398,0.11582,0.11999,0,0
3,GO CIRCADIAN RHYTHM,0.00027832,0.11574,0.12014,0,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.021165,0.11572,0.21201,0,0
3,GO NAD BIOSYNTHETIC PROCESS,0.11636,0.11557,0.10769,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.30815,0.11537,0.11521,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.066855,0.11517,0.14414,0,0
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.029719,0.11515,0.091767,0,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.11235,0.11512,0.098768,0,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.31232,0.11463,0.036559,0,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.71658,0.11441,-0.0077315,0,0
3,GO CATION TRANSPORT,0.0029794,0.11393,0.11537,0,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.31232,0.11349,0.067661,0,0
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.079444,0.11335,0.10939,0,0
3,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.58456,0.11327,0.056794,0,0
3,GO CATION TRANSMEMBRANE TRANSPORT,0.011904,0.11326,0.097415,0,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.063042,0.11311,0.098445,0,0
3,GO CARNITINE SHUTTLE,0.045624,0.11302,0.15812,0,0
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.15517,0.11286,0.078074,0,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.64605,0.11284,0.077729,0,0
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.12259,0.11272,0.071759,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.095625,0.1126,0.096112,0,0
3,GO REGULATION OF HISTONE DEACETYLATION,0.019739,0.11208,0.15662,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.56075,0.11178,0.017063,0,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.087232,0.11166,0.075379,0,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.023205,0.1112,0.17567,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.59664,0.11093,0.021455,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.029719,0.11092,0.094591,0,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.072231,0.11083,0.066507,0,0
3,GO REGULATION OF PHAGOCYTOSIS,0.17653,0.1107,0.068256,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.073629,0.11068,0.13567,0,0
3,GO STRESS FIBER ASSEMBLY,0.16559,0.11055,0.061166,0,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.11841,0.11045,0.076317,0,0
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.077957,0.11038,0.12095,0,0
3,GO AMINO SUGAR METABOLIC PROCESS,0.11434,0.11032,0.096674,0,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.25729,0.11031,0.069155,0,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.10654,0.11019,0.076103,0,0
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.090515,0.11014,0.23207,0,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.12049,0.10995,0.055321,0,0
3,GO MEMBRANE REPOLARIZATION,0.20621,0.10991,0.077901,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.18219,0.10955,0.077562,0,0
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.017549,0.10948,0.11267,0,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.17374,0.10938,0.074127,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.059411,0.10926,0.11563,0,0
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.11841,0.10914,0.081135,0,0
3,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.29992,0.10904,0.080654,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.29586,0.10893,0.10004,0,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.26471,0.10847,0.050154,0,0
3,GO RESPONSE TO PROSTAGLANDIN E,0.35607,0.10841,0.033459,0,0
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.013139,0.10824,0.13583,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.21905,0.10799,0.19779,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.17934,0.10794,0.052714,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.16559,0.10783,0.096855,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.084046,0.10764,0.13725,0,0
3,GO T CELL LINEAGE COMMITMENT,0.0069616,0.10749,0.13861,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.084046,0.10744,0.094517,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.11039,0.10719,0.099748,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.17934,0.10692,0.08553,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.188,0.10686,0.15654,0,0
3,GO IRON ION HOMEOSTASIS,0.059411,0.10674,0.11649,0,0
3,GO ELECTRON TRANSPORT CHAIN,0.0073363,0.10666,0.18144,0,0
3,GO RESPONSE TO LEUCINE,0.17653,0.10654,0.12749,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.56666,0.10635,0.033064,0,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.063042,0.10617,0.057167,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.44402,0.10616,-0.0071978,0,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.0071468,0.10553,0.096585,0,0
3,GO REGULATION OF SYNAPSE MATURATION,0.98255,0.10552,-0.04364,0,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.099158,0.10548,0.04633,0,0
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.02068,0.10537,0.12936,0,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.21256,0.10533,0.068564,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.66501,0.10518,-0.0018245,0,0
3,GO GLUTATHIONE METABOLIC PROCESS,0.082489,0.10497,0.19081,0,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.27999,0.10481,0.02413,0,0
3,GO EPITHELIAL CELL MATURATION,0.3746,0.10479,0.099762,0,0
3,GO LIPID IMPORT INTO CELL,0.16828,0.10474,0.13581,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,0.12473,0.10469,0.096611,0,0
3,GO MITOCHONDRIAL TRANSCRIPTION,0.19695,0.10454,0.10432,0,0
3,GO T CELL SELECTION,0.0033369,0.10452,0.12647,0,0
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.03939,0.10446,0.14201,0,0
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.05824,0.10433,0.077321,0,0
3,GO COMPLEMENT ACTIVATION,0.068167,0.10428,0.12113,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.54903,0.10424,0.039872,0,0
3,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.2839,0.10417,0.050142,0,0
3,GO DIENCEPHALON DEVELOPMENT,0.26098,0.10415,0.079236,0,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.17934,0.10396,0.055951,0,0
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.19695,0.10395,0.073382,0,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0042883,0.10391,0.10433,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.36064,0.10389,0.13376,0,0
3,GO REGULATION OF MITOPHAGY,0.10096,0.1038,0.093301,0,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.19695,0.10376,0.056174,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.59664,0.10372,0.022538,0,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,0.011047,0.10372,0.12701,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.076492,0.10367,0.16765,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.12473,0.1036,0.19382,0,0
3,GO COLLAGEN CATABOLIC PROCESS,0.28785,0.1032,0.034755,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.092194,0.10272,0.061589,0,0
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.036164,0.10269,0.11501,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.22568,0.10262,0.087947,0,0
3,GO STORE OPERATED CALCIUM ENTRY,0.37932,0.1025,0.086852,0,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.073629,0.10246,0.058772,0,0
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.061812,0.10223,0.058189,0,0
3,GO DEVELOPMENTAL INDUCTION,0.10654,0.1021,0.087635,0,0
3,GO MATING BEHAVIOR,0.29992,0.10181,0.042254,0,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.19393,0.10157,0.13118,0,0
3,GO ESTROUS CYCLE,0.47049,0.10147,0.067079,0,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.32077,0.10142,0.050997,0,0
3,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.21579,0.10088,0.14163,0,0
3,GO RESPONSE TO AMPHETAMINE,0.31653,0.10082,0.099874,0,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.1313,0.10077,0.099558,0,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.072231,0.10057,0.15059,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.18508,0.10033,0.054159,0,0
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.20309,0.10028,0.039274,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.17934,0.10027,0.042457,0,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.57857,0.10008,-0.068288,0,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.78962,0.10001,0.01803,0,0
3,GO RESPONSE TO RETINOIC ACID,0.19095,0.099901,0.055168,0,0
3,GO REGULATION OF HAIR CYCLE,0.087232,0.099894,0.093076,0,0
3,GO SEQUESTERING OF TRIGLYCERIDE,0.22568,0.099782,0.11691,0,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.20309,0.099738,0.13441,0,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.018398,0.099731,0.086978,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.85768,0.099536,6.9356e-05,0,0
3,GO L AMINO ACID TRANSPORT,0.20309,0.099398,0.096157,0,0
3,GO AUTOPHAGIC CELL DEATH,0.024846,0.099367,0.15787,0,0
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.3746,0.099231,0.10687,0,0
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.11235,0.099006,0.065888,0,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.02268,0.09896,0.086555,0,0
3,GO ASTROCYTE ACTIVATION,0.63354,0.098928,-0.0082109,0,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.36991,0.09887,0.022985,0,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.019283,0.098705,0.089533,0,0
3,GO CARDIAC CONDUCTION,0.17934,0.098621,0.067927,0,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.13814,0.098615,0.097809,0,0
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.14048,0.098589,0.10807,0,0
3,GO ORGAN INDUCTION,0.24288,0.098569,0.043996,0,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.025994,0.098568,0.21212,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.20937,0.098557,0.13023,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.18508,0.098502,0.072658,0,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.00042998,0.098429,0.17778,0,0
3,GO ENDOSOMAL TRANSPORT,0.0030654,0.098015,0.086413,0,0
3,GO OOCYTE MATURATION,0.14526,0.097783,0.065304,0,0
3,GO GROOMING BEHAVIOR,0.21256,0.097677,0.12431,0,0
3,GO IMMATURE T CELL PROLIFERATION,0.57857,0.097653,0.078694,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.25729,0.097468,0.072799,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.10654,0.097445,0.094292,0,0
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.16294,0.097344,0.084626,0,0
3,GO MUSCLE SYSTEM PROCESS,0.038561,0.097302,0.069482,0,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.011612,0.097043,0.1154,0,0
3,GO PROTEIN PALMITOYLATION,0.097379,0.096921,0.088598,0,0
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.11434,0.096905,0.10267,0,0
3,GO MEMBRANE INVAGINATION,0.097379,0.096814,0.081359,0,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.033894,0.096689,0.12961,0,0
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.36991,0.096452,0.040939,0,0
3,GO VACUOLAR TRANSPORT,0.0039469,0.096403,0.13487,0,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.98953,0.096302,-0.022482,0,0
3,GO INNER DYNEIN ARM ASSEMBLY,0.4598,0.096201,0.046238,0,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.17374,0.096116,0.053433,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.24643,0.096063,0.15322,0,0
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.085627,0.095969,0.13751,0,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.59059,0.095969,-0.0018419,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.055956,0.095825,0.099194,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.080955,0.095538,0.075522,0,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.41842,0.095414,0.090485,0,0
3,GO COPPER ION HOMEOSTASIS,0.26847,0.095388,0.080417,0,0
3,GO CELL SUBSTRATE ADHESION,0.20309,0.095328,0.037121,0,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.16294,0.095321,0.048015,0,0
3,GO LACTATE METABOLIC PROCESS,0.30815,0.09489,0.052622,0,0
3,GO TUBE MORPHOGENESIS,0.093897,0.094824,0.058816,0,0
3,GO CELL FATE DETERMINATION,0.22235,0.094817,0.089476,0,0
3,GO CATECHOLAMINE UPTAKE,0.079444,0.094792,0.18561,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.39858,0.094745,0.047119,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.53167,0.094738,0.078681,0,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.047551,0.094647,0.10114,0,0
3,GO SECONDARY PALATE DEVELOPMENT,0.40843,0.094628,0.052918,0,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.59059,0.094457,0.03878,0,0
3,GO POSITIVE REGULATION OF JNK CASCADE,0.0050528,0.094436,0.12533,0,0
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.12259,0.094119,0.11396,0,0
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.016734,0.094026,0.085604,0,0
3,GO METANEPHROS DEVELOPMENT,0.31232,0.093988,0.05236,0,0
3,GO AMP METABOLIC PROCESS,0.22568,0.093907,0.12593,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.14526,0.093695,0.063853,0,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.092194,0.093685,0.10288,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.23589,0.093444,0.077871,0,0
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.10654,0.093418,0.11699,0,0
3,GO P38MAPK CASCADE,0.20309,0.093295,0.071276,0,0
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.22905,0.093226,0.079556,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.32077,0.093163,0.013893,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.088862,0.093115,0.15579,0,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.079444,0.09302,0.087358,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.48131,0.092842,0.018992,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.38408,0.092674,0.058414,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.13583,0.092636,0.090568,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.9686,0.092632,-0.0013407,0,0
3,GO ADULT FEEDING BEHAVIOR,0.98255,0.09263,-0.031975,0,0
3,GO MUSCLE CELL DEVELOPMENT,0.05161,0.092581,0.079751,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.47049,0.092528,0.018933,0,0
3,GO VASCULATURE DEVELOPMENT,0.22905,0.092478,0.034456,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.041967,0.092465,0.081413,0,0
3,GO OXIDATIVE PHOSPHORYLATION,0.088862,0.092413,0.11462,0,0
3,GO BRONCHUS DEVELOPMENT,0.62113,0.092317,0.064073,0,0
3,GO THIOESTER METABOLIC PROCESS,0.0069616,0.092179,0.15644,0,0
3,GO NEURON CELL CELL ADHESION,0.62732,0.092022,0.10983,0,0
3,GO FATTY ACID HOMEOSTASIS,0.59664,0.091868,0.050965,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.093897,0.09178,0.068766,0,0
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.042857,0.091509,0.11357,0,0
3,GO LAMELLIPODIUM ORGANIZATION,0.26471,0.091328,0.04137,0,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.15773,0.091266,0.060894,0,0
3,GO EPIDERMIS MORPHOGENESIS,0.19095,0.091191,0.05007,0,0
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.077957,0.090963,0.065164,0,0
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.55487,0.09092,0.0042891,0,0
3,GO REGULATION OF PROTEIN DEACETYLATION,0.11636,0.090889,0.099935,0,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.188,0.090805,0.10366,0,0
3,GO RESPONSE TO UV C,0.17653,0.090702,0.076184,0,0
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.027188,0.09056,0.088247,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.26847,0.090431,0.049173,0,0
3,GO POSITIVE REGULATION OF CELL GROWTH,0.065563,0.090309,0.063747,0,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.066855,0.09021,0.10786,0,0
3,GO PYRUVATE METABOLIC PROCESS,0.20937,0.090146,0.060914,0,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.15517,0.089711,0.14567,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.041093,0.089559,0.12274,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.62732,0.089442,0.015179,0,0
3,GO ARTERY MORPHOGENESIS,0.0695,0.08941,0.052987,0,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.10096,0.089313,0.17265,0,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.23589,0.089078,0.041816,0,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.20937,0.089056,0.080183,0,0
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.87144,0.089021,0.026543,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.12259,0.088945,0.062902,0,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.064293,0.088517,0.093518,0,0
3,GO MYOBLAST DIFFERENTIATION,0.36526,0.088499,0.018735,0,0
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.013139,0.088449,0.13374,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.19393,0.088419,0.017914,0,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.023741,0.088373,0.070945,0,0
3,GO TISSUE MORPHOGENESIS,0.11636,0.088288,0.044063,0,0
3,GO PROTEIN OXIDATION,0.68418,0.088123,-0.030787,0,0
3,GO RESPONSE TO MISFOLDED PROTEIN,0.079444,0.088007,0.12263,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.29184,0.087946,0.043017,0,0
3,GO TRNA 5 END PROCESSING,0.37932,0.087807,0.049895,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.16032,0.08771,0.048553,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.52594,0.087611,0.046249,0,0
3,GO RESPONSE TO INACTIVITY,0.092194,0.087449,0.13899,0,0
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.63978,0.087347,-0.011527,0,0
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.12689,0.087335,0.089736,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.088862,0.087296,0.078864,0,0
3,GO MIDGUT DEVELOPMENT,0.36526,0.08711,0.092101,0,0
3,GO DE NOVO PROTEIN FOLDING,0.066855,0.087042,0.11119,0,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.81668,0.087016,-0.054741,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.055956,0.086987,0.088316,0,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.12908,0.086834,0.094206,0,0
3,GO CELLULAR SENESCENCE,0.14285,0.08681,0.052524,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.43367,0.086807,0.073192,0,0
3,GO CELL AGING,0.063042,0.086541,0.061939,0,0
3,GO THYMUS DEVELOPMENT,0.49227,0.086489,0.027193,0,0
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.63978,0.086403,-0.0016275,0,0
3,GO BONE MINERALIZATION,0.055956,0.086398,0.097166,0,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.075049,0.086231,0.074258,0,0
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.076492,0.086145,0.13136,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.21256,0.086138,0.025649,0,0
3,GO OSSIFICATION,0.1028,0.086124,0.062531,0,0
3,GO STEROL IMPORT,0.13355,0.085962,0.1684,0,0
3,GO SENSORY PERCEPTION,0.015203,0.085896,0.071953,0,0
3,GO GLIAL CELL MIGRATION,0.81668,0.085892,-0.016468,0,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.11434,0.085844,0.23842,0,0
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.33373,0.085541,0.076385,0,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.14769,0.085517,0.052738,0,0
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.05824,0.08547,0.12655,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.19393,0.08535,0.064117,0,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.27227,0.084977,0.037728,0,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.18508,0.084894,0.091964,0,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.05824,0.084863,0.086614,0,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.23589,0.084761,0.049938,0,0
3,GO REGULATION OF PROTON TRANSPORT,0.30815,0.084723,0.085676,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.49227,0.084504,0.079454,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.4598,0.084416,0.040567,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.20309,0.084237,0.041223,0,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.84397,0.084099,-0.0247,0,0
3,GO GLIAL CELL ACTIVATION,0.21905,0.083833,0.053632,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.48131,0.08375,0.036148,0,0
3,GO REGULATION OF SYSTEM PROCESS,0.068167,0.083507,0.066128,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.37932,0.083235,0.017214,0,0
3,GO SLEEP,0.42347,0.083148,0.050427,0,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.29992,0.082965,0.086987,0,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.16294,0.082902,0.048767,0,0
3,GO CELL JUNCTION ASSEMBLY,0.090515,0.082805,0.075548,0,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.17374,0.08279,0.079952,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16294,0.082695,0.053888,0,0
3,GO DETECTION OF MECHANICAL STIMULUS,0.49227,0.082564,0.042262,0,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.30402,0.082533,0.13345,0,0
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.21905,0.082492,0.048656,0,0
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.42347,0.082442,0.043273,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.40349,0.082009,0.027034,0,0
3,GO IMMATURE B CELL DIFFERENTIATION,0.32506,0.081854,0.080967,0,0
3,GO REGULATION OF ENDOCYTOSIS,0.18508,0.081835,0.050925,0,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.26471,0.08182,0.043436,0,0
3,GO RESPONSE TO ZINC ION,0.14285,0.081675,0.15296,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.092194,0.081664,0.077699,0,0
3,GO NOTOCHORD DEVELOPMENT,0.68418,0.081387,-0.030123,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.088862,0.081139,0.15294,0,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.10845,0.080979,0.10277,0,0
3,GO VITAMIN TRANSPORT,0.12473,0.080749,0.14476,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.23937,0.080648,0.061214,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.095625,0.08064,0.051169,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.43883,0.080631,0.05187,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.26471,0.080511,0.045137,0,0
3,GO MOLTING CYCLE,0.12049,0.080484,0.05888,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.070855,0.080204,0.12961,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.05824,0.080143,0.075857,0,0
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0059384,0.0801,0.12639,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.51459,0.080078,0.029671,0,0
3,GO AMINO ACID ACTIVATION,0.32938,0.080047,0.069538,0,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.32938,0.079514,0.14996,0,0
3,GO LEFT RIGHT PATTERN FORMATION,0.67776,0.079485,0.024362,0,0
3,GO PIGMENT METABOLIC PROCESS,0.11434,0.07944,0.10103,0,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.28785,0.079219,0.03631,0,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.27999,0.079119,0.066648,0,0
3,GO NEUTROPHIL HOMEOSTASIS,0.77618,0.079084,-0.043226,0,0
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.11235,0.079072,0.074484,0,0
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.41842,0.079059,0.061866,0,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.24288,0.079043,0.039083,0,0
3,GO FEMALE GAMETE GENERATION,0.060602,0.078975,0.066079,0,0
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.11235,0.078905,0.11591,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.4545,0.078823,0.016462,0,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.11039,0.078781,0.085273,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.19695,0.078772,0.059524,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.12908,0.078629,0.1308,0,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.042857,0.078546,0.09381,0,0
3,GO FACE DEVELOPMENT,0.86455,0.078409,-0.0042319,0,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.18219,0.078168,0.085687,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.082489,0.078068,0.076808,0,0
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.20309,0.078007,0.052525,0,0
3,GO GMP METABOLIC PROCESS,0.16032,0.077815,0.093639,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.30402,0.07758,0.079191,0,0
3,GO VESICLE DOCKING,0.26847,0.077284,0.056795,0,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.29992,0.077242,0.04734,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.011612,0.077195,0.10662,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.36991,0.077148,0.025558,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.25729,0.077088,0.061771,0,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.053746,0.076979,0.067338,0,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.054842,0.076857,0.092721,0,0
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.15773,0.076737,0.085431,0,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.32506,0.076499,0.04094,0,0
3,GO SPROUTING ANGIOGENESIS,0.44924,0.076419,0.014318,0,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.50337,0.076279,0.035287,0,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.13583,0.076232,0.11256,0,0
3,GO ACTIN FILAMENT BASED MOVEMENT,0.24643,0.076188,0.046844,0,0
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.13583,0.075885,0.050867,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.12049,0.07566,0.13517,0,0
3,GO IMPORT INTO CELL,0.12473,0.075636,0.076736,0,0
3,GO SECRETORY GRANULE ORGANIZATION,0.188,0.075518,0.078659,0,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.12908,0.075459,0.072159,0,0
3,GO REGULATION OF ERAD PATHWAY,0.51459,0.07538,0.021676,0,0
3,GO ATP METABOLIC PROCESS,0.059411,0.075372,0.085588,0,0
3,GO RESPONSE TO GAMMA RADIATION,0.15264,0.075366,0.060008,0,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.86455,0.075294,-0.0057921,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.26847,0.07515,0.060912,0,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.065563,0.075103,0.08718,0,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.72969,0.075081,-0.03783,0,0
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.19695,0.075074,0.1008,0,0
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.14048,0.074747,0.054445,0,0
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.046579,0.074725,0.14607,0,0
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.68418,0.074671,0.01136,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.013465,0.074628,0.091724,0,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.097379,0.073884,0.14068,0,0
3,GO NEGATIVE REGULATION OF SIGNALING,0.066855,0.073609,0.057193,0,0
3,GO POTASSIUM ION TRANSPORT,0.14526,0.073402,0.085761,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.32938,0.073086,0.045027,0,0
3,GO VISUAL BEHAVIOR,0.21256,0.072972,0.084028,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.18508,0.072744,0.057853,0,0
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.188,0.072637,0.092585,0,0
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.073629,0.072519,0.13677,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.40843,0.072367,0.03734,0,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.14048,0.072322,0.035949,0,0
3,GO TOXIN TRANSPORT,0.12689,0.072312,0.10273,0,0
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.20621,0.072213,0.093093,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.22905,0.072078,0.05239,0,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.18508,0.072068,0.050659,0,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.042857,0.072005,0.072054,0,0
3,GO RHYTHMIC PROCESS,0.017549,0.071908,0.072486,0,0
3,GO ADHERENS JUNCTION ORGANIZATION,0.12689,0.071856,0.099257,0,0
3,GO DEPHOSPHORYLATION,0.013798,0.071715,0.066299,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.22235,0.071686,0.065168,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.24288,0.071667,0.091508,0,0
3,GO REGULATION OF RECEPTOR RECYCLING,0.14048,0.071545,0.087115,0,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.16559,0.071446,0.059541,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.23937,0.07141,0.073119,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.36064,0.071405,0.026451,0,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.10096,0.071388,0.048806,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.12689,0.071284,0.074839,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.75615,0.071163,0.011544,0,0
3,GO GOLGI LOCALIZATION,0.20937,0.071161,0.074174,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.23937,0.070997,0.068857,0,0
3,GO STRIATED MUSCLE CONTRACTION,0.17934,0.070997,0.059959,0,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.55487,0.07088,0.032107,0,0
3,GO LYSINE METABOLIC PROCESS,0.26471,0.070821,0.11873,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.72313,0.070737,0.029872,0,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.22568,0.070403,0.097923,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.13355,0.070288,0.10092,0,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.24643,0.070241,0.11144,0,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.188,0.070159,0.060668,0,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.16828,0.069956,0.094163,0,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.56075,0.069866,0.0095827,0,0
3,GO GASTRIC ACID SECRETION,0.17374,0.069594,0.10222,0,0
3,GO GRANULOCYTE DIFFERENTIATION,0.54321,0.069572,0.048774,0,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.43883,0.069531,0.041403,0,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.40843,0.069449,0.040771,0,0
3,GO ASTROCYTE DEVELOPMENT,0.89215,0.0691,0.0016112,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.50896,0.06904,0.0080944,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.093897,0.068501,0.065273,0,0
3,GO PRIMARY MIRNA PROCESSING,0.29992,0.068353,0.031262,0,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.67776,0.068295,0.028997,0,0
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.53742,0.068251,0.05848,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.59664,0.068201,0.027182,0,0
3,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.53742,0.068129,0.049375,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.049546,0.068091,0.10226,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.78289,0.068013,-0.035494,0,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.17653,0.067942,0.087966,0,0
3,GO STEROID CATABOLIC PROCESS,0.038561,0.067905,0.22504,0,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.82348,0.067801,-0.075551,0,0
3,GO REGULATION OF PODOSOME ASSEMBLY,0.60272,0.067686,0.018947,0,0
3,GO DETECTION OF ABIOTIC STIMULUS,0.11039,0.067658,0.059597,0,0
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.23245,0.067442,0.1103,0,0
3,GO REGULATION OF DNA METHYLATION,0.31232,0.067283,0.053585,0,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.14048,0.066843,0.042212,0,0
3,GO PHOTOPERIODISM,0.14048,0.066771,0.10142,0,0
3,GO REGULATION OF CELL SHAPE,0.17934,0.066738,0.043649,0,0
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.010245,0.066709,0.12465,0,0
3,GO INTERMEMBRANE LIPID TRANSFER,0.15517,0.066686,0.062922,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.10465,0.066544,0.072907,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.29586,0.066497,0.058985,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.064293,0.066341,0.06706,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.24643,0.066152,0.030697,0,0
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.36991,0.066035,0.042574,0,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.59059,0.065893,0.018724,0,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.23937,0.065716,0.11132,0,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.69707,0.065521,-0.068593,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.51459,0.065291,0.023789,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.38408,0.065149,0.036572,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.093897,0.064922,0.081967,0,0
3,GO RENAL FILTRATION,0.7495,0.064921,0.042421,0,0
3,GO RESPONSE TO FOOD,0.55487,0.064799,0.01981,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.24288,0.064775,0.032646,0,0
3,GO MIRNA METABOLIC PROCESS,0.80989,0.064582,-0.0079048,0,0
3,GO LYSOSOMAL TRANSPORT,0.045624,0.064501,0.11519,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.16559,0.064405,0.060487,0,0
3,GO ASSOCIATIVE LEARNING,0.55487,0.064371,0.0258,0,0
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.10845,0.064341,0.1459,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.47588,0.06433,0.038436,0,0
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.71006,0.064311,0.030985,0,0
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.78962,0.064218,0.011303,0,0
3,GO RESPONSE TO IONIZING RADIATION,0.079444,0.064201,0.043251,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.29586,0.064129,0.098839,0,0
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.35607,0.064104,0.078866,0,0
3,GO REGULATION OF NUCLEAR DIVISION,0.11434,0.06407,0.045269,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.17653,0.063947,0.12601,0,0
3,GO REGULATION OF CELL FATE COMMITMENT,0.20621,0.063874,0.072826,0,0
3,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.78289,0.063778,-0.0072105,0,0
3,GO COENZYME A METABOLIC PROCESS,0.11235,0.063669,0.11124,0,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.37932,0.063655,0.053764,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.32938,0.063621,0.03731,0,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.55487,0.063575,0.020315,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.23245,0.063336,0.079512,0,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.31232,0.063299,0.061759,0,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.15015,0.063273,0.056382,0,0
3,GO REGULATION OF CELL AGING,0.85082,0.062553,-0.0031971,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.18508,0.062317,0.052412,0,0
3,GO REGULATION OF URINE VOLUME,0.94073,0.061881,-0.020808,0,0
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.14048,0.061786,0.11941,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.21905,0.061572,0.044221,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.89907,0.061553,-0.026485,0,0
3,GO RECEPTOR RECYCLING,0.11636,0.061313,0.085856,0,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.14048,0.06131,0.057738,0,0
3,GO ENDODERM DEVELOPMENT,0.29184,0.06129,0.040924,0,0
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.18219,0.061282,0.050731,0,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.082489,0.061138,0.053716,0,0
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.47049,0.061046,0.064707,0,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.85768,0.060946,-0.030905,0,0
3,GO EPITHELIAL TUBE FORMATION,0.63978,0.060899,-0.0043144,0,0
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.50337,0.060794,0.0086456,0,0
3,GO REGULATION OF JUN KINASE ACTIVITY,0.076492,0.060747,0.079981,0,0
3,GO RELAXATION OF MUSCLE,0.68418,0.060702,0.023067,0,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.78289,0.060627,-0.0049316,0,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.47588,0.060626,0.011514,0,0
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.48678,0.060548,0.022314,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.4978,0.060471,0.0072077,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.26847,0.060454,0.052067,0,0
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.48678,0.060436,0.080356,0,0
3,GO POSITIVE T CELL SELECTION,0.024288,0.060366,0.096673,0,0
3,GO PROTEIN FOLDING,0.084046,0.06035,0.081673,0,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.30402,0.060347,0.029248,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.77618,0.060262,-0.059841,0,0
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.37932,0.060151,0.051857,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.56666,0.060036,0.039055,0,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.29586,0.060031,0.05383,0,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.073629,0.059961,0.048584,0,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.066855,0.059919,0.043015,0,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.91987,0.059884,-0.0098213,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.38408,0.059654,0.16576,0,0
3,GO REGULATION OF PINOCYTOSIS,0.55487,0.059651,-0.017608,0,0
3,GO APOPTOTIC DNA FRAGMENTATION,0.41341,0.059649,0.027821,0,0
3,GO PIGMENT ACCUMULATION,0.38888,0.059614,0.051057,0,0
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.14526,0.059605,0.062499,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.5726,0.059366,0.013128,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.25363,0.059329,0.042863,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.188,0.059315,0.062453,0,0
3,GO REGULATION OF RECEPTOR CLUSTERING,0.54321,0.059231,0.088841,0,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.26471,0.059131,0.043906,0,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.16032,0.059107,0.058011,0,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.52594,0.059105,0.014743,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.70355,0.0591,0.0111,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.15773,0.05907,0.071534,0,0
3,GO BICARBONATE TRANSPORT,0.26471,0.059056,0.060198,0,0
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.42855,0.05903,0.070702,0,0
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.17099,0.059023,0.082449,0,0
3,GO WATER TRANSPORT,0.17099,0.059004,0.051863,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.1313,0.058976,0.17222,0,0
3,GO RESPONSE TO RADIATION,0.041093,0.058946,0.041561,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.41842,0.058498,0.036362,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.66501,0.058477,0.0050003,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.041967,0.058467,0.064603,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.36526,0.058381,0.019179,0,0
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.32506,0.058316,0.080358,0,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.73628,0.058231,0.0083262,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.54321,0.058074,0.045908,0,0
3,GO PORE COMPLEX ASSEMBLY,0.4545,0.05794,0.049659,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.87144,0.057857,0.012701,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.13583,0.057825,0.047951,0,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.80312,0.057783,-0.0018253,0,0
3,GO TAXIS,0.93377,0.057722,-0.010139,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.79636,0.057719,0.018782,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.097379,0.05765,0.060346,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.13814,0.05757,0.062654,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.41341,0.057521,0.063949,0,0
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.22235,0.05745,0.11006,0,0
3,GO RESPONSE TO NICOTINE,0.79636,0.057102,0.0081399,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.22568,0.057075,0.05206,0,0
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.38408,0.056998,0.027722,0,0
3,GO DEVELOPMENTAL MATURATION,0.17099,0.05696,0.06317,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.15773,0.056821,0.046632,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.72313,0.056811,-7.2385e-05,0,0
3,GO RESPONSE TO GROWTH FACTOR,0.13814,0.056544,0.048345,0,0
3,GO REGULATION OF GTPASE ACTIVITY,0.04854,0.056291,0.066526,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.10845,0.056234,0.042209,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.71658,0.056191,0.0066461,0,0
3,GO MUSCLE CONTRACTION,0.13814,0.055996,0.043525,0,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.50896,0.055801,0.061418,0,0
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.025994,0.055781,0.085389,0,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.17374,0.055736,0.094338,0,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.67137,0.055674,0.016585,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.19695,0.055543,0.077051,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.095625,0.055526,0.030271,0,0
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.29586,0.055464,0.038076,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.34702,0.055248,0.012685,0,0
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.40843,0.055208,0.055182,0,0
3,GO APOPTOTIC CELL CLEARANCE,0.67137,0.055112,-0.04912,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.52025,0.055046,0.013661,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.22235,0.054942,0.099332,0,0
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.40349,0.054805,0.07073,0,0
3,GO CELL AGGREGATION,0.80312,0.054765,-0.041634,0,0
3,GO COPPER ION TRANSPORT,0.10845,0.05474,0.1282,0,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.44924,0.054663,0.037694,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.17653,0.054546,0.040333,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.20309,0.054409,0.033333,0,0
3,GO LIPID PHOSPHORYLATION,0.25363,0.054209,0.062431,0,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.4545,0.054001,0.024658,0,0
3,GO CATECHOLAMINE SECRETION,0.16294,0.05396,0.19001,0,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.014138,0.053954,0.080793,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.1028,0.053937,0.050262,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.56075,0.053886,0.016914,0,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.31232,0.053696,0.052333,0,0
3,GO REGULATION OF SPINDLE ASSEMBLY,0.082489,0.053618,0.087455,0,0
3,GO ANIMAL ORGAN MATURATION,0.43883,0.053611,0.037538,0,0
3,GO TRABECULA MORPHOGENESIS,0.94073,0.053517,-0.018428,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.30815,0.0535,0.089904,0,0
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.40349,0.053486,0.023995,0,0
3,GO HETEROCHROMATIN ORGANIZATION,0.20309,0.053429,0.023381,0,0
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.10465,0.053282,0.12076,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.24643,0.053269,0.028359,0,0
3,GO NEURON REMODELING,0.71006,0.053239,0.0019767,0,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.40843,0.053206,0.039778,0,0
3,GO PHOSPHATE ION TRANSPORT,0.15264,0.053182,0.078416,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.077957,0.053049,0.043445,0,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.66501,0.053001,0.030015,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.73628,0.052928,-0.0080949,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.11039,0.052847,0.067421,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.20937,0.052782,0.07623,0,0
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.96163,0.052745,-0.018744,0,0
3,GO CELLULAR RESPONSE TO DRUG,0.77618,0.052742,0.018092,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.56075,0.052716,0.016088,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.76281,0.052687,0.015735,0,0
3,GO REGULATION OF GLIOGENESIS,0.26471,0.052586,0.066424,0,0
3,GO URONIC ACID METABOLIC PROCESS,0.21905,0.052399,0.090405,0,0
3,GO APICAL PROTEIN LOCALIZATION,0.50337,0.052157,0.041445,0,0
3,GO DECIDUALIZATION,0.71006,0.052145,-0.060441,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.24643,0.052107,0.036296,0,0
3,GO EXTRACELLULAR TRANSPORT,0.32077,0.052048,0.058451,0,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.19393,0.051832,0.044368,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.35153,0.051754,0.058309,0,0
3,GO NUCLEOSIDE METABOLIC PROCESS,0.26471,0.051679,0.034746,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.59059,0.051527,0.023228,0,0
3,GO SOMITE DEVELOPMENT,0.092194,0.051469,0.057776,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.7495,0.051212,0.0027357,0,0
3,GO RECEPTOR METABOLIC PROCESS,0.4545,0.05117,0.029225,0,0
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.36991,0.051022,0.07976,0,0
3,GO GLIOGENESIS,0.36526,0.050917,0.042138,0,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.19695,0.050906,0.068334,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.41341,0.0509,0.021073,0,0
3,GO CARBOHYDRATE PHOSPHORYLATION,0.84397,0.050673,-0.003951,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.50896,0.050539,0.022598,0,0
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.88523,0.050371,-0.02713,0,0
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.35153,0.050318,0.035908,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.18219,0.050102,0.062228,0,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.8303,0.05007,-0.0023891,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.41842,0.050035,0.025991,0,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.85768,0.049995,-0.042873,0,0
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.57857,0.049989,0.057669,0,0
3,GO NCRNA 3 END PROCESSING,0.61497,0.049545,-0.014085,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.72313,0.049482,0.0092528,0,0
3,GO SEX DIFFERENTIATION,0.23245,0.049381,0.048268,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.7495,0.04933,0.037132,0,0
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.99651,0.049238,-0.028726,0,0
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.72969,0.049218,-0.076038,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.47049,0.049161,0.030621,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.69061,0.048899,0.0018533,0,0
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.33373,0.048856,0.0715,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.50337,0.048722,0.045071,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.04854,0.048706,0.082271,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.23937,0.048691,0.029458,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.082489,0.048658,0.083942,0,0
3,GO GASTRULATION,0.27611,0.048609,0.045615,0,0
3,GO CILIUM MOVEMENT,0.26471,0.048502,0.023233,0,0
3,GO MYOFIBRIL ASSEMBLY,0.15264,0.048427,0.056751,0,0
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.71006,0.048316,-0.073435,0,0
3,GO VASCULOGENESIS,0.89215,0.048259,-0.036834,0,0
3,GO DENDRITE EXTENSION,0.24643,0.048194,0.13995,0,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.25729,0.048171,0.032074,0,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.40349,0.048109,0.063542,0,0
3,GO RESPONSE TO LIGHT STIMULUS,0.24288,0.048039,0.018708,0,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.095625,0.04781,0.072834,0,0
3,GO INTERACTION WITH SYMBIONT,0.30815,0.047754,0.021048,0,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.36064,0.047667,0.085572,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.77618,0.047629,0.0064345,0,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.33812,0.047628,0.029643,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.12689,0.047607,0.050206,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.42347,0.047559,0.019223,0,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.76948,0.047548,0.020919,0,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.87833,0.04753,-0.0045327,0,0
3,GO INTERLEUKIN 17 PRODUCTION,0.28785,0.047482,0.076349,0,0
3,GO PROTEIN NITROSYLATION,0.95466,0.047446,-0.054094,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.11039,0.047411,0.035716,0,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.29992,0.047395,0.039762,0,0
3,GO PEPTIDE METABOLIC PROCESS,0.55487,0.047357,0.025574,0,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.065563,0.047309,0.068482,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.21256,0.047294,0.096542,0,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.59059,0.047278,0.012268,0,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.18219,0.04717,0.098887,0,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.15015,0.047157,0.15928,0,0
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.10845,0.047103,0.039096,0,0
3,GO REGULATION OF GROWTH,0.20621,0.047085,0.041344,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.69061,0.046828,0.028944,0,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.36064,0.046487,0.021056,0,0
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.42347,0.046481,0.041484,0,0
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.54321,0.046463,-0.10316,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.14048,0.046418,0.1408,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.94073,0.046389,0.011411,0,0
3,GO P BODY ASSEMBLY,0.16032,0.046369,0.051706,0,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.39858,0.046352,0.081126,0,0
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.35153,0.046193,0.068614,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.44402,0.046187,0.045303,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.12689,0.046151,0.049363,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.55487,0.046104,0.022101,0,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.50337,0.046019,0.004796,0,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.55487,0.045921,0.030616,0,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.42855,0.045843,0.059759,0,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.26847,0.045743,0.089617,0,0
3,GO MATING,0.1313,0.045733,0.076435,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.35153,0.04572,0.047306,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.42855,0.04562,0.035648,0,0
3,GO HEME METABOLIC PROCESS,0.26098,0.045559,0.12588,0,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.97557,0.045559,-0.039903,0,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.17099,0.045491,0.039431,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.20621,0.045284,0.075638,0,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.29992,0.045003,0.0947,0,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.42855,0.045002,0.059029,0,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.14769,0.044917,0.057188,0,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.21579,0.044896,0.030855,0,0
3,GO EMBRYO IMPLANTATION,0.94073,0.044889,-0.025736,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.36064,0.04483,0.077785,0,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.085627,0.044726,0.10967,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.16032,0.044688,0.052913,0,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.41341,0.044559,0.10605,0,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.53742,0.044544,0.020678,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.98255,0.044454,-0.10259,0,0
3,GO PROTEIN HOMOOLIGOMERIZATION,0.21579,0.044451,0.034317,0,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.47049,0.044421,0.09066,0,0
3,GO RESPONSE TO INTERLEUKIN 4,0.2,0.044335,0.061185,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.44924,0.044331,0.038822,0,0
3,GO MACROPHAGE APOPTOTIC PROCESS,0.38888,0.044307,0.079066,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.15773,0.043913,0.069143,0,0
3,GO ATP BIOSYNTHETIC PROCESS,0.092194,0.043851,0.12448,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.22905,0.04368,0.052272,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.17934,0.043617,0.054385,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.20937,0.043489,0.050526,0,0
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.92682,0.04348,-0.018941,0,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.47588,0.043317,0.039173,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.4978,0.043021,0.034861,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.43367,0.043008,0.049291,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.20937,0.042784,0.081046,0,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.54321,0.042685,-0.0049756,0,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.86455,0.042552,-0.0027498,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.10654,0.042387,0.063028,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.25001,0.042368,0.03246,0,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.87833,0.042336,-0.016362,0,0
3,GO OVULATION CYCLE,0.62732,0.042181,0.016225,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.33373,0.042167,0.028279,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.83713,0.042018,0.00098858,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.24643,0.041937,0.028371,0,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.35153,0.041935,0.020253,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.47049,0.041918,0.017665,0,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.13583,0.04187,0.10991,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.99651,0.041806,-0.0052779,0,0
3,GO PROTEIN HOMOTETRAMERIZATION,0.48131,0.041751,0.021506,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.40349,0.041596,0.036829,0,0
3,GO TORC1 SIGNALING,0.18219,0.041454,0.036163,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.81668,0.041373,-0.00046566,0,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.42855,0.041337,0.073107,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.82348,0.041133,-0.0049127,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.65866,0.041004,0.016196,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.5726,0.04098,0.045731,0,0
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.32938,0.040964,0.045608,0,0
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.5726,0.040838,0.069194,0,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.20937,0.040818,0.05163,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.41341,0.040795,0.02605,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.37932,0.040792,0.039112,0,0
3,GO EMBRYO DEVELOPMENT,0.64605,0.040699,0.0078452,0,0
3,GO NUCLEOTIDE PHOSPHORYLATION,0.39371,0.040608,0.03735,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.12473,0.040534,0.033373,0,0
3,GO CELL GROWTH,0.67137,0.040454,0.010858,0,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.32506,0.040354,0.022738,0,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.86455,0.040161,-0.019402,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.39858,0.040153,0.059385,0,0
3,GO OVULATION,0.38888,0.040041,0.067615,0,0
3,GO PROTEASOME ASSEMBLY,0.43883,0.040028,0.059046,0,0
3,GO FEVER GENERATION,0.84397,0.03996,0.0053482,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.85082,0.039756,-0.0078458,0,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.26847,0.039753,0.047066,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.81668,0.039729,-0.028076,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.65866,0.039638,-0.00028203,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.97557,0.03963,-0.018651,0,0
3,GO CHEMOSENSORY BEHAVIOR,0.70355,0.039608,0.0075248,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.51459,0.039524,0.035906,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.58456,0.039494,-0.0051577,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.47049,0.03947,0.023609,0,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.60883,0.039438,0.042614,0,0
3,GO ORGANELLE FISSION,0.26098,0.039426,0.027589,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.64605,0.039418,0.036378,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.084046,0.039357,0.048199,0,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.57857,0.039276,0.014263,0,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.16828,0.039274,0.094582,0,0
3,GO EAR DEVELOPMENT,0.36064,0.039132,0.035563,0,0
3,GO REGULATION OF CELL DIFFERENTIATION,0.40349,0.038972,0.027803,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.47588,0.038754,0.055161,0,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.33373,0.03875,0.018387,0,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.60272,0.038663,0.042757,0,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.21579,0.038626,0.066145,0,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.89907,0.038523,-0.01173,0,0
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.54903,0.03852,0.039708,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.71658,0.037883,0.029904,0,0
3,GO CARDIOCYTE DIFFERENTIATION,0.76948,0.037808,0.0022045,0,0
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.099158,0.037745,0.073323,0,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.27227,0.037732,0.042273,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.67137,0.037568,0.02419,0,0
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.68418,0.037392,0.016014,0,0
3,GO RESPONSE TO HYDROXYUREA,0.16294,0.037323,0.0972,0,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.082489,0.037278,0.039766,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.52594,0.037271,0.016572,0,0
3,GO TUBE FORMATION,0.85768,0.037176,-0.013056,0,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.36526,0.037107,0.027609,0,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.05824,0.037076,0.045847,0,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.26847,0.036969,0.074298,0,0
3,GO ACTIN CROSSLINK FORMATION,0.94073,0.036921,-0.010668,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.72313,0.036773,0.00043255,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.91293,0.03673,0.0018769,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.42347,0.036681,0.020972,0,0
3,GO ENDODERM FORMATION,0.61497,0.036617,-0.0037312,0,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,1,0.036548,-0.025899,0,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.26098,0.03642,0.025541,0,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.055956,0.036413,0.065609,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.17653,0.036297,0.075442,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.5726,0.036295,0.047484,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.67776,0.036203,0.018429,0,0
3,GO HEART FIELD SPECIFICATION,0.72969,0.035949,-0.031172,0,0
3,GO AXIS SPECIFICATION,0.46512,0.035887,0.040426,0,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.67137,0.035754,0.09146,0,0
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.96163,0.035723,-0.024923,0,0
3,GO GROWTH,0.65866,0.035521,0.010989,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.60883,0.035495,0.019509,0,0
3,GO SPERM MOTILITY,0.56666,0.035378,0.018938,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.68418,0.035257,0.012373,0,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.62113,0.034839,-0.0058648,0,0
3,GO NEPHRON MORPHOGENESIS,0.5726,0.034787,0.021925,0,0
3,GO STARTLE RESPONSE,0.87144,0.034676,0.0018284,0,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.13814,0.034637,0.031353,0,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.50337,0.03432,0.091355,0,0
3,GO MESODERM MORPHOGENESIS,0.59059,0.034266,0.011061,0,0
3,GO RNA DESTABILIZATION,0.78962,0.034245,-0.0094379,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.75615,0.034231,0.021405,0,0
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.30402,0.034151,0.048308,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.76281,0.034107,0.028726,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.98255,0.034024,-0.0070652,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.47588,0.034018,0.054812,0,0
3,GO VESICLE CARGO LOADING,0.76281,0.033922,0.047199,0,0
3,GO MAINTENANCE OF CELL NUMBER,0.59664,0.033876,-0.043951,0,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.53167,0.033871,0.036729,0,0
3,GO SMOOTH MUSCLE CONTRACTION,0.52025,0.033857,0.010986,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.62113,0.033828,0.017829,0,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.092194,0.033813,0.12792,0,0
3,GO NEGATIVE REGULATION OF GROWTH,0.11235,0.033809,0.067815,0,0
3,GO SYNAPTIC VESICLE RECYCLING,0.72313,0.03362,0.033617,0,0
3,GO NOREPINEPHRINE SECRETION,0.96163,0.033582,0.01842,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.53742,0.033569,0.029246,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.89215,0.033301,0.0033021,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.28785,0.033297,0.026207,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.95466,0.033286,-0.028371,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.7495,0.033258,0.019953,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.71658,0.033146,0.055057,0,0
3,GO GENE SILENCING,0.32506,0.033107,0.013324,0,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.62113,0.033093,0.016096,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.63978,0.03291,-0.066834,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.64605,0.032781,0.021766,0,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.41341,0.032752,0.017173,0,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.42855,0.032657,0.017163,0,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.085627,0.032585,0.036988,0,0
3,GO PROTEIN TETRAMERIZATION,0.78289,0.032531,0.0013128,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.39858,0.032368,0.034994,0,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.23245,0.032257,0.080084,0,0
3,GO MEIOTIC CELL CYCLE,0.036164,0.032216,0.062744,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.26098,0.031998,0.035175,0,0
3,GO POSITIVE REGULATION OF RNA SPLICING,0.43883,0.031963,0.051999,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.92682,0.031841,0.018977,0,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.43367,0.031786,0.043556,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.91987,0.031751,-0.071486,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.2839,0.031617,0.044455,0,0
3,GO AMIDE BIOSYNTHETIC PROCESS,0.63978,0.03152,0.013877,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.61497,0.031387,0.013949,0,0
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.54321,0.031023,-0.11533,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.89907,0.030963,-0.014709,0,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.32077,0.030948,0.060074,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.51459,0.03088,0.038856,0,0
3,GO MITOCHONDRIAL FUSION,0.48678,0.030738,0.055802,0,0
3,GO NEURON APOPTOTIC PROCESS,0.64605,0.030602,0.014943,0,0
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.92682,0.030513,-0.025249,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.30402,0.030282,0.075866,0,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.43883,0.030211,0.014189,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.41341,0.030137,0.01476,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.62113,0.030104,-0.046682,0,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.96163,0.030095,-0.013687,0,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.85082,0.029943,-0.0029869,0,0
3,GO AMINO ACID TRANSPORT,0.19393,0.029925,0.094382,0,0
3,GO CELL CYCLE,0.33373,0.029761,0.016009,0,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.89907,0.029738,-0.0058615,0,0
3,GO CYTOSKELETON ORGANIZATION,0.59664,0.029653,0.011409,0,0
3,GO HISTONE DEACETYLATION,0.47588,0.029172,0.020376,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.50896,0.029126,0.081912,0,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.72313,0.029124,-0.067649,0,0
3,GO GOLGI TO VACUOLE TRANSPORT,0.10654,0.029085,0.10778,0,0
3,GO FEAR RESPONSE,0.42347,0.029044,0.045432,0,0
3,GO ECTODERM DEVELOPMENT,0.59664,0.028843,0.028427,0,0
3,GO REGULATION OF MACROAUTOPHAGY,0.05824,0.028468,0.081878,0,0
3,GO HISTONE H2B UBIQUITINATION,0.28785,0.028447,0.044238,0,0
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.32077,0.028394,0.025578,0,0
3,GO PROTEIN STABILIZATION,0.077957,0.028359,0.061561,0,0
3,GO NEURAL TUBE DEVELOPMENT,0.9686,0.028321,-0.019811,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.32938,0.028289,0.0267,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.63354,0.028209,0.046618,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.72313,0.028155,0.00023142,0,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.53742,0.028145,0.044028,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.98953,0.02809,-0.097671,0,0
3,GO LACTATION,0.92682,0.027991,0.0095602,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.35607,0.027808,0.024126,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.43883,0.02776,0.13456,0,0
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.63978,0.02747,0.0028249,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.2839,0.027441,0.057174,0,0
3,GO PROTEIN ACTIVATION CASCADE,0.35607,0.027412,0.12522,0,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.67137,0.027319,0.0015287,0,0
3,GO BODY MORPHOGENESIS,0.84397,0.027249,-0.0015991,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.36064,0.027243,0.033745,0,0
3,GO SPERM AXONEME ASSEMBLY,0.93377,0.027162,8.2116e-05,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.55487,0.027079,0.024314,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.85082,0.027022,-0.00878,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.32938,0.026869,0.044264,0,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.87144,0.02672,0.019393,0,0
3,GO SARCOMERE ORGANIZATION,0.27999,0.026711,0.05765,0,0
3,GO MITOCHONDRION ORGANIZATION,0.033166,0.026664,0.077287,0,0
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.90599,0.026376,-0.0059776,0,0
3,GO RESPONSE TO CAMP,0.40349,0.026299,0.035881,0,0
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.29992,0.026235,0.059266,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.36064,0.025959,0.030086,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.47049,0.02592,0.0026057,0,0
3,GO PULMONARY VALVE DEVELOPMENT,0.48678,0.025895,0.059865,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.23245,0.025854,0.078163,0,0
3,GO MACROMOLECULE DEACYLATION,0.32077,0.025786,0.027359,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.78962,0.025704,0.0056446,0,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.93377,0.025562,0.0044117,0,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.60883,0.025503,-0.12318,0,0
3,GO RECEPTOR INTERNALIZATION,0.92682,0.025416,-0.018528,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.87144,0.025361,-0.019375,0,0
3,GO NEURAL TUBE FORMATION,0.63978,0.025298,0.0059324,0,0
3,GO SENSORY PERCEPTION OF PAIN,0.23589,0.025239,0.068563,0,0
3,GO BLASTOCYST FORMATION,0.44924,0.025225,0.06305,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.17374,0.025196,0.035105,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.79636,0.024918,0.022013,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.65866,0.024827,0.01351,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.78962,0.024752,0.0058596,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.28785,0.024735,0.019429,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.55487,0.024723,0.027517,0,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.42855,0.024529,0.0088149,0,0
3,GO RESPONSE TO COCAINE,0.52594,0.024279,0.045323,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.32506,0.02421,0.02752,0,0
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.14048,0.024159,0.038453,0,0
3,GO MRNA MODIFICATION,0.80989,0.023998,-0.035682,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.14769,0.023998,0.039738,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,1,0.02399,-0.010759,0,0
3,GO REGULATION OF PROTEIN IMPORT,0.44402,0.023987,0.022297,0,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.52594,0.02394,0.0083109,0,0
3,GO GONADOTROPIN SECRETION,0.69707,0.023791,0.019303,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.26098,0.023664,0.033037,0,0
3,GO NON RECOMBINATIONAL REPAIR,0.94073,0.023625,-0.011184,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.67137,0.023598,0.033237,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.40349,0.023562,0.018909,0,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.36526,0.023484,0.015621,0,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.42347,0.023455,0.038468,0,0
3,GO MITOTIC CYTOKINESIS,0.91293,0.02331,-0.0010837,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.76281,0.023242,-0.0025262,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.95466,0.023235,-0.0078831,0,0
3,GO MITOCHONDRIAL GENE EXPRESSION,0.44402,0.023165,0.039157,0,0
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.72969,0.02311,-0.065153,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.47588,0.023089,0.0073729,0,0
3,GO RESPONSE TO HEAT,0.43883,0.022972,0.048616,0,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.30402,0.022841,0.056134,0,0
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.22568,0.022833,0.057232,0,0
3,GO FIBROBLAST MIGRATION,0.57857,0.022815,0.010331,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.42347,0.022807,0.020657,0,0
3,GO REGULATION OF CELL CYCLE ARREST,0.63354,0.022795,0.01832,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.89907,0.022767,-0.014227,0,0
3,GO RESPONSE TO ATP,0.71658,0.022728,0.033035,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.30402,0.022727,0.041045,0,0
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.74288,0.022623,0.019198,0,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.66501,0.022466,0.020371,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.64605,0.022392,0.003625,0,0
3,GO REGULATION OF PROTEIN TARGETING,0.84397,0.02236,0.0070067,0,0
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.38408,0.022355,0.027019,0,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.4545,0.022345,0.02015,0,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.43367,0.022342,0.014657,0,0
3,GO HISTONE H3 DEACETYLATION,0.89907,0.022323,-0.011525,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.48678,0.022234,0.036342,0,0
3,GO DENDRITIC SPINE MAINTENANCE,0.65234,0.0222,-0.051076,0,0
3,GO RESPONSE TO BMP,0.23937,0.022149,0.039014,0,0
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.71006,0.022114,0.0058449,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.89907,0.02198,-0.018107,0,0
3,GO PEPTIDYL THREONINE MODIFICATION,0.18508,0.021563,0.056625,0,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.22235,0.021561,0.068107,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.96163,0.021555,-0.03068,0,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.73628,0.021516,0.0010128,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.64605,0.021335,-0.021401,0,0
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.44402,0.021299,0.02402,0,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.16032,0.021169,0.061565,0,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.58456,0.021082,0.0033442,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.48678,0.021063,0.018361,0,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.90599,0.021022,0.046248,0,0
3,GO NUCLEUS ORGANIZATION,0.37932,0.020839,0.034332,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.8303,0.020793,0.013404,0,0
3,GO EMBRYONIC MORPHOGENESIS,0.53742,0.02071,0.010849,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.82348,0.020693,-0.034067,0,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.21905,0.020666,0.080648,0,0
3,GO DNA METHYLATION,0.39858,0.020613,0.034911,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.50337,0.020433,0.046776,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.98953,0.020271,-0.010709,0,0
3,GO PLASMA MEMBRANE TUBULATION,0.80312,0.020267,0.0070938,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.25001,0.020025,0.054872,0,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.82348,0.019969,0.019401,0,0
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.77618,0.019671,-0.019599,0,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.9686,0.01965,-0.0056065,0,0
3,GO RESPONSE TO GLUCAGON,0.77618,0.019594,0.037682,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.82348,0.019586,-0.079183,0,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.8303,0.019556,-0.0094338,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.63978,0.019168,0.021798,0,0
3,GO DNA INTEGRITY CHECKPOINT,0.66501,0.018978,0.0046139,0,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.090515,0.018851,0.098545,0,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.69061,0.018754,0.0049258,0,0
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.19095,0.018625,0.058535,0,0
3,GO FOCAL ADHESION ASSEMBLY,0.67137,0.018624,-0.00067272,0,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.99651,0.018611,-0.0063912,0,0
3,GO MITOCHONDRIAL FISSION,0.40843,0.018536,0.075506,0,0
3,GO SPERMATID DIFFERENTIATION,0.39371,0.018394,0.03177,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.5726,0.018356,0.055498,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.53742,0.018354,0.027058,0,0
3,GO RESPONSE TO HYDROPEROXIDE,0.95466,0.01833,0.0059967,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.70355,0.018264,0.018028,0,0
3,GO CYTOKINESIS,0.87144,0.018106,0.0015385,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.99651,0.018,-0.016219,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.25729,0.017925,0.11743,0,0
3,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.78289,0.017648,-0.021932,0,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.19393,0.017537,0.03366,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.98953,0.017494,-0.021389,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.7495,0.017435,-0.023723,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.32506,0.017337,0.046476,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.87144,0.017321,-0.0038181,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.72313,0.017312,-0.001056,0,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.88523,0.017271,-0.0022067,0,0
3,GO DOSAGE COMPENSATION,0.2,0.017197,0.059375,0,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.56666,0.017188,0.096191,0,0
3,GO PROTEIN TARGETING TO MEMBRANE,0.43883,0.016939,-0.066711,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.60272,0.01689,0.058281,0,0
3,GO PIGMENT GRANULE MATURATION,0.87833,0.016596,-0.018649,0,0
3,GO ADAPTATION OF SIGNALING PATHWAY,0.71658,0.016355,-0.042385,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.88523,0.016195,-0.0043354,0,0
3,GO REGULATION OF GASTRULATION,0.97557,0.015912,-0.022499,0,0
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.59664,0.015886,-0.03734,0,0
3,GO MITOTIC CELL CYCLE,0.66501,0.015855,0.0082848,0,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.24288,0.015762,0.091214,0,0
3,GO REGULATION OF LIPASE ACTIVITY,0.54903,0.015739,0.010121,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.61497,0.015722,-0.1279,0,0
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.63978,0.015645,0.021572,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.81668,0.015514,0.0014043,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.78289,0.015401,0.0092607,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.74288,0.015301,-0.050983,0,0
3,GO PROTEIN TARGETING,0.72969,0.015191,0.0095556,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.24643,0.014969,0.067663,0,0
3,GO MESENCHYME DEVELOPMENT,0.42347,0.01495,-0.066146,0,0
3,GO RESPONSE TO VITAMIN D,0.52594,0.014876,-0.086389,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.56666,0.014875,0.00026409,0,0
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.42855,0.014833,-0.082231,0,0
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.30402,0.014745,0.052359,0,0
3,GO PROSTATE GLAND DEVELOPMENT,0.71006,0.014729,-0.084141,0,0
3,GO CELLULAR RESPONSE TO ATP,0.54903,0.014721,0.054717,0,0
3,GO GENITALIA DEVELOPMENT,0.62732,0.014611,0.024985,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.80312,0.014569,0.0034536,0,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.40349,0.01448,-0.066834,0,0
3,GO DNA METABOLIC PROCESS,0.87144,0.014375,-0.010887,0,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.93377,0.014365,-0.016013,0,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.56075,0.014126,0.010234,0,0
3,GO CELL JUNCTION DISASSEMBLY,0.89215,0.014058,-0.00046995,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.91293,0.014057,-0.024874,0,0
3,GO MRNA CLEAVAGE,0.72313,0.014023,-0.016444,0,0
3,GO CELLULAR OXIDANT DETOXIFICATION,0.30402,0.013911,0.085663,0,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.55487,0.01391,0.024773,0,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.85768,0.013901,-0.014033,0,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.90599,0.013835,-0.0098607,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.59664,0.013789,-0.030021,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.72969,0.013783,-0.037515,0,0
3,GO BONE DEVELOPMENT,0.32077,0.013781,-0.063857,0,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.72969,0.013714,-0.023382,0,0
3,GO SKELETAL MUSCLE ADAPTATION,0.23937,0.013475,0.098669,0,0
3,GO FACIAL NERVE MORPHOGENESIS,0.61497,0.013445,-0.11052,0,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.59059,0.013429,-0.081269,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.83713,0.013316,-0.00049052,0,0
3,GO CELLULAR RESPONSE TO CAMP,0.67776,0.013243,0.02191,0,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.78962,0.01297,0.016265,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.5726,0.012905,0.009355,0,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.65234,0.012903,0.027193,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.89215,0.012896,0.0073665,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.74288,0.012785,0.0085874,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.87144,0.012773,0.012856,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.87833,0.012769,0.0036007,0,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.53167,0.012753,0.090402,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.52594,0.01267,0.022248,0,0
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.78289,0.012616,-0.029758,0,0
3,GO INNERVATION,0.9686,0.012546,0.056476,0,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.52594,0.0125,0.033996,0,0
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.5726,0.012357,0.070635,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.80989,0.012222,-0.032461,0,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.62732,0.012212,0.020004,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.91987,0.012153,-0.020933,0,0
3,GO ASYMMETRIC CELL DIVISION,0.55487,0.012129,0.045274,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.53167,0.012126,0.0061204,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.29992,0.012071,0.098237,0,0
3,GO HISTONE H3 K9 METHYLATION,0.98255,0.01194,-0.011267,0,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.99651,0.011819,-0.011706,0,0
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.38888,0.011794,0.073123,0,0
3,GO SNRNA METABOLIC PROCESS,0.46512,0.011723,0.014799,0,0
3,GO VIRAL LATENCY,0.72969,0.011637,-0.049227,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.84397,0.011578,-0.019881,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.67137,0.011473,-0.018907,0,0
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.65866,0.011401,-0.044804,0,0
3,GO PROTEIN SUMOYLATION,0.8303,0.011349,-0.011183,0,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.71006,0.011322,-0.028229,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.61497,0.011299,0.015216,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.96163,0.01124,0.0038572,0,0
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.89215,0.011071,0.013558,0,0
3,GO EAR MORPHOGENESIS,0.71006,0.010971,-0.029317,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.80312,0.010868,0.0057376,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.56666,0.010752,0.01499,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.22235,0.010468,0.05146,0,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.74288,0.010464,0.022948,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.36991,0.010452,0.050435,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.78962,0.010452,0.012802,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.54903,0.010419,0.096899,0,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.32938,0.010364,0.040269,0,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.41341,0.010342,0.023213,0,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.9686,0.010202,-0.0027202,0,0
3,GO RESPONSE TO CATECHOLAMINE,0.31232,0.010136,0.056353,0,0
3,GO OSTEOBLAST DEVELOPMENT,0.63978,0.010038,-0.0088463,0,0
3,GO REGULATION OF CENTROSOME DUPLICATION,0.20937,0.0099619,0.064596,0,0
3,GO ERYTHROCYTE DEVELOPMENT,0.91987,0.0098535,-0.00098692,0,0
3,GO BLASTODERM SEGMENTATION,0.87144,0.0098449,-0.05159,0,0
3,GO CELL CELL SIGNALING BY WNT,0.98255,0.0095261,-0.0043587,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.84397,0.0093923,-0.0023619,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.19695,0.0092685,0.1777,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.93377,0.0092621,-0.061565,0,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.86455,0.0092331,-0.061802,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.67776,0.0091918,0.015045,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.94073,0.009184,-0.0081494,0,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.98255,0.0090643,-0.009138,0,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.88523,0.0090588,-0.0024534,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.49227,0.008992,0.011005,0,0
3,GO RESPONSE TO AMINO ACID STARVATION,0.39858,0.0089687,0.046645,0,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.79636,0.0088368,0.0021341,0,0
3,GO SNRNA TRANSCRIPTION,0.41842,0.0087523,-0.037552,0,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.60272,0.0087357,-0.092855,0,0
3,GO IMPORT INTO NUCLEUS,0.90599,0.0085624,0.0031741,0,0
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.68418,0.0084986,-0.039398,0,0
3,GO NERVOUS SYSTEM PROCESS,0.4978,0.0084899,0.021986,0,0
3,GO RNA CATABOLIC PROCESS,0.89907,0.0084772,-0.012169,0,0
3,GO CRANIAL NERVE MORPHOGENESIS,0.60883,0.0084174,-0.056193,0,0
3,GO CELL DIVISION,0.54903,0.0080844,-0.018567,0,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.65234,0.0080232,0.025576,0,0
3,GO REGULATION OF CELL DIVISION,0.78289,0.0079281,0.0060581,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.89907,0.0078319,-0.0073408,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.34256,0.0078262,0.021749,0,0
3,GO HISTONE H4 DEACETYLATION,0.57857,0.0076457,-0.058864,0,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.77618,0.0075801,0.013674,0,0
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.95466,0.0075789,-0.020375,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.69061,0.0074049,0.018101,0,0
3,GO MULTI ORGANISM LOCALIZATION,0.70355,0.0072834,-0.04428,0,0
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.36064,0.0072392,0.062293,0,0
3,GO CELL CYCLE PROCESS,0.90599,0.0071615,-0.0018909,0,0
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.8303,0.0070735,0.0016902,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.79636,0.0069923,-0.034301,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.74288,0.006985,-0.089597,0,0
3,GO REGULATION OF TORC1 SIGNALING,0.63978,0.0069714,0.018792,0,0
3,GO DEMETHYLATION,0.54903,0.0068863,0.017237,0,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.73628,0.0068331,-0.026578,0,0
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.46512,0.0067455,-0.041662,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.87833,0.0065842,-0.029856,0,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.78962,0.0065002,0.0086747,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.65866,0.0064815,0.0082552,0,0
3,GO METAPHASE PLATE CONGRESSION,0.59664,0.0064094,0.030061,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.82348,0.0063649,0.010842,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.70355,0.006228,-0.027855,0,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.90599,0.0061475,-0.035674,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.94073,0.0061201,0.00023787,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.65866,0.0060114,-0.064146,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.69707,0.0058446,-0.030608,0,0
3,GO HEPARIN METABOLIC PROCESS,0.7495,0.0058243,0.023061,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.55487,0.0057673,0.063482,0,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.53742,0.0056626,0.046529,0,0
3,GO MRNA METHYLATION,0.52594,0.0056236,-0.063212,0,0
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.19695,0.0056057,0.16037,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.97557,0.0054552,-0.013078,0,0
3,GO HISTONE MONOUBIQUITINATION,0.92682,0.005439,-0.014149,0,0
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.72969,0.0052504,-0.0036818,0,0
3,GO HEART DEVELOPMENT,0.94769,0.0051669,-0.0056783,0,0
3,GO CELL CYCLE CHECKPOINT,0.62732,0.0051545,0.010095,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.85082,0.0048443,0.01873,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.69061,0.0047076,0.06727,0,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.36526,0.0046721,-0.038285,0,0
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.74288,0.0046339,-0.016249,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.59059,0.0046243,0.061825,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.89215,0.0042074,-0.01778,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.75615,0.0041842,-0.050819,0,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.20621,0.0041469,0.06347,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.74288,0.0040068,-0.035023,0,0
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.57857,0.0039649,0.028945,0,0
3,GO LIVER REGENERATION,0.54903,0.0036415,0.0225,0,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.80989,0.0035413,0.0062488,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.98953,0.0035157,-0.0014721,0,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.73628,0.0033713,0.017345,0,0
3,GO PROTEIN HETEROOLIGOMERIZATION,0.96163,0.0033489,-0.0035245,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.62113,0.0032827,0.0080212,0,0
3,GO MICROTUBULE BUNDLE FORMATION,0.56666,0.0031868,0.022038,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.98255,0.0031347,-0.0075984,0,0
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.99651,0.0031326,0.040679,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.93377,0.0029572,-0.0022483,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.89907,0.0025241,0.0027342,0,0
3,GO INNER EAR MORPHOGENESIS,0.66501,0.0022967,-0.026556,0,0
3,GO TOOTH MINERALIZATION,0.91987,0.0022929,-0.0013389,0,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.91293,0.0021269,-0.0063663,0,0
3,GO PEPTIDYL SERINE MODIFICATION,0.15264,0.0020493,0.040937,0,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.87833,0.0020182,-0.0026465,0,0
3,GO ARTERY DEVELOPMENT,0.37932,0.0019977,-0.068914,0,0
3,GO RESPONSE TO VITAMIN A,0.81668,0.001889,-0.043404,0,0
3,GO AXONAL FASCICULATION,0.14526,0.0018092,-0.20465,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.98255,0.0017938,-0.025243,0,0
3,GO RNA MODIFICATION,0.83713,0.0014311,0.0061926,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.82348,0.001376,-0.0011564,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.72969,0.0013136,0.02486,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.59059,0.0013082,-0.037813,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.85768,0.001291,-0.0096418,0,0
3,GO T CELL CHEMOTAXIS,0.80312,0.0012771,-0.031523,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.98953,0.0011991,-0.031714,0,0
3,GO FOLIC ACID METABOLIC PROCESS,0.83713,0.0011715,-0.049317,0,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.32938,0.00091134,-0.11846,0,0
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.72313,0.0007506,-0.013583,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.98255,0.00064911,-0.035344,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.86455,0.00060993,-0.042646,0,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.77618,0.00054712,0.017501,0,0
3,GO POSITIVE REGULATION OF TRANSLATION,0.81668,0.00047386,-0.037096,0,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.89907,0.00032438,0.019069,0,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.49227,0.00026262,0.07851,0,0
3,GO MITOCHONDRIAL TRANSLATION,0.63978,0.00022451,0.024842,0,0
3,GO CELL CELL SIGNALING,0.59664,0.00020379,0.018682,0,0
3,GO ORGANELLE ASSEMBLY,0.99651,0.00019558,0.00012809,0,0
3,GO RHYTHMIC BEHAVIOR,0.65866,0.0001069,0.031302,0,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.82348,1.8642e-05,-0.020901,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.35153,-0.00015299,-0.2021,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.86455,-0.00026364,-0.033589,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.94769,-0.00048655,-0.0036447,0,0
3,GO RNA METHYLATION,0.91987,-0.00060742,-0.0063832,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.97557,-0.00068917,0.010833,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.97557,-0.00071358,-0.016159,0,0
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.34256,-0.00072061,0.086067,0,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.49227,-0.00080327,-0.02092,0,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.72313,-0.00090257,0.021406,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.91987,-0.00097339,-0.0090087,0,0
3,GO LOCOMOTORY BEHAVIOR,0.84397,-0.0011554,0.032965,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.80312,-0.001202,-0.015965,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.91987,-0.0012966,-0.012654,0,0
3,GO HYPOTONIC RESPONSE,0.57857,-0.0013745,-0.072228,0,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.83713,-0.0014466,-0.01859,0,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.93377,-0.0015778,0.029199,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.90599,-0.0016769,-0.012516,0,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.91987,-0.0017996,0.0085824,0,0
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.78289,-0.0018591,0.026875,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.53742,-0.0018792,0.02849,0,0
3,GO FOREGUT MORPHOGENESIS,0.75615,-0.0021372,-0.049874,0,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.44924,-0.0022126,-0.043352,0,0
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.53167,-0.0024444,-0.018213,0,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.60272,-0.0024589,0.032474,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.88523,-0.002492,0.0097682,0,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.64605,-0.0028882,-0.018313,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.86455,-0.0029019,-0.0043504,0,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.29992,-0.0030197,0.094918,0,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.8303,-0.0031114,-0.023179,0,0
3,GO INTERLEUKIN 2 PRODUCTION,0.76281,-0.0031357,-0.055661,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.98255,-0.0031984,-0.014614,0,0
3,GO HISTONE H3 K9 MODIFICATION,0.76281,-0.0032472,-0.02192,0,0
3,GO CRISTAE FORMATION,0.89215,-0.003271,0.02781,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.78289,-0.0033493,-0.031232,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.60883,-0.0033999,-0.016908,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.74288,-0.0035256,-0.034694,0,0
3,GO HISTONE H3 ACETYLATION,0.9686,-0.0035999,-0.0061325,0,0
3,GO CELL PROJECTION ASSEMBLY,0.84397,-0.0036031,-0.00037244,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.86455,-0.0036472,-0.02493,0,0
3,GO REGULATION OF HISTONE UBIQUITINATION,0.52594,-0.0037239,-0.019047,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.67776,-0.0037807,-0.021648,0,0
3,GO SYNAPTIC TRANSMISSION GABAERGIC,0.13355,-0.0037935,-0.10941,0,0
3,GO PEPTIDE CROSS LINKING,0.52594,-0.0041389,0.01818,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.71006,-0.0042473,0.025282,0,0
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.26847,-0.0042751,0.065006,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.89907,-0.0043377,-0.021323,0,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.91987,-0.0043654,-0.022315,0,0
3,GO CELL RECOGNITION,0.7495,-0.0044357,-0.03304,0,0
3,GO TRNA METABOLIC PROCESS,0.89215,-0.004449,-0.011416,0,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.72313,-0.0045963,-0.0092115,0,0
3,GO PROTEIN IMPORT,0.76281,-0.0048194,0.023235,0,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.53167,-0.0048688,-0.027191,0,0
3,GO MISMATCH REPAIR,0.96163,-0.0048811,-0.010934,0,0
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,1,-0.0049004,-0.0050173,0,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.85082,-0.0049655,-0.024732,0,0
3,GO RESPONSE TO MANGANESE ION,0.48678,-0.0050432,0.073242,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.96163,-0.0053081,-0.014454,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,1,-0.0053533,-0.0088468,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.89215,-0.0054491,-0.0093263,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.44402,-0.0054556,-0.071845,0,0
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.62732,-0.0054865,-0.038038,0,0
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.75615,-0.0055118,0.01042,0,0
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.78289,-0.0057303,-0.038806,0,0
3,GO TRABECULA FORMATION,0.91293,-0.0058384,-0.031228,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.53742,-0.0060261,-0.099432,0,0
3,GO REGULATION OF HISTONE METHYLATION,0.80312,-0.0063446,-0.0054068,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.83713,-0.0063955,-0.025108,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.83713,-0.0063978,-0.01935,0,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.4545,-0.0064352,-0.025808,0,0
3,GO HISTONE H3 K36 METHYLATION,0.4978,-0.0064549,-0.055044,0,0
3,GO CELL JUNCTION ORGANIZATION,0.75615,-0.0064762,0.0080567,0,0
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.91293,-0.0064787,0.007638,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.54321,-0.0065961,0.026105,0,0
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.64605,-0.0066769,-0.036678,0,0
3,GO CHROMATIN ORGANIZATION,0.25729,-0.006861,-0.031154,0,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.96163,-0.0069366,0.033284,0,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.49227,-0.0070545,0.06496,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.99651,-0.0072395,0.003741,0,0
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.97557,-0.007305,0.013565,0,0
3,GO RNA 5 END PROCESSING,0.72313,-0.0073268,0.017306,0,0
3,GO EXIT FROM MITOSIS,0.72313,-0.0074765,0.017193,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.69707,-0.0078619,-0.037738,0,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.61497,-0.0079476,0.069648,0,0
3,GO PERICARDIUM DEVELOPMENT,0.80989,-0.0080048,-0.053069,0,0
3,GO RESPONSE TO POTASSIUM ION,0.58456,-0.0082432,-0.036266,0,0
3,GO REGULATION OF CYTOKINESIS,0.80989,-0.0082724,-0.0012073,0,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.47049,-0.0083819,-0.032964,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.71658,-0.008477,0.0054821,0,0
3,GO LIPOPROTEIN LOCALIZATION,0.23589,-0.0086436,-0.09621,0,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.63354,-0.0086575,-0.032225,0,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.67137,-0.0087704,-0.072123,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.89215,-0.0087918,0.001174,0,0
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.53742,-0.0088006,-0.050618,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.54903,-0.0090775,-0.049015,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.83713,-0.0091513,0.093977,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.79636,-0.0093986,0.0012239,0,0
3,GO NOREPINEPHRINE TRANSPORT,0.71658,-0.0094869,0.027495,0,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.78289,-0.0095844,-0.0695,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.40349,-0.0096037,-0.040805,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.54321,-0.0096937,-0.029572,0,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.85768,-0.0097649,0.040808,0,0
3,GO SPECIFICATION OF SYMMETRY,0.56075,-0.0097952,-0.037353,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.87833,-0.0099182,0.024755,0,0
3,GO CENTROSOME DUPLICATION,0.96163,-0.0099355,0.0048099,0,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.50337,-0.010114,0.058688,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.66501,-0.010398,-0.030799,0,0
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.93377,-0.010403,-0.00041221,0,0
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.89907,-0.010567,-0.024354,0,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.63354,-0.010587,-0.016438,0,0
3,GO MRNA 3 END PROCESSING,0.21905,-0.011042,-0.05495,0,0
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.37932,-0.011049,-0.028449,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.84397,-0.011148,-0.02609,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.94769,-0.011296,0.00012428,0,0
3,GO NUCLEAR EXPORT,0.4598,-0.011308,-0.042017,0,0
3,GO NUCLEAR TRANSPORT,0.72313,-0.01131,-0.017131,0,0
3,GO NOTCH RECEPTOR PROCESSING,0.41842,-0.01169,0.17353,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.79636,-0.01177,-0.016229,0,0
3,GO PENTOSE METABOLIC PROCESS,0.99651,-0.011867,0.026633,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.65866,-0.011873,0.051849,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.72313,-0.011938,-0.015404,0,0
3,GO PROTEIN TRIMERIZATION,0.94769,-0.012208,-0.026718,0,0
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.22235,-0.012265,-0.17742,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.67776,-0.012366,-0.034004,0,0
3,GO AORTIC VALVE DEVELOPMENT,0.48678,-0.012396,-0.088451,0,0
3,GO SENSORY ORGAN DEVELOPMENT,0.78289,-0.012413,-0.015028,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.48131,-0.012416,-0.075524,0,0
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.30402,-0.012548,-0.045913,0,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.51459,-0.012616,-0.034492,0,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.54321,-0.012638,-0.028555,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.95466,-0.012777,-0.00018031,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.54321,-0.012793,-0.024305,0,0
3,GO EXPLORATION BEHAVIOR,0.25363,-0.012843,-0.17499,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.70355,-0.012951,-0.039481,0,0
3,GO TRANSLATIONAL TERMINATION,0.82348,-0.012956,0.004501,0,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.7495,-0.013051,-0.019489,0,0
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.76948,-0.013059,-0.038574,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.46512,-0.013159,-0.066797,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.89215,-0.01321,-0.0017296,0,0
3,GO STEM CELL DIFFERENTIATION,0.44924,-0.013299,-0.030844,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,1,-0.013417,0.021136,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.72969,-0.013471,-0.0022593,0,0
3,GO NOSE DEVELOPMENT,0.85082,-0.013647,0.11742,0,0
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.24288,-0.013704,-0.047172,0,0
3,GO RNA POLYADENYLATION,0.3746,-0.013791,-0.041028,0,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.47588,-0.013853,-0.034243,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.30402,-0.013886,-0.047857,0,0
3,GO EYE MORPHOGENESIS,0.76281,-0.014016,-0.022131,0,0
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.76948,-0.014311,-0.038975,0,0
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.71006,-0.014325,0.0015253,0,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.4978,-0.014349,0.047568,0,0
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.39371,-0.014412,-0.060076,0,0
3,GO CELL FATE COMMITMENT,0.85768,-0.014725,-0.0077891,0,0
3,GO REGIONALIZATION,0.7495,-0.014741,0.017451,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.83713,-0.014948,-0.00063786,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.49227,-0.015067,-0.042008,0,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.82348,-0.015155,0.025778,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.84397,-0.015177,0.078881,0,0
3,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.98255,-0.01523,0.025732,0,0
3,GO PROTEIN MONOUBIQUITINATION,0.91987,-0.015415,-0.0088683,0,0
3,GO GROWTH HORMONE SECRETION,0.91293,-0.015544,0.040316,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.89907,-0.015679,0.012072,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.4598,-0.015867,0.054918,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.80989,-0.015868,-0.053699,0,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.71658,-0.015887,-0.0093727,0,0
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.80312,-0.01593,0.00043128,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.79636,-0.016129,-0.010961,0,0
3,GO CHROMATIN SILENCING,0.36991,-0.016147,-0.032113,0,0
3,GO DNA REPLICATION,0.31653,-0.016149,-0.036847,0,0
3,GO PROTEIN ACYLATION,0.50896,-0.016175,-0.010349,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.57857,-0.016205,0.051173,0,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.55487,-0.016214,0.039721,0,0
3,GO BEHAVIOR,0.93377,-0.016252,0.0048384,0,0
3,GO TRANSEPITHELIAL TRANSPORT,0.99651,-0.016348,0.031962,0,0
3,GO CHROMOSOME LOCALIZATION,0.84397,-0.016365,0.01806,0,0
3,GO FIBROBLAST APOPTOTIC PROCESS,0.91293,-0.016426,-0.012129,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.61497,-0.016448,-0.038674,0,0
3,GO NUCLEUS LOCALIZATION,0.53742,-0.016545,-0.04081,0,0
3,GO REGULATION OF DNA BINDING,0.78962,-0.016581,-0.0024712,0,0
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.38888,-0.016685,-0.094456,0,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.66501,-0.01695,-0.038273,0,0
3,GO RNA 3 END PROCESSING,0.38888,-0.017075,-0.046239,0,0
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.89907,-0.017284,-0.028566,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.42855,-0.017374,-0.025631,0,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.85768,-0.017425,0.054537,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.38408,-0.017496,-0.084172,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.65866,-0.017502,-0.043626,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.14285,-0.01767,-0.04275,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.72969,-0.01782,-0.033108,0,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.99651,-0.017852,-0.0027978,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.67776,-0.018022,-0.061325,0,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.86455,-0.018023,-0.010766,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.91293,-0.018252,-0.011835,0,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.2,-0.018264,-0.026711,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.65234,-0.018373,-0.020332,0,0
3,GO DNA REPAIR,0.28785,-0.018404,-0.02957,0,0
3,GO PROTEIN NEDDYLATION,0.41341,-0.018432,-0.050897,0,0
3,GO COVALENT CHROMATIN MODIFICATION,0.19695,-0.018604,-0.03606,0,0
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.16032,-0.018624,-0.062686,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.92682,-0.018759,-0.0052015,0,0
3,GO DEVELOPMENTAL GROWTH,0.42855,-0.01876,-0.038405,0,0
3,GO MEMORY,0.77618,-0.018769,-0.014459,0,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.62113,-0.019116,-0.023708,0,0
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.69707,-0.019171,-0.059585,0,0
3,GO NCRNA METABOLIC PROCESS,0.71658,-0.019357,-0.028918,0,0
3,GO MIDBRAIN DEVELOPMENT,0.61497,-0.01944,-0.024788,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.74288,-0.019485,-0.031152,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.39371,-0.019572,-0.060997,0,0
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.94769,-0.019612,0.029653,0,0
3,GO REGULATION OF TUBULIN DEACETYLATION,0.9686,-0.01978,0.01979,0,0
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.39858,-0.019823,-0.042236,0,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.68418,-0.019902,-0.010631,0,0
3,GO SNRNA PROCESSING,0.58456,-0.020009,-0.0056158,0,0
3,GO OVULATION CYCLE PROCESS,0.85082,-0.020104,0.023394,0,0
3,GO THALAMUS DEVELOPMENT,0.80989,-0.020172,0.0025147,0,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.89215,-0.020215,-0.017951,0,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.29586,-0.020374,-0.070374,0,0
3,GO NEGATIVE REGULATION OF CELL SIZE,0.89907,-0.020518,-0.037329,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.76281,-0.020641,0.043148,0,0
3,GO MUSCLE ORGAN MORPHOGENESIS,0.59664,-0.020714,-0.043024,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.77618,-0.020739,0.016617,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.99651,-0.020789,0.015157,0,0
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.29992,-0.020929,-0.078097,0,0
3,GO RNA LOCALIZATION,0.14769,-0.020933,-0.069186,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.67776,-0.020979,-0.0062025,0,0
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.48678,-0.020985,-0.048329,0,0
3,GO PROTEIN HETEROTETRAMERIZATION,0.7495,-0.021002,0.012128,0,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.4545,-0.021013,-0.0393,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.5726,-0.02135,-0.051507,0,0
3,GO SPINDLE ASSEMBLY,0.59664,-0.021593,-0.016947,0,0
3,GO PEPTIDYL LYSINE METHYLATION,0.47588,-0.021744,-0.021948,0,0
3,GO ERBB2 SIGNALING PATHWAY,0.78289,-0.021795,0.041296,0,0
3,GO MEMBRANE DOCKING,0.70355,-0.021876,-0.01024,0,0
3,GO NUCLEOSOME ASSEMBLY,0.32077,-0.02201,-0.054317,0,0
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.75615,-0.022055,-0.0066306,0,0
3,GO REGULATION OF MEMBRANE POTENTIAL,0.80989,-0.022192,0.021041,0,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.38408,-0.02235,-0.042164,0,0
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.95466,-0.022412,0.0054257,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.59059,-0.022415,0.052806,0,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.2839,-0.022679,-0.056314,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.42347,-0.022761,-0.17188,0,0
3,GO NUCLEOTIDE EXCISION REPAIR,0.25729,-0.023054,-0.037031,0,0
3,GO CARTILAGE DEVELOPMENT,0.5726,-0.023231,-0.043133,0,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.87833,-0.023286,0.12434,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.78962,-0.02331,0.019812,0,0
3,GO REGULATION OF MRNA POLYADENYLATION,0.23245,-0.02337,-0.058817,0,0
3,GO RESPONSE TO AMYLOID BETA,0.95466,-0.02338,0.0052028,0,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.50896,-0.02349,-0.052136,0,0
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.71006,-0.02364,0.10389,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.4978,-0.023731,-0.047184,0,0
3,GO MRNA TRANSCRIPTION,0.52594,-0.024095,-0.044806,0,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.7495,-0.02417,-0.017928,0,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.4978,-0.024612,-0.014827,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.67776,-0.024674,-0.00082679,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.2,-0.024788,-0.069875,0,0
3,GO SERTOLI CELL DEVELOPMENT,0.68418,-0.024798,-0.084448,0,0
3,GO ONE CARBON COMPOUND TRANSPORT,0.5726,-0.024889,0.045233,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.73628,-0.024906,-0.016039,0,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.59664,-0.025133,-0.03322,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.21905,-0.025211,-0.086621,0,0
3,GO MESODERM DEVELOPMENT,0.36064,-0.025275,-0.050303,0,0
3,GO RNA EXPORT FROM NUCLEUS,0.14048,-0.025303,-0.066408,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.77618,-0.025411,-0.020822,0,0
3,GO HEAT GENERATION,0.86455,-0.025457,0.020116,0,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.42855,-0.025576,-0.0203,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.48678,-0.025588,0.039119,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.69707,-0.025641,-0.060717,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.40349,-0.025789,-0.066227,0,0
3,GO REGULATION OF CENTROSOME CYCLE,0.87833,-0.025936,0.0079962,0,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.53742,-0.026073,-0.077357,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.17934,-0.026116,-0.07178,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.74288,-0.026166,-0.016298,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.78289,-0.026198,0.016482,0,0
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.56075,-0.026352,-0.033313,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.88523,-0.026436,0.074233,0,0
3,GO CHROMOSOME ORGANIZATION,0.33373,-0.026497,-0.024463,0,0
3,GO REGULATION OF HEAT GENERATION,0.94769,-0.026571,0.016033,0,0
3,GO SISTER CHROMATID SEGREGATION,0.58456,-0.026588,-0.010984,0,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.60883,-0.026609,0.039414,0,0
3,GO PROTEIN METHYLATION,0.78962,-0.026654,-0.0043026,0,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.11235,-0.027091,-0.10281,0,0
3,GO RETINA LAYER FORMATION,0.76948,-0.027094,0.068821,0,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.86455,-0.027189,0.056165,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.38888,-0.027206,-0.044671,0,0
3,GO ODONTOGENESIS,0.32938,-0.027247,-0.082948,0,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.65866,-0.027307,-0.040419,0,0
3,GO DNA PACKAGING,0.093897,-0.027313,-0.048966,0,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.43883,-0.027412,0.05855,0,0
3,GO MESENCHYME MORPHOGENESIS,0.53742,-0.027499,-0.06715,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.32506,-0.02772,-0.076091,0,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.61497,-0.027727,-0.016711,0,0
3,GO VAGINA DEVELOPMENT,0.87144,-0.027754,-0.044166,0,0
3,GO REGULATION OF DNA REPLICATION,0.93377,-0.027854,-0.0068567,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.65234,-0.027998,-0.033485,0,0
3,GO AORTA DEVELOPMENT,0.21579,-0.028043,-0.10903,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.69707,-0.028275,-0.031884,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.85768,-0.028342,0.05016,0,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.40349,-0.028463,-0.093951,0,0
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.23589,-0.028486,-0.092123,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.52025,-0.028568,-0.033814,0,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.47049,-0.028615,-0.044338,0,0
3,GO GANGLION DEVELOPMENT,0.9686,-0.028822,0.064261,0,0
3,GO ANIMAL ORGAN FORMATION,0.22235,-0.028877,-0.085328,0,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.32077,-0.028968,-0.095717,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.53742,-0.029197,-0.040207,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.32077,-0.029304,-0.066695,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.43367,-0.029448,-0.074957,0,0
3,GO CELLULAR RESPONSE TO HEAT,0.60272,-0.029635,-0.023804,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.59059,-0.029655,0.036447,0,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.51459,-0.029709,0.005487,0,0
3,GO REGULATION OF GENE SILENCING,0.61497,-0.02983,-0.031922,0,0
3,GO HISTONE H4 ACETYLATION,0.29586,-0.030041,-0.02647,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.72313,-0.030181,-0.038687,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.19095,-0.030215,-0.11023,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.75615,-0.030257,0.0081509,0,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.69061,-0.030287,-0.0143,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.92682,-0.03034,-0.017377,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.23589,-0.030354,-0.027795,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.26471,-0.030723,-0.1325,0,0
3,GO REGULATION OF GTP BINDING,0.93377,-0.030724,-0.0070032,0,0
3,GO SCHWANN CELL DIFFERENTIATION,0.75615,-0.03086,-0.018207,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.22568,-0.030917,-0.04005,0,0
3,GO INTRACELLULAR MRNA LOCALIZATION,0.86455,-0.031052,-0.0052027,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.74288,-0.031065,-0.011089,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.69061,-0.031067,-0.0081264,0,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.56666,-0.031099,-0.0090004,0,0
3,GO STEM CELL DIVISION,0.5726,-0.031119,-0.040658,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.25001,-0.031207,-0.10784,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.25001,-0.031556,-0.058355,0,0
3,GO HISTONE H3 K4 METHYLATION,0.54321,-0.031667,-0.014054,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.68418,-0.031787,0.048743,0,0
3,GO NCRNA TRANSCRIPTION,0.16032,-0.031815,-0.059052,0,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.1313,-0.032058,-0.073199,0,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.12259,-0.032079,-0.040386,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.34702,-0.032115,-0.066076,0,0
3,GO HISTONE PHOSPHORYLATION,0.91987,-0.032227,-0.0072471,0,0
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.10845,-0.032281,-0.084424,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.72969,-0.032356,-0.012433,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.48678,-0.032397,-0.045374,0,0
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.94073,-0.032598,-0.013369,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.71658,-0.032734,-0.017306,0,0
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.39858,-0.032744,-0.044653,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,1,-0.033094,-0.024256,0,0
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.54321,-0.033173,-0.075324,0,0
3,GO MINERALOCORTICOID METABOLIC PROCESS,0.52025,-0.033254,-0.10073,0,0
3,GO HISTONE EXCHANGE,0.30815,-0.033256,-0.046621,0,0
3,GO TELOMERE ORGANIZATION,0.19695,-0.033281,-0.053576,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS,0.54903,-0.033365,0.082848,0,0
3,GO NEUROTRANSMITTER REUPTAKE,0.67776,-0.033621,0.042785,0,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.17653,-0.033621,-0.042967,0,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.90599,-0.033806,-0.00061491,0,0
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.37932,-0.033808,-0.055388,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.37932,-0.033897,-0.078021,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.46512,-0.03396,-0.075404,0,0
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.18219,-0.033988,-0.046658,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.39858,-0.034009,-0.066863,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.60272,-0.034219,-0.083048,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.41842,-0.034222,-0.077206,0,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.93377,-0.03424,-0.039887,0,0
3,GO THYROID GLAND DEVELOPMENT,0.29586,-0.034281,-0.11594,0,0
3,GO NAD METABOLIC PROCESS,0.75615,-0.034316,0.033649,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.67137,-0.034319,-0.023586,0,0
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.73628,-0.034584,-0.035513,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.89907,-0.0346,-0.035652,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.4598,-0.034637,-0.053184,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.44924,-0.034676,-0.12331,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.16828,-0.034757,-0.093067,0,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.25001,-0.035305,-0.04125,0,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.14285,-0.035335,-0.054242,0,0
3,GO FEMALE GENITALIA DEVELOPMENT,0.5726,-0.035471,-0.042339,0,0
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.60883,-0.035517,0.0059905,0,0
3,GO PROTEIN ACETYLATION,0.12689,-0.035971,-0.029188,0,0
3,GO HISTONE H3 K14 ACETYLATION,0.63354,-0.036107,-0.027213,0,0
3,GO DNA CONFORMATION CHANGE,0.1313,-0.036215,-0.046569,0,0
3,GO PROTEIN KINASE A SIGNALING,0.22905,-0.036296,-0.067677,0,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.62732,-0.036347,-0.04565,0,0
3,GO HISTONE UBIQUITINATION,0.11434,-0.036561,-0.054105,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.50896,-0.036718,-0.029827,0,0
3,GO REGULATION OF OOGENESIS,0.78962,-0.036725,-0.0062754,0,0
3,GO RNA STABILIZATION,0.18508,-0.036872,-0.073467,0,0
3,GO NCRNA PROCESSING,0.33812,-0.036889,-0.065097,0,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.58456,-0.036915,-0.019097,0,0
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.38408,-0.036942,-0.074039,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.87144,-0.037056,-0.019435,0,0
3,GO CELL CYCLE DNA REPLICATION,0.37932,-0.037138,-0.045949,0,0
3,GO CGMP MEDIATED SIGNALING,0.40349,-0.037154,-0.054795,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.63354,-0.037246,-0.022609,0,0
3,GO MRNA EXPORT FROM NUCLEUS,0.061812,-0.037266,-0.074386,0,0
3,GO STRIATUM DEVELOPMENT,0.94073,-0.037281,0.014187,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.79636,-0.037475,-0.011589,0,0
3,GO HISTONE METHYLATION,0.41842,-0.037496,-0.02344,0,0
3,GO HEART VALVE DEVELOPMENT,0.42347,-0.037674,-0.073883,0,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.38888,-0.037862,-0.10826,0,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.54903,-0.03801,-0.026875,0,0
3,GO RNA PROCESSING,0.14048,-0.038085,-0.056625,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.31232,-0.038352,-0.055086,0,0
3,GO REGULATION OF BEHAVIOR,0.31653,-0.038367,-0.066977,0,0
3,GO CONVERGENT EXTENSION,0.43367,-0.038594,-0.085207,0,0
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.56666,-0.038624,-0.014225,0,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.52594,-0.038666,-0.032194,0,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.41341,-0.03879,-0.056777,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.49227,-0.03882,-0.047443,0,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.22905,-0.038909,-0.063515,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.36064,-0.038993,-0.041344,0,0
3,GO ANATOMICAL STRUCTURE REGRESSION,0.43883,-0.039045,-0.10475,0,0
3,GO SPINDLE MIDZONE ASSEMBLY,0.26471,-0.039158,-0.078309,0,0
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.092194,-0.03945,-0.068271,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.092194,-0.039701,-0.05788,0,0
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.3746,-0.039863,-0.095117,0,0
3,GO DETECTION OF VISIBLE LIGHT,0.52025,-0.040016,-0.051313,0,0
3,GO REGULATION OF MRNA BINDING,0.39858,-0.040136,-0.088741,0,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.15773,-0.040416,-0.045854,0,0
3,GO PSEUDOURIDINE SYNTHESIS,0.4598,-0.040447,-0.064953,0,0
3,GO NUCLEOBASE METABOLIC PROCESS,0.81668,-0.040918,0.014458,0,0
3,GO TRANSLATIONAL ELONGATION,0.69707,-0.040948,-0.036042,0,0
3,GO DOUBLE STRAND BREAK REPAIR,0.15517,-0.041098,-0.053593,0,0
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.40349,-0.041129,-0.09423,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.43883,-0.041197,-0.058633,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.12259,-0.041303,-0.060851,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.95466,-0.04148,-0.015895,0,0
3,GO PATTERN SPECIFICATION PROCESS,0.64605,-0.041611,-0.015668,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.39371,-0.041856,-0.035288,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.10096,-0.041872,-0.086042,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.89907,-0.042016,0.015008,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.69707,-0.042044,-0.031784,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.96163,-0.042063,0.0021532,0,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.20621,-0.042161,-0.06944,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.63978,-0.042373,-0.024629,0,0
3,GO STEM CELL PROLIFERATION,0.60272,-0.042426,-0.021561,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.90599,-0.04246,-0.0093142,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.43367,-0.042595,-0.10304,0,0
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.33373,-0.042633,-0.032654,0,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.24643,-0.042647,-0.06317,0,0
3,GO GLUTAMINE METABOLIC PROCESS,0.47588,-0.042704,-0.064086,0,0
3,GO SHORT TERM MEMORY,0.73628,-0.04285,-0.047112,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.73628,-0.042894,-0.021913,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.56075,-0.043071,-0.053817,0,0
3,GO REGULATION OF RNA SPLICING,0.053746,-0.043108,-0.048226,0,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.83713,-0.043151,-0.0355,0,0
3,GO RECOMBINATIONAL REPAIR,0.057089,-0.043275,-0.068451,0,0
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.25729,-0.043313,-0.099566,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.47588,-0.043681,-0.054879,0,0
3,GO HISTONE H2A UBIQUITINATION,0.21579,-0.043699,-0.059306,0,0
3,GO TROPHOBLAST CELL MIGRATION,0.53742,-0.044463,-0.10506,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.57857,-0.044769,-0.019054,0,0
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.92682,-0.045219,0.016926,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.53167,-0.045223,-0.041948,0,0
3,GO RESPONSE TO DOPAMINE,0.95466,-0.045287,0.010807,0,0
3,GO ORGAN GROWTH,0.29184,-0.045302,-0.055485,0,0
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.65866,-0.045384,0.028255,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.43883,-0.045533,-0.030177,0,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.36991,-0.045558,-0.049718,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.23245,-0.045899,-0.039401,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.77618,-0.046057,-0.011578,0,0
3,GO NEUROMUSCULAR PROCESS,0.18508,-0.04627,-0.074618,0,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.3746,-0.046334,-0.085867,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.20309,-0.046354,-0.084282,0,0
3,GO CELL CELL JUNCTION MAINTENANCE,0.52594,-0.046672,-0.067644,0,0
3,GO DNA RECOMBINATION,0.16294,-0.046888,-0.039754,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.72313,-0.046901,-0.017033,0,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.28785,-0.047176,-0.050886,0,0
3,GO RRNA METABOLIC PROCESS,0.32077,-0.047621,-0.06762,0,0
3,GO MRNA METABOLIC PROCESS,0.11841,-0.047649,-0.05262,0,0
3,GO NEUROTRANSMITTER UPTAKE,0.93377,-0.047696,0.022457,0,0
3,GO DNA REPLICATION CHECKPOINT,0.16828,-0.048015,-0.085082,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.85768,-0.048051,-0.0064138,0,0
3,GO CEREBELLAR CORTEX FORMATION,0.36526,-0.04814,-0.052186,0,0
3,GO GENITALIA MORPHOGENESIS,0.90599,-0.048544,0.011485,0,0
3,GO CHROMOSOME SEGREGATION,0.35607,-0.048906,-0.021013,0,0
3,GO DNA STRAND ELONGATION,0.37932,-0.049013,-0.039853,0,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.59059,-0.049086,-0.048939,0,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.15264,-0.049594,-0.045373,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.32506,-0.049981,-0.048612,0,0
3,GO DNA GEOMETRIC CHANGE,0.090515,-0.05004,-0.072758,0,0
3,GO CELL MORPHOGENESIS,0.17653,-0.0501,-0.062634,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.39858,-0.050108,-0.0447,0,0
3,GO RESPONSE TO UV,0.19695,-0.050155,-0.043507,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.34256,-0.050164,-0.077476,0,0
3,GO IRON COORDINATION ENTITY TRANSPORT,0.87833,-0.05027,0.028893,0,0
3,GO NADH METABOLIC PROCESS,0.67776,-0.050402,-0.01347,0,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.78962,-0.050552,-0.049155,0,0
3,GO REGULATION OF ORGAN GROWTH,0.17374,-0.050707,-0.078494,0,0
3,GO REGULATION OF CILIUM BEAT FREQUENCY,0.4545,-0.050713,-0.054943,0,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.44924,-0.050925,-0.11543,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.20937,-0.051084,-0.071232,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.24643,-0.051167,-0.043983,0,0
3,GO OTIC VESICLE MORPHOGENESIS,0.33812,-0.051218,-0.10527,0,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.25001,-0.051518,-0.077111,0,0
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.4978,-0.051557,-0.031099,0,0
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.70355,-0.051821,-0.038679,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.13583,-0.051951,-0.047021,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.9686,-0.051997,0.010741,0,0
3,GO MRNA TRANSPORT,0.14285,-0.052034,-0.062412,0,0
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.11235,-0.052043,-0.083731,0,0
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.1028,-0.05212,-0.088281,0,0
3,GO NCRNA EXPORT FROM NUCLEUS,0.36991,-0.052132,-0.061171,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.70355,-0.05242,-0.024281,0,0
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.16559,-0.052468,-0.12807,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.18508,-0.052481,-0.14822,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.12259,-0.052487,-0.069845,0,0
3,GO COLLAGEN METABOLIC PROCESS,0.72313,-0.0528,-0.065956,0,0
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.48678,-0.05299,-0.036439,0,0
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.20309,-0.053144,-0.050369,0,0
3,GO TRANSLATIONAL INITIATION,0.29184,-0.053223,-0.099231,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.72969,-0.053276,-0.0063759,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.41842,-0.05332,-0.058043,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.46512,-0.053368,-0.082545,0,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.36991,-0.053371,-0.030079,0,0
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.188,-0.053419,-0.10912,0,0
3,GO MOTILE CILIUM ASSEMBLY,0.82348,-0.053752,-0.026834,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.73628,-0.053886,-0.0015915,0,0
3,GO SPINDLE ORGANIZATION,0.085627,-0.053962,-0.051776,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.17653,-0.05436,-0.053961,0,0
3,GO RNA CAPPING,0.2,-0.054466,-0.053103,0,0
3,GO GLUCOSE CATABOLIC PROCESS,0.93377,-0.054747,0.003651,0,0
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.48131,-0.054748,-0.026472,0,0
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.63354,-0.054854,-0.010272,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.22568,-0.054901,-0.056031,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.1028,-0.055504,-0.10109,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.85082,-0.055533,-0.07485,0,0
3,GO HISTONE ARGININE METHYLATION,0.25001,-0.05561,-0.056926,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.61497,-0.05564,-0.073139,0,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.31653,-0.056021,-0.082521,0,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.014486,-0.056182,-0.069666,0,0
3,GO CHROMATIN REMODELING,0.018836,-0.056206,-0.067289,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.17099,-0.056349,-0.1101,0,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.17374,-0.056699,-0.080988,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.69707,-0.056899,-0.0561,0,0
3,GO PROTEIN DENEDDYLATION,0.58456,-0.057028,-0.037258,0,0
3,GO ERYTHROCYTE MATURATION,0.34702,-0.057178,-0.087805,0,0
3,GO TRNA TRANSPORT,0.35153,-0.057228,-0.06774,0,0
3,GO EPIBOLY,0.69061,-0.057438,-0.095416,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.7495,-0.057504,-0.016854,0,0
3,GO ACTIVATION OF JNKK ACTIVITY,0.55487,-0.057612,-0.035445,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.061812,-0.057674,-0.047695,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.19393,-0.057951,-0.047839,0,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.21905,-0.057971,-0.061153,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.43367,-0.058016,-0.038261,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.26098,-0.058122,-0.063022,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.41341,-0.058257,-0.064969,0,0
3,GO HEART GROWTH,0.44924,-0.058298,-0.037828,0,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.29586,-0.058439,-0.056546,0,0
3,GO MICROTUBULE BASED PROCESS,0.05824,-0.058481,-0.046555,0,0
3,GO LEFT RIGHT AXIS SPECIFICATION,0.91293,-0.058709,-0.0054224,0,0
3,GO CHROMOSOME SEPARATION,0.15773,-0.058841,-0.053363,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.2839,-0.058909,-0.072559,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.60272,-0.059102,-0.023848,0,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.13355,-0.059309,-0.15312,0,0
3,GO TRNA PROCESSING,0.25729,-0.059399,-0.06357,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.46512,-0.059489,-0.039323,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.10845,-0.059646,-0.10027,0,0
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.70355,-0.059677,-0.051371,0,0
3,GO VIRAL GENE EXPRESSION,0.42347,-0.059708,-0.074273,0,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.39858,-0.059841,-0.03302,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.32077,-0.05988,-0.11263,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.65234,-0.059995,-0.032286,0,0
3,GO ETHANOL CATABOLIC PROCESS,0.36064,-0.060088,-0.090925,0,0
3,GO MAST CELL MIGRATION,0.53167,-0.060427,-0.090057,0,0
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.63354,-0.060447,-0.067272,0,0
3,GO NODAL SIGNALING PATHWAY,0.56075,-0.061181,-0.035217,0,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.68418,-0.06132,-0.065884,0,0
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.20937,-0.061464,-0.084559,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.38888,-0.061509,-0.04259,0,0
3,GO SPINDLE LOCALIZATION,0.22235,-0.061732,-0.04928,0,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.21579,-0.061794,-0.049805,0,0
3,GO PEPTIDYL ARGININE MODIFICATION,0.12259,-0.061889,-0.0612,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.76948,-0.061946,0.16499,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.97557,-0.061984,6.0343e-05,0,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.69061,-0.062175,-0.070784,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.28785,-0.062243,-0.071508,0,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.12473,-0.06233,-0.053759,0,0
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.30815,-0.062412,-0.075698,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.35153,-0.062417,-0.066335,0,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.88523,-0.062455,0.01451,0,0
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.54321,-0.062575,-0.022453,0,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.89907,-0.062636,0.0033337,0,0
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.075049,-0.062908,-0.1109,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.60272,-0.063045,-0.056517,0,0
3,GO SULFATION,0.12049,-0.06317,-0.10552,0,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.090515,-0.063508,-0.16433,0,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.35153,-0.063873,-0.069939,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.50896,-0.064016,-0.028016,0,0
3,GO TRNA METHYLATION,0.36064,-0.06411,-0.051466,0,0
3,GO LYMPH VESSEL MORPHOGENESIS,0.33812,-0.064302,-0.088694,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.16032,-0.064543,-0.1238,0,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.35607,-0.06461,-0.036261,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.17934,-0.064614,-0.2114,0,0
3,GO HISTONE MRNA METABOLIC PROCESS,0.11636,-0.064637,-0.079694,0,0
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.8303,-0.06467,0.094181,0,0
3,GO HISTONE H2A ACETYLATION,0.18219,-0.064743,-0.072906,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.17934,-0.064908,-0.044706,0,0
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.36526,-0.064918,-0.070044,0,0
3,GO RESPONSE TO AXON INJURY,0.36064,-0.064964,-0.048137,0,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,0.14769,-0.064979,-0.03123,0,0
3,GO CELL PROJECTION ORGANIZATION,0.22235,-0.065123,-0.042565,0,0
3,GO GENETIC IMPRINTING,0.30402,-0.06525,-0.062491,0,0
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.16032,-0.065566,-0.11967,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.4598,-0.065728,-0.044693,0,0
3,GO RIBOSOME BIOGENESIS,0.24643,-0.066219,-0.085114,0,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.033166,-0.066259,-0.13011,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.4598,-0.066283,-0.064835,0,0
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.88523,-0.066348,-0.015894,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.11235,-0.066522,-0.085772,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.5726,-0.066561,-0.044596,0,0
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.19695,-0.06669,-0.05735,0,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.58456,-0.066699,-0.024609,0,0
3,GO DEVELOPMENTAL CELL GROWTH,0.088862,-0.067142,-0.099195,0,0
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.5726,-0.06717,-0.039318,0,0
3,GO PEPTIDYL ARGININE METHYLATION,0.15015,-0.067244,-0.068718,0,0
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.95466,-0.067688,0.02649,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.24288,-0.067759,-0.039796,0,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.092194,-0.067761,-0.093678,0,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.19393,-0.067804,-0.080425,0,0
3,GO EMBRYONIC HEMOPOIESIS,0.36064,-0.067807,-0.061209,0,0
3,GO RNA SURVEILLANCE,0.28785,-0.06784,-0.056144,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.48678,-0.068374,-0.06714,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.63978,-0.068406,-0.016141,0,0
3,GO SEQUESTERING OF METAL ION,0.24643,-0.068442,-0.1083,0,0
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.14285,-0.068824,-0.098945,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.4598,-0.069003,-0.10475,0,0
3,GO HEART MORPHOGENESIS,0.34256,-0.069146,-0.052799,0,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.36991,-0.069173,-0.052502,0,0
3,GO MESODERMAL CELL FATE COMMITMENT,0.4978,-0.069235,-0.057791,0,0
3,GO AXIS ELONGATION,0.35607,-0.069577,-0.086854,0,0
3,GO REGULATION OF CELL DEVELOPMENT,0.29586,-0.0696,-0.044398,0,0
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.21256,-0.069612,-0.076826,0,0
3,GO SKELETAL MUSCLE CONTRACTION,0.48678,-0.069928,-0.047319,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.10096,-0.070107,-0.10245,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.29586,-0.070222,-0.1295,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.188,-0.070487,-0.074004,0,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.55487,-0.070654,-0.05941,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.13814,-0.070705,-0.050883,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.4598,-0.070888,-0.077288,0,0
3,GO NEUROGENESIS,0.19393,-0.070965,-0.056227,0,0
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.36526,-0.071,-0.07165,0,0
3,GO CYTOPLASMIC TRANSLATION,0.20937,-0.071038,-0.13092,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.44402,-0.071062,-0.03958,0,0
3,GO REGULATION OF DNA RECOMBINATION,0.077957,-0.071367,-0.078691,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.57857,-0.071376,-0.043726,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.83713,-0.071551,0.028815,0,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.50896,-0.07163,-0.057946,0,0
3,GO REGULATION OF RNA BINDING,0.11636,-0.071756,-0.10723,0,0
3,GO SNORNA METABOLIC PROCESS,0.13814,-0.072186,-0.12182,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.15015,-0.072198,-0.068817,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.02843,-0.072271,-0.11304,0,0
3,GO NUCLEAR PORE ORGANIZATION,0.43883,-0.072358,-0.074548,0,0
3,GO CELLULAR RESPONSE TO UV,0.12908,-0.072409,-0.062882,0,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.11841,-0.072615,-0.069093,0,0
3,GO PROSTATE GLAND GROWTH,0.17099,-0.072775,-0.14972,0,0
3,GO CHROMOSOME CONDENSATION,0.23245,-0.072939,-0.038561,0,0
3,GO REGULATION OF CELL SIZE,0.070855,-0.073223,-0.097085,0,0
3,GO G0 TO G1 TRANSITION,0.097379,-0.073243,-0.069834,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.33373,-0.073293,-0.042616,0,0
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.67137,-0.073616,-0.025853,0,0
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.23937,-0.07372,-0.11528,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.22905,-0.073823,-0.065641,0,0
3,GO POSITIVE REGULATION OF HEART GROWTH,0.13583,-0.074422,-0.1119,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.22568,-0.074547,-0.065555,0,0
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.38888,-0.074885,-0.07839,0,0
3,GO MICROTUBULE POLYMERIZATION,0.023741,-0.075028,-0.11365,0,0
3,GO HINDBRAIN DEVELOPMENT,0.85768,-0.075077,0.012952,0,0
3,GO SUCKLING BEHAVIOR,0.37932,-0.07509,-0.095245,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.21256,-0.075164,-0.12394,0,0
3,GO RESPONSE TO SALT STRESS,0.4598,-0.075247,-0.077573,0,0
3,GO HAIR FOLLICLE MATURATION,0.34256,-0.075436,-0.10236,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.83713,-0.075466,-0.032135,0,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.15517,-0.075469,-0.10995,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.78962,-0.075726,0.0066037,0,0
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.036948,-0.075817,-0.14293,0,0
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.072231,-0.075904,-0.064342,0,0
3,GO HEAD DEVELOPMENT,0.24643,-0.076016,-0.039619,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.31653,-0.076216,-0.088269,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.25001,-0.076243,-0.042047,0,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.65234,-0.07636,-0.035199,0,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.0059384,-0.076421,-0.085081,0,0
3,GO TRNA MODIFICATION,0.15773,-0.076741,-0.085045,0,0
3,GO DISTAL TUBULE DEVELOPMENT,0.80989,-0.07687,0.0024296,0,0
3,GO COGNITION,0.25363,-0.077142,-0.061502,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.81668,-0.077352,0.092278,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.94769,-0.077373,0.050475,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.4978,-0.077398,-0.045791,0,0
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.40349,-0.077585,-0.073331,0,0
3,GO MICROTUBULE NUCLEATION,0.054842,-0.078206,-0.082501,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.30815,-0.07826,-0.051684,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.23245,-0.078457,-0.12271,0,0
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.1313,-0.078859,-0.10255,0,0
3,GO MATURATION OF 5 8S RRNA,0.21905,-0.079107,-0.1048,0,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.14769,-0.079271,-0.10094,0,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.13583,-0.07939,-0.12732,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.56666,-0.079648,0.0046818,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.60272,-0.079962,-0.05714,0,0
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.23589,-0.080012,-0.11226,0,0
3,GO MEMBRANE DISASSEMBLY,0.16294,-0.080071,-0.097441,0,0
3,GO CELL JUNCTION MAINTENANCE,0.26098,-0.080135,-0.090148,0,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.34256,-0.080163,-0.055921,0,0
3,GO SYNAPTIC VESICLE DOCKING,0.82348,-0.080277,0.045676,0,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.11434,-0.080296,-0.075509,0,0
3,GO URETER DEVELOPMENT,0.42855,-0.080422,-0.086004,0,0
3,GO NUCLEAR MIGRATION,0.20309,-0.080513,-0.092793,0,0
3,GO OXIDATIVE DEMETHYLATION,0.21256,-0.080529,-0.048101,0,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.36526,-0.080535,-0.048554,0,0
3,GO MICROTUBULE ANCHORING,0.018398,-0.080629,-0.092599,0,0
3,GO SEROTONIN TRANSPORT,0.54321,-0.080675,-0.030305,0,0
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.12259,-0.080993,-0.10417,0,0
3,GO MEMBRANE BIOGENESIS,0.41341,-0.081007,-0.075239,0,0
3,GO REGULATION OF TELOMERE CAPPING,0.059411,-0.081028,-0.078409,0,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.19393,-0.081106,-0.058431,0,0
3,GO HEART FORMATION,0.36526,-0.081538,-0.069729,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.80312,-0.08157,-0.0050199,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.12049,-0.081582,-0.082541,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.2,-0.081594,-0.059662,0,0
3,GO MITOTIC RECOMBINATION,0.14048,-0.081629,-0.088596,0,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.4598,-0.081653,-0.023864,0,0
3,GO CILIUM ORGANIZATION,0.27227,-0.081664,-0.034624,0,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.41341,-0.081713,-0.06923,0,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.068167,-0.082032,-0.13558,0,0
3,GO SISTER CHROMATID COHESION,0.36526,-0.082135,-0.027329,0,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.14769,-0.082275,-0.072055,0,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.60883,-0.082563,-0.02984,0,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.72969,-0.082572,-0.053002,0,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0090226,-0.082675,-0.14557,0,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.050569,-0.082903,-0.081901,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.27611,-0.083132,-0.093123,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0027346,-0.083374,-0.086234,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.9686,-0.084177,0.03895,0,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.031059,-0.084255,-0.091667,0,0
3,GO SEROTONIN SECRETION,0.77618,-0.084524,-0.00082372,0,0
3,GO NEUROTRANSMITTER TRANSPORT,0.27611,-0.084693,-0.025807,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.17934,-0.084856,-0.076991,0,0
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.073629,-0.085014,-0.17977,0,0
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.16032,-0.085041,-0.11904,0,0
3,GO TELOMERE CAPPING,0.087232,-0.08522,-0.051503,0,0
3,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.99651,-0.085306,-0.0051269,0,0
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.25729,-0.085469,-0.099264,0,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.91987,-0.085879,-0.0011537,0,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.31653,-0.086001,-0.055036,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.059411,-0.086203,-0.15942,0,0
3,GO REGULATION OF GONAD DEVELOPMENT,0.33373,-0.086378,-0.074934,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.16032,-0.0866,-0.12316,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.023205,-0.086957,-0.093348,0,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.14285,-0.087125,-0.070794,0,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.38408,-0.087197,-0.12351,0,0
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.10096,-0.087233,-0.096236,0,0
3,GO ADULT BEHAVIOR,0.95466,-0.087462,0.0313,0,0
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.58456,-0.087526,-0.083957,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.063042,-0.087794,-0.079651,0,0
3,GO PRENYLATION,0.38888,-0.087823,-0.064946,0,0
3,GO LYMPH VESSEL DEVELOPMENT,0.11434,-0.087956,-0.12858,0,0
3,GO MOTOR NEURON AXON GUIDANCE,0.02843,-0.087995,-0.18894,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.25001,-0.088157,-0.051711,0,0
3,GO NEGATIVE REGULATION OF CELL AGING,0.27999,-0.088223,-0.11133,0,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.12908,-0.088731,-0.16614,0,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.054842,-0.088782,-0.12853,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.26847,-0.088943,-0.077573,0,0
3,GO NEURON DEVELOPMENT,0.12049,-0.089175,-0.074785,0,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.036948,-0.089486,-0.14275,0,0
3,GO ACIDIC AMINO ACID TRANSPORT,0.27999,-0.089488,-0.04063,0,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.21256,-0.089653,-0.072881,0,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.39858,-0.089892,-0.13675,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.3746,-0.089924,-0.069286,0,0
3,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.51459,-0.08994,0.0081651,0,0
3,GO WALKING BEHAVIOR,0.030383,-0.08996,-0.13755,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.43883,-0.089976,-0.067071,0,0
3,GO INTERSTRAND CROSS LINK REPAIR,0.10096,-0.089985,-0.045981,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0695,-0.089998,-0.11505,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.38408,-0.090026,-0.082957,0,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.78962,-0.090175,0.035495,0,0
3,GO COLLATERAL SPROUTING,0.23589,-0.090299,-0.09284,0,0
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.4545,-0.090307,-0.11087,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.26098,-0.09093,-0.10813,0,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.073629,-0.091008,-0.17014,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.39371,-0.091258,-0.080202,0,0
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.099158,-0.091461,-0.15776,0,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.90599,-0.091704,0.011677,0,0
3,GO BIOLOGICAL PHASE,0.63978,-0.091877,-0.050009,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.063042,-0.092248,-0.14281,0,0
3,GO TUBULIN DEACETYLATION,0.36064,-0.092279,-0.04705,0,0
3,GO BRANCHING MORPHOGENESIS OF A NERVE,0.26847,-0.092745,-0.13577,0,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.37932,-0.092846,-0.060793,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.064293,-0.093385,-0.13429,0,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.69061,-0.093534,-0.0476,0,0
3,GO TRANSPORT ALONG MICROTUBULE,0.00353,-0.0936,-0.10949,0,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.046579,-0.093733,-0.12379,0,0
3,GO NEGATIVE REGULATION OF DNA BINDING,0.066855,-0.093972,-0.096809,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.33812,-0.094111,-0.09419,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.15517,-0.094206,-0.13615,0,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.15773,-0.094257,-0.096811,0,0
3,GO REGULATION OF MYELINATION,0.011904,-0.09426,-0.12337,0,0
3,GO KINETOCHORE ASSEMBLY,0.85082,-0.094597,-0.024199,0,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.38888,-0.094599,-0.15015,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.13814,-0.094727,-0.1089,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.86455,-0.09483,-0.015492,0,0
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.27611,-0.095193,-0.09867,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.39858,-0.095195,-0.053509,0,0
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0099891,-0.095234,-0.085915,0,0
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.082489,-0.095426,-0.09557,0,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0073363,-0.095492,-0.15741,0,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.76281,-0.09551,-0.00051985,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.21579,-0.095664,-0.11517,0,0
3,GO REGULATION OF MICROTUBULE BINDING,0.097379,-0.095788,-0.11615,0,0
3,GO NEUROBLAST DIVISION,0.53742,-0.095982,-0.062906,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.40349,-0.096459,-0.070314,0,0
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.082489,-0.096461,-0.12781,0,0
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.22905,-0.097116,-0.14494,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.37932,-0.097598,-0.083849,0,0
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.17653,-0.097681,-0.043243,0,0
3,GO PREPULSE INHIBITION,0.59059,-0.097834,-0.069147,0,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.40349,-0.097838,-0.10298,0,0
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.47588,-0.097936,-0.06775,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.027803,-0.098764,-0.11588,0,0
3,GO LONG TERM MEMORY,0.11636,-0.098815,-0.12542,0,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.095625,-0.099105,-0.075284,0,0
3,GO REGULATION OF SPINDLE CHECKPOINT,0.05824,-0.099196,-0.10345,0,0
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.085627,-0.099222,-0.16999,0,0
3,GO PEPTIDYL HISTIDINE MODIFICATION,0.2839,-0.099474,-0.075717,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.043763,-0.099704,-0.13589,0,0
3,GO LEARNING,0.099158,-0.099909,-0.11125,0,0
3,GO FILOPODIUM ASSEMBLY,0.31232,-0.099964,-0.067535,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.15773,-0.10009,-0.082275,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.33812,-0.10033,-0.081886,0,0
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.11841,-0.1005,-0.15357,0,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.23937,-0.10051,-0.064604,0,0
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.60272,-0.10055,-0.04661,0,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.46512,-0.10103,-0.0087095,0,0
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.67137,-0.10104,-0.03093,0,0
3,GO RIBOSOME ASSEMBLY,0.33812,-0.1015,-0.092822,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.04854,-0.10236,-0.091816,0,0
3,GO APPENDAGE DEVELOPMENT,0.13355,-0.10239,-0.073794,0,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.017969,-0.10282,-0.11126,0,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.097379,-0.10283,-0.14457,0,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.15773,-0.10297,-0.085016,0,0
3,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.69061,-0.10299,0.044419,0,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.029068,-0.103,-0.11459,0,0
3,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.73628,-0.10348,-0.10885,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.099158,-0.1035,-0.076483,0,0
3,GO TRACHEA MORPHOGENESIS,0.4978,-0.10363,-0.045884,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.54321,-0.10372,-0.055746,0,0
3,GO RRNA 3 END PROCESSING,0.44924,-0.10453,-0.042969,0,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.66501,-0.10508,-0.031918,0,0
3,GO NEURON DIFFERENTIATION,0.12049,-0.1052,-0.074319,0,0
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.19095,-0.10543,-0.10209,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.34702,-0.10553,-0.044665,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.068167,-0.1057,-0.10276,0,0
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.74288,-0.10579,-0.037037,0,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.1313,-0.10596,-0.089573,0,0
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.11636,-0.10599,-0.082448,0,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0051916,-0.10614,-0.1177,0,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.19095,-0.10616,-0.20318,0,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.087232,-0.10736,-0.099082,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.29184,-0.10742,-0.076878,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.48678,-0.10824,-0.084216,0,0
3,GO RESPONSE TO PARATHYROID HORMONE,0.14048,-0.10847,-0.14407,0,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.36064,-0.1086,-0.080644,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.064293,-0.10861,-0.13881,0,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.0060989,-0.10863,-0.12414,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.072231,-0.10869,-0.14391,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.073629,-0.10917,-0.10335,0,0
3,GO PROSTATIC BUD FORMATION,0.077957,-0.1096,-0.23948,0,0
3,GO NEURON FATE SPECIFICATION,0.58456,-0.10975,-0.013203,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.066855,-0.10975,-0.15169,0,0
3,GO ACROSOME ASSEMBLY,0.063042,-0.11013,-0.12647,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.32938,-0.11028,-0.097413,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.20309,-0.11032,-0.093308,0,0
3,GO SOMATIC STEM CELL DIVISION,0.16294,-0.1104,-0.18361,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.14769,-0.1106,-0.10322,0,0
3,GO CENTRIOLE ASSEMBLY,0.087232,-0.11066,-0.073227,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.21905,-0.11072,-0.11376,0,0
3,GO MUSCLE FIBER DEVELOPMENT,0.15015,-0.11097,-0.067676,0,0
3,GO CELLULAR RESPONSE TO PH,0.084046,-0.11098,-0.10313,0,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0021689,-0.11139,-0.13205,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.4545,-0.11153,-0.044855,0,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0069616,-0.11174,-0.1585,0,0
3,GO BLASTOCYST GROWTH,0.2,-0.11186,-0.051267,0,0
3,GO HISTONE DEUBIQUITINATION,0.057089,-0.11205,-0.070202,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.89907,-0.11219,0.065915,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.27227,-0.11228,-0.048765,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.054842,-0.11241,-0.14616,0,0
3,GO BONE MATURATION,0.070855,-0.11276,-0.143,0,0
3,GO RRNA MODIFICATION,0.29586,-0.11302,-0.079938,0,0
3,GO RRNA TRANSCRIPTION,0.073629,-0.11313,-0.12067,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.56666,-0.11329,-0.02364,0,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.40349,-0.11345,-0.13273,0,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.085627,-0.11405,-0.11853,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.24643,-0.11423,-0.069004,0,0
3,GO NEURAL RETINA DEVELOPMENT,0.25729,-0.11498,-0.049635,0,0
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.053746,-0.11507,-0.14342,0,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.24288,-0.11519,-0.071862,0,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.26098,-0.11526,-0.14497,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.025414,-0.1155,-0.13939,0,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.16828,-0.11626,-0.066569,0,0
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.054842,-0.11663,-0.14931,0,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.11841,-0.11714,-0.07743,0,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.22568,-0.1172,-0.13603,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.088862,-0.11736,-0.15738,0,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.14285,-0.11736,-0.052304,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.25363,-0.11742,-0.17748,0,0
3,GO RESPONSE TO X RAY,0.099158,-0.11777,-0.13488,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.86455,-0.11818,0.027406,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.033166,-0.11822,-0.19153,0,0
3,GO SYNAPTIC VESICLE PRIMING,0.44924,-0.11842,0.0060725,0,0
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.11434,-0.11852,-0.13318,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.052669,-0.11864,-0.11011,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0057817,-0.11874,-0.13004,0,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.14048,-0.11875,-0.098761,0,0
3,GO DNA REPLICATION INITIATION,0.001228,-0.11879,-0.15918,0,0
3,GO MYOBLAST PROLIFERATION,0.092194,-0.11914,-0.13561,0,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.2,-0.11934,-0.055337,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.23589,-0.12002,-0.10928,0,0
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.087232,-0.12005,-0.10563,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.05824,-0.12056,-0.10297,0,0
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.36526,-0.12098,-0.10087,0,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.12689,-0.12112,-0.088202,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.13814,-0.12143,-0.19599,0,0
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.099158,-0.12154,-0.11403,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.057089,-0.12166,-0.081238,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.48678,-0.122,-0.020535,0,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0069616,-0.12203,-0.093134,0,0
3,GO PROTEIN POLYGLUTAMYLATION,0.047551,-0.12205,-0.10851,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.05161,-0.12208,-0.11491,0,0
3,GO CELL PART MORPHOGENESIS,0.015574,-0.12214,-0.1397,0,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.061812,-0.12215,-0.14383,0,0
3,GO UTERUS DEVELOPMENT,0.38408,-0.12215,-0.090191,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.4545,-0.12241,-0.034464,0,0
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.031748,-0.12255,-0.1334,0,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.046579,-0.12295,-0.17001,0,0
3,GO METENCEPHALON DEVELOPMENT,0.4598,-0.123,-0.0099898,0,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.42347,-0.1234,-0.083618,0,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.05161,-0.12378,-0.1158,0,0
3,GO VIRAL TRANSLATION,0.075049,-0.12406,-0.15533,0,0
3,GO PEPTIDYL ARGININE N METHYLATION,0.12259,-0.12418,-0.10652,0,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.23589,-0.12438,-0.082954,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.077957,-0.12455,-0.067017,0,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.052669,-0.12503,-0.085982,0,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.41341,-0.12549,-0.031919,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.18508,-0.12551,-0.096123,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.025414,-0.12567,-0.13509,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.090515,-0.12567,-0.070173,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.188,-0.1257,-0.072668,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.057089,-0.12576,-0.10953,0,0
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.079444,-0.12591,-0.14425,0,0
3,GO SPINAL CORD PATTERNING,0.75615,-0.12605,-0.0079986,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.2,-0.12607,-0.14333,0,0
3,GO KINETOCHORE ORGANIZATION,0.65866,-0.12664,-0.024521,0,0
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.054842,-0.12683,-0.16144,0,0
3,GO RRNA METHYLATION,0.50896,-0.12684,-0.03521,0,0
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.40843,-0.12733,-0.088069,0,0
3,GO FOREBRAIN DEVELOPMENT,0.05161,-0.12741,-0.0823,0,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.025994,-0.12753,-0.090387,0,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.16032,-0.12797,-0.099884,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.046579,-0.12822,-0.16268,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.12049,-0.12855,-0.13305,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.42347,-0.12886,-0.032633,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0056288,-0.12891,-0.12832,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.011047,-0.12909,-0.15977,0,0
3,GO OXYGEN TRANSPORT,0.24643,-0.12948,-0.21567,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.41341,-0.12976,-0.063497,0,0
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.16559,-0.13062,-0.16107,0,0
3,GO CELL FATE SPECIFICATION,0.26471,-0.13094,-0.059618,0,0
3,GO L GLUTAMATE IMPORT,0.11636,-0.13115,-0.11631,0,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.0021689,-0.13137,-0.17404,0,0
3,GO REGULATION OF HEART GROWTH,0.080955,-0.13149,-0.098148,0,0
3,GO NEURON FATE COMMITMENT,0.27611,-0.13186,-0.072786,0,0
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.17934,-0.13267,-0.08205,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.024846,-0.13316,-0.12851,0,0
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.10465,-0.13338,-0.08956,0,0
3,GO MYOTUBE CELL DEVELOPMENT,0.39858,-0.13416,-0.040409,0,0
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.076492,-0.13438,-0.095576,0,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15517,-0.13441,-0.10471,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.041093,-0.13461,-0.17033,0,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.82348,-0.13472,-0.0011484,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.057089,-0.13524,-0.19572,0,0
3,GO NEUROTRANSMITTER SECRETION,0.087232,-0.13553,-0.059729,0,0
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.10096,-0.13577,-0.15855,0,0
3,GO NEURON PROJECTION EXTENSION,0.017549,-0.13724,-0.15441,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.073629,-0.13727,-0.087775,0,0
3,GO CHONDROCYTE PROLIFERATION,0.14285,-0.13745,-0.15781,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.19695,-0.13793,-0.055364,0,0
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.36064,-0.13808,-0.041114,0,0
3,GO GLUTAMATE SECRETION,0.12259,-0.13833,-0.094148,0,0
3,GO GAS TRANSPORT,0.15517,-0.13886,-0.19657,0,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.019283,-0.13906,-0.13246,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.12473,-0.14057,-0.13143,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.9686,-0.14074,-0.0077327,0,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0046564,-0.1411,-0.10757,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.05161,-0.14119,-0.13259,0,0
3,GO PYRAMIDAL NEURON DIFFERENTIATION,0.05824,-0.14127,-0.22487,0,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.029068,-0.14136,-0.10554,0,0
3,GO CELL MIGRATION IN HINDBRAIN,0.38408,-0.14147,-0.058425,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.15773,-0.14163,-0.10417,0,0
3,GO COLLECTING DUCT DEVELOPMENT,0.11636,-0.14227,-0.14093,0,0
3,GO APPENDAGE MORPHOGENESIS,0.076492,-0.14244,-0.098526,0,0
3,GO DIVALENT METAL ION EXPORT,0.061812,-0.14256,-0.23302,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.073629,-0.14314,-0.16946,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.16294,-0.1433,-0.14412,0,0
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.32938,-0.14368,-0.051398,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.25729,-0.14444,-0.070988,0,0
3,GO NEURON PROJECTION ARBORIZATION,0.036948,-0.14448,-0.17103,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.16559,-0.14557,-0.11189,0,0
3,GO NEURON PROJECTION REGENERATION,0.040234,-0.14564,-0.14744,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.75615,-0.14592,-0.010995,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.13583,-0.146,-0.14176,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.057089,-0.14712,-0.13957,0,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.20309,-0.1473,-0.090008,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0042883,-0.14744,-0.19567,0,0
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.20309,-0.14752,-0.11775,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0047853,-0.14767,-0.17549,0,0
3,GO NEURON PROJECTION GUIDANCE,0.0024367,-0.14769,-0.21989,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.0071468,-0.14775,-0.1486,0,0
3,GO AXON DEVELOPMENT,0.0039469,-0.14808,-0.19204,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.52594,-0.14906,-0.060359,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.16294,-0.14941,-0.15688,0,0
3,GO V D J RECOMBINATION,0.11039,-0.14989,-0.12447,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.084046,-0.15011,-0.1703,0,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.059411,-0.1507,-0.14843,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0064317,-0.15077,-0.16794,0,0
3,GO COCHLEA DEVELOPMENT,0.064293,-0.15153,-0.16229,0,0
3,GO RESPONSE TO LEAD ION,0.010506,-0.15156,-0.14473,0,0
3,GO MATURATION OF SSU RRNA,0.065563,-0.15162,-0.15731,0,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.23937,-0.15216,-0.084536,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.2,-0.15232,-0.16951,0,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.0041716,-0.15241,-0.21483,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.54321,-0.15358,-0.046465,0,0
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.11841,-0.15472,-0.1424,0,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.16032,-0.15543,-0.11159,0,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.17934,-0.15564,-0.083426,0,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.050569,-0.15579,-0.12833,0,0
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.064293,-0.15648,-0.19801,0,0
3,GO CARDIOBLAST PROLIFERATION,0.15517,-0.15652,-0.24208,0,0
3,GO REGULATION OF AXONOGENESIS,0.012508,-0.15653,-0.19375,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.188,-0.15663,-0.17285,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.088862,-0.15745,-0.1668,0,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0075304,-0.15826,-0.16068,0,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.080955,-0.15841,-0.13996,0,0
3,GO NEUROBLAST PROLIFERATION,0.049546,-0.15892,-0.13591,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.060602,-0.16082,-0.14579,0,0
3,GO HISTONE H3 K27 METHYLATION,0.0045306,-0.16085,-0.15294,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.54321,-0.16175,-0.038377,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.16032,-0.16192,-0.16925,0,0
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.068167,-0.16228,-0.18451,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.013139,-0.16268,-0.15956,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.12049,-0.16281,-0.15183,0,0
3,GO SYNAPTIC SIGNALING,0.14769,-0.16311,-0.081476,0,0
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.055956,-0.16384,-0.16433,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.055956,-0.16401,-0.10424,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.099158,-0.16436,-0.14914,0,0
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.12259,-0.16557,-0.090823,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.23589,-0.16563,-0.15368,0,0
3,GO AXO DENDRITIC TRANSPORT,0.0006154,-0.1659,-0.1581,0,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.67776,-0.16638,-0.03516,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.055956,-0.16667,-0.21038,0,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.018836,-0.16738,-0.18259,0,0
3,GO REGULATION OF AXON GUIDANCE,0.0053338,-0.16775,-0.20406,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.1028,-0.16786,-0.14155,0,0
3,GO MATURATION OF LSU RRNA,0.14048,-0.16791,-0.15381,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.13583,-0.16832,-0.16662,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.42347,-0.16841,-0.1681,0,0
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.30815,-0.16919,-0.12246,0,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.63354,-0.16975,-0.00040826,0,0
3,GO DENDRITE SELF AVOIDANCE,0.059411,-0.17056,-0.19447,0,0
3,GO NEURAL CREST FORMATION,0.046579,-0.17177,-0.18735,0,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.016339,-0.17189,-0.22296,0,0
3,GO INTRACILIARY TRANSPORT,0.12259,-0.17222,-0.097575,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.073629,-0.17522,-0.12609,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.093897,-0.17565,-0.12498,0,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.32077,-0.1764,-0.10656,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.044685,-0.17697,-0.14231,0,0
3,GO SYNAPSE ASSEMBLY,0.29586,-0.17704,-0.072026,0,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.085627,-0.17751,-0.17153,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0060989,-0.17867,-0.22413,0,0
3,GO NEURON RECOGNITION,0.064293,-0.17936,-0.20702,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.0027346,-0.18024,-0.17765,0,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.052669,-0.18028,-0.15399,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.0021689,-0.18093,-0.23417,0,0
3,GO SYNAPTIC VESICLE LOCALIZATION,0.0022332,-0.18312,-0.1976,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.21579,-0.18321,-0.097165,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.007729,-0.18397,-0.14407,0,0
3,GO COCHLEA MORPHOGENESIS,0.0030654,-0.18406,-0.22679,0,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.097379,-0.18409,-0.11188,0,0
3,GO TRACHEA DEVELOPMENT,0.03939,-0.18558,-0.17888,0,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.05824,-0.18563,-0.10683,0,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.0073363,-0.18564,-0.21176,0,0
3,GO AXONAL TRANSPORT,0.00067758,-0.18595,-0.16804,0,0
3,GO DENDRITE DEVELOPMENT,0.019283,-0.18792,-0.1258,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.36991,-0.18891,-0.078049,0,0
3,GO SIALYLATION,0.37932,-0.19032,-0.10869,0,0
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.011326,-0.19392,-0.21916,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.26471,-0.19413,-0.11555,0,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.24288,-0.19553,-0.10654,0,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.092194,-0.19579,-0.18725,0,0
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.20309,-0.19677,-0.10142,0,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.03939,-0.19706,-0.20164,0,0
3,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.36064,-0.19819,-0.15495,0,0
3,GO SYNAPSE MATURATION,0.23937,-0.19824,-0.18249,0,0
3,GO AXON EXTENSION,0.00022676,-0.19879,-0.25566,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.11841,-0.19889,-0.1032,0,0
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.12908,-0.19919,-0.15832,0,0
3,GO MECHANOSENSORY BEHAVIOR,0.75615,-0.19951,-0.04181,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.041093,-0.19983,-0.14269,0,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.027188,-0.20011,-0.12781,0,0
3,GO MICROTUBULE SEVERING,0.17934,-0.2026,-0.10096,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.02166,-0.2032,-0.25376,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.02166,-0.2035,-0.14954,0,0
3,GO DENSE CORE GRANULE TRANSPORT,0.28785,-0.20397,-0.10018,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.024846,-0.20485,-0.26457,0,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.061812,-0.20536,-0.11467,0,0
3,GO SPINAL CORD DEVELOPMENT,0.029719,-0.20543,-0.13955,0,0
3,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.076492,-0.20671,-0.18938,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.001872,-0.20721,-0.18844,0,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.11636,-0.2082,-0.10557,0,0
3,GO DNA LIGATION,0.055956,-0.20878,-0.14195,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.02843,-0.21003,-0.16853,0,0
3,GO PROTEIN DEMETHYLATION,0.00045924,-0.21017,-0.19613,0,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.068167,-0.21094,-0.15278,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.00045924,-0.21102,-0.19521,0,0
3,GO IMP METABOLIC PROCESS,0.17653,-0.21355,-0.15729,0,0
3,GO RECEPTOR CLUSTERING,0.0026572,-0.21358,-0.2054,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.12908,-0.21385,-0.17582,0,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0010859,-0.21482,-0.21325,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.022165,-0.21631,-0.17511,0,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.02843,-0.21634,-0.26055,0,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.05824,-0.21688,-0.23003,0,0
3,GO FORELIMB MORPHOGENESIS,0.0075304,-0.21803,-0.23371,0,0
3,GO NEURON MIGRATION,0.013798,-0.21904,-0.18689,0,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0060989,-0.21923,-0.31972,0,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.026586,-0.22034,-0.21815,0,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.019739,-0.22059,-0.20224,0,0
3,GO CGMP METABOLIC PROCESS,0.36526,-0.22097,-0.07747,0,0
3,GO NEURAL CREST CELL MIGRATION,0.0012662,-0.2222,-0.26246,0,0
3,GO RETROGRADE AXONAL TRANSPORT,0.00029782,-0.22488,-0.27957,0,0
3,GO DENDRITIC SPINE DEVELOPMENT,0.0027346,-0.22514,-0.19029,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.044685,-0.22749,-0.30654,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0079323,-0.22887,-0.25206,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.088862,-0.22977,-0.18613,0,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.031748,-0.23031,-0.14181,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.020205,-0.23206,-0.19496,0,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.017969,-0.23208,-0.12951,0,0
3,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.0695,-0.23249,-0.23574,0,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0017641,-0.23606,-0.20403,0,0
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0025817,-0.23664,-0.17501,0,0
3,GO GLYCINE METABOLIC PROCESS,0.047551,-0.23727,-0.12379,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.4421e-05,-0.23789,-0.25664,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.077957,-0.23884,-0.14353,0,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.00059588,-0.24042,-0.34316,0,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.11841,-0.24086,-0.13429,0,0
3,GO HINDLIMB MORPHOGENESIS,0.012203,-0.24242,-0.19514,0,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00013433,-0.24253,-0.27706,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.1313,-0.24395,-0.14929,0,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.045624,-0.24435,-0.16926,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.00067758,-0.24453,-0.32332,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.001986,-0.24687,-0.22633,0,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.044685,-0.24721,-0.1843,0,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.010245,-0.24806,-0.33627,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0075304,-0.24881,-0.22896,0,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.02068,-0.25002,-0.24327,0,0
3,GO DENDRITE MORPHOGENESIS,0.011326,-0.25078,-0.16048,0,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0023671,-0.25199,-0.25908,0,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0010859,-0.25418,-0.23602,0,0
3,GO RESPIRATORY SYSTEM PROCESS,4.4878e-05,-0.2548,-0.26096,0,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0037331,-0.25606,-0.29221,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.00037661,-0.25678,-0.28097,0,0
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.070855,-0.25704,-0.1651,0,0
3,GO RESPONSE TO ACETYLCHOLINE,0.023741,-0.25768,-0.23378,0,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.001191,-0.25982,-0.4371,0,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0071468,-0.26142,-0.19948,0,0
3,GO BRAIN MORPHOGENESIS,4.0073e-05,-0.26251,-0.23793,0,0
3,GO PRESYNAPSE ORGANIZATION,0.13583,-0.26619,-0.14526,0,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.001872,-0.26733,-0.26051,0,0
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,3.9418e-06,-0.27079,-0.26073,0,0
3,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00092958,-0.27203,-0.38718,0,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0031536,-0.27231,-0.24659,0,0
3,GO L SERINE METABOLIC PROCESS,0.19393,-0.27318,-0.13837,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.011612,-0.27356,-0.30377,0,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.0060989,-0.27414,-0.22441,0,0
3,GO EMBRYONIC BRAIN DEVELOPMENT,0.00010462,-0.27499,-0.28702,0,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.22235,-0.27512,-0.097762,0,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0013872,-0.27689,-0.2855,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.0006154,-0.27963,-0.31806,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0017123,-0.27977,-0.26492,0,0
3,GO CARDIAC CELL FATE COMMITMENT,0.024288,-0.28139,-0.27989,0,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.055956,-0.28155,-0.28181,0,0
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.00353,-0.28173,-0.22356,0,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.02843,-0.28235,-0.16061,0,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.084046,-0.28331,-0.19581,0,0
3,GO DENTATE GYRUS DEVELOPMENT,0.075049,-0.28767,-0.17271,0,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.02268,-0.28925,-0.17604,0,0
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0042883,-0.28953,-0.23471,0,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0007696,-0.29056,-0.3438,0,0
3,GO PLASMA MEMBRANE REPAIR,0.099158,-0.29122,-0.1636,0,0
3,GO CHROMATIN DISASSEMBLY,2.0033e-05,-0.29309,-0.29806,0,0
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00028792,-0.29434,-0.26341,0,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0034322,-0.30127,-0.30242,0,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0028957,-0.30138,-0.33938,0,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0056288,-0.30153,-0.24598,0,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,3.4421e-05,-0.30283,-0.31493,0,0
3,GO HEART VALVE FORMATION,0.077957,-0.30686,-0.22083,0,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.013139,-0.30848,-0.20786,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,1.4609e-05,-0.30979,-0.27404,0,0
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.013798,-0.31109,-0.27095,0,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,5.4121e-05,-0.31349,-0.30324,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.03245,-0.31492,-0.23442,0,0
3,GO FOREBRAIN MORPHOGENESIS,6.2786e-05,-0.3181,-0.31721,0,0
3,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.018836,-0.31907,-0.2434,0,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.00014418,-0.32114,-0.33921,0,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.009256,-0.32152,-0.32305,0,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.026586,-0.32372,-0.31777,0,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.001872,-0.32783,-0.26735,0,0
3,GO DENDRITIC SPINE MORPHOGENESIS,0.00041602,-0.33169,-0.27574,0,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0022332,-0.33275,-0.29349,0,0
3,GO CARTILAGE MORPHOGENESIS,0.0051916,-0.33826,-0.34475,0,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.014138,-0.34682,-0.3408,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.00057693,-0.36312,-0.33071,0,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.041967,-0.36512,-0.27903,0,0
3,GO LIMB BUD FORMATION,0.010773,-0.36817,-0.33086,0,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,7.2754e-05,-0.37376,-0.34954,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0023671,-0.37911,-0.34817,0,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0062634,-0.37942,-0.30077,0,0
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0059384,-0.38005,-0.34646,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0062634,-0.38128,-0.29237,0,0
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.22905,-0.38749,-0.11723,0,0
3,GO PHAGOCYTOSIS RECOGNITION,4.0073e-05,-0.4021,-0.42045,0,0
3,GO LONG TERM SYNAPTIC DEPRESSION,0.00027832,-0.4058,-0.36227,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,4.1617e-05,-0.41276,-0.44131,0,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0031536,-0.43983,-0.39065,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00042998,-0.48477,-0.56859,0,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0056288,-0.49257,-0.37921,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.00031859,-0.49511,-0.45823,0,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,4.0073e-05,-0.51494,-0.5974,0,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0014299,-0.61235,-0.44949,0,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.021165,-0.62037,-0.37096,0,0
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00014935,-0.66794,-0.5946,0,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.00014935,-0.79277,-0.63071,0,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,6.5149e-05,0.73192,0.83554,1,1
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.0012662,0.54552,0.40372,1,1
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0057817,0.52017,0.41061,1,1
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0034322,0.51584,0.38169,1,1
4,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.004408,0.48262,0.48711,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,2.4346e-05,0.4627,0.47053,1,1
4,GO GANGLION DEVELOPMENT,0.0020453,0.40488,0.39085,1,1
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0024367,0.40189,0.42301,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00057693,0.37051,0.35265,1,1
4,GO NOSE DEVELOPMENT,0.00012074,0.35766,0.53896,1,1
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.00059588,0.35455,0.37652,1,1
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,3.0689e-05,0.35264,0.39851,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.010773,0.33388,0.36385,1,1
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0031536,0.32926,0.2864,1,1
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,7.547e-05,0.30278,0.46125,1,1
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.010506,0.29878,0.31093,1,1
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.0041716,0.29631,0.33167,1,1
4,GO THALAMUS DEVELOPMENT,0.014486,0.29575,0.25277,1,1
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.019739,0.27628,0.25116,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0022992,0.27087,0.34953,1,1
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0090226,0.26035,0.22564,1,1
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0049174,0.25445,0.2194,1,1
4,GO KINETOCHORE ORGANIZATION,0.00047456,0.25256,0.2283,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0014299,0.23977,0.22012,1,1
4,GO MRNA SPLICE SITE SELECTION,0.00017796,0.23498,0.24923,1,1
4,GO VIRAL LATENCY,0.0085714,0.22431,0.17658,1,1
4,GO REGULATION OF SISTER CHROMATID COHESION,0.00059588,0.22176,0.18529,1,1
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.004408,0.2162,0.15676,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0033369,0.21256,0.20385,1,1
4,GO KINETOCHORE ASSEMBLY,0.0025083,0.21244,0.19026,1,1
4,GO HISTONE H4 K16 ACETYLATION,0.00010092,0.20893,0.20782,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.025414,0.20268,0.14571,1,1
4,GO CHROMATIN REMODELING AT CENTROMERE,0.00087311,0.20199,0.19563,1,1
4,GO HISTONE H2A MONOUBIQUITINATION,2.0833e-05,0.19936,0.23382,1,1
4,GO PARENTAL BEHAVIOR,0.033894,0.19777,0.2891,1,1
4,GO CARDIOBLAST DIFFERENTIATION,0.030383,0.19668,0.17282,1,1
4,GO HISTONE H3 K9 TRIMETHYLATION,0.00037661,0.19526,0.17953,1,1
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0085714,0.19285,0.18205,1,1
4,GO APICAL PROTEIN LOCALIZATION,0.004408,0.18962,0.18031,1,1
4,GO SINGLE STRAND BREAK REPAIR,0.0056288,0.18818,0.16033,1,1
4,GO CENTROMERE COMPLEX ASSEMBLY,0.0012662,0.1826,0.183,1,1
4,GO DENDRITIC TRANSPORT,0.033166,0.1809,0.16839,1,1
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.031059,0.17925,0.14976,1,1
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,9.0551e-05,0.17735,0.19836,1,1
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0032441,0.17643,0.19938,1,1
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.0042883,0.17501,0.15487,1,1
4,GO GENETIC IMPRINTING,0.001986,0.17474,0.1918,1,1
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.025994,0.16964,0.14179,1,1
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0010528,0.16926,0.15522,1,1
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0062634,0.16873,0.1475,1,1
4,GO HISTONE H3 K9 METHYLATION,0.0015189,0.16495,0.15333,1,1
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.001228,0.16197,0.15866,1,1
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0066042,0.16126,0.13324,1,1
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.00059588,0.16114,0.1529,1,1
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0066042,0.16109,0.15344,1,1
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.023205,0.15991,0.13764,1,1
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.017969,0.15752,0.12124,1,1
4,GO MITOTIC SISTER CHROMATID COHESION,0.001191,0.15708,0.19539,1,1
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0069616,0.15629,0.14054,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.015953,0.15067,0.14098,1,1
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,8.1192e-05,0.14761,0.15361,1,1
4,GO COPULATION,0.046579,0.14744,0.13528,1,1
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.02068,0.14734,0.1475,1,1
4,GO CENTROSOME DUPLICATION,0.0010859,0.14612,0.13878,1,1
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.004408,0.14572,0.16357,1,1
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.021165,0.14457,0.092121,1,1
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.014841,0.14431,0.17856,1,1
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.015953,0.14333,0.092095,1,1
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0067808,0.14327,0.11995,1,1
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.001872,0.14262,0.14307,1,1
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0075304,0.14194,0.10835,1,1
4,GO HISTONE H2A UBIQUITINATION,0.0022332,0.14116,0.14206,1,1
4,GO MITOTIC CHROMOSOME CONDENSATION,0.0013054,0.1411,0.18113,1,1
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.024846,0.13966,0.1203,1,1
4,GO DOSAGE COMPENSATION,0.0028141,0.13802,0.12387,1,1
4,GO CENTRIOLE ASSEMBLY,0.0062634,0.13652,0.11065,1,1
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.031748,0.13621,0.15014,1,1
4,GO DNA DEMETHYLATION,0.041093,0.12979,0.10298,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.02843,0.12766,0.098878,1,1
4,GO POST ANAL TAIL MORPHOGENESIS,0.031059,0.12724,0.11676,1,1
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0047853,0.12632,0.24321,1,1
4,GO CENTRIOLE CENTRIOLE COHESION,0.045624,0.12593,0.1252,1,1
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.026586,0.12424,0.10963,1,1
4,GO HISTONE H3 K9 MODIFICATION,0.0013457,0.12246,0.13179,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.017549,0.12059,0.13672,1,1
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.00095906,0.11954,0.13302,1,1
4,GO HISTONE H2A ACETYLATION,0.0069616,0.11909,0.14549,1,1
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.027188,0.11613,0.13691,1,1
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.034637,0.11335,0.11178,1,1
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0083534,0.11291,0.096996,1,1
4,GO REGULATION OF CILIUM ASSEMBLY,0.0066042,0.112,0.1111,1,1
4,GO HISTONE MONOUBIQUITINATION,0.00042998,0.11174,0.132,1,1
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0079323,0.11063,0.13786,1,1
4,GO G0 TO G1 TRANSITION,0.0022332,0.10972,0.13708,1,1
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0059384,0.10927,0.12731,1,1
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.0099891,0.10913,0.11065,1,1
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.017969,0.10741,0.13352,1,1
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.02268,0.10711,0.14448,1,1
4,GO NUCLEOSOME ASSEMBLY,0.007729,0.10641,0.1306,1,1
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.007729,0.1054,0.10199,1,1
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0041716,0.10436,0.089469,1,1
4,GO HISTONE UBIQUITINATION,0.0075304,0.1027,0.08436,1,1
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.015203,0.10152,0.14485,1,1
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0085714,0.10112,0.098933,1,1
4,GO REGULATION OF CENTRIOLE REPLICATION,0.034637,0.10095,0.086272,1,1
4,GO SISTER CHROMATID COHESION,0.0040578,0.095238,0.1236,1,1
4,GO CHROMATIN SILENCING,0.014138,0.094697,0.094194,1,1
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.009256,0.093737,0.093567,1,1
4,GO PEPTIDYL LYSINE ACETYLATION,0.0022332,0.08858,0.081499,1,1
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.044685,0.088149,0.10667,1,1
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.009256,0.086238,0.11253,1,1
4,GO NUCLEOSOME ORGANIZATION,0.02068,0.085869,0.088084,1,1
4,GO PROTEIN ACETYLATION,0.0085714,0.085217,0.060142,1,1
4,GO POSITIVE REGULATION OF DNA REPAIR,0.0071468,0.084598,0.097344,1,1
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.0042883,0.083858,0.1008,1,1
4,GO RECOMBINATIONAL REPAIR,0.033894,0.077691,0.058192,1,1
4,GO CHROMOSOME SEGREGATION,0.021165,0.07699,0.056893,1,1
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0069616,0.07494,0.096738,1,1
4,GO HISTONE EXCHANGE,0.02268,0.074262,0.10068,1,1
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.0075304,0.073894,0.074685,1,1
4,GO SISTER CHROMATID SEGREGATION,0.012203,0.069227,0.073967,1,1
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.029719,0.067949,0.072144,1,1
4,GO HETEROCHROMATIN ORGANIZATION,0.0090226,0.064468,0.091426,1,1
4,GO REGULATION OF HISTONE METHYLATION,0.052669,0.062353,0.076376,1,1
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.025414,0.056554,0.052015,1,1
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.036948,0.055987,0.049316,1,1
4,GO DNA INTEGRITY CHECKPOINT,0.037747,0.055462,0.045768,1,1
4,GO PROTEIN MONOUBIQUITINATION,0.042857,0.055354,0.055484,1,1
4,GO CELL CYCLE CHECKPOINT,0.017549,0.053169,0.053872,1,1
4,GO CHROMATIN ORGANIZATION,0.012203,0.052844,0.0523,1,1
4,GO DNA PACKAGING,0.0075304,0.051835,0.088078,1,1
4,GO REGULATION OF RNA SPLICING,0.041093,0.048391,0.052706,1,1
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.014486,0.30733,0.25301,1,0
4,GO MYOBLAST MIGRATION,0.04854,0.27438,0.17773,1,0
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.040234,0.26233,0.26604,1,0
4,GO FOREBRAIN REGIONALIZATION,0.0028141,0.24111,0.24751,1,0
4,GO DENDRITE SELF AVOIDANCE,0.044685,0.19426,0.1486,1,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.021165,0.15185,0.1514,1,0
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0097392,0.12948,0.15452,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.030383,0.10365,0.085106,1,0
4,GO CHROMOSOME LOCALIZATION,0.0081404,0.10145,0.082127,1,0
4,GO REGULATION OF CENTROSOME CYCLE,0.013139,0.081563,0.09818,1,0
4,GO METAPHASE PLATE CONGRESSION,0.03939,0.080375,0.062537,1,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.026586,0.070226,0.089925,1,0
4,GO CHROMOSOME CONDENSATION,0.05161,0.063726,0.083202,1,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.033166,0.044852,0.048716,1,0
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.047551,-0.032646,-0.060068,1,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.05161,-0.039574,-0.062386,1,0
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.050569,-0.039701,-0.067447,1,0
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.017549,-0.039773,-0.051251,1,0
4,GO REPRODUCTION,0.04854,-0.043776,-0.056022,1,0
4,GO MULTI ORGANISM PROCESS,0.026586,-0.044374,-0.058059,1,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.031748,-0.04651,-0.073734,1,0
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0087944,-0.047073,-0.063939,1,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.012508,-0.048521,-0.053257,1,0
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0090226,-0.048538,-0.079811,1,0
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.04854,-0.050215,-0.08686,1,0
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.034637,-0.050285,-0.12905,1,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.017969,-0.052056,-0.065889,1,0
4,GO LYMPHOCYTE DIFFERENTIATION,0.05161,-0.053087,-0.079112,1,0
4,GO IMPORT INTO NUCLEUS,0.023741,-0.053582,-0.075004,1,0
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.029719,-0.054178,-0.093536,1,0
4,GO REGULATION OF PH,0.033894,-0.056029,-0.07425,1,0
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.02068,-0.056554,-0.099086,1,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0027346,-0.057647,-0.06195,1,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0040578,-0.058042,-0.059343,1,0
4,GO MESODERM DEVELOPMENT,0.031748,-0.058192,-0.10101,1,0
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.025414,-0.060285,-0.10473,1,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.034637,-0.061449,-0.16601,1,0
4,GO UBIQUINONE METABOLIC PROCESS,0.045624,-0.061824,-0.116,1,0
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.02843,-0.062358,-0.10407,1,0
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.016734,-0.062696,-0.1067,1,0
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.036164,-0.063044,-0.086153,1,0
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.03939,-0.063708,-0.1115,1,0
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0033369,-0.06472,-0.0805,1,0
4,GO MRNA METABOLIC PROCESS,0.052669,-0.064764,-0.06211,1,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.0085714,-0.064772,-0.11529,1,0
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.0021062,-0.064797,-0.076329,1,0
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.03245,-0.065085,-0.10844,1,0
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.044685,-0.065678,-0.064686,1,0
4,GO EPITHELIUM DEVELOPMENT,0.034637,-0.06575,-0.088215,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.03939,-0.066567,-0.11053,1,0
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.018398,-0.06676,-0.08416,1,0
4,GO DETECTION OF STIMULUS,0.0053338,-0.067765,-0.07334,1,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.043763,-0.067928,-0.13509,1,0
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.033166,-0.068136,-0.062124,1,0
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0041716,-0.068215,-0.065699,1,0
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.02166,-0.068472,-0.083698,1,0
4,GO LIPOPROTEIN METABOLIC PROCESS,0.0069616,-0.070426,-0.11927,1,0
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.00057693,-0.070558,-0.077275,1,0
4,GO DNA BIOSYNTHETIC PROCESS,0.013139,-0.070952,-0.065143,1,0
4,GO POSITIVE REGULATION OF SECRETION,0.040234,-0.071031,-0.077768,1,0
4,GO REGULATION OF SECRETION,0.027188,-0.071236,-0.078698,1,0
4,GO ORGANELLE DISASSEMBLY,0.017969,-0.071362,-0.082025,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.038561,-0.071642,-0.13075,1,0
4,GO PROTEIN O LINKED GLYCOSYLATION,0.017969,-0.072213,-0.14216,1,0
4,GO ENDOSOME ORGANIZATION,0.049546,-0.072436,-0.084131,1,0
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0025083,-0.073609,-0.081905,1,0
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0083534,-0.073773,-0.12045,1,0
4,GO REGULATION OF URINE VOLUME,0.016339,-0.074572,-0.12693,1,0
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.02268,-0.074876,-0.079445,1,0
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.052669,-0.075084,-0.10218,1,0
4,GO REGULATION OF PROTEIN FOLDING,0.050569,-0.075579,-0.094483,1,0
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.00054072,-0.075906,-0.1116,1,0
4,GO CELLULAR RESPONSE TO ALCOHOL,0.02843,-0.075925,-0.10054,1,0
4,GO RESPONSE TO IONIZING RADIATION,0.015574,-0.076144,-0.086571,1,0
4,GO GOLGI ORGANIZATION,0.0028957,-0.076158,-0.10658,1,0
4,GO CANONICAL WNT SIGNALING PATHWAY,0.034637,-0.076313,-0.083441,1,0
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.038561,-0.076744,-0.059619,1,0
4,GO ALPHA BETA T CELL ACTIVATION,0.036164,-0.076883,-0.11516,1,0
4,GO CYTOSOLIC TRANSPORT,0.030383,-0.07689,-0.07672,1,0
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0019282,-0.076984,-0.075049,1,0
4,GO PROTEIN KINASE A SIGNALING,0.017549,-0.076988,-0.11277,1,0
4,GO PROTON TRANSMEMBRANE TRANSPORT,0.013798,-0.077038,-0.09564,1,0
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.029068,-0.077092,-0.080948,1,0
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.044685,-0.077155,-0.085892,1,0
4,GO BLASTOCYST DEVELOPMENT,0.023205,-0.077279,-0.069949,1,0
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.016339,-0.077353,-0.14366,1,0
4,GO CELL CELL ADHESION,0.0017123,-0.077426,-0.13924,1,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.0039469,-0.077525,-0.12431,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION,0.0050528,-0.077859,-0.079028,1,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.037747,-0.077861,-0.062627,1,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0064317,-0.078563,-0.081475,1,0
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.027803,-0.078931,-0.13825,1,0
4,GO IMMUNOGLOBULIN PRODUCTION,0.015203,-0.07902,-0.10807,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.012203,-0.079212,-0.096102,1,0
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.050569,-0.079233,-0.10649,1,0
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.00090094,-0.07925,-0.11054,1,0
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.015203,-0.079632,-0.11687,1,0
4,GO CELL AGING,0.0099891,-0.079735,-0.094963,1,0
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.037747,-0.079824,-0.19676,1,0
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.00353,-0.080516,-0.10271,1,0
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0039469,-0.080938,-0.096812,1,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.034637,-0.081335,-0.082587,1,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.033166,-0.081476,-0.062534,1,0
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.036948,-0.081603,-0.14402,1,0
4,GO REGULATION OF HISTONE UBIQUITINATION,0.045624,-0.081637,-0.073298,1,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00036427,-0.081701,-0.10867,1,0
4,GO HISTONE PHOSPHORYLATION,0.014486,-0.08224,-0.12097,1,0
4,GO CELLULAR PIGMENTATION,0.027188,-0.082299,-0.099059,1,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0025083,-0.082528,-0.10135,1,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0039469,-0.082757,-0.13514,1,0
4,GO RECEPTOR RECYCLING,0.010506,-0.083237,-0.12048,1,0
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.042857,-0.083244,-0.11265,1,0
4,GO RESPONSE TO ALKALOID,0.05161,-0.083536,-0.085656,1,0
4,GO REGULATION OF PEPTIDE TRANSPORT,0.0081404,-0.08367,-0.079446,1,0
4,GO IMMUNE SYSTEM DEVELOPMENT,0.0047853,-0.08382,-0.092792,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0087944,-0.083895,-0.099277,1,0
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0014738,-0.083925,-0.11201,1,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.03939,-0.084188,-0.13151,1,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.0042883,-0.084667,-0.085818,1,0
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0010528,-0.084951,-0.084275,1,0
4,GO TISSUE MORPHOGENESIS,0.0025817,-0.085331,-0.1219,1,0
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0013054,-0.08537,-0.10611,1,0
4,GO REGULATION OF MUSCLE ADAPTATION,0.022165,-0.08538,-0.11919,1,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.045624,-0.085741,-0.091121,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.024846,-0.085859,-0.085584,1,0
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.027188,-0.085963,-0.12426,1,0
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0022992,-0.086137,-0.086355,1,0
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0060989,-0.086154,-0.10224,1,0
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.00013433,-0.086212,-0.080571,1,0
4,GO METHIONINE METABOLIC PROCESS,0.0069616,-0.086239,-0.14498,1,0
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.02843,-0.086328,-0.12503,1,0
4,GO MESENCHYME DEVELOPMENT,0.0049174,-0.086529,-0.12938,1,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.013798,-0.086748,-0.092091,1,0
4,GO GOLGI TO ENDOSOME TRANSPORT,0.041093,-0.086829,-0.1325,1,0
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.02166,-0.087018,-0.12431,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0094949,-0.087129,-0.10146,1,0
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.046579,-0.08727,-0.10851,1,0
4,GO AUTOPHAGY OF MITOCHONDRION,0.0053338,-0.087394,-0.1059,1,0
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.010773,-0.087642,-0.1066,1,0
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00087311,-0.087808,-0.12968,1,0
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0010528,-0.088029,-0.13531,1,0
4,GO MACROAUTOPHAGY,0.00084609,-0.08828,-0.10126,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.01282,-0.088514,-0.11756,1,0
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.043763,-0.088622,-0.11793,1,0
4,GO REGULATION OF TOR SIGNALING,0.014841,-0.088721,-0.077557,1,0
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,1.5816e-05,-0.089674,-0.094422,1,0
4,GO AMINO ACID TRANSPORT,0.02268,-0.089873,-0.089456,1,0
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.041967,-0.091455,-0.094931,1,0
4,GO PROTEIN KINASE B SIGNALING,0.010773,-0.091596,-0.11377,1,0
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0014299,-0.091835,-0.092313,1,0
4,GO POLYOL CATABOLIC PROCESS,0.026586,-0.092129,-0.087292,1,0
4,GO LYMPHOCYTE HOMEOSTASIS,0.011904,-0.092394,-0.098378,1,0
4,GO PROTEIN IMPORT,0.00079435,-0.092637,-0.11482,1,0
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0013054,-0.092729,-0.10958,1,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.0020453,-0.092948,-0.12457,1,0
4,GO POSITIVE REGULATION OF TRANSPORT,0.00081984,-0.093234,-0.10761,1,0
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.036164,-0.093734,-0.081049,1,0
4,GO PROTEOLYSIS,0.00010462,-0.093768,-0.11367,1,0
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0013054,-0.094346,-0.088286,1,0
4,GO POSITIVE REGULATION OF SIGNALING,0.00067758,-0.094437,-0.10661,1,0
4,GO CELLULAR RESPONSE TO KETONE,0.0042883,-0.094646,-0.14458,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.014841,-0.094766,-0.13387,1,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.011904,-0.09478,-0.14016,1,0
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.00032948,-0.094938,-0.1073,1,0
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.016734,-0.094988,-0.11729,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00024286,-0.095141,-0.097415,1,0
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.020205,-0.095504,-0.092527,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.013139,-0.09558,-0.13113,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.014841,-0.095767,-0.10806,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0097392,-0.096139,-0.12406,1,0
4,GO INTERLEUKIN 12 PRODUCTION,0.036948,-0.096306,-0.10067,1,0
4,GO ARACHIDONIC ACID SECRETION,0.02068,-0.096324,-0.1289,1,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.0042883,-0.096351,-0.1555,1,0
4,GO LEUKOCYTE DIFFERENTIATION,0.0011199,-0.096696,-0.12636,1,0
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.041967,-0.096707,-0.11661,1,0
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.049546,-0.096834,-0.083743,1,0
4,GO REGULATION OF TRANSPORT,0.00063551,-0.097215,-0.10454,1,0
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.04854,-0.097228,-0.10592,1,0
4,GO SMOOTH MUSCLE CELL MIGRATION,0.019739,-0.097436,-0.18047,1,0
4,GO POSITIVE REGULATION OF CELL AGING,0.019283,-0.097458,-0.14307,1,0
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.02068,-0.097511,-0.13414,1,0
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.05161,-0.097581,-0.19397,1,0
4,GO RNA INTERFERENCE,0.047551,-0.097587,-0.12098,1,0
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.010245,-0.097617,-0.15619,1,0
4,GO PROTEIN CATABOLIC PROCESS,0.00016595,-0.097677,-0.096246,1,0
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0053338,-0.097749,-0.14832,1,0
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.019739,-0.097956,-0.12167,1,0
4,GO AMINE METABOLIC PROCESS,0.0036303,-0.098015,-0.13314,1,0
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.02843,-0.098089,-0.12187,1,0
4,GO MULTI ORGANISM LOCALIZATION,0.0059384,-0.098154,-0.13517,1,0
4,GO REGULATION OF HYDROLASE ACTIVITY,0.00024286,-0.098269,-0.12369,1,0
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.01282,-0.098444,-0.10865,1,0
4,GO AORTA DEVELOPMENT,0.013465,-0.098612,-0.1648,1,0
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.018836,-0.098715,-0.16562,1,0
4,GO NOTCH SIGNALING PATHWAY,0.027803,-0.098836,-0.10406,1,0
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00054072,-0.098975,-0.093849,1,0
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0046564,-0.099085,-0.12797,1,0
4,GO REGULATION OF HORMONE LEVELS,0.0087944,-0.099313,-0.10909,1,0
4,GO RESPONSE TO ESTRADIOL,0.0018173,-0.099389,-0.12629,1,0
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.0094949,-0.099559,-0.16961,1,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0051916,-0.099703,-0.10619,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.013465,-0.099784,-0.13001,1,0
4,GO LEUKOCYTE HOMEOSTASIS,0.0051916,-0.099831,-0.12056,1,0
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.0013054,-0.099859,-0.11498,1,0
4,GO CALCIUM ION IMPORT,0.011326,-0.10016,-0.11004,1,0
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.034637,-0.10017,-0.13637,1,0
4,GO SINGLE FERTILIZATION,0.009256,-0.10021,-0.10169,1,0
4,GO POSITIVE REGULATION OF CELL DEATH,0.00016595,-0.10026,-0.12437,1,0
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.031059,-0.10037,-0.12178,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.029719,-0.10043,-0.08318,1,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.041967,-0.10054,-0.11892,1,0
4,GO NEUTROPHIL MIGRATION,0.0060989,-0.10064,-0.13504,1,0
4,GO RENAL TUBULE DEVELOPMENT,0.04854,-0.10071,-0.11231,1,0
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,1.2962e-05,-0.10083,-0.11439,1,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.012508,-0.10086,-0.15326,1,0
4,GO ORGAN GROWTH,0.011904,-0.10101,-0.10652,1,0
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.0097392,-0.10126,-0.14214,1,0
4,GO BONE DEVELOPMENT,0.0057817,-0.10143,-0.11579,1,0
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00057693,-0.10153,-0.10488,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.009256,-0.10186,-0.10714,1,0
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0079323,-0.10187,-0.12463,1,0
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.025994,-0.10189,-0.13536,1,0
4,GO REGULATION OF T CELL ACTIVATION,0.0060989,-0.10199,-0.12859,1,0
4,GO ENDOCYTIC RECYCLING,0.04854,-0.10201,-0.084734,1,0
4,GO TOR SIGNALING,0.0026572,-0.10202,-0.080303,1,0
4,GO MYELOID CELL DIFFERENTIATION,0.00087311,-0.10211,-0.12385,1,0
4,GO HEART DEVELOPMENT,0.0024367,-0.10223,-0.1135,1,0
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.007729,-0.10227,-0.13395,1,0
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0040578,-0.10235,-0.10154,1,0
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0019282,-0.10237,-0.11419,1,0
4,GO PHOSPHOLIPID TRANSPORT,0.0011549,-0.10243,-0.158,1,0
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0001547,-0.10256,-0.1087,1,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.031059,-0.10268,-0.089229,1,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.046579,-0.10284,-0.11829,1,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0049174,-0.10289,-0.11544,1,0
4,GO TUBE DEVELOPMENT,0.001986,-0.10292,-0.1313,1,0
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0015653,-0.10299,-0.1157,1,0
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0012662,-0.10301,-0.11232,1,0
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.026586,-0.10305,-0.12392,1,0
4,GO APOPTOTIC PROCESS,6.0504e-05,-0.10309,-0.11855,1,0
4,GO GOLGI TO VACUOLE TRANSPORT,0.029068,-0.1031,-0.13578,1,0
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.013139,-0.10326,-0.15691,1,0
4,GO REGULATION OF B CELL ACTIVATION,0.011904,-0.10328,-0.13,1,0
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.0042883,-0.1033,-0.11205,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.010245,-0.1034,-0.14579,1,0
4,GO CHEMOKINE PRODUCTION,0.029068,-0.10355,-0.15421,1,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.014841,-0.10358,-0.13783,1,0
4,GO T CELL ACTIVATION,0.0053338,-0.10372,-0.1331,1,0
4,GO RESPONSE TO ACTIVITY,0.0051916,-0.10391,-0.11221,1,0
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.013798,-0.10423,-0.11296,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.024288,-0.10426,-0.11362,1,0
4,GO INTERFERON BETA PRODUCTION,0.052669,-0.10441,-0.12056,1,0
4,GO ACID SECRETION,0.013139,-0.10443,-0.13276,1,0
4,GO REGULATION OF LYASE ACTIVITY,0.04854,-0.10456,-0.12137,1,0
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0006154,-0.10462,-0.12812,1,0
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.00032948,-0.10466,-0.10689,1,0
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.0054795,-0.10468,-0.13353,1,0
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.033894,-0.10486,-0.14685,1,0
4,GO INTRACELLULAR TRANSPORT,4.8379e-05,-0.10489,-0.091473,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.026586,-0.10491,-0.10286,1,0
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.014841,-0.1051,-0.14136,1,0
4,GO HEART VALVE DEVELOPMENT,0.050569,-0.1052,-0.14726,1,0
4,GO GLAND DEVELOPMENT,0.0066042,-0.10558,-0.10811,1,0
4,GO LIVER REGENERATION,0.0028957,-0.10567,-0.21635,1,0
4,GO CELLULAR DEFENSE RESPONSE,0.0097392,-0.10574,-0.18985,1,0
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.0083534,-0.10584,-0.17974,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.05161,-0.10585,-0.15652,1,0
4,GO ERAD PATHWAY,0.00087311,-0.10591,-0.14374,1,0
4,GO PROTEIN TARGETING TO VACUOLE,0.0081404,-0.106,-0.14408,1,0
4,GO REGULATION OF CELL DEATH,9.0551e-05,-0.10613,-0.11779,1,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0049174,-0.10613,-0.13847,1,0
4,GO BONE MORPHOGENESIS,0.043763,-0.10615,-0.1283,1,0
4,GO CELL MOTILITY,0.0010528,-0.10628,-0.12811,1,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.046579,-0.10652,-0.12407,1,0
4,GO PEPTIDE SECRETION,0.0075304,-0.10663,-0.10599,1,0
4,GO PROTEIN LOCALIZATION TO ORGANELLE,0.00010092,-0.10667,-0.091689,1,0
4,GO NEGATIVE REGULATION OF BINDING,0.0012662,-0.10667,-0.1113,1,0
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.001191,-0.10669,-0.10342,1,0
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0022332,-0.10673,-0.17406,1,0
4,GO NEUTRAL AMINO ACID TRANSPORT,0.0083534,-0.10673,-0.1761,1,0
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,8.7323e-05,-0.10683,-0.096526,1,0
4,GO VIRAL RELEASE FROM HOST CELL,0.035393,-0.10684,-0.1113,1,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0010206,-0.10692,-0.19349,1,0
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0010859,-0.10692,-0.15912,1,0
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00040247,-0.10695,-0.11986,1,0
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.0056288,-0.10699,-0.18945,1,0
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.011612,-0.10702,-0.1015,1,0
4,GO AGING,0.00017186,-0.10708,-0.14275,1,0
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00012964,-0.10717,-0.13383,1,0
4,GO AUTOPHAGOSOME ORGANIZATION,0.007729,-0.1073,-0.13075,1,0
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.031059,-0.1073,-0.12402,1,0
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00019079,-0.10736,-0.1203,1,0
4,GO RESPONSE TO ABIOTIC STIMULUS,1.9263e-05,-0.10736,-0.12791,1,0
4,GO REGULATION OF CELL AGING,0.019283,-0.10737,-0.11756,1,0
4,GO EPITHELIAL CELL PROLIFERATION,0.001872,-0.10742,-0.15072,1,0
4,GO INTERLEUKIN 2 PRODUCTION,0.0046564,-0.10757,-0.15508,1,0
4,GO PIGMENTATION,0.0010528,-0.10766,-0.13559,1,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.023205,-0.10767,-0.13086,1,0
4,GO METANEPHROS DEVELOPMENT,0.02166,-0.1077,-0.12286,1,0
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.013798,-0.10774,-0.12843,1,0
4,GO REGULATION OF BINDING,0.00063551,-0.10778,-0.11015,1,0
4,GO COAGULATION,0.00023468,-0.10795,-0.17686,1,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0049174,-0.10806,-0.16346,1,0
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0045306,-0.10829,-0.15313,1,0
4,GO AUTOPHAGOSOME MATURATION,0.029719,-0.10841,-0.12533,1,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02068,-0.1085,-0.10324,1,0
4,GO GOLGI VESICLE TRANSPORT,0.00084609,-0.10854,-0.10465,1,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.029068,-0.10886,-0.14875,1,0
4,GO CYTOKINE SECRETION,0.02268,-0.1089,-0.10972,1,0
4,GO REGULATION OF CELL ACTIVATION,0.0022992,-0.10913,-0.13484,1,0
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0013872,-0.10918,-0.12383,1,0
4,GO NEGATIVE REGULATION OF CELL DEATH,0.00026903,-0.10924,-0.11956,1,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0040578,-0.10928,-0.096255,1,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00017186,-0.10946,-0.11717,1,0
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0064317,-0.10952,-0.11049,1,0
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.026586,-0.10954,-0.12766,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.014486,-0.10975,-0.12066,1,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.043763,-0.10985,-0.16862,1,0
4,GO VESICLE CARGO LOADING,0.0049174,-0.11078,-0.16729,1,0
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0083534,-0.11084,-0.12054,1,0
4,GO REGULATION OF SYSTEM PROCESS,0.00353,-0.11103,-0.11804,1,0
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.022165,-0.11104,-0.18304,1,0
4,GO ACTIN FILAMENT ORGANIZATION,0.0017641,-0.11113,-0.1213,1,0
4,GO MACROMOLECULE CATABOLIC PROCESS,5.508e-06,-0.11124,-0.1217,1,0
4,GO RESPONSE TO RETINOIC ACID,0.0016129,-0.11137,-0.17025,1,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0027346,-0.11139,-0.12388,1,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.041967,-0.11139,-0.14488,1,0
4,GO APOPTOTIC SIGNALING PATHWAY,0.00041602,-0.11139,-0.12929,1,0
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.041093,-0.1114,-0.15889,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0056288,-0.11143,-0.13767,1,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.043763,-0.11163,-0.10162,1,0
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.00025131,-0.11164,-0.1639,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0090226,-0.1118,-0.13537,1,0
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00017796,-0.11181,-0.13382,1,0
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00044439,-0.11184,-0.13017,1,0
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0090226,-0.11184,-0.09027,1,0
4,GO PROTEIN N LINKED GLYCOSYLATION,0.00040247,-0.11194,-0.17015,1,0
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.0022332,-0.11215,-0.12581,1,0
4,GO OSTEOCLAST DIFFERENTIATION,0.015574,-0.11232,-0.10615,1,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.033894,-0.11251,-0.11037,1,0
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0094949,-0.11258,-0.16509,1,0
4,GO CARTILAGE DEVELOPMENT,0.0040578,-0.11266,-0.14371,1,0
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,9.7346e-05,-0.1127,-0.13116,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.05161,-0.11281,-0.10879,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.024846,-0.11287,-0.11179,1,0
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,3.7145e-05,-0.11296,-0.13129,1,0
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.018398,-0.11299,-0.11321,1,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.00353,-0.11305,-0.15302,1,0
4,GO GLYCOSYLATION,0.00016595,-0.11329,-0.15726,1,0
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.046579,-0.11352,-0.14915,1,0
4,GO FC RECEPTOR SIGNALING PATHWAY,0.0097392,-0.11355,-0.10434,1,0
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0013457,-0.11359,-0.1389,1,0
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00038934,-0.1136,-0.13324,1,0
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.018398,-0.11367,-0.11622,1,0
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.016339,-0.11371,-0.09262,1,0
4,GO INTERLEUKIN 4 PRODUCTION,0.0057817,-0.11374,-0.16137,1,0
4,GO PLATELET ACTIVATION,0.0016129,-0.11374,-0.15905,1,0
4,GO ER NUCLEUS SIGNALING PATHWAY,0.033166,-0.11375,-0.12097,1,0
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.033894,-0.1138,-0.15177,1,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.027188,-0.11385,-0.20929,1,0
4,GO URETER DEVELOPMENT,0.046579,-0.1139,-0.18096,1,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.023741,-0.11392,-0.14301,1,0
4,GO MAINTENANCE OF PROTEIN LOCATION,0.0060989,-0.11399,-0.11586,1,0
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.00038934,-0.11399,-0.12052,1,0
4,GO LYMPHOCYTE ACTIVATION,0.0013872,-0.11403,-0.12792,1,0
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0034322,-0.11421,-0.17345,1,0
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0024367,-0.11421,-0.11056,1,0
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.043763,-0.11426,-0.10541,1,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.0079323,-0.11468,-0.17064,1,0
4,GO LEUKOCYTE TETHERING OR ROLLING,0.0033369,-0.11475,-0.12258,1,0
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.012203,-0.11478,-0.11822,1,0
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00014418,-0.11492,-0.15094,1,0
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00034072,-0.11496,-0.15955,1,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.043763,-0.11499,-0.15456,1,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0079323,-0.11519,-0.10772,1,0
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.026586,-0.11526,-0.1622,1,0
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,7.013e-05,-0.11528,-0.12334,1,0
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0022332,-0.11531,-0.11944,1,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.046579,-0.11537,-0.14272,1,0
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,5.2139e-05,-0.11542,-0.13254,1,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0006154,-0.11547,-0.15495,1,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.012203,-0.11552,-0.14455,1,0
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.012203,-0.11557,-0.14792,1,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0034322,-0.11564,-0.15536,1,0
4,GO INTRACELLULAR PROTEIN TRANSPORT,4.6597e-05,-0.11574,-0.096793,1,0
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0050528,-0.11576,-0.14194,1,0
4,GO DEFENSE RESPONSE TO VIRUS,0.040234,-0.11581,-0.16099,1,0
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.00014935,-0.1159,-0.11859,1,0
4,GO AMELOGENESIS,0.047551,-0.11595,-0.16222,1,0
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0050528,-0.11598,-0.14355,1,0
4,GO FERTILIZATION,0.0013872,-0.11609,-0.11156,1,0
4,GO REGULATION OF HEMOPOIESIS,0.0012662,-0.11641,-0.12613,1,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0060989,-0.11648,-0.18965,1,0
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,3.7145e-05,-0.11658,-0.15612,1,0
4,GO REGULATION OF PROTEIN MATURATION,0.0040578,-0.11673,-0.16498,1,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0083534,-0.11676,-0.13825,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.034637,-0.1168,-0.11941,1,0
4,GO CIRCULATORY SYSTEM PROCESS,0.00021909,-0.117,-0.14441,1,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.02166,-0.11703,-0.12101,1,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.0097392,-0.11709,-0.17317,1,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.025414,-0.11709,-0.08993,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0025083,-0.1172,-0.12962,1,0
4,GO REGULATION OF BODY FLUID LEVELS,0.00042998,-0.11726,-0.15581,1,0
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00044439,-0.11781,-0.13046,1,0
4,GO REGULATION OF PROTEIN IMPORT,0.02166,-0.11784,-0.14665,1,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.0031536,-0.11786,-0.13263,1,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.0079323,-0.11796,-0.12654,1,0
4,GO MUSCLE ADAPTATION,0.0019282,-0.118,-0.16554,1,0
4,GO MANGANESE ION TRANSPORT,0.017549,-0.1181,-0.14187,1,0
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.030383,-0.11822,-0.13807,1,0
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0036303,-0.11834,-0.1082,1,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.014486,-0.11844,-0.18351,1,0
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0094949,-0.1185,-0.14501,1,0
4,GO MESONEPHROS DEVELOPMENT,0.031748,-0.11872,-0.13462,1,0
4,GO REGULATION OF PEPTIDE SECRETION,0.009256,-0.11872,-0.099237,1,0
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0045306,-0.11882,-0.14144,1,0
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.017549,-0.11899,-0.15557,1,0
4,GO TUBE MORPHOGENESIS,0.00072223,-0.11919,-0.15059,1,0
4,GO CYTOLYSIS,0.026586,-0.11923,-0.19715,1,0
4,GO PHAGOSOME MATURATION,0.026586,-0.11937,-0.1187,1,0
4,GO HUMORAL IMMUNE RESPONSE,0.00014935,-0.11942,-0.16484,1,0
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.033894,-0.1195,-0.12662,1,0
4,GO PINOCYTOSIS,0.0042883,-0.11963,-0.20259,1,0
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0033369,-0.11963,-0.13295,1,0
4,GO RESPONSE TO MECHANICAL STIMULUS,0.015574,-0.11965,-0.11712,1,0
4,GO MEMBRANE ORGANIZATION,9.7346e-05,-0.11977,-0.12837,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00042998,-0.1198,-0.19113,1,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00014418,-0.11993,-0.14188,1,0
4,GO MYELOID CELL HOMEOSTASIS,0.0090226,-0.11996,-0.1134,1,0
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0099891,-0.11997,-0.14792,1,0
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0038387,-0.12,-0.10129,1,0
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.019283,-0.12005,-0.20511,1,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0071468,-0.1201,-0.11835,1,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00092958,-0.1201,-0.14064,1,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.00044439,-0.12019,-0.15218,1,0
4,GO LIPID BIOSYNTHETIC PROCESS,1.0184e-05,-0.12024,-0.15941,1,0
4,GO REGULATION OF RESPONSE TO STRESS,0.00012964,-0.12026,-0.12372,1,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00081984,-0.12035,-0.14325,1,0
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0025083,-0.12041,-0.15354,1,0
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.0094949,-0.12044,-0.13007,1,0
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0090226,-0.12056,-0.095849,1,0
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,9.0551e-05,-0.12061,-0.12145,1,0
4,GO REGULATION OF PHOSPHORYLATION,5.6174e-05,-0.12062,-0.1299,1,0
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.022165,-0.121,-0.1568,1,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00054072,-0.12109,-0.12557,1,0
4,GO PHOSPHATE ION TRANSPORT,0.013465,-0.12125,-0.11126,1,0
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00035231,-0.12125,-0.15061,1,0
4,GO CARBOHYDRATE TRANSPORT,0.00084609,-0.12156,-0.12695,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.010506,-0.12168,-0.13602,1,0
4,GO REGULATION OF PROTEIN STABILITY,1.7806e-05,-0.12173,-0.12809,1,0
4,GO INSULIN SECRETION,0.050569,-0.12188,-0.085332,1,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.001872,-0.12196,-0.13788,1,0
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.001228,-0.1221,-0.13309,1,0
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.00018427,-0.1221,-0.1213,1,0
4,GO RIG I SIGNALING PATHWAY,0.025414,-0.12217,-0.1405,1,0
4,GO RESPIRATORY BURST,0.018836,-0.12225,-0.1886,1,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0028957,-0.12226,-0.13412,1,0
4,GO HOMEOSTATIC PROCESS,1.2962e-05,-0.12228,-0.12143,1,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.010506,-0.12241,-0.15885,1,0
4,GO I KAPPAB PHOSPHORYLATION,0.0046564,-0.12248,-0.17991,1,0
4,GO REGULATION OF ORGAN GROWTH,0.024846,-0.12287,-0.11501,1,0
4,GO ARTERY DEVELOPMENT,0.009256,-0.12295,-0.1412,1,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,9.7801e-06,-0.1231,-0.14008,1,0
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0094949,-0.12317,-0.12844,1,0
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.025994,-0.12324,-0.14222,1,0
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.021165,-0.12332,-0.1559,1,0
4,GO RESPONSE TO MONOSACCHARIDE,7.8282e-05,-0.12357,-0.13693,1,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.044685,-0.12372,-0.25373,1,0
4,GO SECRETION,4.6597e-05,-0.12384,-0.14837,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00013917,-0.12384,-0.12696,1,0
4,GO LEUKOTRIENE METABOLIC PROCESS,0.011612,-0.12398,-0.18104,1,0
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0034322,-0.12412,-0.1325,1,0
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.0029794,-0.12429,-0.12979,1,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.0006154,-0.12429,-0.14423,1,0
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00095906,-0.12434,-0.10719,1,0
4,GO OSSIFICATION,0.00025131,-0.1244,-0.1624,1,0
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00010462,-0.12443,-0.13416,1,0
4,GO CARDIAC SEPTUM DEVELOPMENT,0.014841,-0.12469,-0.15087,1,0
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0022992,-0.12469,-0.1484,1,0
4,GO PROTEIN TARGETING TO LYSOSOME,0.017137,-0.12469,-0.1931,1,0
4,GO RNA METHYLATION,0.0015189,-0.12497,-0.14269,1,0
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.04854,-0.12529,-0.121,1,0
4,GO RESPONSE TO ENDOGENOUS STIMULUS,9.389e-05,-0.12534,-0.12259,1,0
4,GO DIGESTION,0.036164,-0.12538,-0.10451,1,0
4,GO SUPEROXIDE METABOLIC PROCESS,0.025414,-0.12545,-0.13285,1,0
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.011326,-0.1255,-0.14773,1,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0025083,-0.1255,-0.1574,1,0
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0060989,-0.12561,-0.13276,1,0
4,GO REGULATION OF FERTILIZATION,0.0059384,-0.12568,-0.18976,1,0
4,GO CELLULAR RESPONSE TO HEAT,0.0049174,-0.12568,-0.11117,1,0
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.024288,-0.1257,-0.15093,1,0
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0046564,-0.12574,-0.13916,1,0
4,GO HISTONE ARGININE METHYLATION,0.017549,-0.12578,-0.11265,1,0
4,GO TRANSFERRIN TRANSPORT,0.0041716,-0.12583,-0.1579,1,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.044685,-0.12599,-0.1864,1,0
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.004408,-0.12617,-0.176,1,0
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0015189,-0.12629,-0.13032,1,0
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0090226,-0.12632,-0.19892,1,0
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.0073363,-0.12638,-0.1593,1,0
4,GO CRISTAE FORMATION,0.0039469,-0.12647,-0.20631,1,0
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.035393,-0.12655,-0.28551,1,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.020205,-0.12664,-0.13176,1,0
4,GO NEPHRON DEVELOPMENT,0.014486,-0.12665,-0.12696,1,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.00036427,-0.12696,-0.10015,1,0
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0071468,-0.12708,-0.13111,1,0
4,GO CELLULAR RESPONSE TO PEPTIDE,0.00025131,-0.12723,-0.12234,1,0
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,1.1493e-05,-0.12736,-0.12821,1,0
4,GO DENDRITIC CELL MIGRATION,0.025994,-0.12749,-0.18373,1,0
4,GO TYPE I INTERFERON PRODUCTION,0.0060989,-0.12768,-0.16736,1,0
4,GO B CELL ACTIVATION,0.0026572,-0.12777,-0.12988,1,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.031748,-0.12784,-0.17951,1,0
4,GO ERBB SIGNALING PATHWAY,0.0062634,-0.12786,-0.13075,1,0
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0014738,-0.12787,-0.17611,1,0
4,GO NIK NF KAPPAB SIGNALING,0.0020453,-0.12796,-0.16879,1,0
4,GO JNK CASCADE,0.00017796,-0.12812,-0.1336,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.014138,-0.12819,-0.10112,1,0
4,GO REGULATION OF INSULIN SECRETION,0.02166,-0.12826,-0.093144,1,0
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00074557,-0.12829,-0.16191,1,0
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.02166,-0.12836,-0.13457,1,0
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,6.7596e-05,-0.12849,-0.13002,1,0
4,GO RESPONSE TO NITROGEN COMPOUND,2.0033e-05,-0.12852,-0.13017,1,0
4,GO RESPONSE TO OSMOTIC STRESS,0.0025817,-0.12876,-0.15193,1,0
4,GO NEGATIVE REGULATION OF SECRETION,0.00049035,-0.12877,-0.12421,1,0
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0010528,-0.12884,-0.12306,1,0
4,GO REGULATION OF RUFFLE ASSEMBLY,0.042857,-0.12888,-0.11994,1,0
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00029782,-0.12889,-0.14897,1,0
4,GO RESPONSE TO PEPTIDE,2.6307e-05,-0.12903,-0.13987,1,0
4,GO VESICLE BUDDING FROM MEMBRANE,0.00034072,-0.12913,-0.1543,1,0
4,GO ERYTHROCYTE HOMEOSTASIS,0.0081404,-0.12914,-0.11257,1,0
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0007696,-0.12915,-0.17942,1,0
4,GO INTERMEMBRANE LIPID TRANSFER,0.0026572,-0.12923,-0.13804,1,0
4,GO FEEDING BEHAVIOR,0.029068,-0.12927,-0.092949,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.019739,-0.12934,-0.13682,1,0
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.031748,-0.12938,-0.15874,1,0
4,GO TEMPERATURE HOMEOSTASIS,0.0029794,-0.12938,-0.12308,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.023741,-0.12943,-0.18293,1,0
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.015574,-0.12947,-0.14475,1,0
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.031059,-0.12953,-0.15714,1,0
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0023671,-0.12963,-0.12725,1,0
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0049174,-0.12969,-0.17085,1,0
4,GO REGULATION OF CELL CELL ADHESION,0.001191,-0.12979,-0.16949,1,0
4,GO AMYLOID FIBRIL FORMATION,0.046579,-0.12979,-0.17254,1,0
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.001872,-0.13007,-0.14669,1,0
4,GO NEGATIVE REGULATION OF TRANSPORT,0.00012964,-0.13018,-0.1243,1,0
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.00059588,-0.13025,-0.13288,1,0
4,GO STRESS FIBER ASSEMBLY,0.0057817,-0.13035,-0.15634,1,0
4,GO PHOSPHOLIPID METABOLIC PROCESS,4.6623e-06,-0.13047,-0.14838,1,0
4,GO REGULATION OF CATABOLIC PROCESS,1.7118e-05,-0.13048,-0.12415,1,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.0097392,-0.13058,-0.1613,1,0
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.00035231,-0.13059,-0.12596,1,0
4,GO LIPOPROTEIN LOCALIZATION,0.001986,-0.13062,-0.18522,1,0
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0007696,-0.13068,-0.18565,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.020205,-0.13094,-0.14554,1,0
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.00014418,-0.13096,-0.13202,1,0
4,GO BIOLOGICAL ADHESION,0.00013433,-0.13099,-0.16464,1,0
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0053338,-0.13104,-0.12261,1,0
4,GO RESPONSE TO CARBOHYDRATE,3.0689e-05,-0.1311,-0.14248,1,0
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,8.4205e-05,-0.13121,-0.1284,1,0
4,GO VESICLE ORGANIZATION,0.00024286,-0.13127,-0.13031,1,0
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0046564,-0.13132,-0.13695,1,0
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.043763,-0.13134,-0.11668,1,0
4,GO GLUTAMATE METABOLIC PROCESS,0.031059,-0.13136,-0.10718,1,0
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0041716,-0.13149,-0.20956,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.014486,-0.13152,-0.15494,1,0
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0066042,-0.13157,-0.19564,1,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.00021167,-0.13159,-0.15537,1,0
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00026903,-0.13162,-0.15474,1,0
4,GO DIGESTIVE SYSTEM PROCESS,0.046579,-0.13162,-0.09828,1,0
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0017123,-0.13164,-0.16364,1,0
4,GO RNA MODIFICATION,0.0010528,-0.13171,-0.14142,1,0
4,GO SECONDARY METABOLIC PROCESS,0.033894,-0.13179,-0.15269,1,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0053338,-0.13185,-0.18775,1,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.013139,-0.13193,-0.1308,1,0
4,GO VIRAL LIFE CYCLE,0.0021062,-0.13199,-0.16935,1,0
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0028141,-0.13213,-0.15629,1,0
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.014138,-0.13222,-0.11651,1,0
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,6.2786e-05,-0.13223,-0.14054,1,0
4,GO CHONDROCYTE DIFFERENTIATION,0.012508,-0.13228,-0.14254,1,0
4,GO REGULATION OF AUTOPHAGY,1.7118e-05,-0.13232,-0.15257,1,0
4,GO OSTEOBLAST DIFFERENTIATION,0.00045924,-0.13255,-0.17513,1,0
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.009256,-0.13256,-0.15368,1,0
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.8301e-05,-0.1326,-0.18175,1,0
4,GO CELLULAR ION HOMEOSTASIS,1.906e-06,-0.13278,-0.15571,1,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.012203,-0.13279,-0.31051,1,0
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00026003,-0.13283,-0.15471,1,0
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00017186,-0.13323,-0.13644,1,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00092958,-0.13325,-0.16679,1,0
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.001191,-0.13333,-0.15791,1,0
4,GO RESPONSE TO VIRUS,0.009256,-0.13339,-0.1609,1,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.036164,-0.13347,-0.16006,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00041602,-0.13358,-0.14432,1,0
4,GO REGULATION OF PROTEOLYSIS,3.8583e-05,-0.13367,-0.15484,1,0
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00029782,-0.13378,-0.12665,1,0
4,GO COPII COATED VESICLE BUDDING,4.3218e-05,-0.13385,-0.16692,1,0
4,GO POSITIVE REGULATION OF TRANSLATION,6.0504e-05,-0.13391,-0.19005,1,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.00067758,-0.13401,-0.12285,1,0
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.018836,-0.13405,-0.17858,1,0
4,GO IRON ION TRANSPORT,7.2754e-05,-0.13416,-0.15612,1,0
4,GO REGULATION OF SODIUM ION TRANSPORT,0.0090226,-0.13417,-0.15284,1,0
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.016339,-0.13424,-0.21373,1,0
4,GO CERAMIDE METABOLIC PROCESS,0.00040247,-0.13434,-0.15924,1,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.018398,-0.13435,-0.16315,1,0
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00037661,-0.13442,-0.11964,1,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0011199,-0.1345,-0.16047,1,0
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0034322,-0.13451,-0.15063,1,0
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.0030654,-0.13453,-0.10725,1,0
4,GO LEUKOCYTE CELL CELL ADHESION,0.00055855,-0.13457,-0.17095,1,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.0041716,-0.13493,-0.19141,1,0
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00057693,-0.13499,-0.16573,1,0
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.040234,-0.13501,-0.15944,1,0
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.020205,-0.13507,-0.1766,1,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00032948,-0.13508,-0.15408,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00095906,-0.13517,-0.16248,1,0
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.029068,-0.13532,-0.24248,1,0
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,9.7346e-05,-0.13535,-0.23129,1,0
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0069616,-0.13539,-0.16336,1,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,4.0073e-05,-0.13545,-0.16967,1,0
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.00084609,-0.13552,-0.1615,1,0
4,GO URONIC ACID METABOLIC PROCESS,0.0015189,-0.13555,-0.16919,1,0
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.001228,-0.13567,-0.17576,1,0
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00027832,-0.13571,-0.14122,1,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.007729,-0.13625,-0.20196,1,0
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,5.0226e-05,-0.13636,-0.14639,1,0
4,GO RESPONSE TO ALCOHOL,0.00017186,-0.13643,-0.15218,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00049035,-0.13647,-0.19729,1,0
4,GO TRANSMEMBRANE TRANSPORT,1.5201e-05,-0.13654,-0.14236,1,0
4,GO CARBOHYDRATE HOMEOSTASIS,7.2754e-05,-0.13678,-0.15999,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0040578,-0.13679,-0.16963,1,0
4,GO POSITIVE REGULATION OF BINDING,0.00072223,-0.13682,-0.12492,1,0
4,GO SYMBIOTIC PROCESS,2.5308e-05,-0.13696,-0.15798,1,0
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,3.4421e-05,-0.13699,-0.13927,1,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.014841,-0.13709,-0.17529,1,0
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00022676,-0.13729,-0.14769,1,0
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.02268,-0.13746,-0.23876,1,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0069616,-0.1375,-0.17326,1,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.033894,-0.13757,-0.12786,1,0
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0021689,-0.13757,-0.15371,1,0
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0051916,-0.1376,-0.18883,1,0
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.045624,-0.13768,-0.11486,1,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.0034322,-0.13768,-0.14347,1,0
4,GO ALANINE TRANSPORT,0.021165,-0.13771,-0.1769,1,0
4,GO IMMUNOGLOBULIN SECRETION,0.0029794,-0.13772,-0.2247,1,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,7.013e-05,-0.13789,-0.16214,1,0
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0018173,-0.13799,-0.12631,1,0
4,GO CELLULAR RESPONSE TO DSRNA,0.015203,-0.13804,-0.18193,1,0
4,GO MITOCHONDRIAL TRANSPORT,0.00013917,-0.1381,-0.11756,1,0
4,GO VESICLE TARGETING,0.00023468,-0.13812,-0.17256,1,0
4,GO GRANULOCYTE CHEMOTAXIS,0.0025817,-0.13823,-0.1619,1,0
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00038934,-0.13827,-0.13823,1,0
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0050528,-0.1383,-0.13934,1,0
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0020453,-0.13834,-0.12719,1,0
4,GO RESPONSE TO OXYGEN RADICAL,0.038561,-0.13847,-0.11135,1,0
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0060989,-0.1385,-0.12377,1,0
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.00049035,-0.13856,-0.14658,1,0
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.016734,-0.13859,-0.17016,1,0
4,GO PRIMARY MIRNA PROCESSING,0.0017641,-0.13861,-0.19782,1,0
4,GO REGULATION OF T CELL MIGRATION,0.0059384,-0.13867,-0.15542,1,0
4,GO METAL ION HOMEOSTASIS,2.0784e-06,-0.13874,-0.16153,1,0
4,GO GRANULOCYTE MIGRATION,0.00049035,-0.13885,-0.18315,1,0
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0027346,-0.13885,-0.17385,1,0
4,GO RECEPTOR METABOLIC PROCESS,0.00087311,-0.13893,-0.13073,1,0
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,6.2786e-05,-0.13895,-0.1353,1,0
4,GO REGULATION OF GLUCONEOGENESIS,0.0026572,-0.13925,-0.12747,1,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0094949,-0.13929,-0.14267,1,0
4,GO RESPONSE TO INTERLEUKIN 1,3.3132e-05,-0.13931,-0.19184,1,0
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0021689,-0.13935,-0.17592,1,0
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.015953,-0.13941,-0.16345,1,0
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0017641,-0.13942,-0.16772,1,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.012203,-0.13946,-0.12934,1,0
4,GO CELLULAR COMPONENT DISASSEMBLY,4.2876e-06,-0.13951,-0.14571,1,0
4,GO RESPONSE TO STEROL,0.0039469,-0.13956,-0.19067,1,0
4,GO CELL ACTIVATION,0.00010462,-0.13957,-0.16835,1,0
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.041093,-0.13966,-0.16939,1,0
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.6597e-05,-0.13989,-0.14515,1,0
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0020453,-0.14001,-0.16994,1,0
4,GO CHEMICAL HOMEOSTASIS,5.0683e-06,-0.14003,-0.1488,1,0
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,5.508e-06,-0.14008,-0.15386,1,0
4,GO ADAPTIVE THERMOGENESIS,0.0032441,-0.14015,-0.12709,1,0
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00010845,-0.1402,-0.16627,1,0
4,GO TOXIN TRANSPORT,0.020205,-0.14037,-0.11437,1,0
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00044439,-0.14043,-0.14736,1,0
4,GO ORGANIC ACID TRANSPORT,3.3132e-05,-0.1405,-0.14785,1,0
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0069616,-0.14071,-0.19467,1,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0033369,-0.14077,-0.1891,1,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.017969,-0.1409,-0.1771,1,0
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.001191,-0.14109,-0.14281,1,0
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00025131,-0.14122,-0.13444,1,0
4,GO REGULATION OF CELL ADHESION,0.00072223,-0.14142,-0.17181,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.017969,-0.14154,-0.13597,1,0
4,GO GLIAL CELL ACTIVATION,0.0018173,-0.14161,-0.19242,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.026586,-0.14172,-0.16624,1,0
4,GO LINOLEIC ACID METABOLIC PROCESS,0.03939,-0.14176,-0.20824,1,0
4,GO INORGANIC ANION TRANSPORT,1.2962e-05,-0.1418,-0.15854,1,0
4,GO ION TRANSPORT,5.8301e-05,-0.14193,-0.14098,1,0
4,GO LIPID MODIFICATION,4.8379e-05,-0.14201,-0.15495,1,0
4,GO MUSCLE CELL PROLIFERATION,0.001662,-0.14209,-0.15916,1,0
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00010845,-0.14212,-0.14061,1,0
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.00092958,-0.14216,-0.14869,1,0
4,GO PIGMENT GRANULE MATURATION,0.017549,-0.1422,-0.20996,1,0
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.044685,-0.14231,-0.1731,1,0
4,GO REGULATION OF TUBE SIZE,0.0067808,-0.14235,-0.12812,1,0
4,GO VASCULATURE DEVELOPMENT,0.00030804,-0.14236,-0.17781,1,0
4,GO REGULATION OF DEFENSE RESPONSE,0.0001547,-0.14237,-0.15058,1,0
4,GO RESPONSE TO KETONE,0.00013433,-0.14243,-0.17019,1,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.034637,-0.14243,-0.13377,1,0
4,GO MUSCLE CELL FATE COMMITMENT,0.021165,-0.14254,-0.20938,1,0
4,GO SPHINGOLIPID METABOLIC PROCESS,0.00045924,-0.14264,-0.17425,1,0
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.001662,-0.14267,-0.24572,1,0
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.022165,-0.14279,-0.10849,1,0
4,GO GOLGI VESICLE BUDDING,1.7118e-05,-0.14282,-0.1763,1,0
4,GO RESPONSE TO PEPTIDE HORMONE,2.7343e-05,-0.14283,-0.14222,1,0
4,GO RESPONSE TO FATTY ACID,0.00079435,-0.14284,-0.18309,1,0
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0017123,-0.14292,-0.1528,1,0
4,GO POTASSIUM ION TRANSPORT,0.034637,-0.1431,-0.094908,1,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.014138,-0.14313,-0.15503,1,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.016734,-0.14317,-0.15164,1,0
4,GO RRNA TRANSCRIPTION,0.043763,-0.14322,-0.12334,1,0
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.00013917,-0.14327,-0.17736,1,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00020448,-0.14335,-0.13537,1,0
4,GO PROSTAGLANDIN TRANSPORT,0.033894,-0.14365,-0.13226,1,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.031748,-0.1437,-0.1424,1,0
4,GO AMMONIUM ION METABOLIC PROCESS,0.052669,-0.14399,-0.16971,1,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0029794,-0.14404,-0.14378,1,0
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0094949,-0.14426,-0.14536,1,0
4,GO PROTEIN HETEROOLIGOMERIZATION,0.0014299,-0.14429,-0.15121,1,0
4,GO REGULATION OF NUCLEASE ACTIVITY,0.0049174,-0.14452,-0.16843,1,0
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,1.0184e-05,-0.14464,-0.16812,1,0
4,GO REGULATION OF HIPPO SIGNALING,0.046579,-0.14467,-0.20802,1,0
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00021909,-0.14482,-0.14893,1,0
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.010773,-0.14504,-0.15247,1,0
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.025994,-0.14511,-0.13403,1,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.0067808,-0.14515,-0.14549,1,0
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,3.6228e-06,-0.14518,-0.14409,1,0
4,GO POSITIVE REGULATION OF CELL KILLING,0.0090226,-0.14542,-0.18469,1,0
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0069616,-0.14547,-0.18489,1,0
4,GO ANION TRANSPORT,1.0604e-05,-0.14548,-0.14856,1,0
4,GO MAMMARY GLAND DEVELOPMENT,0.00067758,-0.14554,-0.16138,1,0
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0015189,-0.14557,-0.16883,1,0
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,1.7806e-05,-0.14578,-0.12719,1,0
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.05161,-0.14605,-0.22924,1,0
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.014486,-0.14609,-0.10905,1,0
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,6.4994e-06,-0.14632,-0.15282,1,0
4,GO RRNA METHYLATION,0.012203,-0.14633,-0.17117,1,0
4,GO EXOCYTOSIS,4.6597e-05,-0.14638,-0.17807,1,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.036164,-0.14646,-0.16424,1,0
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0079323,-0.14646,-0.14938,1,0
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,9.389e-05,-0.14649,-0.13172,1,0
4,GO ORGANIC ANION TRANSPORT,1.8521e-05,-0.1465,-0.15256,1,0
4,GO OSTEOBLAST DEVELOPMENT,0.03939,-0.14653,-0.15972,1,0
4,GO WOUND HEALING,0.00063551,-0.14672,-0.19338,1,0
4,GO HYPOTONIC RESPONSE,0.0071468,-0.14692,-0.22735,1,0
4,GO REGULATION OF SYMBIOTIC PROCESS,0.011904,-0.14693,-0.15898,1,0
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00017186,-0.14698,-0.14504,1,0
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.037747,-0.14698,-0.19311,1,0
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0017123,-0.147,-0.18301,1,0
4,GO CELLULAR RESPONSE TO STEROL,0.029068,-0.14709,-0.17098,1,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0099891,-0.14722,-0.11308,1,0
4,GO T CELL CHEMOTAXIS,0.023205,-0.14756,-0.12699,1,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.045624,-0.14762,-0.23127,1,0
4,GO RESPONSE TO INSULIN,7.3528e-06,-0.1477,-0.15398,1,0
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.031748,-0.1478,-0.23962,1,0
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.6228e-06,-0.14798,-0.16742,1,0
4,GO BLOOD VESSEL MORPHOGENESIS,0.00026003,-0.14806,-0.19125,1,0
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.011904,-0.14807,-0.16766,1,0
4,GO REGULATION OF B CELL PROLIFERATION,0.001872,-0.14814,-0.188,1,0
4,GO MACROMOLECULE DEPALMITOYLATION,0.012203,-0.14815,-0.1819,1,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.004408,-0.14819,-0.19738,1,0
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.011326,-0.14835,-0.1554,1,0
4,GO ALCOHOL CATABOLIC PROCESS,0.00025131,-0.14835,-0.1656,1,0
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0014738,-0.14852,-0.17125,1,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.034637,-0.14857,-0.28368,1,0
4,GO RESPONSE TO WOUNDING,0.0010206,-0.1486,-0.17801,1,0
4,GO ISOPRENOID METABOLIC PROCESS,0.0047853,-0.14862,-0.16068,1,0
4,GO GLYCOPROTEIN METABOLIC PROCESS,2.4346e-05,-0.14867,-0.16996,1,0
4,GO LIPID EXPORT FROM CELL,0.0046564,-0.14873,-0.16159,1,0
4,GO RESPONSE TO TEMPERATURE STIMULUS,5.6174e-05,-0.1488,-0.14625,1,0
4,GO ACTIVATION OF IMMUNE RESPONSE,0.00025131,-0.14884,-0.15222,1,0
4,GO FACE DEVELOPMENT,0.04854,-0.14885,-0.11608,1,0
4,GO REGULATION OF CELL KILLING,0.0054795,-0.1491,-0.17827,1,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00090094,-0.14913,-0.17136,1,0
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0006154,-0.14922,-0.15642,1,0
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.00081984,-0.14953,-0.17893,1,0
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.0016129,-0.14968,-0.15984,1,0
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00026003,-0.1498,-0.15877,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0019282,-0.14981,-0.20849,1,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00023468,-0.15002,-0.23963,1,0
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00023468,-0.15012,-0.15154,1,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00087311,-0.15036,-0.14469,1,0
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0015189,-0.15036,-0.15509,1,0
4,GO TRANSITION METAL ION TRANSPORT,2.0033e-05,-0.15045,-0.14391,1,0
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0097392,-0.15055,-0.15213,1,0
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.001986,-0.15056,-0.12934,1,0
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.014841,-0.1507,-0.15722,1,0
4,GO LIPID HOMEOSTASIS,0.00026003,-0.15074,-0.16078,1,0
4,GO GLIAL CELL PROLIFERATION,0.029068,-0.15112,-0.13658,1,0
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00047456,-0.15116,-0.16792,1,0
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00019753,-0.15124,-0.13988,1,0
4,GO ALPHA BETA T CELL PROLIFERATION,0.016734,-0.15136,-0.17573,1,0
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00044439,-0.15141,-0.14953,1,0
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00095906,-0.15146,-0.23399,1,0
4,GO RESPONSE TO INORGANIC SUBSTANCE,1.5816e-05,-0.1515,-0.17219,1,0
4,GO CORONARY VASCULATURE DEVELOPMENT,0.00081984,-0.15155,-0.2025,1,0
4,GO PROTEIN TARGETING,1.7806e-05,-0.15177,-0.18813,1,0
4,GO VACUOLAR ACIDIFICATION,0.00092958,-0.15178,-0.18984,1,0
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00010092,-0.15179,-0.15892,1,0
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0010859,-0.15184,-0.1405,1,0
4,GO RESPONSE TO HEAT,0.00028792,-0.15196,-0.14558,1,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00037661,-0.15206,-0.16788,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00052342,-0.15212,-0.18068,1,0
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0036303,-0.15213,-0.16239,1,0
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0024367,-0.15218,-0.15039,1,0
4,GO HYALURONAN METABOLIC PROCESS,0.00029782,-0.15223,-0.22161,1,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00041602,-0.15224,-0.11937,1,0
4,GO DRUG CATABOLIC PROCESS,2.4346e-05,-0.15225,-0.22862,1,0
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0024367,-0.15228,-0.2143,1,0
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.00098941,-0.15237,-0.21634,1,0
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,2.8418e-05,-0.15248,-0.15269,1,0
4,GO PEPTIDYL ARGININE METHYLATION,0.0057817,-0.15273,-0.1495,1,0
4,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.044685,-0.15274,-0.19309,1,0
4,GO CELLULAR HOMEOSTASIS,1.2862e-06,-0.15301,-0.15575,1,0
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.011047,-0.15312,-0.21325,1,0
4,GO CELLULAR EXTRAVASATION,0.00057693,-0.15334,-0.17167,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00031859,-0.15345,-0.18557,1,0
4,GO PROTEASOME ASSEMBLY,0.02068,-0.15346,-0.15121,1,0
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00027832,-0.15351,-0.21095,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00014935,-0.15352,-0.16055,1,0
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00031859,-0.15358,-0.13719,1,0
4,GO TERPENOID METABOLIC PROCESS,0.0057817,-0.15367,-0.16534,1,0
4,GO REGULATION OF BLOOD PRESSURE,0.00041602,-0.15372,-0.15323,1,0
4,GO BLOOD VESSEL REMODELING,0.0014299,-0.15388,-0.24209,1,0
4,GO MESODERM MORPHOGENESIS,0.0025083,-0.15403,-0.19503,1,0
4,GO REGULATION OF MACROPHAGE MIGRATION,0.0028957,-0.15405,-0.165,1,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0028141,-0.15408,-0.19999,1,0
4,GO CELL KILLING,0.00044439,-0.15409,-0.17519,1,0
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00010462,-0.15411,-0.20004,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00030804,-0.15424,-0.16149,1,0
4,GO DENDRITIC CELL CHEMOTAXIS,0.015203,-0.15438,-0.17646,1,0
4,GO PEPTIDYL TYROSINE MODIFICATION,0.00038934,-0.15454,-0.15776,1,0
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.011904,-0.15458,-0.14079,1,0
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0032441,-0.15467,-0.20421,1,0
4,GO LENS FIBER CELL DIFFERENTIATION,0.03245,-0.1548,-0.15641,1,0
4,GO RESPONSE TO ACID CHEMICAL,0.00032948,-0.15487,-0.15464,1,0
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00021167,-0.15487,-0.18811,1,0
4,GO ORGANELLE MEMBRANE FUSION,0.00055855,-0.15489,-0.16515,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0024367,-0.15492,-0.17225,1,0
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,1.6455e-05,-0.15496,-0.17734,1,0
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00029782,-0.15502,-0.20209,1,0
4,GO FEAR RESPONSE,0.0010528,-0.15504,-0.16961,1,0
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00069957,-0.15506,-0.22846,1,0
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.047551,-0.15512,-0.14402,1,0
4,GO ORGANELLE FUSION,0.00028792,-0.15514,-0.14113,1,0
4,GO RNA CATABOLIC PROCESS,0.00038934,-0.15515,-0.16584,1,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0081404,-0.15524,-0.11926,1,0
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0025083,-0.15528,-0.16172,1,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.011047,-0.15534,-0.18498,1,0
4,GO LEUKOCYTE CHEMOTAXIS,0.0017641,-0.15542,-0.16056,1,0
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00063551,-0.15554,-0.1498,1,0
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0085714,-0.15576,-0.1563,1,0
4,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00013917,-0.15582,-0.18467,1,0
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,3.3132e-05,-0.15584,-0.17064,1,0
4,GO CELLULAR KETONE METABOLIC PROCESS,0.00020448,-0.1562,-0.17491,1,0
4,GO CELLULAR LIPID METABOLIC PROCESS,5.0683e-06,-0.15625,-0.1744,1,0
4,GO STEROID BIOSYNTHETIC PROCESS,5.4121e-05,-0.15634,-0.19116,1,0
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0032441,-0.15636,-0.19383,1,0
4,GO ANION TRANSMEMBRANE TRANSPORT,1.104e-05,-0.1564,-0.16163,1,0
4,GO ACTIVATION OF MAPK ACTIVITY,0.00038934,-0.1564,-0.14192,1,0
4,GO ION HOMEOSTASIS,2.1702e-06,-0.15649,-0.16384,1,0
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0083534,-0.1565,-0.15159,1,0
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,7.9801e-06,-0.15658,-0.14639,1,0
4,GO RESPONSE TO INTERLEUKIN 15,0.00059588,-0.15659,-0.29055,1,0
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.027188,-0.15671,-0.19609,1,0
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.00025131,-0.15714,-0.14982,1,0
4,GO L AMINO ACID TRANSPORT,0.00069957,-0.15732,-0.17835,1,0
4,GO ICOSANOID METABOLIC PROCESS,0.0011199,-0.15738,-0.20406,1,0
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0028141,-0.15742,-0.21208,1,0
4,GO REGULATION OF STEROL TRANSPORT,0.0025817,-0.15744,-0.19787,1,0
4,GO GLYCEROLIPID METABOLIC PROCESS,9.0179e-06,-0.15749,-0.15378,1,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0023671,-0.1575,-0.22963,1,0
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,9.0179e-06,-0.15753,-0.17465,1,0
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.02068,-0.15781,-0.14433,1,0
4,GO NEUROMUSCULAR PROCESS,0.0083534,-0.15782,-0.12482,1,0
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,3.5759e-05,-0.15786,-0.15701,1,0
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,3.4421e-05,-0.1579,-0.17238,1,0
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00063551,-0.15793,-0.17638,1,0
4,GO POSITIVE REGULATION OF FERTILIZATION,0.033166,-0.15799,-0.21265,1,0
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0011549,-0.15807,-0.19587,1,0
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00026903,-0.15815,-0.1825,1,0
4,GO REGULATION OF LIPASE ACTIVITY,5.7413e-06,-0.15822,-0.20094,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,3.7145e-05,-0.15833,-0.15488,1,0
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,2.0833e-05,-0.15836,-0.1535,1,0
4,GO OUTFLOW TRACT MORPHOGENESIS,0.011326,-0.15838,-0.16668,1,0
4,GO TRIGLYCERIDE METABOLIC PROCESS,4.6597e-05,-0.1584,-0.20462,1,0
4,GO RESPONSE TO AMPHETAMINE,0.024288,-0.1584,-0.19323,1,0
4,GO ACUTE PHASE RESPONSE,0.001191,-0.15843,-0.20256,1,0
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00074557,-0.15843,-0.19855,1,0
4,GO ESTROGEN METABOLIC PROCESS,0.00045924,-0.15847,-0.21202,1,0
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.011612,-0.15847,-0.20369,1,0
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0064317,-0.15849,-0.11786,1,0
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00038934,-0.15853,-0.18334,1,0
4,GO NEUTRAL LIPID METABOLIC PROCESS,2.1663e-05,-0.15856,-0.19375,1,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00045924,-0.15866,-0.19412,1,0
4,GO L GLUTAMATE IMPORT,0.020205,-0.15881,-0.17267,1,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0041716,-0.15886,-0.20647,1,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0037331,-0.15887,-0.22498,1,0
4,GO MYOTUBE DIFFERENTIATION,0.0029794,-0.1589,-0.14847,1,0
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,3.7145e-05,-0.15896,-0.15836,1,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00010462,-0.15901,-0.22746,1,0
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0021062,-0.15922,-0.17278,1,0
4,GO TRNA MODIFICATION,0.0017123,-0.15923,-0.16953,1,0
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0090226,-0.15926,-0.17236,1,0
4,GO RESPONSE TO HORMONE,1.104e-05,-0.15934,-0.15869,1,0
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.01282,-0.1594,-0.16308,1,0
4,GO SEQUESTERING OF METAL ION,0.015953,-0.15955,-0.17546,1,0
4,GO OSTEOCLAST DEVELOPMENT,0.030383,-0.15956,-0.15667,1,0
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0025817,-0.15957,-0.18243,1,0
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00013917,-0.15968,-0.16777,1,0
4,GO T CELL PROLIFERATION,0.00034072,-0.15971,-0.18822,1,0
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.00027832,-0.15978,-0.1497,1,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0034322,-0.15994,-0.15944,1,0
4,GO MEMBRANE FUSION,0.00034072,-0.15997,-0.15359,1,0
4,GO ACROSOME REACTION,0.019739,-0.15999,-0.15544,1,0
4,GO RESPONSE TO INTERLEUKIN 7,0.0010206,-0.16014,-0.17902,1,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0025083,-0.1602,-0.20264,1,0
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0011199,-0.16039,-0.16598,1,0
4,GO AMINO SUGAR CATABOLIC PROCESS,0.0025083,-0.16041,-0.21599,1,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.023205,-0.16052,-0.21337,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.0060989,-0.16065,-0.2281,1,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,1.5201e-05,-0.16068,-0.16338,1,0
4,GO MONOCARBOXYLIC ACID TRANSPORT,4.0073e-05,-0.16075,-0.16247,1,0
4,GO CELLULAR RESPONSE TO STARVATION,0.0012662,-0.16076,-0.13703,1,0
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00050664,-0.16092,-0.18674,1,0
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,4.6623e-06,-0.16093,-0.16716,1,0
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.0081404,-0.16097,-0.1632,1,0
4,GO LIPID METABOLIC PROCESS,4.2876e-06,-0.16101,-0.17018,1,0
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00012512,-0.16101,-0.175,1,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,6.0504e-05,-0.16104,-0.18309,1,0
4,GO MULTI ORGANISM CELLULAR PROCESS,0.0066042,-0.16137,-0.29223,1,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00014418,-0.16162,-0.16837,1,0
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0073363,-0.16167,-0.16436,1,0
4,GO RESPONSE TO OXIDATIVE STRESS,1.8521e-05,-0.16168,-0.1761,1,0
4,GO REGULATION OF VIRAL LIFE CYCLE,0.030383,-0.1617,-0.18597,1,0
4,GO HEART GROWTH,0.0085714,-0.16176,-0.12118,1,0
4,GO TRNA PROCESSING,0.0019282,-0.16177,-0.14844,1,0
4,GO PROTEIN AUTOPHOSPHORYLATION,0.00014935,-0.16178,-0.14255,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00038934,-0.16181,-0.19696,1,0
4,GO DIVALENT INORGANIC CATION TRANSPORT,2.3418e-05,-0.16184,-0.15769,1,0
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0051916,-0.16188,-0.17368,1,0
4,GO CYTOKINE METABOLIC PROCESS,0.00052342,-0.16195,-0.21259,1,0
4,GO RESPONSE TO STEROID HORMONE,4.6597e-05,-0.16204,-0.17847,1,0
4,GO BONE REMODELING,0.0041716,-0.16204,-0.19349,1,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00016595,-0.16208,-0.18135,1,0
4,GO DEFENSE RESPONSE TO BACTERIUM,0.00059588,-0.16225,-0.1637,1,0
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0028141,-0.16226,-0.16725,1,0
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0099891,-0.16236,-0.18652,1,0
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.00045924,-0.16248,-0.15481,1,0
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00052342,-0.16251,-0.16975,1,0
4,GO CHLORIDE TRANSPORT,0.00042998,-0.16273,-0.15107,1,0
4,GO INTRACELLULAR LIPID TRANSPORT,0.014138,-0.16273,-0.14509,1,0
4,GO PLASMA MEMBRANE TUBULATION,0.031059,-0.16276,-0.14951,1,0
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00013433,-0.1629,-0.19163,1,0
4,GO RESPONSE TO PROSTAGLANDIN,0.027803,-0.16299,-0.16563,1,0
4,GO GLAND MORPHOGENESIS,0.013465,-0.16305,-0.19782,1,0
4,GO SELECTIVE AUTOPHAGY,0.00037661,-0.16309,-0.17675,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00016595,-0.16316,-0.20223,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00098941,-0.1632,-0.18957,1,0
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,2.1663e-05,-0.16334,-0.16579,1,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.021165,-0.16336,-0.17955,1,0
4,GO LYMPHOCYTE CHEMOTAXIS,0.00069957,-0.16346,-0.1736,1,0
4,GO REGULATION OF FATTY ACID OXIDATION,0.0039469,-0.16361,-0.1856,1,0
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0017641,-0.16367,-0.17944,1,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.0015653,-0.16367,-0.19397,1,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0062634,-0.16371,-0.17104,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.016734,-0.16388,-0.16558,1,0
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0099891,-0.16397,-0.24004,1,0
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,9.0551e-05,-0.16403,-0.16243,1,0
4,GO FATTY ACID TRANSPORT,6.5149e-05,-0.16407,-0.17423,1,0
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.007729,-0.1642,-0.13593,1,0
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0039469,-0.16425,-0.18618,1,0
4,GO EXCRETION,0.0010859,-0.16428,-0.16344,1,0
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.014486,-0.16429,-0.22817,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0087944,-0.16433,-0.13483,1,0
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.001872,-0.16433,-0.15548,1,0
4,GO CHYLOMICRON ASSEMBLY,7.2754e-05,-0.16435,-0.23247,1,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.0049174,-0.16445,-0.25982,1,0
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.035393,-0.16458,-0.20615,1,0
4,GO INNATE IMMUNE RESPONSE,0.00018427,-0.16458,-0.19047,1,0
4,GO B CELL PROLIFERATION,0.00013917,-0.16476,-0.19581,1,0
4,GO CELLULAR RESPONSE TO ATP,0.0028141,-0.16478,-0.16156,1,0
4,GO REGULATION OF CHEMOTAXIS,0.00081984,-0.16486,-0.15876,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.014486,-0.16487,-0.1473,1,0
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00012512,-0.16529,-0.17335,1,0
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.019739,-0.1654,-0.23178,1,0
4,GO CELLULAR RESPIRATION,0.00050664,-0.1655,-0.19683,1,0
4,GO GLUCOSE METABOLIC PROCESS,6.4994e-06,-0.16551,-0.17115,1,0
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.4121e-05,-0.16578,-0.2091,1,0
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.00012964,-0.16606,-0.19768,1,0
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0024367,-0.16616,-0.16938,1,0
4,GO CHOLESTEROL EFFLUX,0.00072223,-0.16627,-0.18364,1,0
4,GO OXIDATIVE PHOSPHORYLATION,0.00072223,-0.16629,-0.20296,1,0
4,GO CELLULAR RESPONSE TO LIPID,1.4039e-05,-0.16638,-0.17111,1,0
4,GO BONE RESORPTION,0.0046564,-0.16648,-0.18238,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,1.1964e-05,-0.1665,-0.15982,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00014418,-0.16656,-0.17937,1,0
4,GO RESPONSE TO METAL ION,3.8583e-05,-0.16662,-0.17802,1,0
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.0067808,-0.16673,-0.15322,1,0
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0090226,-0.16689,-0.15797,1,0
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.00035231,-0.16693,-0.16124,1,0
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.0028957,-0.16694,-0.16187,1,0
4,GO PROTEIN MATURATION,1.4609e-05,-0.16716,-0.17373,1,0
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00013433,-0.16733,-0.19031,1,0
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,9.4334e-07,-0.16734,-0.18051,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00050664,-0.16734,-0.1783,1,0
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0057817,-0.16737,-0.24415,1,0
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0038387,-0.16737,-0.16174,1,0
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.001872,-0.1674,-0.24504,1,0
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.03939,-0.16748,-0.21147,1,0
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0056288,-0.16749,-0.1666,1,0
4,GO REGULATION OF IMMUNE RESPONSE,8.4205e-05,-0.16753,-0.16476,1,0
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.05161,-0.16753,-0.20864,1,0
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.00098941,-0.16753,-0.17836,1,0
4,GO REGULATION OF ATP METABOLIC PROCESS,0.00012964,-0.16758,-0.14771,1,0
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.02166,-0.1677,-0.12156,1,0
4,GO ATP METABOLIC PROCESS,1.0604e-05,-0.16778,-0.17513,1,0
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0011549,-0.16781,-0.17814,1,0
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0025817,-0.168,-0.15763,1,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.001191,-0.16813,-0.23222,1,0
4,GO MYELOID LEUKOCYTE MIGRATION,0.00017796,-0.16816,-0.19516,1,0
4,GO LIPID OXIDATION,0.00027832,-0.1682,-0.18764,1,0
4,GO RESPONSE TO SALT,0.0036303,-0.16827,-0.13915,1,0
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.025994,-0.16828,-0.18246,1,0
4,GO LIPID LOCALIZATION,2.0033e-05,-0.16845,-0.18598,1,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.014138,-0.1685,-0.17391,1,0
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0021062,-0.16869,-0.1602,1,0
4,GO IMMATURE T CELL PROLIFERATION,0.009256,-0.16875,-0.20035,1,0
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.020205,-0.16877,-0.14112,1,0
4,GO PROTEIN HOMOTETRAMERIZATION,0.00030804,-0.16878,-0.13872,1,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.00041602,-0.16894,-0.1692,1,0
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.0038387,-0.16896,-0.20016,1,0
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00041602,-0.16905,-0.18869,1,0
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,1.7118e-05,-0.16917,-0.16837,1,0
4,GO LYMPHOCYTE MIGRATION,7.2754e-05,-0.16926,-0.19201,1,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00014935,-0.16932,-0.19545,1,0
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.015953,-0.16933,-0.19953,1,0
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.004408,-0.16935,-0.21896,1,0
4,GO RESPONSE TO OXYGEN LEVELS,7.889e-07,-0.16939,-0.20858,1,0
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00021167,-0.16942,-0.21407,1,0
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.046579,-0.16946,-0.21446,1,0
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00050664,-0.1695,-0.21606,1,0
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0017123,-0.1696,-0.16429,1,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.027188,-0.1697,-0.2668,1,0
4,GO CYTOKINE PRODUCTION,0.0001165,-0.16982,-0.1774,1,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0037331,-0.16985,-0.25747,1,0
4,GO MYELOID CELL APOPTOTIC PROCESS,0.018836,-0.16987,-0.18523,1,0
4,GO B CELL MEDIATED IMMUNITY,0.0042883,-0.17015,-0.18164,1,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0036303,-0.17044,-0.16479,1,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0032441,-0.17047,-0.2555,1,0
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00025131,-0.17053,-0.23143,1,0
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.00095906,-0.17071,-0.14222,1,0
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,3.0689e-05,-0.17075,-0.17351,1,0
4,GO FATTY ACID BETA OXIDATION,0.0015189,-0.17097,-0.17339,1,0
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,1.906e-06,-0.17116,-0.17728,1,0
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.8379e-05,-0.17118,-0.21275,1,0
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.00050664,-0.17128,-0.15237,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00021167,-0.17147,-0.21099,1,0
4,GO PROTEIN DEMANNOSYLATION,0.001191,-0.1715,-0.26496,1,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS,4.8379e-05,-0.17156,-0.16057,1,0
4,GO PROTEIN FOLDING,7.6603e-06,-0.17169,-0.18287,1,0
4,GO REGULATION OF ENDOCRINE PROCESS,0.0017123,-0.17183,-0.17288,1,0
4,GO LEUKOCYTE PROLIFERATION,0.00010092,-0.17195,-0.18996,1,0
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,9.0551e-05,-0.17204,-0.18632,1,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.05161,-0.17209,-0.18971,1,0
4,GO INTERACTION WITH SYMBIONT,5.9841e-06,-0.17214,-0.19877,1,0
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,5.6174e-05,-0.17221,-0.19193,1,0
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,4.4878e-05,-0.17226,-0.156,1,0
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,3.7145e-05,-0.17228,-0.16678,1,0
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.0094949,-0.17236,-0.16237,1,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.043763,-0.17248,-0.15232,1,0
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.0087944,-0.17265,-0.27889,1,0
4,GO MACROPHAGE MIGRATION,0.00081984,-0.17288,-0.20224,1,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.052669,-0.17296,-0.15169,1,0
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0045306,-0.17305,-0.17801,1,0
4,GO SENSORY PERCEPTION OF TASTE,0.0040578,-0.17324,-0.14411,1,0
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00011241,-0.17328,-0.14999,1,0
4,GO TISSUE REGENERATION,0.001228,-0.17335,-0.21855,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00081984,-0.17341,-0.17858,1,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,8.7323e-05,-0.17351,-0.17869,1,0
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.018398,-0.17359,-0.13478,1,0
4,GO LENS FIBER CELL DEVELOPMENT,0.010245,-0.17376,-0.24137,1,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.001986,-0.17377,-0.21999,1,0
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00041602,-0.17386,-0.19378,1,0
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,4.1112e-06,-0.17391,-0.19252,1,0
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00031859,-0.17402,-0.17823,1,0
4,GO NUCLEOSIDE METABOLIC PROCESS,0.00014418,-0.17409,-0.15288,1,0
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00012512,-0.17414,-0.16957,1,0
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0012662,-0.17424,-0.21718,1,0
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,9.389e-05,-0.17444,-0.22829,1,0
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,1.0604e-05,-0.17444,-0.22688,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0071468,-0.17448,-0.1776,1,0
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00021909,-0.17452,-0.20229,1,0
4,GO REGULATION OF LIPID METABOLIC PROCESS,1.7806e-05,-0.17474,-0.17369,1,0
4,GO GASTRULATION,0.00038934,-0.17474,-0.20373,1,0
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.0060989,-0.17477,-0.20276,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00038934,-0.17477,-0.19678,1,0
4,GO MACROPHAGE APOPTOTIC PROCESS,0.018836,-0.17481,-0.20016,1,0
4,GO COLLAGEN FIBRIL ORGANIZATION,0.0053338,-0.17512,-0.25609,1,0
4,GO INFLAMMATORY RESPONSE,7.8282e-05,-0.17513,-0.18465,1,0
4,GO MUSCLE ORGAN MORPHOGENESIS,0.0054795,-0.17519,-0.14211,1,0
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0028141,-0.1752,-0.1812,1,0
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.017549,-0.17525,-0.16511,1,0
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00029782,-0.17525,-0.21707,1,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0021062,-0.17538,-0.21364,1,0
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.05161,-0.17544,-0.1495,1,0
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0041716,-0.17551,-0.16891,1,0
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.00092958,-0.17575,-0.25359,1,0
4,GO LEUKOCYTE MEDIATED IMMUNITY,6.2786e-05,-0.17585,-0.20684,1,0
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,3.3132e-05,-0.17596,-0.1913,1,0
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.012508,-0.17603,-0.17319,1,0
4,GO PROTEIN PROCESSING,0.00013917,-0.17604,-0.17976,1,0
4,GO REGULATION OF MAPK CASCADE,4.0073e-05,-0.17608,-0.1728,1,0
4,GO RESPONSE TO ANGIOTENSIN,0.0079323,-0.17611,-0.20063,1,0
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00036427,-0.17621,-0.19714,1,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00021909,-0.17634,-0.18068,1,0
4,GO REGULATION OF LIPID TRANSPORT,0.00019753,-0.17658,-0.17875,1,0
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0016129,-0.17667,-0.21564,1,0
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.0025817,-0.17667,-0.23255,1,0
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.016734,-0.17674,-0.17224,1,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00012074,-0.17681,-0.18834,1,0
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00057693,-0.17687,-0.24167,1,0
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,5.7413e-06,-0.17694,-0.19751,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.011047,-0.17696,-0.19453,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0037331,-0.17702,-0.20029,1,0
4,GO VACUOLE ORGANIZATION,2.8418e-05,-0.1771,-0.16873,1,0
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00013433,-0.17721,-0.1609,1,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.00098941,-0.17736,-0.2254,1,0
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00041602,-0.1775,-0.19275,1,0
4,GO FOCAL ADHESION ASSEMBLY,0.0027346,-0.17756,-0.19372,1,0
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0020453,-0.17786,-0.1521,1,0
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0010528,-0.17802,-0.22637,1,0
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0041716,-0.17808,-0.20316,1,0
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.014486,-0.1781,-0.15705,1,0
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0042883,-0.17826,-0.20542,1,0
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00038934,-0.1783,-0.18755,1,0
4,GO DEFENSE RESPONSE,4.0073e-05,-0.17832,-0.17888,1,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00014935,-0.17842,-0.22596,1,0
4,GO RESPONSE TO BIOTIC STIMULUS,2.7343e-05,-0.17853,-0.1825,1,0
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.004408,-0.17857,-0.16437,1,0
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0042883,-0.17878,-0.1933,1,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.012203,-0.1788,-0.18884,1,0
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0053338,-0.17901,-0.18751,1,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0013054,-0.17918,-0.20752,1,0
4,GO PIGMENT GRANULE ORGANIZATION,0.01282,-0.17942,-0.1444,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0034322,-0.17943,-0.18156,1,0
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.016734,-0.17952,-0.18125,1,0
4,GO RESPONSE TO LIPID,8.6584e-06,-0.17964,-0.17998,1,0
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.031059,-0.17969,-0.15952,1,0
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0083534,-0.17975,-0.35867,1,0
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.0014738,-0.17977,-0.21746,1,0
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.01282,-0.17995,-0.16323,1,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0011549,-0.18,-0.1747,1,0
4,GO SPERM EGG RECOGNITION,3.0689e-05,-0.18001,-0.20824,1,0
4,GO CELLULAR IRON ION HOMEOSTASIS,0.00010092,-0.1801,-0.17795,1,0
4,GO MUSCLE HYPERTROPHY,0.00047456,-0.18013,-0.187,1,0
4,GO POSITIVE REGULATION OF WOUND HEALING,0.022165,-0.18016,-0.17299,1,0
4,GO RESPONSE TO ETHANOL,0.00016023,-0.1802,-0.16944,1,0
4,GO REGULATION OF PLATELET ACTIVATION,0.0054795,-0.18026,-0.25365,1,0
4,GO AMINO SUGAR METABOLIC PROCESS,0.00063551,-0.18027,-0.19476,1,0
4,GO REGULATION OF LEUKOCYTE MIGRATION,5.0226e-05,-0.1803,-0.20084,1,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00040247,-0.18033,-0.23359,1,0
4,GO CELLULAR RESPONSE TO SALT STRESS,0.02068,-0.18045,-0.2185,1,0
4,GO POLYSACCHARIDE METABOLIC PROCESS,8.7323e-05,-0.18051,-0.17531,1,0
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,2.4692e-06,-0.18059,-0.1863,1,0
4,GO IMMUNE EFFECTOR PROCESS,7.547e-05,-0.18061,-0.193,1,0
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00011241,-0.18076,-0.20011,1,0
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0007696,-0.18077,-0.26985,1,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00035231,-0.18078,-0.21183,1,0
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0007696,-0.18085,-0.15974,1,0
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.041967,-0.18115,-0.18057,1,0
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00026003,-0.18132,-0.15318,1,0
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.00016023,-0.18137,-0.21576,1,0
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.010245,-0.18147,-0.21665,1,0
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,8.1192e-05,-0.1816,-0.21777,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.00034072,-0.18178,-0.21798,1,0
4,GO RESPONSE TO DSRNA,0.00025131,-0.18179,-0.19712,1,0
4,GO PLATELET AGGREGATION,0.0021062,-0.18204,-0.22355,1,0
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.00037661,-0.18213,-0.20871,1,0
4,GO REGENERATION,0.00013433,-0.18215,-0.19278,1,0
4,GO CARBOHYDRATE METABOLIC PROCESS,2.2879e-07,-0.18218,-0.19986,1,0
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,1.5331e-06,-0.18236,-0.16715,1,0
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0001547,-0.18267,-0.18521,1,0
4,GO PLATELET MORPHOGENESIS,0.00041602,-0.18269,-0.19823,1,0
4,GO PROTEIN ACTIVATION CASCADE,0.00019079,-0.18285,-0.2613,1,0
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0053338,-0.18289,-0.18171,1,0
4,GO TRANSLATIONAL ELONGATION,0.00031859,-0.1829,-0.21998,1,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,2.5308e-05,-0.18304,-0.20415,1,0
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,4.6597e-05,-0.18313,-0.20399,1,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.001228,-0.18314,-0.21652,1,0
4,GO LEUKOCYTE MIGRATION,0.00028792,-0.18319,-0.18369,1,0
4,GO AEROBIC RESPIRATION,2.9532e-05,-0.1832,-0.24098,1,0
4,GO FATTY ACID CATABOLIC PROCESS,0.00011241,-0.18328,-0.19899,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0062634,-0.1834,-0.27268,1,0
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,7.3528e-06,-0.18341,-0.18818,1,0
4,GO REGULATION OF TISSUE REMODELING,0.0012662,-0.18346,-0.19881,1,0
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00353,-0.18357,-0.18224,1,0
4,GO PROTEIN AUTOPROCESSING,0.00065623,-0.18369,-0.23558,1,0
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,6.2786e-05,-0.1837,-0.19875,1,0
4,GO RESPONSE TO TOXIC SUBSTANCE,2.8418e-05,-0.18393,-0.18846,1,0
4,GO INTERLEUKIN 1 PRODUCTION,0.0069616,-0.18394,-0.20435,1,0
4,GO REGULATION OF OSSIFICATION,0.00047456,-0.18398,-0.1794,1,0
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0011549,-0.18402,-0.21687,1,0
4,GO TISSUE REMODELING,0.004408,-0.18412,-0.18272,1,0
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00055855,-0.18412,-0.25943,1,0
4,GO PROTEIN TETRAMERIZATION,6.2786e-05,-0.18414,-0.15762,1,0
4,GO TRNA METABOLIC PROCESS,0.00050664,-0.18416,-0.17024,1,0
4,GO RESPONSE TO NUTRIENT,0.00052342,-0.18418,-0.17592,1,0
4,GO RESPONSE TO STARVATION,0.00024286,-0.18419,-0.16025,1,0
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00063551,-0.18427,-0.2008,1,0
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.00012074,-0.18427,-0.18358,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.021165,-0.18436,-0.25095,1,0
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0013054,-0.18445,-0.17006,1,0
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0049174,-0.18455,-0.15884,1,0
4,GO RESPONSE TO DEXAMETHASONE,0.00037661,-0.18459,-0.24613,1,0
4,GO LONG CHAIN FATTY ACID TRANSPORT,2.4346e-05,-0.18463,-0.18391,1,0
4,GO RESPONSE TO ESTROGEN,0.00012074,-0.1847,-0.22626,1,0
4,GO POSITIVE REGULATION OF CELL ADHESION,0.00019753,-0.18472,-0.20514,1,0
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00049035,-0.18481,-0.16283,1,0
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.00026903,-0.18493,-0.22169,1,0
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.014138,-0.18498,-0.16346,1,0
4,GO STEROID METABOLIC PROCESS,1.5201e-05,-0.18518,-0.19992,1,0
4,GO REGULATION OF PROTEIN BINDING,5.508e-06,-0.18519,-0.18917,1,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0050528,-0.18522,-0.1595,1,0
4,GO B CELL HOMEOSTASIS,0.0022332,-0.18522,-0.17892,1,0
4,GO MYELOID LEUKOCYTE ACTIVATION,1.7118e-05,-0.18527,-0.22277,1,0
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0036303,-0.18541,-0.16687,1,0
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,3.3132e-05,-0.18544,-0.1938,1,0
4,GO RESPONSE TO CYTOKINE,2.4346e-05,-0.18564,-0.19657,1,0
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,4.1802e-07,-0.18565,-0.18274,1,0
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00030804,-0.18568,-0.17973,1,0
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00017186,-0.18569,-0.19547,1,0
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0030654,-0.1858,-0.19911,1,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.0069616,-0.18586,-0.2829,1,0
4,GO VASCULOGENESIS,0.0073363,-0.18587,-0.24798,1,0
4,GO SUPEROXIDE ANION GENERATION,0.04854,-0.18613,-0.20168,1,0
4,GO CELLULAR RESPONSE TO FATTY ACID,0.0067808,-0.18616,-0.18997,1,0
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.042857,-0.18638,-0.19095,1,0
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,2.7343e-05,-0.18642,-0.19605,1,0
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,1.0604e-05,-0.18643,-0.20451,1,0
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00017796,-0.18645,-0.20816,1,0
4,GO MYOBLAST PROLIFERATION,0.0038387,-0.18662,-0.1887,1,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00012074,-0.18685,-0.19118,1,0
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.010773,-0.18697,-0.15262,1,0
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,5.0226e-05,-0.18705,-0.20985,1,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.001228,-0.1871,-0.2665,1,0
4,GO SULFUR COMPOUND TRANSPORT,0.00040247,-0.18711,-0.16978,1,0
4,GO TRNA METHYLATION,0.00084609,-0.18721,-0.18091,1,0
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,2.2524e-05,-0.18726,-0.24792,1,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.029068,-0.18735,-0.20786,1,0
4,GO CELL CHEMOTAXIS,0.00041602,-0.18762,-0.18851,1,0
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0045306,-0.18769,-0.19215,1,0
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,9.0551e-05,-0.18772,-0.21237,1,0
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,6.2985e-07,-0.18774,-0.16938,1,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.015203,-0.18789,-0.2063,1,0
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,2.1702e-06,-0.18796,-0.185,1,0
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0056288,-0.18797,-0.20383,1,0
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.011047,-0.18814,-0.21443,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00090094,-0.18826,-0.20817,1,0
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00022676,-0.18828,-0.17487,1,0
4,GO AMINO ACID IMPORT,0.00052342,-0.1883,-0.22598,1,0
4,GO TROPHOBLAST CELL MIGRATION,0.014486,-0.18842,-0.26838,1,0
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0059384,-0.18861,-0.19224,1,0
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.013139,-0.18892,-0.31551,1,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.001228,-0.18898,-0.20182,1,0
4,GO GLUTAMINE METABOLIC PROCESS,0.0037331,-0.189,-0.16552,1,0
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,2.5308e-05,-0.189,-0.19402,1,0
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0054795,-0.18901,-0.1626,1,0
4,GO TRICARBOXYLIC ACID CYCLE,0.00024286,-0.18913,-0.22825,1,0
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0050528,-0.1892,-0.23396,1,0
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,7.8282e-05,-0.18922,-0.18255,1,0
4,GO AUTOPHAGY OF NUCLEUS,0.0021062,-0.18925,-0.19626,1,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0021062,-0.18926,-0.20421,1,0
4,GO ENDOTHELIAL CELL PROLIFERATION,8.4205e-05,-0.18929,-0.21608,1,0
4,GO STEROL TRANSPORT,0.00012074,-0.18943,-0.21853,1,0
4,GO REGULATION OF CALCIUM ION TRANSPORT,5.2837e-06,-0.18945,-0.19932,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.9263e-05,-0.1895,-0.23039,1,0
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00022676,-0.18964,-0.26277,1,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.02166,-0.18977,-0.17941,1,0
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.017137,-0.18997,-0.14793,1,0
4,GO INTERLEUKIN 8 PRODUCTION,0.0022992,-0.19016,-0.20319,1,0
4,GO MOVEMENT IN HOST ENVIRONMENT,0.00019079,-0.19026,-0.23643,1,0
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.019739,-0.19046,-0.1985,1,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0018173,-0.19053,-0.18001,1,0
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0011199,-0.19062,-0.15343,1,0
4,GO RESPONSE TO COLD,0.001191,-0.19063,-0.26307,1,0
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.013139,-0.19066,-0.18204,1,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.010773,-0.19072,-0.18949,1,0
4,GO MEMBRANE INVAGINATION,0.00037661,-0.19076,-0.20956,1,0
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,2.2524e-05,-0.19081,-0.22056,1,0
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,8.4205e-05,-0.19084,-0.23398,1,0
4,GO MACROPHAGE CHEMOTAXIS,0.00074557,-0.19088,-0.21873,1,0
4,GO POSITIVE REGULATION OF MAPK CASCADE,2.0833e-05,-0.19088,-0.18566,1,0
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0090226,-0.19094,-0.2791,1,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00035231,-0.19103,-0.30684,1,0
4,GO PROSTANOID METABOLIC PROCESS,0.0099891,-0.19114,-0.25522,1,0
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00019079,-0.19115,-0.26595,1,0
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,5.508e-06,-0.19122,-0.22325,1,0
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00035231,-0.19125,-0.24041,1,0
4,GO DIET INDUCED THERMOGENESIS,0.0034322,-0.19126,-0.20886,1,0
4,GO REGULATION OF RESPONSE TO WOUNDING,0.0099891,-0.19136,-0.16968,1,0
4,GO INTERACTION WITH HOST,0.00026003,-0.19149,-0.20164,1,0
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.031059,-0.1915,-0.18766,1,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00011241,-0.19163,-0.15596,1,0
4,GO GENITALIA DEVELOPMENT,0.00072223,-0.19168,-0.16806,1,0
4,GO LAMELLIPODIUM MORPHOGENESIS,0.017549,-0.19168,-0.19482,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00057693,-0.19173,-0.22371,1,0
4,GO INTERLEUKIN 17 PRODUCTION,6.5149e-05,-0.19183,-0.24335,1,0
4,GO REGULATION OF ACTION POTENTIAL,0.0036303,-0.19193,-0.18065,1,0
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,4.3218e-05,-0.192,-0.22632,1,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0049174,-0.19207,-0.20256,1,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00010092,-0.19207,-0.18036,1,0
4,GO ADAPTIVE IMMUNE RESPONSE,0.00016023,-0.19221,-0.21331,1,0
4,GO REGULATION OF T CELL CHEMOTAXIS,0.024288,-0.19269,-0.14602,1,0
4,GO REGULATION OF BONE REMODELING,0.02166,-0.19275,-0.17263,1,0
4,GO ENGULFMENT OF APOPTOTIC CELL,0.0019282,-0.19285,-0.21264,1,0
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0040578,-0.19288,-0.27079,1,0
4,GO T CELL MIGRATION,0.00029782,-0.19297,-0.22444,1,0
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.025414,-0.19307,-0.14202,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,4.0073e-05,-0.19312,-0.19573,1,0
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.041093,-0.19316,-0.17153,1,0
4,GO TRANSLATIONAL TERMINATION,0.00087311,-0.1936,-0.22241,1,0
4,GO MONOSACCHARIDE METABOLIC PROCESS,3.9926e-07,-0.19363,-0.21853,1,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.027803,-0.19381,-0.20747,1,0
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,5.2837e-06,-0.19392,-0.18255,1,0
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.044685,-0.19426,-0.19247,1,0
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.02166,-0.1943,-0.22062,1,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00087311,-0.19431,-0.1792,1,0
4,GO PEPTIDYL ARGININE N METHYLATION,0.0066042,-0.19439,-0.19103,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,9.7346e-05,-0.19459,-0.18832,1,0
4,GO RESPONSE TO CHEMOKINE,5.7413e-06,-0.19466,-0.20381,1,0
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.03939,-0.19474,-0.18841,1,0
4,GO REGULATION OF PHAGOCYTOSIS,9.389e-05,-0.19496,-0.22068,1,0
4,GO BONE GROWTH,0.012508,-0.195,-0.2376,1,0
4,GO AMYLOID BETA CLEARANCE,0.0019282,-0.19503,-0.22871,1,0
4,GO RESPONSE TO PEPTIDOGLYCAN,0.00067758,-0.19506,-0.25242,1,0
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0081404,-0.19512,-0.18421,1,0
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.031059,-0.19522,-0.16548,1,0
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,9.7346e-05,-0.19529,-0.21155,1,0
4,GO VITAMIN METABOLIC PROCESS,1.8521e-05,-0.19532,-0.20295,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.024288,-0.19541,-0.27653,1,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.013139,-0.19542,-0.20734,1,0
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.6455e-05,-0.19545,-0.25738,1,0
4,GO MAINTENANCE OF LOCATION,2.3654e-06,-0.19558,-0.19205,1,0
4,GO PEPTIDYL PROLINE MODIFICATION,3.0689e-05,-0.19558,-0.28231,1,0
4,GO RESPONSE TO DRUG,2.8077e-06,-0.19559,-0.21878,1,0
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00022676,-0.1956,-0.17099,1,0
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00084609,-0.19581,-0.20873,1,0
4,GO STEROL HOMEOSTASIS,0.00027832,-0.19585,-0.20558,1,0
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0013457,-0.19587,-0.18646,1,0
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,1.2454e-05,-0.19595,-0.19302,1,0
4,GO PYRUVATE METABOLIC PROCESS,7.3528e-06,-0.19602,-0.20141,1,0
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00050664,-0.19605,-0.23642,1,0
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,4.1112e-06,-0.19612,-0.20975,1,0
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00017186,-0.19618,-0.17651,1,0
4,GO RESPONSE TO CADMIUM ION,0.0029794,-0.19632,-0.22573,1,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.011326,-0.19652,-0.3074,1,0
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00026903,-0.19671,-0.22098,1,0
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.001191,-0.19671,-0.23922,1,0
4,GO CELLULAR RESPONSE TO PH,0.00081984,-0.19677,-0.19726,1,0
4,GO T CELL CYTOKINE PRODUCTION,0.00054072,-0.19683,-0.21915,1,0
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0053338,-0.19704,-0.22323,1,0
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.9904e-06,-0.19749,-0.24441,1,0
4,GO EXPLORATION BEHAVIOR,0.05161,-0.19787,-0.16149,1,0
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.0036303,-0.19793,-0.21481,1,0
4,GO SCHWANN CELL DEVELOPMENT,5.4121e-05,-0.19804,-0.20391,1,0
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.00032948,-0.19812,-0.23107,1,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.011612,-0.19823,-0.20655,1,0
4,GO SERTOLI CELL DIFFERENTIATION,0.0099891,-0.19828,-0.20256,1,0
4,GO SPROUTING ANGIOGENESIS,7.013e-05,-0.19829,-0.22138,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0046564,-0.19835,-0.29713,1,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0019282,-0.19848,-0.18725,1,0
4,GO POLYOL BIOSYNTHETIC PROCESS,6.7728e-06,-0.1989,-0.20812,1,0
4,GO ORGANIC ACID METABOLIC PROCESS,1.0779e-06,-0.1991,-0.19347,1,0
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0051916,-0.19921,-0.26036,1,0
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,7.2111e-07,-0.19974,-0.19654,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0046564,-0.19977,-0.24744,1,0
4,GO SPHINGOID METABOLIC PROCESS,0.00029782,-0.20002,-0.25481,1,0
4,GO ERK1 AND ERK2 CASCADE,0.00010092,-0.2001,-0.20279,1,0
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.036164,-0.2001,-0.17982,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00026903,-0.20024,-0.20461,1,0
4,GO REGULATION OF LIPID LOCALIZATION,2.8418e-05,-0.20025,-0.19972,1,0
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00042998,-0.20028,-0.20507,1,0
4,GO CELL CELL RECOGNITION,5.9841e-06,-0.20037,-0.23983,1,0
4,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.03245,-0.20044,-0.20408,1,0
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.016734,-0.20066,-0.36482,1,0
4,GO REGULATION OF LIPID STORAGE,0.00012964,-0.20068,-0.23155,1,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00017796,-0.2007,-0.26854,1,0
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0012662,-0.20073,-0.22446,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0022332,-0.20079,-0.19098,1,0
4,GO RESPONSE TO MINERALOCORTICOID,0.00063551,-0.20092,-0.23557,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0027346,-0.20112,-0.24799,1,0
4,GO ANDROGEN METABOLIC PROCESS,0.0056288,-0.20113,-0.20807,1,0
4,GO REGULATION OF BIOMINERALIZATION,4.6597e-05,-0.20129,-0.22852,1,0
4,GO PEPTIDYL HISTIDINE MODIFICATION,0.001191,-0.2014,-0.21539,1,0
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.038561,-0.20142,-0.13167,1,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00050664,-0.20156,-0.19279,1,0
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,7.2754e-05,-0.20157,-0.25747,1,0
4,GO MUSCLE FILAMENT SLIDING,0.0013457,-0.20162,-0.2393,1,0
4,GO HAIR FOLLICLE MATURATION,0.0028957,-0.20175,-0.27638,1,0
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,2.2524e-05,-0.20192,-0.22504,1,0
4,GO NUCLEOTIDE PHOSPHORYLATION,1.4609e-05,-0.20198,-0.20011,1,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0025817,-0.20212,-0.31147,1,0
4,GO STEROL METABOLIC PROCESS,0.0001165,-0.20218,-0.18716,1,0
4,GO NCRNA PROCESSING,0.0013457,-0.20232,-0.18873,1,0
4,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.011612,-0.20233,-0.19447,1,0
4,GO REGULATION OF MAP KINASE ACTIVITY,0.00013433,-0.20239,-0.16296,1,0
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,1.1964e-05,-0.20241,-0.19497,1,0
4,GO LIPID CATABOLIC PROCESS,4.8612e-06,-0.20252,-0.2058,1,0
4,GO RRNA MODIFICATION,0.0032441,-0.20258,-0.20884,1,0
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.00021909,-0.2027,-0.25175,1,0
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.0026572,-0.20294,-0.26526,1,0
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00025131,-0.20303,-0.26759,1,0
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.038561,-0.20307,-0.2468,1,0
4,GO NCRNA METABOLIC PROCESS,0.00038934,-0.20307,-0.18393,1,0
4,GO INTERFERON GAMMA PRODUCTION,2.1663e-05,-0.20311,-0.20489,1,0
4,GO CYTOPLASMIC TRANSLATION,0.0027346,-0.20315,-0.27421,1,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.03939,-0.20341,-0.2148,1,0
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00019079,-0.20341,-0.21894,1,0
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0056288,-0.20355,-0.34381,1,0
4,GO T CELL EXTRAVASATION,0.0053338,-0.20366,-0.35184,1,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00098941,-0.20378,-0.22935,1,0
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00034072,-0.20385,-0.21747,1,0
4,GO DIOL BIOSYNTHETIC PROCESS,0.0059384,-0.20386,-0.18923,1,0
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00040247,-0.2039,-0.23433,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0067808,-0.20393,-0.21052,1,0
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.00054072,-0.20432,-0.34191,1,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00072223,-0.20434,-0.21398,1,0
4,GO CD40 SIGNALING PATHWAY,0.00038934,-0.20435,-0.28769,1,0
4,GO POSITIVE REGULATION OF COAGULATION,0.0021062,-0.20453,-0.21389,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00014935,-0.20461,-0.22525,1,0
4,GO PEPTIDE CATABOLIC PROCESS,0.0034322,-0.20464,-0.18857,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00038934,-0.20465,-0.2206,1,0
4,GO TRANSITION METAL ION HOMEOSTASIS,2.6902e-06,-0.20477,-0.22252,1,0
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0025817,-0.2048,-0.21565,1,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.025414,-0.20491,-0.20094,1,0
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,5.4977e-07,-0.20492,-0.21546,1,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.034637,-0.20511,-0.26076,1,0
4,GO ORGANIC ACID CATABOLIC PROCESS,1.4039e-05,-0.2053,-0.21103,1,0
4,GO HEPATOCYTE DIFFERENTIATION,0.025414,-0.20531,-0.22811,1,0
4,GO RESPONSE TO CALCIUM ION,0.00012512,-0.20537,-0.2069,1,0
4,GO OSTEOBLAST PROLIFERATION,0.0028957,-0.20546,-0.26246,1,0
4,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.030383,-0.20565,-0.26592,1,0
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00072223,-0.20567,-0.25562,1,0
4,GO CELLULAR AMIDE METABOLIC PROCESS,7.5427e-07,-0.20568,-0.20172,1,0
4,GO HORMONE METABOLIC PROCESS,0.0001165,-0.20573,-0.19843,1,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00057693,-0.20578,-0.22921,1,0
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0001547,-0.20587,-0.2796,1,0
4,GO IRON ION HOMEOSTASIS,1.9263e-05,-0.20591,-0.21346,1,0
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,4.8612e-06,-0.20614,-0.18872,1,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00054072,-0.20616,-0.28113,1,0
4,GO RESPONSE TO BACTERIUM,7.9801e-06,-0.20621,-0.21175,1,0
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00037661,-0.20648,-0.19445,1,0
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,9.7801e-06,-0.20655,-0.21387,1,0
4,GO PEPTIDE METABOLIC PROCESS,3.3287e-06,-0.20675,-0.20544,1,0
4,GO MATURATION OF 5 8S RRNA,0.0028957,-0.20691,-0.23274,1,0
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00027832,-0.20723,-0.24348,1,0
4,GO ENDOCRINE PROCESS,0.00047456,-0.20724,-0.20342,1,0
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,1.7118e-05,-0.20733,-0.18159,1,0
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00013917,-0.20745,-0.23545,1,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0040578,-0.20755,-0.23903,1,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0042883,-0.20761,-0.21595,1,0
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.015203,-0.20776,-0.24356,1,0
4,GO DIOL METABOLIC PROCESS,0.0019282,-0.208,-0.21908,1,0
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.00353,-0.20817,-0.21789,1,0
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.014138,-0.20819,-0.20221,1,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0026572,-0.20824,-0.20196,1,0
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.041967,-0.20839,-0.20392,1,0
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.017137,-0.20844,-0.29531,1,0
4,GO PEPTIDE CROSS LINKING,0.00023468,-0.20845,-0.32554,1,0
4,GO RESPONSE TO FLUID SHEAR STRESS,0.0013054,-0.20849,-0.23401,1,0
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.009256,-0.2086,-0.20172,1,0
4,GO IMPORT INTO CELL,0.00010845,-0.20869,-0.18717,1,0
4,GO ALCOHOL METABOLIC PROCESS,2.0784e-06,-0.20877,-0.2098,1,0
4,GO ETHER METABOLIC PROCESS,0.00069957,-0.20885,-0.25775,1,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0064317,-0.2089,-0.27295,1,0
4,GO FATTY ACID BIOSYNTHETIC PROCESS,9.3916e-06,-0.20891,-0.22825,1,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.013465,-0.20901,-0.19106,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0036303,-0.20902,-0.18594,1,0
4,GO REGULATION OF RECEPTOR BINDING,0.015953,-0.20902,-0.23374,1,0
4,GO DE NOVO PROTEIN FOLDING,0.001872,-0.20903,-0.17306,1,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00063551,-0.20942,-0.22354,1,0
4,GO SMALL MOLECULE CATABOLIC PROCESS,3.3287e-06,-0.20961,-0.20048,1,0
4,GO CELL MATRIX ADHESION,0.00032948,-0.20971,-0.22059,1,0
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.00041602,-0.20986,-0.25611,1,0
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00025131,-0.21,-0.22226,1,0
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.044685,-0.21055,-0.19295,1,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.029068,-0.21058,-0.30169,1,0
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0007696,-0.2106,-0.20919,1,0
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00029782,-0.21067,-0.17871,1,0
4,GO ENDODERM DEVELOPMENT,0.00059588,-0.21079,-0.27706,1,0
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0013457,-0.21098,-0.19292,1,0
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.020205,-0.211,-0.21541,1,0
4,GO OXIDATION REDUCTION PROCESS,6.8936e-07,-0.21128,-0.21146,1,0
4,GO AMIDE BIOSYNTHETIC PROCESS,1.4039e-05,-0.21133,-0.19494,1,0
4,GO FATTY ACID METABOLIC PROCESS,1.0604e-05,-0.21166,-0.20598,1,0
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.029719,-0.21181,-0.12389,1,0
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00067758,-0.21193,-0.21595,1,0
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0031536,-0.21197,-0.21008,1,0
4,GO PROGRAMMED NECROTIC CELL DEATH,0.00047456,-0.21214,-0.27054,1,0
4,GO T HELPER 1 CELL DIFFERENTIATION,0.0094949,-0.21221,-0.30715,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00074557,-0.21247,-0.22471,1,0
4,GO AMEBOIDAL TYPE CELL MIGRATION,8.4205e-05,-0.2126,-0.20712,1,0
4,GO CERAMIDE TRANSPORT,0.0057817,-0.21275,-0.21476,1,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0046564,-0.21276,-0.23071,1,0
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.547e-05,-0.21294,-0.25412,1,0
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00038934,-0.21303,-0.19662,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0030654,-0.21306,-0.2177,1,0
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.001191,-0.21315,-0.2299,1,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.0018173,-0.21332,-0.27564,1,0
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.03939,-0.21342,-0.18163,1,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00018427,-0.21357,-0.24123,1,0
4,GO PSEUDOURIDINE SYNTHESIS,0.00090094,-0.2136,-0.27811,1,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00013433,-0.21377,-0.28685,1,0
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00028792,-0.21389,-0.27431,1,0
4,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.00087311,-0.21394,-0.27185,1,0
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00036427,-0.21405,-0.22231,1,0
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.00029782,-0.21412,-0.22606,1,0
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0018173,-0.21425,-0.27759,1,0
4,GO T CELL APOPTOTIC PROCESS,0.00021167,-0.21431,-0.22147,1,0
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0033369,-0.21436,-0.20558,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0031536,-0.21439,-0.23394,1,0
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.052669,-0.21481,-0.1246,1,0
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00054072,-0.21498,-0.23821,1,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0051916,-0.21516,-0.16923,1,0
4,GO IMPORT ACROSS PLASMA MEMBRANE,4.6597e-05,-0.21558,-0.19301,1,0
4,GO CELL SUBSTRATE ADHESION,0.00010092,-0.21561,-0.229,1,0
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0010528,-0.21562,-0.22776,1,0
4,GO POSITIVE CHEMOTAXIS,8.4205e-05,-0.21565,-0.23854,1,0
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.012203,-0.21587,-0.18146,1,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.012203,-0.21633,-0.25632,1,0
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0039469,-0.21649,-0.1789,1,0
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00012512,-0.21666,-0.26111,1,0
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00026903,-0.21667,-0.23031,1,0
4,GO ENTRY INTO HOST,6.7596e-05,-0.21668,-0.2834,1,0
4,GO POLYOL METABOLIC PROCESS,2.1831e-07,-0.21669,-0.22266,1,0
4,GO MAINTENANCE OF LOCATION IN CELL,5.7413e-06,-0.21674,-0.19775,1,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.00055855,-0.21675,-0.2482,1,0
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,2.0784e-06,-0.21697,-0.26232,1,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.01282,-0.21708,-0.22961,1,0
4,GO TRNA 5 LEADER REMOVAL,0.00095906,-0.21718,-0.22435,1,0
4,GO FIBROBLAST PROLIFERATION,0.00081984,-0.21727,-0.2347,1,0
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.010245,-0.21732,-0.20249,1,0
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,1.104e-05,-0.2174,-0.211,1,0
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,3.5759e-05,-0.21772,-0.23228,1,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00034072,-0.21774,-0.21951,1,0
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0011549,-0.21781,-0.25374,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0079323,-0.21796,-0.1836,1,0
4,GO B CELL APOPTOTIC PROCESS,0.0081404,-0.21826,-0.19343,1,0
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.025414,-0.21827,-0.22927,1,0
4,GO CELLULAR RESPONSE TO DRUG,1.2962e-05,-0.21827,-0.20448,1,0
4,GO REGULATION OF CELL MATRIX ADHESION,0.0026572,-0.21829,-0.21808,1,0
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0014299,-0.21834,-0.219,1,0
4,GO REGULATION OF VESICLE FUSION,0.01282,-0.21855,-0.25118,1,0
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,4.6597e-05,-0.21868,-0.19831,1,0
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,8.1192e-05,-0.21872,-0.16567,1,0
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.011047,-0.21874,-0.21481,1,0
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00052342,-0.21883,-0.28073,1,0
4,GO PULMONARY VALVE DEVELOPMENT,0.001986,-0.21893,-0.34443,1,0
4,GO REGULATION OF WOUND HEALING,0.0025083,-0.21895,-0.21768,1,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00020448,-0.21916,-0.18264,1,0
4,GO PROSTAGLANDIN SECRETION,0.0056288,-0.21946,-0.19111,1,0
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0028141,-0.21959,-0.25073,1,0
4,GO LYTIC VACUOLE ORGANIZATION,2.2524e-05,-0.2199,-0.22496,1,0
4,GO T CELL MEDIATED IMMUNITY,4.6597e-05,-0.22003,-0.30097,1,0
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00037661,-0.22016,-0.24502,1,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0027346,-0.2203,-0.18429,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0034322,-0.22041,-0.24058,1,0
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00010092,-0.22065,-0.21508,1,0
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00092958,-0.22065,-0.29358,1,0
4,GO FOLIC ACID METABOLIC PROCESS,0.00063551,-0.22074,-0.21935,1,0
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.014486,-0.22084,-0.18179,1,0
4,GO PHAGOCYTOSIS,1.7118e-05,-0.22093,-0.22638,1,0
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.00037661,-0.22121,-0.27019,1,0
4,GO BIOMINERALIZATION,1.5201e-05,-0.22123,-0.22475,1,0
4,GO VITAMIN D METABOLIC PROCESS,0.0049174,-0.22134,-0.22384,1,0
4,GO TRNA 5 END PROCESSING,0.0031536,-0.22136,-0.19117,1,0
4,GO NEGATIVE CHEMOTAXIS,0.00049035,-0.22168,-0.27492,1,0
4,GO STORE OPERATED CALCIUM ENTRY,0.00050664,-0.22172,-0.25583,1,0
4,GO EMBRYO IMPLANTATION,0.007729,-0.22175,-0.19341,1,0
4,GO SULFUR COMPOUND METABOLIC PROCESS,2.8891e-07,-0.22176,-0.23737,1,0
4,GO FORMATION OF PRIMARY GERM LAYER,0.00010092,-0.22177,-0.26644,1,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0041716,-0.22214,-0.22061,1,0
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00013433,-0.22214,-0.24981,1,0
4,GO MITOCHONDRIAL TRANSLATION,0.00019753,-0.22219,-0.23893,1,0
4,GO SYNCYTIUM FORMATION,0.00011241,-0.22227,-0.25397,1,0
4,GO DISACCHARIDE METABOLIC PROCESS,0.0081404,-0.22228,-0.23293,1,0
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00090094,-0.22228,-0.25991,1,0
4,GO GERMINAL CENTER FORMATION,0.0033369,-0.22277,-0.34263,1,0
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.00017796,-0.22281,-0.20557,1,0
4,GO REGULATION OF ANOIKIS,0.041093,-0.22325,-0.22093,1,0
4,GO FUCOSYLATION,0.00010845,-0.22339,-0.27263,1,0
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00012512,-0.2234,-0.24825,1,0
4,GO REGULATION OF VACUOLE ORGANIZATION,2.9532e-05,-0.22351,-0.23065,1,0
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.047551,-0.22355,-0.26603,1,0
4,GO REGULATION OF COAGULATION,0.00065623,-0.2236,-0.27355,1,0
4,GO RNA 5 END PROCESSING,0.00081984,-0.2241,-0.21624,1,0
4,GO VIRAL TRANSLATION,0.0047853,-0.22424,-0.24168,1,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0021062,-0.22443,-0.31053,1,0
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00013917,-0.22452,-0.24029,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00012512,-0.22502,-0.26603,1,0
4,GO DENDRITIC CELL DIFFERENTIATION,0.0010859,-0.22559,-0.27979,1,0
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0016129,-0.22563,-0.28686,1,0
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,7.2754e-05,-0.22568,-0.28951,1,0
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00035231,-0.22576,-0.22416,1,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.033166,-0.22586,-0.19896,1,0
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00084609,-0.22589,-0.24427,1,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00035231,-0.22633,-0.21316,1,0
4,GO FOAM CELL DIFFERENTIATION,0.00032948,-0.2264,-0.25121,1,0
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0015189,-0.22642,-0.22879,1,0
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.00069957,-0.22643,-0.28557,1,0
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0073363,-0.22647,-0.20284,1,0
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0049174,-0.22662,-0.24513,1,0
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0037331,-0.2269,-0.20685,1,0
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,9.3916e-06,-0.2272,-0.21954,1,0
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,6.7596e-05,-0.2273,-0.20413,1,0
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.012508,-0.22747,-0.2262,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00022676,-0.22752,-0.20958,1,0
4,GO VITAMIN CATABOLIC PROCESS,0.010245,-0.22761,-0.24717,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00045924,-0.22798,-0.21671,1,0
4,GO ACUTE INFLAMMATORY RESPONSE,1.8521e-05,-0.22859,-0.29679,1,0
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.00023468,-0.22865,-0.22004,1,0
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00012074,-0.22869,-0.31102,1,0
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,3.8583e-05,-0.22987,-0.22204,1,0
4,GO RESPONSE TO HYPEROXIA,0.0010206,-0.22991,-0.29856,1,0
4,GO DETOXIFICATION,1.8521e-05,-0.22995,-0.24404,1,0
4,GO POSITIVE REGULATION OF AUTOPHAGY,2.6307e-05,-0.23056,-0.19903,1,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00036427,-0.23065,-0.26081,1,0
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.0040578,-0.23072,-0.20343,1,0
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.016734,-0.23089,-0.26894,1,0
4,GO COPPER ION TRANSPORT,0.00050664,-0.2315,-0.2582,1,0
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0015189,-0.23151,-0.22098,1,0
4,GO LIPID STORAGE,0.00019079,-0.23157,-0.22896,1,0
4,GO COLLAGEN CATABOLIC PROCESS,3.1888e-05,-0.23163,-0.3142,1,0
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.8418e-05,-0.23176,-0.23238,1,0
4,GO SIGNAL PEPTIDE PROCESSING,0.011612,-0.23181,-0.20636,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0066042,-0.23205,-0.22413,1,0
4,GO BODY FLUID SECRETION,1.1493e-05,-0.23208,-0.22532,1,0
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00013433,-0.23214,-0.19957,1,0
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,4.6597e-05,-0.23238,-0.29173,1,0
4,GO ENDODERMAL CELL DIFFERENTIATION,0.00013917,-0.23296,-0.35451,1,0
4,GO REGULATION OF ACROSOME REACTION,0.007729,-0.23314,-0.25686,1,0
4,GO ACTIN FILAMENT SEVERING,0.038561,-0.23344,-0.23775,1,0
4,GO RESPONSE TO CORTICOSTEROID,2.9532e-05,-0.23363,-0.24028,1,0
4,GO MITOCHONDRIAL GENE EXPRESSION,0.00012512,-0.23373,-0.2434,1,0
4,GO RESPONSE TO TESTOSTERONE,0.0014738,-0.23373,-0.20764,1,0
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00013917,-0.23378,-0.22945,1,0
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.001872,-0.23382,-0.30394,1,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00031859,-0.23393,-0.25782,1,0
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0087944,-0.23397,-0.15831,1,0
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,1.4039e-05,-0.23424,-0.28916,1,0
4,GO RESPONSE TO INTERLEUKIN 12,0.00024286,-0.23428,-0.24587,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00026003,-0.23442,-0.25246,1,0
4,GO LACTATION,0.0001165,-0.23449,-0.23268,1,0
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.00050664,-0.23462,-0.21724,1,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0021689,-0.23467,-0.21316,1,0
4,GO FIBRINOLYSIS,0.00010092,-0.23477,-0.37526,1,0
4,GO RRNA METABOLIC PROCESS,0.0011199,-0.23481,-0.21727,1,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00041602,-0.23511,-0.2966,1,0
4,GO REGULATION OF STEROID METABOLIC PROCESS,2.5308e-05,-0.2352,-0.25084,1,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00034072,-0.2352,-0.28108,1,0
4,GO RESPONSE TO REDOX STATE,0.00072223,-0.23552,-0.25998,1,0
4,GO RESPONSE TO DIETARY EXCESS,0.03939,-0.23595,-0.18865,1,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0099891,-0.23607,-0.18512,1,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,6.7596e-05,-0.23634,-0.30716,1,0
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,9.3916e-06,-0.23637,-0.21967,1,0
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,4.6623e-06,-0.23643,-0.24575,1,0
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,8.3127e-06,-0.23649,-0.25342,1,0
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,8.3127e-06,-0.23655,-0.27398,1,0
4,GO CELLULAR LIPID CATABOLIC PROCESS,3.3287e-06,-0.23675,-0.22376,1,0
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,8.6584e-06,-0.23678,-0.24771,1,0
4,GO PIGMENT BIOSYNTHETIC PROCESS,9.0551e-05,-0.23705,-0.23132,1,0
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.001228,-0.23714,-0.26036,1,0
4,GO NECROTIC CELL DEATH,0.00017186,-0.23735,-0.28295,1,0
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0030654,-0.23749,-0.22946,1,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00018427,-0.23783,-0.27778,1,0
4,GO RESPONSE TO CORTICOSTERONE,0.0020453,-0.23843,-0.25769,1,0
4,GO CARDIAC CONDUCTION,0.0015653,-0.23853,-0.19131,1,0
4,GO BEHAVIORAL RESPONSE TO PAIN,0.00079435,-0.23855,-0.39462,1,0
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00045924,-0.23877,-0.23578,1,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,7.9801e-06,-0.23894,-0.28367,1,0
4,GO RIBOSOME BIOGENESIS,0.0015653,-0.23936,-0.22559,1,0
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0081404,-0.23945,-0.19346,1,0
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,6.0504e-05,-0.23954,-0.26333,1,0
4,GO RESPONSE TO MANGANESE ION,0.00025131,-0.23954,-0.25438,1,0
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,4.8379e-05,-0.23993,-0.23774,1,0
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.00012964,-0.24016,-0.26489,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.016339,-0.24027,-0.17096,1,0
4,GO VIRAL GENE EXPRESSION,0.0011549,-0.2404,-0.26022,1,0
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0021062,-0.24042,-0.21423,1,0
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.033166,-0.24045,-0.26479,1,0
4,GO MAMMARY GLAND MORPHOGENESIS,0.011904,-0.24129,-0.21097,1,0
4,GO OLIGOPEPTIDE TRANSPORT,0.020205,-0.2413,-0.26787,1,0
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00012964,-0.24147,-0.26359,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00072223,-0.24171,-0.2685,1,0
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.025994,-0.24201,-0.18185,1,0
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,4.1112e-06,-0.24226,-0.29018,1,0
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00012074,-0.24268,-0.24028,1,0
4,GO REVERSE CHOLESTEROL TRANSPORT,0.0018173,-0.24275,-0.2901,1,0
4,GO DRUG METABOLIC PROCESS,2.0033e-05,-0.2428,-0.2844,1,0
4,GO CHOLESTEROL STORAGE,0.0010206,-0.24291,-0.23846,1,0
4,GO SULFUR AMINO ACID METABOLIC PROCESS,3.5759e-05,-0.24303,-0.2582,1,0
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.00065623,-0.24306,-0.22607,1,0
4,GO BILE ACID AND BILE SALT TRANSPORT,0.025994,-0.24313,-0.21535,1,0
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.00079435,-0.2433,-0.282,1,0
4,GO SPHINGOMYELIN METABOLIC PROCESS,0.00042998,-0.24354,-0.28316,1,0
4,GO PEROXISOME ORGANIZATION,3.4728e-06,-0.24368,-0.25125,1,0
4,GO NCRNA CATABOLIC PROCESS,0.001872,-0.24375,-0.17971,1,0
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0016129,-0.24379,-0.27727,1,0
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0010206,-0.24401,-0.24007,1,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,3.5759e-05,-0.24402,-0.22201,1,0
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.00014935,-0.24413,-0.27067,1,0
4,GO LYMPHOCYTE APOPTOTIC PROCESS,9.7346e-05,-0.24414,-0.21257,1,0
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0014299,-0.24418,-0.24223,1,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0062634,-0.2443,-0.33953,1,0
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0064317,-0.24437,-0.19121,1,0
4,GO REGULATION OF CARDIAC CONDUCTION,3.1888e-05,-0.24442,-0.23861,1,0
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.010773,-0.24445,-0.18764,1,0
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.00040247,-0.24448,-0.20946,1,0
4,GO REGULATION OF FIBRINOLYSIS,3.9926e-07,-0.24495,-0.42819,1,0
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.00028792,-0.24496,-0.30356,1,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.015574,-0.24603,-0.43766,1,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.8583e-05,-0.24604,-0.24675,1,0
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.0057817,-0.24619,-0.28572,1,0
4,GO MITOCHONDRIAL DEPOLARIZATION,0.0026572,-0.24665,-0.24278,1,0
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0034322,-0.24676,-0.27849,1,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00034072,-0.24683,-0.31952,1,0
4,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0023671,-0.24694,-0.25004,1,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0040578,-0.24701,-0.22055,1,0
4,GO ANIMAL ORGAN REGENERATION,9.0179e-06,-0.24725,-0.28297,1,0
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00021909,-0.24736,-0.25624,1,0
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00014418,-0.24755,-0.25447,1,0
4,GO TETRAPYRROLE METABOLIC PROCESS,6.7728e-06,-0.24759,-0.27519,1,0
4,GO CELL JUNCTION DISASSEMBLY,0.00018427,-0.24771,-0.27863,1,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00011241,-0.24772,-0.29425,1,0
4,GO GLOMERULUS DEVELOPMENT,0.00074557,-0.24791,-0.252,1,0
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.033894,-0.24803,-0.20064,1,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,2.7343e-05,-0.24808,-0.30414,1,0
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0021062,-0.24823,-0.26764,1,0
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00042998,-0.2487,-0.26913,1,0
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.00035231,-0.24871,-0.30054,1,0
4,GO MATURE B CELL DIFFERENTIATION,0.0010859,-0.24893,-0.29996,1,0
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00095906,-0.24899,-0.26608,1,0
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,5.8301e-05,-0.24938,-0.27368,1,0
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00069957,-0.24983,-0.30451,1,0
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,5.2837e-06,-0.25002,-0.27048,1,0
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0014738,-0.25068,-0.26059,1,0
4,GO CARBOHYDRATE PHOSPHORYLATION,0.0017641,-0.25077,-0.20815,1,0
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00014935,-0.25086,-0.33527,1,0
4,GO HYALURONAN CATABOLIC PROCESS,0.0013872,-0.25098,-0.35565,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0026572,-0.25123,-0.30988,1,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0001165,-0.25148,-0.26295,1,0
4,GO MYOBLAST FUSION,5.6174e-05,-0.25161,-0.29905,1,0
4,GO RESPONSE TO GONADOTROPIN,5.8301e-05,-0.25198,-0.29695,1,0
4,GO ENAMEL MINERALIZATION,0.05161,-0.25218,-0.20749,1,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0036303,-0.25228,-0.20316,1,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00040247,-0.25242,-0.25746,1,0
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,2.0784e-06,-0.2527,-0.27777,1,0
4,GO RESPONSE TO PROTOZOAN,6.5149e-05,-0.25306,-0.26191,1,0
4,GO RETINAL METABOLIC PROCESS,0.023741,-0.25334,-0.28701,1,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0017641,-0.25364,-0.30051,1,0
4,GO BONE TRABECULA FORMATION,0.013465,-0.25372,-0.41134,1,0
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0001165,-0.25377,-0.27871,1,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0015653,-0.25419,-0.25169,1,0
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.0018173,-0.25421,-0.25702,1,0
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00032948,-0.25458,-0.26142,1,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0013054,-0.25465,-0.23476,1,0
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0071468,-0.25469,-0.28106,1,0
4,GO EPIBOLY,0.00065623,-0.25508,-0.32599,1,0
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.023205,-0.25561,-0.30178,1,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0019282,-0.25567,-0.25023,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0051916,-0.25581,-0.29437,1,0
4,GO CHEMOSENSORY BEHAVIOR,1.2454e-05,-0.25649,-0.26968,1,0
4,GO REGULATION OF MYOBLAST FUSION,0.0015653,-0.2566,-0.30567,1,0
4,GO TRANSLATIONAL INITIATION,0.00074557,-0.25661,-0.28806,1,0
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0025083,-0.25682,-0.21666,1,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00044439,-0.25693,-0.25023,1,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS,8.1192e-05,-0.25698,-0.29581,1,0
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00011241,-0.25716,-0.23059,1,0
4,GO HOMOTYPIC CELL CELL ADHESION,0.00079435,-0.25719,-0.25241,1,0
4,GO XENOBIOTIC TRANSPORT,5.508e-06,-0.25766,-0.28955,1,0
4,GO HYPEROSMOTIC RESPONSE,0.037747,-0.25768,-0.15242,1,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.014486,-0.2581,-0.26032,1,0
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,2.1663e-05,-0.25811,-0.28517,1,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.011612,-0.25833,-0.25181,1,0
4,GO RESPONSE TO TYPE I INTERFERON,0.0064317,-0.25838,-0.35315,1,0
4,GO ELASTIC FIBER ASSEMBLY,0.0073363,-0.25886,-0.35622,1,0
4,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0021062,-0.25943,-0.29484,1,0
4,GO KERATAN SULFATE CATABOLIC PROCESS,5.4121e-05,-0.25944,-0.33996,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0020453,-0.25964,-0.2281,1,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00028792,-0.25997,-0.25022,1,0
4,GO PLASMA MEMBRANE FUSION,0.0039469,-0.26,-0.26555,1,0
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0019282,-0.26088,-0.34661,1,0
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0006154,-0.26089,-0.24214,1,0
4,GO POSITIVE REGULATION OF PROTEIN BINDING,4.1617e-05,-0.261,-0.20695,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.00074557,-0.26114,-0.22084,1,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.010245,-0.2613,-0.20006,1,0
4,GO ADAPTATION OF SIGNALING PATHWAY,0.00353,-0.26133,-0.21321,1,0
4,GO PROTEIN DEGLYCOSYLATION,5.2139e-05,-0.2619,-0.32746,1,0
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.001986,-0.26196,-0.2275,1,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00035231,-0.26228,-0.24775,1,0
4,GO PLATELET DEGRANULATION,1.9263e-05,-0.2626,-0.3016,1,0
4,GO MEMBRANE LIPID CATABOLIC PROCESS,9.0551e-05,-0.26277,-0.30384,1,0
4,GO RESPONSE TO PH,9.389e-05,-0.26295,-0.26004,1,0
4,GO SULFUR COMPOUND CATABOLIC PROCESS,3.6228e-06,-0.263,-0.28467,1,0
4,GO REGULATION OF NECROTIC CELL DEATH,0.00049035,-0.26306,-0.30773,1,0
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,3.1888e-05,-0.26384,-0.30116,1,0
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,4.2876e-06,-0.26384,-0.29431,1,0
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00011241,-0.26385,-0.24625,1,0
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.015953,-0.2639,-0.25781,1,0
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,3.0264e-07,-0.26393,-0.28156,1,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,2.2658e-06,-0.26412,-0.26277,1,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,1.4044e-06,-0.2646,-0.29464,1,0
4,GO BLEB ASSEMBLY,0.0024367,-0.26484,-0.54069,1,0
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.4878e-05,-0.26506,-0.2986,1,0
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00010845,-0.26581,-0.38331,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00049035,-0.26584,-0.35586,1,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00040247,-0.26595,-0.32923,1,0
4,GO RECEPTOR CATABOLIC PROCESS,0.00098941,-0.26638,-0.21605,1,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00092958,-0.26638,-0.23968,1,0
4,GO OVULATION,0.0030654,-0.26644,-0.24808,1,0
4,GO AORTIC VALVE DEVELOPMENT,0.0015189,-0.26685,-0.28614,1,0
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,6.0504e-05,-0.26692,-0.33114,1,0
4,GO FUCOSE METABOLIC PROCESS,0.0011199,-0.26697,-0.27056,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,2.5308e-05,-0.26709,-0.30919,1,0
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.02166,-0.26722,-0.24729,1,0
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,4.6597e-05,-0.26727,-0.25526,1,0
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.001662,-0.26749,-0.24922,1,0
4,GO PEROXISOMAL TRANSPORT,4.2876e-06,-0.26753,-0.26655,1,0
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0099891,-0.2677,-0.33884,1,0
4,GO RESPONSE TO ACIDIC PH,0.00040247,-0.26773,-0.31789,1,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.027188,-0.26816,-0.33523,1,0
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.001662,-0.26858,-0.2587,1,0
4,GO ENDOTHELIAL CELL MIGRATION,2.8418e-05,-0.26895,-0.26916,1,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0013872,-0.26914,-0.2344,1,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.024288,-0.27,-0.17882,1,0
4,GO RESPONSE TO MISFOLDED PROTEIN,5.2139e-05,-0.27043,-0.25433,1,0
4,GO NADP METABOLIC PROCESS,0.00016595,-0.27059,-0.26435,1,0
4,GO APOPTOTIC CELL CLEARANCE,3.4421e-05,-0.27075,-0.32833,1,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,8.6584e-06,-0.27085,-0.32404,1,0
4,GO TYPE 2 IMMUNE RESPONSE,0.00017186,-0.2713,-0.3183,1,0
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0059384,-0.27274,-0.22444,1,0
4,GO TISSUE MIGRATION,2.9532e-05,-0.27285,-0.25001,1,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0013872,-0.27303,-0.30126,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.9263e-05,-0.27304,-0.30982,1,0
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.014138,-0.27371,-0.25347,1,0
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,2.7343e-05,-0.27371,-0.27147,1,0
4,GO REGULATION OF BONE DEVELOPMENT,0.00012074,-0.27388,-0.23721,1,0
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,7.0571e-06,-0.27397,-0.31293,1,0
4,GO CELL REDOX HOMEOSTASIS,4.1617e-05,-0.27414,-0.26873,1,0
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,1.1493e-05,-0.27415,-0.38495,1,0
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.0017641,-0.27421,-0.3475,1,0
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00010092,-0.27427,-0.32955,1,0
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00018427,-0.27479,-0.30225,1,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0042883,-0.27517,-0.27805,1,0
4,GO RETINOL METABOLIC PROCESS,0.00014935,-0.27521,-0.3026,1,0
4,GO ARACHIDONIC ACID METABOLIC PROCESS,2.6902e-06,-0.27594,-0.31614,1,0
4,GO ZINC ION HOMEOSTASIS,0.0018173,-0.27648,-0.29003,1,0
4,GO MATURATION OF SSU RRNA,0.00072223,-0.27715,-0.27663,1,0
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,4.6597e-05,-0.27724,-0.26181,1,0
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,4.1617e-05,-0.27735,-0.26279,1,0
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.001872,-0.27738,-0.29194,1,0
4,GO KERATINOCYTE MIGRATION,2.6307e-05,-0.27741,-0.27215,1,0
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0042883,-0.27747,-0.26193,1,0
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,4.4878e-05,-0.2776,-0.29147,1,0
4,GO THIOESTER BIOSYNTHETIC PROCESS,2.8418e-05,-0.27779,-0.26572,1,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00037661,-0.27799,-0.28418,1,0
4,GO PODOSOME ASSEMBLY,0.0027346,-0.27831,-0.24095,1,0
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00057693,-0.2785,-0.44289,1,0
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00023468,-0.27866,-0.32945,1,0
4,GO PHOSPHOLIPID EFFLUX,0.00038934,-0.27868,-0.31027,1,0
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.018836,-0.2788,-0.25749,1,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.0833e-05,-0.27908,-0.26564,1,0
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0054795,-0.27924,-0.24503,1,0
4,GO RIBOSOME ASSEMBLY,0.00072223,-0.27943,-0.30906,1,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0019282,-0.27948,-0.32093,1,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,1.0604e-05,-0.2809,-0.3244,1,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00074557,-0.28112,-0.33535,1,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.00054072,-0.28119,-0.36292,1,0
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,1.4039e-05,-0.28181,-0.2954,1,0
4,GO NEUTROPHIL HOMEOSTASIS,0.0028957,-0.28203,-0.33662,1,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00030804,-0.28224,-0.34048,1,0
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00050664,-0.28239,-0.27258,1,0
4,GO PIGMENT METABOLIC PROCESS,4.6597e-05,-0.28241,-0.25965,1,0
4,GO RESPONSE TO GROWTH HORMONE,0.00065623,-0.28258,-0.25495,1,0
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,5.6174e-05,-0.28262,-0.29577,1,0
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.00016595,-0.28275,-0.2327,1,0
4,GO MONONUCLEAR CELL MIGRATION,1.4039e-05,-0.28296,-0.28551,1,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0085714,-0.28324,-0.35799,1,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0025817,-0.28342,-0.31832,1,0
4,GO ZYMOGEN INHIBITION,0.010773,-0.2835,-0.26515,1,0
4,GO COLLAGEN METABOLIC PROCESS,0.00012512,-0.28377,-0.30352,1,0
4,GO AMYLOID BETA METABOLIC PROCESS,0.00016023,-0.28385,-0.24626,1,0
4,GO VASCULAR TRANSPORT,0.018836,-0.284,-0.28942,1,0
4,GO SEQUESTERING OF CALCIUM ION,3.6228e-06,-0.2843,-0.25253,1,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.015574,-0.28442,-0.18181,1,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00014418,-0.28444,-0.34694,1,0
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00012512,-0.28496,-0.28017,1,0
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0066042,-0.28513,-0.26301,1,0
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.5308e-05,-0.28516,-0.31016,1,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,1.2962e-05,-0.28586,-0.33177,1,0
4,GO CORTICOSTEROID HORMONE SECRETION,0.00069957,-0.28588,-0.31667,1,0
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,8.7323e-05,-0.28635,-0.31,1,0
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.0094949,-0.28649,-0.22216,1,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.0073e-05,-0.28663,-0.32764,1,0
4,GO KETONE BIOSYNTHETIC PROCESS,1.9263e-05,-0.28685,-0.29584,1,0
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0069616,-0.28721,-0.35225,1,0
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,3.3132e-05,-0.28767,-0.26747,1,0
4,GO T HELPER 2 CELL DIFFERENTIATION,0.0045306,-0.28891,-0.37494,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00011241,-0.28904,-0.35478,1,0
4,GO RESPONSE TO INTERFERON GAMMA,1.0184e-05,-0.28941,-0.36557,1,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00010462,-0.28964,-0.30424,1,0
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,3.6228e-06,-0.28964,-0.32144,1,0
4,GO DETECTION OF BIOTIC STIMULUS,3.7145e-05,-0.28975,-0.34905,1,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.1964e-05,-0.29021,-0.30697,1,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00042998,-0.29032,-0.29547,1,0
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,2.7343e-05,-0.29084,-0.28009,1,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00024286,-0.29086,-0.22976,1,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.00098941,-0.2914,-0.30204,1,0
4,GO SECRETION BY TISSUE,0.0013457,-0.29287,-0.23522,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,9.7346e-05,-0.29327,-0.35949,1,0
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,2.7343e-05,-0.2943,-0.26153,1,0
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,7.2754e-05,-0.29446,-0.28007,1,0
4,GO PROTEIN OXIDATION,3.1888e-05,-0.29468,-0.36344,1,0
4,GO FATTY ACYL COA METABOLIC PROCESS,0.00028792,-0.29468,-0.24723,1,0
4,GO KERATAN SULFATE METABOLIC PROCESS,1.7474e-06,-0.29489,-0.35327,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.0833e-05,-0.295,-0.34121,1,0
4,GO REGULATION OF TOLERANCE INDUCTION,0.00025131,-0.29546,-0.39931,1,0
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0090226,-0.2955,-0.27247,1,0
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00012512,-0.2958,-0.30192,1,0
4,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0020453,-0.29616,-0.30225,1,0
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0059384,-0.29678,-0.25808,1,0
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,7.013e-05,-0.29685,-0.31299,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.00065623,-0.29688,-0.34468,1,0
4,GO NEGATIVE REGULATION OF COAGULATION,0.0001165,-0.2969,-0.36047,1,0
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0010859,-0.29694,-0.31773,1,0
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.4421e-05,-0.29717,-0.36968,1,0
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,6.2786e-05,-0.29895,-0.32577,1,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.013465,-0.29907,-0.30056,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0039469,-0.29923,-0.25588,1,0
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.00013917,-0.29951,-0.3262,1,0
4,GO CERAMIDE CATABOLIC PROCESS,0.00026003,-0.29967,-0.34969,1,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00042998,-0.30011,-0.30049,1,0
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,4.8379e-05,-0.30051,-0.29216,1,0
4,GO LIPID IMPORT INTO CELL,1.7118e-05,-0.30114,-0.30822,1,0
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0094949,-0.30268,-0.25258,1,0
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,1.4609e-05,-0.30286,-0.32584,1,0
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.00012074,-0.30289,-0.3285,1,0
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,5.8301e-05,-0.30297,-0.3361,1,0
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00024286,-0.30299,-0.34969,1,0
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00045924,-0.30301,-0.40032,1,0
4,GO ENDODERM FORMATION,8.4205e-05,-0.30355,-0.34458,1,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.0010206,-0.30404,-0.30288,1,0
4,GO RESPONSE TO STEROL DEPLETION,0.0017123,-0.30422,-0.24965,1,0
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00042998,-0.30465,-0.32501,1,0
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.00050664,-0.30465,-0.27749,1,0
4,GO RESPONSE TO MAGNESIUM ION,0.0015653,-0.30515,-0.32116,1,0
4,GO MICROVILLUS ORGANIZATION,0.0054795,-0.30516,-0.25036,1,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00067758,-0.30601,-0.33938,1,0
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,4.0073e-05,-0.30604,-0.46898,1,0
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00045924,-0.30628,-0.39778,1,0
4,GO MATURATION OF LSU RRNA,0.0057817,-0.30713,-0.26071,1,0
4,GO STEROID ESTERIFICATION,5.0226e-05,-0.30831,-0.39466,1,0
4,GO COPPER ION HOMEOSTASIS,0.00038934,-0.30992,-0.26395,1,0
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00011241,-0.30995,-0.31859,1,0
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,6.5149e-05,-0.3101,-0.31421,1,0
4,GO CELLULAR RESPONSE TO COPPER ION,0.0025817,-0.31029,-0.40093,1,0
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00059588,-0.31072,-0.25915,1,0
4,GO HORMONE BIOSYNTHETIC PROCESS,2.3654e-06,-0.31108,-0.30464,1,0
4,GO MONOCYTE CHEMOTAXIS,3.3132e-05,-0.31113,-0.31207,1,0
4,GO CELL ADHESION MEDIATED BY INTEGRIN,4.6623e-06,-0.31187,-0.39628,1,0
4,GO SNARE COMPLEX ASSEMBLY,0.00047456,-0.31232,-0.26841,1,0
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.00095906,-0.31355,-0.33312,1,0
4,GO POSITIVE REGULATION OF LIPID STORAGE,4.2876e-06,-0.31377,-0.37534,1,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.00049035,-0.3145,-0.28649,1,0
4,GO T CELL MEDIATED CYTOTOXICITY,0.00010845,-0.31557,-0.43578,1,0
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00055855,-0.31564,-0.36827,1,0
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0050528,-0.31627,-0.3164,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.001228,-0.31689,-0.35847,1,0
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0014738,-0.31691,-0.31953,1,0
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,2.6902e-06,-0.31744,-0.3479,1,0
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0040578,-0.31761,-0.32945,1,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.00353,-0.31813,-0.26775,1,0
4,GO VAGINA DEVELOPMENT,0.0026572,-0.31888,-0.261,1,0
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,3.3132e-05,-0.3195,-0.29641,1,0
4,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00019753,-0.31981,-0.36035,1,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00021909,-0.3205,-0.31093,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0001547,-0.32113,-0.3166,1,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.00014935,-0.32129,-0.33994,1,0
4,GO NEUROTRANSMITTER REUPTAKE,0.0022992,-0.32132,-0.26416,1,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00054072,-0.32247,-0.3689,1,0
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.023741,-0.32251,-0.30498,1,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.8521e-05,-0.32296,-0.28863,1,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0056288,-0.32315,-0.29405,1,0
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00019753,-0.3233,-0.40248,1,0
4,GO ZYMOGEN ACTIVATION,3.0689e-05,-0.32364,-0.39779,1,0
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.0010528,-0.32486,-0.39587,1,0
4,GO THYMOCYTE APOPTOTIC PROCESS,0.0011549,-0.3249,-0.29588,1,0
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0007696,-0.32585,-0.33328,1,0
4,GO MACROPHAGE PROLIFERATION,0.00098941,-0.32636,-0.36346,1,0
4,GO PROTEIN TRIMERIZATION,3.5759e-05,-0.32694,-0.38046,1,0
4,GO RESPONSE TO TUMOR CELL,1.2308e-06,-0.32782,-0.3929,1,0
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.6455e-05,-0.32854,-0.38966,1,0
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0011199,-0.32867,-0.39577,1,0
4,GO NEURON REMODELING,0.00031859,-0.32913,-0.36291,1,0
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00057693,-0.32927,-0.29424,1,0
4,GO GLYCINE TRANSPORT,0.0038387,-0.32993,-0.33165,1,0
4,GO DETECTION OF OTHER ORGANISM,0.00040247,-0.33094,-0.3445,1,0
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.00027832,-0.33096,-0.28001,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.010506,-0.33169,-0.28322,1,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0007696,-0.33215,-0.32922,1,0
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,3.0689e-05,-0.33298,-0.30398,1,0
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0081404,-0.33467,-0.2886,1,0
4,GO GAS TRANSPORT,0.0042883,-0.33473,-0.3271,1,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.0012662,-0.33518,-0.35593,1,0
4,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.00032948,-0.33572,-0.36924,1,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,6.0504e-05,-0.33618,-0.31568,1,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.00052342,-0.33683,-0.35609,1,0
4,GO FRUCTOSE METABOLIC PROCESS,0.016339,-0.33754,-0.32619,1,0
4,GO RESPONSE TO THYROID HORMONE,0.00012512,-0.33768,-0.32546,1,0
4,GO NAD METABOLIC PROCESS,2.6307e-05,-0.33781,-0.34045,1,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,6.5149e-05,-0.33789,-0.36498,1,0
4,GO POSITIVE REGULATION OF HEART RATE,0.00030804,-0.33801,-0.33499,1,0
4,GO RESPONSE TO CAFFEINE,4.3218e-05,-0.33882,-0.31504,1,0
4,GO SALIVARY GLAND DEVELOPMENT,0.00027832,-0.33917,-0.32542,1,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.029068,-0.33936,-0.32353,1,0
4,GO RESPONSE TO COPPER ION,0.00021167,-0.34102,-0.39454,1,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.00065623,-0.34162,-0.28441,1,0
4,GO REGULATION OF PODOSOME ASSEMBLY,0.007729,-0.34224,-0.26049,1,0
4,GO REGULATION OF VASCULOGENESIS,0.010245,-0.34439,-0.37091,1,0
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,7.2754e-05,-0.34449,-0.32192,1,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00052342,-0.34455,-0.33277,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,5.2837e-06,-0.34513,-0.33694,1,0
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,4.3218e-05,-0.34689,-0.27794,1,0
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00010462,-0.3469,-0.39779,1,0
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,1.5816e-05,-0.34749,-0.3619,1,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.00072223,-0.34752,-0.29733,1,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0012662,-0.34841,-0.3368,1,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.0033369,-0.34869,-0.26081,1,0
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.011612,-0.34879,-0.3116,1,0
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,5.2139e-05,-0.34906,-0.38187,1,0
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,2.1663e-05,-0.34997,-0.39627,1,0
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00029782,-0.35064,-0.36083,1,0
4,GO MEMBRANE RAFT ORGANIZATION,0.0014299,-0.35159,-0.41285,1,0
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00026903,-0.35233,-0.34518,1,0
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0042883,-0.35233,-0.28855,1,0
4,GO VASODILATION,2.4346e-05,-0.35365,-0.36263,1,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,3.1888e-05,-0.35407,-0.37401,1,0
4,GO NOTOCHORD DEVELOPMENT,0.0023671,-0.35686,-0.31318,1,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00072223,-0.35705,-0.34188,1,0
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.001872,-0.35732,-0.40152,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00063551,-0.35737,-0.37219,1,0
4,GO GLYCOPROTEIN CATABOLIC PROCESS,1.7118e-05,-0.35742,-0.51029,1,0
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,3.7145e-05,-0.35761,-0.33603,1,0
4,GO POLYOL TRANSPORT,0.00017186,-0.35768,-0.31364,1,0
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,2.1702e-06,-0.35885,-0.36989,1,0
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00045924,-0.36022,-0.38657,1,0
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00025131,-0.36046,-0.40163,1,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00012512,-0.3621,-0.38458,1,0
4,GO NEGATIVE REGULATION OF BONE REMODELING,0.00036427,-0.36229,-0.34395,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0014738,-0.36259,-0.38556,1,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0024367,-0.36262,-0.38091,1,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00010845,-0.36279,-0.36736,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.9263e-05,-0.3634,-0.30541,1,0
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0029794,-0.36356,-0.31814,1,0
4,GO HISTAMINE SECRETION,0.007729,-0.36516,-0.31832,1,0
4,GO HEME METABOLIC PROCESS,3.7145e-05,-0.36725,-0.38454,1,0
4,GO CYSTEINE METABOLIC PROCESS,0.00023468,-0.36804,-0.44782,1,0
4,GO HISTAMINE TRANSPORT,0.0027346,-0.36851,-0.33368,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00063551,-0.36905,-0.39852,1,0
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,3.4421e-05,-0.36939,-0.48538,1,0
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00081984,-0.37015,-0.39822,1,0
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,9.3916e-06,-0.37081,-0.44868,1,0
4,GO EPOXYGENASE P450 PATHWAY,0.00012512,-0.37168,-0.35681,1,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0001165,-0.37172,-0.35752,1,0
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00016023,-0.37309,-0.3789,1,0
4,GO EOSINOPHIL MIGRATION,0.00036427,-0.37421,-0.39758,1,0
4,GO STEROL IMPORT,0.00012074,-0.37426,-0.33878,1,0
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,3.8583e-05,-0.37612,-0.30532,1,0
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.015203,-0.37646,-0.37921,1,0
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0051916,-0.37784,-0.28978,1,0
4,GO REGULATION OF HORMONE METABOLIC PROCESS,1.7474e-06,-0.37836,-0.44167,1,0
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0010206,-0.3784,-0.36831,1,0
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0023671,-0.37855,-0.42162,1,0
4,GO BASEMENT MEMBRANE ORGANIZATION,1.5201e-05,-0.38012,-0.43141,1,0
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0012662,-0.38069,-0.40775,1,0
4,GO GTP METABOLIC PROCESS,2.5308e-05,-0.38131,-0.34506,1,0
4,GO BASEMENT MEMBRANE ASSEMBLY,0.0020453,-0.38372,-0.3626,1,0
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00069957,-0.38454,-0.42188,1,0
4,GO MITOCHONDRIAL TRANSCRIPTION,4.8612e-06,-0.38462,-0.38907,1,0
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,8.7323e-05,-0.3848,-0.41678,1,0
4,GO GLYCOLIPID CATABOLIC PROCESS,0.00010462,-0.38663,-0.41878,1,0
4,GO PLASMINOGEN ACTIVATION,3.1904e-06,-0.387,-0.45306,1,0
4,GO RESPONSE TO INTERFERON BETA,0.0012662,-0.3878,-0.47062,1,0
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,1.7474e-06,-0.3879,-0.37014,1,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00047456,-0.39044,-0.41019,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.7806e-05,-0.39156,-0.42196,1,0
4,GO DENDRITIC CELL APOPTOTIC PROCESS,1.7118e-05,-0.39173,-0.44594,1,0
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00035231,-0.39437,-0.37637,1,0
4,GO BIOLOGICAL PHASE,0.001872,-0.39583,-0.4307,1,0
4,GO ARGININE METABOLIC PROCESS,0.0006154,-0.39643,-0.36252,1,0
4,GO POSITIVE REGULATION OF ACTION POTENTIAL,5.0226e-05,-0.3966,-0.40032,1,0
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,1.9263e-05,-0.39772,-0.38358,1,0
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00018427,-0.39841,-0.41714,1,0
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,2.9532e-05,-0.39963,-0.40025,1,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,4.4878e-05,-0.40024,-0.46901,1,0
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.00090094,-0.40152,-0.37244,1,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.1617e-05,-0.40225,-0.47512,1,0
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0042883,-0.40374,-0.2825,1,0
4,GO IMP METABOLIC PROCESS,0.0014299,-0.40428,-0.32808,1,0
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0073363,-0.4047,-0.27876,1,0
4,GO TRNA CATABOLIC PROCESS,0.050569,-0.40505,-0.22835,1,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00020448,-0.40522,-0.32791,1,0
4,GO REGULATION OF METANEPHROS DEVELOPMENT,2.1663e-05,-0.40952,-0.50303,1,0
4,GO RESPONSE TO INTERLEUKIN 18,0.0017123,-0.41206,-0.4453,1,0
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.0029794,-0.41266,-0.30417,1,0
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00026903,-0.41277,-0.41763,1,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.00016023,-0.41617,-0.31659,1,0
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00030804,-0.41831,-0.57799,1,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00026903,-0.41946,-0.45892,1,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,7.8282e-05,-0.42059,-0.41912,1,0
4,GO EOSINOPHIL CHEMOTAXIS,0.00065623,-0.4207,-0.42363,1,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,1.2308e-06,-0.42133,-0.45351,1,0
4,GO L PHENYLALANINE METABOLIC PROCESS,0.00021909,-0.42256,-0.36497,1,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00012512,-0.4227,-0.43909,1,0
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,1.1493e-05,-0.42558,-0.42944,1,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00042998,-0.4262,-0.38653,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0028957,-0.42755,-0.30832,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0010859,-0.43156,-0.53197,1,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,1.1267e-06,-0.43406,-0.47513,1,0
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.00029782,-0.43406,-0.47206,1,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.0006154,-0.43839,-0.50437,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,4.8612e-06,-0.43861,-0.43109,1,0
4,GO INTERLEUKIN 13 PRODUCTION,0.00012512,-0.43931,-0.35989,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.00063551,-0.44253,-0.47665,1,0
4,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,1.5816e-05,-0.44338,-0.53553,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00024286,-0.44614,-0.53933,1,0
4,GO ACTIN FILAMENT NETWORK FORMATION,6.2786e-05,-0.45243,-0.44259,1,0
4,GO OXYGEN TRANSPORT,0.011612,-0.45304,-0.39672,1,0
4,GO HEMIDESMOSOME ASSEMBLY,0.00036427,-0.4574,-0.55003,1,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0022992,-0.4575,-0.33682,1,0
4,GO TOLERANCE INDUCTION,1.2454e-05,-0.45819,-0.54418,1,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,5.9841e-06,-0.46281,-0.47997,1,0
4,GO CHAPERONE MEDIATED AUTOPHAGY,2.6307e-05,-0.46548,-0.51794,1,0
4,GO ADHESION OF SYMBIONT TO HOST,9.389e-05,-0.46558,-0.40325,1,0
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.011904,-0.46591,-0.52196,1,0
4,GO NEGATIVE REGULATION OF CELL KILLING,0.00012074,-0.46664,-0.52792,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,5.6174e-05,-0.47001,-0.46896,1,0
4,GO GALACTOSE METABOLIC PROCESS,4.1112e-06,-0.47797,-0.49764,1,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,1.9904e-06,-0.4787,-0.52433,1,0
4,GO CYCLOOXYGENASE PATHWAY,5.2837e-06,-0.48337,-0.60697,1,0
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,2.2524e-05,-0.49518,-0.56084,1,0
4,GO XENOBIOTIC CATABOLIC PROCESS,0.0010859,-0.49785,-0.49756,1,0
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,6.2367e-06,-0.49791,-0.56621,1,0
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,8.3127e-06,-0.5037,-0.47558,1,0
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00017796,-0.51384,-0.61184,1,0
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,7.547e-05,-0.51717,-0.51235,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0031536,-0.51748,-0.67916,1,0
4,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.00065623,-0.52213,-0.45174,1,0
4,GO REGULATION OF PLASMINOGEN ACTIVATION,3.3287e-06,-0.53743,-0.63861,1,0
4,GO MUCUS SECRETION,0.00084609,-0.54961,-0.54585,1,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0017641,-0.55171,-0.39016,1,0
4,GO RESPONSE TO EPINEPHRINE,0.0012662,-0.55953,-0.41922,1,0
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,1.6455e-05,-0.56005,-0.52838,1,0
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,3.3132e-05,-0.56083,-0.47978,1,0
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,5.2139e-05,-0.56225,-0.59762,1,0
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,2.0829e-07,-0.56341,-0.60738,1,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00012074,-0.56395,-0.59094,1,0
4,GO MEMBRANE RAFT ASSEMBLY,0.0050528,-0.574,-0.57001,1,0
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,1.5816e-05,-0.57845,-0.45727,1,0
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.2454e-05,-0.59302,-0.59644,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0023671,-0.71999,-0.87803,1,0
4,GO ESTROUS CYCLE,0.090515,0.22779,0.15297,0,1
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.11039,0.19702,0.11173,0,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.12908,0.17393,0.13219,0,1
4,GO THYROID GLAND DEVELOPMENT,0.72313,0.17359,0.026291,0,1
4,GO MITOTIC DNA REPLICATION CHECKPOINT,0.057089,0.16388,0.1038,0,1
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.0695,0.15282,0.12919,0,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.16828,0.13827,0.090281,0,1
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.093897,0.13117,0.13087,0,1
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.057089,0.11881,0.1083,0,1
4,GO NEURON PROJECTION ARBORIZATION,0.18219,0.11809,0.11179,0,1
4,GO INSEMINATION,0.14048,0.11246,0.10586,0,1
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.15517,0.11232,0.088685,0,1
4,GO REGULATION OF HELICASE ACTIVITY,0.082489,0.10959,0.142,0,1
4,GO DNA REPLICATION CHECKPOINT,0.10465,0.10935,0.085542,0,1
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.082489,0.10841,0.11216,0,1
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.20309,0.10645,0.066177,0,1
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.2,0.10612,0.036421,0,1
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.38408,0.086667,0.057028,0,1
4,GO CELL CYCLE DNA REPLICATION,0.059411,0.083346,0.07016,0,1
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.25729,0.082387,0.044061,0,1
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.0695,0.076548,0.11195,0,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.40349,0.074782,0.039748,0,1
4,GO REGULATION OF PROTEIN ACETYLATION,0.11039,0.070401,0.048744,0,1
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.25001,0.062642,0.050141,0,1
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.28785,0.06016,0.033947,0,1
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.24643,0.05978,0.057694,0,1
4,GO SPINDLE ORGANIZATION,0.11841,0.058772,0.035003,0,1
4,GO UV DAMAGE EXCISION REPAIR,0.54903,0.055616,0.023033,0,1
4,GO REGULATION OF EXIT FROM MITOSIS,0.89907,0.054974,-0.0072238,0,1
4,GO REGULATION OF DNA REPAIR,0.10654,0.050768,0.043497,0,1
4,GO PROTEIN METHYLATION,0.076492,0.045231,0.048278,0,1
4,GO PROTEIN ACYLATION,0.10845,0.038611,0.035708,0,1
4,GO DOUBLE STRAND BREAK REPAIR,0.17099,0.037909,0.031223,0,1
4,GO CARDIOBLAST PROLIFERATION,0.0026572,0.50011,0.44939,0,0
4,GO NEURON FATE SPECIFICATION,0.00042998,0.44934,0.46737,0,0
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00013917,0.3867,0.50691,0,0
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.025994,0.3841,0.27326,0,0
4,GO NEURON FATE COMMITMENT,2.2524e-05,0.37594,0.42101,0,0
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.015953,0.33777,0.26518,0,0
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0049174,0.31537,0.31642,0,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0069616,0.30948,0.3746,0,0
4,GO SPINAL CORD PATTERNING,0.00090094,0.27147,0.34947,0,0
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.00024286,0.26719,0.36017,0,0
4,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.14769,0.25699,0.18284,0,0
4,GO CELL DIFFERENTIATION IN SPINAL CORD,9.389e-05,0.247,0.23689,0,0
4,GO POSITIVE REGULATION OF BEHAVIOR,0.023205,0.23876,0.18417,0,0
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.1028,0.23439,0.26162,0,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.045624,0.22198,0.22882,0,0
4,GO ADENOHYPOPHYSIS DEVELOPMENT,0.16032,0.22148,0.18563,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0062634,0.21832,0.21258,0,0
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.02843,0.21738,0.17122,0,0
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.10654,0.21555,0.19788,0,0
4,GO CELL FATE SPECIFICATION,0.0040578,0.21076,0.17334,0,0
4,GO VOCALIZATION BEHAVIOR,0.24643,0.20997,0.17802,0,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.015953,0.20156,0.24954,0,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.073629,0.20055,0.17232,0,0
4,GO PITUITARY GLAND DEVELOPMENT,0.13355,0.19907,0.13601,0,0
4,GO MICROTUBULE DEPOLYMERIZATION,0.038561,0.19877,0.15089,0,0
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.011612,0.19677,0.17891,0,0
4,GO NEPHRON TUBULE FORMATION,0.23937,0.19595,0.10379,0,0
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.047551,0.19509,0.22254,0,0
4,GO GDP METABOLIC PROCESS,0.11636,0.19468,0.141,0,0
4,GO SYNAPTIC VESICLE CLUSTERING,0.072231,0.19285,0.31135,0,0
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.060602,0.19146,0.22275,0,0
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.43367,0.18846,0.037759,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.050569,0.18824,0.2028,0,0
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.011612,0.18584,0.16174,0,0
4,GO LIMB BUD FORMATION,0.073629,0.18522,0.16025,0,0
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.026586,0.18221,0.19107,0,0
4,GO LATERAL MESODERM DEVELOPMENT,0.29992,0.17847,0.052824,0,0
4,GO INTRACILIARY TRANSPORT,0.0037331,0.17781,0.20129,0,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.17934,0.17573,0.12098,0,0
4,GO CARDIAC VENTRICLE FORMATION,0.085627,0.17485,0.2723,0,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.068167,0.17406,0.15726,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0011199,0.17405,0.19769,0,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0087944,0.17377,0.17756,0,0
4,GO DNA DEAMINATION,0.41341,0.17369,0.039973,0,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.26098,0.17214,0.18943,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0047853,0.17195,0.27541,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0075304,0.17126,0.20877,0,0
4,GO MEGAKARYOCYTE DEVELOPMENT,0.070855,0.17078,0.17098,0,0
4,GO REGULATION OF STEM CELL DIVISION,0.05824,0.16735,0.12976,0,0
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.042857,0.16707,0.13545,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.0060989,0.16616,0.34057,0,0
4,GO PENILE ERECTION,0.095625,0.16614,0.17341,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.009256,0.16537,0.26786,0,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.05161,0.16525,0.19733,0,0
4,GO RESPONSE TO FORSKOLIN,0.22235,0.16521,0.13417,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.25729,0.16516,0.088939,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.17374,0.16432,0.1578,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0029794,0.16246,0.16804,0,0
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.34256,0.16223,0.090671,0,0
4,GO TONGUE DEVELOPMENT,0.39371,0.16197,0.045707,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.19095,0.16181,0.19415,0,0
4,GO MALE SEX DETERMINATION,0.065563,0.16099,0.16741,0,0
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.024846,0.15998,0.14126,0,0
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.8303,0.15838,-0.083971,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.14769,0.15827,0.14427,0,0
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.017137,0.15551,0.15774,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.05161,0.15396,0.13718,0,0
4,GO MICROTUBULE SEVERING,0.059411,0.15324,0.13275,0,0
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0099891,0.15302,0.15679,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.063042,0.15183,0.19586,0,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.18508,0.1507,0.21281,0,0
4,GO CELL PROLIFERATION IN HINDBRAIN,0.34256,0.15031,0.081268,0,0
4,GO GLIAL CELL FATE COMMITMENT,0.059411,0.15009,0.25957,0,0
4,GO FORELIMB MORPHOGENESIS,0.041967,0.14932,0.13792,0,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.033894,0.14929,0.18855,0,0
4,GO FOREBRAIN MORPHOGENESIS,0.56666,0.148,0.033814,0,0
4,GO V D J RECOMBINATION,0.02166,0.14637,0.18374,0,0
4,GO REGULATION OF TRANSPOSITION,0.37932,0.14563,0.057972,0,0
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.14285,0.14498,0.12373,0,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.10845,0.14463,0.16236,0,0
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0022332,0.1445,0.19573,0,0
4,GO CEREBELLAR CORTEX FORMATION,0.024288,0.14437,0.19186,0,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.89907,0.14419,-0.055917,0,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.11039,0.14253,0.19263,0,0
4,GO PYRAMIDAL NEURON DIFFERENTIATION,0.32077,0.14176,0.08912,0,0
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.12908,0.14167,0.15826,0,0
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.20309,0.14012,0.23205,0,0
4,GO HISTONE H4 K5 ACETYLATION,0.00036427,0.14011,0.21394,0,0
4,GO CARDIAC CHAMBER FORMATION,0.17099,0.13947,0.20565,0,0
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.044685,0.13938,0.13516,0,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.17653,0.13925,0.19536,0,0
4,GO SUBPALLIUM DEVELOPMENT,0.15773,0.13736,0.14947,0,0
4,GO NEURAL TUBE PATTERNING,0.097379,0.13694,0.085297,0,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.023741,0.13607,0.32898,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.20309,0.13534,0.12988,0,0
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.25363,0.13213,0.084999,0,0
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.11636,0.13189,0.17275,0,0
4,GO TRANSPOSITION,0.25729,0.13139,0.086352,0,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.034637,0.13103,0.11706,0,0
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.20621,0.13029,0.093135,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.16828,0.12846,0.060125,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.12908,0.12788,0.099975,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.51459,0.12787,0.075065,0,0
4,GO DORSAL VENTRAL PATTERN FORMATION,0.0037331,0.12738,0.15052,0,0
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0085714,0.12664,0.15552,0,0
4,GO EMBRYONIC BRAIN DEVELOPMENT,0.17653,0.12582,0.082633,0,0
4,GO SPINAL CORD DEVELOPMENT,0.011326,0.12517,0.12805,0,0
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.020205,0.12499,0.11759,0,0
4,GO FOREBRAIN GENERATION OF NEURONS,0.088862,0.12496,0.13977,0,0
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.057089,0.12466,0.16492,0,0
4,GO LONG TERM SYNAPTIC DEPRESSION,0.10654,0.12415,0.12209,0,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.050569,0.12401,0.23955,0,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.012508,0.124,0.13842,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.16032,0.12342,0.10623,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.1313,0.12339,0.41514,0,0
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.23937,0.12322,0.054009,0,0
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.34256,0.123,0.09757,0,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.82348,0.12217,0.016033,0,0
4,GO GROWTH HORMONE SECRETION,0.12259,0.1218,0.15549,0,0
4,GO OTIC VESICLE DEVELOPMENT,0.14769,0.12114,0.14465,0,0
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.24643,0.12081,0.093128,0,0
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.78289,0.12057,0.023088,0,0
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.12049,0.12032,0.11153,0,0
4,GO PROTEIN DEMETHYLATION,0.19393,0.12024,0.063755,0,0
4,GO DNA LIGATION,0.25001,0.11945,0.076975,0,0
4,GO TELENCEPHALON REGIONALIZATION,0.19095,0.11926,0.16182,0,0
4,GO LUNG CELL DIFFERENTIATION,0.50337,0.11911,0.13849,0,0
4,GO SEGMENT SPECIFICATION,0.25729,0.11849,0.12706,0,0
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.049546,0.11836,0.10709,0,0
4,GO KERATINOCYTE DEVELOPMENT,0.26098,0.11798,0.1436,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.17653,0.11777,0.1459,0,0
4,GO RESPONSE TO FOOD,0.099158,0.11771,0.073971,0,0
4,GO CELL FATE DETERMINATION,0.38408,0.11583,0.056299,0,0
4,GO NATURAL KILLER CELL PROLIFERATION,0.36526,0.11555,0.054305,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.26098,0.11553,0.10045,0,0
4,GO HISTONE H3 K9 ACETYLATION,0.070855,0.11545,0.073068,0,0
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.22235,0.11534,0.11449,0,0
4,GO NEURAL NUCLEUS DEVELOPMENT,0.11434,0.11523,0.13378,0,0
4,GO REGULATION OF STEM CELL PROLIFERATION,0.033894,0.11453,0.088272,0,0
4,GO NEURAL RETINA DEVELOPMENT,0.087232,0.11433,0.10297,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.13583,0.11384,0.16323,0,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.21579,0.11383,0.082538,0,0
4,GO ACROSOME ASSEMBLY,0.10845,0.11305,0.094081,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.14526,0.11292,0.11669,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.36064,0.11231,0.14893,0,0
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.092194,0.11108,0.16143,0,0
4,GO RETINA LAYER FORMATION,0.10096,0.11101,0.18278,0,0
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.064293,0.1098,0.10459,0,0
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.90599,0.10938,-0.00058945,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.34256,0.10931,0.067755,0,0
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.03939,0.10927,0.078266,0,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.052669,0.10924,0.17914,0,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.16032,0.10877,0.083294,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.42347,0.10853,0.065856,0,0
4,GO DNA STRAND ELONGATION,0.027188,0.10788,0.10285,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.31232,0.10784,0.065377,0,0
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.057089,0.10609,0.15361,0,0
4,GO SPERM AXONEME ASSEMBLY,0.16032,0.10554,0.11462,0,0
4,GO ATRIAL SEPTUM DEVELOPMENT,0.25001,0.1049,0.11347,0,0
4,GO DIENCEPHALON DEVELOPMENT,0.16032,0.1044,0.097436,0,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.71006,0.10293,0.010843,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.044685,0.10268,0.11474,0,0
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.76948,0.10255,0.019319,0,0
4,GO SEROTONIN SECRETION,0.14769,0.10235,0.13599,0,0
4,GO NOREPINEPHRINE SECRETION,0.26471,0.10216,0.081717,0,0
4,GO CENTROSOME SEPARATION,0.012508,0.10202,0.15986,0,0
4,GO HISTONE H4 ACETYLATION,0.0018173,0.10171,0.1071,0,0
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.98953,0.10132,-0.011798,0,0
4,GO SYNAPTIC VESICLE LOCALIZATION,0.040234,0.10062,0.17326,0,0
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.087232,0.10053,0.12051,0,0
4,GO CELL MIGRATION IN HINDBRAIN,0.29184,0.10045,0.083261,0,0
4,GO MAGNESIUM ION HOMEOSTASIS,0.61497,0.099985,0.022005,0,0
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.015574,0.099644,0.093906,0,0
4,GO RESPONSE TO HYDROXYUREA,0.018398,0.098928,0.16817,0,0
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.23589,0.09824,0.085285,0,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.059411,0.097048,0.10011,0,0
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.12049,0.096882,0.17543,0,0
4,GO HISTONE H3 K27 METHYLATION,0.046579,0.09634,0.087934,0,0
4,GO COLLECTING DUCT DEVELOPMENT,0.16559,0.096176,0.09786,0,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.22235,0.095574,0.062326,0,0
4,GO RESPONSE TO DOPAMINE,0.50896,0.095194,0.03229,0,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.188,0.094989,0.11976,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.25001,0.09462,0.13713,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.023741,0.092235,0.081073,0,0
4,GO REGULATION OF CHROMATIN BINDING,0.11841,0.091874,0.082727,0,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.81668,0.091808,0.064668,0,0
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.18219,0.09062,0.1227,0,0
4,GO REGULATION OF NEUROBLAST PROLIFERATION,0.082489,0.089761,0.11967,0,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.2,0.087602,0.055688,0,0
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.15015,0.087337,0.078921,0,0
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.37932,0.086289,0.048572,0,0
4,GO MICROTUBULE NUCLEATION,0.40843,0.085811,0.036285,0,0
4,GO ERYTHROCYTE MATURATION,0.49227,0.085692,0.028553,0,0
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.75615,0.085534,0.024879,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.17099,0.085394,0.047045,0,0
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.16828,0.085095,0.065912,0,0
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.15517,0.084887,0.10744,0,0
4,GO REGULATION OF PROTON TRANSPORT,0.55487,0.08427,0.047048,0,0
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.32506,0.084096,0.047456,0,0
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.20937,0.083273,0.10557,0,0
4,GO NEURON CELL CELL ADHESION,0.27611,0.082056,0.19768,0,0
4,GO UTERUS DEVELOPMENT,0.59059,0.082028,0.044226,0,0
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.084046,0.081871,0.11562,0,0
4,GO HISTONE H3 K4 TRIMETHYLATION,0.095625,0.081235,0.095785,0,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.10654,0.080385,0.042818,0,0
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.23937,0.080078,0.04489,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0695,0.079962,0.079773,0,0
4,GO CILIUM ORGANIZATION,0.027188,0.079889,0.088157,0,0
4,GO PEPTIDYL LYSINE METHYLATION,0.014138,0.079729,0.083537,0,0
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.3746,0.079433,0.058089,0,0
4,GO DNA DEALKYLATION,0.17099,0.079103,0.059366,0,0
4,GO CHROMATIN SILENCING AT TELOMERE,0.25729,0.078861,0.048811,0,0
4,GO REGULATION OF MICROTUBULE BINDING,0.04854,0.078527,0.14472,0,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.69061,0.078464,0.06105,0,0
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.004408,0.077647,0.10525,0,0
4,GO REGULATION OF MRNA PROCESSING,0.068167,0.077168,0.062086,0,0
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.62732,0.076691,0.048929,0,0
4,GO HISTONE H3 K4 METHYLATION,0.013139,0.076309,0.12514,0,0
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.031748,0.075977,0.12467,0,0
4,GO ERYTHROCYTE DEVELOPMENT,0.18219,0.07597,0.045926,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.30402,0.075887,0.2401,0,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.066855,0.075786,0.098894,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.24643,0.075588,0.074943,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.34702,0.075401,0.087625,0,0
4,GO CELLULAR RESPONSE TO VITAMIN D,0.72313,0.075249,-0.068013,0,0
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.30402,0.074874,0.24185,0,0
4,GO IMMATURE B CELL DIFFERENTIATION,0.14285,0.07477,0.11179,0,0
4,GO POSITIVE T CELL SELECTION,0.20937,0.074163,0.048409,0,0
4,GO SOMATIC STEM CELL DIVISION,0.13814,0.074081,0.22697,0,0
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.65234,0.073782,0.039404,0,0
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.29992,0.073779,0.055419,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.20937,0.073683,0.052964,0,0
4,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.74288,0.073648,-0.10454,0,0
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0099891,0.073482,0.10599,0,0
4,GO DNA REPLICATION INITIATION,0.19095,0.072994,0.0571,0,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.26098,0.072954,0.059915,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.082489,0.072743,0.044198,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.49227,0.07263,0.049907,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.81668,0.072438,0.0094533,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.35153,0.072411,0.047538,0,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.21905,0.07239,0.11045,0,0
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.03939,0.072175,0.133,0,0
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.50896,0.071958,0.03914,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.97557,0.071801,-0.038614,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.5726,0.071583,0.03443,0,0
4,GO RETROGRADE AXONAL TRANSPORT,0.14769,0.071422,0.11399,0,0
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.29586,0.07116,0.054406,0,0
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.29992,0.071093,0.038728,0,0
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.35607,0.071027,0.04742,0,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.72313,0.070947,-0.0060235,0,0
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.15517,0.070741,0.061181,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.69061,0.070719,0.007031,0,0
4,GO REGULATION OF AMINO ACID TRANSPORT,0.59664,0.070603,0.037225,0,0
4,GO RESPONSE TO LITHIUM ION,0.15517,0.070154,0.18382,0,0
4,GO PRO B CELL DIFFERENTIATION,0.41842,0.069712,0.062225,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.85768,0.069596,0.0062091,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING,0.25001,0.068986,0.055338,0,0
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.63354,0.068927,0.034424,0,0
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0069616,0.068733,0.090907,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.38408,0.068244,0.053648,0,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.19095,0.067896,0.065065,0,0
4,GO SEX DETERMINATION,0.32506,0.067835,0.075528,0,0
4,GO T CELL SELECTION,0.21256,0.067414,0.049793,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.080955,0.067324,0.045424,0,0
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.22905,0.067203,0.11328,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.78962,0.066642,0.0076944,0,0
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.072231,0.066405,0.093143,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.5726,0.066166,0.070428,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.65234,0.06614,0.084075,0,0
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.02843,0.066075,0.088815,0,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.15773,0.06596,0.10868,0,0
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.095625,0.065918,0.060192,0,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.0695,0.065909,0.053217,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.060602,0.065614,0.075147,0,0
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.20309,0.065434,0.071254,0,0
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.35153,0.065378,0.11026,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.98255,0.064908,-0.022745,0,0
4,GO MICROTUBULE BASED PROCESS,0.13355,0.064322,0.037103,0,0
4,GO ECTODERM DEVELOPMENT,0.17653,0.064147,0.056847,0,0
4,GO MITOTIC DNA REPLICATION,0.29184,0.063917,0.060176,0,0
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.41341,0.063911,0.10226,0,0
4,GO RETINAL CONE CELL DIFFERENTIATION,0.62732,0.063879,0.024137,0,0
4,GO MICROTUBULE BUNDLE FORMATION,0.23245,0.063852,0.078186,0,0
4,GO MICROTUBULE BASED MOVEMENT,0.20937,0.063852,0.040265,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.43883,0.063327,0.029264,0,0
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.50896,0.062786,0.020632,0,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.16828,0.062699,0.059609,0,0
4,GO SYNAPTIC VESICLE TRANSPORT,0.14285,0.062598,0.11414,0,0
4,GO NON RECOMBINATIONAL REPAIR,0.32506,0.062471,0.032093,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.17653,0.06222,0.051415,0,0
4,GO T HELPER CELL LINEAGE COMMITMENT,0.46512,0.061977,0.028197,0,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.17374,0.061614,0.074488,0,0
4,GO CHROMATIN REMODELING,0.0094949,0.061533,0.079489,0,0
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.5726,0.061297,0.010393,0,0
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.17099,0.061228,0.065985,0,0
4,GO REPLICATION FORK PROCESSING,0.1313,0.061159,0.059812,0,0
4,GO METENCEPHALON DEVELOPMENT,0.22905,0.060921,0.07421,0,0
4,GO HINDBRAIN MORPHOGENESIS,0.11434,0.060704,0.071158,0,0
4,GO DNA DEPENDENT DNA REPLICATION,0.22235,0.060367,0.043756,0,0
4,GO REGULATION OF RECEPTOR CLUSTERING,0.62732,0.059704,0.068984,0,0
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.37932,0.059666,0.076714,0,0
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.21256,0.058996,0.074817,0,0
4,GO CELLULAR RESPONSE TO X RAY,0.60272,0.058859,-0.023175,0,0
4,GO LIPID DROPLET FORMATION,0.69707,0.058834,-0.066214,0,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.63978,0.058656,0.026496,0,0
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.69707,0.058388,0.036652,0,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.98953,0.058182,-0.01097,0,0
4,GO CELL JUNCTION MAINTENANCE,0.16032,0.058126,0.10582,0,0
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.94769,0.057855,-0.0058221,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.4598,0.057386,0.034356,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.15264,0.057144,0.050722,0,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.18219,0.057092,0.036916,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.26847,0.057058,0.040376,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.26847,0.057015,0.056291,0,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.19695,0.056727,0.068945,0,0
4,GO REGULATION OF CIRCADIAN RHYTHM,0.0695,0.056651,0.050874,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.57857,0.056558,0.028173,0,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.36064,0.056536,0.018024,0,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.019739,0.056527,0.1457,0,0
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.35153,0.056461,0.11934,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.14769,0.056029,0.080636,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.059411,0.055996,0.064005,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.054842,0.055706,0.085249,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.80312,0.055373,0.012731,0,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.17934,0.05513,0.054729,0,0
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.94769,0.055124,-0.043448,0,0
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.30815,0.05507,0.11399,0,0
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.35153,0.054923,0.038749,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.51459,0.054799,-0.082756,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.57857,0.05456,-0.001785,0,0
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.28785,0.054095,0.076404,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.59059,0.053525,0.0013481,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.99651,0.053473,0.015703,0,0
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.72969,0.053408,-0.026232,0,0
4,GO DNA CONFORMATION CHANGE,0.046579,0.053238,0.052859,0,0
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.16294,0.053174,0.057679,0,0
4,GO SULFATION,0.85082,0.052843,-0.0085396,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.76948,0.052648,0.050901,0,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.77618,0.052371,0.0052199,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.4598,0.052201,0.02268,0,0
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.23589,0.05199,0.072284,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.19695,0.051951,0.072012,0,0
4,GO ER OVERLOAD RESPONSE,0.76948,0.051535,0.024276,0,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.66501,0.051019,0.032442,0,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.89907,0.050997,-0.013658,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.42347,0.050946,0.04286,0,0
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.87833,0.05059,0.013449,0,0
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.17653,0.050064,0.036005,0,0
4,GO SPLEEN DEVELOPMENT,0.64605,0.049499,0.026432,0,0
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.70355,0.049218,0.039458,0,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.36064,0.04909,0.027683,0,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.8303,0.048593,-0.00013772,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.12049,0.048465,0.078003,0,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.93377,0.04842,-0.035348,0,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.65234,0.048103,0.033981,0,0
4,GO AMINE BIOSYNTHETIC PROCESS,0.72313,0.047977,0.029039,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.19393,0.047866,0.058265,0,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.43367,0.047455,0.030659,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.31653,0.047362,0.11378,0,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.24288,0.04736,0.19883,0,0
4,GO HISTONE METHYLATION,0.084046,0.047251,0.056412,0,0
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.39858,0.047143,0.043031,0,0
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.94073,0.047077,0.013788,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.35153,0.046869,0.081375,0,0
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.89215,0.046844,0.0063912,0,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.13814,0.046824,0.052435,0,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.26471,0.046792,0.045752,0,0
4,GO RESPONSE TO UV B,0.98953,0.046716,0.0067453,0,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.32938,0.046687,0.050508,0,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.7495,0.046555,0.038018,0,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.16032,0.046497,0.041441,0,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.59059,0.046443,0.042774,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.12908,0.046335,0.055252,0,0
4,GO SPINDLE ASSEMBLY,0.15015,0.046098,0.035968,0,0
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.11235,0.04586,0.070231,0,0
4,GO PALLIUM DEVELOPMENT,0.57857,0.045839,0.025086,0,0
4,GO CELL FATE COMMITMENT,0.22568,0.045803,0.028166,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.50337,0.045667,0.011094,0,0
4,GO DORSAL AORTA DEVELOPMENT,0.88523,0.045291,0.004528,0,0
4,GO REGULATION OF CILIUM BEAT FREQUENCY,0.40843,0.045242,0.046371,0,0
4,GO SMOOTHENED SIGNALING PATHWAY,0.36991,0.045121,0.028539,0,0
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.064293,0.045097,0.058532,0,0
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.87144,0.045094,0.031409,0,0
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.4545,0.045092,0.086998,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.59664,0.044738,-0.05947,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.42347,0.044483,0.028412,0,0
4,GO NEURAL CREST FORMATION,0.21256,0.04433,0.10182,0,0
4,GO LUNG EPITHELIUM DEVELOPMENT,0.68418,0.043989,0.05616,0,0
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.51459,0.043877,0.021068,0,0
4,GO RESPONSE TO ETHER,0.26471,0.043776,0.050703,0,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,1,0.043317,-0.043274,0,0
4,GO CELL PROLIFERATION IN FOREBRAIN,0.87144,0.043303,-0.01485,0,0
4,GO RESPONSE TO ACETYLCHOLINE,0.37932,0.043129,0.091623,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.073629,0.043119,0.043666,0,0
4,GO SPINDLE LOCALIZATION,0.19695,0.043017,0.053204,0,0
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.27999,0.042962,0.089408,0,0
4,GO DEMETHYLATION,0.061812,0.042949,0.054411,0,0
4,GO BRAIN MORPHOGENESIS,0.38408,0.04292,0.033385,0,0
4,GO MRNA EXPORT FROM NUCLEUS,0.24288,0.042893,0.038735,0,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.60272,0.042874,0.011173,0,0
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.38888,0.042821,0.057819,0,0
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.34702,0.042518,0.079927,0,0
4,GO CELL PROJECTION ASSEMBLY,1,0.042466,-0.0007327,0,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.7495,0.042109,0.04141,0,0
4,GO ACTIN FILAMENT BASED TRANSPORT,0.44924,0.041975,0.063125,0,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.47049,0.041823,0.035339,0,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.84397,0.04125,0.0065592,0,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.56666,0.041173,0.0078611,0,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.52025,0.040862,0.030116,0,0
4,GO CHROMATIN DISASSEMBLY,0.67776,0.040294,0.02352,0,0
4,GO MATERNAL PLACENTA DEVELOPMENT,0.94769,0.040184,-0.0092819,0,0
4,GO ADRENAL GLAND DEVELOPMENT,0.71658,0.040142,0.016181,0,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.60883,0.039938,0.0069723,0,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.29184,0.039932,0.040162,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.27227,0.039845,0.035267,0,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.27999,0.03982,0.060443,0,0
4,GO REGULATION OF GLUTAMATE SECRETION,0.12049,0.039739,0.20588,0,0
4,GO INTERSTRAND CROSS LINK REPAIR,0.054842,0.039709,0.065157,0,0
4,GO TRANSPORT ALONG MICROTUBULE,0.0695,0.039666,0.064123,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.91987,0.039628,-0.021607,0,0
4,GO PANCREAS DEVELOPMENT,0.4978,0.039474,0.03732,0,0
4,GO PROTEIN LOCALIZATION TO CILIUM,0.37932,0.039461,0.062646,0,0
4,GO CELLULAR COMPONENT MAINTENANCE,0.50896,0.039259,0.040262,0,0
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.26471,0.038943,0.034943,0,0
4,GO HISTONE H3 K36 METHYLATION,0.33812,0.038932,0.056191,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.39371,0.038869,0.014953,0,0
4,GO PEPTIDYL LYSINE MODIFICATION,0.075049,0.0388,0.036074,0,0
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.76281,0.038712,-0.01314,0,0
4,GO STEM CELL PROLIFERATION,0.12259,0.038483,0.060065,0,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.5726,0.03844,0.021665,0,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.34702,0.038411,0.030241,0,0
4,GO FOREBRAIN DEVELOPMENT,0.21905,0.038323,0.04406,0,0
4,GO DENSE CORE GRANULE TRANSPORT,0.62113,0.03809,0.11532,0,0
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.51459,0.037855,0.045078,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.43883,0.037826,0.019097,0,0
4,GO REGULATION OF COLLATERAL SPROUTING,0.87833,0.03778,0.0095008,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.19695,0.037753,0.046858,0,0
4,GO DNA GEOMETRIC CHANGE,0.35607,0.037632,0.027486,0,0
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.87833,0.037591,-0.053262,0,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.76281,0.037111,-0.0035206,0,0
4,GO MICROTUBULE BASED TRANSPORT,0.15517,0.037067,0.046321,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.61497,0.036611,0.042618,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.28785,0.036195,0.094107,0,0
4,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.83713,0.03545,-0.016633,0,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.33373,0.035296,0.051674,0,0
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.87144,0.034953,-0.022589,0,0
4,GO RENAL WATER HOMEOSTASIS,0.4978,0.034951,0.045808,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.72969,0.034947,0.0082074,0,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.39371,0.03458,0.045837,0,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.4598,0.034428,0.054925,0,0
4,GO TONGUE MORPHOGENESIS,0.54321,0.034314,0.091431,0,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.58456,0.034214,0.043705,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.84397,0.034078,-0.030914,0,0
4,GO P BODY ASSEMBLY,0.12259,0.033973,0.053274,0,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.188,0.033915,0.050451,0,0
4,GO SOMITE DEVELOPMENT,0.54321,0.033805,-0.0036124,0,0
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.27227,0.033788,0.06273,0,0
4,GO MEIOTIC SPINDLE ORGANIZATION,0.36064,0.033639,0.038185,0,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.85082,0.033375,-0.044699,0,0
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.39371,0.033136,0.061506,0,0
4,GO ANTEROGRADE AXONAL TRANSPORT,0.4978,0.032968,0.034878,0,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.58456,0.032808,0.021797,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.063042,0.032664,0.064509,0,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.73628,0.032653,0.0079172,0,0
4,GO DNA REPLICATION,0.21905,0.032593,0.030371,0,0
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.79636,0.032428,-0.028524,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.75615,0.032214,0.04468,0,0
4,GO ASTROCYTE ACTIVATION,0.9686,0.032155,-0.006802,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.24643,0.031792,0.10839,0,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.33812,0.031762,0.031771,0,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.15773,0.031622,0.055633,0,0
4,GO CARDIAC ATRIUM DEVELOPMENT,0.63354,0.03157,0.037877,0,0
4,GO POSITIVE REGULATION OF RNA SPLICING,0.44924,0.031253,0.023444,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.1313,0.031077,0.054129,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.61497,0.030848,0.036828,0,0
4,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.90599,0.030788,0.019179,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.40843,0.03049,0.041746,0,0
4,GO HINDBRAIN DEVELOPMENT,0.42347,0.030444,0.047219,0,0
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.29184,0.030402,0.072861,0,0
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.87833,0.030205,-0.0049689,0,0
4,GO LEFT RIGHT PATTERN FORMATION,0.9686,0.030164,-0.0030908,0,0
4,GO NOTCH RECEPTOR PROCESSING,0.56666,0.029948,0.051514,0,0
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.4978,0.029932,0.02985,0,0
4,GO CHROMOSOME ORGANIZATION,0.085627,0.029845,0.028761,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.72969,0.029831,-0.052766,0,0
4,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.64605,0.029566,0.030348,0,0
4,GO MAINTENANCE OF CELL NUMBER,0.89215,0.029558,-0.013601,0,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.93377,0.029381,-0.019611,0,0
4,GO EPITHELIAL CELL MATURATION,0.52594,0.029378,0.060294,0,0
4,GO REGULATION OF ORGANIC ACID TRANSPORT,0.91987,0.029159,-0.032188,0,0
4,GO MITRAL VALVE DEVELOPMENT,0.81668,0.029128,-0.0078609,0,0
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.82348,0.029046,0.015105,0,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.24643,0.028685,0.029945,0,0
4,GO MITOTIC RECOMBINATION,0.44402,0.028667,0.046881,0,0
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.8303,0.028615,-0.0096393,0,0
4,GO MITOTIC NUCLEAR DIVISION,0.16032,0.028533,0.038895,0,0
4,GO DNA METHYLATION OR DEMETHYLATION,0.2839,0.028262,0.026985,0,0
4,GO VIRAL RNA GENOME REPLICATION,0.94769,0.027894,-0.024804,0,0
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.71006,0.027465,0.017493,0,0
4,GO TELENCEPHALON DEVELOPMENT,0.59059,0.027434,0.018037,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.56666,0.027173,0.017664,0,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.24288,0.026826,0.085769,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.78289,0.026578,-0.0022562,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.63354,0.026541,0.094415,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.43883,0.026523,0.034761,0,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.74288,0.026427,0.0087703,0,0
4,GO HISTONE H3 ACETYLATION,0.86455,0.026267,0.00095824,0,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.076492,0.026256,0.059971,0,0
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.63354,0.026081,-0.069661,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.77618,0.026034,-0.076743,0,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.74288,0.025745,0.014536,0,0
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.50896,0.025495,0.020377,0,0
4,GO COVALENT CHROMATIN MODIFICATION,0.11434,0.025276,0.034065,0,0
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.39371,0.024786,0.015566,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.83713,0.024746,0.025061,0,0
4,GO MICROTUBULE POLYMERIZATION,0.7495,0.024723,0.010887,0,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.76281,0.024219,0.0067021,0,0
4,GO T CELL LINEAGE COMMITMENT,0.48131,0.023941,0.037499,0,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.87144,0.023862,-0.016071,0,0
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.90599,0.023685,0.005349,0,0
4,GO REPRODUCTIVE BEHAVIOR,0.94073,0.023641,-0.0038903,0,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.33812,0.023621,0.13717,0,0
4,GO OOGENESIS,0.72969,0.023532,0.013584,0,0
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.22568,0.023465,0.017155,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.58456,0.02335,0.01652,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.53742,0.02328,0.038806,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.32077,0.023273,0.012222,0,0
4,GO SNRNA TRANSCRIPTION,0.56075,0.023199,0.010279,0,0
4,GO HIPPOCAMPUS DEVELOPMENT,0.66501,0.022858,0.019314,0,0
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.34702,0.02267,0.025347,0,0
4,GO REGULATION OF PROTEIN SUMOYLATION,0.98255,0.02255,0.0092974,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.83713,0.022496,0.015023,0,0
4,GO CYTOKINESIS,0.88523,0.022485,-0.0030814,0,0
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.69061,0.022431,0.024122,0,0
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.073629,0.022246,0.054508,0,0
4,GO AXONEME ASSEMBLY,0.31232,0.02158,0.0953,0,0
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.54321,0.021403,-0.060551,0,0
4,GO APPENDAGE MORPHOGENESIS,0.46512,0.02121,0.014839,0,0
4,GO MICROTUBULE ANCHORING,0.53742,0.021001,0.02199,0,0
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.56075,0.020995,0.025105,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.32077,0.020878,0.051786,0,0
4,GO REGULATION OF CYTOKINESIS,0.68418,0.020645,0.0017582,0,0
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.87144,0.02058,0.0021888,0,0
4,GO EXIT FROM MITOSIS,0.90599,0.020559,-0.00091868,0,0
4,GO SECRETORY GRANULE LOCALIZATION,0.93377,0.020559,0.012123,0,0
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.87833,0.020157,0.019055,0,0
4,GO REGULATION OF APPETITE,0.88523,0.020126,-0.007166,0,0
4,GO RNA SPLICING,0.188,0.019986,0.039157,0,0
4,GO LEFT RIGHT AXIS SPECIFICATION,0.99651,0.019762,-0.024541,0,0
4,GO MYELOID CELL DEVELOPMENT,0.48678,0.019718,0.02666,0,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.85082,0.019704,-0.016344,0,0
4,GO NEURON PROJECTION REGENERATION,0.56075,0.019567,-0.040381,0,0
4,GO EMBRYONIC AXIS SPECIFICATION,0.87144,0.019068,-0.018263,0,0
4,GO EATING BEHAVIOR,0.64605,0.019038,-0.023014,0,0
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.4598,0.018964,0.019345,0,0
4,GO MULTICELLULAR ORGANISM AGING,0.92682,0.018723,-0.011035,0,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.95466,0.018671,-0.016507,0,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.93377,0.018542,0.0054639,0,0
4,GO MEMBRANE DOCKING,0.63354,0.018388,0.013225,0,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.77618,0.018383,0.052532,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS,0.76281,0.018342,0.044276,0,0
4,GO CELL DIVISION,0.32506,0.018259,0.018165,0,0
4,GO FAT CELL PROLIFERATION,0.5726,0.01821,0.047896,0,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.83713,0.018071,-0.017467,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.83713,0.018071,-0.0094457,0,0
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.32938,0.017981,0.011762,0,0
4,GO MRNA 3 END PROCESSING,0.37932,0.01789,0.027541,0,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.80312,0.017844,-0.035451,0,0
4,GO REGULATION OF TORC1 SIGNALING,0.78962,0.017717,-0.0092938,0,0
4,GO REGULATION OF FIBROBLAST MIGRATION,0.91293,0.017676,-0.033065,0,0
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.44402,0.017643,0.025598,0,0
4,GO TELOMERE CAPPING,0.36064,0.017522,0.028642,0,0
4,GO CIRCADIAN RHYTHM,0.63354,0.01752,-0.023046,0,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.87833,0.017437,0.0023692,0,0
4,GO AMMONIUM TRANSPORT,0.91987,0.01741,0.0066573,0,0
4,GO DNA RECOMBINATION,0.30815,0.017134,0.021687,0,0
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.68418,0.017069,0.019588,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.94769,0.01695,0.0044113,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.78962,0.016884,0.023298,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.65234,0.016843,0.010624,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.56666,0.016678,0.029921,0,0
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.78289,0.016434,0.031875,0,0
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.50896,0.016379,0.033562,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.87144,0.016372,0.014295,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.93377,0.016343,-0.0043734,0,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.87144,0.016215,-0.015744,0,0
4,GO MRNA METHYLATION,0.89907,0.016013,-0.012015,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.95466,0.015939,-0.05677,0,0
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.89215,0.015741,-0.02086,0,0
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.71006,0.015615,-0.04254,0,0
4,GO DNA REPAIR,0.32077,0.015607,0.016628,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.62732,0.015126,0.01249,0,0
4,GO REGULATION OF HISTONE MODIFICATION,0.65234,0.014848,0.0075595,0,0
4,GO DETECTION OF VISIBLE LIGHT,0.47588,0.014627,0.0088011,0,0
4,GO REGULATION OF MITOTIC CELL CYCLE,0.94769,0.014553,-0.0097801,0,0
4,GO NEURON PROJECTION GUIDANCE,0.77618,0.014531,0.010098,0,0
4,GO TRANSCYTOSIS,0.97557,0.014329,-0.018081,0,0
4,GO RESPONSE TO CATECHOLAMINE,0.4545,0.014117,-0.040464,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.63978,0.014101,0.0093213,0,0
4,GO MULTIVESICULAR BODY ORGANIZATION,0.87833,0.013855,0.0074459,0,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.8303,0.013422,0.0024509,0,0
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.36991,0.013332,0.02925,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.40349,0.013166,0.1475,0,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.66501,0.01301,-0.11176,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.78962,0.012976,-0.018702,0,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.54321,0.01294,-0.065525,0,0
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.55487,0.012758,0.018094,0,0
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.57857,0.012692,0.035341,0,0
4,GO MITOCHONDRION LOCALIZATION,0.96163,0.012644,0.0051247,0,0
4,GO REGULATION OF CELL FATE SPECIFICATION,0.71006,0.012568,0.02797,0,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.39371,0.012496,-0.11015,0,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.28785,0.012493,0.062091,0,0
4,GO AROMATIC AMINO ACID TRANSPORT,0.70355,0.012473,-0.088999,0,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.55487,0.012461,-0.077174,0,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.92682,0.012252,-0.0038062,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.77618,0.012137,0.0079598,0,0
4,GO MEIOTIC CELL CYCLE,0.71658,0.011915,0.0020562,0,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.94769,0.011885,-0.00024521,0,0
4,GO CYTIDINE TO URIDINE EDITING,0.65866,0.011816,-0.095746,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.76948,0.011808,-0.077984,0,0
4,GO NEURON RECOGNITION,0.4978,0.01178,0.057136,0,0
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.84397,0.011763,0.0098002,0,0
4,GO MALE GAMETE GENERATION,0.75615,0.011749,-0.012246,0,0
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.93377,0.011724,-0.028799,0,0
4,GO CGMP METABOLIC PROCESS,0.67776,0.011575,-0.05679,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.75615,0.011451,-0.015753,0,0
4,GO DETECTION OF ABIOTIC STIMULUS,0.87833,0.011151,0.0066471,0,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.80989,0.011014,0.018954,0,0
4,GO ORGANELLE LOCALIZATION,0.92682,0.011012,0.0026742,0,0
4,GO HISTONE H3 K9 DEMETHYLATION,0.65234,0.010992,0.040192,0,0
4,GO MITOTIC CELL CYCLE,0.94769,0.010778,-0.0086495,0,0
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.91987,0.010572,-0.015851,0,0
4,GO CRANIAL NERVE DEVELOPMENT,0.54903,0.010503,-0.053145,0,0
4,GO REGULATION OF CELL CYCLE PROCESS,0.80312,0.010439,-0.0016439,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.83713,0.01043,-0.0093513,0,0
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.51459,0.010411,0.046485,0,0
4,GO REGULATION OF DNA RECOMBINATION,0.73628,0.010039,0.00039866,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,1,0.010005,-0.028737,0,0
4,GO GAMETE GENERATION,0.91987,0.0098808,-0.0058828,0,0
4,GO CEREBRAL CORTEX CELL MIGRATION,0.94073,0.0097536,-0.0052428,0,0
4,GO REGULATORY T CELL DIFFERENTIATION,0.89215,0.0097463,-0.016191,0,0
4,GO BONE CELL DEVELOPMENT,0.89215,0.009479,-0.0024819,0,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.86455,0.009331,-0.011693,0,0
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.7495,0.0093201,0.014866,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.79636,0.0091192,0.0073289,0,0
4,GO DENDRITE DEVELOPMENT,0.85768,0.008916,0.019874,0,0
4,GO TELENCEPHALON GLIAL CELL MIGRATION,0.71006,0.008873,-0.049383,0,0
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.72313,0.0087283,0.0044171,0,0
4,GO DENDRITE MORPHOGENESIS,0.54903,0.0086192,0.053996,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.47049,0.0086095,-0.053283,0,0
4,GO NEUROBLAST PROLIFERATION,0.25001,0.0085335,0.064676,0,0
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.82348,0.0085114,-0.026044,0,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.82348,0.0084654,-0.0024449,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.84397,0.0084504,0.0033275,0,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.85082,0.008385,0.0062211,0,0
4,GO AXONAL TRANSPORT,0.3746,0.0082362,0.0594,0,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.78962,0.0081275,0.040964,0,0
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.80989,0.0081153,0.03641,0,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.83713,0.0079747,-0.014985,0,0
4,GO PROTEIN MANNOSYLATION,0.85768,0.0079463,-0.011846,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.46512,0.0079009,-0.055619,0,0
4,GO AXO DENDRITIC TRANSPORT,0.50337,0.0078359,0.048278,0,0
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.87833,0.0078345,-0.01643,0,0
4,GO AXIS SPECIFICATION,0.35607,0.0076718,-0.057749,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.88523,0.0075882,-0.008745,0,0
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.9686,0.0074672,-0.0097318,0,0
4,GO GENE SILENCING,0.59664,0.0074361,-0.01631,0,0
4,GO SPERMATID DIFFERENTIATION,0.8303,0.0074189,0.021229,0,0
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.32077,0.0073777,0.075297,0,0
4,GO PHOTOTRANSDUCTION,0.87833,0.0073716,-0.014248,0,0
4,GO GERM CELL DEVELOPMENT,0.63354,0.0072977,0.015769,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.72313,0.0072829,0.031206,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.90599,0.0071646,0.0019564,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.63354,0.0071605,-0.030515,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.94073,0.0070768,0.03548,0,0
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.57857,0.0070433,0.14632,0,0
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.55487,0.0069535,0.053251,0,0
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.82348,0.0069197,-0.0099626,0,0
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.92682,0.0067544,-0.0012302,0,0
4,GO REGULATION OF AXONOGENESIS,0.99651,0.0066747,-0.004646,0,0
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.90599,0.0065015,-0.011886,0,0
4,GO RESPONSE TO NITROSATIVE STRESS,0.58456,0.0065015,-0.12055,0,0
4,GO REGULATION OF NEURON DIFFERENTIATION,0.65234,0.0064745,-0.015051,0,0
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.69061,0.0063978,0.0084264,0,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.31653,0.0063623,-0.032262,0,0
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.96163,0.0063437,-0.0079888,0,0
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.91293,0.0061985,-0.013446,0,0
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.30815,0.0061658,0.043417,0,0
4,GO REGULATION OF GOLGI ORGANIZATION,0.93377,0.0059992,0.0072716,0,0
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.80312,0.0059327,-0.014248,0,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.83713,0.0059208,-0.01906,0,0
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.98953,0.0059129,-0.0080326,0,0
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.82348,0.0058918,-0.0023737,0,0
4,GO CELL CELL JUNCTION MAINTENANCE,0.59059,0.0058855,0.063789,0,0
4,GO RNA CAPPING,0.80989,0.005672,-0.014525,0,0
4,GO CELL CYCLE,0.75615,0.0056602,-0.011967,0,0
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.46512,0.0055854,0.039256,0,0
4,GO REGULATION OF BEHAVIOR,0.89907,0.0055798,-0.020481,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.94769,0.0055003,-0.0073037,0,0
4,GO MISMATCH REPAIR,0.85082,0.0054893,-0.016369,0,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.62113,0.0054628,-0.042585,0,0
4,GO EYE MORPHOGENESIS,0.67776,0.0054502,0.0077647,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.65234,0.0054382,0.025737,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.85082,0.0053016,-0.014568,0,0
4,GO DNA METHYLATION,0.87144,0.0052058,0.00020001,0,0
4,GO REGULATION OF CELL CYCLE ARREST,0.98953,0.0051429,-0.0015843,0,0
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.4545,0.0050901,0.040049,0,0
4,GO MRNA PROCESSING,0.25729,0.0049878,0.029489,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.94073,0.00498,-0.014085,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.36526,0.0049781,0.021998,0,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.4598,0.0049465,-0.064461,0,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.59059,0.0048575,0.012066,0,0
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.91293,0.0047964,-0.066452,0,0
4,GO HEAD DEVELOPMENT,0.82348,0.0047904,0.011145,0,0
4,GO PROTEIN SUMOYLATION,0.75615,0.0047598,0.010073,0,0
4,GO HYPOTHALAMUS DEVELOPMENT,0.67137,0.0047549,-0.03838,0,0
4,GO MALE SEX DIFFERENTIATION,0.28785,0.0046571,-0.0636,0,0
4,GO NUCLEAR BODY ORGANIZATION,0.94769,0.004624,0.0063097,0,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.8303,0.0045335,-0.016968,0,0
4,GO REGULATION OF CELL CYCLE,0.68418,0.0043848,-0.01729,0,0
4,GO LYMPHANGIOGENESIS,0.62113,0.0043268,-0.076131,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE,0.75615,0.0042366,-0.0089373,0,0
4,GO REGULATION OF DNA REPLICATION,0.87144,0.0041086,-0.00015208,0,0
4,GO FOREGUT MORPHOGENESIS,0.93377,0.0040717,-0.031383,0,0
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.53167,0.0040542,0.0030634,0,0
4,GO DETECTION OF LIGHT STIMULUS,0.87833,0.003878,-0.01339,0,0
4,GO POST EMBRYONIC DEVELOPMENT,0.99651,0.0037792,0.0090248,0,0
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.67137,0.0035951,0.024719,0,0
4,GO SYNAPTIC MEMBRANE ADHESION,0.99651,0.0035647,-0.0098306,0,0
4,GO DETERMINATION OF ADULT LIFESPAN,0.71006,0.0033718,-0.030912,0,0
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.98255,0.0033687,0.038628,0,0
4,GO REGULATION OF DNA BINDING,0.62732,0.0033538,0.015418,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.59059,0.0032315,-0.037822,0,0
4,GO CHROMOSOME SEPARATION,0.64605,0.0031706,0.019161,0,0
4,GO REGULATION OF GLIOGENESIS,0.44924,0.003094,0.024378,0,0
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.91987,0.0030704,0.0084708,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.42347,0.003059,0.021793,0,0
4,GO ORGANELLE FISSION,0.65234,0.0030165,0.0039315,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.76948,0.0030072,-1.02e-05,0,0
4,GO MRNA TRANSPORT,0.91987,0.0028803,-0.0082675,0,0
4,GO CELL CYCLE PHASE TRANSITION,0.97557,0.002768,-0.0087275,0,0
4,GO ROOF OF MOUTH DEVELOPMENT,0.69061,0.0025864,0.014516,0,0
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.94769,0.0025757,-0.0081924,0,0
4,GO AXONAL FASCICULATION,0.60272,0.0025505,-0.052373,0,0
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.34702,0.0025111,-0.085583,0,0
4,GO DNA CATABOLIC PROCESS,0.92682,0.0024619,0.0067583,0,0
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.83713,0.0024344,0.016325,0,0
4,GO LYMPHOCYTE COSTIMULATION,0.50896,0.0023991,-0.044871,0,0
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.94073,0.0023564,-0.009675,0,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.71658,0.0023303,-0.030426,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.49227,0.0021767,-0.032859,0,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.98255,0.0020064,0.004286,0,0
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.91293,0.0018025,-0.0094187,0,0
4,GO NEGATIVE T CELL SELECTION,0.67137,0.0016768,-0.061077,0,0
4,GO NODAL SIGNALING PATHWAY,0.66501,0.0016259,-0.0418,0,0
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.71006,0.0013691,-0.026211,0,0
4,GO SPERM MOTILITY,0.85768,0.0011182,0.0088936,0,0
4,GO SYNAPTIC VESICLE MATURATION,0.94769,0.0010208,0.042749,0,0
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.69061,0.0007687,0.048647,0,0
4,GO CELL PROJECTION ORGANIZATION,0.51459,0.00066289,-0.019732,0,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.52594,0.00055945,0.014653,0,0
4,GO NEURON MIGRATION,0.49227,0.0005227,0.078471,0,0
4,GO REGULATION OF CELL DIVISION,0.91987,0.00040656,-0.0090306,0,0
4,GO THYMUS DEVELOPMENT,0.4978,0.00038251,0.040669,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.70355,0.0003753,-0.0077082,0,0
4,GO RUFFLE ASSEMBLY,0.68418,0.00036327,-0.027279,0,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.64605,0.00026442,0.064247,0,0
4,GO POSITIVE REGULATION OF DNA BINDING,0.85082,0.00018966,0.0074765,0,0
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.72969,0.0001594,-0.01274,0,0
4,GO AXON DEVELOPMENT,0.82348,-0.00031519,-0.0045216,0,0
4,GO THYMIC T CELL SELECTION,0.78289,-0.00032982,0.011243,0,0
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.48678,-0.00045772,-0.026933,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.57857,-0.00046375,-0.027391,0,0
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.58456,-0.0005193,-0.094449,0,0
4,GO REGULATION OF CILIUM MOVEMENT,0.98953,-0.00053132,0.0093448,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.83713,-0.00055678,-0.013788,0,0
4,GO MITOTIC CYTOKINETIC PROCESS,0.62113,-0.00058832,0.03866,0,0
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.36991,-0.00058989,-0.17462,0,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.26471,-0.00062496,-0.099645,0,0
4,GO POSITIVE REGULATION OF CELL DIVISION,0.9686,-0.0009407,-0.015456,0,0
4,GO MITOTIC CYTOKINESIS,0.86455,-0.00099683,0.0012124,0,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.78289,-0.0010223,0.016077,0,0
4,GO RNA DECAPPING,0.48131,-0.0010231,-0.052323,0,0
4,GO MEMBRANE HYPERPOLARIZATION,0.62732,-0.0011084,-0.054562,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.65234,-0.0011681,0.023966,0,0
4,GO REGULATION OF CELL MATURATION,0.68418,-0.0013623,-0.021448,0,0
4,GO REGULATION OF MRNA POLYADENYLATION,0.72313,-0.0013866,-0.022767,0,0
4,GO RESPONSE TO COCAINE,0.90599,-0.0014056,0.023051,0,0
4,GO REGULATION OF DNA METABOLIC PROCESS,0.85768,-0.0014717,-0.00077648,0,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.75615,-0.0016958,-0.010934,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.97557,-0.0017279,0.010004,0,0
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.62113,-0.00221,-0.059323,0,0
4,GO MIDBODY ABSCISSION,0.65234,-0.0022293,0.059863,0,0
4,GO MALE MEIOSIS I,0.44924,-0.0023277,-0.090139,0,0
4,GO CELL CYCLE PROCESS,0.72969,-0.0025053,-0.016396,0,0
4,GO G2 DNA DAMAGE CHECKPOINT,0.77618,-0.0025613,0.014282,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.78962,-0.0028213,-0.017799,0,0
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.9686,-0.002976,0.0082954,0,0
4,GO INTRACELLULAR MRNA LOCALIZATION,0.79636,-0.0029797,-0.027289,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.88523,-0.0031439,0.018526,0,0
4,GO HISTONE H3 K14 ACETYLATION,0.83713,-0.0031469,0.014122,0,0
4,GO COCHLEA DEVELOPMENT,0.85082,-0.0031533,-0.00081642,0,0
4,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.39858,-0.0032213,0.071694,0,0
4,GO HISTONE DEUBIQUITINATION,0.82348,-0.0032314,-0.018693,0,0
4,GO PHAGOSOME ACIDIFICATION,0.62113,-0.0032446,-0.048948,0,0
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.68418,-0.003275,-0.080406,0,0
4,GO REGULATION OF NUCLEAR DIVISION,0.94073,-0.0033345,-0.0003552,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.91987,-0.0033467,0.076121,0,0
4,GO SECRETORY GRANULE ORGANIZATION,0.96163,-0.0036986,-0.0033995,0,0
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.49227,-0.0037041,-0.034825,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.99651,-0.0040559,-0.0009164,0,0
4,GO GRANULOCYTE DIFFERENTIATION,0.22905,-0.0044369,-0.096639,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.65234,-0.0044925,-0.055348,0,0
4,GO MOTILE CILIUM ASSEMBLY,0.94769,-0.0045878,0.027704,0,0
4,GO OXIDATIVE DEMETHYLATION,0.70355,-0.0047559,0.021471,0,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.97557,-0.0047889,-0.0077261,0,0
4,GO PHOTOPERIODISM,0.58456,-0.0048237,-0.031133,0,0
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.64605,-0.0048515,0.053041,0,0
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.64605,-0.004909,0.022532,0,0
4,GO RESPONSE TO UV,0.94073,-0.0049277,-0.0075452,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.87144,-0.0049369,-0.035783,0,0
4,GO ORGANELLE ASSEMBLY,0.36991,-0.0049886,-0.024121,0,0
4,GO DNA METABOLIC PROCESS,0.88523,-0.0050077,-0.0064635,0,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.49227,-0.005022,-0.026503,0,0
4,GO NCRNA TRANSCRIPTION,0.62113,-0.0050332,-0.017619,0,0
4,GO ENDOCARDIUM DEVELOPMENT,0.32077,-0.0054394,0.11988,0,0
4,GO VIRAL BUDDING,0.87833,-0.005456,0.024777,0,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.34702,-0.0054591,-0.054982,0,0
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.53742,-0.00562,-0.023053,0,0
4,GO SODIUM ION HOMEOSTASIS,0.76948,-0.0056541,0.017672,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.41341,-0.0056804,0.060953,0,0
4,GO RESPONSE TO AUDITORY STIMULUS,0.50896,-0.0057075,0.11672,0,0
4,GO SEXUAL REPRODUCTION,0.43367,-0.005766,-0.024808,0,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.98953,-0.0059026,-0.0088702,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.73628,-0.005925,0.01582,0,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.60272,-0.0059332,0.02468,0,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.7495,-0.0063069,-0.013326,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.67137,-0.0063165,0.015807,0,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1,-0.006481,0.0018544,0,0
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.36991,-0.0066255,-0.11352,0,0
4,GO PROTEIN DEPOLYMERIZATION,0.89907,-0.0066302,0.0068108,0,0
4,GO CARTILAGE MORPHOGENESIS,0.88523,-0.0066979,0.0072461,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.98255,-0.006706,-0.013257,0,0
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.59664,-0.006744,-0.086001,0,0
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.23589,-0.0067557,-0.11,0,0
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.78962,-0.0068222,-0.026716,0,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.72313,-0.0069424,0.019064,0,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.87833,-0.0069942,-0.0070553,0,0
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.62113,-0.0070114,-0.01321,0,0
4,GO SENSORY ORGAN MORPHOGENESIS,0.7495,-0.0072381,-0.021111,0,0
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.63978,-0.0073045,-0.013609,0,0
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.58456,-0.0073956,-0.053337,0,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.87144,-0.0074844,-0.01156,0,0
4,GO INNER DYNEIN ARM ASSEMBLY,0.8303,-0.0074931,0.052027,0,0
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.98255,-0.007513,0.0073879,0,0
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.52594,-0.0077865,-0.03534,0,0
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.52594,-0.0080026,-0.028027,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.70355,-0.0081655,-0.018209,0,0
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.76281,-0.0083506,-0.014184,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.46512,-0.0084042,-0.035538,0,0
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.82348,-0.0084273,-0.0057077,0,0
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.53742,-0.0084318,-0.023968,0,0
4,GO POTASSIUM ION HOMEOSTASIS,0.91293,-0.008539,-0.0073338,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.62732,-0.0085422,-0.024475,0,0
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.87144,-0.0085476,0.0062911,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.72969,-0.0085753,-0.012604,0,0
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.72969,-0.0085788,-0.012651,0,0
4,GO DETECTION OF MECHANICAL STIMULUS,0.92682,-0.0088652,0.019243,0,0
4,GO ACTIN CROSSLINK FORMATION,0.84397,-0.0090008,-0.032099,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.78962,-0.0090566,0.0098259,0,0
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.66501,-0.0091015,-0.026771,0,0
4,GO DNA MODIFICATION,0.73628,-0.0092481,-0.0085696,0,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.32506,-0.0093817,-0.030687,0,0
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.34702,-0.0093852,-0.043413,0,0
4,GO HISTONE H4 DEACETYLATION,0.75615,-0.0094035,-0.027157,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.32938,-0.0094165,-0.036566,0,0
4,GO NUCLEUS ORGANIZATION,0.49227,-0.0094517,-0.028573,0,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.91987,-0.0095142,-0.028927,0,0
4,GO RESPIRATORY SYSTEM PROCESS,0.80989,-0.0098352,0.030557,0,0
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.34256,-0.010029,-0.10456,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.84397,-0.010072,0.011492,0,0
4,GO BLASTOCYST GROWTH,0.69061,-0.010268,-0.038,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.96163,-0.010279,0.0019621,0,0
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.94769,-0.010422,-0.024597,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.50337,-0.010422,-0.063549,0,0
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.20937,-0.010672,-0.042902,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.63978,-0.010732,0.021784,0,0
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.96163,-0.010851,0.063085,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.39371,-0.010969,-0.042493,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.38408,-0.010994,-0.026743,0,0
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.71658,-0.011026,0.090219,0,0
4,GO RETINOIC ACID METABOLIC PROCESS,0.87833,-0.011027,-0.019261,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.70355,-0.011052,-0.056627,0,0
4,GO POSITIVE THYMIC T CELL SELECTION,0.80312,-0.01106,0.031706,0,0
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.52025,-0.01111,0.023565,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.76281,-0.011117,-0.032765,0,0
4,GO NEURON DIFFERENTIATION,0.81668,-0.011291,-0.00078607,0,0
4,GO DENDRITIC SPINE DEVELOPMENT,0.49227,-0.011337,-0.048452,0,0
4,GO TRACHEA MORPHOGENESIS,0.99651,-0.011517,0.0096802,0,0
4,GO RESPONSE TO L GLUTAMATE,0.60883,-0.011532,0.052888,0,0
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.41842,-0.011694,-0.035417,0,0
4,GO REGULATION OF CELL DEVELOPMENT,0.39371,-0.011921,-0.031349,0,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.82348,-0.01204,0.0026002,0,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.90599,-0.012046,-0.011521,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.78962,-0.012101,-0.090121,0,0
4,GO RESPONSE TO POTASSIUM ION,0.71658,-0.012139,0.063031,0,0
4,GO COLLATERAL SPROUTING,0.4978,-0.012153,-0.03951,0,0
4,GO SIALYLATION,0.99651,-0.012305,-0.00058933,0,0
4,GO CELL PART MORPHOGENESIS,0.95466,-0.012319,0.0027828,0,0
4,GO RNA EXPORT FROM NUCLEUS,0.89907,-0.012427,-0.00019646,0,0
4,GO BASE EXCISION REPAIR,0.55487,-0.012554,-0.047421,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.49227,-0.012603,-0.059548,0,0
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.68418,-0.012678,-0.013676,0,0
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.19095,-0.012701,-0.1188,0,0
4,GO REGULATION OF TELOMERE CAPPING,0.96163,-0.012736,-0.0079809,0,0
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.67137,-0.012794,-0.036364,0,0
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.90599,-0.012805,0.00050619,0,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.56075,-0.012842,-0.030753,0,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.67776,-0.012888,-0.038852,0,0
4,GO REGULATION OF GLUCOSE IMPORT,0.49227,-0.0131,-0.030387,0,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.91293,-0.013267,0.0083583,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.56666,-0.013311,-0.075936,0,0
4,GO ADULT BEHAVIOR,0.63978,-0.013333,0.0041417,0,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.69707,-0.01334,0.021294,0,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.57857,-0.013396,0.031847,0,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.79636,-0.013401,0.016425,0,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.48131,-0.013728,-0.021672,0,0
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.35607,-0.01387,-0.020822,0,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.4598,-0.013929,-0.086474,0,0
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.91987,-0.014067,0.0050525,0,0
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.67776,-0.014087,-0.033063,0,0
4,GO OOCYTE MATURATION,0.60272,-0.014106,-0.019466,0,0
4,GO STRIATUM DEVELOPMENT,0.59664,-0.014649,-0.049363,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.78962,-0.014655,-0.011047,0,0
4,GO SPERM CAPACITATION,0.76281,-0.014678,0.0099131,0,0
4,GO REGULATION OF HEAT GENERATION,0.93377,-0.014699,0.039656,0,0
4,GO REGULATION OF SENSORY PERCEPTION,0.29992,-0.014861,-0.078559,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.89907,-0.014922,-0.012802,0,0
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.72313,-0.014926,-0.026598,0,0
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.78962,-0.015025,-0.021846,0,0
4,GO REGULATION OF B CELL DIFFERENTIATION,0.96163,-0.015405,-0.0035366,0,0
4,GO FOREBRAIN CELL MIGRATION,0.54321,-0.015409,-0.028714,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.92682,-0.015425,-5.6713e-05,0,0
4,GO MITOCHONDRIAL FUSION,0.43367,-0.015479,-0.031725,0,0
4,GO NEURON DEVELOPMENT,0.62113,-0.015513,-0.015437,0,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.75615,-0.015603,-0.01354,0,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.65866,-0.015739,-0.025951,0,0
4,GO REGULATION OF RNA BINDING,0.48131,-0.015755,-0.059619,0,0
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.74288,-0.015791,0.0067482,0,0
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.67776,-0.015793,-0.029373,0,0
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.46512,-0.015921,-0.035853,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.58456,-0.016018,-0.009809,0,0
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.075049,-0.016037,-0.097921,0,0
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.54321,-0.016058,-0.039429,0,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.87833,-0.016195,-0.00054933,0,0
4,GO HISTONE H3 DEACETYLATION,0.62113,-0.016305,-0.021123,0,0
4,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.88523,-0.016438,-0.064639,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.44402,-0.016466,-0.025978,0,0
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.33373,-0.016471,-0.025832,0,0
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.40843,-0.016612,-0.053963,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.64605,-0.016832,-0.045941,0,0
4,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.89907,-0.016928,0.020861,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.71658,-0.017198,-0.02823,0,0
4,GO NEUROGENESIS,0.53742,-0.017213,-0.015437,0,0
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.94769,-0.017219,-0.018807,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.83713,-0.01725,-0.023995,0,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.52594,-0.017335,0.035174,0,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.67776,-0.017472,0.051952,0,0
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.47049,-0.017488,-0.043031,0,0
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.94073,-0.017531,-0.00033464,0,0
4,GO SKELETAL MUSCLE ADAPTATION,0.37932,-0.017549,-0.064831,0,0
4,GO VESICLE LOCALIZATION,0.16559,-0.017564,-0.042499,0,0
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.47588,-0.017651,-0.044278,0,0
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.80312,-0.017773,-0.058807,0,0
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.96163,-0.017777,-0.027189,0,0
4,GO EMBRYONIC EYE MORPHOGENESIS,0.75615,-0.01779,0.017206,0,0
4,GO REGULATION OF NEURON MIGRATION,0.98953,-0.017796,-0.0021014,0,0
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.3746,-0.017908,-0.040054,0,0
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.67776,-0.017912,-0.035745,0,0
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.26847,-0.017964,-0.028031,0,0
4,GO ACIDIC AMINO ACID TRANSPORT,0.60883,-0.017968,-0.013556,0,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.54903,-0.018027,-0.014896,0,0
4,GO STRESS GRANULE ASSEMBLY,0.50337,-0.018032,-0.046471,0,0
4,GO EAR DEVELOPMENT,0.47049,-0.018158,-0.040588,0,0
4,GO CYTOPLASM ORGANIZATION,0.90599,-0.018234,-0.014047,0,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.70355,-0.018285,-0.028676,0,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.51459,-0.018332,-0.045683,0,0
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.24643,-0.018547,-0.044115,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.59664,-0.01859,-0.021441,0,0
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.69707,-0.018689,0.11128,0,0
4,GO REGULATION OF ERAD PATHWAY,0.32938,-0.018819,-0.047364,0,0
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.36991,-0.018905,-0.0040163,0,0
4,GO POSITIVE REGULATION OF CELL GROWTH,0.34702,-0.01907,-0.037008,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.49227,-0.019212,-0.10498,0,0
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.98953,-0.019258,0.04107,0,0
4,GO SENSORY ORGAN DEVELOPMENT,0.51459,-0.019319,-0.028692,0,0
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.56075,-0.019336,-0.096295,0,0
4,GO SPECIFICATION OF SYMMETRY,0.65234,-0.01945,-0.0093361,0,0
4,GO WATER HOMEOSTASIS,0.63354,-0.01963,-0.030941,0,0
4,GO POSTREPLICATION REPAIR,0.50337,-0.019645,-0.021053,0,0
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.61497,-0.019728,-0.017662,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.15773,-0.020006,-0.037366,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.61497,-0.020033,-0.030321,0,0
4,GO REGULATION OF DENDRITE MORPHOGENESIS,1,-0.020081,0.0099551,0,0
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.61497,-0.020084,-0.019193,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.96163,-0.02019,-0.0003868,0,0
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.21579,-0.020204,-0.053249,0,0
4,GO REGULATION OF LIGASE ACTIVITY,0.68418,-0.020293,-0.046587,0,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.53742,-0.020414,-0.045788,0,0
4,GO CLATHRIN COAT ASSEMBLY,0.98953,-0.02044,-0.00044878,0,0
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.66501,-0.020519,-0.0098489,0,0
4,GO DECIDUALIZATION,0.95466,-0.020552,-0.020189,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.03245,-0.020577,-0.048183,0,0
4,GO REGULATION OF ODONTOGENESIS,0.40843,-0.020684,-0.094813,0,0
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.69061,-0.020814,-0.012733,0,0
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.22905,-0.021176,-0.081186,0,0
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.2839,-0.021231,-0.025824,0,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.23245,-0.021407,-0.091407,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.50896,-0.021441,-0.046708,0,0
4,GO AXON EXTENSION,0.48678,-0.021469,-0.038699,0,0
4,GO NEURON APOPTOTIC PROCESS,0.94073,-0.021541,0.000932,0,0
4,GO NUCLEAR EXPORT,0.2839,-0.021613,-0.04026,0,0
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.33373,-0.021639,-0.058388,0,0
4,GO RENAL ABSORPTION,0.33812,-0.021649,-0.1637,0,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.57857,-0.021727,-0.06041,0,0
4,GO RESPONSE TO LIGHT STIMULUS,0.29586,-0.021856,-0.02861,0,0
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.5726,-0.022021,-0.011331,0,0
4,GO MYOTUBE CELL DEVELOPMENT,0.71006,-0.022023,-0.030742,0,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.92682,-0.022058,0.006581,0,0
4,GO MULTICELLULAR ORGANISM GROWTH,0.44924,-0.022089,-0.024257,0,0
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.42347,-0.02219,-0.047053,0,0
4,GO MEMBRANE FISSION,0.55487,-0.022511,0.050398,0,0
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.94769,-0.022548,-0.011611,0,0
4,GO SNORNA 3 END PROCESSING,0.94769,-0.022588,0.020485,0,0
4,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.64605,-0.022592,-0.063819,0,0
4,GO REGULATION OF DNA METHYLATION,0.21256,-0.022647,-0.074188,0,0
4,GO PATTERN SPECIFICATION PROCESS,0.80989,-0.022824,-0.016689,0,0
4,GO CALCINEURIN MEDIATED SIGNALING,0.32938,-0.022829,-0.056669,0,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.91987,-0.022988,-0.0025941,0,0
4,GO HIPPO SIGNALING,0.47588,-0.023011,-0.10426,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.97557,-0.023044,0.0014746,0,0
4,GO DISTAL TUBULE DEVELOPMENT,0.88523,-0.023046,-0.057751,0,0
4,GO INNER EAR MORPHOGENESIS,0.51459,-0.023083,-0.040859,0,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.44924,-0.023086,-0.055717,0,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.4545,-0.023311,-0.029599,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.40349,-0.023523,-0.090629,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.188,-0.023527,-0.035439,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.65234,-0.02354,-0.029124,0,0
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.38888,-0.023699,-0.051227,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.97557,-0.023793,-0.026076,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.76281,-0.023844,-0.073982,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.40843,-0.023941,-0.063553,0,0
4,GO REGULATION OF MYELINATION,0.54321,-0.023982,-0.027684,0,0
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.91987,-0.02405,-0.031639,0,0
4,GO ORGANELLE INHERITANCE,0.23245,-0.024058,-0.054196,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.26098,-0.024338,-0.059581,0,0
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.64605,-0.024357,-0.02069,0,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.85768,-0.024381,-0.014983,0,0
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.48678,-0.024394,-0.027496,0,0
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.60272,-0.024401,-0.0062913,0,0
4,GO RESPONSE TO INSECTICIDE,0.71658,-0.024584,-0.010452,0,0
4,GO NEURAL TUBE DEVELOPMENT,0.63978,-0.024596,-0.035417,0,0
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.11039,-0.02463,-0.070952,0,0
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.66501,-0.02464,-0.022171,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.47049,-0.024689,-0.074888,0,0
4,GO LIMBIC SYSTEM DEVELOPMENT,0.71658,-0.024701,-0.018411,0,0
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.83713,-0.024716,-0.0039687,0,0
4,GO RESPONSE TO UV C,0.7495,-0.024758,-0.020306,0,0
4,GO ACTIVATION OF GTPASE ACTIVITY,0.15015,-0.024881,-0.065852,0,0
4,GO CHONDROCYTE DEVELOPMENT,0.62732,-0.025057,-0.066932,0,0
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.54903,-0.025074,-0.048477,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.37932,-0.025132,-0.034065,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.94769,-0.025344,0.002484,0,0
4,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.8303,-0.025489,-0.040424,0,0
4,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.29184,-0.025619,-0.15127,0,0
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.64605,-0.025652,-0.02778,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.82348,-0.025667,-0.010247,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.73628,-0.02574,0.0022786,0,0
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.4598,-0.025899,-0.030006,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.9686,-0.025933,-0.00020069,0,0
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.63978,-0.026003,-0.015638,0,0
4,GO NUCLEAR MIGRATION,0.96163,-0.026036,-0.016978,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.7495,-0.026214,-0.0018288,0,0
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.3746,-0.026273,-0.048622,0,0
4,GO REGULATION OF VASOCONSTRICTION,0.29586,-0.026627,-0.069011,0,0
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.26098,-0.026636,-0.064685,0,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.9686,-0.026653,-0.00054666,0,0
4,GO REGULATION OF TELOMERE MAINTENANCE,0.41842,-0.02668,-0.038054,0,0
4,GO POSITIVE REGULATION OF NEURON MIGRATION,0.37932,-0.026778,-0.099523,0,0
4,GO CELLULAR RESPONSE TO UV,0.78289,-0.026909,-0.013306,0,0
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.13583,-0.027122,-0.058444,0,0
4,GO APPENDAGE DEVELOPMENT,0.4978,-0.027356,-0.041534,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.36991,-0.027358,-0.055992,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.32938,-0.027493,-0.082043,0,0
4,GO FEMALE GAMETE GENERATION,0.30402,-0.027555,-0.035017,0,0
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.38888,-0.027572,-0.032758,0,0
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.62113,-0.02766,-0.011168,0,0
4,GO FOREBRAIN NEURON DEVELOPMENT,0.89215,-0.027736,0.042672,0,0
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.12473,-0.027915,-0.060493,0,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.88523,-0.027995,-0.034924,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.37932,-0.028179,-0.043175,0,0
4,GO CYTOKINETIC PROCESS,0.50337,-0.028182,-0.046472,0,0
4,GO VIRION ASSEMBLY,0.29184,-0.028213,-0.046622,0,0
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.52594,-0.028216,-0.035233,0,0
4,GO PROTEIN NEDDYLATION,0.35153,-0.028266,-0.063078,0,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.22235,-0.028399,-0.19494,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.58456,-0.028412,-0.037447,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.31653,-0.028429,-0.094404,0,0
4,GO RNA LOCALIZATION,0.188,-0.028475,-0.05538,0,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.84397,-0.028494,0.005286,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.27611,-0.028521,-0.043058,0,0
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.54321,-0.028843,-0.023804,0,0
4,GO HAIR CELL DIFFERENTIATION,0.66501,-0.028848,-0.041402,0,0
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.8303,-0.028981,-0.018902,0,0
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.43367,-0.029124,-0.02328,0,0
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.73628,-0.029125,-0.03447,0,0
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.83713,-0.029283,-0.035469,0,0
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.87833,-0.029358,-0.004585,0,0
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.30402,-0.029379,-0.038128,0,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.67137,-0.029427,-0.044301,0,0
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.39371,-0.029573,-0.040977,0,0
4,GO GAMMA DELTA T CELL ACTIVATION,0.41341,-0.029614,0.094106,0,0
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.54903,-0.029749,-0.032119,0,0
4,GO SYNAPTIC VESICLE PRIMING,0.82348,-0.029843,0.050368,0,0
4,GO DENDRITIC SPINE MORPHOGENESIS,0.83713,-0.030118,-0.01864,0,0
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.23589,-0.030177,-0.080471,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.17099,-0.030194,-0.055593,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.32506,-0.030208,-0.12386,0,0
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.59664,-0.030275,-0.021293,0,0
4,GO CAMERA TYPE EYE DEVELOPMENT,0.58456,-0.030286,-0.024159,0,0
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.39858,-0.030417,-0.039809,0,0
4,GO T CELL HOMEOSTASIS,0.66501,-0.030473,-0.017587,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.56666,-0.030474,-0.019353,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.36526,-0.030485,-0.036195,0,0
4,GO NATURAL KILLER CELL ACTIVATION,0.4545,-0.030521,-0.057893,0,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.53742,-0.03058,-0.057251,0,0
4,GO ACTIVATION OF MAPKK ACTIVITY,0.47049,-0.030671,-0.054477,0,0
4,GO ALDEHYDE CATABOLIC PROCESS,0.40349,-0.030704,-0.06615,0,0
4,GO SLEEP,0.30402,-0.030719,-0.064239,0,0
4,GO OUTER DYNEIN ARM ASSEMBLY,0.67776,-0.030883,-0.013176,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.46512,-0.031262,-0.065783,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.26847,-0.031315,-0.14634,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.19393,-0.03139,-0.090094,0,0
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.69707,-0.031509,-0.0014562,0,0
4,GO ERBB2 SIGNALING PATHWAY,0.4598,-0.031582,-0.057206,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.99651,-0.031598,-0.028396,0,0
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.12473,-0.031834,-0.15137,0,0
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.2,-0.031852,-0.028655,0,0
4,GO METHYLATION,0.075049,-0.031857,-0.038256,0,0
4,GO NUCLEAR TRANSPORT,0.057089,-0.031874,-0.056041,0,0
4,GO CYTOSKELETON ORGANIZATION,0.11235,-0.031974,-0.051339,0,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.78289,-0.03207,-0.028476,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.22568,-0.03235,-0.041864,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.4598,-0.032413,-0.047372,0,0
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.5726,-0.032419,-0.064915,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.60883,-0.032451,-0.02897,0,0
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.83713,-0.032561,0.045197,0,0
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.50337,-0.032579,-0.028579,0,0
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.025994,-0.032583,-0.07853,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.12689,-0.03264,-0.10686,0,0
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.33812,-0.032811,-0.061912,0,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.26471,-0.032874,-0.090214,0,0
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.94073,-0.032881,0.027105,0,0
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.17934,-0.032992,-0.038734,0,0
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.41842,-0.03316,-0.088096,0,0
4,GO SOMITOGENESIS,0.17374,-0.03321,-0.065127,0,0
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.48678,-0.033214,-0.10182,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.32077,-0.033275,-0.047488,0,0
4,GO REGULATION OF GENE SILENCING,0.054842,-0.033335,-0.079419,0,0
4,GO CILIUM MOVEMENT,0.94073,-0.033433,0.0042025,0,0
4,GO MRNA CLEAVAGE,0.33373,-0.033464,-0.033001,0,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.64605,-0.033651,-0.052783,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.51459,-0.03366,-0.068213,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.62113,-0.033685,-0.018181,0,0
4,GO MIDBRAIN DEVELOPMENT,0.4598,-0.03381,-0.0283,0,0
4,GO PH REDUCTION,0.66501,-0.033854,-0.024804,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.96163,-0.033859,-0.0043601,0,0
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.74288,-0.033865,-0.00018937,0,0
4,GO REGULATION OF OOGENESIS,0.96163,-0.033887,0.0090271,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.84397,-0.034029,-0.017234,0,0
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.81668,-0.034098,0.0036597,0,0
4,GO REGULATION OF PINOCYTOSIS,0.11841,-0.034153,-0.15149,0,0
4,GO SKIN EPIDERMIS DEVELOPMENT,0.30815,-0.034247,-0.086202,0,0
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.22905,-0.034325,-0.045488,0,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.26847,-0.034476,-0.041177,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.44924,-0.034499,-0.041251,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.18508,-0.034598,-0.048809,0,0
4,GO HEART FORMATION,0.85082,-0.034826,0.0133,0,0
4,GO SENSORY SYSTEM DEVELOPMENT,0.59664,-0.034831,-0.02187,0,0
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.11841,-0.03491,-0.14735,0,0
4,GO RESPONSE TO RADIATION,0.064293,-0.034911,-0.04346,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.43367,-0.034959,-0.054367,0,0
4,GO RNA POLYADENYLATION,0.16559,-0.035,-0.066466,0,0
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.91987,-0.035204,-0.010709,0,0
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.30815,-0.035224,-0.073926,0,0
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.50337,-0.035457,-0.062202,0,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.4545,-0.035483,-0.045164,0,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.90599,-0.035536,0.026218,0,0
4,GO PROTEIN O LINKED MANNOSYLATION,0.49227,-0.035747,-0.039299,0,0
4,GO DENDRITIC SPINE MAINTENANCE,0.32938,-0.035763,-0.072581,0,0
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.98255,-0.03589,-0.0089915,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.47049,-0.036479,-0.052976,0,0
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.36526,-0.036567,-0.066877,0,0
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.011904,-0.036594,-0.053649,0,0
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.43883,-0.036667,-0.034162,0,0
4,GO GOLGI LOCALIZATION,0.59059,-0.036695,-0.03598,0,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.85768,-0.03678,-0.0050046,0,0
4,GO PROTEIN AUTOUBIQUITINATION,0.13355,-0.03682,-0.044093,0,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.2839,-0.03682,-0.05943,0,0
4,GO MIDGUT DEVELOPMENT,0.44924,-0.036834,-0.086962,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.75615,-0.03685,-0.015082,0,0
4,GO COGNITION,0.60883,-0.03714,-0.020595,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.25001,-0.037214,-0.07971,0,0
4,GO TORC1 SIGNALING,0.3746,-0.037373,-0.049576,0,0
4,GO REGULATION OF CELL DIFFERENTIATION,0.025994,-0.037404,-0.068276,0,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.4545,-0.037586,-0.091898,0,0
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.41842,-0.03763,-0.079771,0,0
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.55487,-0.037695,0.070189,0,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.91293,-0.037851,-0.019954,0,0
4,GO WATER TRANSPORT,0.60272,-0.037861,-0.0021762,0,0
4,GO POLYAMINE METABOLIC PROCESS,0.93377,-0.037995,0.0068744,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.56666,-0.038049,-0.022887,0,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.47049,-0.038333,-0.031254,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.49227,-0.038419,-0.051591,0,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.94769,-0.038481,0.032888,0,0
4,GO ACTIN NUCLEATION,0.14285,-0.038486,-0.070029,0,0
4,GO SEROTONIN TRANSPORT,0.44924,-0.038506,-0.086441,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.7495,-0.038642,-0.046801,0,0
4,GO DEVELOPMENTAL CELL GROWTH,0.14048,-0.039008,-0.063177,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.25001,-0.039172,-0.10414,0,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.2,-0.039177,-0.050443,0,0
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.11636,-0.039192,-0.06072,0,0
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.33373,-0.039418,-0.10791,0,0
4,GO LIPID PHOSPHORYLATION,0.15773,-0.039483,-0.048741,0,0
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.74288,-0.039532,-0.076368,0,0
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.26847,-0.039569,-0.052568,0,0
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.34702,-0.039634,-0.068492,0,0
4,GO SYNAPTIC VESICLE DOCKING,0.65234,-0.039677,0.028161,0,0
4,GO EPITHELIAL CELL MORPHOGENESIS,0.76281,-0.039778,-0.023819,0,0
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.65234,-0.039821,-0.070667,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.32506,-0.039898,-0.080848,0,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.12049,-0.040013,-0.046515,0,0
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.78962,-0.040137,-0.017627,0,0
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.75615,-0.040321,-0.021469,0,0
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.24288,-0.040493,-0.04762,0,0
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.30402,-0.040527,-0.066228,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.53167,-0.040575,-0.074809,0,0
4,GO AORTA MORPHOGENESIS,0.71658,-0.040621,-0.036696,0,0
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.40843,-0.04074,-0.031125,0,0
4,GO HINDLIMB MORPHOGENESIS,0.67137,-0.040823,-0.035762,0,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.31232,-0.040875,-0.10484,0,0
4,GO NEURON PROJECTION ORGANIZATION,0.56666,-0.040919,-0.045429,0,0
4,GO PROTEIN POLYGLUTAMYLATION,0.87833,-0.040948,0.045197,0,0
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.34256,-0.040995,-0.045041,0,0
4,GO CELLULAR SENESCENCE,0.10845,-0.04108,-0.06011,0,0
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.96163,-0.041125,-0.004376,0,0
4,GO ADHERENS JUNCTION ORGANIZATION,0.26471,-0.041233,-0.056871,0,0
4,GO RESPONSE TO MUSCLE INACTIVITY,0.64605,-0.041278,-0.022397,0,0
4,GO EPITHELIAL CELL CELL ADHESION,0.99651,-0.041303,0.0081787,0,0
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.65866,-0.04144,-0.043321,0,0
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.42347,-0.041515,-0.039509,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.24288,-0.041575,-0.064104,0,0
4,GO TUMOR NECROSIS FACTOR SECRETION,0.40349,-0.041694,-0.045631,0,0
4,GO MEMORY,0.31653,-0.041726,-0.048813,0,0
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.50337,-0.041841,-0.048617,0,0
4,GO REGULATION OF MRNA 3 END PROCESSING,0.43883,-0.041886,-0.041057,0,0
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.39371,-0.041892,-0.086778,0,0
4,GO NEURON PROJECTION EXTENSION,0.44402,-0.041947,-0.037715,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.34702,-0.041981,-0.090693,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.22235,-0.042012,-0.050225,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.36064,-0.042114,-0.066731,0,0
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.40843,-0.042131,-0.057537,0,0
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.71006,-0.042242,-0.017274,0,0
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.4598,-0.042246,-0.053069,0,0
4,GO REGULATION OF CELLULAR PH,0.05824,-0.042585,-0.071334,0,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.86455,-0.042634,0.0036608,0,0
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.23245,-0.04269,-0.06072,0,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.53742,-0.042692,-0.047205,0,0
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.34256,-0.042722,-0.10334,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.47049,-0.042789,-0.038914,0,0
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.47588,-0.042874,-0.026986,0,0
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.81668,-0.042924,-0.021912,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.96163,-0.042926,-0.0098533,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.86455,-0.042956,-0.00099449,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.19095,-0.042994,-0.047495,0,0
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.2,-0.04301,-0.076253,0,0
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.23937,-0.043079,-0.057838,0,0
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.23245,-0.043145,-0.068789,0,0
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.65866,-0.04316,-0.052057,0,0
4,GO RESPONSE TO GLUCAGON,0.21905,-0.04323,-0.054922,0,0
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.36064,-0.043242,-0.025012,0,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.068167,-0.043395,-0.061258,0,0
4,GO POSTSYNAPSE ASSEMBLY,1,-0.043401,0.0067141,0,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.76281,-0.04343,0.032381,0,0
4,GO CELL MATURATION,0.2839,-0.043436,-0.038479,0,0
4,GO SYNAPSE MATURATION,0.48678,-0.043566,-0.081285,0,0
4,GO REGULATION OF ATPASE ACTIVITY,0.1313,-0.043664,-0.049311,0,0
4,GO ARTERY MORPHOGENESIS,0.32077,-0.043674,-0.071715,0,0
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.78962,-0.043799,-0.022507,0,0
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.31232,-0.043819,-0.050503,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.67776,-0.043869,-0.035887,0,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.054842,-0.043884,-0.058674,0,0
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.13583,-0.043964,-0.04176,0,0
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.18508,-0.043971,-0.056744,0,0
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.77618,-0.044099,0.0010504,0,0
4,GO EMBRYONIC BODY MORPHOGENESIS,0.58456,-0.044143,-0.040342,0,0
4,GO EPITHELIAL TUBE FORMATION,0.4598,-0.04415,-0.046391,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.34256,-0.044192,-0.046598,0,0
4,GO CAMP BIOSYNTHETIC PROCESS,0.9686,-0.044288,0.0090746,0,0
4,GO REGULATION OF EXOCYTOSIS,0.1313,-0.044297,-0.045769,0,0
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.27999,-0.044354,-0.047252,0,0
4,GO RESPONSE TO ANTIBIOTIC,0.24643,-0.044357,-0.059513,0,0
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.50337,-0.044401,-0.044143,0,0
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.20309,-0.044463,-0.077847,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.34256,-0.044541,-0.07758,0,0
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.11841,-0.04466,-0.041368,0,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.99651,-0.044776,0.0072348,0,0
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.090515,-0.045258,-0.070816,0,0
4,GO REGIONALIZATION,0.69061,-0.045354,-0.02416,0,0
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.46512,-0.045403,-0.031589,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.27227,-0.045435,-0.035897,0,0
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.87144,-0.045471,-0.022138,0,0
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.13814,-0.045824,-0.11302,0,0
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.55487,-0.045862,-0.044227,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.92682,-0.045862,-0.012181,0,0
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.86455,-0.045864,-0.026776,0,0
4,GO NUCLEUS LOCALIZATION,0.4545,-0.045964,-0.040361,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.38888,-0.045965,-0.033874,0,0
4,GO ENDODERMAL CELL FATE COMMITMENT,0.38888,-0.045978,-0.054761,0,0
4,GO PROTEIN POLYUBIQUITINATION,0.12689,-0.046034,-0.047254,0,0
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.69707,-0.046082,-0.043723,0,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.70355,-0.046181,-0.015578,0,0
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.26471,-0.04627,-0.067571,0,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.4598,-0.046392,-0.041419,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.47049,-0.046415,-0.03442,0,0
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.46512,-0.046424,-0.045751,0,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.47588,-0.046466,-0.10032,0,0
4,GO RESPONSE TO INTERLEUKIN 2,0.48678,-0.046663,-0.049162,0,0
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.61497,-0.046778,-0.072185,0,0
4,GO NEUROTRANSMITTER SECRETION,0.62113,-0.046888,0.019988,0,0
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.91987,-0.046917,0.012202,0,0
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.17099,-0.047172,-0.066,0,0
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.25729,-0.04718,-0.069986,0,0
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.25729,-0.047205,-0.057291,0,0
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.2,-0.047474,-0.048178,0,0
4,GO SEGMENTATION,0.15264,-0.047559,-0.073997,0,0
4,GO ASTROCYTE DIFFERENTIATION,0.18219,-0.04776,-0.090619,0,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.78962,-0.047977,-0.078824,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.29184,-0.04803,-0.043976,0,0
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.72313,-0.048085,-0.044655,0,0
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.15015,-0.048152,-0.066572,0,0
4,GO SEX DIFFERENTIATION,0.050569,-0.048194,-0.066494,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.12259,-0.048255,-0.057427,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.18219,-0.048438,-0.090677,0,0
4,GO REGULATION OF ACTIN NUCLEATION,0.20309,-0.048593,-0.083045,0,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.83713,-0.048668,-0.00046588,0,0
4,GO REGULATION OF CELL MORPHOGENESIS,0.21579,-0.048683,-0.052387,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.27999,-0.048725,-0.056696,0,0
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.21256,-0.048773,-0.090079,0,0
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.54903,-0.048823,-0.024763,0,0
4,GO EAR MORPHOGENESIS,0.30815,-0.048854,-0.054979,0,0
4,GO RNA DESTABILIZATION,0.43367,-0.04889,-0.045283,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.188,-0.048966,-0.13998,0,0
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.48678,-0.048966,-0.1312,0,0
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.76281,-0.049065,0.0068356,0,0
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.188,-0.049073,-0.063262,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.12689,-0.049184,-0.032504,0,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.65234,-0.049492,-0.0099635,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.47049,-0.049538,-0.018249,0,0
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.46512,-0.049539,-0.034811,0,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.55487,-0.049605,-0.054428,0,0
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.25363,-0.049617,-0.039121,0,0
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.30815,-0.049618,-0.10157,0,0
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.19095,-0.04982,-0.077582,0,0
4,GO PEPTIDYL THREONINE MODIFICATION,0.085627,-0.049849,-0.059363,0,0
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.12049,-0.050043,-0.087894,0,0
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.23937,-0.050404,-0.057182,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.15517,-0.050461,-0.08093,0,0
4,GO SULFATE TRANSPORT,0.059411,-0.050694,-0.12793,0,0
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.25729,-0.050915,-0.044691,0,0
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.50896,-0.051112,-0.07866,0,0
4,GO RHYTHMIC PROCESS,0.12908,-0.051241,-0.046337,0,0
4,GO ACTIVATED T CELL PROLIFERATION,0.49227,-0.051368,-0.042971,0,0
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.47049,-0.051382,-0.062742,0,0
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.35153,-0.051441,-0.0074058,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00353,-0.051592,-0.083622,0,0
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.96163,-0.051596,-0.0038349,0,0
4,GO RUFFLE ORGANIZATION,0.36526,-0.051657,-0.043556,0,0
4,GO SYNAPTIC SIGNALING,0.5726,-0.051686,-0.0057611,0,0
4,GO EPIDERMIS MORPHOGENESIS,0.8303,-0.051867,-0.02037,0,0
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.095625,-0.05233,-0.11272,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.188,-0.052348,-0.10874,0,0
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.43367,-0.052397,-0.060468,0,0
4,GO REGULATION OF HEART MORPHOGENESIS,0.67137,-0.05242,-0.066424,0,0
4,GO DEVELOPMENTAL INDUCTION,0.25001,-0.052488,-0.069863,0,0
4,GO NUCLEAR PORE ORGANIZATION,0.67776,-0.052539,-0.042328,0,0
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.057089,-0.052594,-0.070466,0,0
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.50896,-0.052647,-0.048025,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.34702,-0.052653,-0.07761,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.097379,-0.052687,-0.056012,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.29586,-0.052702,-0.05101,0,0
4,GO TRANSLESION SYNTHESIS,0.22235,-0.052704,-0.047589,0,0
4,GO STEM CELL DIFFERENTIATION,0.073629,-0.052753,-0.064369,0,0
4,GO B CELL DIFFERENTIATION,0.10654,-0.052924,-0.079355,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.65866,-0.053044,-0.030585,0,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.98953,-0.053206,0.0085939,0,0
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.25001,-0.053237,-0.058107,0,0
4,GO TISSUE HOMEOSTASIS,0.11841,-0.053367,-0.070793,0,0
4,GO SYNAPSE ASSEMBLY,0.35607,-0.053495,-0.024382,0,0
4,GO POSITIVE REGULATION OF GROWTH,0.075049,-0.053539,-0.05958,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.11841,-0.053562,-0.052033,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.10654,-0.053763,-0.096012,0,0
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.50896,-0.053859,-0.060394,0,0
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.54321,-0.053897,-0.012262,0,0
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.23937,-0.053947,-0.058536,0,0
4,GO GLUTAMATE SECRETION,0.98953,-0.053979,0.022731,0,0
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.076492,-0.053986,-0.068236,0,0
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.14526,-0.053989,-0.094132,0,0
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.24643,-0.054331,-0.092043,0,0
4,GO INOSITOL METABOLIC PROCESS,0.89215,-0.054385,-0.0096999,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.15517,-0.054542,-0.10264,0,0
4,GO GPI ANCHOR METABOLIC PROCESS,0.054842,-0.054554,-0.1151,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.26098,-0.054804,-0.062726,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0022332,-0.054888,-0.080003,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.26098,-0.054988,-0.083239,0,0
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.31653,-0.055194,-0.072879,0,0
4,GO SYNAPTIC VESICLE RECYCLING,0.44924,-0.055229,-0.029147,0,0
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.099158,-0.055283,-0.079563,0,0
4,GO NEURAL TUBE FORMATION,0.40349,-0.055339,-0.04637,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.29184,-0.055477,-0.049139,0,0
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.11636,-0.055575,-0.05498,0,0
4,GO REGULATION OF MRNA BINDING,0.11636,-0.055614,-0.13832,0,0
4,GO MAST CELL MIGRATION,0.93377,-0.055622,0.034715,0,0
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.98255,-0.055813,0.0062899,0,0
4,GO EMBRYONIC PATTERN SPECIFICATION,0.24643,-0.055923,-0.062374,0,0
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.061812,-0.056027,-0.13628,0,0
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.13355,-0.056033,-0.097594,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.53167,-0.056059,-0.011447,0,0
4,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.26471,-0.056118,-0.1287,0,0
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.78962,-0.056153,0.0021926,0,0
4,GO PROTEIN DESTABILIZATION,0.16294,-0.056168,-0.056677,0,0
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.56075,-0.056183,-0.028408,0,0
4,GO PROTEIN POLYMERIZATION,0.03245,-0.056189,-0.067188,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.18219,-0.056255,-0.053317,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.22905,-0.056289,-0.10425,0,0
4,GO REGULATION OF GLIAL CELL MIGRATION,0.66501,-0.056358,-0.028155,0,0
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.40349,-0.056362,-0.054552,0,0
4,GO ADULT FEEDING BEHAVIOR,0.72969,-0.05637,-0.041534,0,0
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.11841,-0.056443,-0.058808,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.24288,-0.056515,-0.14193,0,0
4,GO REGULATION OF GTP BINDING,0.12049,-0.056546,-0.1431,0,0
4,GO CELL MORPHOGENESIS,0.22235,-0.056556,-0.044183,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.47588,-0.056658,-0.048332,0,0
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.79636,-0.056669,-0.0080807,0,0
4,GO POSITIVE REGULATION OF NEURON DEATH,0.23245,-0.056729,-0.045671,0,0
4,GO PARTURITION,0.88523,-0.056762,-0.014596,0,0
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.13583,-0.056893,-0.083764,0,0
4,GO PIGMENT GRANULE LOCALIZATION,0.50337,-0.05692,-0.036515,0,0
4,GO NEGATIVE REGULATION OF CELL SIZE,0.053746,-0.056924,-0.13512,0,0
4,GO LEARNING,0.53742,-0.056928,-0.026709,0,0
4,GO KERATINIZATION,0.66501,-0.056947,-0.012858,0,0
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.21579,-0.05705,-0.0974,0,0
4,GO CONVERGENT EXTENSION,0.49227,-0.057086,-0.047996,0,0
4,GO REGULATION OF PLATELET AGGREGATION,0.28785,-0.05713,-0.13651,0,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.30815,-0.057182,-0.12978,0,0
4,GO BARBED END ACTIN FILAMENT CAPPING,0.47588,-0.057293,-0.088617,0,0
4,GO HISTONE DEACETYLATION,0.099158,-0.057352,-0.056757,0,0
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.063042,-0.05738,-0.090778,0,0
4,GO CELL VOLUME HOMEOSTASIS,0.10845,-0.057435,-0.069996,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.35607,-0.057508,-0.07286,0,0
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.27999,-0.057575,-0.10998,0,0
4,GO REGULATION OF MITOPHAGY,0.43883,-0.057596,-0.031619,0,0
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.085627,-0.057608,-0.056914,0,0
4,GO PROTEIN PALMITOYLATION,0.36064,-0.057637,-0.03433,0,0
4,GO CELL CELL SIGNALING,0.072231,-0.057666,-0.056197,0,0
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.71006,-0.057737,-0.024079,0,0
4,GO MAST CELL MEDIATED IMMUNITY,0.34256,-0.057811,-0.053719,0,0
4,GO HEAT GENERATION,0.52594,-0.057849,-0.021745,0,0
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.11841,-0.057852,-0.10418,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.36526,-0.058001,-0.08289,0,0
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.1313,-0.058053,-0.14685,0,0
4,GO LACTATE METABOLIC PROCESS,0.84397,-0.058058,0.0041546,0,0
4,GO COCHLEA MORPHOGENESIS,0.19695,-0.058081,-0.12211,0,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.43367,-0.058112,-0.16084,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.34256,-0.058116,-0.086702,0,0
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.060602,-0.058237,-0.15681,0,0
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.37932,-0.058256,-0.05583,0,0
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.22568,-0.058319,-0.081675,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.015203,-0.058439,-0.089085,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.22905,-0.058477,-0.067514,0,0
4,GO EMBRYO DEVELOPMENT,0.073629,-0.058648,-0.061441,0,0
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.20937,-0.058716,-0.081596,0,0
4,GO RNA STABILIZATION,0.2839,-0.058718,-0.056732,0,0
4,GO RNA 3 END PROCESSING,0.62113,-0.05879,-0.027774,0,0
4,GO CELLULAR RESPONSE TO ALKALOID,0.17653,-0.058895,-0.061588,0,0
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.72313,-0.058913,-0.011137,0,0
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.56075,-0.058958,-0.019098,0,0
4,GO GMP METABOLIC PROCESS,0.68418,-0.059028,-0.026105,0,0
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.62732,-0.059154,-0.032855,0,0
4,GO RESPONSE TO VITAMIN D,0.33373,-0.059198,-0.11055,0,0
4,GO RESPONSE TO BMP,0.084046,-0.05948,-0.089377,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.05824,-0.059484,-0.10398,0,0
4,GO RESPONSE TO INTERLEUKIN 6,0.28785,-0.059723,-0.068455,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.88523,-0.059755,-0.043149,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.22568,-0.059811,-0.17971,0,0
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.16032,-0.059916,-0.079804,0,0
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.55487,-0.059977,-0.039772,0,0
4,GO POSITIVE REGULATION OF MITOPHAGY,0.59664,-0.060085,-0.033184,0,0
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.38888,-0.060115,-0.044966,0,0
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.32506,-0.060195,-0.042856,0,0
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.13814,-0.060202,-0.073213,0,0
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.075049,-0.060233,-0.061351,0,0
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.21905,-0.060246,-0.096716,0,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.34256,-0.060255,-0.052837,0,0
4,GO MIRNA METABOLIC PROCESS,0.038561,-0.060289,-0.087474,0,0
4,GO BRONCHUS DEVELOPMENT,0.91987,-0.060328,-0.030518,0,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.42347,-0.060547,-0.056207,0,0
4,GO COPII COATED VESICLE CARGO LOADING,0.079444,-0.060629,-0.10708,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.53742,-0.060726,-0.067203,0,0
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.11039,-0.060727,-0.04866,0,0
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.097379,-0.060787,-0.06036,0,0
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.32506,-0.06099,-0.069407,0,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.78289,-0.061215,-0.092126,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.48678,-0.061419,-0.057078,0,0
4,GO BEHAVIOR,0.23937,-0.061614,-0.046544,0,0
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.11235,-0.061674,-0.054058,0,0
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.35607,-0.061756,-0.083865,0,0
4,GO CELL CELL SIGNALING BY WNT,0.065563,-0.061777,-0.06655,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.088862,-0.061861,-0.13824,0,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.74288,-0.062007,-0.044889,0,0
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.13355,-0.062013,-0.099251,0,0
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.11235,-0.062053,-0.09598,0,0
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.63354,-0.062147,-0.041175,0,0
4,GO VASCULAR WOUND HEALING,0.14526,-0.06218,-0.13268,0,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.80312,-0.062202,-0.018133,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.12908,-0.062319,-0.10092,0,0
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.18219,-0.062447,-0.062226,0,0
4,GO PHOSPHOLIPID HOMEOSTASIS,0.36526,-0.06246,-0.092008,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.62732,-0.062499,-0.0432,0,0
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.44924,-0.06254,-0.044916,0,0
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.072231,-0.0626,-0.066914,0,0
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.066855,-0.062612,-0.080741,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.13583,-0.062632,-0.06534,0,0
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.60272,-0.062647,-0.051626,0,0
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.35607,-0.062652,-0.056882,0,0
4,GO DENDRITE EXTENSION,0.87144,-0.062741,0.0832,0,0
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.26471,-0.06275,-0.040187,0,0
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.23937,-0.06286,-0.065579,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.15264,-0.062938,-0.064865,0,0
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.004408,-0.06305,-0.080592,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.22905,-0.063135,-0.098781,0,0
4,GO REGULATION OF RESPIRATORY BURST,0.29184,-0.06319,-0.10573,0,0
4,GO CELL GROWTH,0.004408,-0.063301,-0.096564,0,0
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.56075,-0.063316,-0.082774,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.43883,-0.063419,-0.036216,0,0
4,GO WALKING BEHAVIOR,0.36526,-0.063532,-0.050439,0,0
4,GO RESPONSE TO LEAD ION,0.20621,-0.063604,-0.074672,0,0
4,GO INTERLEUKIN 10 PRODUCTION,0.11434,-0.063644,-0.093034,0,0
4,GO TELOMERE ORGANIZATION,0.088862,-0.063663,-0.058413,0,0
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.26847,-0.063691,-0.10887,0,0
4,GO TELOMERASE RNA LOCALIZATION,0.097379,-0.064076,-0.15077,0,0
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.087232,-0.064125,-0.081267,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0045306,-0.064137,-0.09383,0,0
4,GO DENTATE GYRUS DEVELOPMENT,0.44402,-0.064176,-0.078556,0,0
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.15015,-0.064241,-0.072209,0,0
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.14769,-0.064256,-0.080792,0,0
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.23245,-0.064277,-0.067587,0,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.050569,-0.064354,-0.097678,0,0
4,GO RECEPTOR CLUSTERING,0.44402,-0.064371,-0.047686,0,0
4,GO LIPID DROPLET ORGANIZATION,0.072231,-0.064449,-0.1151,0,0
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.20621,-0.064514,-0.064372,0,0
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.23937,-0.064545,-0.078688,0,0
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.42347,-0.064604,-0.066955,0,0
4,GO FIBROBLAST MIGRATION,0.28785,-0.064611,-0.058234,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.099158,-0.064667,-0.052652,0,0
4,GO POSITIVE REGULATION OF URINE VOLUME,0.097379,-0.064822,-0.11008,0,0
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.15773,-0.064933,-0.063858,0,0
4,GO PROSTATE GLAND GROWTH,0.39371,-0.06516,-0.11141,0,0
4,GO LONG TERM SYNAPTIC POTENTIATION,0.36991,-0.065189,-0.061232,0,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.17374,-0.065294,-0.088609,0,0
4,GO VISUAL BEHAVIOR,0.30402,-0.065304,-0.04336,0,0
4,GO TUBE FORMATION,0.30815,-0.06538,-0.055237,0,0
4,GO TRANSMISSION OF NERVE IMPULSE,0.16032,-0.065472,-0.086806,0,0
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.77618,-0.065526,-0.013445,0,0
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.88523,-0.065592,0.068462,0,0
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.093897,-0.065614,-0.11868,0,0
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.070855,-0.06564,-0.16334,0,0
4,GO SNORNA METABOLIC PROCESS,0.62113,-0.065773,-0.029418,0,0
4,GO MAGNESIUM ION TRANSPORT,0.55487,-0.065816,-0.025958,0,0
4,GO LOCALIZATION WITHIN MEMBRANE,0.3746,-0.065866,-0.044971,0,0
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.066855,-0.065933,-0.074268,0,0
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.12259,-0.066012,-0.057319,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.12259,-0.066055,-0.063741,0,0
4,GO ENDOSOMAL TRANSPORT,0.0695,-0.066107,-0.051152,0,0
4,GO EPIDERMIS DEVELOPMENT,0.2,-0.066134,-0.074239,0,0
4,GO ANIMAL ORGAN FORMATION,0.033166,-0.066142,-0.12365,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.23937,-0.06617,-0.064984,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.71006,-0.066264,-0.024722,0,0
4,GO PROSTATIC BUD FORMATION,0.26471,-0.0663,-0.19565,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.085627,-0.066422,-0.054413,0,0
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.037747,-0.066439,-0.091878,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.14048,-0.066517,-0.091065,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.7495,-0.066551,-0.017848,0,0
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.32938,-0.066568,-0.063056,0,0
4,GO DEVELOPMENTAL GROWTH,0.018836,-0.066691,-0.074644,0,0
4,GO REGULATION OF GASTRIC ACID SECRETION,0.38408,-0.06693,-0.10006,0,0
4,GO RESPONSE TO FUNGUS,0.17934,-0.066953,-0.05715,0,0
4,GO T CELL DIFFERENTIATION,0.14769,-0.067239,-0.074905,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION,0.066855,-0.067314,-0.088331,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.076492,-0.067411,-0.13286,0,0
4,GO POSTSYNAPSE ORGANIZATION,0.55487,-0.067422,-0.031083,0,0
4,GO CHLORIDE ION HOMEOSTASIS,0.27611,-0.067444,-0.074329,0,0
4,GO RENAL SYSTEM PROCESS,0.085627,-0.067457,-0.10078,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.2,-0.067503,-0.11369,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.2,-0.067547,-0.11519,0,0
4,GO ESTABLISHMENT OF CELL POLARITY,0.23589,-0.06756,-0.041332,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.14769,-0.067615,-0.088407,0,0
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.046579,-0.067693,-0.054318,0,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.78289,-0.067707,-0.04511,0,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,0.69707,-0.067724,-0.042114,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.39858,-0.067827,-0.088911,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.78289,-0.067898,-0.035875,0,0
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.34256,-0.067957,-0.06469,0,0
4,GO INTERFERON ALPHA PRODUCTION,0.25363,-0.068061,-0.089403,0,0
4,GO COBALAMIN METABOLIC PROCESS,0.16559,-0.068107,-0.1066,0,0
4,GO WHITE FAT CELL DIFFERENTIATION,0.088862,-0.068184,-0.11733,0,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.29184,-0.06822,-0.074715,0,0
4,GO PROGESTERONE METABOLIC PROCESS,0.27611,-0.068284,-0.21539,0,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.082489,-0.068437,-0.047585,0,0
4,GO NEURON DEATH,0.065563,-0.068626,-0.051803,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.070855,-0.068652,-0.091198,0,0
4,GO REGULATION OF NEUTROPHIL MIGRATION,0.13355,-0.068696,-0.10096,0,0
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.85768,-0.06879,-0.023621,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0056288,-0.06886,-0.070146,0,0
4,GO PIRNA METABOLIC PROCESS,0.14769,-0.068872,-0.13446,0,0
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.041093,-0.068899,-0.066361,0,0
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.2,-0.068942,-0.11427,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.073629,-0.06896,-0.085493,0,0
4,GO POSITIVE REGULATION OF CELL MATURATION,0.36991,-0.069024,-0.14277,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.44924,-0.069064,-0.087542,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.12259,-0.069124,-0.081461,0,0
4,GO ETHANOL CATABOLIC PROCESS,0.22905,-0.069284,-0.10277,0,0
4,GO REGULATION OF HAIR CYCLE,0.066855,-0.069345,-0.13282,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.26471,-0.069353,-0.053332,0,0
4,GO NEURONAL ACTION POTENTIAL,0.53742,-0.069369,-0.031737,0,0
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.019739,-0.069394,-0.0673,0,0
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.20621,-0.06964,-0.085356,0,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.076492,-0.069678,-0.064753,0,0
4,GO HEART VALVE FORMATION,0.43883,-0.069809,-0.1038,0,0
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.44402,-0.069824,-0.064319,0,0
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.088862,-0.069855,-0.080777,0,0
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.057089,-0.069914,-0.092284,0,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.16559,-0.069951,-0.10899,0,0
4,GO RESPONSE TO PROGESTERONE,0.12689,-0.070111,-0.1212,0,0
4,GO NERVOUS SYSTEM PROCESS,0.068167,-0.070223,-0.058337,0,0
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.17099,-0.070287,-0.10358,0,0
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.02268,-0.070324,-0.11816,0,0
4,GO SYNAPTIC VESICLE BUDDING,0.35607,-0.070402,-0.08083,0,0
4,GO REGULATION OF ANION TRANSPORT,0.11636,-0.07043,-0.077827,0,0
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.5726,-0.070524,0.011196,0,0
4,GO REGULATION OF ISOTYPE SWITCHING,0.63978,-0.070528,-0.077404,0,0
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.088862,-0.070582,-0.12488,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.095625,-0.070619,-0.098124,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.52594,-0.070643,-0.015173,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.053746,-0.070701,-0.072996,0,0
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.25729,-0.070733,-0.05774,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.014138,-0.070806,-0.14036,0,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.37932,-0.071234,-0.047338,0,0
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.075049,-0.071245,-0.09991,0,0
4,GO GLIAL CELL DIFFERENTIATION,0.14048,-0.071276,-0.07013,0,0
4,GO EPITHELIAL CELL DEVELOPMENT,0.079444,-0.071435,-0.10111,0,0
4,GO PRENYLATION,0.53167,-0.071491,-0.026542,0,0
4,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.22905,-0.071518,-0.15374,0,0
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.76948,-0.071745,0.00060392,0,0
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.14526,-0.071905,-0.091284,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.088862,-0.071927,-0.15317,0,0
4,GO RNA PROCESSING,0.061812,-0.071988,-0.066738,0,0
4,GO MRNA MODIFICATION,0.188,-0.072007,-0.084999,0,0
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.41842,-0.072009,-0.063605,0,0
4,GO FILOPODIUM ASSEMBLY,0.60883,-0.072012,-0.024965,0,0
4,GO HISTONE H2B UBIQUITINATION,0.54321,-0.072015,-0.030857,0,0
4,GO TAXIS,0.0053338,-0.072031,-0.1014,0,0
4,GO TRACHEA DEVELOPMENT,0.26471,-0.072148,-0.12148,0,0
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.21256,-0.072203,-0.03983,0,0
4,GO MATING,0.26471,-0.07221,-0.046854,0,0
4,GO MANNOSYLATION,0.14526,-0.07224,-0.082242,0,0
4,GO LYSOSOME LOCALIZATION,0.22905,-0.072288,-0.042614,0,0
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.17653,-0.072342,-0.05733,0,0
4,GO OOCYTE DIFFERENTIATION,0.095625,-0.072458,-0.079886,0,0
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.11841,-0.072527,-0.097342,0,0
4,GO DICARBOXYLIC ACID TRANSPORT,0.13814,-0.072714,-0.051729,0,0
4,GO SECONDARY PALATE DEVELOPMENT,0.22568,-0.07295,-0.092189,0,0
4,GO GLUCOSE IMPORT,0.079444,-0.073036,-0.064934,0,0
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.099158,-0.073158,-0.083714,0,0
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.43367,-0.073205,-0.033155,0,0
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.20309,-0.073222,-0.055015,0,0
4,GO MOLTING CYCLE,0.064293,-0.073255,-0.10128,0,0
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.053746,-0.07335,-0.053656,0,0
4,GO MITOCHONDRION DISTRIBUTION,0.51459,-0.073366,-0.017001,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.10654,-0.073548,-0.096558,0,0
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.0049174,-0.073597,-0.10681,0,0
4,GO SNRNA METABOLIC PROCESS,0.11235,-0.073613,-0.10792,0,0
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.12908,-0.073683,-0.16909,0,0
4,GO NEUTROPHIL CHEMOTAXIS,0.057089,-0.073742,-0.099701,0,0
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.31232,-0.073747,-0.069227,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.41842,-0.073893,-0.056198,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.14769,-0.073994,-0.12365,0,0
4,GO ENDOTHELIUM DEVELOPMENT,0.15015,-0.074111,-0.085047,0,0
4,GO RESPONSE TO AXON INJURY,0.0695,-0.074213,-0.098968,0,0
4,GO LYMPH VESSEL DEVELOPMENT,0.11841,-0.074337,-0.1306,0,0
4,GO RETINA HOMEOSTASIS,0.26471,-0.074346,-0.047645,0,0
4,GO REGULATION OF FEEDING BEHAVIOR,0.20937,-0.074497,-0.09165,0,0
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.24288,-0.074497,-0.12759,0,0
4,GO RESPONSE TO WATER,0.50337,-0.074536,-0.060221,0,0
4,GO THYROID HORMONE METABOLIC PROCESS,0.27611,-0.074731,-0.046417,0,0
4,GO REGULATION OF CYCLASE ACTIVITY,0.18219,-0.074795,-0.081585,0,0
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.96163,-0.074811,0.0088438,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.13814,-0.075062,-0.068328,0,0
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.62732,-0.075184,0.0051065,0,0
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.65866,-0.075225,-0.040408,0,0
4,GO MUSCLE TISSUE DEVELOPMENT,0.0067808,-0.075235,-0.093215,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.044685,-0.075373,-0.064102,0,0
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.14769,-0.075384,-0.065809,0,0
4,GO EXECUTION PHASE OF APOPTOSIS,0.079444,-0.075416,-0.057999,0,0
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.099158,-0.075519,-0.061324,0,0
4,GO REGULATION OF CELL PROJECTION SIZE,0.51459,-0.07553,-0.07562,0,0
4,GO DEPHOSPHORYLATION,0.0062634,-0.075574,-0.07545,0,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.052669,-0.07563,-0.099774,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.61497,-0.075696,-0.02896,0,0
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.76948,-0.075721,0.070289,0,0
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.12259,-0.075894,-0.055254,0,0
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.23245,-0.075935,-0.058675,0,0
4,GO SIGNAL RELEASE,0.11235,-0.076114,-0.046184,0,0
4,GO POSITIVE REGULATION OF ANION TRANSPORT,0.15015,-0.076186,-0.094993,0,0
4,GO DEVELOPMENTAL MATURATION,0.12049,-0.076248,-0.060915,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.009256,-0.076378,-0.068515,0,0
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.22568,-0.076399,-0.067904,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.20621,-0.076474,-0.074222,0,0
4,GO RESPONSE TO LEUCINE,0.44402,-0.076647,-0.036178,0,0
4,GO EPIDERMAL CELL DIFFERENTIATION,0.29184,-0.076685,-0.052562,0,0
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.012203,-0.076688,-0.082783,0,0
4,GO SARCOMERE ORGANIZATION,0.16294,-0.07696,-0.077308,0,0
4,GO MOTOR NEURON AXON GUIDANCE,0.25729,-0.077014,-0.061872,0,0
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.0075304,-0.077085,-0.1128,0,0
4,GO T CELL DIFFERENTIATION IN THYMUS,0.15264,-0.077366,-0.072876,0,0
4,GO RHYTHMIC BEHAVIOR,0.017549,-0.077448,-0.095549,0,0
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.29992,-0.077464,-0.053985,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.14048,-0.077526,-0.044101,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.35607,-0.077602,-0.074416,0,0
4,GO MAST CELL ACTIVATION,0.14285,-0.077717,-0.085114,0,0
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.082489,-0.077767,-0.10365,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.42347,-0.077817,-0.11472,0,0
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0075304,-0.078109,-0.09869,0,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.27999,-0.078288,-0.12518,0,0
4,GO REGULATION OF ICOSANOID SECRETION,0.54321,-0.078338,-0.039268,0,0
4,GO TUBULIN DEACETYLATION,0.40349,-0.078382,-0.043618,0,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.18219,-0.078422,-0.070217,0,0
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.12049,-0.078477,-0.124,0,0
4,GO MATING BEHAVIOR,0.29586,-0.078492,-0.06903,0,0
4,GO BILE ACID METABOLIC PROCESS,0.085627,-0.078531,-0.12566,0,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.10465,-0.078562,-0.083961,0,0
4,GO SENSORY PERCEPTION OF SMELL,0.0012662,-0.078635,-0.13201,0,0
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.36064,-0.078643,-0.0762,0,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.11235,-0.078665,-0.11179,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.046579,-0.078773,-0.09438,0,0
4,GO SENSORY PERCEPTION OF PAIN,0.11039,-0.078914,-0.059041,0,0
4,GO PORE COMPLEX ASSEMBLY,0.099158,-0.079008,-0.094877,0,0
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0033369,-0.07901,-0.11062,0,0
4,GO DEVELOPMENTAL PIGMENTATION,0.063042,-0.079047,-0.091749,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.75615,-0.079119,-0.028465,0,0
4,GO CELL CYCLE ARREST,0.009256,-0.079149,-0.07369,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.057089,-0.079333,-0.13809,0,0
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.011612,-0.079476,-0.10235,0,0
4,GO HORMONE TRANSPORT,0.11235,-0.079484,-0.066344,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0032441,-0.079631,-0.089468,0,0
4,GO RESPONSE TO GAMMA RADIATION,0.087232,-0.079755,-0.074921,0,0
4,GO AXIS ELONGATION,0.37932,-0.079865,-0.085301,0,0
4,GO REGULATION OF DEPHOSPHORYLATION,0.029719,-0.080087,-0.055529,0,0
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.32506,-0.080131,-0.091915,0,0
4,GO EPITHELIAL CELL FATE COMMITMENT,0.48131,-0.080187,-0.045896,0,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.13583,-0.080203,-0.10185,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.0046564,-0.080253,-0.093116,0,0
4,GO LIPID TRANSLOCATION,0.188,-0.08036,-0.096862,0,0
4,GO APICAL JUNCTION ASSEMBLY,0.23589,-0.080535,-0.06622,0,0
4,GO REGULATION OF HORMONE SECRETION,0.11841,-0.080541,-0.06523,0,0
4,GO REGULATION OF GASTRULATION,0.11636,-0.080965,-0.10363,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.077957,-0.08127,-0.10442,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.17099,-0.08127,-0.13012,0,0
4,GO REGULATION OF CELLULAR LOCALIZATION,0.0033369,-0.08129,-0.077878,0,0
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.29184,-0.08148,-0.080889,0,0
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0695,-0.081486,-0.11935,0,0
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.010245,-0.081603,-0.10382,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.088862,-0.081755,-0.075916,0,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.036164,-0.081965,-0.08509,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.13355,-0.082017,-0.069722,0,0
4,GO LYMPH NODE DEVELOPMENT,0.25729,-0.082081,-0.072853,0,0
4,GO PROTEIN DEPHOSPHORYLATION,0.011904,-0.082266,-0.068454,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.05824,-0.082297,-0.1063,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.11235,-0.082416,-0.13793,0,0
4,GO ATP BIOSYNTHETIC PROCESS,0.092194,-0.082466,-0.10907,0,0
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.085627,-0.08271,-0.10277,0,0
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.30402,-0.082744,-0.095909,0,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.17653,-0.082947,-0.13408,0,0
4,GO PROTEIN ADP RIBOSYLATION,0.26471,-0.082986,-0.046402,0,0
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.0047853,-0.083081,-0.1017,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.1313,-0.083135,-0.10201,0,0
4,GO GROWTH,0.0024367,-0.08319,-0.088937,0,0
4,GO PLACENTA DEVELOPMENT,0.15264,-0.083251,-0.084314,0,0
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.18508,-0.083367,-0.12167,0,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.60883,-0.083394,-0.058774,0,0
4,GO OLIGODENDROCYTE DEVELOPMENT,0.093897,-0.083399,-0.097174,0,0
4,GO NEUROTRANSMITTER METABOLIC PROCESS,0.32506,-0.083407,-0.079227,0,0
4,GO VESICLE DOCKING,0.031748,-0.083675,-0.098575,0,0
4,GO RESPONSE TO INACTIVITY,0.20621,-0.083808,-0.12422,0,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.38888,-0.08382,-0.023509,0,0
4,GO INTERLEUKIN 6 PRODUCTION,0.053746,-0.08395,-0.091103,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.37932,-0.084117,-0.16284,0,0
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0073363,-0.084226,-0.099213,0,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.063042,-0.084357,-0.12213,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.087232,-0.084394,-0.085411,0,0
4,GO NAD BIOSYNTHETIC PROCESS,0.188,-0.084428,-0.087193,0,0
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.12259,-0.084428,-0.079032,0,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.44924,-0.084448,-0.14135,0,0
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.15264,-0.084497,-0.065554,0,0
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.26471,-0.084545,-0.10056,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.28785,-0.084651,-0.061629,0,0
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.30402,-0.08466,-0.068604,0,0
4,GO TOXIN METABOLIC PROCESS,0.32938,-0.084681,-0.10198,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.055956,-0.084834,-0.10467,0,0
4,GO MUSCLE ORGAN DEVELOPMENT,0.0037331,-0.084976,-0.10113,0,0
4,GO ANIMAL ORGAN MORPHOGENESIS,0.0031536,-0.085048,-0.10778,0,0
4,GO SENSORY PERCEPTION,0.0038387,-0.085206,-0.086154,0,0
4,GO FIBROBLAST ACTIVATION,0.1313,-0.085244,-0.12294,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.21256,-0.085273,-0.11678,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION,0.1028,-0.085322,-0.075317,0,0
4,GO LOCOMOTORY BEHAVIOR,0.24288,-0.085329,-0.044488,0,0
4,GO SKIN DEVELOPMENT,0.13355,-0.085396,-0.094538,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.057089,-0.085457,-0.14778,0,0
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.087232,-0.085514,-0.1202,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.27227,-0.085727,-0.031535,0,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.32506,-0.085759,-0.059258,0,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.088862,-0.085923,-0.080665,0,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.73628,-0.086446,-0.017679,0,0
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.073629,-0.086775,-0.091463,0,0
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.079444,-0.086848,-0.10816,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.71006,-0.086983,0.0063601,0,0
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0099891,-0.087098,-0.16672,0,0
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.21579,-0.087145,-0.10346,0,0
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0036303,-0.087204,-0.10943,0,0
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.13583,-0.087209,-0.10033,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.26471,-0.087297,-0.039096,0,0
4,GO REGULATION OF CELL SIZE,0.041967,-0.08732,-0.073823,0,0
4,GO TRNA TRANSPORT,0.17374,-0.087452,-0.060032,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.12259,-0.087585,-0.10295,0,0
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.20309,-0.08759,-0.030504,0,0
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.42855,-0.087595,-0.042984,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.077957,-0.087609,-0.10847,0,0
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.018398,-0.087635,-0.063327,0,0
4,GO CELL CELL JUNCTION ASSEMBLY,0.085627,-0.087706,-0.094724,0,0
4,GO DEFENSE RESPONSE TO FUNGUS,0.045624,-0.087739,-0.10541,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.087232,-0.087782,-0.095676,0,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.097379,-0.088115,-0.13826,0,0
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.19695,-0.088157,-0.08638,0,0
4,GO MECHANORECEPTOR DIFFERENTIATION,0.11235,-0.088167,-0.10436,0,0
4,GO MYOBLAST DIFFERENTIATION,0.21579,-0.088311,-0.082045,0,0
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.087232,-0.088348,-0.065696,0,0
4,GO REGULATION OF GROWTH,0.0021062,-0.088551,-0.098072,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.27999,-0.088552,-0.1179,0,0
4,GO ADULT LOCOMOTORY BEHAVIOR,0.23937,-0.088585,-0.055662,0,0
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.71658,-0.088627,-0.013054,0,0
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.12049,-0.088701,-0.10327,0,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0695,-0.088766,-0.10294,0,0
4,GO PEPTIDYL SERINE MODIFICATION,0.013465,-0.088802,-0.06923,0,0
4,GO ANATOMICAL STRUCTURE MATURATION,0.097379,-0.088842,-0.062595,0,0
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.013139,-0.088866,-0.087023,0,0
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.14769,-0.089016,-0.11898,0,0
4,GO KIDNEY MORPHOGENESIS,0.28785,-0.089191,-0.055022,0,0
4,GO MUSCLE CELL MIGRATION,0.12473,-0.089421,-0.12077,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.16294,-0.089615,-0.15117,0,0
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.077957,-0.089619,-0.080856,0,0
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.11434,-0.089715,-0.12093,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.4978,-0.089906,-0.043225,0,0
4,GO CELL CELL JUNCTION ORGANIZATION,0.18508,-0.090072,-0.081494,0,0
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.16559,-0.090099,-0.090984,0,0
4,GO ASTROCYTE DEVELOPMENT,0.061812,-0.090536,-0.15093,0,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,0.17934,-0.090604,-0.16554,0,0
4,GO HEMOGLOBIN METABOLIC PROCESS,0.14769,-0.09072,-0.10958,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.19095,-0.09076,-0.071364,0,0
4,GO OTIC VESICLE MORPHOGENESIS,0.92682,-0.09083,0.0049816,0,0
4,GO BODY MORPHOGENESIS,0.060602,-0.090893,-0.10354,0,0
4,GO AMINE TRANSPORT,0.41341,-0.0909,-0.026144,0,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.11235,-0.090936,-0.14652,0,0
4,GO CATECHOLAMINE METABOLIC PROCESS,0.54321,-0.091317,-0.016345,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.092194,-0.091358,-0.075086,0,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.02268,-0.091363,-0.072567,0,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.17934,-0.091375,-0.091176,0,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.20621,-0.091425,-0.11069,0,0
4,GO HEART TRABECULA MORPHOGENESIS,0.02268,-0.091516,-0.1594,0,0
4,GO REGULATION OF PROTEIN DEACETYLATION,0.11039,-0.091738,-0.065727,0,0
4,GO MUSCLE CELL DIFFERENTIATION,0.0042883,-0.091824,-0.10799,0,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.061812,-0.092034,-0.12045,0,0
4,GO MITOPHAGY,0.061812,-0.092135,-0.084814,0,0
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.19095,-0.092159,-0.06878,0,0
4,GO NEUROTRANSMITTER TRANSPORT,0.2839,-0.092443,-0.021037,0,0
4,GO REPLICATIVE SENESCENCE,0.13583,-0.09248,-0.15073,0,0
4,GO TELOMERIC LOOP DISASSEMBLY,0.31232,-0.0925,-0.060696,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.053746,-0.092503,-0.077261,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.090515,-0.092516,-0.083124,0,0
4,GO LYMPH VESSEL MORPHOGENESIS,0.092194,-0.092587,-0.13807,0,0
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.060602,-0.092642,-0.13274,0,0
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.16294,-0.092739,-0.097719,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.12259,-0.092766,-0.07002,0,0
4,GO REGULATION OF AXON GUIDANCE,0.14285,-0.092875,-0.082952,0,0
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.17934,-0.092971,-0.11763,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0011549,-0.093062,-0.10208,0,0
4,GO VACUOLAR TRANSPORT,0.014138,-0.093091,-0.1008,0,0
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.21905,-0.093149,-0.076476,0,0
4,GO FACIAL NERVE MORPHOGENESIS,0.39858,-0.093199,-0.08345,0,0
4,GO GLIOGENESIS,0.05161,-0.093349,-0.084786,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.060602,-0.093367,-0.07316,0,0
4,GO PANCREATIC JUICE SECRETION,0.12049,-0.093464,-0.10544,0,0
4,GO QUINONE METABOLIC PROCESS,0.16828,-0.093576,-0.15052,0,0
4,GO ADULT HEART DEVELOPMENT,0.68418,-0.093579,-0.048496,0,0
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.23589,-0.093681,-0.057721,0,0
4,GO REGULATION OF WATER LOSS VIA SKIN,0.10654,-0.093752,-0.17403,0,0
4,GO REGULATION OF RESPONSE TO FOOD,0.21579,-0.093778,-0.071591,0,0
4,GO MAINTENANCE OF CELL POLARITY,0.32077,-0.093841,-0.06493,0,0
4,GO KETONE CATABOLIC PROCESS,0.15517,-0.093864,-0.16004,0,0
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0021062,-0.093883,-0.11218,0,0
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.024846,-0.093893,-0.09049,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.42855,-0.093926,-0.091262,0,0
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.50337,-0.093952,-0.1006,0,0
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.063042,-0.094039,-0.098267,0,0
4,GO RRNA 3 END PROCESSING,0.1313,-0.094041,-0.10604,0,0
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.10845,-0.094084,-0.12265,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.095625,-0.094153,-0.077077,0,0
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.22235,-0.094166,-0.10092,0,0
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.22568,-0.094363,-0.050308,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.14048,-0.094406,-0.11418,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.15264,-0.094542,-0.10903,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.16032,-0.094651,-0.081176,0,0
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.12473,-0.094883,-0.096918,0,0
4,GO GANGLIOSIDE METABOLIC PROCESS,0.21256,-0.094906,-0.095441,0,0
4,GO FEMALE SEX DIFFERENTIATION,0.042857,-0.095092,-0.090651,0,0
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.32077,-0.095127,-0.11385,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.41341,-0.095193,-0.064756,0,0
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.054842,-0.095272,-0.12808,0,0
4,GO EMBRYONIC MORPHOGENESIS,0.064293,-0.095275,-0.083875,0,0
4,GO REGULATION OF MACROAUTOPHAGY,0.00059588,-0.095319,-0.11292,0,0
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0046564,-0.095472,-0.084434,0,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0094949,-0.095863,-0.12058,0,0
4,GO TRABECULA MORPHOGENESIS,0.013139,-0.095915,-0.16338,0,0
4,GO DOPAMINE METABOLIC PROCESS,0.50337,-0.095936,-0.020085,0,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.11235,-0.095937,-0.099335,0,0
4,GO ACTIN FILAMENT BASED PROCESS,0.0019282,-0.09602,-0.11713,0,0
4,GO HEAD MORPHOGENESIS,0.099158,-0.096054,-0.094948,0,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.066855,-0.096062,-0.1855,0,0
4,GO LATERAL VENTRICLE DEVELOPMENT,0.38408,-0.096074,-0.070986,0,0
4,GO CRANIAL NERVE MORPHOGENESIS,0.16828,-0.096158,-0.14211,0,0
4,GO LUNG MORPHOGENESIS,0.17099,-0.096167,-0.1019,0,0
4,GO REGULATION OF HISTONE DEACETYLATION,0.25363,-0.096176,-0.067123,0,0
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.014486,-0.09637,-0.14523,0,0
4,GO REGULATION OF PROTEIN TARGETING,0.010773,-0.096407,-0.094467,0,0
4,GO RESPONSE TO AMINO ACID STARVATION,0.085627,-0.096506,-0.088922,0,0
4,GO STEROL BIOSYNTHETIC PROCESS,0.090515,-0.096513,-0.1053,0,0
4,GO PRESYNAPTIC ENDOCYTOSIS,0.35607,-0.096563,-0.039474,0,0
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.69061,-0.096655,-0.025312,0,0
4,GO BONE TRABECULA MORPHOGENESIS,0.12049,-0.096659,-0.21405,0,0
4,GO PRESYNAPSE ORGANIZATION,0.26847,-0.096757,-0.058544,0,0
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.061812,-0.096831,-0.12884,0,0
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.095625,-0.096975,-0.10974,0,0
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.16828,-0.097029,-0.12105,0,0
4,GO DEFINITIVE HEMOPOIESIS,0.29992,-0.097271,-0.082757,0,0
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.013139,-0.097288,-0.11301,0,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.19695,-0.097295,-0.11744,0,0
4,GO REGULATION OF MEMBRANE POTENTIAL,0.053746,-0.097393,-0.087266,0,0
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.10845,-0.097464,-0.13705,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.17653,-0.097799,-0.14404,0,0
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.014841,-0.097891,-0.14869,0,0
4,GO MACROMOLECULE DEACYLATION,0.0067808,-0.097898,-0.075726,0,0
4,GO CELLULAR RESPONSE TO VIRUS,0.05824,-0.097974,-0.10838,0,0
4,GO RESPONSE TO X RAY,0.18508,-0.098013,-0.11404,0,0
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.057089,-0.098081,-0.11902,0,0
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.0081404,-0.098119,-0.10093,0,0
4,GO REGULATION OF HEART GROWTH,0.066855,-0.098228,-0.09641,0,0
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.23245,-0.098241,-0.10083,0,0
4,GO SYNAPSE ORGANIZATION,0.16828,-0.09826,-0.060387,0,0
4,GO ADHERENS JUNCTION ASSEMBLY,0.21256,-0.098367,-0.074872,0,0
4,GO CELL RECOGNITION,0.0075304,-0.098494,-0.11844,0,0
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.35153,-0.098578,-0.075785,0,0
4,GO SKELETAL SYSTEM DEVELOPMENT,0.0031536,-0.098635,-0.11063,0,0
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.16559,-0.098709,-0.12698,0,0
4,GO CALCIUM MEDIATED SIGNALING,0.0049174,-0.098806,-0.09159,0,0
4,GO AUTOPHAGIC CELL DEATH,0.36991,-0.099068,-0.06185,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.12049,-0.099254,-0.10306,0,0
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.10654,-0.099526,-0.098781,0,0
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.065563,-0.099786,-0.17718,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.59664,-0.099788,-0.05134,0,0
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.17374,-0.099885,-0.10487,0,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.0038387,-0.099965,-0.12809,0,0
4,GO NEURON MATURATION,0.10096,-0.09997,-0.097341,0,0
4,GO PEPTIDE HORMONE SECRETION,0.14526,-0.10017,-0.057117,0,0
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.064293,-0.10021,-0.070253,0,0
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.018836,-0.10053,-0.11272,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.082489,-0.10054,-0.1202,0,0
4,GO GOLGI RIBBON FORMATION,0.075049,-0.10054,-0.10173,0,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.188,-0.10082,-0.12403,0,0
4,GO OVULATION CYCLE,0.05161,-0.10086,-0.10373,0,0
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.014841,-0.10105,-0.10409,0,0
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.69061,-0.10122,-0.023132,0,0
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.26471,-0.10129,-0.073624,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.042857,-0.10129,-0.1123,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.26471,-0.10156,-0.085659,0,0
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0038387,-0.1016,-0.12672,0,0
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.5726,-0.10163,-0.074867,0,0
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.41842,-0.10173,-0.052306,0,0
4,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.17934,-0.10175,-0.10944,0,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.19095,-0.10193,-0.091681,0,0
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.061812,-0.10212,-0.09398,0,0
4,GO RENAL SODIUM EXCRETION,0.21579,-0.10237,-0.074928,0,0
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.029068,-0.1024,-0.1648,0,0
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.18508,-0.10245,-0.11188,0,0
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.16032,-0.10252,-0.12612,0,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.15015,-0.10254,-0.10053,0,0
4,GO CELL AGGREGATION,0.26098,-0.10276,-0.076362,0,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.53167,-0.10277,-0.053389,0,0
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.088862,-0.10303,-0.049069,0,0
4,GO REGULATION OF FATTY ACID TRANSPORT,0.084046,-0.10311,-0.11114,0,0
4,GO NEPHRON MORPHOGENESIS,0.05824,-0.10311,-0.093867,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.040234,-0.10313,-0.1014,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.064293,-0.10328,-0.12391,0,0
4,GO REGULATION OF EXOSOMAL SECRETION,0.087232,-0.10331,-0.13783,0,0
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.072231,-0.10333,-0.11923,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0028957,-0.10333,-0.10688,0,0
4,GO CELL JUNCTION ASSEMBLY,0.013465,-0.10338,-0.10649,0,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.41341,-0.10345,-0.042669,0,0
4,GO KERATINOCYTE DIFFERENTIATION,0.18219,-0.10351,-0.077402,0,0
4,GO NUCLEOTIDE TRANSPORT,0.070855,-0.10405,-0.090671,0,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.0695,-0.10417,-0.10407,0,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.085627,-0.10419,-0.10966,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.15773,-0.10428,-0.082061,0,0
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.082489,-0.10433,-0.17708,0,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.27227,-0.10449,-0.085036,0,0
4,GO HETEROTYPIC CELL CELL ADHESION,0.12049,-0.10458,-0.102,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.018398,-0.10477,-0.20464,0,0
4,GO RNA SURVEILLANCE,0.46512,-0.10478,-0.029819,0,0
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.0085714,-0.10482,-0.13562,0,0
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.054842,-0.10494,-0.1335,0,0
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.99651,-0.10495,0.040723,0,0
4,GO REGULATION OF JUN KINASE ACTIVITY,0.031748,-0.10508,-0.099377,0,0
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00063551,-0.10512,-0.1139,0,0
4,GO ACTIVATION OF JNKK ACTIVITY,0.085627,-0.10514,-0.097111,0,0
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.51459,-0.10516,-0.071659,0,0
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0030654,-0.10577,-0.1162,0,0
4,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.15015,-0.10586,-0.10317,0,0
4,GO PURINE NUCLEOTIDE TRANSPORT,0.077957,-0.1059,-0.095844,0,0
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.16559,-0.10597,-0.089529,0,0
4,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.20309,-0.10606,-0.069646,0,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0049174,-0.10611,-0.10528,0,0
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.54903,-0.10635,-0.077295,0,0
4,GO IRON COORDINATION ENTITY TRANSPORT,0.19695,-0.10644,-0.088183,0,0
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.017137,-0.10647,-0.11529,0,0
4,GO CELL JUNCTION ORGANIZATION,0.013465,-0.10653,-0.10703,0,0
4,GO PRE MIRNA PROCESSING,0.10654,-0.10655,-0.11194,0,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.188,-0.10672,-0.096637,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.24288,-0.10679,-0.084404,0,0
4,GO REGULATION OF INTEGRIN ACTIVATION,0.26471,-0.10706,-0.11217,0,0
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.12689,-0.10717,-0.1237,0,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.25729,-0.10719,-0.14276,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.001986,-0.10726,-0.11735,0,0
4,GO MEMBRANE DISASSEMBLY,0.14285,-0.10752,-0.10216,0,0
4,GO EXOCYTIC PROCESS,0.17099,-0.10761,-0.047921,0,0
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.077957,-0.10761,-0.12978,0,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.2,-0.10763,-0.10609,0,0
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00055855,-0.10802,-0.10922,0,0
4,GO LIPOXYGENASE PATHWAY,0.11636,-0.10804,-0.18672,0,0
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.16828,-0.10822,-0.12803,0,0
4,GO TONIC SMOOTH MUSCLE CONTRACTION,0.11841,-0.10823,-0.15239,0,0
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.029719,-0.10837,-0.095928,0,0
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.021165,-0.10845,-0.098564,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.30402,-0.10847,-0.060851,0,0
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.91293,-0.1088,-0.032146,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.024846,-0.10883,-0.12573,0,0
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.22568,-0.10887,-0.14712,0,0
4,GO REGULATION OF DENDRITE EXTENSION,0.22568,-0.10892,-0.023841,0,0
4,GO NEGATIVE REGULATION OF GROWTH,0.00036427,-0.10896,-0.15165,0,0
4,GO N GLYCAN PROCESSING,0.29992,-0.10906,-0.081064,0,0
4,GO RESPONSE TO GROWTH FACTOR,0.0011199,-0.10908,-0.12231,0,0
4,GO RESPONSE TO IRON ION,0.02068,-0.10946,-0.12348,0,0
4,GO VIRAL GENOME REPLICATION,0.053746,-0.10948,-0.15829,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.44924,-0.10948,-0.05755,0,0
4,GO MESENCHYME MORPHOGENESIS,0.031059,-0.10969,-0.15759,0,0
4,GO MESENCHYMAL CELL PROLIFERATION,0.33812,-0.1098,-0.10461,0,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.41341,-0.10991,-0.054257,0,0
4,GO REGULATION OF EXCRETION,0.52025,-0.11002,-0.03636,0,0
4,GO FAT CELL DIFFERENTIATION,0.0046564,-0.11008,-0.13776,0,0
4,GO PROTEIN DENEDDYLATION,0.17099,-0.11014,-0.079057,0,0
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.34702,-0.11035,-0.047495,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.075049,-0.11074,-0.13388,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.17934,-0.11085,-0.10932,0,0
4,GO LYSINE METABOLIC PROCESS,0.19695,-0.11101,-0.15235,0,0
4,GO SHORT TERM MEMORY,0.43367,-0.11114,-0.096419,0,0
4,GO RESPONSE TO SALT STRESS,0.13814,-0.11119,-0.10416,0,0
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.15015,-0.11148,-0.073067,0,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.041093,-0.11148,-0.1082,0,0
4,GO NEUROINFLAMMATORY RESPONSE,0.015953,-0.11164,-0.14173,0,0
4,GO PROSTATE GLAND DEVELOPMENT,0.079444,-0.11172,-0.15898,0,0
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.064293,-0.11184,-0.11781,0,0
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.063042,-0.11196,-0.1126,0,0
4,GO DIVALENT METAL ION EXPORT,0.23589,-0.11204,-0.10197,0,0
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00063551,-0.11205,-0.12762,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.054842,-0.11212,-0.11238,0,0
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.072231,-0.11214,-0.10749,0,0
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.001191,-0.11232,-0.11559,0,0
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0024367,-0.11244,-0.12644,0,0
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.03245,-0.1125,-0.15255,0,0
4,GO PIGMENT CELL DIFFERENTIATION,0.061812,-0.11256,-0.10471,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.10096,-0.11263,-0.17258,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.099158,-0.11277,-0.11981,0,0
4,GO TOOTH MINERALIZATION,0.060602,-0.11281,-0.16338,0,0
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.2,-0.11287,-0.16634,0,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.066855,-0.11292,-0.10174,0,0
4,GO SEROTONIN METABOLIC PROCESS,0.4978,-0.11297,-0.060895,0,0
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.076492,-0.11319,-0.22347,0,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.092194,-0.1132,-0.11417,0,0
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.061812,-0.11321,-0.074577,0,0
4,GO NERVE DEVELOPMENT,0.12049,-0.11327,-0.10147,0,0
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.23589,-0.11354,-0.086655,0,0
4,GO NEURAL CREST CELL DIFFERENTIATION,0.045624,-0.11383,-0.12073,0,0
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.25729,-0.11385,-0.080559,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.17934,-0.11393,-0.12283,0,0
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.11039,-0.1141,-0.13203,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.20309,-0.11417,-0.082967,0,0
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.02843,-0.11442,-0.13533,0,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.14769,-0.11461,-0.076062,0,0
4,GO NCRNA 3 END PROCESSING,0.059411,-0.11467,-0.11985,0,0
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0046564,-0.11507,-0.15645,0,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.059411,-0.11507,-0.12487,0,0
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.064293,-0.11519,-0.1131,0,0
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.053746,-0.11526,-0.13753,0,0
4,GO CARDIOCYTE DIFFERENTIATION,0.009256,-0.11531,-0.12823,0,0
4,GO POSITIVE REGULATION OF CELL SIZE,0.1313,-0.11536,-0.12055,0,0
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.18508,-0.1154,-0.061358,0,0
4,GO OXALATE TRANSPORT,0.0069616,-0.11575,-0.20793,0,0
4,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.055956,-0.1158,-0.13794,0,0
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.025994,-0.11581,-0.11886,0,0
4,GO REGULATION OF GTPASE ACTIVITY,0.0015653,-0.11585,-0.1117,0,0
4,GO O GLYCAN PROCESSING,0.068167,-0.11617,-0.16153,0,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.35607,-0.11641,-0.088168,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.076492,-0.11643,-0.15991,0,0
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.031748,-0.11691,-0.11464,0,0
4,GO ENERGY HOMEOSTASIS,0.046579,-0.11697,-0.13255,0,0
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.085627,-0.11719,-0.14279,0,0
4,GO MITOCHONDRION ORGANIZATION,8.4205e-05,-0.11722,-0.11636,0,0
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.16559,-0.11764,-0.094397,0,0
4,GO NEGATIVE REGULATION OF SIGNALING,0.00041602,-0.11772,-0.10962,0,0
4,GO DETECTION OF CALCIUM ION,0.49227,-0.11819,-0.07254,0,0
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.16294,-0.11837,-0.087901,0,0
4,GO MUSCLE FIBER DEVELOPMENT,0.0053338,-0.11845,-0.12314,0,0
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.0016129,-0.11858,-0.1173,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00095906,-0.11878,-0.11087,0,0
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.099158,-0.11894,-0.11004,0,0
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.061812,-0.11894,-0.089647,0,0
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.085627,-0.11904,-0.10574,0,0
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0017123,-0.11919,-0.14659,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.14769,-0.11919,-0.08184,0,0
4,GO METANEPHROS MORPHOGENESIS,0.39371,-0.11928,-0.048198,0,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.10845,-0.11935,-0.082209,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.084046,-0.11976,-0.1006,0,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.18219,-0.12023,-0.16424,0,0
4,GO NOREPINEPHRINE TRANSPORT,0.33812,-0.12033,-0.060743,0,0
4,GO GLIAL CELL APOPTOTIC PROCESS,0.65866,-0.12053,-0.059472,0,0
4,GO PEPTIDYL ARGININE MODIFICATION,0.00098941,-0.12056,-0.14866,0,0
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.018836,-0.12106,-0.12264,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.088862,-0.12112,-0.18079,0,0
4,GO REGULATION OF GLOMERULAR FILTRATION,0.76948,-0.12121,-0.019791,0,0
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.007729,-0.12122,-0.11481,0,0
4,GO OVULATION CYCLE PROCESS,0.012203,-0.12125,-0.15028,0,0
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.084046,-0.12131,-0.16735,0,0
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.21256,-0.1214,-0.07904,0,0
4,GO SNRNA PROCESSING,0.080955,-0.1215,-0.14034,0,0
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0090226,-0.12163,-0.13903,0,0
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.095625,-0.12179,-0.13928,0,0
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.33373,-0.12182,-0.071941,0,0
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.11235,-0.12195,-0.171,0,0
4,GO ONE CARBON COMPOUND TRANSPORT,0.068167,-0.12195,-0.14462,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.27999,-0.12198,-0.17401,0,0
4,GO INTESTINAL LIPID ABSORPTION,0.092194,-0.12202,-0.18065,0,0
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.17374,-0.12231,-0.19307,0,0
4,GO HORMONE CATABOLIC PROCESS,0.65866,-0.12235,-0.013799,0,0
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0045306,-0.12238,-0.12295,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.11636,-0.12242,-0.10777,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00010845,-0.12278,-0.12183,0,0
4,GO REGULATION OF ION TRANSPORT,0.0017123,-0.12292,-0.13395,0,0
4,GO MITOCHONDRIAL FISSION,0.012508,-0.12298,-0.11706,0,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.068167,-0.12344,-0.20283,0,0
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.068167,-0.12414,-0.17433,0,0
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.11841,-0.12432,-0.11966,0,0
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0021062,-0.12442,-0.18491,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.11841,-0.12444,-0.10454,0,0
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00045924,-0.12458,-0.14207,0,0
4,GO CELLULAR ANION HOMEOSTASIS,0.36064,-0.12472,-0.064072,0,0
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.12049,-0.12473,-0.17297,0,0
4,GO ASSOCIATIVE LEARNING,0.05824,-0.12474,-0.094607,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.20621,-0.12481,-0.080245,0,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.99651,-0.12499,0.013404,0,0
4,GO RESPONSE TO NICOTINE,0.55487,-0.12518,-0.0089713,0,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.066855,-0.12528,-0.13039,0,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.073629,-0.12534,-0.17453,0,0
4,GO PHAGOLYSOSOME ASSEMBLY,0.061812,-0.12551,-0.18477,0,0
4,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.12049,-0.12567,-0.16264,0,0
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.053746,-0.12571,-0.12265,0,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.099158,-0.12583,-0.22747,0,0
4,GO ORGAN INDUCTION,0.0087944,-0.12596,-0.17214,0,0
4,GO ADIPOSE TISSUE DEVELOPMENT,0.099158,-0.12627,-0.080969,0,0
4,GO ENDOCRINE HORMONE SECRETION,0.020205,-0.12629,-0.13886,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.068167,-0.1264,-0.10255,0,0
4,GO HEART FIELD SPECIFICATION,0.84397,-0.12651,-0.0071764,0,0
4,GO CATION TRANSPORT,0.00042998,-0.12665,-0.12865,0,0
4,GO LEUKOCYTE AGGREGATION,0.21579,-0.12709,-0.16741,0,0
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.97557,-0.12711,0.026007,0,0
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.15264,-0.12712,-0.18432,0,0
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0097392,-0.12716,-0.15234,0,0
4,GO HEART MORPHOGENESIS,0.02068,-0.12716,-0.10706,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0075304,-0.12738,-0.13257,0,0
4,GO BONE MATURATION,0.065563,-0.12756,-0.11723,0,0
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.10465,-0.12764,-0.13044,0,0
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.17934,-0.12777,-0.082671,0,0
4,GO ENSHEATHMENT OF NEURONS,0.0025083,-0.12779,-0.12583,0,0
4,GO PROTEIN STABILIZATION,7.2754e-05,-0.12781,-0.13158,0,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.2839,-0.12785,-0.096276,0,0
4,GO ATP TRANSPORT,0.076492,-0.12799,-0.091203,0,0
4,GO RESPONSE TO NITRIC OXIDE,0.019739,-0.12799,-0.089475,0,0
4,GO LIPID DIGESTION,0.077957,-0.12807,-0.16999,0,0
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0081404,-0.12829,-0.16436,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.11636,-0.12846,-0.088351,0,0
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.5726,-0.12855,-0.027238,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.059411,-0.12856,-0.12651,0,0
4,GO NUCLEOSIDE SALVAGE,0.082489,-0.12881,-0.14087,0,0
4,GO PREPULSE INHIBITION,0.44924,-0.12897,-0.084568,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0015653,-0.12904,-0.13605,0,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0034322,-0.12907,-0.15961,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.0695,-0.12919,-0.18067,0,0
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.040234,-0.12922,-0.27848,0,0
4,GO NEURON CELLULAR HOMEOSTASIS,0.25363,-0.1293,-0.10891,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.099158,-0.12946,-0.15227,0,0
4,GO STEM CELL DIVISION,0.087232,-0.12954,-0.10794,0,0
4,GO REPLACEMENT OSSIFICATION,0.23589,-0.12986,-0.11712,0,0
4,GO KERATINOCYTE PROLIFERATION,0.12689,-0.12994,-0.12939,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.14048,-0.13015,-0.2009,0,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.31232,-0.13018,-0.11874,0,0
4,GO LYSOSOMAL TRANSPORT,0.0036303,-0.13028,-0.12752,0,0
4,GO MACROPHAGE DIFFERENTIATION,0.0047853,-0.13033,-0.17562,0,0
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0011549,-0.13034,-0.11938,0,0
4,GO RESPONSE TO VITAMIN,0.018836,-0.13044,-0.14869,0,0
4,GO INTESTINAL ABSORPTION,0.15773,-0.13048,-0.12665,0,0
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.043763,-0.13166,-0.18156,0,0
4,GO METAL ION TRANSPORT,0.00014935,-0.13186,-0.13648,0,0
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.16032,-0.13197,-0.091184,0,0
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,7.547e-05,-0.13232,-0.10254,0,0
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.00353,-0.13306,-0.13997,0,0
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.015574,-0.13314,-0.12905,0,0
4,GO CGMP MEDIATED SIGNALING,0.0060989,-0.13323,-0.17972,0,0
4,GO REGULATION OF CELL SHAPE,0.12473,-0.13336,-0.079844,0,0
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.11636,-0.13351,-0.091129,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.27227,-0.13364,-0.070488,0,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.019283,-0.13365,-0.12123,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.084046,-0.13391,-0.15657,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.28785,-0.13402,-0.10112,0,0
4,GO PROTEIN HOMOOLIGOMERIZATION,6.2786e-05,-0.13447,-0.13587,0,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.14526,-0.13457,-0.14075,0,0
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00031859,-0.1347,-0.13075,0,0
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.033166,-0.13483,-0.12214,0,0
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.030383,-0.13488,-0.16608,0,0
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.41341,-0.13515,-0.076764,0,0
4,GO FEVER GENERATION,0.033166,-0.13534,-0.16127,0,0
4,GO ION TRANSMEMBRANE TRANSPORT,0.00012964,-0.13535,-0.13486,0,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.188,-0.13537,-0.078732,0,0
4,GO PERICARDIUM DEVELOPMENT,0.21579,-0.13538,-0.10659,0,0
4,GO CHONDROCYTE PROLIFERATION,0.31653,-0.13542,-0.12208,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0020453,-0.13576,-0.1303,0,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.036164,-0.13612,-0.14585,0,0
4,GO BASIC AMINO ACID TRANSPORT,0.02166,-0.13643,-0.20574,0,0
4,GO SKELETAL MUSCLE CONTRACTION,0.029719,-0.13661,-0.15576,0,0
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.080955,-0.13671,-0.10574,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0075304,-0.13672,-0.11954,0,0
4,GO INTRACELLULAR STEROL TRANSPORT,0.05824,-0.13697,-0.13932,0,0
4,GO PIGMENT ACCUMULATION,0.11434,-0.13698,-0.11329,0,0
4,GO GLIAL CELL MIGRATION,0.011904,-0.13707,-0.16984,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.62113,-0.13743,-0.029263,0,0
4,GO RESPONSE TO AMYLOID BETA,0.0046564,-0.13761,-0.15875,0,0
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.034637,-0.13782,-0.1239,0,0
4,GO MONOAMINE TRANSPORT,0.11235,-0.13782,-0.060071,0,0
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.10845,-0.13792,-0.15622,0,0
4,GO EXTRACELLULAR TRANSPORT,0.39858,-0.13805,-0.051275,0,0
4,GO CATION TRANSMEMBRANE TRANSPORT,0.00049035,-0.13843,-0.1307,0,0
4,GO PROTEIN NITROSYLATION,0.061812,-0.13857,-0.13439,0,0
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0695,-0.13884,-0.14506,0,0
4,GO MYELIN MAINTENANCE,0.017969,-0.13893,-0.24172,0,0
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0062634,-0.13901,-0.11021,0,0
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.20621,-0.13902,-0.10189,0,0
4,GO REGULATION OF RECEPTOR RECYCLING,0.057089,-0.13907,-0.11051,0,0
4,GO MYOFIBRIL ASSEMBLY,0.029719,-0.13923,-0.11394,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00067758,-0.13927,-0.14193,0,0
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,7.2754e-05,-0.13929,-0.16346,0,0
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0015653,-0.13945,-0.13106,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0071468,-0.13953,-0.27657,0,0
4,GO LUNG ALVEOLUS DEVELOPMENT,0.024288,-0.13993,-0.13732,0,0
4,GO SMOOTH MUSCLE CONTRACTION,0.00021167,-0.14006,-0.17302,0,0
4,GO STRIATED MUSCLE ADAPTATION,0.0099891,-0.14023,-0.16394,0,0
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.01282,-0.14052,-0.13091,0,0
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0062634,-0.14055,-0.12943,0,0
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,9.0179e-06,-0.14092,-0.16608,0,0
4,GO MODIFIED AMINO ACID TRANSPORT,0.0021062,-0.14099,-0.19109,0,0
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.19393,-0.14116,-0.074262,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.057089,-0.14116,-0.092066,0,0
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.088862,-0.14153,-0.1809,0,0
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.095625,-0.14153,-0.13781,0,0
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0059384,-0.14186,-0.16399,0,0
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.19095,-0.14225,-0.066403,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.097379,-0.14291,-0.096795,0,0
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.093897,-0.14304,-0.19017,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.055956,-0.14326,-0.14884,0,0
4,GO RECEPTOR INTERNALIZATION,0.0022992,-0.14335,-0.12814,0,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.13583,-0.14384,-0.14137,0,0
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00026903,-0.144,-0.13354,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0099891,-0.14432,-0.1519,0,0
4,GO BROWN FAT CELL DIFFERENTIATION,0.019739,-0.14433,-0.1464,0,0
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.2839,-0.14435,-0.080217,0,0
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00031859,-0.14471,-0.18238,0,0
4,GO REFLEX,0.34702,-0.14475,-0.10379,0,0
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.11039,-0.1448,-0.10139,0,0
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.11235,-0.14507,-0.099738,0,0
4,GO CARDIAC CHAMBER DEVELOPMENT,0.0030654,-0.14522,-0.14738,0,0
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00090094,-0.14544,-0.17842,0,0
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0066042,-0.14559,-0.16465,0,0
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.16559,-0.14566,-0.13909,0,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.12049,-0.14572,-0.11401,0,0
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.15517,-0.14574,-0.16445,0,0
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0037331,-0.14574,-0.16727,0,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.00012074,-0.14577,-0.13825,0,0
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.12259,-0.14578,-0.1058,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.043763,-0.14589,-0.12438,0,0
4,GO ENDOCYTOSIS,8.1192e-05,-0.14593,-0.14984,0,0
4,GO MRNA TRANSCRIPTION,0.24288,-0.14615,-0.082124,0,0
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.080955,-0.14636,-0.14775,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0087944,-0.14648,-0.17804,0,0
4,GO SODIUM ION TRANSPORT,0.0022992,-0.14658,-0.13326,0,0
4,GO GASTRIC ACID SECRETION,0.088862,-0.14666,-0.1313,0,0
4,GO REGULATION OF CALCIUM ION IMPORT,0.0022332,-0.14678,-0.16829,0,0
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.22568,-0.14707,-0.064793,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.14526,-0.14709,-0.14023,0,0
4,GO ANOIKIS,0.16828,-0.14717,-0.11391,0,0
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.25001,-0.1473,-0.065182,0,0
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0050528,-0.14735,-0.18909,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.085627,-0.1478,-0.076909,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0087944,-0.14788,-0.21214,0,0
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.29992,-0.14796,-0.10059,0,0
4,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.17653,-0.1481,-0.16432,0,0
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.057089,-0.14892,-0.10927,0,0
4,GO P38MAPK CASCADE,0.0031536,-0.14899,-0.18287,0,0
4,GO NEURONAL ION CHANNEL CLUSTERING,0.16828,-0.14916,-0.17234,0,0
4,GO REGULATION OF NEURON MATURATION,0.12049,-0.14937,-0.1163,0,0
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.013798,-0.14963,-0.1343,0,0
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00012964,-0.14974,-0.19826,0,0
4,GO RESPONSE TO HISTAMINE,0.087232,-0.14979,-0.22844,0,0
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.14526,-0.14982,-0.09647,0,0
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.15015,-0.15,-0.14842,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.19095,-0.15003,-0.11109,0,0
4,GO CORNIFICATION,0.30402,-0.15005,-0.075628,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.69707,-0.1501,0.11199,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.061812,-0.15012,-0.16274,0,0
4,GO MEMBRANE DEPOLARIZATION,0.036164,-0.15031,-0.1404,0,0
4,GO REGULATION OF METAL ION TRANSPORT,3.3132e-05,-0.15038,-0.16153,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.1028,-0.15052,-0.13057,0,0
4,GO ODONTOGENESIS,0.0090226,-0.15057,-0.15748,0,0
4,GO PROTEIN COMPLEX OLIGOMERIZATION,7.0571e-06,-0.15087,-0.15874,0,0
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00021167,-0.1509,-0.18579,0,0
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.084046,-0.15097,-0.15793,0,0
4,GO RESPONSE TO ISCHEMIA,0.0042883,-0.15118,-0.15344,0,0
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0041716,-0.15166,-0.15961,0,0
4,GO MUSCLE SYSTEM PROCESS,2.2658e-06,-0.1517,-0.18457,0,0
4,GO PROTEIN LOCALIZATION TO MEMBRANE,9.0551e-05,-0.15174,-0.12045,0,0
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.05824,-0.15252,-0.11818,0,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.034637,-0.15268,-0.12837,0,0
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0010859,-0.15294,-0.16505,0,0
4,GO GROOMING BEHAVIOR,0.67776,-0.15313,-0.0027316,0,0
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,3.7145e-05,-0.15319,-0.18222,0,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.057089,-0.15321,-0.14851,0,0
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,1.5201e-05,-0.15352,-0.13207,0,0
4,GO SERTOLI CELL DEVELOPMENT,0.097379,-0.15444,-0.15004,0,0
4,GO CARDIOLIPIN METABOLIC PROCESS,0.00055855,-0.1545,-0.21463,0,0
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.00021167,-0.15463,-0.1558,0,0
4,GO ENERGY RESERVE METABOLIC PROCESS,7.2754e-05,-0.15467,-0.18359,0,0
4,GO GLIAL CELL DEVELOPMENT,0.0079323,-0.15506,-0.13082,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0071468,-0.15514,-0.22014,0,0
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00014418,-0.15525,-0.16149,0,0
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.24288,-0.15583,-0.06153,0,0
4,GO SUCKLING BEHAVIOR,0.1313,-0.15587,-0.11699,0,0
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.188,-0.15596,-0.11584,0,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.16294,-0.15601,-0.098362,0,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.087232,-0.15603,-0.15919,0,0
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.001986,-0.15614,-0.14183,0,0
4,GO RESPONSE TO VITAMIN A,0.20621,-0.15662,-0.093142,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.014138,-0.15677,-0.25171,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.0031536,-0.15677,-0.12956,0,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.061812,-0.15697,-0.18897,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.097379,-0.15699,-0.074811,0,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.00090094,-0.15757,-0.14753,0,0
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.25001,-0.15761,-0.069339,0,0
4,GO CORPUS CALLOSUM DEVELOPMENT,0.05824,-0.15771,-0.16266,0,0
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.0018173,-0.15774,-0.14981,0,0
4,GO REGULATION OF MAST CELL ACTIVATION,0.053746,-0.15789,-0.11617,0,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.12473,-0.15835,-0.13892,0,0
4,GO CELLULAR RESPONSE TO CAMP,0.0051916,-0.15844,-0.14537,0,0
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00031859,-0.15851,-0.20294,0,0
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.11636,-0.15858,-0.11921,0,0
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.057089,-0.15865,-0.13759,0,0
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.054842,-0.15868,-0.11595,0,0
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0046564,-0.15877,-0.15368,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.17934,-0.15879,-0.13498,0,0
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.075049,-0.15882,-0.2305,0,0
4,GO LEYDIG CELL DIFFERENTIATION,0.36526,-0.15884,-0.10028,0,0
4,GO PARAXIAL MESODERM DEVELOPMENT,0.14526,-0.15916,-0.13479,0,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.10096,-0.15972,-0.12887,0,0
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.23937,-0.15983,-0.061509,0,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.011326,-0.15989,-0.1574,0,0
4,GO ELECTRON TRANSPORT CHAIN,0.00037661,-0.15992,-0.18085,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.054842,-0.15995,-0.18806,0,0
4,GO NEPHRIC DUCT MORPHOGENESIS,0.027803,-0.16001,-0.26508,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.057089,-0.16018,-0.14556,0,0
4,GO MUSCLE CONTRACTION,3.0576e-06,-0.16041,-0.19067,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.009256,-0.16044,-0.1609,0,0
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.061812,-0.16063,-0.15463,0,0
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00054072,-0.16072,-0.14319,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.00065623,-0.16083,-0.13755,0,0
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.012508,-0.16124,-0.15348,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.064293,-0.16128,-0.27013,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.0094949,-0.16129,-0.1666,0,0
4,GO LAMELLIPODIUM ORGANIZATION,0.00021167,-0.16142,-0.18399,0,0
4,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.0085714,-0.16279,-0.18617,0,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.041093,-0.163,-0.17039,0,0
4,GO NEURAL CREST CELL MIGRATION,0.019739,-0.16334,-0.17379,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.061812,-0.16335,-0.14905,0,0
4,GO RESPONSE TO LEPTIN,0.00353,-0.16337,-0.19,0,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.084046,-0.16351,-0.14084,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.10654,-0.16365,-0.14843,0,0
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,1.9263e-05,-0.16366,-0.17285,0,0
4,GO POSITIVE REGULATION OF MYELINATION,0.007729,-0.16375,-0.15663,0,0
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0087944,-0.16389,-0.14694,0,0
4,GO CELLULAR RESPONSE TO IRON ION,0.063042,-0.164,-0.15265,0,0
4,GO REGULATION OF TUBULIN DEACETYLATION,0.31653,-0.16405,-0.072563,0,0
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.035393,-0.16409,-0.21884,0,0
4,GO GAP JUNCTION ASSEMBLY,0.11636,-0.16414,-0.17062,0,0
4,GO SCHWANN CELL DIFFERENTIATION,0.0028957,-0.16415,-0.14609,0,0
4,GO RESPONSE TO ATP,7.2754e-05,-0.16433,-0.17889,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.073629,-0.16439,-0.13305,0,0
4,GO PROTEIN KINASE C SIGNALING,0.024846,-0.16477,-0.14566,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.080955,-0.1648,-0.17314,0,0
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00028792,-0.16496,-0.1893,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.4545,-0.16517,-0.063446,0,0
4,GO RENAL FILTRATION,0.71006,-0.16535,-0.048233,0,0
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.030383,-0.1657,-0.15182,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,2.4692e-06,-0.16594,-0.16651,0,0
4,GO TRANSEPITHELIAL TRANSPORT,0.00012512,-0.16604,-0.19725,0,0
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.10465,-0.16671,-0.19583,0,0
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.17653,-0.16679,-0.12127,0,0
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.57857,-0.16681,-0.05737,0,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.14048,-0.1669,-0.19237,0,0
4,GO COENZYME A METABOLIC PROCESS,0.0099891,-0.1669,-0.16195,0,0
4,GO MUSCLE CELL DEVELOPMENT,0.00040247,-0.16705,-0.16268,0,0
4,GO LIVER MORPHOGENESIS,0.066855,-0.16724,-0.18807,0,0
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.15015,-0.1674,-0.070185,0,0
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.13583,-0.1674,-0.1157,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.00072223,-0.16777,-0.20467,0,0
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.25001,-0.16798,-0.062477,0,0
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00098941,-0.16804,-0.16042,0,0
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.023741,-0.16813,-0.1247,0,0
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.00353,-0.16817,-0.15744,0,0
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.010773,-0.16821,-0.12087,0,0
4,GO MEMBRANE BIOGENESIS,0.068167,-0.1683,-0.13781,0,0
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.17374,-0.16867,-0.20497,0,0
4,GO FLUID TRANSPORT,0.0064317,-0.16877,-0.15423,0,0
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.03939,-0.16881,-0.14466,0,0
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.014486,-0.16897,-0.16633,0,0
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00057693,-0.16973,-0.18231,0,0
4,GO ORGANIC CATION TRANSPORT,0.0034322,-0.17017,-0.17194,0,0
4,GO REGULATION OF VASCULAR PERMEABILITY,0.0050528,-0.17028,-0.17005,0,0
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0062634,-0.17035,-0.19466,0,0
4,GO BLASTODERM SEGMENTATION,0.070855,-0.1704,-0.20519,0,0
4,GO MITOCHONDRIAL TRNA PROCESSING,0.04854,-0.17049,-0.16343,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.014138,-0.17051,-0.14424,0,0
4,GO LAMELLIPODIUM ASSEMBLY,0.00084609,-0.17067,-0.1625,0,0
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0051916,-0.1711,-0.16255,0,0
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.073629,-0.17187,-0.11394,0,0
4,GO ACYLGLYCEROL HOMEOSTASIS,0.00038934,-0.17203,-0.20155,0,0
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.42855,-0.17208,-0.059022,0,0
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.075049,-0.17238,-0.23529,0,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.090515,-0.17256,-0.21636,0,0
4,GO PEPTIDYL METHIONINE MODIFICATION,0.0060989,-0.17263,-0.17966,0,0
4,GO CARNITINE METABOLIC PROCESS,0.16294,-0.17269,-0.10024,0,0
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.00012964,-0.1728,-0.22268,0,0
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0050528,-0.17334,-0.15043,0,0
4,GO RESPONSE TO ORGANOPHOSPHORUS,3.0576e-06,-0.1736,-0.20718,0,0
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.036164,-0.17385,-0.13286,0,0
4,GO REGULATION OF BLOOD CIRCULATION,0.0011199,-0.17385,-0.15605,0,0
4,GO HEART PROCESS,0.00069957,-0.17393,-0.16866,0,0
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.12049,-0.17402,-0.18398,0,0
4,GO CARNITINE SHUTTLE,0.060602,-0.17421,-0.14451,0,0
4,GO ASYMMETRIC CELL DIVISION,0.022165,-0.17431,-0.18016,0,0
4,GO RESPONSE TO INTERLEUKIN 4,0.00018427,-0.17432,-0.18859,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.061812,-0.17435,-0.1939,0,0
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,1.2308e-06,-0.17455,-0.18107,0,0
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.013139,-0.17464,-0.14705,0,0
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0087944,-0.17465,-0.13129,0,0
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.27999,-0.17475,-0.093434,0,0
4,GO NEGATIVE REGULATION OF CELL AGING,0.17653,-0.17514,-0.12863,0,0
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.02268,-0.17551,-0.14519,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,4.4712e-06,-0.17581,-0.19239,0,0
4,GO REGULATION OF SYNAPSE MATURATION,0.25729,-0.17595,-0.14444,0,0
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.00019079,-0.17614,-0.18356,0,0
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0018173,-0.17628,-0.17708,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.013465,-0.17636,-0.15555,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.019283,-0.17654,-0.18221,0,0
4,GO RESPONSE TO CAMP,1.4039e-05,-0.17661,-0.21445,0,0
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0010528,-0.17698,-0.14841,0,0
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0024367,-0.17711,-0.15893,0,0
4,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.061812,-0.17715,-0.1811,0,0
4,GO GONADOTROPIN SECRETION,0.27611,-0.17719,-0.065254,0,0
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0047853,-0.17741,-0.19881,0,0
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.2839,-0.17778,-0.11192,0,0
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.095625,-0.17779,-0.16398,0,0
4,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.17099,-0.17783,-0.1119,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.036164,-0.17819,-0.14437,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.1028,-0.17826,-0.17825,0,0
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.05824,-0.17833,-0.25075,0,0
4,GO POSITIVE REGULATION OF OSSIFICATION,0.0017641,-0.17868,-0.20377,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.046579,-0.17868,-0.20323,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.044685,-0.17919,-0.13821,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.066855,-0.17934,-0.10861,0,0
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.11039,-0.17969,-0.19123,0,0
4,GO LONG TERM MEMORY,0.027188,-0.17978,-0.14807,0,0
4,GO UV PROTECTION,0.055956,-0.17983,-0.16882,0,0
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.010506,-0.17996,-0.22484,0,0
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,1.5201e-05,-0.18039,-0.17701,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.099158,-0.18082,-0.16576,0,0
4,GO MEMBRANE REPOLARIZATION,0.0013054,-0.1812,-0.20054,0,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.070855,-0.18139,-0.13272,0,0
4,GO REGULATION OF GONAD DEVELOPMENT,0.10845,-0.18142,-0.12384,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.12259,-0.18152,-0.11842,0,0
4,GO REGULATION OF ENDOCYTOSIS,6.7596e-05,-0.18163,-0.16502,0,0
4,GO ACETYL COA METABOLIC PROCESS,0.0041716,-0.18172,-0.16824,0,0
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,8.1192e-05,-0.18183,-0.20574,0,0
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0027346,-0.18189,-0.20247,0,0
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,7.5427e-07,-0.18207,-0.19009,0,0
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0010206,-0.18237,-0.20086,0,0
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.011612,-0.18247,-0.21028,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.10096,-0.18258,-0.085823,0,0
4,GO ALPHA AMINO ACID METABOLIC PROCESS,2.2524e-05,-0.1828,-0.20296,0,0
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.090515,-0.1829,-0.13326,0,0
4,GO ANATOMICAL STRUCTURE REGRESSION,0.0066042,-0.183,-0.24603,0,0
4,GO AMINE CATABOLIC PROCESS,0.02166,-0.18309,-0.20189,0,0
4,GO MUSCLE ATROPHY,0.090515,-0.18309,-0.14887,0,0
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.077957,-0.18325,-0.19032,0,0
4,GO REGULATION OF MUSCLE CONTRACTION,3.3132e-05,-0.18335,-0.19125,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0071468,-0.18346,-0.1853,0,0
4,GO MECHANOSENSORY BEHAVIOR,0.48678,-0.18483,-0.039532,0,0
4,GO CATECHOLAMINE SECRETION,0.11636,-0.18517,-0.057362,0,0
4,GO STEROID CATABOLIC PROCESS,0.0020453,-0.18518,-0.19511,0,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.0695,-0.18545,-0.28627,0,0
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.024288,-0.18553,-0.1403,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.021165,-0.18603,-0.12404,0,0
4,GO MITOCHONDRIAL RNA PROCESSING,0.012508,-0.18631,-0.19826,0,0
4,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.017137,-0.18658,-0.15763,0,0
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.019739,-0.18667,-0.19329,0,0
4,GO STRIATED MUSCLE CONTRACTION,0.00018427,-0.18677,-0.19812,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.12473,-0.1868,-0.087986,0,0
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0039469,-0.18686,-0.16923,0,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.073629,-0.18704,-0.21088,0,0
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.050569,-0.18712,-0.21237,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.1028,-0.18769,-0.10584,0,0
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.076492,-0.18798,-0.20427,0,0
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.00052342,-0.18811,-0.16795,0,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00030804,-0.18833,-0.17723,0,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.0073363,-0.18833,-0.20509,0,0
4,GO COMPLEMENT ACTIVATION,0.0001165,-0.18856,-0.23476,0,0
4,GO RESPONSE TO LIGHT INTENSITY,0.017969,-0.18866,-0.1916,0,0
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.009256,-0.18905,-0.22186,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.21256,-0.18926,-0.14711,0,0
4,GO MYELIN ASSEMBLY,0.0039469,-0.18995,-0.20528,0,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0099891,-0.19012,-0.19471,0,0
4,GO BONE MINERALIZATION,1.8521e-05,-0.19099,-0.23828,0,0
4,GO POSITIVE REGULATION OF JNK CASCADE,5.8301e-05,-0.19214,-0.16853,0,0
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0071468,-0.19255,-0.15168,0,0
4,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.14526,-0.19347,-0.15993,0,0
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,6.0504e-05,-0.1936,-0.23712,0,0
4,GO GLYCINE METABOLIC PROCESS,0.0064317,-0.19366,-0.26834,0,0
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00013433,-0.19433,-0.18925,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.00014935,-0.19478,-0.27058,0,0
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,4.0073e-05,-0.19488,-0.17793,0,0
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.14285,-0.19489,-0.21161,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.011904,-0.19547,-0.20365,0,0
4,GO ANIMAL ORGAN MATURATION,0.017549,-0.19548,-0.15642,0,0
4,GO INTEGRIN ACTIVATION,0.0045306,-0.19582,-0.19975,0,0
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.009256,-0.19588,-0.24253,0,0
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.076492,-0.19604,-0.14652,0,0
4,GO ACTIN FILAMENT BASED MOVEMENT,0.00030804,-0.19622,-0.19407,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.068167,-0.19761,-0.17384,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.05161,-0.19764,-0.2078,0,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.00353,-0.19799,-0.27811,0,0
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.11841,-0.19807,-0.12704,0,0
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,7.547e-05,-0.19824,-0.21445,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.001191,-0.19847,-0.24848,0,0
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.15015,-0.19899,-0.12642,0,0
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.077957,-0.19958,-0.18452,0,0
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.035393,-0.2009,-0.17121,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.027188,-0.20103,-0.13602,0,0
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0062634,-0.20107,-0.18304,0,0
4,GO REGULATION OF CHLORIDE TRANSPORT,0.016734,-0.20124,-0.20412,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0017641,-0.20126,-0.21646,0,0
4,GO REGULATION OF MACROPHAGE ACTIVATION,9.389e-05,-0.20152,-0.22083,0,0
4,GO RESPONSE TO INTERFERON ALPHA,0.15773,-0.20153,-0.32133,0,0
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,1.5331e-06,-0.20246,-0.207,0,0
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,4.4878e-05,-0.20268,-0.20894,0,0
4,GO ONE CARBON METABOLIC PROCESS,0.00095906,-0.20349,-0.18918,0,0
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,8.628e-07,-0.20394,-0.19718,0,0
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.34256,-0.2041,-0.057643,0,0
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,4.4712e-06,-0.20495,-0.20263,0,0
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.13355,-0.20551,-0.13307,0,0
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.038561,-0.20599,-0.17782,0,0
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00047456,-0.20601,-0.19373,0,0
4,GO ANION HOMEOSTASIS,0.0019282,-0.20651,-0.18963,0,0
4,GO MACROPHAGE ACTIVATION,5.2139e-05,-0.20734,-0.21414,0,0
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,4.4712e-06,-0.20752,-0.21377,0,0
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.00025131,-0.20793,-0.27139,0,0
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.10096,-0.20808,-0.25601,0,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00010845,-0.20827,-0.2146,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.26847,-0.20842,-0.083746,0,0
4,GO CATECHOLAMINE UPTAKE,0.007729,-0.2086,-0.23043,0,0
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,1.7806e-05,-0.20871,-0.20443,0,0
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00074557,-0.20891,-0.16054,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.030383,-0.20906,-0.20365,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.019739,-0.20912,-0.19976,0,0
4,GO CARBOHYDRATE CATABOLIC PROCESS,7.889e-07,-0.20989,-0.22059,0,0
4,GO DOPAMINE BIOSYNTHETIC PROCESS,0.74288,-0.21006,-0.047971,0,0
4,GO LOCOMOTOR RHYTHM,0.033166,-0.21034,-0.1634,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.10096,-0.2108,-0.13362,0,0
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.020205,-0.21085,-0.21411,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.012203,-0.21151,-0.19451,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.041093,-0.2117,-0.18999,0,0
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,1.6015e-06,-0.21174,-0.21911,0,0
4,GO ETHER BIOSYNTHETIC PROCESS,0.0025083,-0.21181,-0.3392,0,0
4,GO RRNA CATABOLIC PROCESS,0.2,-0.21188,-0.074197,0,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.009256,-0.21208,-0.19703,0,0
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.025994,-0.2121,-0.17474,0,0
4,GO ACTION POTENTIAL,0.0046564,-0.21252,-0.16074,0,0
4,GO CARDIAC CELL DEVELOPMENT,0.00014935,-0.21289,-0.19924,0,0
4,GO PLASMA MEMBRANE REPAIR,0.10845,-0.21295,-0.13336,0,0
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00038934,-0.2131,-0.255,0,0
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.0007696,-0.21328,-0.22348,0,0
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,1.8521e-05,-0.2134,-0.20058,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00057693,-0.21458,-0.18328,0,0
4,GO REGULATION OF BONE MINERALIZATION,1.7806e-05,-0.2146,-0.25484,0,0
4,GO RESPONSE TO MUSCLE ACTIVITY,0.0031536,-0.21574,-0.23526,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.066855,-0.21672,-0.22482,0,0
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,4.2876e-06,-0.21684,-0.2221,0,0
4,GO STEROID HORMONE SECRETION,0.0020453,-0.21721,-0.24344,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00012512,-0.2175,-0.21062,0,0
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0025083,-0.21752,-0.21576,0,0
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.033166,-0.2179,-0.24371,0,0
4,GO OPTIC NERVE DEVELOPMENT,0.11841,-0.21865,-0.15473,0,0
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.0073363,-0.21947,-0.17403,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGY,1.2962e-05,-0.21967,-0.21758,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.01282,-0.22038,-0.23383,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.012508,-0.22154,-0.27075,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,0.044685,-0.22179,-0.13108,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.016339,-0.22228,-0.16336,0,0
4,GO CELLULAR OXIDANT DETOXIFICATION,0.00052342,-0.22248,-0.18834,0,0
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,8.7323e-05,-0.22322,-0.23469,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0011199,-0.22332,-0.24614,0,0
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.065563,-0.22344,-0.17364,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.022165,-0.22353,-0.15495,0,0
4,GO NEGATIVE REGULATION OF ANOIKIS,0.073629,-0.22364,-0.23015,0,0
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0030654,-0.2241,-0.20109,0,0
4,GO PLASMA MEMBRANE ORGANIZATION,9.0551e-05,-0.22442,-0.2153,0,0
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0033369,-0.22515,-0.21589,0,0
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00049035,-0.22581,-0.25322,0,0
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.035393,-0.22636,-0.25566,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0001547,-0.22656,-0.20887,0,0
4,GO INACTIVATION OF MAPK ACTIVITY,0.027803,-0.22677,-0.19352,0,0
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.0021062,-0.22723,-0.2157,0,0
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.15015,-0.22869,-0.17377,0,0
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.014486,-0.2288,-0.27956,0,0
4,GO PENTOSE METABOLIC PROCESS,0.00035231,-0.22937,-0.29398,0,0
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0037331,-0.2301,-0.18209,0,0
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.00031859,-0.2307,-0.2588,0,0
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.05824,-0.23176,-0.21774,0,0
4,GO VITAMIN TRANSPORT,2.6307e-05,-0.23184,-0.26,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,4.1112e-06,-0.2324,-0.22497,0,0
4,GO CARDIAC MUSCLE CONTRACTION,0.00014418,-0.23313,-0.20971,0,0
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,5.8301e-05,-0.23317,-0.19564,0,0
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.03939,-0.23345,-0.25139,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0011549,-0.23477,-0.27116,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00090094,-0.23479,-0.35777,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.00041602,-0.2361,-0.2442,0,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.18219,-0.23633,-0.16669,0,0
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.0014299,-0.23653,-0.20507,0,0
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.00067758,-0.23712,-0.2753,0,0
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,4.3218e-05,-0.23796,-0.23313,0,0
4,GO KETONE BODY METABOLIC PROCESS,0.0075304,-0.23876,-0.24073,0,0
4,GO RESPONSE TO PAIN,0.0016129,-0.23918,-0.28864,0,0
4,GO ETHANOL METABOLIC PROCESS,0.0097392,-0.23964,-0.22304,0,0
4,GO BICARBONATE TRANSPORT,0.0007696,-0.24062,-0.19637,0,0
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,9.0179e-06,-0.24089,-0.23357,0,0
4,GO PHAGOCYTOSIS RECOGNITION,0.0060989,-0.24115,-0.27306,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0014738,-0.24205,-0.22447,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.00047456,-0.24249,-0.22616,0,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,3.5759e-05,-0.24258,-0.2452,0,0
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.080955,-0.24293,-0.2407,0,0
4,GO STARTLE RESPONSE,0.17934,-0.24296,-0.13404,0,0
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.070855,-0.24331,-0.17545,0,0
4,GO ZINC ION TRANSPORT,0.00010845,-0.24342,-0.2185,0,0
4,GO PROTEIN LOCALIZATION TO AXON,0.19393,-0.24371,-0.13094,0,0
4,GO RESPONSE TO AMINE,0.00032948,-0.24382,-0.25582,0,0
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.042857,-0.24505,-0.18255,0,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.057089,-0.24525,-0.12053,0,0
4,GO REGULATION OF DOPAMINE SECRETION,0.070855,-0.24528,-0.14983,0,0
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.053746,-0.24542,-0.22085,0,0
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.14769,-0.24581,-0.10664,0,0
4,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.016734,-0.24582,-0.21946,0,0
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.0013054,-0.24592,-0.31014,0,0
4,GO SEQUESTERING OF TRIGLYCERIDE,0.0017123,-0.24658,-0.33202,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.011904,-0.24666,-0.21355,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00084609,-0.24687,-0.23313,0,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.0051916,-0.24698,-0.22374,0,0
4,GO DRINKING BEHAVIOR,0.073629,-0.24704,-0.18529,0,0
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0045306,-0.24712,-0.27382,0,0
4,GO NADPH REGENERATION,0.0071468,-0.2472,-0.21846,0,0
4,GO THIOESTER METABOLIC PROCESS,1.2454e-05,-0.24734,-0.23321,0,0
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,8.6584e-06,-0.24793,-0.24568,0,0
4,GO AMINOGLYCAN METABOLIC PROCESS,2.7343e-05,-0.24794,-0.23842,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.00021167,-0.2486,-0.27659,0,0
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,2.8418e-05,-0.24924,-0.26154,0,0
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.00010845,-0.24995,-0.31643,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00054072,-0.2501,-0.21967,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.030383,-0.25024,-0.18156,0,0
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0030654,-0.25076,-0.34484,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,7.2754e-05,-0.25103,-0.32167,0,0
4,GO MICROVILLUS ASSEMBLY,0.013139,-0.25202,-0.23947,0,0
4,GO DOPAMINE TRANSPORT,0.035393,-0.25205,-0.14962,0,0
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.021165,-0.25294,-0.28185,0,0
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.080955,-0.25378,-0.1982,0,0
4,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.00072223,-0.25482,-0.24765,0,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.05824,-0.25497,-0.16151,0,0
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,1.7806e-05,-0.25571,-0.23777,0,0
4,GO GLUTATHIONE METABOLIC PROCESS,2.6307e-05,-0.25581,-0.33715,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.00040247,-0.25583,-0.28083,0,0
4,GO BLASTOCYST FORMATION,9.3916e-06,-0.25592,-0.23242,0,0
4,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.00010462,-0.25636,-0.32357,0,0
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00010462,-0.25669,-0.26182,0,0
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.00029782,-0.25682,-0.23832,0,0
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,5.0226e-05,-0.25818,-0.2815,0,0
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.11434,-0.25916,-0.21851,0,0
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00037661,-0.26024,-0.24441,0,0
4,GO INNERVATION,0.16294,-0.26044,-0.10412,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0001547,-0.26107,-0.27503,0,0
4,GO HEART TRABECULA FORMATION,0.0073363,-0.26176,-0.27491,0,0
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.00049035,-0.26197,-0.36174,0,0
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00013917,-0.26224,-0.26785,0,0
4,GO L SERINE METABOLIC PROCESS,0.11235,-0.26226,-0.16298,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0039469,-0.26331,-0.24725,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,5.2139e-05,-0.26354,-0.25074,0,0
4,GO REGULATION OF HEART RATE,0.00028792,-0.26492,-0.2295,0,0
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0079323,-0.26555,-0.25401,0,0
4,GO ALDITOL METABOLIC PROCESS,8.6584e-06,-0.26579,-0.3025,0,0
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.093897,-0.26584,-0.1573,0,0
4,GO MALE GENITALIA DEVELOPMENT,0.0013054,-0.26624,-0.22998,0,0
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.00069957,-0.26706,-0.23308,0,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,4.8379e-05,-0.26763,-0.26386,0,0
4,GO NEUROBLAST DIVISION,0.00034072,-0.26822,-0.32758,0,0
4,GO NEUROTRANSMITTER UPTAKE,0.0041716,-0.2689,-0.21061,0,0
4,GO PROTEIN REFOLDING,0.0032441,-0.26957,-0.21199,0,0
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.16032,-0.27007,-0.19974,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.0001165,-0.27011,-0.27312,0,0
4,GO CAMP METABOLIC PROCESS,0.00047456,-0.27081,-0.25106,0,0
4,GO AMYLOID BETA FORMATION,0.00010092,-0.27123,-0.27471,0,0
4,GO TRABECULA FORMATION,0.00074557,-0.27337,-0.30562,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0014299,-0.2753,-0.25998,0,0
4,GO GENITALIA MORPHOGENESIS,0.016734,-0.27548,-0.23612,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.055956,-0.27572,-0.24136,0,0
4,GO ETHANOL OXIDATION,0.0079323,-0.27573,-0.35822,0,0
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.090515,-0.27628,-0.18771,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0025083,-0.27679,-0.22354,0,0
4,GO RESPONSE TO ZINC ION,0.00021167,-0.27683,-0.29983,0,0
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0022992,-0.28012,-0.25808,0,0
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.037747,-0.28071,-0.20118,0,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.00028792,-0.28173,-0.23973,0,0
4,GO MONOSACCHARIDE CATABOLIC PROCESS,2.4692e-06,-0.28174,-0.29817,0,0
4,GO GLUCOCORTICOID METABOLIC PROCESS,6.2786e-05,-0.28229,-0.2945,0,0
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,5.0226e-05,-0.28282,-0.29577,0,0
4,GO HEXOSE CATABOLIC PROCESS,6.2367e-06,-0.28341,-0.3186,0,0
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.00028792,-0.28369,-0.28529,0,0
4,GO ACTIN MEDIATED CELL CONTRACTION,2.7343e-05,-0.28467,-0.26063,0,0
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.00018427,-0.28741,-0.26413,0,0
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.077957,-0.2879,-0.1787,0,0
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.077957,-0.28887,-0.16022,0,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.033894,-0.28906,-0.17188,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.00027832,-0.28955,-0.28143,0,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.055956,-0.29034,-0.28053,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0067808,-0.29203,-0.27897,0,0
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.00013917,-0.29274,-0.31464,0,0
4,GO SKIN MORPHOGENESIS,0.0057817,-0.29356,-0.35627,0,0
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0066042,-0.29359,-0.24478,0,0
4,GO INCLUSION BODY ASSEMBLY,0.0041716,-0.29453,-0.23381,0,0
4,GO REGULATION OF CELLULAR RESPIRATION,4.3218e-05,-0.29562,-0.30423,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.0036303,-0.29607,-0.23624,0,0
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.009256,-0.297,-0.30924,0,0
4,GO GLYCOSIDE METABOLIC PROCESS,0.087232,-0.29812,-0.23237,0,0
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00054072,-0.30267,-0.24934,0,0
4,GO NEPHRIC DUCT DEVELOPMENT,0.00084609,-0.30532,-0.31326,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.007729,-0.30821,-0.27176,0,0
4,GO PULMONARY VALVE MORPHOGENESIS,0.00067758,-0.31039,-0.44269,0,0
4,GO RESPONSE TO MUSCLE STRETCH,0.00081984,-0.31149,-0.33452,0,0
4,GO RELAXATION OF MUSCLE,0.00031859,-0.31476,-0.28623,0,0
4,GO GLUCOSE CATABOLIC PROCESS,5.6174e-05,-0.31527,-0.33067,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.0013872,-0.32292,-0.29315,0,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0013054,-0.32413,-0.36711,0,0
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0064317,-0.32473,-0.28383,0,0
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.010773,-0.32569,-0.26985,0,0
4,GO RELAXATION OF CARDIAC MUSCLE,0.0028957,-0.32745,-0.30262,0,0
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.00095906,-0.32771,-0.29543,0,0
4,GO AMINO ACID ACTIVATION,0.00013433,-0.3282,-0.26917,0,0
4,GO PROTEIN HYDROXYLATION,2.9532e-05,-0.33084,-0.40189,0,0
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.001986,-0.33202,-0.33263,0,0
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00090094,-0.33355,-0.36194,0,0
4,GO REGULATION OF CELLULAR EXTRAVASATION,3.5759e-05,-0.33441,-0.33083,0,0
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.7118e-05,-0.33761,-0.31944,0,0
4,GO AMP METABOLIC PROCESS,2.3418e-05,-0.33777,-0.37756,0,0
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,3.5759e-05,-0.34328,-0.29404,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.0018173,-0.34434,-0.29226,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.043763,-0.34827,-0.22756,0,0
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0060989,-0.34911,-0.33083,0,0
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,1.906e-06,-0.3522,-0.37754,0,0
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00011241,-0.35343,-0.36006,0,0
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.025994,-0.35407,-0.52355,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.0056288,-0.35932,-0.30113,0,0
4,GO REGULATION OF AMYLOID BETA FORMATION,1.1493e-05,-0.36001,-0.34517,0,0
4,GO NUCLEOTIDE SALVAGE,3.1888e-05,-0.36107,-0.44237,0,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.0013872,-0.36153,-0.4534,0,0
4,GO FATTY ACID HOMEOSTASIS,0.00010092,-0.36386,-0.35505,0,0
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.0057817,-0.37074,-0.39713,0,0
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0025083,-0.37109,-0.34825,0,0
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,8.4205e-05,-0.37364,-0.32377,0,0
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.0007696,-0.37491,-0.30032,0,0
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0099891,-0.37865,-0.28106,0,0
4,GO MINERALOCORTICOID METABOLIC PROCESS,6.7596e-05,-0.38366,-0.43366,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00087311,-0.38397,-0.43596,0,0
4,GO ESTROGEN BIOSYNTHETIC PROCESS,3.5759e-05,-0.38406,-0.36222,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0010206,-0.38421,-0.32387,0,0
4,GO INTERLEUKIN 5 PRODUCTION,0.00037661,-0.38438,-0.34415,0,0
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.00029782,-0.38538,-0.3398,0,0
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0013054,-0.38714,-0.28673,0,0
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00059588,-0.39131,-0.32993,0,0
4,GO NADH METABOLIC PROCESS,1.6455e-05,-0.40048,-0.34689,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00072223,-0.40209,-0.35624,0,0
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,4.3218e-05,-0.41254,-0.37042,0,0
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,1.7806e-05,-0.41809,-0.49619,0,0
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,1.8521e-05,-0.41959,-0.43458,0,0
4,GO HEPARIN METABOLIC PROCESS,4.6597e-05,-0.42313,-0.43543,0,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,4.0073e-05,-0.42748,-0.43608,0,0
4,GO IMMUNE RESPONSE TO TUMOR CELL,3.1904e-06,-0.43038,-0.47998,0,0
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.0028957,-0.43593,-0.3612,0,0
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,6.5149e-05,-0.43869,-0.43865,0,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,6.2786e-05,-0.44119,-0.45443,0,0
4,GO HEART INDUCTION,0.0073363,-0.45443,-0.31378,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00020448,-0.45705,-0.4097,0,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.4692e-06,-0.45794,-0.47055,0,0
4,GO PEPTIDYL PROLINE HYDROXYLATION,7.013e-05,-0.49813,-0.47576,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,4.1617e-05,-0.51386,-0.48804,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00074557,-0.52624,-0.47048,0,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,3.6414e-07,-0.5331,-0.63212,0,0
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,2.7343e-05,-0.54096,-0.52627,0,0
